Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - olfactory bulb [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - olfactory bulb [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530739-139563459	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2470	"liver: 710.7"	"Cell type enriched"	"Detected in some"	32	"Hepatocytes: 609.1"	"Cancer enriched"	"Detected in single"	1354	"liver cancer: 67.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		8200000000										"prognostic favorable (6.69e-4)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	710.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	609.1	0.0	0.0	0.1	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903800-173917327	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1339	"liver: 5098.2"	"Cell type enriched"	"Detected in some"	49	"Hepatocytes: 2707.9"	"Cancer enriched"	"Detected in some"	871	"liver cancer: 1504.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	37	"Hep G2: 84.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	NA	NA		120000000000			"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"	"unprognostic (1.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.28e-3)"	"unprognostic (5.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.21e-2)"	0.2	0.1	0.3	0.0	0.3	0.0	0.1	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.3	0.3	0.2	3.8	5098.2	0.3	0.1	0.3	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.0	0.3	0.1	0.2	0.0	0.3	1.6	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	84.2	0.0	1.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.2	1.8	0.1	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.4	0.1	3.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	37.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.0	1.6	0.0	34.7	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.1	42.1	2707.9	0.2	0.0	0.1	0.0	0.0	55.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	4.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.3	3.7	0.0	0.0	0.2
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197038741-197067260	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	211	"liver: 201.8"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 54.9"	"Cancer enriched"	"Detected in single"	816	"liver cancer: 46.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"	NA	NA		4700000000			"HPA003827: AB_1078794, HPA052139: AB_2681744"					"unprognostic (1.46e-1)"		"prognostic favorable (6.78e-5)"							"unprognostic (1.21e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	201.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	54.9	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CFHR1	"CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2"	ENSG00000244414	"Complement factor H related 1"	Q03591	1	196819731-196832189	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	276	"liver: 2098.7"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 320.0"	"Cancer enriched"	"Detected in single"	798	"liver cancer: 182.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.0;HeLa: 1.2;HL-60: 2.0;U-266/70: 2.4"	"Not detected"	"Not detected"							"HPA038915, HPA038922, HPA040726"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		13000000000	Vesicles		"HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101"	"unprognostic (2.28e-1)"	"unprognostic (3.18e-1)"			"unprognostic (3.50e-2)"	"unprognostic (1.88e-2)"	"prognostic favorable (8.71e-6)"	"unprognostic (3.02e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.48e-2)"		"unprognostic (7.21e-4)"	"unprognostic (7.01e-4)"	"unprognostic (1.13e-1)"		"unprognostic (6.41e-2)"	1.5	0.6	0.0	1.8	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.9	7.6	2098.7	0.1	6.7	0.1	0.8	0.1	0.3	0.3	0.0	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	0.2	0.1	0.8	0.2	0.1	6.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.9	0.3	0.0	0.6	0.0	0.3	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.5	0.3	0.1	0.1	0.0	2.4	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.9	0.1	0.8	0.1	0.2	0.1	0.2	0.1	0.5	3.2	0.0	0.0	2.2	0.4	0.1	0.0	0.0	1.2	0.0	0.1	1.8	11.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	18.7	0.0	0.0	0.0	9.9	0.0	0.0	0.0	6.0	15.0	320.0	5.6	0.0	0.4	0.0	0.0	16.9	0.4	0.2	1.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	41.0	2.1	0.3	1.5	0.0	0.0	0.3	1.4	5.6	0.1	0.1
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 27875.1"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 84691.9"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 107.3;Hep G2: 296.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	45000000000	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			2.2	1.2	0.0	1.0	0.0	0.0	2.5	0.0	0.1	0.3	0.0	6.0	915.3	0.5	0.0	1.1	1.9	0.0	1.6	0.0	0.0	18.4	27875.1	1.4	0.9	0.0	0.0	0.0	0.8	2.4	0.0	0.8	0.9	0.0	0.6	0.0	0.0	0.6	0.0	0.6	1.0	1115.8	0.5	0.0	8.0	1.5	1.0	0.0	0.5	0.8	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.1	107.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	296.2	0.0	10.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	2.3	0.2	0.0	0.0	0.0	6.3	3.9	0.0	0.1	1.1	3.8	4.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	3.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	674.9	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	4.2	0.0	0.0	39.7	0.0	823.7	0.0	0.4	1.5	0.1	0.0	0.0	0.0	0.3	707.9	84691.9	1.1	0.0	0.0	264.5	0.0	1107.4	0.0	12.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.0	0.0	0.0	0.0	10473.3	121.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	39.8	0.0	135.5	0.0
ITIH1	"H1P, IATIH, ITIH"	ENSG00000055957	"Inter-alpha-trypsin inhibitor heavy chain 1"	P19827	3	52777595-52792068	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	782	"liver: 1517.2"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 1087.0"	"Cancer enriched"	"Detected in some"	598	"liver cancer: 329.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.3;Hep G2: 1.7;HL-60: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041639, HPA042049"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	4490000	59000000000	Vesicles		"HPA041639: AB_10796349, HPA042049: AB_10797379"	"unprognostic (1.87e-4)"	"unprognostic (1.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.53e-4)"	"unprognostic (4.02e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	0.7	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.2	1517.2	0.1	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	1.9	0.4	0.4	0.1	0.4	0.1	0.1	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.1	0.0	29.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.5	1087.0	0.1	0.0	0.0	0.0	0.0	20.2	0.0	1.7	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.1
APOA5	"APOA-V, RAP3"	ENSG00000110243	"Apolipoprotein A5"	Q6Q788	11	116789367-116792420	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	216	"liver: 586.9"	"Cell type enriched"	"Detected in some"	88	"Hepatocytes: 1249.5"	"Cancer enriched"	"Detected in single"	489	"liver cancer: 112.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	55	"Hep G2: 35.6"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA	114000000	21000000				"unprognostic (1.57e-4)"						"unprognostic (4.67e-3)"	"unprognostic (5.57e-2)"		"unprognostic (2.60e-3)"		"unprognostic (2.40e-1)"		"unprognostic (2.31e-4)"				0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	586.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	35.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.4	1249.5	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0
UGT1A4	"HUG-BR2, UGT1D"	ENSG00000244474	"UDP glucuronosyltransferase family 1 member A4"	P22310	2	233718736-233773300	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"liver: 394.9"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 15.1"	"Cancer enriched"	"Detected in single"	487	"liver cancer: 24.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA												"unprognostic (9.89e-3)"						"unprognostic (6.77e-5)"	"unprognostic (2.59e-1)"			"unprognostic (3.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	394.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSM2A	"A-923A4.1, ACSM2, MGC150530"	ENSG00000183747	"Acyl-CoA synthetase medium chain family member 2A"	Q08AH3	16	20451461-20487669	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	1182	"kidney: 279.8;liver: 366.3"	"Group enriched"	"Detected in some"	17	"Hepatocytes: 708.7;Proximal tubular cells: 372.5"	"Group enriched"	"Detected in some"	479	"liver cancer: 22.7;renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Hep G2: 1.9"									HPA057699	Supported					NA	NA					"HPA057699: AB_2683506"	"unprognostic (1.17e-4)"						"prognostic favorable (1.41e-5)"				"unprognostic (5.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.09e-1)"		0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	279.8	366.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	1.0	4.5	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	21.5	0.0	7.3	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.0	2.7	0.0	13.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.2	708.7	0.0	0.0	0.2	0.0	0.0	18.3	0.0	0.2	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	372.5	0.0	0.0	0.0	0.5	0.1	0.2	0.1	0.0	0.1	0.3	1.7	0.0	0.0	0.1
ACSM2B	"ACSM2, HXMA, HYST1046"	ENSG00000066813	"Acyl-CoA synthetase medium chain family member 2B"	Q68CK6	16	20536226-20576427	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	133	"kidney: 418.0;liver: 527.8"	"Group enriched"	"Detected in some"	20	"Hepatocytes: 1036.1;Proximal tubular cells: 441.9"	"Group enriched"	"Detected in some"	449	"liver cancer: 30.9;renal cancer: 17.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;Hep G2: 5.5;U-937: 1.9"									HPA057699	Supported					NA	NA					"HPA057699: AB_2683506"	"unprognostic (1.34e-2)"						"prognostic favorable (3.31e-4)"				"unprognostic (7.13e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"		0.4	0.5	0.3	0.0	0.6	0.2	0.3	2.4	1.6	0.1	0.1	0.9	0.3	0.3	0.3	0.3	0.4	0.5	0.6	0.6	3.5	418.0	527.8	0.4	0.2	0.7	0.5	0.0	0.4	0.2	0.2	0.1	0.1	0.9	0.2	0.0	0.5	0.1	0.0	1.0	0.8	0.1	0.1	0.0	0.3	0.6	0.9	0.3	0.1	1.0	0.0	0.1	0.0	0.1	0.8	0.5	0.0	2.9	0.7	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.7	0.5	0.0	1.4	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.4	0.1	0.7	5.5	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.5	0.0	0.0	0.4	0.3	0.5	0.6	0.7	0.0	0.0	0.6	0.1	0.0	0.1	0.9	0.5	1.4	0.0	0.5	0.1	1.1	0.2	0.0	0.0	0.5	0.0	0.4	0.3	0.2	0.3	0.2	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	2.4	1.6	0.6	3.5	0.7	0.5	0.0	0.9	0.0	0.3	0.8	0.5	0.0	0.0	0.0	6.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	28.6	0.0	7.3	0.0	0.0	0.0	0.2	35.2	0.1	0.8	0.0	0.0	2.2	1.8	24.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.7	1036.1	0.1	0.0	0.0	0.0	0.0	23.2	0.4	0.7	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	441.9	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	2.7	0.1	0.0	0.0
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine--glyoxylate and serine--pyruvate aminotransferase"	P21549	2	240868824-240880502	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	322	"liver: 2217.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 2037.9"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		NA	NA		4700000	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favorable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.8	2217.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	44.3	0.1	7.3	0.0	0.7	0.0	7.6	23.5	0.1	0.1	0.2	0.0	2.8	9.0	128.4	0.0	1.7	26.7	0.4	0.0	0.4	0.0	0.0	52.5	2037.9	0.2	0.0	0.0	8.1	4.1	53.5	0.0	1.6	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.8	0.4	0.0	0.8	1.9	343.9	0.1	0.0	0.0	2.7	0.1	0.1	0.0	0.0	0.0	1.9	5.2	0.1	1.5	0.4
CFHR5	"CFHL5, FHR-5, FHR5"	ENSG00000134389	"Complement factor H related 5"	Q9BXR6	1	196977556-197009678	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1689	"liver: 168.8"	"Cell type enriched"	"Detected in some"	19	"Hepatocytes: 102.7"	"Cancer enriched"	"Detected in single"	396	"liver cancer: 57.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726"	Supported				"Secreted to blood"	NA	NA		1900000000			"HPA038915: AB_2676269, HPA040726: AB_2677101"							"unprognostic (9.12e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	102.7	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"liver: 214254.8"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 65190.0"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	38	"Hep G2: 4500.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000		"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	6.4	3.8	1.1	0.0	1.2	0.0	6.0	0.8	1.2	1.5	0.8	2.2	0.0	1.8	15.5	2.7	4.3	3.9	6.3	0.9	1.0	469.5	214254.8	6.7	1.3	0.9	0.9	0.9	2.5	1582.3	1.0	3.4	4.6	1.0	2.2	0.1	0.5	2.1	0.1	2.0	2.6	2.3	0.0	0.9	37.3	10.1	3.6	0.9	0.3	3.6	0.1	1.4	0.9	1.7	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.8	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.6	0.0	31.7	2.1	4500.0	0.0	117.1	3.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	17.0	0.2	0.0	0.1	2.0	0.0	4.0	0.0	0.1	2.1	95.1	0.0	0.0	3.2	0.0	0.0	52.3	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.4	0.1	0.1	7.0	0.6	32.9	0.1	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	0.8	1.2	0.9	1.0	0.9	0.9	0.9	1.0	0.9	0.9	1.0	0.1	0.0	0.0	1.0	187.5	0.0	0.0	0.0	0.0	0.0	43.4	18.9	0.1	13788.8	0.0	38.6	0.0	1.4	0.6	0.1	72.4	5.3	2.5	0.2	0.1	65.5	1.8	1133.8	0.2	273.8	11.1	0.5	4.6	0.0	0.0	0.1	1252.5	65190.0	8.5	0.0	0.2	0.0	0.0	1764.5	0.0	0.1	0.0	2.9	0.0	0.0	1.0	0.0	0.0	0.0	0.1	160.6	0.0	0.0	0.0	0.2	0.0	686.5	0.0	0.0	0.0	0.0	1.1	0.2	1.3	0.0	0.1	21.2	77.1	0.1	0.0	0.1
APOA2		ENSG00000158874	"Apolipoprotein A2"	P02652	1	161222292-161223631	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction, Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1385	"liver: 36306.5"	"Cell type enriched"	"Detected in some"	75	"Hepatocytes: 50065.8"	"Cancer enriched"	"Detected in many"	329	"liver cancer: 11230.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"Hep G2: 16822.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025885, HPA072575"	Supported				"Secreted to blood"	NA	NA	115000000000	92000000000			"CAB025885: , HPA072575: "		"unprognostic (2.05e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.99e-1)"		"unprognostic (9.82e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"		"unprognostic (4.40e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	2.1	1.1	0.6	0.7	0.5	26.2	1.8	0.4	1.1	0.7	0.8	0.7	0.0	0.7	0.1	1.0	1.9	0.0	1.7	0.5	1.7	9.6	36306.5	2.1	0.3	0.7	0.6	0.2	0.7	2.1	0.0	1.2	1.3	0.7	0.6	0.5	0.0	0.6	0.0	0.6	0.8	0.9	0.0	0.6	7.7	1.9	1.2	0.8	0.4	0.9	0.0	0.3	0.4	0.8	1.2	0.0	0.6	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	1814.4	0.0	3.6	0.0	0.0	0.0	2.3	1.5	0.0	0.0	0.0	0.0	5.8	10.0	16822.4	0.0	19.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.7	0.7	1.5	0.0	1.1	1.3	14.6	0.3	0.0	11.3	0.8	0.0	7.8	0.0	0.2	5.2	0.1	0.0	4.1	0.0	0.1	0.0	0.0	3.8	0.0	5.2	0.0	6.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	0.0	0.6	0.5	0.4	1.1	0.5	1.7	0.7	0.6	0.2	0.7	0.6	0.8	1.2	0.0	0.0	0.0	0.0	40.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	480.4	0.0	0.0	0.0	0.8	0.0	0.1	1.9	0.0	1.7	0.0	0.0	22.5	0.0	323.6	0.0	0.6	6.4	0.2	0.0	0.0	0.0	0.0	425.9	50065.8	4.7	0.0	0.0	0.2	0.0	665.8	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	9.8	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.0	0.0	5.6	26.0	0.0	0.0	0.0
FGF21		ENSG00000105550	"Fibroblast growth factor 21"	Q9NSA1	19	48755524-48758333	"Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	106	"liver: 84.8"	"Cell type enriched"	"Detected in some"	19	"Cardiomyocytes: 116.4"	"Cancer enriched"	"Detected in single"	315	"liver cancer: 33.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HHSteC: 1.4;U-2 OS: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061286	Supported				"Secreted to blood"	NA	NA	254000	73000			"HPA061286: AB_2684466"				"unprognostic (1.64e-2)"		"unprognostic (3.62e-1)"	"unprognostic (3.21e-2)"			"unprognostic (3.42e-1)"				"unprognostic (1.54e-1)"	"unprognostic (1.85e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815994-68832023	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	149	"liver: 235.6"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 245.3"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	116	"Hep G2: 12.0"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	235.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	21.0	0.1	0.0	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	245.3	0.0	0.0	0.0	0.3	0.0	7.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186613060-186621318	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease variant, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4297	"liver: 5864.7"	"Cell type enriched"	"Detected in some"	38	"Hepatocytes: 1242.5"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	78	"Hep G2: 2287.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	864000000000	110000000000	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	1.3	5864.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	1.0	2287.3	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	3.5	0.0	0.0	1.1	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.4	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.2	0.0	0.1	3.9	0.2	4.3	0.2	0.1	0.9	0.0	32.0	0.6	0.6	2.4	0.1	0.0	0.1	0.0	0.0	28.2	1242.5	1.3	0.0	0.1	0.0	0.0	32.4	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	2.0	0.0	0.0	0.1
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854797-56918223	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	194	"liver: 641.0"	"Cell type enriched"	"Detected in some"	36	"Hepatocytes: 296.4"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Hep G2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		6400000000										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	641.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	5.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	296.4	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1
ITIH2	H2P	ENSG00000151655	"Inter-alpha-trypsin inhibitor heavy chain 2"	P19823	10	7703316-7749520	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	494	"liver: 2173.8"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 489.6"	"Cancer enriched"	"Detected in many"	279	"liver cancer: 626.9"	"Region enhanced"	"Detected in some"		"cerebral cortex: 4.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	453	"Hep G2: 1103.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059150	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		32000000000	"Golgi apparatus"		"HPA059150: AB_2683930"	"unprognostic (4.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.10e-8)"	"unprognostic (9.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.46e-4)"	0.1	0.2	0.4	0.1	0.8	0.1	3.1	1.4	4.3	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.1	0.4	1.0	0.8	2173.8	0.6	0.1	0.5	0.7	0.3	0.0	0.2	0.0	1.7	0.1	0.8	0.0	0.0	0.3	0.0	0.0	0.8	0.4	0.1	0.0	0.8	0.3	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	1103.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	2.4	0.0	0.1	0.7	0.0	0.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.8	1.4	4.3	0.4	1.0	0.5	0.7	0.3	0.8	0.8	0.7	1.3	0.1	0.0	2.2	0.7	1.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.4	117.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.1	0.0	0.0	0.6	0.0	2.7	3.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	8.2	489.6	0.1	0.0	1.4	0.0	0.0	9.4	0.0	2.1	0.0	0.0	0.0	18.7	0.0	0.0	0.0	1.5	1.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	308	"liver: 10463.6"	"Cell type enriched"	"Detected in many"	58	"Hepatocytes: 6272.7"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.5;myeloid DC: 6.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 6.2;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 11.0;HL-60: 8.9;HMC-1: 8.9;NB-4: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	2.4	3.0	5.1	0.6	5.4	0.8	3.0	9.0	7.6	4.8	3.1	4.0	1.4	4.5	8.4	16.9	5.5	2.5	2.1	5.6	5.6	9.2	10463.6	2.6	2.0	6.2	5.8	4.7	4.2	12.5	0.6	4.1	1.4	6.8	5.4	1.2	11.6	3.6	6.2	2.8	14.0	2.2	2.2	5.1	7.3	6.8	3.7	6.2	1.8	4.0	0.9	33.9	3.5	3.3	7.5	0.1	0.0	0.3	1.0	3.5	1.9	0.7	1.6	4.5	0.0	0.3	0.0	2.7	1.4	0.2	0.5	0.0	11.0	0.0	0.2	0.4	0.3	1.5	1.8	0.2	1.3	0.6	8.9	8.9	1.0	0.2	0.0	0.7	1.9	0.0	3.1	0.6	0.4	1.0	0.7	0.6	24.0	6.4	4.3	0.4	0.4	6.1	0.0	2.0	0.0	0.0	0.0	4.2	0.0	0.6	0.2	0.3	0.9	0.0	1.4	0.4	2.3	1.0	2.2	1.0	3.0	1.5	7.4	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	0.6	6.2	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	5.1	5.4	9.0	7.6	5.6	5.6	6.2	5.8	4.7	6.8	5.1	6.2	7.5	0.8	0.0	1.1	5.5	9.2	2.3	0.2	0.7	0.6	5.7	0.6	0.5	2.8	48.6	1.9	0.0	2.1	0.0	0.4	0.1	0.0	1.6	2.1	0.6	0.8	4.6	0.0	67.6	6.7	1.3	0.1	1.1	1.5	0.5	1.3	0.7	67.1	6272.7	0.0	8.4	5.3	0.0	0.0	108.0	2.8	2.1	1.5	0.3	0.0	1.9	0.4	0.7	0.0	2.0	2.2	3.2	0.0	2.6	0.3	0.6	0.0	0.6	2.2	5.8	0.0	0.2	0.6	4.1	4.2	2.0	7.5	0.1	5.7	0.2	0.0	0.0
MBL2	"COLEC1, MBL"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52772784	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2833	"liver: 283.2"	"Cell type enriched"	"Detected in some"	66	"Hepatocytes: 238.5"	"Cancer enriched"	"Detected in single"	275	"liver cancer: 22.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 2.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"basal ganglia: 1.1"	"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	NA	NA	1220000000	1900000000			"CAB016782: , HPA002027: AB_1079324"							"unprognostic (1.72e-2)"		"unprognostic (3.03e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	283.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	238.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0
SLC25A47	C14orf68	ENSG00000140107	"Solute carrier family 25 member 47"	Q6Q0C1	14	100323339-100330421	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	366	"liver: 539.1"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 270.2"	"Cancer enriched"	"Detected in single"	273	"liver cancer: 56.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (2.54e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.4	539.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.9	270.2	0.0	0.0	0.0	0.6	0.0	6.7	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	3.5	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.1
HRG	"HPRG, HRGP"	ENSG00000113905	"Histidine rich glycoprotein"	P04196	3	186660216-186678234	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis"	Heparin-binding	"Disease variant, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"liver: 5478.2"	"Cell type enriched"	"Detected in some"	29	"Hepatocytes: 479.7"	"Cancer enriched"	"Detected in some"	262	"liver cancer: 406.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.7;RH-30: 3.0;SiHa: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050269, HPA054598"	Supported				"Secreted to blood"	NA	NA	120000000000	28000000000			"HPA050269: AB_2681068, HPA054598: AB_2682539"		"unprognostic (2.67e-1)"		"unprognostic (1.74e-2)"		"unprognostic (7.58e-5)"	"prognostic favorable (9.64e-5)"	"unprognostic (1.44e-1)"		"unprognostic (2.98e-3)"	"unprognostic (2.22e-1)"		"unprognostic (1.55e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.7	5478.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	3.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.7	0.0	3.7	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.6	0.0	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	479.7	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276369-99291003	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	305	"liver: 2761.4"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 200.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 8.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		38000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	7.2	1.6	0.2	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.3	9.0	0.3	0.5	0.1	0.5	6.7	0.2	0.0	0.0	0.7	2761.4	0.8	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.3	0.1	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.8	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.1	1.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.1	0.3	0.0	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	8.6	200.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0
ITIH3	H3P	ENSG00000162267	"Inter-alpha-trypsin inhibitor heavy chain 3"	Q06033	3	52794768-52809009	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	97	"liver: 799.2"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1183.8"	"Cancer enriched"	"Detected in some"	247	"liver cancer: 273.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Hep G2: 17.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA017373	Approved				"Secreted to blood"	NA	NA		9100000000			"HPA017373: AB_1851954"	"unprognostic (2.07e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-4)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.49e-8)"	"unprognostic (2.09e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.31e-2)"	4.3	0.7	0.4	0.9	0.5	0.0	2.2	0.4	0.8	4.5	0.7	1.0	0.3	3.6	1.7	1.3	3.5	1.3	0.7	0.4	0.3	0.7	799.2	3.0	2.5	0.4	0.4	0.4	2.8	0.3	0.1	0.4	1.7	0.4	1.1	1.0	0.1	0.4	2.4	0.6	0.9	1.3	1.2	0.3	8.2	1.2	3.5	0.4	0.2	1.2	0.4	1.8	1.4	2.3	0.5	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.8	0.4	0.3	0.4	0.4	0.4	0.4	0.3	0.4	0.5	0.1	0.0	0.0	0.0	21.6	0.1	0.0	0.0	0.0	0.5	0.1	1.4	0.8	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.1	0.1	3.5	0.0	90.9	0.0	0.0	0.1	2.1	0.0	0.0	0.0	12.3	66.4	1183.8	0.0	0.0	0.0	0.0	0.0	85.1	0.3	132.0	1.2	0.1	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	9.1	0.4	0.3	0.0	0.1	0.3	3.6	19.2	0.0	0.1
C9		ENSG00000113600	"Complement C9"	P02748	5	39284140-39424868	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	287	"liver: 1408.7"	"Cell type enriched"	"Detected in some"	37	"Hepatocytes: 1962.3"	"Cancer enriched"	"Detected in single"	244	"liver cancer: 90.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"JURKAT: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002151, HPA029577"	Uncertain				"Secreted to blood"	NA	NA	69600000000	64000000000			"CAB002151: AB_563670, HPA029577: AB_10603779"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.50e-1)"		"unprognostic (2.01e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.49e-3)"		"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.43e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.04e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1408.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	20.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.8	2.0	0.0	18.7	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	42.5	1962.3	1.2	0.0	0.1	0.2	0.0	52.6	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.1	3.7	1.7	0.0	0.0	0.3	3.0	0.0	0.0	0.1
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784248	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 3827.5"	"Group enriched"	"Detected in some"	40	"Hepatocytes: 2612.9;Proximal enterocytes: 1685.2"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;NB-4: 2.2;RPMI-8226: 3.4;SCLC-21H: 1.3;SH-SY5Y: 2.0"					"Low region specificity"	"Detected in all"			"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.3	3.9	0.0	1.1	0.3	0.0	0.3	0.0	0.8	0.1	0.0	3.5	804.8	0.6	0.2	0.4	0.1	0.6	0.1	0.1	0.0	4.9	3827.5	0.1	0.9	0.0	0.0	0.0	0.1	43.7	0.0	1.1	0.0	0.0	0.2	2.2	0.5	0.3	0.0	2.4	1.9	860.3	0.0	0.0	0.1	1.2	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.8	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.2	0.2	0.0	0.0	0.0	0.8	3.4	0.0	0.1	1.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	2.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.4	32.9	0.0	0.0	0.0	0.3	0.0	5.6	0.0	0.1	0.4	0.0	0.0	1.4	0.0	26.7	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.0	30.0	2612.9	0.0	0.0	0.6	29.6	2.0	52.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.1	38.9	0.0	0.0	0.6	1685.2	3.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.9	0.1	2.3	0.5	16.1	1.1
CYP2A7	CYP2A	ENSG00000198077	"Cytochrome P450 family 2 subfamily A member 7"	P20853	19	40875439-40882752	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"liver: 153.7"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 195.3"	"Group enriched"	"Detected in some"	238	"breast cancer: 9.2;liver cancer: 25.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033510, HPA046713, HPA047262"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (2.18e-1)"				"unprognostic (3.60e-2)"		"unprognostic (2.65e-3)"	"unprognostic (8.89e-2)"		"unprognostic (1.39e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.99e-2)"		"unprognostic (1.06e-2)"		0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.0	0.6	1.5	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	153.7	0.1	0.0	0.4	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.6	0.3	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	24.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	11.0	195.3	0.0	0.0	0.1	0.8	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.9
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	562	"liver: 18114.5"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 7680.6"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"Hep G2: 1253.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	247000000000	41000000000	"Golgi apparatus"		"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favorable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavorable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.6	0.3	0.0	0.1	0.1	0.5	0.2	0.1	0.2	0.2	0.3	0.8	2.5	0.1	1.0	0.2	0.8	2.8	0.5	0.1	0.1	32.2	18114.5	5.6	0.3	0.2	0.1	0.2	0.2	11.0	0.0	0.2	0.4	0.4	0.2	0.7	0.2	0.2	0.3	0.2	0.2	1.0	0.0	0.1	4.3	3.8	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	33.5	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	1.4	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.4	0.0	2.6	1.4	1253.3	0.0	6.4	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.4	0.5	0.2	0.0	0.2	0.1	0.6	31.5	0.0	0.8	6.4	0.1	0.0	0.9	0.4	0.0	3.4	0.1	0.2	0.0	0.0	0.0	1.7	0.2	0.1	0.1	0.0	0.8	0.1	2.9	15.3	2.4	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.4	0.1	0.1	0.2	0.0	0.0	12.3	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	183.0	0.6	0.0	0.0	0.0	0.0	0.2	3.9	0.8	0.2	0.2	0.0	5.2	0.0	109.7	0.2	2.3	0.6	0.0	0.0	0.1	0.0	0.0	120.0	7680.6	0.5	0.0	0.2	0.4	0.0	182.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.8	0.0	0.0	0.0	0.4	25.6	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	8.8	0.0	0.8	0.0
LECT2	"chm-II, chm2"	ENSG00000145826	"Leukocyte cell derived chemotaxin 2"	O14960	5	135922279-135954983	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"liver: 481.9"	"Group enriched"	"Detected in some"	15	"Early spermatids: 147.7;Hepatocytes: 100.7;Late spermatids: 55.8"	"Cancer enriched"	"Detected in single"	216	"liver cancer: 35.1"	"Region enhanced"	"Detected in some"		"cerebellum: 5.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043883, HPA058246"	Enhanced		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	26500000	5300000	Cytosol	Vesicles	"HPA043883: AB_2678714, HPA058246: "							"prognostic favorable (4.16e-5)"						"unprognostic (2.57e-2)"		"unprognostic (3.52e-1)"			0.2	0.5	0.3	0.4	0.8	2.4	0.4	5.9	2.3	0.1	0.0	0.2	0.5	0.3	0.9	0.4	0.1	0.4	0.1	0.9	0.1	0.6	481.9	0.3	0.9	0.2	0.3	0.4	0.3	0.1	0.2	0.0	0.2	2.3	0.4	0.2	3.1	0.7	0.2	2.1	1.4	0.9	0.1	0.0	1.0	0.4	8.9	0.2	0.2	0.4	0.0	0.2	0.2	0.0	1.2	0.3	0.4	0.5	0.7	0.2	0.4	0.6	0.1	0.0	0.0	0.0	0.1	0.4	0.8	0.6	0.3	0.3	0.5	0.0	0.2	0.0	0.3	1.0	0.7	0.7	1.3	0.3	1.0	0.1	0.2	0.1	0.3	0.3	0.6	0.1	0.8	0.2	0.3	0.6	0.0	0.4	0.4	0.5	0.3	0.6	0.5	0.5	0.2	0.2	0.9	0.3	0.6	0.0	0.2	0.0	0.9	0.1	0.5	0.8	0.3	0.4	0.4	0.1	1.1	0.5	0.3	0.3	0.9	0.8	0.6	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.8	5.9	2.3	0.9	0.1	0.2	0.3	0.4	2.3	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	147.7	0.0	0.1	0.3	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	100.7	0.0	0.0	0.1	0.0	0.0	2.9	0.0	55.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1
MT1B	"MT1, MT1Q"	ENSG00000169688	"Metallothionein 1B"	P07438	16	56651886-56653204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"liver: 23.1"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 4.4;Hepatocytes: 12.8;Proximal enterocytes: 3.2;Proximal tubular cells: 6.7"	"Cancer enriched"	"Detected in single"	209	"liver cancer: 57.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																	"unprognostic (2.66e-1)"						0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.9	0.0	0.0	0.7	12.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	3.2	6.7	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0
SERPINA7	TBG	ENSG00000123561	"Serpin family A member 7"	P05543	X	106032435-106038727	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	612	"liver: 284.5"	"Cell type enriched"	"Detected in some"	27	"Hepatocytes: 182.8"	"Cancer enriched"	"Detected in single"	203	"liver cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	475	"Hep G2: 69.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002803	Approved				"Secreted to blood"	NA	NA	39800000000	25000000000			"HPA002803: AB_1079915"			"unprognostic (6.22e-2)"				"unprognostic (1.63e-3)"				"unprognostic (3.34e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-3)"		"unprognostic (2.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	284.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	182.8	0.0	0.0	0.0	0.7	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0
HAO1	"GOX, GOX1"	ENSG00000101323	"Hydroxyacid oxidase 1"	Q9UJM8	20	7882985-7940458	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	582	"liver: 612.8"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 301.4"	"Cancer enriched"	"Detected in some"	184	"liver cancer: 93.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049552, HPA072442"	Enhanced					NA	NA		240000			"HPA049552: AB_2680814, HPA072442: "					"unprognostic (4.88e-2)"		"unprognostic (2.87e-3)"				"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	612.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	13.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	301.4	0.0	0.0	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
C8B		ENSG00000021852	"Complement C8 beta chain"	P07358	1	56929207-56966140	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	156	"liver: 847.0"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 295.1"	"Cancer enriched"	"Detected in some"	181	"liver cancer: 107.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	22	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023694	Supported				"Secreted to blood"	NA	NA		6700000000			"HPA023694: AB_1847128"				"unprognostic (6.65e-2)"			"prognostic favorable (9.31e-5)"	"unprognostic (2.37e-1)"			"unprognostic (2.37e-1)"			"unprognostic (1.29e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.12e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	847.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.2	1.0	0.0	0.1	0.0	5.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	7.1	295.1	0.1	0.0	0.1	0.0	0.0	7.6	0.0	11.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0
CFHR2	"CFHL2, FHR2, HFL3"	ENSG00000080910	"Complement factor H related 2"	P36980	1	196943738-196959622	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2749	"liver: 1322.7"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 38.5"	"Cancer enriched"	"Detected in single"	175	"liver cancer: 8.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"	NA	NA		4800000000			"HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895"							"unprognostic (1.25e-2)"											0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1322.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	38.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
AFM	"ALB2, ALBA"	ENSG00000079557	Afamin	P43652	4	73481745-73504001	"Plasma proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 969.5"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 300.4"	"Cancer enriched"	"Detected in single"	167	"liver cancer: 62.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017006, HPA052437"	Enhanced				"Secreted to blood"	NA	NA	54900000000	8700000000			"HPA017006: AB_1844635, HPA052437: AB_2732575"							"prognostic favorable (1.80e-4)"				"unprognostic (5.73e-2)"		"unprognostic (4.24e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	80.4	969.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.3	0.2	4.3	0.0	1.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.2	300.4	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0
SLC22A9	"FLJ23666, OAT4, OAT7, UST3"	ENSG00000149742	"Solute carrier family 22 member 9"	Q8IVM8	11	63369785-63410294	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 46.7"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 2.7;Excitatory neurons: 5.0;granulocytes: 4.5;Hepatocytes: 15.4"	"Cancer enriched"	"Detected in single"	166	"liver cancer: 19.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA											"unprognostic (2.45e-1)"	"unprognostic (7.24e-2)"	"unprognostic (8.86e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.08e-2)"		"unprognostic (2.26e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.71e-1)"		"unprognostic (3.09e-2)"	0.1	0.0	0.5	0.0	0.6	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	1.3	0.3	0.2	46.7	0.0	0.1	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.5	0.6	0.0	1.7	1.3	0.3	0.0	0.1	1.0	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	2.7	5.0	0.2	0.0	0.1	0.0	0.0	4.5	0.1	0.0	15.4	0.0	0.0	0.3	0.0	0.0	0.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1
GLYAT	"ACGNAT, GAT"	ENSG00000149124	Glycine-N-acyltransferase	Q6IB77	11	58640426-58731974	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Detoxification	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"kidney: 577.2;liver: 703.8"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 346.7;Proximal tubular cells: 1261.0"	"Group enriched"	"Detected in some"	158	"liver cancer: 21.7;renal cancer: 25.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-937: 1.4"	"Not detected"	"Not detected"							"HPA040251, HPA044094"	Enhanced					NA	NA		21000			"HPA040251: AB_2676902, HPA044094: AB_2678807"	"unprognostic (2.15e-2)"				"unprognostic (9.38e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.65e-3)"		"unprognostic (1.83e-1)"		"unprognostic (1.60e-1)"		"prognostic favorable (1.31e-6)"	"unprognostic (2.69e-1)"				47.4	0.1	0.0	0.1	0.1	0.1	8.6	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.0	577.2	703.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	1.2	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.4	0.3	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	11.5	0.0	31.3	0.0	0.1	0.0	0.0	123.3	0.0	6.0	0.0	0.0	0.6	0.0	8.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	346.7	0.0	0.0	0.2	0.0	0.0	10.7	0.0	8.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1261.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0
UGT1A9	"HLUGP4, LUGP4, UGT1AI"	ENSG00000241119	"UDP glucuronosyltransferase family 1 member A9"	O60656	2	233671898-233773300	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	650	"kidney: 462.8;liver: 197.1"	"Group enriched"	"Detected in some"	11	"Hepatocytes: 7.5;Proximal tubular cells: 6.6"	"Group enriched"	"Detected in some"	157	"liver cancer: 16.1;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"A549: 1.4;RT4: 1.2"															NA	NA												"unprognostic (2.46e-2)"				"unprognostic (3.56e-1)"		"prognostic unfavorable (5.04e-5)"	"unprognostic (4.26e-2)"			"unprognostic (1.60e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	462.8	197.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCL16	"CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4"	ENSG00000275152	"C-C motif chemokine ligand 16"	O15467	17	35976493-35981497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"liver: 121.3"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 262.0"	"Cancer enriched"	"Detected in single"	154	"liver cancer: 49.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"Hep G2: 10.1"					"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	2780000	23000000				"unprognostic (3.85e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-2)"		"unprognostic (2.72e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	0.6	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.2	0.1	0.5	0.0	0.2	0.5	0.2	0.1	0.0	0.0	0.3	121.3	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.0	2.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	262.0	0.0	0.0	0.0	0.2	0.0	4.1	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1
SLC17A1	"NAPI-1, NPT1"	ENSG00000124568	"Solute carrier family 17 member 1"	Q14916	6	25782915-25832052	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"kidney: 170.8;liver: 49.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 13.5;Hepatocytes: 10.3;Proximal tubular cells: 49.2"	"Group enriched"	"Detected in some"	150	"liver cancer: 7.6;renal cancer: 19.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	647	"RPTEC TERT1: 64.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050513			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA050513: AB_2681152"			"unprognostic (6.98e-2)"		"unprognostic (2.99e-1)"		"unprognostic (1.03e-1)"				"unprognostic (1.26e-1)"		"unprognostic (2.71e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.74e-1)"		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	170.8	49.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	49.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0
CFHR4	"CFHL4, FHR-4, FHR4"	ENSG00000134365	"Complement factor H related 4"	Q92496	1	196888014-196918713	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	432	"liver: 125.0"	"Cell type enriched"	"Detected in some"	28	"Hepatocytes: 62.6"	"Cancer enriched"	"Detected in single"	145	"liver cancer: 13.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.3"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		170000000									"unprognostic (5.97e-1)"	"prognostic favorable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.26e-1)"				"unprognostic (1.68e-2)"			"unprognostic (4.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	125.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.2	62.6	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SAA4	"C-SAA, CSAA"	ENSG00000148965	"Serum amyloid A4, constitutive"	P35542	11	18231355-18236802	"Plasma proteins, Predicted secreted proteins"	"Acute phase"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	124	"liver: 1959.7"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 2132.8;Respiratory ciliated cells: 706.8"	"Cancer enriched"	"Detected in many"	141	"liver cancer: 118.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"Hep G2: 28.8"	"Not detected"	"Not detected"							"CAB026061, HPA060139"	Supported				"Secreted to blood"	NA	NA	65000000000	33000000000			"CAB026061: , HPA060139: AB_2684210"	"unprognostic (4.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.83e-1)"	"unprognostic (4.15e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.94e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.35e-2)"	"unprognostic (2.54e-8)"	"unprognostic (2.49e-1)"			"unprognostic (6.46e-2)"	7.4	0.5	0.3	0.4	0.3	0.0	6.7	0.3	0.6	15.8	0.3	0.2	0.0	0.0	0.2	0.5	0.5	1.0	0.1	0.3	0.8	0.4	1959.7	0.7	0.0	0.4	0.3	0.3	0.0	0.1	0.0	0.8	0.0	0.3	1.2	0.0	0.1	11.5	0.1	3.5	0.4	0.1	0.1	0.3	1.2	0.1	1.3	0.4	1.0	0.0	0.0	0.2	0.1	0.1	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.3	0.1	28.8	0.3	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.6	0.3	0.8	0.4	0.3	0.3	0.3	0.3	0.4	0.5	0.1	0.0	0.0	0.0	2.5	0.0	0.0	184.7	0.0	0.0	2.1	1.4	0.0	18.6	172.6	0.0	0.0	0.0	0.0	3.5	0.0	4.0	0.6	0.4	0.0	1.6	0.0	21.5	0.0	1.2	0.1	0.0	0.0	0.3	0.0	0.0	27.5	2132.8	0.1	0.0	0.0	0.0	71.2	38.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	706.8	0.0	0.0	0.0	23.6	0.1	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.5
KNG1	"BDK, BK, KNG"	ENSG00000113889	"Kininogen 1"	P01042	3	186717348-186744410	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis, Inflammatory response"	"Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 3221.7"	"Group enriched"	"Detected in some"	25	"Distal tubular cells: 655.4;Hepatocytes: 1816.9"	"Cancer enriched"	"Detected in some"	126	"liver cancer: 608.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.6;Hep G2: 1.7;RH-30: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001616, HPA001645, CAB009809"	Enhanced				"Secreted to blood"	NA	NA	90000000000	47000000000			"CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215"	"unprognostic (3.88e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (1.28e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.52e-2)"		0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	468.4	3221.7	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.7	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	48.6	0.0	33.1	0.0	0.0	0.0	1.8	655.4	0.0	0.4	0.0	0.0	1.5	0.0	40.2	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	30.0	1816.9	0.1	0.0	0.8	0.1	0.0	47.2	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.5	0.1	1.1	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.7	0.0	0.1	0.1
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078328	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"liver: 11037.4"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 10517.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	173	"Hep G2: 1398.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"	"Secreted to blood"	NA	NA		47000000000	Vesicles	"Golgi apparatus, Cytosol"	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.5	0.2	0.1	0.0	0.1	0.0	6.5	0.3	0.4	0.1	0.2	0.3	2.3	0.1	0.4	0.3	0.4	161.9	0.4	0.1	0.3	11.1	11037.4	0.3	0.1	0.1	0.1	0.1	0.2	126.4	0.0	0.2	0.4	0.1	0.2	0.5	0.2	0.1	0.0	0.2	0.2	0.7	0.0	0.1	3.1	2.6	1.0	0.1	0.1	0.4	0.0	0.2	0.1	0.2	0.1	0.0	6.7	0.1	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	1.8	0.0	1.8	2.1	0.2	0.9	0.5	0.0	0.0	0.0	3.2	0.0	3.0	1.0	1398.1	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.3	0.0	0.9	3.1	0.0	0.2	8.1	0.4	5.9	0.6	1.7	0.0	2.8	1.1	0.0	0.1	0.0	0.2	1.0	0.0	0.8	0.0	0.4	1.0	0.3	1.5	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	19.1	1.5	0.6	0.0	2.2	0.0	1.9	0.4	0.2	2585.0	0.6	1.8	0.0	0.1	0.0	0.6	3.9	216.5	30.4	0.2	0.1	10.0	2.4	219.2	0.1	28.2	0.8	0.1	0.0	1.0	0.0	0.0	181.3	10517.4	0.7	0.0	0.1	1.6	0.0	243.7	0.5	59.4	0.6	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	14.9	1.7	0.0	0.0	0.6	0.6	13.7	0.0	0.0	0.0	0.0	0.5	0.6	0.2	1.1	0.4	1.4	14.3	0.0	1.2	0.3
MYH4	"MYH2B, MyHC-2B, MyHC-IIb"	ENSG00000264424	"Myosin heavy chain 4"	Q9Y623	17	10443290-10469559	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"skeletal muscle: 10.7"	"Cell type enriched"	"Detected in single"	5	"Cardiomyocytes: 3.3"	"Cancer enriched"	"Detected in single"	115	"liver cancer: 9.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	25	"OE19: 9.0"									HPA001349	Supported		Uncertain	"Focal adhesion sites"		NA	NA		86000000	"Focal adhesion sites"		"HPA001349: AB_1079437"	"unprognostic (3.27e-2)"		"unprognostic (2.94e-2)"			"unprognostic (4.94e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.72e-1)"			"unprognostic (1.37e-1)"		"unprognostic (3.32e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.52e-4)"		"unprognostic (9.97e-2)"	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0
AGXT2	AGT2	ENSG00000113492	"Alanine--glyoxylate aminotransferase 2"	Q9BYV1	5	34998101-35048135	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"kidney: 209.8;liver: 124.5"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 105.9;Proximal tubular cells: 359.5"	"Group enriched"	"Detected in some"	112	"liver cancer: 9.2;renal cancer: 12.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037382	Enhanced					NA	NA		13000			"HPA037382: AB_10670851"	"unprognostic (2.61e-1)"						"unprognostic (1.40e-2)"						"prognostic favorable (7.47e-4)"	"unprognostic (8.24e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	209.8	124.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	2.8	0.0	9.2	0.0	0.0	0.0	0.0	45.0	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	105.9	0.0	0.0	0.2	0.6	0.0	2.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	1.2	0.4	0.0	0.0	6.7	359.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.3	0.0
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053186-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"liver: 1496.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1332.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	86	"Hep G2: 173.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004146	Approved				"Secreted to blood"	NA	NA		8500000000			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.0	0.0	0.3	0.1	2.6	0.7	0.1	0.7	2.4	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	4.9	0.0	0.4	1.3	0.4	1496.4	17.7	0.1	2.6	1.8	0.3	0.0	0.5	0.0	0.0	0.0	2.5	0.1	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.0	0.5	0.4	0.1	0.2	1.6	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.3	173.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.5	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	2.6	0.7	2.4	0.4	1.3	2.6	1.8	0.3	2.5	0.5	1.6	4.9	0.0	3.2	27.0	3.9	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	190.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	1.0	0.0	10.7	4.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	15.7	1332.7	0.1	0.0	5.3	0.0	0.0	22.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	13.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
SPP2	SPP24	ENSG00000072080	"Secreted phosphoprotein 2"	Q13103	2	234050679-234077134	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4368	"liver: 523.3"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 258.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 65.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		480000000										"prognostic favorable (2.33e-6)"	"unprognostic (7.02e-3)"		"unprognostic (9.62e-3)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	523.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	3.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	5.3	0.3	0.6	0.0	0.7	0.0	0.1	5.1	0.0	5.0	258.7	0.1	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719196-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1655	"liver: 1227.2"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 991.0"	"Cancer enriched"	"Detected in some"	110	"liver cancer: 508.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"Hep G2: 281.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016780, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	NA	NA	108000000000	41000000000			"CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.94e-2)"		"unprognostic (5.79e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.75e-12)"	"unprognostic (5.65e-3)"	"unprognostic (5.80e-2)"		"unprognostic (1.54e-3)"	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	1227.2	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.9	0.0	0.2	2.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	281.0	0.0	1.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.2	0.0	37.5	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	21.8	991.0	0.0	0.0	0.2	0.2	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.1
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 2551.0"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 1373.6;Proximal tubular cells: 2144.0"	"Cancer enriched"	"Detected in many"	100	"liver cancer: 540.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 8.0"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 7.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;granulocytes: 7.8"	"Cell line enriched"	"Detected in some"	31	"Hep G2: 516.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"		NA	NA		26000000	"Nuclear speckles"		"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.14e-3)"	"unprognostic (9.72e-3)"	"unprognostic (8.61e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.34e-1)"	2.1	5.3	0.5	0.7	0.3	1.0	4.7	3.1	1.6	1.7	96.2	1.0	0.1	4.2	0.7	0.7	6.4	1.1	2.5	8.0	1.7	536.0	2551.0	2.0	0.3	1.4	2.0	0.2	4.8	4.0	0.1	1.1	0.3	1.0	2.3	0.5	0.3	0.2	7.4	2.2	0.2	0.9	1.4	0.6	2.3	1.9	10.3	2.8	0.1	0.8	0.1	0.1	3.7	1.9	0.9	0.3	0.9	0.6	0.6	0.3	0.6	0.6	0.0	0.1	0.0	0.0	0.2	0.5	0.2	0.6	1.1	0.2	0.4	0.2	0.0	0.0	0.3	0.8	1.2	5.4	516.4	11.5	1.8	16.4	3.6	0.3	0.0	0.0	1.3	0.0	0.5	0.8	0.0	1.3	1.3	0.2	0.4	9.9	0.4	0.0	0.3	1.6	0.5	0.0	1.4	0.1	0.1	1.5	0.1	0.1	6.9	1.1	0.9	0.2	0.0	0.3	0.1	0.1	0.8	0.6	0.7	0.2	1.2	0.0	0.0	0.6	7.8	0.0	0.8	0.0	0.1	0.1	0.1	1.0	0.1	0.2	0.2	3.9	0.0	1.3	3.8	0.0	0.3	0.5	0.3	3.1	1.6	8.0	1.7	1.4	2.0	0.2	1.0	0.6	2.8	0.9	0.0	0.0	0.0	0.7	15.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	55.8	0.0	92.0	0.0	0.8	0.0	0.0	193.7	0.5	38.0	0.1	0.0	2.6	0.0	80.2	1.0	16.2	0.3	0.4	0.0	0.1	0.0	0.0	38.9	1373.6	0.3	0.0	1.0	0.0	0.0	37.8	0.3	121.0	2.5	10.8	0.0	0.0	0.4	0.0	0.0	1.5	0.7	0.2	0.0	5.3	0.0	0.0	0.0	2144.0	0.0	0.0	0.0	2.0	0.2	1.8	1.4	0.0	0.0	1.1	8.0	7.1	0.0	0.0
UROC1	"FLJ31300, HMFN0320"	ENSG00000159650	"Urocanate hydratase 1"	Q96N76	3	126481166-126517773	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	391	"liver: 117.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 62.2"	"Cancer enriched"	"Detected in single"	100	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"NB-4: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069863	Enhanced					NA	NA		670000			"HPA069863: AB_2732143"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.71e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.65e-5)"	"unprognostic (3.97e-2)"	"unprognostic (2.66e-1)"		"unprognostic (5.52e-2)"	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	117.6	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	13.5	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.1	3.3	62.2	0.3	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	171	"intestine: 306.9;liver: 1200.8"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 2967.4;Proximal enterocytes: 1585.9"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 1079.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1490000000000	100000000000	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	2.7	0.0	0.1	0.2	0.1	0.1	0.9	0.1	0.1	0.7	0.2	0.4	183.0	0.2	0.0	0.1	0.1	0.5	4.4	0.1	0.3	0.3	1200.8	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.1	0.4	306.9	0.2	0.2	0.5	0.3	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	35.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1079.8	0.0	0.6	0.1	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.5	0.6	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	277.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	1.6	3.5	0.0	104.2	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	52.8	2967.4	0.1	0.0	0.2	30.8	0.0	69.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.5	1.5	0.0	0.0	1585.9	0.6	0.0	0.0	0.0	1.1	0.2	0.5	0.3	0.0	0.0	0.0	3.9	0.9	14.5	0.0
CYP7A1	CYP7	ENSG00000167910	"Cytochrome P450 family 7 subfamily A member 1"	P22680	8	58490178-58500163	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	91	"liver: 49.9"	"Cell type enriched"	"Detected in single"	17	"Hepatocytes: 7.0"	"Cancer enriched"	"Detected in single"	96	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (5.20e-2)"			"unprognostic (1.93e-2)"	"unprognostic (1.77e-2)"		"prognostic favorable (3.19e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"		0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
HJV	"haemojuvelin, hemojuvelin, HFE2, HFE2A, JH, RGMC"	ENSG00000168509	"Hemojuvelin BMP co-receptor"	Q6ZVN8	1	146017468-146036746	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"liver: 241.5;skeletal muscle: 596.7;tongue: 294.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	96	"liver cancer: 87.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 1.5;K-562: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA		69000				"unprognostic (2.30e-1)"			"unprognostic (6.98e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.55e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.96e-8)"	"unprognostic (6.61e-2)"	"unprognostic (2.72e-1)"		"unprognostic (1.76e-2)"	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	8.0	0.1	0.1	68.2	0.1	0.1	0.2	241.5	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.2	0.0	0.0	6.0	0.0	596.7	0.2	0.1	0.2	0.4	0.2	0.1	1.6	0.1	0.3	0.1	294.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.4	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131194-21239796	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	613	"liver: 541.6"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 83.1"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NTERA-2: 1.3;RPMI-8226: 1.8;SuSa: 2.2"									"HPA050892, HPA073093"	Supported		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA050892: AB_2681265, HPA073093: "			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	541.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	83.1	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	106	"liver: 1284.2"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 883.5"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"RH-30: 4.6"									"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.0	0.0	0.0	1.3	1284.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	10.7	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	11.7	883.5	0.1	0.0	0.1	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins, Predicted secreted proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	41	"liver: 1101.2"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 1107.9"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 115.2;intermediate monocyte: 55.5;myeloid DC: 41.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 41.2;monocytes: 115.2"	"Cell line enriched"	"Detected in some"	29	"Hep G2: 493.2"	"Region enriched"	"Detected in all"	9	"cerebellum: 44.1"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA		10000	Vesicles	"Cell Junctions"	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	2.1	1.5	6.6	3.7	7.0	2.5	1.9	14.5	10.2	1.6	6.0	1.2	2.3	1.3	0.6	1.7	1.8	2.9	1.0	7.5	6.9	1.2	1101.2	3.9	1.3	7.3	7.6	7.4	1.2	1.0	7.1	2.9	0.5	9.1	1.7	0.5	4.9	0.9	0.3	1.5	4.2	1.4	1.3	5.4	4.9	1.4	26.7	7.8	0.4	5.9	0.4	0.3	1.7	1.5	8.0	0.3	0.7	9.2	4.2	0.0	0.2	0.8	0.8	0.9	0.9	1.6	16.8	0.5	0.3	1.1	0.2	0.4	0.2	0.3	0.2	0.4	0.3	0.8	1.2	1.4	493.2	0.1	0.8	1.7	1.2	0.2	0.5	0.1	0.6	8.4	7.4	1.1	0.6	0.5	0.4	0.7	1.2	1.7	0.2	0.4	0.9	3.5	0.2	0.1	0.7	0.6	3.5	0.7	0.3	0.6	1.5	0.5	0.2	1.2	0.9	3.4	0.7	0.4	0.2	0.3	0.5	0.6	0.4	0.3	10.0	115.2	0.4	0.2	55.5	1.1	0.5	0.2	0.2	41.2	0.5	0.3	0.4	3.3	0.5	14.9	1.8	0.3	36.7	6.6	7.0	14.5	10.2	7.5	6.9	7.3	7.6	7.4	9.1	5.4	7.8	8.0	6.0	0.0	4.7	2.9	2.6	3.2	1.7	2.0	3.4	37.8	5.6	6.0	1.5	55.8	2.0	3.7	160.6	3.6	2.9	1.4	3.9	0.9	235.4	4.2	3.6	13.2	15.6	16.8	4.6	0.2	3.7	1.9	3.6	16.5	0.0	5.1	27.5	1107.9	39.9	15.2	4.8	2.3	2.0	97.4	11.9	115.8	2.5	52.6	0.0	1.9	77.2	3.6	0.0	2.0	0.6	0.3	1.3	1.2	0.0	0.9	0.2	6.8	1.6	42.3	0.0	0.8	1.9	6.5	9.7	9.9	4.8	12.4	1.4	1.6	1.3	2.4
ABCB11	"ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP"	ENSG00000073734	"ATP binding cassette subfamily B member 11"	O95342	2	168915498-169031324	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 81.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 41.7;Alveolar cells type 2: 44.1;Club cells: 19.3;Early spermatids: 16.5;granulocytes: 24.0;Hepatocytes: 20.4"	"Cancer enriched"	"Detected in single"	87	"liver cancer: 6.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.6;RT4: 1.6;TIME: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019035	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA019035: AB_1844429"	"unprognostic (7.78e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-1)"	"unprognostic (5.26e-6)"	"unprognostic (7.12e-2)"	"unprognostic (1.82e-1)"		"unprognostic (1.94e-1)"	1.0	0.0	0.3	0.1	0.3	0.0	0.6	0.3	0.5	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	81.5	0.0	0.1	0.9	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.4	0.1	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.0	6.3	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.4	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.2	0.2	0.9	0.5	0.2	0.3	0.3	0.2	0.2	0.0	41.7	44.1	1.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	19.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	16.5	0.1	0.0	1.8	0.0	2.7	0.8	0.0	0.0	6.6	0.0	0.0	24.0	0.0	0.0	20.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	9.1	0.0	3.8	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.6	0.2	0.0	0.6
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 723.4"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 613.3"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.6;OE19: 2.9"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		3800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.2	0.0	0.4	42.2	0.0	0.0	0.1	0.3	723.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.2	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.2	0.0	0.8	0.0	13.5	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	13.6	613.3	0.0	0.0	0.0	0.6	0.0	14.5	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	1.0	1.5	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1
A1BG		ENSG00000121410	"Alpha-1-B glycoprotein"	P04217	19	58345178-58353492	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1492	"liver: 1234.7"	"Cell type enriched"	"Detected in many"	13	"Hepatocytes: 1548.5"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;RH-30: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB016673, HPA044252"	Supported				"Secreted to blood"	NA	NA	200000000000	51000000000			"CAB016673: AB_1611892, HPA044252: AB_2678876"	"unprognostic (9.95e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (3.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.72e-2)"	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.2	0.1	0.0	0.1	1234.7	0.1	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.0	2.5	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.0	0.0	0.9	0.3	0.8	0.0	0.1	0.1	0.7	1.3	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.3	0.4	0.0	0.6	0.2	0.0	0.0	0.9	0.9	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	10.2	12.8	14.1	0.7	50.2	8.8	2.2	16.2	12.0	3.4	52.0	64.3	0.7	27.1	10.6	22.0	2.1	1.0	71.2	0.0	7.9	0.9	0.6	5.0	52.6	10.9	1.2	56.2	2.2	9.2	15.6	20.3	5.1	2.1	17.7	10.8	43.2	1548.5	25.1	8.4	1.7	0.1	20.3	110.9	66.0	2.1	1.2	49.4	115.6	0.0	60.8	3.1	15.5	0.0	8.7	5.4	0.0	1.2	94.4	11.1	0.0	2.0	15.0	5.5	26.3	29.2	43.8	4.1	7.9	1.5	3.7	1.9	52.6	0.7	0.2	0.6
INHBC		ENSG00000175189	"Inhibin subunit beta C"	P55103	12	57434784-57452062	"Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	172	"liver: 166.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Hepatocytes: 5.7;Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 6.4;Karpas-707: 6.3;RH-30: 2.8;U-266/70: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050755			Approved	Cytosol	"Secreted to blood"	NA	NA		21000000	Cytosol		"HPA050755: "	"unprognostic (5.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-4)"	"unprognostic (2.90e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.05e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	166.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	1.0	0.0	0.2	0.0	6.4	0.0	0.4	0.0	0.1	0.0	0.1	0.4	0.0	0.0	1.6	0.0	6.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	2.8	0.5	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.3	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.7	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367284-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"liver: 6088.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 5507.4"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"CACO-2: 1748.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016695, CAB016765, HPA060933, HPA068011"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	606000000000	33000000000	"Endoplasmic reticulum, Vesicles"		"CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: "	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"	3.2	99.8	2.3	2.5	2.5	0.3	0.9	4.8	3.7	0.9	0.3	0.7	4.7	1.5	0.9	0.5	2.2	61.8	53.6	2.4	2.1	3.6	6088.3	1.8	4.3	2.2	2.6	2.5	1.9	17.8	0.1	3.0	40.9	2.8	1.3	0.3	47.8	0.6	4.4	0.4	0.8	1.3	2.8	1.3	2.9	5.1	10.1	2.0	0.1	0.8	0.5	0.4	4.2	0.7	2.3	0.0	28.4	0.7	0.4	0.2	0.3	7.3	1.8	0.8	0.9	0.9	1748.9	0.1	1.2	0.2	0.2	0.2	0.7	0.0	0.0	0.1	0.2	0.2	1.2	1.1	86.7	2.5	6.1	0.5	0.4	0.0	0.6	0.0	3.9	0.1	0.0	1.6	0.3	0.2	0.7	0.2	0.0	0.8	0.4	0.1	0.4	3.5	0.1	0.3	0.0	1.0	1.4	115.6	8.0	0.2	4.3	0.3	0.0	1.0	0.4	0.3	0.1	0.2	1.0	0.5	1.4	0.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	2.3	2.5	4.8	3.7	2.4	2.1	2.2	2.6	2.5	2.8	1.3	2.0	2.3	0.1	0.0	1.1	2.0	21.5	0.0	0.0	0.0	0.0	13.0	0.1	0.1	18.1	1162.4	0.0	0.0	77.2	3.7	0.0	0.0	3.9	16.8	0.0	0.0	1.2	7.3	0.0	131.0	0.9	19.7	2.8	48.1	0.0	0.0	0.0	1.8	120.3	5507.4	4.7	38.7	1.0	0.1	0.0	160.3	0.3	0.2	0.0	0.3	0.0	0.0	20.1	6.9	0.0	1.0	0.5	23.5	1.2	1.5	0.0	0.0	0.1	9.5	0.0	38.3	0.0	0.4	1.5	4.2	0.6	0.0	0.0	9.6	9.0	0.7	0.0	0.0
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160754097	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 2688.2"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1772.7"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	NA	NA	140000000000	45000000000			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532"		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.4	0.4	0.2	0.2	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.3	0.2	0.0	0.1	2.4	0.5	0.0	0.3	0.2	243.2	2688.2	0.4	0.7	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.4	0.1	0.6	0.0	0.1	0.9	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	0.3	0.2	0.1	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	30.0	0.0	1.8	0.0	0.0	0.3	0.0	19.6	0.0	0.2	3.0	0.1	1.2	0.0	24.0	0.6	0.0	0.0	0.0	0.0	0.1	1.3	0.0	28.5	1772.7	0.1	0.0	0.5	0.0	0.0	35.4	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	235.7	1.5	0.1	0.0	0.4	0.2	0.4	0.4	0.0	0.0	0.0	2.3	0.1	0.0	0.0
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	359	"liver: 2174.2"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 1834.2"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA013547, HPA013970, HPA015066, HPA074424"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			Vesicles	"Plasma membrane"	"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433, HPA074424: "	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.2	1.8	1.6	0.0	1.9	0.2	0.3	1.3	2.0	0.2	1.4	0.3	0.2	0.1	0.3	0.1	1.1	4.7	0.2	1.8	2.1	1.4	2174.2	0.4	0.1	1.7	2.1	1.6	0.1	1.7	0.5	3.1	0.1	1.7	0.6	0.0	3.1	0.2	0.3	0.2	0.1	1.1	0.0	1.3	1.0	6.0	4.0	1.9	0.2	0.9	0.0	0.1	0.2	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	1.3	2.0	1.8	2.1	1.7	2.1	1.6	1.7	1.3	1.9	2.6	0.0	0.0	0.0	1.6	8.9	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.2	147.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	7.3	0.9	0.1	2.0	1.8	57.5	4.5	0.2	0.0	0.1	0.0	0.2	0.0	0.6	52.8	1834.2	0.0	5.0	3.7	0.1	0.0	70.9	0.0	7.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	1.2	0.5	1.2	0.0	0.0	0.1	1.0	0.8	0.9	1.7	0.0	0.0	0.3	2.1	0.6	0.0	0.0	0.0	3.3	0.0	0.2	0.2
HP		ENSG00000257017	Haptoglobin	P00738	16	72054505-72061055	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Immunity"	"Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	194	"liver: 61616.4"	"Cell type enriched"	"Detected in many"	43	"Hepatocytes: 59512.7"	"Cancer enriched"	"Detected in many"	81	"liver cancer: 1297.4"	"Group enriched"	"Detected in all"	4	"hypothalamus: 29.8;medulla oblongata: 29.9"	"Group enriched"	"Detected in many"	5	"classical monocyte: 49.3;eosinophil: 80.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 80.2;monocytes: 49.3"	"Group enriched"	"Detected in some"	5	"Hep G2: 232.2;HSkMC: 121.4"									"CAB003787, HPA047750, HPA066795"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	998000000000	100000000000	Vesicles		"CAB003787: , HPA047750: AB_2680146, HPA066795: "	"unprognostic (6.38e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (6.94e-13)"	"unprognostic (4.34e-4)"	"unprognostic (1.80e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.49e-2)"	318.1	11.5	2.1	27.1	2.4	233.7	34.5	2.0	2.9	72.5	3.9	3.6	1.5	3.5	3.0	5.4	75.2	1.3	86.5	2.1	29.8	19.2	61616.4	92.1	1.8	29.9	2.5	2.0	10.0	7.7	0.2	50.3	2.5	3.9	7.4	0.6	0.7	6.2	0.2	5.0	3.2	4.5	4.5	2.9	72.5	6.2	2.1	7.3	2.7	6.4	0.4	3.1	3.8	3.4	6.7	0.0	0.0	0.0	0.0	6.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	8.5	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.2	0.2	232.2	0.3	33.3	6.2	121.4	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	2.0	0.4	2.6	0.0	0.0	1.1	23.6	0.0	0.0	0.1	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.8	5.1	0.0	0.8	0.0	0.0	3.9	0.0	14.1	0.0	12.7	0.0	6.2	49.3	80.2	0.0	2.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	14.2	0.0	2.1	0.0	0.0	15.2	2.1	2.4	2.0	2.9	2.1	29.8	29.9	2.5	2.0	3.9	2.9	7.3	6.7	0.4	19.2	228.7	1.6	96.1	0.1	0.7	1.9	0.0	0.4	0.4	0.3	66.6	1085.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	56.7	0.0	1128.3	0.0	10.4	0.1	45.5	0.0	1.3	3.8	0.4	1038.7	59512.7	2.3	0.0	0.0	0.2	4.1	1381.4	0.0	0.5	10.2	7.8	1.8	0.0	0.3	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	1.5	7.5	0.2	0.0	2.6	1.8	0.0	0.0	0.1	0.3	0.1	90.3	0.0	0.3	0.1
SLC22A1	OCT1	ENSG00000175003	"Solute carrier family 22 member 1"	O15245	6	160121815-160158718	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	381	"liver: 614.5"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 966.3"	"Cancer enriched"	"Detected in some"	81	"liver cancer: 83.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029846	Approved					NA	NA					"HPA029846: AB_10603026"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.61e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.72e-2)"	"unprognostic (8.07e-4)"	0.3	0.3	0.2	0.1	0.2	0.4	0.3	0.0	0.8	0.3	0.2	0.2	0.0	0.3	0.1	0.2	0.3	0.7	0.1	0.5	0.0	0.9	614.5	0.4	0.2	0.2	0.1	0.2	0.4	0.4	0.0	0.3	0.0	0.3	0.4	0.1	0.1	0.4	0.1	1.0	0.4	0.3	0.0	0.0	1.6	0.3	0.3	0.1	0.1	0.7	0.1	0.0	0.1	0.3	0.4	0.0	0.2	0.2	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.8	0.0	0.0	0.4	0.1	0.4	0.2	0.1	0.2	0.6	0.0	0.3	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.2	0.1	0.0	0.6	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.7	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.8	0.5	0.0	0.2	0.1	0.2	0.3	0.0	0.1	0.4	0.2	0.0	1.3	2.0	1.4	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.5	47.1	0.0	0.0	2.1	0.0	0.4	0.1	0.0	0.5	0.3	0.5	0.1	0.9	0.0	13.5	6.1	0.2	0.1	0.2	0.0	0.7	0.0	0.2	11.4	966.3	0.1	0.0	3.7	0.1	0.0	16.3	0.0	0.2	0.3	0.4	0.0	1.0	0.0	0.9	0.0	0.0	0.9	0.1	0.0	0.7	0.1	0.3	0.1	1.8	0.1	0.0	0.0	0.7	0.3	0.0	0.4	0.0	0.3	0.1	1.2	0.3	0.1	0.2
CFHR3	"CFHL3, DOWN16, FHR-3, FHR3, HLF4"	ENSG00000116785	"Complement factor H related 3"	Q02985	1	196774813-196795407	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	581	"liver: 510.0"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 205.5"	"Cancer enriched"	"Detected in single"	80	"liver cancer: 27.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;SuSa: 1.5;T-47d: 3.6;U-266/70: 6.4"														"Secreted to blood"	NA	NA	582000000	3100000000				"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (2.86e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.06e-10)"	"unprognostic (2.67e-4)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.32e-1)"	0.8	0.2	0.2	0.2	0.4	0.1	0.2	0.0	0.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.3	0.1	0.3	510.0	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.3	0.1	0.0	0.4	0.1	0.7	0.0	0.7	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.4	0.0	0.9	0.0	0.0	0.0	0.3	0.0	1.5	3.6	0.0	0.0	0.1	0.2	0.3	0.0	6.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.6	0.3	0.1	0.2	0.1	0.1	0.2	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.5	1.8	16.0	0.1	0.0	0.1	1.7	0.0	0.0	0.0	0.0	7.1	205.5	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.7
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20774113-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 1263.3"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 283.7"	"Cancer enriched"	"Detected in many"	80	"liver cancer: 334.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"Hep G2: 208.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		50000000000	Vesicles		"CAB008639: AB_1618010, HPA055767: AB_2682912"	"unprognostic (1.68e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-9)"	"unprognostic (2.01e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.46e-1)"	0.2	0.2	0.1	0.0	0.9	0.2	0.4	1.6	0.9	0.9	70.3	0.0	0.0	2.0	0.0	0.1	0.9	0.4	0.6	1.8	0.2	0.3	1263.3	2.5	0.0	0.1	0.0	0.2	1.8	0.5	10.2	0.8	1.6	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.2	0.4	0.1	0.2	0.0	0.7	0.0	0.0	0.8	0.5	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	208.2	0.1	0.8	0.5	0.1	0.0	1.6	0.0	0.0	20.4	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	2.4	16.5	0.0	0.7	0.0	0.0	3.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.1	0.0	0.1	0.1	0.0	0.2	7.2	0.2	13.9	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.5	0.2	0.1	0.1	0.3	0.0	0.5	0.1	0.0	0.1	0.9	1.6	0.9	1.8	0.2	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.0	11.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.7	1.6	0.0	0.1	2.3	0.0	0.0	1.3	0.0	3.9	283.7	0.1	0.0	0.9	0.0	0.0	6.3	0.0	0.0	1.2	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.5	3.4	0.0	0.0
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	908	"liver: 5485.4"	"Cell type enriched"	"Detected in some"	38	"Hepatocytes: 6095.8"	"Cancer enriched"	"Detected in many"	79	"liver cancer: 571.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"Hep G2: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016725, HPA065318, HPA068847"	Approved				"Secreted to blood"	NA	NA	425000000000	190000000000			"CAB016725: , HPA065318: , HPA068847: "	"unprognostic (3.39e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-1)"	"unprognostic (6.19e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.33e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.88e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.78e-2)"	"unprognostic (5.82e-12)"	"unprognostic (2.01e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	1.1	0.8	0.8	0.1	0.7	0.1	6.0	1.0	1.0	1.6	0.6	1.1	0.4	1.0	0.2	0.5	1.6	0.3	0.9	0.7	0.8	1.4	5485.4	1.2	0.3	0.7	0.7	0.8	1.6	5.6	0.1	1.2	0.3	0.8	2.4	0.6	1.7	1.1	0.6	0.3	1.6	1.1	0.3	0.7	3.9	0.9	1.1	0.8	0.1	0.9	0.0	0.1	1.1	1.2	0.7	0.2	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.3	1.3	0.0	0.8	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.6	0.2	21.3	0.0	3.0	0.0	0.8	0.6	0.1	0.0	0.5	0.1	0.2	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.9	0.0	0.1	1.3	0.2	0.0	0.1	0.2	0.0	1.0	3.0	0.2	0.2	1.1	0.0	0.5	0.3	0.2	1.0	0.1	0.4	0.2	0.9	0.2	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	1.0	1.0	0.7	0.8	0.7	0.7	0.8	0.8	0.7	0.8	0.7	0.5	3.2	0.5	0.3	15.1	0.6	0.2	0.2	0.0	1.5	19.1	7.7	0.7	80.1	0.2	0.0	2.1	0.1	0.1	0.6	0.0	0.1	2.3	0.2	0.3	6.2	0.0	157.7	0.7	0.6	0.1	0.4	0.0	1.2	0.0	1.1	132.8	6095.8	0.2	0.0	0.8	0.7	0.0	155.3	0.2	2.9	0.3	0.2	0.0	1.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.7	0.2	0.0	1.0	2.1	0.0	0.4	0.5	0.6	0.5	0.0	0.3	0.0	11.3	0.2	0.5	0.3
SLC10A1	NTCP	ENSG00000100652	"Solute carrier family 10 member 1"	Q14973	14	69775416-69797241	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	158	"liver: 430.4"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 147.2"	"Cancer enriched"	"Detected in some"	79	"liver cancer: 65.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042727	Approved					NA	NA					"HPA042727: AB_10960691"	"unprognostic (3.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.51e-3)"	"prognostic favorable (9.53e-6)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	0.0	0.0	0.8	0.1	0.6	0.4	0.0	2.7	1.6	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.5	0.4	0.1	430.4	0.0	0.0	0.6	0.8	0.2	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.8	0.6	2.7	1.6	1.5	0.4	0.6	0.8	0.2	1.0	0.2	0.6	1.5	0.4	0.0	0.0	1.3	0.6	0.1	0.1	0.4	0.0	0.6	0.2	0.1	0.5	5.7	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.0	1.1	0.1	0.6	0.7	0.0	2.7	4.2	0.0	0.1	0.6	0.5	0.6	0.0	0.1	1.4	147.2	0.1	0.0	2.7	0.0	2.0	3.8	0.0	5.4	0.0	0.3	0.0	2.8	0.0	0.2	0.0	3.0	2.4	0.0	0.1	0.0	0.5	0.1	0.2	0.0	0.1	0.2	0.0	3.4	0.7	0.1	0.0	0.2	0.0	0.3	1.7	0.2	0.0	0.1
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324532	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	103	"liver: 536.1"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 440.0"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	17000000000			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	4.2	0.6	0.0	0.6	0.0	0.1	0.7	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.5	0.2	536.1	0.1	0.0	0.6	0.5	0.5	0.6	0.1	0.0	0.8	0.0	0.6	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.5	5.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.6	0.5	0.5	0.6	0.5	0.5	0.6	0.3	0.5	0.6	0.0	0.0	1.5	7.2	1.1	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.6	18.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	3.0	13.5	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.1	8.9	440.0	0.0	0.0	0.2	0.2	0.0	13.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.6	0.5	0.4	0.2	0.0	0.1	0.0	0.6	0.5	0.3	0.1
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138118305	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	82	"liver: 430.4"	"Group enriched"	"Detected in some"	31	"Early spermatids: 65.4;Hepatocytes: 110.3;Late spermatids: 126.1"	"Cancer enriched"	"Detected in single"	77	"liver cancer: 20.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 12.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol		No	NA		61000	Nucleoplasm	Cytosol	"HPA057002: AB_2683308"	"unprognostic (2.38e-1)"	"unprognostic (1.65e-2)"			"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (9.91e-5)"	"unprognostic (6.11e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.67e-2)"	0.0	0.1	0.2	0.0	0.1	0.2	5.2	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	430.4	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	12.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	65.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	110.3	0.4	0.0	0.2	0.2	0.0	3.2	0.4	126.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	1.6	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.2
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81329996-81394179	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 101.5"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 36.2"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA037723			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			Cytosol	"Nucleoplasm, Cytokinetic bridge"	"HPA037723: AB_10672606"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.6	2.7	101.5	0.0	0.0	0.4	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.3	0.4	0.6	0.4	0.4	0.5	0.4	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	8.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	36.2	0.5	0.0	1.2	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	3.4	4.2	0.0	0.0	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0
G6PC	"G6PC1, G6PT, GSD1a"	ENSG00000131482	"Glucose-6-phosphatase catalytic subunit"	P35575	17	42900797-42914438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 75.7;liver: 289.1"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 246.2;Proximal enterocytes: 176.2"	"Cancer enriched"	"Detected in some"	72	"liver cancer: 151.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052324	Enhanced					NA	NA					"HPA052324: AB_2681790"				"unprognostic (4.23e-2)"	"unprognostic (1.49e-2)"		"prognostic favorable (5.42e-5)"				"unprognostic (8.37e-2)"		"prognostic favorable (3.79e-5)"	"unprognostic (4.79e-2)"	"unprognostic (6.46e-2)"		"unprognostic (2.56e-3)"	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.4	0.2	0.0	0.2	0.1	19.8	0.0	0.1	0.0	0.0	4.1	0.0	0.2	0.2	75.7	289.1	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	30.2	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	28.6	0.0	1.8	0.0	0.0	0.0	0.0	1.9	0.7	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.5	246.2	0.1	0.0	0.0	2.1	0.0	3.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	176.2	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.2
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047239	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	64	"liver: 480.4"	"Cell type enriched"	"Detected in some"	52	"Hepatocytes: 658.6"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Group enriched"	"Detected in some"	5	"cerebellum: 5.6;pons: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	820000000	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	1.7	1.3	0.0	1.8	0.0	7.5	2.3	5.6	0.7	2.3	0.0	2.7	1.6	2.8	0.0	1.2	2.8	1.2	1.3	0.4	0.0	1.0	480.4	1.9	2.7	0.0	0.0	0.0	2.9	2.9	0.0	2.4	0.6	2.3	1.6	0.0	7.0	2.5	0.0	5.2	5.3	3.5	0.0	0.0	2.5	2.4	1.5	0.0	0.0	1.9	0.0	0.0	2.1	1.7	0.0	0.5	0.3	2.6	1.6	0.0	0.1	0.4	0.7	0.0	0.0	0.0	1.2	1.0	2.3	0.6	0.0	0.5	0.7	0.0	0.0	0.0	0.6	2.3	1.3	2.7	16.4	0.0	2.0	1.5	0.0	0.0	0.1	0.0	1.8	0.0	1.7	0.7	0.5	0.0	0.5	0.6	1.1	0.3	0.2	0.7	1.6	0.9	0.6	0.0	1.3	1.7	0.7	0.9	0.4	0.4	1.6	0.6	1.2	1.2	0.9	0.5	0.8	0.5	0.5	0.9	1.5	0.5	1.7	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.7	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.1	0.9	0.2	0.0	0.6	0.2	0.2	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	5.3	9.5	0.0	0.0	0.1	0.0	0.1	1.3	0.0	8.2	658.6	0.1	0.0	8.3	0.0	0.0	12.6	0.3	0.0	0.0	0.0	1.8	1.9	0.0	0.1	0.0	8.0	10.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	0.4	0.0	0.7	0.2	0.0	0.0	0.4	0.6	0.0	0.8	0.1	0.0	0.1
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 348.9"	"Group enriched"	"Detected in some"	13	"Erythroid cells: 152.8;Hepatocytes: 455.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"basophil: 2.5;eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Group enriched"	"Detected in some"	11	"HEL: 69.7;HMC-1: 92.7;K-562: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA		410000	"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.0	0.2	0.0	0.0	0.1	22.7	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	348.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.7	0.0	7.2	0.0	1.6	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	65.8	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.3	2.1	0.3	0.9	0.4	0.0	8.5	0.3	0.6	1.2	10.0	0.8	0.0	8.4	0.1	1.7	0.1	0.0	0.4	5.8	0.1	0.6	1.2	0.0	152.8	5.4	0.2	1.1	0.5	1.5	0.2	0.0	0.2	7.1	455.7	0.3	21.9	5.4	0.3	0.0	8.6	1.7	8.4	0.0	0.4	0.0	1.0	0.2	0.4	6.2	1.5	0.7	0.1	0.1	0.0	0.4	0.6	0.1	0.1	0.3	1.9	0.0	0.4	0.7	0.7	2.9	0.2	0.6	0.1	2.6	0.1	0.6	0.5
NR1I3	"CAR, CAR1, MB67"	ENSG00000143257	"Nuclear receptor subfamily 1 group I member 3"	Q14994	1	161229666-161238244	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 171.3"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 134.8;Proximal tubular cells: 47.1"	"Cancer enriched"	"Detected in single"	67	"liver cancer: 17.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA051365			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051365: AB_2616454"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-2)"	"unprognostic (9.33e-2)"	"unprognostic (6.92e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.62e-2)"	0.1	0.1	0.2	0.0	2.0	0.6	0.0	0.4	0.8	0.0	0.0	0.1	2.4	0.1	0.0	0.2	0.1	0.0	0.4	0.1	0.0	10.1	171.3	0.2	0.2	1.0	0.1	0.1	0.1	0.2	0.0	1.7	0.0	0.5	0.1	0.0	1.0	0.0	0.0	1.5	1.2	3.6	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.1	0.4	0.4	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	3.8	0.1	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.9	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.2	0.0	0.3	0.1	0.2	0.7	0.7	0.5	0.4	0.3	0.2	0.0	0.7	0.8	0.6	0.1	1.2	0.1	0.5	0.8	0.5	0.8	0.2	0.3	0.6	0.1	0.6	1.0	0.5	0.2	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.4	0.8	0.1	0.0	1.0	0.1	0.1	0.5	0.0	0.2	0.6	0.8	22.4	11.7	0.0	1.3	0.6	1.2	0.1	0.0	0.7	0.2	0.1	0.5	5.7	5.0	3.7	0.0	0.1	0.2	0.2	3.9	0.1	1.7	0.1	0.2	2.3	0.0	8.0	0.4	0.0	0.2	1.9	0.0	0.1	13.3	0.1	3.9	134.8	0.3	0.0	0.6	0.0	0.0	4.1	1.1	3.1	0.3	1.8	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.1	0.0	0.4	0.8	0.5	5.0	47.1	4.4	1.6	0.0	2.4	0.5	0.2	0.2	0.0	0.0	0.0	1.6	0.1	0.3	0.9
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"liver: 847.6"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 878.6"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 110.0;myeloid DC: 64.1"	"Group enriched"	"Detected in many"	51	"dendritic cells: 64.1;monocytes: 110.0"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 528.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA		14000000	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	1.2	0.3	0.8	8.0	0.9	7.0	0.5	0.8	1.5	0.4	1.5	0.5	0.3	0.3	0.1	0.5	0.6	17.8	0.4	1.1	1.2	1.2	847.6	2.5	0.9	1.1	0.9	0.7	0.2	0.5	0.1	0.2	0.5	0.9	0.4	0.4	0.0	0.5	0.2	0.2	5.3	0.6	1.3	1.0	6.9	0.5	0.5	1.2	0.5	0.3	0.1	1.1	2.0	0.4	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	528.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	42.3	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	1.0	110.0	0.8	0.1	11.2	0.2	0.0	0.0	0.0	64.1	0.0	0.1	0.0	1.7	0.1	0.1	1.6	0.3	31.8	0.8	0.9	0.8	1.5	1.1	1.2	1.1	0.9	0.7	0.9	1.0	1.2	1.5	0.0	0.0	5.1	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	150.2	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	0.4	0.0	0.0	1.3	7.1	19.6	1.9	0.0	0.2	0.1	0.0	0.1	2.5	0.0	16.1	878.6	8.4	0.0	0.1	0.1	0.0	41.1	7.7	0.7	0.0	19.6	0.0	0.0	15.3	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	6.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.3	0.4	1.4	0.0	0.0	0.1
SLC22A25	"HIMTP, MGC120420, UST6"	ENSG00000196600	"Solute carrier family 22 member 25"	Q6T423	11	63163776-63229652	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	17	"liver: 11.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.4;Hepatocytes: 6.4;Inhibitory neurons: 1.2;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 1.2"	"Cancer enriched"	"Detected in single"	66	"liver cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA039390	Uncertain					NA	NA					"HPA039390: AB_10671996"	"unprognostic (3.19e-2)"				"unprognostic (2.38e-1)"	"unprognostic (4.51e-1)"	"prognostic favorable (7.04e-4)"							"unprognostic (1.01e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.4	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945798	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 49.5;kidney: 48.4;liver: 112.2"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 38.6;Hofbauer cells: 54.3;Proximal enterocytes: 86.9;Proximal tubular cells: 93.4"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019551, HPA056247"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nuclear speckles, Cytosol"	"HPA019551: AB_2670187, HPA056247: "	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.3	0.0	0.0	38.2	0.0	0.6	0.1	0.7	0.2	1.0	0.1	0.2	48.4	112.2	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.2	0.2	1.2	0.6	0.0	0.0	0.0	0.1	0.0	1.5	0.0	49.5	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.8	0.3	0.0	0.6	0.5	0.2	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.3	2.2	4.3	0.6	7.3	0.0	0.5	0.0	0.0	11.7	3.0	0.0	0.4	0.1	0.1	0.0	0.0	0.5	0.0	0.5	0.4	0.0	0.6	0.0	0.0	0.4	38.6	54.3	0.0	0.5	2.8	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.5	1.1	0.3	2.5	0.0	0.0	0.0	86.9	93.4	1.4	0.0	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.3	1.5	0.1
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 5193.5"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 975.2"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		20000000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	1.6	0.8	0.5	0.4	0.5	0.5	4.4	1.2	1.2	1.0	0.0	0.6	165.6	0.2	0.5	0.8	0.3	0.4	0.1	0.6	0.5	1.5	5193.5	0.2	0.2	0.3	0.1	0.2	0.1	0.4	0.1	0.0	0.2	0.5	0.3	0.6	0.8	2.7	0.5	0.6	0.6	23.1	0.1	0.0	0.6	0.6	1.0	0.3	0.0	0.4	2.2	0.1	0.4	3.4	0.8	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.4	22.2	0.0	1.6	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.8	0.0	0.1	0.1	0.5	0.3	0.0	0.1	0.1	1.6	0.5	0.0	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.0	0.4	0.4	0.6	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	1.2	1.2	0.6	0.5	0.3	0.1	0.2	0.5	0.0	0.3	0.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.5	0.2	1.8	0.0	0.0	0.0	0.8	0.0	0.0	26.9	0.7	0.6	1.1	0.0	45.5	0.1	0.6	0.0	1.0	0.0	0.3	0.0	0.0	16.1	975.2	0.0	0.0	0.0	1.1	0.0	27.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.8	0.0
C8G		ENSG00000176919	"Complement C8 gamma chain"	P07360	9	136945185-136946975	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 569.1"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1134.7"	"Cancer enriched"	"Detected in all"	58	"liver cancer: 260.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HMC-1: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046269	Approved				"Secreted to blood"	NA	NA		2800000000			"HPA046269: AB_2679606"	"unprognostic (5.00e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.05e-2)"	0.3	1.5	0.1	0.0	0.1	0.0	0.3	0.2	0.3	0.3	0.0	1.3	31.5	0.4	0.9	0.6	0.4	2.5	1.0	0.1	0.0	2.3	569.1	0.3	0.1	0.1	0.1	0.0	0.1	0.3	0.0	0.6	0.0	0.1	0.4	0.3	0.0	0.4	0.1	3.2	0.3	17.9	0.0	0.1	2.1	1.3	2.3	0.1	0.2	0.7	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.4	0.0	0.0	41.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.0	0.0	0.3	2.3	0.4	0.2	0.4	0.0	0.0	0.4	0.9	0.7	28.6	0.3	0.0	2.1	0.4	1.1	25.0	0.0	0.2	0.9	0.1	0.1	0.7	1.8	8.0	0.2	0.8	1.0	0.1	0.0	0.3	8.9	1.2	17.5	1134.7	0.3	0.0	0.2	5.0	0.0	25.3	0.2	1.5	0.0	0.2	0.0	0.0	0.0	1.1	4.1	0.5	0.1	0.5	4.7	0.7	0.0	0.4	122.3	6.7	0.1	0.5	0.0	0.3	0.3	0.7	0.6	0.5	0.4	3.4	1.8	0.2	2.0	0.2
GBP7	"FLJ38822, GBP4L"	ENSG00000213512	"Guanylate binding protein 7"	Q8N8V2	1	89131742-89176009	"Predicted intracellular proteins"		Antimicrobial		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	156	"liver: 101.0"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 4.7;Hepatic stellate cells: 5.7;Hepatocytes: 16.3;Theca cells: 4.1"	"Cancer enriched"	"Detected in single"	58	"liver cancer: 10.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051245	Uncertain					NA	NA					"HPA051245: AB_2681404"	"unprognostic (4.22e-5)"	"unprognostic (7.32e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.66e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.80e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.35e-2)"	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	101.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	1.3	0.8	0.0	0.8	0.2	0.0	0.0	0.1	0.1	0.6	1.5	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.2	0.1	4.7	0.0	0.0	0.6	0.0	0.1	0.6	0.0	0.2	0.0	0.3	5.7	16.3	0.9	0.0	0.8	0.0	0.0	0.8	0.0	0.1	0.6	0.7	0.0	1.9	0.5	3.0	3.1	0.0	0.3	0.1	0.0	0.4	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.3	0.6	0.0	0.4	0.0	0.0	0.0	1.1	4.1	0.0	0.7
TNP1		ENSG00000118245	"Transition protein 1"	P09430	2	216859458-216860064	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1159	"testis: 5999.9"	"Group enriched"	"Detected in some"	205	"Early spermatids: 41424.6;Late spermatids: 136509.6"	"Group enriched"	"Detected in some"	58	"liver cancer: 6.0;testis cancer: 4.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044387	Enhanced					NA	NA					"HPA044387: AB_2678923"															"unprognostic (1.67e-1)"			0.9	0.9	0.9	0.5	4.0	0.0	4.0	1.6	1.7	0.8	0.0	0.9	0.8	0.6	0.0	0.8	0.6	0.0	0.7	1.8	0.7	1.1	2.0	0.6	0.1	0.5	0.2	1.7	0.8	1.3	0.0	0.8	0.0	1.3	5.1	0.0	0.0	0.8	0.0	2.4	1.4	1.6	0.0	0.0	0.6	1.0	5999.9	0.9	0.0	2.4	0.0	0.0	0.6	0.5	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.0	1.6	1.7	1.8	0.7	0.5	0.2	1.7	1.3	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41424.6	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136509.6	410.1	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	246.7	0.0	0.0	0.0	0.0	0.0	0.0	249.8	0.0	0.1	433.2	234.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0
MAT1A	"MAT, MATA1, SAMS, SAMS1"	ENSG00000151224	"Methionine adenosyltransferase 1A"	Q00266	10	80271820-80289658	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 1357.4"	"Cell type enriched"	"Detected in some"	55	"Hepatocytes: 5534.4"	"Cancer enriched"	"Detected in many"	54	"liver cancer: 209.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048627	Supported					NA	NA		1900000			"HPA048627: AB_2680465"	"unprognostic (6.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.59e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.98e-2)"	0.5	0.5	0.6	0.1	0.6	0.0	0.4	0.2	0.4	0.1	0.8	0.2	0.2	0.1	58.0	0.1	1.2	0.0	0.2	0.1	0.6	0.9	1357.4	0.4	0.1	0.4	0.7	0.1	6.4	44.1	0.1	0.9	0.1	0.5	0.0	0.0	0.0	0.3	2.0	0.0	3.8	0.0	0.2	0.9	0.6	0.2	3.7	0.4	0.4	0.4	0.0	0.0	0.5	0.1	0.2	6.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.3	0.0	3.2	0.1	0.0	0.0	0.0	0.3	0.5	1.6	0.0	94.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.1	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	1.0	0.2	0.0	0.5	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.2	0.4	0.1	0.6	0.4	0.7	0.1	0.5	0.9	0.4	0.2	0.0	0.0	0.5	0.0	8.8	2.0	0.1	0.4	0.0	0.0	0.2	0.6	0.7	67.2	0.9	1.8	0.0	0.0	0.0	0.0	1.9	0.1	23.9	3.0	0.0	5.3	0.0	69.5	0.1	4.6	0.0	0.0	0.0	0.2	0.0	7.6	76.8	5534.4	0.1	0.0	0.0	0.0	0.0	100.4	0.6	5.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.0	0.1	0.0	0.6	10.2	0.0	0.0	0.0	0.2	2.7	0.3	0.0	2.7	0.0	6.0	1.0	0.0	0.0
HPR		ENSG00000261701	"Haptoglobin-related protein"	P00739	16	72063148-72077246	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 818.5"	"Group enriched"	"Detected in some"	14	"Hepatocytes: 503.0;Smooth muscle cells: 128.8"	"Cancer enriched"	"Detected in some"	53	"liver cancer: 185.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 50.6"									HPA047750	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	49000000000	55000000000	Vesicles		"HPA047750: AB_2680146"	"unprognostic (2.43e-1)"		"unprognostic (4.69e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.42e-1)"		"unprognostic (2.32e-3)"	"unprognostic (2.36e-1)"		"unprognostic (1.66e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.44e-6)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"		3.6	0.5	16.0	0.2	17.1	0.1	2.0	16.1	16.5	1.1	13.4	1.1	0.6	0.3	0.4	0.3	1.3	0.7	80.7	15.9	15.9	3.9	818.5	1.5	0.7	16.7	16.8	15.0	2.0	0.6	0.0	0.3	0.0	16.0	1.6	0.1	0.8	0.3	0.3	1.7	0.6	1.1	0.1	14.5	0.3	1.7	1.9	17.0	0.2	1.1	0.2	0.1	0.4	1.9	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.6	2.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.2	0.0	0.1	0.0	0.6	0.6	0.0	16.0	17.1	16.1	16.5	15.9	15.9	16.7	16.8	15.0	16.0	14.5	17.0	15.3	0.0	0.0	7.5	2.3	0.4	0.1	0.0	0.9	0.0	0.1	0.0	0.0	22.4	12.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.8	0.0	5.3	0.2	0.2	0.0	2.6	0.0	0.0	0.0	1.1	10.8	503.0	0.0	0.0	0.2	0.0	2.0	12.8	0.0	2.8	9.9	0.0	0.0	0.0	0.0	4.9	0.0	0.0	1.2	0.0	0.0	5.3	0.0	0.0	0.0	13.0	0.2	0.1	0.0	6.1	128.8	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.2	0.0
SULT2A1	"DHEA-ST, STD"	ENSG00000105398	"Sulfotransferase family 2A member 1"	Q06520	19	47870467-47886315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 1081.0"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1578.7"	"Cancer enriched"	"Detected in some"	52	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	34	"Hep G2: 39.6;RT4: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB018755, HPA041487, HPA063633"	Enhanced		Supported	Cytosol		NA	NA		1200000	Cytosol		"CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066"			"unprognostic (2.14e-1)"				"unprognostic (6.79e-3)"							"unprognostic (6.82e-2)"	"unprognostic (1.36e-1)"		"unprognostic (1.31e-2)"	0.1	237.6	0.3	0.1	0.2	0.4	0.0	0.5	0.5	0.0	0.4	0.6	60.1	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	1081.0	0.0	0.2	0.1	0.2	0.3	0.1	0.1	37.2	0.0	0.1	0.3	0.1	0.9	1.0	0.1	3.1	0.1	0.3	87.3	0.0	0.0	0.4	24.6	4.2	0.3	0.0	0.1	0.0	0.1	2.0	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	39.6	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.5	0.3	0.0	26.7	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.1	2.9	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.4	0.4	0.3	0.8	0.5	0.1	0.3	0.2	0.2	0.3	0.2	0.5	0.5	0.2	0.1	0.1	0.2	0.3	0.3	0.0	0.3	0.6	0.0	0.0	0.0	0.3	2.9	0.1	0.6	0.0	0.0	1.3	0.0	0.0	0.6	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	18.7	0.3	0.0	0.0	0.3	5.1	0.1	0.0	0.1	30.0	1578.7	0.0	0.0	0.3	2.8	0.0	31.8	0.4	0.2	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	8.8	0.4	0.0	0.3	171.7	0.1	0.0	2.7	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.5	1.8	81.7	2.2	0.3
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280460-94293268	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	104	"liver: 349.8"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 259.1"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 21.2"	"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	3960000000	4700000000	Nucleoplasm	Cytosol	"HPA048739: AB_2797237"	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.4	0.4	0.5	0.6	0.9	3.3	0.7	3.3	1.5	0.5	0.4	0.7	0.7	0.7	0.5	0.4	0.3	0.5	0.6	0.5	0.6	0.5	349.8	0.4	0.8	1.8	0.9	0.0	0.9	0.5	0.2	0.2	0.5	1.4	0.4	0.7	3.1	0.4	0.4	0.5	1.7	0.7	0.6	0.3	0.7	0.7	0.6	0.9	1.3	0.7	0.4	0.4	0.2	0.1	2.1	0.6	0.2	1.8	0.7	0.7	0.6	0.4	0.5	0.5	0.9	0.8	2.7	0.6	2.1	0.3	0.4	0.2	0.4	2.2	0.5	1.3	0.8	1.4	2.0	0.8	21.2	0.4	1.6	1.1	0.6	0.5	0.3	0.7	1.1	1.0	1.1	0.5	1.3	1.0	0.3	1.4	0.8	0.8	0.2	0.6	0.9	1.2	0.9	0.5	0.7	0.9	0.8	0.4	0.4	0.2	1.0	0.9	0.9	0.6	0.7	0.4	0.7	0.6	1.1	0.5	0.9	0.9	1.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	3.3	1.5	0.5	0.6	1.8	0.9	0.0	1.4	0.3	0.9	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	2.8	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	6.6	8.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	3.3	259.1	0.0	0.0	0.0	0.4	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
APOA1		ENSG00000118137	"Apolipoprotein A1"	P02647	11	116835751-116837622	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Amyloidosis, Atherosclerosis, Cancer-related genes, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 19406.1"	"Group enriched"	"Detected in many"	21	"Hepatocytes: 27332.1;Proximal enterocytes: 18348.1"	"Cancer enriched"	"Detected in many"	48	"liver cancer: 4515.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	17	"Hep G2: 3460.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016778, HPA046715"	Supported		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1450000000000	110000000000	Vesicles	Cytosol	"CAB016778: , HPA046715: AB_2679768"	"unprognostic (1.88e-3)"	"unprognostic (4.53e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (5.05e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.67e-8)"	"unprognostic (3.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.54e-2)"	1.8	1.4	1.0	3.7	1.0	0.0	2.1	1.0	1.4	0.7	0.9	4.8	1724.8	3.5	0.4	1.1	6.2	1.7	42.7	0.9	2.5	3.8	19406.1	2.7	3.3	0.9	1.0	0.9	23.3	2.5	0.0	4.3	1.6	0.9	1.2	0.2	0.1	0.7	1.0	0.8	0.9	4087.0	2.1	1.0	9.0	14.7	387.5	1.0	0.9	3.7	0.2	0.1	0.5	1.5	1.1	0.0	0.0	0.6	0.1	0.0	0.0	15.0	0.0	0.0	0.0	0.0	203.4	0.3	3.1	6.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	7.3	1.9	3460.4	0.0	16.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.2	0.3	15.0	1.2	1.2	0.1	0.5	15.0	20.3	0.0	2.6	5.7	20.7	8.9	0.0	0.0	3.9	0.0	0.1	2.6	0.0	0.4	2.1	0.1	1.2	0.2	4.9	0.0	5.5	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.5	0.2	0.1	0.2	0.5	0.0	0.2	0.0	1.2	0.6	0.1	1.0	1.0	1.0	1.4	0.9	2.5	0.9	1.0	0.9	0.9	1.0	1.0	1.1	2.0	3.2	3.3	0.3	49.7	0.1	0.5	0.2	0.6	0.5	0.9	0.9	37.0	479.0	1.3	0.0	0.0	0.6	5.1	0.4	0.0	0.1	36.9	15.2	4.3	50.3	1.8	541.9	0.5	1.1	4.2	5.8	17.9	1.7	2.5	419.2	458.7	27332.1	3.3	0.0	0.8	458.8	0.0	681.2	2.0	149.7	22.4	2.1	0.0	0.0	0.0	0.3	3.1	0.0	0.3	0.3	458.2	4.9	1.0	0.1	18348.1	9.0	0.4	0.6	6.6	1.6	13.0	39.8	11.2	0.0	0.6	4.2	35.7	1051.7	175.7	0.3
CYP8B1	CYP12	ENSG00000180432	"Cytochrome P450 family 8 subfamily B member 1"	Q9UNU6	3	42856005-42875898	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"liver: 407.9"	"Cell type enriched"	"Detected in some"	76	"Hepatocytes: 920.2"	"Cancer enriched"	"Detected in some"	46	"liver cancer: 69.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;SK-BR-3: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (5.86e-3)"	"unprognostic (2.74e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.24e-1)"	0.3	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.9	0.2	0.1	0.5	0.1	0.3	0.1	14.6	407.9	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	1.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	5.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.9	920.2	0.1	0.0	0.0	0.0	0.0	10.7	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131470832-131584332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 1213.5"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 991.4"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 44.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 44.9"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 2.4"	"Low region specificity"	"Detected in all"			"HPA003595, CAB009434, HPA024006, CAB056159, CAB080011"	Enhanced					NA	NA		9500000			"CAB009434: AB_2058955, CAB056159: AB_2665582, CAB080011: , HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	2.2	0.2	0.2	0.3	0.1	294.9	4.9	1.0	0.4	0.2	0.3	0.2	0.0	0.1	0.0	2.2	1.9	0.0	0.8	0.2	0.2	0.3	1213.5	6.6	0.3	0.5	0.2	0.1	0.2	0.4	0.0	0.2	1.7	0.6	0.3	0.0	0.3	0.9	0.0	0.5	74.8	0.3	0.2	0.0	20.8	0.4	0.1	0.1	1.3	0.5	0.6	0.7	0.2	2.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.2	0.7	0.3	44.9	0.0	0.9	0.2	9.3	0.4	0.2	0.1	1.0	0.4	0.2	0.2	0.5	0.2	0.1	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	1.5	0.0	43.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.2	991.4	0.0	0.0	0.1	0.1	0.0	27.6	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1
CYP3A7	"CP37, P450-HFLA"	ENSG00000160870	"Cytochrome P450 family 3 subfamily A member 7"	P24462	7	99705036-99735196	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 307.5"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 85.8;Hepatocytes: 60.5"	"Cancer enriched"	"Detected in some"	43	"liver cancer: 38.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.3;Hep G2: 2.5;HHSteC: 1.4"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (8.10e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-11)"	"unprognostic (2.02e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.34e-3)"	0.1	0.9	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.2	0.5	0.3	0.3	0.1	0.0	6.6	0.0	0.0	0.1	8.6	307.5	2.4	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.1	85.8	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.3	60.5	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	3.8	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	1.3	0.0	0.2
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583128-154590745	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	387	"liver: 18550.1"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 17365.8"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 429.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016776, HPA051370, HPA064755"	Supported		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	140000000000	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			1.2	1.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.5	0.0	0.6	0.6	0.7	0.9	13.4	1.1	0.0	0.0	18.3	18550.1	5.4	0.1	0.0	0.0	0.0	0.7	18.9	0.0	0.5	0.9	0.0	0.4	0.0	0.0	0.5	0.0	0.5	0.6	0.9	0.0	0.0	10.0	47.9	3.8	0.0	0.1	0.4	0.0	0.1	0.6	0.8	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	2.7	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.1	429.3	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.5	6.1	0.0	0.0	0.5	0.2	0.1	3.5	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	1.0	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	414.6	3.2	0.0	0.0	0.0	0.0	0.0	1.9	38.6	28.3	0.1	0.2	8.1	0.0	205.9	0.0	1.8	0.1	0.1	1.1	1.3	0.0	0.0	238.8	17365.8	0.1	0.0	0.0	0.0	0.0	328.3	0.0	46.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	1.2	0.0	0.0	0.0	2.3	9.5	0.0	0.0	0.0	0.1	17.4	0.7	0.0	0.0	0.1	17.6	0.0	0.0	0.0
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101354182-101385400	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"liver: 727.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 996.7"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.4;CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		NA	NA		520000	Vesicles		"HPA021251: AB_1845247, HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.1	0.0	0.3	0.0	0.5	1.2	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.6	0.1	0.5	0.3	0.3	727.0	0.4	0.0	0.4	0.4	0.3	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	3.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.4	0.8	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	1.0	0.5	0.3	0.4	0.4	0.3	0.5	0.0	0.3	0.7	0.3	0.0	0.0	0.7	2.4	0.0	0.1	0.0	0.0	1.1	0.3	0.1	0.7	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.1	0.7	0.0	16.0	9.7	0.2	0.0	0.1	0.0	0.1	0.0	0.0	12.1	996.7	0.0	0.0	7.2	0.0	0.0	18.2	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	3.0	0.9	1.8	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.4	0.0
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154563011-154572807	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	387	"liver: 18093.6"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 17273.6"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 249.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		110000000000	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			1.1	0.8	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.8	0.0	0.5	0.0	0.6	0.3	0.6	0.8	0.4	1.1	0.0	0.0	46.7	18093.6	0.5	0.1	0.0	0.0	0.0	0.6	3.3	0.0	0.5	1.0	0.0	0.4	0.0	0.0	0.4	0.0	0.5	0.5	1.2	0.0	0.0	12.2	6.9	0.5	0.0	0.3	0.4	0.0	0.1	0.5	0.7	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	2.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.2	0.1	249.9	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.8	0.0	0.9	0.0	2.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	39.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	251.6	0.0	3.7	0.0	0.0	0.0	0.0	1.9	10.6	0.5	0.6	0.8	13.1	1.8	302.1	0.0	3.8	0.2	0.0	0.0	5.9	0.0	0.0	318.1	17273.6	0.3	0.0	0.0	0.0	0.0	421.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.7	0.0	0.0	0.0
TF	"PRO1557, PRO2086"	ENSG00000091513	Transferrin	P02787	3	133746040-133796641	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Ion transport, Iron transport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 7587.8;retina: 2454.2"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 7205.2;Muller glia cells: 12965.3"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 783.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	48	"Hep G2: 780.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001527, HPA005692, CAB009538"	Enhanced				"Secreted to blood"	NA	NA	19800000000000	98000000000			"CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354"	"prognostic favorable (4.05e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavorable (2.35e-13)"	"unprognostic (2.17e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.47e-3)"	"unprognostic (9.70e-2)"	81.6	1.2	185.9	1.0	365.1	2.5	13.4	536.0	234.5	2.0	50.7	1.9	0.9	1.7	1.4	11.0	1.5	2.0	12.2	152.7	330.6	3.5	7587.8	1.9	1.3	657.3	377.2	118.2	2.1	4.6	2.3	4.4	1.3	536.4	5.5	1.2	2454.2	56.2	1.8	2.1	3.1	1.6	1.5	523.9	3.0	1.9	14.4	362.7	1.2	2.2	2.7	3.0	1.3	2.8	812.0	1.9	1.4	1.8	1.2	5.5	3.4	0.9	1.9	2.0	1.0	0.8	3.4	1.5	1.7	1.6	1.8	1.2	2.1	1.3	1.8	1.5	1.1	0.7	16.3	2.7	780.9	1.3	4.6	2.7	2.4	3.8	1.0	1.7	1.8	2.2	0.9	6.4	2.1	2.6	1.3	1.1	1.2	1.2	1.2	1.8	1.5	2.9	1.2	1.1	3.1	1.9	1.4	2.4	2.6	7.0	1.3	1.9	1.3	2.9	2.4	1.5	1.6	1.1	1.7	3.0	1.4	2.0	1.5	1.6	0.6	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	185.9	365.1	536.0	234.5	152.7	330.6	657.3	377.2	118.2	536.4	523.9	362.7	812.0	0.7	16.0	32.4	36.2	11.4	1.0	5.6	0.6	0.0	101.3	5.3	4.3	2.7	117.2	22.9	0.0	91.8	0.2	0.2	0.1	1.9	0.7	5.4	0.8	1.0	16.7	0.0	56.2	34.2	1.1	0.3	3.9	0.0	0.6	17.7	1.3	87.4	7205.2	0.1	47.1	34.7	0.0	0.0	124.7	0.3	3.8	0.3	4.7	0.0	9.4	0.6	12965.3	0.0	45.2	1077.2	1.1	0.0	0.4	0.0	18.7	0.0	0.5	22.1	400.4	0.0	11.6	0.4	0.5	0.4	3.6	0.0	0.3	7.8	0.5	0.0	3.0
CYP2C9	"CYP2C10, P450IIC9"	ENSG00000138109	"Cytochrome P450 family 2 subfamily C member 9"	P11712	10	94938658-94990091	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 1734.1"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 1704.9"	"Cancer enriched"	"Detected in some"	41	"liver cancer: 118.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015066, CAB016123, HPA074424"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			Vesicles	"Plasma membrane"	"CAB016123: AB_629363, HPA015066: AB_1847433, HPA074424: "	"unprognostic (3.37e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.16e-2)"		"unprognostic (1.83e-2)"	"prognostic favorable (2.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-2)"		"unprognostic (4.93e-2)"		"unprognostic (1.26e-4)"	"unprognostic (7.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.24e-2)"	0.1	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.1	0.6	0.0	1.5	88.6	0.0	0.0	7.7	0.0	8.0	0.0	0.0	0.0	4.2	1734.1	0.2	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	2.3	46.6	0.1	0.0	0.5	18.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.6	0.2	1.8	0.0	0.0	0.0	1.5	0.0	7.6	0.0	0.8	0.7	1.1	0.0	16.0	0.0	0.7	0.0	0.2	44.4	7.4	0.0	0.0	26.7	1704.9	0.0	0.0	0.1	1.4	0.0	34.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.6	0.0	0.1	0.0	65.3	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.1	1.9	0.0	2.7	0.0
FGL1	"HFREP-1, HPS"	ENSG00000104760	"Fibrinogen like 1"	Q08830	8	17864380-17910365	"Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 4198.1"	"Cell type enriched"	"Detected in many"	27	"Hepatocytes: 8261.7"	"Cancer enriched"	"Detected in some"	40	"liver cancer: 399.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"A549: 55.4;Hep G2: 131.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		57000000				"unprognostic (3.62e-2)"	"unprognostic (1.14e-2)"		"unprognostic (1.75e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.62e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.86e-7)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.35e-1)"	0.5	0.4	1.0	0.0	1.2	0.0	1.0	0.8	1.7	0.3	0.7	0.2	0.0	0.7	0.8	0.2	0.2	0.1	0.3	1.1	2.4	0.5	4198.1	1.2	0.0	1.1	1.3	1.0	0.3	665.7	0.0	0.2	6.3	1.1	3.8	0.1	0.2	0.2	0.0	0.1	0.1	0.3	0.2	0.9	3.8	0.7	4.3	1.1	0.0	0.3	0.0	0.0	0.1	0.1	2.1	0.0	55.4	0.0	6.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	131.9	0.0	1.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	1.3	0.8	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.8	1.7	1.1	2.4	1.1	1.3	1.0	1.1	0.9	1.1	2.1	0.0	0.0	1.9	12.4	24.6	0.0	0.2	0.0	0.0	0.0	1.3	0.9	2.1	301.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	8.3	42.9	5.4	1.0	7.6	0.0	176.4	0.1	71.2	0.4	0.1	0.0	7.8	0.0	0.0	173.8	8261.7	20.4	0.0	0.3	0.0	0.0	231.6	0.0	32.7	0.6	0.2	0.0	14.0	1.6	0.0	0.0	2.5	0.0	74.1	0.0	0.4	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.0	0.0	1.0	12.8	0.1	0.3	0.2
ANGPTL3	ANGPT5	ENSG00000132855	"Angiopoietin like 3"	Q9Y5C1	1	62597520-62606313	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Lipid metabolism"	Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 681.3"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 567.6;Proximal tubular cells: 272.5"	"Cancer enriched"	"Detected in some"	39	"liver cancer: 94.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038097	Approved				"Secreted to blood"	NA	NA	225000000	120000000			"HPA038097: AB_10675628"	"unprognostic (2.29e-1)"	"unprognostic (8.01e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-3)"	"unprognostic (6.85e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.62e-2)"	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	53.5	681.3	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.3	11.5	0.0	5.5	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.1	0.1	0.7	0.0	16.0	0.1	0.2	0.1	0.0	2.6	0.3	0.0	0.0	9.7	567.6	0.1	0.0	0.1	0.0	0.0	16.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	272.5	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.0
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531482-160664275	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"	"Hydrolase, Protease, Serine protease"	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 77.3"	"Cell type enriched"	"Detected in some"	28	"Hepatocytes: 80.7"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"RT4: 1.0"									"CAB016072, HPA060604"	Supported				"Secreted to blood"	NA	NA	78800000000	1800000000			"CAB016072: AB_2135240, HPA060604: AB_2684330"		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"	0.0	0.1	1.7	0.0	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.8	0.0	0.0	0.9	4.7	0.5	77.3	0.1	0.0	1.5	1.5	1.2	0.2	0.6	0.0	0.0	0.0	1.0	0.6	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	3.3	1.1	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	0.0	1.1	0.9	4.7	1.5	1.5	1.2	1.0	0.2	3.3	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.2	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	80.7	0.0	0.0	1.3	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3
ANGPTL8	"C19orf80, RIFL, TD26"	ENSG00000130173	"Angiopoietin like 8"	Q6UXH0	19	11237450-11241943	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism"	Hormone	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"liver: 413.1"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 151.2"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 84.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"Hep G2: 37.0;MCF7: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042131			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	836000	350000	"Golgi apparatus"	Nucleoplasm	"HPA042131: AB_10794413"	"unprognostic (2.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.75e-2)"	29.8	0.9	1.5	0.2	0.5	0.1	22.7	0.0	1.7	1.2	0.2	1.2	0.4	0.9	1.6	0.3	0.8	0.4	1.3	0.7	0.4	3.9	413.1	0.5	0.1	0.9	0.5	0.0	1.1	0.9	0.0	0.3	0.1	0.4	0.8	0.0	0.1	1.3	0.1	0.8	0.8	1.3	0.1	0.2	0.4	0.7	0.6	1.5	0.0	1.0	0.0	0.0	1.1	1.0	0.7	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	1.3	37.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	21.2	0.0	0.7	0.2	0.0	0.0	0.1	0.4	1.0	0.0	0.3	0.0	0.3	0.4	0.9	0.0	0.4	0.6	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	1.7	0.7	0.4	0.9	0.5	0.0	0.4	0.2	1.5	0.7	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.4	0.2	0.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.2	0.0	2.7	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	4.6	151.2	0.1	0.0	0.0	0.0	0.0	4.4	0.0	1.9	0.9	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.0	0.1
SLC22A7	"NLT, OAT2"	ENSG00000137204	"Solute carrier family 22 member 7"	Q9Y694	6	43295694-43305538	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 431.4"	"Group enriched"	"Detected in some"	17	"Hepatocytes: 254.5;Proximal tubular cells: 91.8"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 81.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 9.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA030220	Approved					NA	NA					"HPA030220: AB_10603027"	"unprognostic (9.17e-2)"			"unprognostic (9.73e-4)"	"unprognostic (2.13e-1)"		"prognostic favorable (5.48e-6)"			"unprognostic (1.45e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"			0.0	0.0	0.4	0.0	0.5	0.0	0.0	1.7	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.1	47.8	431.4	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.7	0.8	0.4	0.1	0.4	0.0	0.2	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	254.5	0.0	0.0	0.7	0.0	0.0	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	91.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0
CYP2D6	"CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D"	ENSG00000100197	"Cytochrome P450 family 2 subfamily D member 6"	P10635	22	42126499-42130865	"Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 322.6"	"Group enriched"	"Detected in many"	35	"Hepatocytes: 512.8;Proximal enterocytes: 465.2"	"Cancer enriched"	"Detected in many"	35	"liver cancer: 90.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.8"					"Low region specificity"	"Detected in many"			HPA045223	Enhanced		Approved	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA045223: AB_10962927"	"unprognostic (4.40e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-4)"	"unprognostic (3.83e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-4)"	"unprognostic (2.11e-2)"	"unprognostic (5.61e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.82e-5)"	0.0	0.2	0.2	0.0	0.3	0.3	0.1	0.7	0.2	0.1	0.2	0.2	3.7	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	322.6	0.1	0.1	0.2	0.1	0.0	0.2	0.8	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.2	11.8	0.0	0.0	0.3	0.1	0.4	0.2	0.0	0.4	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.2	0.2	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.4	0.6	0.0	1.1	5.5	0.7	0.5	0.7	1.3	2.8	7.3	1.1	1.4	0.4	2.8	0.7	1.8	2.1	0.1	0.6	2.9	1.9	0.7	3.1	0.8	0.6	0.6	1.2	0.0	6.5	0.6	0.1	0.3	4.1	1.4	0.0	0.7	5.7	512.8	0.1	11.8	9.4	7.6	0.0	5.6	0.0	13.6	0.0	0.4	0.0	0.0	0.1	0.7	0.0	5.0	4.9	0.7	11.3	1.5	0.4	0.6	465.2	0.5	1.3	2.3	0.0	0.4	2.1	0.8	0.4	0.6	1.1	0.4	1.0	0.1	3.4	0.3
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333251	"Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	327	"liver: 8946.0"	"Cell type enriched"	"Detected in some"	41	"Hepatocytes: 10792.5"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	40	"neutrophil: 12.0"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 12.0"	"Cell line enriched"	"Detected in some"	232	"Hep G2: 831.1"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	422000000	41000000000	Vesicles	"Golgi apparatus"	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavorable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	3.1	4.1	0.9	3.2	0.3	27.3	3.0	0.1	0.2	1.3	0.2	0.3	0.2	2.1	0.1	0.4	0.4	0.6	0.7	0.1	0.2	1.8	8946.0	5.8	1.1	0.2	0.3	0.0	0.3	2.2	0.0	0.2	0.2	0.1	23.8	0.1	3.6	0.3	0.0	0.4	0.4	0.4	0.1	0.7	7.4	22.1	1.4	0.1	0.5	0.3	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	831.1	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.2	0.0	0.0	0.1	1.1	0.4	2.5	0.0	0.3	1.9	0.1	0.0	0.3	0.1	0.0	2.6	2.0	0.2	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.6	2.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.1	0.0	0.0	0.1	0.9	0.3	0.1	0.2	0.1	0.2	0.2	0.3	0.0	0.1	0.7	0.1	0.2	0.0	0.0	10.5	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	263.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.6	1.1	0.1	7.0	0.0	141.7	0.0	6.0	0.0	0.0	15.8	1.3	0.0	0.0	162.8	10792.5	0.0	0.0	0.0	0.0	0.0	236.1	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.2
CPN2	ACBP	ENSG00000178772	"Carboxypeptidase N subunit 2"	P22792	3	194339768-194351328	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 220.4"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 171.8"	"Cancer enriched"	"Detected in some"	32	"liver cancer: 72.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"Hep G2: 61.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA004732	Uncertain				"Secreted to blood"	NA	NA		25000000000			"HPA004732: AB_1078561"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.42e-1)"			"unprognostic (4.12e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (4.59e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.90e-5)"	"unprognostic (8.42e-2)"	0.4	3.1	0.5	0.4	0.6	1.5	0.2	0.6	1.0	0.2	0.0	0.2	0.0	0.4	0.4	0.1	0.2	0.4	1.0	0.8	0.4	14.8	220.4	0.2	0.3	0.3	0.2	0.5	0.3	0.1	0.1	0.0	0.4	0.4	0.2	0.2	1.1	0.2	0.1	0.1	0.6	0.2	0.2	0.0	1.2	0.4	0.7	0.4	0.1	0.3	0.0	0.2	0.1	0.0	1.2	0.2	0.1	0.3	0.3	0.1	0.8	0.2	0.3	0.1	0.0	0.0	0.4	0.2	0.2	0.3	0.8	0.4	0.5	0.1	0.0	0.2	0.1	0.2	0.3	0.6	61.8	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.3	0.5	0.6	0.0	0.3	0.2	0.3	0.3	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.3	0.2	0.3	0.2	0.4	0.3	0.2	1.4	1.6	0.2	2.1	0.2	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.6	1.0	0.8	0.4	0.3	0.2	0.5	0.4	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	171.8	0.2	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304971-99352760	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1514.9;liver: 5906.7"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 4153.7"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 6574.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		39000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	1514.9	141.5	2.7	36.7	3.0	0.1	932.4	2.3	8.1	40.9	17.5	197.2	38.8	162.8	75.5	106.6	388.3	146.5	146.7	2.2	2.1	67.3	5906.7	376.5	26.0	5.1	3.0	2.1	118.7	49.5	7.9	24.4	6.8	4.2	27.0	115.8	0.1	68.5	26.9	67.1	147.3	239.2	74.0	4.7	73.3	142.3	2.8	2.5	20.0	95.3	230.2	16.1	290.3	119.7	2.8	0.0	0.0	0.0	0.0	6574.3	956.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.0	0.0	0.5	1.4	0.0	0.1	0.0	1.1	0.1	0.0	26.9	3.0	0.0	216.8	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.2	0.3	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.0	2.3	8.1	2.2	2.1	5.1	3.0	2.1	4.2	4.7	2.5	2.8	29.0	0.0	3.4	0.0	8.1	22.3	0.5	0.1	6.8	0.1	1.1	2.5	12.2	110.1	2.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.6	0.1	0.9	14.7	0.0	115.0	0.0	0.0	0.1	633.1	11.2	0.0	1.3	0.0	96.8	4153.7	0.1	0.0	0.0	0.0	0.0	98.8	25.4	0.6	55.3	3.5	28.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.7	0.0	0.1	0.2	0.1	6.6	15.0	47.9	0.0	0.1	10.4	13.1	0.1	8.9	0.1	0.0	0.2
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420560-101449664	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	27	"intestine: 5784.2;kidney: 7248.0;liver: 11251.9"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 20078.3;Proximal tubular cells: 7956.0"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 21.4;NB-4: 21.0;RPMI-8226: 28.6;SH-SY5Y: 20.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA002198, CAB020827"	Enhanced					NA	NA		560000000			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	3.4	1.5	0.4	17.1	0.8	0.0	0.7	0.9	2.3	0.1	0.0	30.4	4110.7	2.9	1.0	0.7	0.4	178.6	1.0	2.3	0.1	7248.0	11251.9	0.5	4.9	0.1	0.1	0.4	0.5	295.1	0.0	5.7	0.4	0.4	2.1	5.6	0.3	0.3	0.0	0.4	0.4	5784.2	7.1	0.1	2.0	34.6	1.1	0.1	0.7	0.3	0.0	0.8	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.5	0.0	4.5	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	2.2	0.0	1.0	0.0	6.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.3	21.0	0.4	0.5	0.0	0.3	4.6	28.6	0.0	0.0	4.3	20.6	2.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	1.0	7.1	0.3	0.5	0.7	2.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.9	2.3	2.3	0.1	0.1	0.1	0.4	0.4	0.1	0.1	0.3	0.0	0.0	0.0	0.3	39.4	0.0	0.0	0.3	0.0	1.1	0.0	0.0	1.1	308.8	0.8	150.8	0.0	0.0	0.0	13.5	620.3	4.9	0.0	0.0	0.4	3.6	0.0	50.8	0.5	253.3	0.1	0.0	0.0	0.3	0.0	0.0	49.2	3225.4	0.2	3.3	0.2	464.9	0.0	66.2	0.0	0.0	0.0	38.1	0.0	0.0	3.6	0.3	0.0	0.0	0.3	182.1	997.4	0.0	0.1	0.0	20078.3	7956.0	0.2	0.6	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.3	20.6	0.2	412.7	0.0
SDS	SDH	ENSG00000135094	"Serine dehydratase"	P20132	12	113392445-113426301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Gluconeogenesis	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"liver: 1033.1"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 364.6;Hofbauer cells: 199.4;Langerhans cells: 111.9;Macrophages: 93.7;monocytes: 97.6"	"Cancer enriched"	"Detected in all"	31	"liver cancer: 165.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"myeloid DC: 11.6"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 11.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7;SK-BR-3: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039230	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"HPA039230: AB_10674281"	"unprognostic (1.31e-1)"	"prognostic favorable (5.24e-4)"	"unprognostic (6.37e-3)"	"unprognostic (6.94e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.99e-2)"	3.2	10.1	13.5	4.3	17.5	1.5	1.9	13.4	15.2	1.1	8.7	2.6	2.0	0.9	0.3	0.3	0.6	4.2	0.8	13.4	16.4	0.5	1033.1	6.3	0.8	30.4	17.9	10.2	0.5	1.0	0.8	1.1	2.9	16.7	1.1	2.3	3.1	2.7	0.1	0.8	0.2	2.0	0.5	10.4	1.7	2.9	0.5	19.3	0.4	1.0	0.0	0.3	3.8	0.3	12.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	1.0	0.2	0.0	0.3	0.5	0.2	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.3	0.2	0.1	0.2	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.5	0.1	0.1	1.1	0.0	0.4	13.5	17.5	13.4	15.2	13.4	16.4	30.4	17.9	10.2	16.7	10.4	19.3	12.9	0.2	0.0	0.6	15.0	5.1	2.4	0.4	0.0	0.0	0.2	0.4	1.5	0.5	17.2	0.0	0.0	0.0	0.8	0.3	0.1	0.0	2.8	0.0	0.1	0.2	1.3	0.0	29.5	0.1	0.4	1.3	0.6	0.0	0.1	0.0	0.1	18.9	364.6	199.4	0.0	0.1	0.0	0.0	45.1	111.9	0.0	0.0	93.7	1.8	0.0	97.6	1.9	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.5	0.0	0.3	0.6	0.0	0.0	0.4	3.1	2.5	2.4	0.8	0.0	0.1
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882988	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"intestine: 31.7;liver: 63.9"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 32.0;Proximal enterocytes: 13.8"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	44	"Hep G2: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019556	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.0	0.3	0.1	0.4	0.1	0.0	0.2	1.2	0.0	0.0	0.2	30.1	0.1	0.0	0.0	0.2	0.9	0.0	0.2	0.3	0.2	63.9	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	31.7	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.2	0.2	0.3	0.3	0.1	0.5	0.5	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.8	0.6	1.8	0.0	0.0	0.1	0.0	1.9	0.1	0.0	0.2	0.7	0.6	0.0	2.7	3.6	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.4	32.0	0.0	0.0	2.8	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	5.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.0
AQP9	"HsT17287, SSC1"	ENSG00000103569	"Aquaporin 9"	O43315	15	58138169-58185911	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 708.5"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 313.9;Macrophages: 82.1"	"Cancer enriched"	"Detected in many"	30	"liver cancer: 132.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 13.1"	"Immune cell enriched"	"Detected in many"	20	"neutrophil: 1161.4"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 1161.4"	"Cell line enriched"	"Detected in some"	29	"U-87 MG: 29.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA074762, CAB075684"	Enhanced					NA	NA					"CAB075684: , HPA074762: AB_2732267"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.80e-3)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (5.72e-11)"	"unprognostic (8.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.39e-2)"	18.4	0.8	0.8	73.5	1.2	68.2	2.4	1.0	13.1	1.3	1.8	0.9	0.2	1.2	43.8	1.2	7.2	5.4	1.7	3.3	3.9	0.9	708.5	22.4	0.6	1.0	1.2	1.0	0.5	1.6	5.6	0.3	6.3	4.3	0.9	0.3	0.4	1.1	0.7	0.5	20.6	0.9	6.5	0.8	43.0	1.5	0.3	5.6	1.8	0.6	7.6	0.8	32.9	0.6	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	29.7	0.1	0.0	0.2	58.4	1.2	0.1	17.5	0.1	0.5	0.1	0.0	1.8	0.1	0.1	0.0	1161.4	0.3	23.0	0.6	0.3	18.9	0.8	1.2	1.0	13.1	3.3	3.9	1.0	1.2	1.0	4.3	0.8	5.6	3.0	0.7	0.0	12.2	0.3	2.3	0.4	0.2	0.0	0.0	0.0	0.1	0.0	1.1	5.7	3.1	0.0	0.0	0.3	0.5	0.0	0.0	0.1	2.1	0.3	0.1	0.7	0.0	13.9	2.4	0.2	0.9	1.9	0.0	1.8	7.6	0.0	7.9	313.9	40.8	0.0	0.8	0.0	0.0	28.5	6.2	1.9	0.3	82.1	0.0	0.0	18.9	0.0	1.0	0.5	0.2	0.5	0.0	0.0	0.7	0.2	0.0	0.3	1.5	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.6	0.8	1.5	0.0	0.0	0.1
APOA4		ENSG00000110244	"Apolipoprotein A4"	P06727	11	116820700-116823304	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"intestine: 3138.1"	"Cell type enriched"	"Detected in some"	44	"Proximal enterocytes: 10311.5"	"Cancer enriched"	"Detected in some"	29	"liver cancer: 291.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;CACO-2: 8.0;Hep G2: 7.7;NB-4: 7.3;RPMI-8226: 12.5;SH-SY5Y: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001352, HPA002549, CAB068250, CAB068251, CAB068252"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	61200000000	74000000000	Vesicles		"CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177"							"unprognostic (8.81e-2)"				"unprognostic (2.12e-2)"			"unprognostic (1.75e-2)"	"unprognostic (7.91e-2)"			0.1	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.3	2224.9	1.8	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	259.4	0.0	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	3138.1	3.1	0.0	0.1	4.7	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	3.1	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	77.5	0.0	0.0	0.0	234.3	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	221.5	0.0	0.0	0.0	10311.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	87.7	0.0
GYS2		ENSG00000111713	"Glycogen synthase 2"	P54840	12	21536107-21604847	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"liver: 175.3"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 63.6"	"Cancer enriched"	"Detected in single"	29	"liver cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039482	Approved					NA	NA					"HPA039482: AB_10795107"	"unprognostic (7.22e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (7.62e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-4)"	2.7	0.0	0.1	0.0	0.1	0.0	1.0	0.1	0.1	1.2	0.0	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.1	0.1	0.0	0.2	175.3	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.4	63.6	0.0	0.0	7.7	0.0	6.1	1.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	5.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888360-45893660	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 1208.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 994.8"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Hep G2: 54.7;U-2197: 84.9;U-87 MG: 145.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	28100000	25000000	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavorable (6.90e-11)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	1.2	0.1	0.3	0.0	0.2	0.0	2.4	0.3	0.3	0.2	0.1	0.0	0.3	80.3	0.1	0.0	4.1	0.3	0.3	0.2	0.3	1.6	1208.7	0.1	0.1	0.8	0.4	0.2	46.6	0.5	0.0	0.5	206.2	1.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.5	0.1	0.1	0.4	1.1	0.3	0.0	0.0	0.0	0.2	0.7	0.2	6.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.3	1.4	0.1	1.6	0.3	0.0	0.0	0.7	0.0	0.0	0.3	0.5	54.7	0.3	1.1	0.1	0.1	0.7	11.3	0.1	0.6	0.3	0.0	0.2	0.1	1.3	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.3	0.0	2.2	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	84.9	0.0	0.0	0.0	0.2	145.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.3	0.2	0.3	0.8	0.4	0.2	1.0	0.3	0.4	0.7	0.4	0.0	0.5	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	5.7	1.0	35.8	0.7	0.0	0.0	0.9	0.0	0.0	0.0	11.0	0.1	4.7	94.3	0.9	3.5	10.7	0.1	0.0	1.6	1.8	0.0	15.9	0.0	2.1	6.8	994.8	1.7	0.0	0.1	0.0	0.0	14.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.7	0.1	0.5	0.0	0.0	3.4	0.8	0.0	0.0	0.0
PRAMEF10		ENSG00000187545	"PRAME family member 10"	O60809	1	12892896-12898270	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	24	"liver: 2.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	29	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA												"unprognostic (1.20e-1)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSD11B1	"HSD11, HSD11B, SDR26C1"	ENSG00000117594	"Hydroxysteroid 11-beta dehydrogenase 1"	P28845	1	209686178-209734949	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 976.2"	"Cell type enriched"	"Detected in many"	9	"Hepatocytes: 646.2"	"Cancer enriched"	"Detected in all"	28	"liver cancer: 197.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 5.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.6"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 989.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047729	Enhanced					NA	NA		110000			"HPA047729: AB_2680135"	"unprognostic (1.08e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.35e-3)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.97e-10)"	"unprognostic (3.41e-2)"	"unprognostic (3.91e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.59e-2)"	18.5	7.8	10.2	14.7	15.6	0.3	12.1	23.2	22.2	2.3	9.3	3.9	1.2	4.3	15.9	2.1	5.1	8.1	6.8	11.5	16.0	10.8	976.2	40.2	4.3	14.8	22.5	9.5	60.4	3.3	0.2	8.9	73.1	16.8	28.0	3.3	0.7	2.5	13.1	5.5	30.5	5.1	13.0	9.7	7.3	7.1	7.2	13.2	0.7	5.3	10.7	1.9	28.2	6.3	17.9	0.4	0.0	0.0	0.0	989.2	102.8	0.0	0.1	36.0	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	206.6	0.2	0.1	5.4	0.0	6.9	0.4	0.9	0.0	0.0	0.0	51.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	16.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	34.9	8.4	4.0	0.2	0.2	0.3	1.4	0.3	0.3	5.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	5.6	1.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.7	0.4	10.2	15.6	23.2	22.2	11.5	16.0	14.8	22.5	9.5	16.8	9.7	13.2	17.9	0.4	3.2	0.0	1.3	0.8	0.1	0.4	4.8	0.6	0.5	0.2	0.0	1.4	30.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.9	0.6	1.0	0.0	5.3	3.3	0.0	0.1	66.4	0.5	2.8	0.0	0.0	7.5	646.2	8.3	0.0	2.8	0.0	0.0	7.9	2.3	2.8	29.2	3.7	0.0	28.1	0.6	16.2	0.0	0.5	55.7	0.4	0.0	7.9	0.0	0.9	0.0	0.2	0.1	0.5	0.0	2.6	5.5	0.0	0.2	0.1	0.1	0.3	1.1	0.3	0.0	1.7
SHBG	"ABP, MGC126834, MGC138391, TEBG"	ENSG00000129214	"Sex hormone binding globulin"	P04278	17	7613946-7633382	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 63.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 51.6;Late spermatids: 124.5;Proximal enterocytes: 31.1"	"Cancer enriched"	"Detected in some"	28	"liver cancer: 14.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.4;Hep G2: 3.0;HSkMC: 4.3"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA		9100000000				"unprognostic (3.35e-3)"	"unprognostic (6.47e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.35e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.06e-1)"	0.7	1.3	1.7	0.0	1.5	0.1	0.4	1.5	2.0	0.6	1.5	0.2	5.3	0.5	0.9	0.2	0.6	0.3	0.6	1.6	1.5	3.5	63.9	0.3	0.1	1.6	1.4	1.4	0.7	0.4	0.5	0.7	0.3	1.6	0.5	0.2	0.9	0.2	0.4	0.8	0.1	7.1	0.2	1.5	0.4	0.3	12.5	1.5	0.2	0.8	0.8	0.1	0.3	0.2	1.6	0.1	2.4	2.4	0.3	4.4	2.0	0.1	0.6	0.9	0.9	0.5	0.9	0.3	0.0	0.5	0.8	1.2	0.3	0.1	0.1	0.5	0.1	0.3	0.0	0.6	3.0	1.4	0.0	0.1	4.3	0.3	1.6	0.8	0.8	0.1	0.0	0.2	0.1	0.2	0.5	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.1	0.3	1.8	0.0	0.2	0.8	0.4	0.0	0.8	0.4	0.0	0.0	0.2	0.3	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	1.5	2.0	1.6	1.5	1.6	1.4	1.4	1.6	1.5	1.5	1.6	0.2	0.0	0.0	0.7	0.5	0.0	0.3	0.1	0.0	0.4	0.5	0.6	0.5	0.0	0.2	0.0	0.0	0.4	0.0	0.2	5.9	0.5	51.6	0.4	0.6	0.1	0.0	0.0	1.0	0.2	0.1	0.4	0.0	0.2	0.0	0.6	1.1	13.8	0.3	0.0	0.9	1.3	2.0	0.8	0.0	124.5	0.9	0.5	0.0	0.0	0.0	2.4	0.0	0.5	0.6	0.1	1.3	0.7	0.0	0.3	31.1	12.8	0.4	1.3	6.6	0.2	0.3	7.2	0.8	0.0	0.0	0.3	0.1	1.1	0.5	0.3
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31557009-31598833	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Transport	"Hormone, Thyroid hormone"	"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"choroid plexus: 113301.2"	"Cell type enriched"	"Detected in many"	30	"Hepatocytes: 23659.3"	"Group enriched"	"Detected in many"	28	"liver cancer: 928.2;pancreatic cancer: 666.0"	"Region enhanced"	"Detected in all"		"hippocampal formation: 1942.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 160.1;EFO-21: 39.6;Hep G2: 249.0;U-2 OS: 57.0"	"Group enriched"	"Detected in all"	5	"basal ganglia: 1538.3;hippocampal formation: 4891.0;pons and medulla: 5758.5;thalamus: 3400.4"	"Region enhanced"	"Detected in all"		"medulla oblongata: 1381.8"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	345000000000	99000000000	"Golgi apparatus"		"CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419"	"unprognostic (6.79e-3)"		"unprognostic (3.38e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.74e-1)"		"unprognostic (1.84e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.74e-2)"		"unprognostic (9.66e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.35e-3)"	"unprognostic (5.26e-1)"		"unprognostic (3.52e-2)"	4.2	0.6	128.7	0.5	52.0	9.7	0.4	721.6	513.1	2.0	113301.2	6.1	15.1	1.3	0.9	2.3	0.8	51.7	3.0	1942.6	44.9	18.6	21460.6	0.9	2.4	103.8	810.7	6.3	1.1	1800.0	188.4	6.1	2.7	259.3	1.6	4.5	80.7	1.8	0.4	1.1	15.7	6.8	0.3	9.7	3.9	50.3	2.3	568.1	1.1	1.3	0.0	0.1	2.3	0.6	108.9	1.6	0.4	0.6	0.5	0.8	0.1	1.0	0.8	0.3	0.0	0.0	160.1	0.0	2.9	39.6	0.5	0.6	0.4	0.0	0.3	0.0	5.9	0.8	5.2	1.8	249.0	0.4	11.2	1.0	0.1	0.1	0.1	0.0	0.7	0.0	0.3	2.8	0.4	0.0	0.5	0.4	0.7	0.6	4.5	0.3	0.3	7.4	0.2	0.3	1.6	0.9	1.1	5.8	0.0	0.2	1.7	0.6	0.2	1.7	2.4	57.0	0.5	4.3	1.0	2.6	17.6	0.7	4.3	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	128.7	52.0	721.6	513.1	1942.6	44.9	103.8	810.7	6.3	259.3	9.7	568.1	108.9	0.0	0.0	0.0	0.0	15.1	0.5	0.0	0.0	0.0	144.8	0.0	0.0	1.8	779.2	0.0	5.5	162.6	0.3	0.0	1.5	5.9	3.1	6.8	0.5	0.5	14.1	356.2	192.5	0.0	2.0	3.6	0.7	13.3	0.0	0.0	0.2	192.4	23659.3	2.4	26.9	0.1	19.6	0.0	313.7	0.0	8.7	0.3	1.2	0.0	0.0	0.0	24.9	0.0	0.0	0.0	130.5	5.2	0.0	0.0	0.2	1.3	26.9	0.0	56.0	0.0	0.0	0.3	3.3	1.1	0.0	0.1	4.0	10.9	0.0	1.7	0.0
INHBE	"activin, MGC4638"	ENSG00000139269	"Inhibin subunit beta E"	P58166	12	57452323-57459280	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	94	"liver: 149.6"	"Cell type enriched"	"Detected in single"	43	"Hepatocytes: 35.0"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 34.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 50.8;Karpas-707: 79.1;RH-30: 36.9;U-266/70: 263.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016843, CAB034017"	Enhanced		Supported	Vesicles	"Secreted to blood"	NA	NA		3500000	Vesicles		"CAB034017: AB_2233745, HPA016843: AB_1851796"	"unprognostic (7.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (2.61e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.66e-8)"	"unprognostic (4.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.52e-3)"	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.5	0.3	0.2	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	149.6	0.1	0.1	0.9	0.3	0.1	0.0	0.9	0.1	1.0	0.0	1.2	0.3	0.0	0.1	0.0	0.0	1.5	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.0	1.4	0.5	0.0	0.2	0.1	0.2	0.2	0.4	0.3	0.5	0.0	0.5	0.3	2.9	7.8	0.2	9.2	0.4	0.1	4.0	1.9	0.7	0.2	0.4	1.8	0.0	1.2	18.3	0.2	0.1	0.3	11.9	50.8	2.3	2.4	4.9	5.3	1.2	11.4	0.4	0.0	1.8	5.0	79.1	0.0	0.0	0.2	0.2	0.5	0.1	0.3	0.2	36.9	8.8	0.0	0.1	19.5	0.9	0.0	0.0	7.6	0.3	0.6	8.7	0.3	0.2	4.0	0.1	0.6	263.5	9.2	3.8	1.5	0.4	0.3	0.9	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.1	1.5	0.3	0.1	0.1	0.9	0.3	0.1	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
ITIH4	"H4P, IHRP, ITIHL1"	ENSG00000055955	"Inter-alpha-trypsin inhibitor heavy chain 4"	Q14624	3	52812962-52830688	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"liver: 1878.6"	"Group enriched"	"Detected in many"	5	"Early spermatids: 119.2;Hepatocytes: 134.6;Late spermatids: 126.5"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.4;JURKAT: 2.0;U-266/70: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001835, HPA003948, CAB072872"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	3060000	58000000000	Vesicles		"CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433"	"unprognostic (6.08e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-14)"	"unprognostic (1.71e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.21e-5)"	3.6	18.7	4.4	1.3	4.4	10.1	3.0	3.9	5.1	4.2	3.9	3.1	1.0	2.9	1.7	1.4	3.8	1.1	3.0	4.2	3.8	5.3	1878.6	4.9	1.7	4.2	4.2	4.3	2.5	49.3	0.1	4.3	0.8	4.5	4.0	1.0	3.3	2.1	1.8	40.6	2.3	3.4	1.5	3.8	7.5	3.9	1.9	4.0	2.2	5.3	2.8	1.2	5.3	3.3	4.4	0.0	0.1	0.4	0.9	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.2	0.1	0.4	0.0	0.0	0.2	2.4	0.1	1.0	0.0	1.2	0.4	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.0	0.3	0.8	0.0	0.1	0.2	0.3	0.4	0.1	0.0	0.8	0.3	0.0	0.2	0.3	0.0	0.4	0.3	0.0	0.1	0.4	0.5	0.3	0.1	0.0	0.4	0.4	0.0	3.0	1.4	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	4.4	4.4	3.9	5.1	4.2	3.8	4.2	4.2	4.3	4.5	3.8	4.0	4.4	0.7	0.0	1.1	22.5	0.9	0.8	0.3	0.3	0.0	10.0	0.6	1.3	1.1	2.8	0.8	0.0	12.5	0.0	0.4	0.1	0.0	0.3	119.2	0.7	0.7	0.8	0.0	8.4	11.6	2.6	0.0	0.6	1.1	0.4	0.0	2.7	2.5	134.6	0.5	5.0	8.6	0.2	0.0	2.2	1.0	126.5	1.2	1.3	0.0	5.6	1.9	2.3	2.1	3.0	3.1	2.3	0.5	1.9	0.7	0.2	0.0	0.3	0.3	6.0	6.6	6.2	2.4	1.3	1.5	0.0	0.3	0.3	1.2	3.2	0.1	0.1
PROZ	PZ	ENSG00000126231	"Protein Z, vitamin K dependent plasma glycoprotein"	P22891	13	113158648-113172386	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 110.1"	"Group enriched"	"Detected in some"	52	"Hepatocytes: 63.5;Proximal tubular cells: 20.5"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.2;Hep G2: 3.6"	"Not detected"	"Not detected"							HPA052006	Supported				"Secreted to blood"	NA	NA	1720000000	650000000			"HPA052006: AB_2681691"	"unprognostic (5.03e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.51e-4)"	0.0	0.3	0.1	0.3	0.0	0.1	0.0	0.8	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.0	14.5	110.1	0.1	0.3	0.1	0.0	0.0	0.1	0.7	0.0	1.2	0.0	0.2	0.4	0.0	0.1	0.3	0.0	0.0	0.5	0.4	0.0	0.0	0.4	0.5	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.4	0.6	0.3	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	1.4	0.8	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.4	1.1	0.4	1.6	3.6	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	0.5	0.3	0.4	0.8	1.4	0.1	0.6	0.1	0.1	0.0	0.5	1.3	0.0	0.0	0.1	0.6	0.7	0.0	0.4	0.3	0.3	0.0	0.3	0.1	0.7	0.4	0.3	0.7	0.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	63.5	0.0	0.0	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	20.5	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1
RBP4		ENSG00000138207	"Retinol binding protein 4"	P02753	10	93591687-93601744	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 12018.0"	"Cell type enriched"	"Detected in many"	12	"Hepatocytes: 12711.6"	"Cancer enriched"	"Detected in all"	27	"liver cancer: 3135.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 1117.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001641, CAB004555"	Supported				"Secreted to blood"	NA	NA	46100000000	210000000000			"CAB004555: AB_670938, HPA001641: AB_1079795"	"unprognostic (9.42e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.69e-4)"	"prognostic favorable (1.74e-8)"	"unprognostic (2.39e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.60e-2)"	600.0	32.7	29.9	6.3	39.2	1.1	397.5	16.0	48.5	5.7	16.9	9.2	4.9	2.3	1.0	1.1	2.1	7.5	10.7	34.5	87.4	144.1	12018.0	24.7	0.6	24.4	23.1	36.7	4.1	83.0	0.1	523.9	12.5	23.9	8.7	6.8	3.0	13.8	4.7	6.3	14.6	19.3	0.8	17.8	5.6	12.0	4.7	42.9	1.5	8.0	5.3	0.1	19.2	8.9	26.4	0.0	14.7	0.0	0.0	2.9	0.0	0.1	0.3	0.1	2.5	0.4	264.9	0.5	1.5	2.7	0.3	0.2	0.8	0.0	0.0	0.3	0.2	0.2	2.2	1.1	1117.2	0.2	9.2	0.2	18.7	0.5	0.7	0.0	0.0	0.0	0.0	1.4	0.2	1.2	0.0	0.1	7.3	1.3	2.4	121.7	0.4	7.0	0.0	0.0	0.6	0.9	0.2	9.6	0.0	0.0	0.6	0.5	0.8	0.4	0.0	7.8	0.2	0.3	0.9	0.3	3.7	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	39.2	16.0	48.5	34.5	87.4	24.4	23.1	36.7	23.9	17.8	42.9	26.4	9.1	0.0	4.2	0.3	17.2	0.8	0.5	0.0	0.0	0.0	2.1	6.7	0.7	999.4	0.6	23.9	6.2	0.3	0.2	21.9	97.8	7.8	2.8	1.6	3.1	10.8	62.5	152.4	5.8	0.2	22.6	10.5	0.0	22.1	0.0	0.0	158.1	12711.6	17.8	0.0	7.2	40.7	0.0	210.4	3.0	2.4	3.1	7.8	1.8	1.0	0.0	0.8	0.0	1.0	1.1	29.2	28.0	5.7	0.3	2.1	0.8	785.3	0.7	0.5	0.0	7.3	3.8	3.1	13.9	0.0	0.9	1.4	12.3	0.0	1.7	1.4
CA5A	"CA5, CAV, CAVA"	ENSG00000174990	"Carbonic anhydrase 5A"	P35218	16	87881546-87936580	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Lyase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"liver: 24.4"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 39.0"	"Cancer enriched"	"Detected in single"	26	"liver cancer: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"Hep G2: 25.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.91e-1)"	"unprognostic (8.64e-3)"	"unprognostic (3.36e-2)"	"unprognostic (6.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.39e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.03e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.76e-2)"	0.0	0.0	0.5	0.1	0.4	0.1	0.1	0.5	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	24.4	0.1	0.1	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	25.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.5	0.7	0.4	0.4	0.5	0.4	0.3	0.5	0.4	0.6	0.5	0.2	0.0	3.4	0.3	0.3	0.4	2.5	0.0	0.0	1.7	0.2	0.3	2.1	0.0	1.3	1.8	4.2	0.4	0.5	0.1	0.0	0.0	0.3	0.6	0.4	5.4	0.0	2.7	0.8	0.0	0.3	1.0	0.0	0.8	6.3	0.2	1.1	39.0	0.1	3.3	0.6	0.2	0.0	1.4	1.6	0.8	0.3	1.5	0.0	2.8	0.2	0.8	2.1	0.0	0.5	0.0	0.0	1.2	0.1	1.9	0.2	0.3	1.5	3.8	0.0	4.1	1.1	0.4	0.4	0.0	0.3	0.3	1.2	1.7	0.1	1.8
HAO2	"GIG16, HAOX2"	ENSG00000116882	"Hydroxyacid oxidase 2"	Q9NYQ3	1	119368779-119394130	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"kidney: 306.5;liver: 429.1"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 256.8;Proximal tubular cells: 450.1"	"Group enriched"	"Detected in some"	26	"liver cancer: 25.6;renal cancer: 11.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050355			Uncertain	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA050355: "	"unprognostic (1.13e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.33e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (5.14e-4)"	0.0	0.6	0.2	0.1	0.5	0.0	0.7	0.1	0.7	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	306.5	429.1	0.0	0.3	0.2	0.1	0.5	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.1	0.4	0.2	0.1	0.2	23.5	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.7	0.2	0.0	0.2	0.1	0.5	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.7	0.0	11.0	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.6	0.0	13.5	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	4.2	256.8	0.1	0.0	0.1	0.0	0.0	6.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	450.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0
HSD17B13	"SCDR9, SDR16C3"	ENSG00000170509	"Hydroxysteroid 17-beta dehydrogenase 13"	Q7Z5P4	4	87303789-87322886	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"liver: 578.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.0;Club cells: 42.9;Hepatocytes: 131.3;Respiratory ciliated cells: 34.0;Urothelial cells: 57.0"	"Cancer enriched"	"Detected in some"	26	"liver cancer: 52.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"NB-4: 1.4"	"Not detected"	"Not detected"							HPA029125	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA029125: AB_10601580"	"unprognostic (2.49e-1)"	"unprognostic (7.46e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.86e-4)"	"unprognostic (4.74e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (2.94e-4)"	"prognostic favorable (7.80e-4)"	"unprognostic (4.97e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.18e-4)"	"unprognostic (3.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.52e-3)"	9.4	0.3	0.8	0.2	0.8	1.4	6.5	2.6	1.1	2.1	0.3	0.7	0.4	2.7	0.2	0.2	1.0	0.2	0.4	0.7	0.6	0.4	578.4	3.6	0.2	1.0	0.8	0.9	0.5	1.8	0.1	0.3	0.8	1.1	4.6	0.4	0.8	0.2	0.2	0.4	6.6	0.7	4.3	0.5	0.7	0.3	0.4	0.6	0.3	0.2	0.1	0.1	1.2	7.8	1.0	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.4	0.2	0.7	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.2	0.1	0.0	0.1	1.4	0.1	0.4	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.2	1.0	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.8	0.8	2.6	1.1	0.7	0.6	1.0	0.8	0.9	1.1	0.5	0.6	1.0	100.0	3.2	6.4	1.6	0.0	2.5	22.6	0.3	0.0	0.2	0.2	0.3	0.3	4.3	42.9	1.8	0.0	0.1	0.4	1.0	0.0	0.1	2.7	0.4	0.5	2.4	1.8	5.3	3.7	0.4	0.3	0.8	0.0	0.1	0.0	0.2	1.8	131.3	0.2	0.0	3.0	0.5	0.0	2.4	0.4	2.7	0.0	0.7	0.0	0.0	0.3	0.3	0.0	1.5	2.8	0.1	1.4	0.4	0.1	4.7	0.2	0.5	34.0	0.1	0.0	0.7	0.4	0.0	0.9	0.2	0.4	0.0	0.7	0.2	0.7	57.0
SLC27A5	"ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2"	ENSG00000083807	"Solute carrier family 27 member 5"	Q9Y2P5	19	58479512-58512413	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Ligase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"liver: 1031.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 144.4;Hepatocytes: 439.9;Late spermatids: 464.4"	"Cancer enriched"	"Detected in all"	26	"liver cancer: 49.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA007292, CAB056160, CAB068239"	Enhanced					NA	NA					"CAB056160: AB_2665590, CAB068239: AB_2665592, HPA007292: AB_1857064"	"unprognostic (5.97e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-2)"	"prognostic favorable (1.57e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.16e-1)"	5.1	10.0	34.2	3.3	34.0	3.8	6.5	33.0	50.3	7.1	30.9	6.4	2.5	5.4	2.9	5.4	9.2	2.9	6.1	33.8	34.0	11.0	1031.9	4.1	4.4	33.8	33.9	32.8	6.8	10.7	7.1	10.9	1.7	33.7	8.1	1.7	3.0	10.0	4.5	4.9	5.6	4.0	4.5	33.9	5.3	7.3	20.8	35.9	6.2	6.6	4.4	4.6	8.3	6.3	33.8	41.2	55.0	9.6	10.2	9.0	9.3	6.1	2.3	5.3	7.5	10.3	4.4	8.7	52.9	6.5	2.8	1.4	8.4	11.0	35.3	3.2	24.8	37.0	35.8	58.3	46.7	13.5	18.9	12.2	10.9	5.9	1.2	20.5	12.9	3.9	39.4	33.5	0.0	9.1	33.4	47.2	39.8	5.8	34.4	31.9	23.4	0.2	72.6	25.0	19.3	13.1	17.8	0.1	53.5	12.1	2.7	15.8	16.3	3.1	0.0	6.8	0.0	4.7	33.5	41.0	22.7	10.9	35.0	2.0	0.1	4.0	3.8	13.5	5.3	29.6	24.3	17.5	18.0	10.8	15.8	21.3	21.7	0.5	18.1	4.0	18.2	23.3	13.9	34.2	34.0	33.0	50.3	33.8	34.0	33.8	33.9	32.8	33.7	33.9	35.9	33.8	12.5	0.0	7.3	3.3	9.8	9.1	15.5	16.0	14.2	11.8	50.1	73.2	8.3	20.0	9.9	5.5	0.0	7.3	6.9	4.6	39.2	9.6	144.4	12.4	10.1	11.3	10.1	25.0	4.3	15.4	3.3	8.9	8.6	8.0	5.1	20.2	16.8	439.9	10.5	10.1	5.3	4.7	6.1	16.7	9.6	464.4	10.8	6.7	16.0	1.9	3.4	12.0	12.3	5.0	7.4	8.0	1.2	9.4	8.9	32.2	1.8	57.6	11.5	8.5	6.6	7.4	18.4	50.9	12.7	15.5	14.1	3.4	11.3	26.7	6.1	15.0
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587826-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 3659.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 4141.9"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	NA	NA	27700000000	39000000000			"CAB007817: AB_598185, HPA053294: AB_2682104"							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	48.1	0.1	0.0	0.0	1.2	3659.1	0.1	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	388.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.8	0.0	0.0	0.0	2.7	0.0	45.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	4141.9	0.0	0.0	0.0	0.0	0.0	88.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
PLGLB2	PLGP1	ENSG00000125551	"Plasminogen like B2"	Q02325	2	87748087-87759476	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Tissue enriched"	"Detected in some"	163	"liver: 458.2"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 76.3"	"Cancer enriched"	"Detected in single"	25	"liver cancer: 1.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"																"Secreted to blood"	NA	NA						"unprognostic (1.10e-2)"	"unprognostic (8.78e-2)"			"unprognostic (3.42e-2)"	"unprognostic (7.03e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.77e-1)"		"unprognostic (1.82e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.04e-4)"	"unprognostic (6.39e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.11e-2)"	0.3	0.8	1.0	0.5	0.7	0.5	0.3	1.8	0.9	0.6	0.1	0.3	0.2	0.6	0.6	0.6	0.7	0.2	0.6	0.8	0.2	0.8	458.2	0.3	0.9	0.5	0.2	0.8	0.5	1.3	0.4	0.9	0.4	1.4	0.7	0.3	2.8	0.4	0.4	0.6	1.0	0.5	0.2	0.1	0.9	0.5	1.0	0.2	0.8	0.5	0.5	0.7	0.3	0.2	1.0	0.0	0.1	1.2	0.3	0.4	0.5	0.4	0.6	0.4	0.1	0.2	0.1	0.3	0.7	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.5	1.2	0.0	0.1	0.5	0.2	0.5	0.3	0.1	0.2	1.0	0.4	0.7	0.0	0.1	0.4	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.4	0.0	0.0	0.7	0.2	0.2	0.0	0.3	0.0	0.3	0.2	0.1	0.5	0.4	0.3	0.5	1.2	0.3	0.4	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.1	0.0	1.0	0.7	1.8	0.9	0.8	0.2	0.5	0.2	0.8	1.4	0.1	0.2	1.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	4.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	76.3	0.1	0.0	0.3	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0
CYP1A1	"CP11, CYP1, P1-450, P450-C, P450DX"	ENSG00000140465	"Cytochrome P450 family 1 subfamily A member 1"	P04798	15	74719542-74725536	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 66.6;urinary bladder: 64.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 21.9;Endothelial cells: 13.7;Glandular and luminal cells: 5.9;Hepatocytes: 9.9;Urothelial cells: 16.4"	"Group enriched"	"Detected in some"	24	"liver cancer: 18.6;urothelial cancer: 54.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 36.9;hTCEpi: 19.5;HUVEC TERT2: 19.1;SK-BR-3: 14.7;SuSa: 35.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018654	Uncertain					NA	NA					"CAB018654: AB_2088699"	"unprognostic (1.71e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.45e-3)"	"unprognostic (6.34e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.28e-1)"	15.9	0.6	0.2	0.0	0.2	0.0	14.8	0.1	0.4	2.0	0.0	1.9	0.6	2.4	0.6	1.9	1.2	0.7	6.4	0.2	0.4	1.4	66.6	12.3	0.0	0.3	0.3	0.2	0.5	0.6	0.0	0.5	0.3	0.2	0.7	0.1	0.3	1.8	0.6	4.2	11.8	19.9	0.0	0.1	0.1	1.9	0.3	0.2	0.2	2.0	0.2	0.1	64.1	2.3	0.3	0.3	2.1	0.2	0.0	0.5	0.1	11.7	0.0	0.1	0.7	0.3	36.9	1.6	0.3	9.6	0.0	8.8	11.4	0.7	7.3	0.3	0.0	1.0	0.5	2.6	5.5	0.2	0.3	11.5	0.0	19.5	0.3	1.4	0.4	19.1	0.3	2.3	0.3	0.1	0.7	0.1	0.4	0.2	12.1	2.9	1.2	0.0	0.4	0.0	2.4	0.6	0.3	1.7	14.7	3.8	35.6	0.4	0.2	1.0	1.6	0.5	5.2	0.0	0.7	0.2	0.5	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.2	0.4	0.3	0.3	0.2	0.2	0.1	0.2	0.3	21.9	0.0	0.0	0.0	0.1	0.5	2.4	0.0	0.0	0.0	0.4	0.5	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	3.4	1.1	13.7	0.0	0.0	0.1	0.2	0.0	0.2	0.0	5.9	0.0	0.0	0.0	9.9	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.0	16.4
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818487	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 31.5;liver: 47.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 26.1;Hepatocytes: 32.2;Paneth cells: 13.8;Proximal enterocytes: 51.7;Undifferentiated cells: 9.0"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	15	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	15	"NK-cells: 2.8"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.1	0.1	0.2	1.0	0.1	0.6	0.1	0.0	0.1	0.0	0.1	12.4	28.4	0.0	0.1	0.0	0.1	5.2	0.0	0.1	0.3	0.0	47.8	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	13.4	0.2	0.0	0.2	0.0	0.0	31.5	0.6	0.1	0.1	1.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	1.5	0.0	1.8	0.0	0.0	0.1	26.1	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.1	3.1	0.0	0.0	1.7	0.0	32.2	0.2	0.0	0.4	6.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	13.8	0.0	0.1	0.2	51.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.5	9.0	0.0
ABCG5	STSL	ENSG00000138075	"ATP binding cassette subfamily G member 5"	Q9H222	2	43812472-43838865	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	69	"intestine: 48.2;liver: 62.5"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 60.3;Paneth cells: 23.9;Proximal enterocytes: 30.9"	"Cancer enriched"	"Detected in some"	23	"liver cancer: 11.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	54	"Hep G2: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.71e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.59e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.52e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.08e-2)"	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	48.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	62.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.5	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	5.7	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.1	0.6	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.7	60.3	0.0	0.0	3.2	2.5	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	1.8	0.0	23.9	0.0	0.0	0.0	30.9	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0
ACMSD		ENSG00000153086	"Aminocarboxymuconate semialdehyde decarboxylase"	Q8TDX5	2	134838616-134902034	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"kidney: 142.4;liver: 163.8"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 120.2;Proximal tubular cells: 408.1"	"Group enriched"	"Detected in some"	23	"liver cancer: 21.2;renal cancer: 19.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"RPTEC TERT1: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010533, HPA011179"	Enhanced		Approved	Cytosol		NA	NA		12000	Cytosol		"HPA010533: AB_1844517, HPA011179: AB_1844516"	"unprognostic (1.06e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.60e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.44e-3)"	"prognostic favorable (2.39e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.65e-5)"	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.8	0.3	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	7.2	0.2	0.0	0.1	142.4	163.8	0.1	0.3	0.9	0.1	0.0	0.7	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.4	0.4	0.2	0.6	0.4	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.4	0.1	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.8	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.3	0.8	0.3	1.2	0.2	0.5	0.1	0.6	0.3	26.7	0.4	1.0	0.3	0.1	0.3	0.4	0.8	0.2	0.7	1.0	0.0	0.4	0.2	0.8	0.2	0.1	0.5	0.2	0.3	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.8	0.3	0.0	0.1	0.9	0.1	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.2	50.1	0.0	9.2	0.0	0.0	0.0	0.0	54.8	0.2	0.0	0.0	0.1	0.0	0.0	2.7	8.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.9	120.2	0.0	0.0	7.3	0.0	0.0	1.9	0.0	0.0	0.0	2.8	0.0	1.0	0.0	0.0	0.0	2.5	1.9	0.1	0.0	0.0	0.0	0.0	0.0	408.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0
ETNPPL	AGXT2L1	ENSG00000164089	"Ethanolamine-phosphate phospho-lyase"	Q8TBG4	4	108742048-108763054	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 156.3;liver: 192.6"	"Cell type enriched"	"Detected in some"	8	"Astrocytes: 219.4"	"Group enriched"	"Detected in some"	23	"glioma: 7.9;liver cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.7;Hep G2: 2.3;NTERA-2: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044546, HPA072938"	Supported		Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA044546: AB_10962867, HPA072938: AB_2686560"	"unprognostic (5.20e-3)"	"unprognostic (1.33e-1)"		"unprognostic (3.93e-1)"	"prognostic favorable (9.52e-5)"		"unprognostic (5.93e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.32e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.48e-2)"	0.1	5.5	156.0	0.1	126.1	0.0	0.1	93.8	145.6	0.1	41.2	0.0	0.2	0.3	0.0	0.1	0.0	0.2	7.5	124.7	122.9	9.2	192.6	0.1	0.0	145.7	115.9	103.7	0.1	0.0	2.9	1.9	0.0	156.3	0.0	0.0	1.7	34.7	0.1	2.5	0.0	0.0	0.0	79.0	0.7	18.4	0.5	110.6	0.1	1.1	1.5	0.0	0.0	0.0	109.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	5.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.0	126.1	93.8	145.6	124.7	122.9	145.7	115.9	103.7	156.3	79.0	110.6	109.3	0.0	0.0	0.0	219.4	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.5	1.5	0.4	0.0	0.0	0.7	26.8	0.0	0.0	0.6	0.0	0.0	1.6	0.0	1.7	0.0	0.0	0.0	7.5	0.0	8.5	0.0	1.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814073-151828488	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 226.8;intestine: 243.7;liver: 954.5"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 687.7;Proximal enterocytes: 460.5"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.5;ASC diff: 4.2;EFO-21: 4.6;HBEC3-KT: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002911	Approved					NA	NA					"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.58e-6)"	"prognostic unfavorable (5.02e-4)"			"prognostic unfavorable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	6.0	226.8	0.3	0.4	0.0	0.0	5.0	0.0	0.1	0.1	0.1	0.2	222.9	0.2	0.0	2.7	0.6	27.7	0.4	0.0	0.0	0.2	954.5	9.1	0.3	0.0	0.0	0.0	0.1	37.0	0.0	0.1	1.5	0.0	0.1	0.2	0.0	1.3	0.0	0.0	13.9	243.7	0.0	0.0	0.2	52.8	0.8	0.0	0.4	0.3	0.0	2.5	0.7	0.4	0.2	0.0	9.5	0.0	0.0	4.2	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	4.6	0.0	0.0	0.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	1.0	0.4	0.1	0.3	1.7	0.0	1.7	0.1	1.2	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.0	0.9	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	0.0	14.3	0.0	0.7	0.3	0.0	4.4	0.0	0.0	0.0	0.0	1.1	71.4	8.7	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.3	1.8	0.1	0.7	0.0	2.7	0.0	51.9	0.0	39.3	53.5	0.2	0.0	0.0	5.0	687.7	0.2	0.0	0.0	9.6	0.0	14.8	0.3	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	10.0	0.0	0.1	0.2	460.5	0.0	2.9	0.0	0.0	0.0	3.4	0.0	0.1	1.4	3.4	0.3	0.7	0.3	18.4	0.2
CYP1A2	"CP12, P3-450"	ENSG00000140505	"Cytochrome P450 family 1 subfamily A member 2"	P05177	15	74748845-74756607	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	311	"liver: 517.6"	"Cell type enriched"	"Detected in some"	57	"Hepatocytes: 85.7"	"Group enriched"	"Detected in some"	22	"liver cancer: 25.3;urothelial cancer: 6.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016531	Enhanced					NA	NA					"CAB016531: AB_629359"				"unprognostic (1.54e-4)"			"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.53e-1)"	0.2	0.3	0.6	0.2	0.5	1.0	0.1	1.6	0.9	0.0	0.2	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.1	0.5	0.3	0.2	517.6	0.4	0.3	0.5	0.5	0.8	0.1	0.0	0.0	0.0	0.7	0.8	0.1	0.1	0.4	0.2	0.3	0.3	0.6	0.2	0.0	0.2	0.3	0.2	0.3	0.5	0.1	1.4	0.0	0.1	0.1	0.0	1.6	0.4	0.3	0.8	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.4	0.8	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.4	0.9	0.6	0.1	0.0	0.7	0.3	0.1	0.1	0.0	0.0	0.3	0.1	1.3	0.7	1.3	0.0	0.2	0.9	0.3	0.4	0.3	0.2	0.9	0.8	0.3	0.1	0.7	0.7	0.3	0.6	2.3	0.1	0.6	0.5	0.2	0.2	0.3	0.4	0.3	0.3	0.3	0.2	0.5	0.3	0.9	0.3	1.5	0.3	0.5	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.5	0.2	0.2	2.1	0.4	0.2	0.4	0.1	0.1	0.6	0.5	1.6	0.9	0.5	0.3	0.5	0.5	0.8	0.8	0.2	0.5	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	85.7	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2
HGFAC	"HGFA, HGFAP"	ENSG00000109758	"HGF activator"	Q04756	4	3441968-3449486	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	56	"liver: 218.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 85.6;Hepatocytes: 72.0;Late spermatids: 165.9"	"Cancer enriched"	"Detected in some"	22	"liver cancer: 26.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"Hep G2: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA058279, HPA059076"	Enhanced				"Secreted to blood"	NA	NA	7590000	9300000000			"HPA058279: AB_2683665, HPA059076: AB_2683898"	"unprognostic (2.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-3)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.74e-4)"	0.0	0.0	1.3	0.0	2.1	0.0	0.1	1.9	2.6	0.4	0.3	0.1	0.0	0.2	0.2	0.0	0.3	0.0	0.1	1.9	0.3	0.5	218.9	0.1	0.0	1.6	0.4	1.2	0.2	0.1	0.0	0.7	0.0	2.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.1	3.8	0.9	0.0	0.1	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.1	1.9	2.6	1.9	0.3	1.6	0.4	1.2	2.0	0.4	0.9	1.3	0.1	0.0	0.0	1.3	0.2	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	85.6	0.5	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.4	0.0	4.4	2.2	72.0	0.0	3.3	3.9	0.0	0.0	3.2	0.0	165.9	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.5	0.3	0.0	0.0	1.2	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.1	21.5	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429242	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"liver: 603.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 432.9"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 118.3"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 59.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 59.7"	"Cell line enriched"	"Detected in some"	16	"Hep G2: 156.1"					"Low region specificity"	"Detected in all"			"HPA005550, CAB016721, CAB016792"	Approved				"Secreted to blood"	NA	NA		5200000000			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.06e-2)"	0.1	0.0	0.7	0.1	0.9	1.1	0.1	0.6	1.0	0.2	0.0	0.7	0.8	0.1	0.1	0.1	0.2	0.6	0.1	0.6	0.6	14.6	603.4	0.2	0.7	1.3	0.6	0.5	0.2	0.4	0.0	0.3	0.1	1.6	0.2	0.6	0.2	0.2	0.1	0.2	0.6	0.8	0.0	0.7	0.4	2.7	0.2	0.7	0.6	0.2	0.0	0.3	0.4	0.2	1.2	0.1	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.1	0.0	0.9	0.1	0.4	9.5	0.0	0.3	0.0	0.0	0.2	0.1	7.8	156.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.6	0.4	2.3	0.7	0.0	0.1	0.0	0.0	0.9	0.4	0.0	1.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.1	0.0	0.0	6.3	0.0	0.0	59.7	0.0	0.3	0.7	0.9	0.6	1.0	0.6	0.6	1.3	0.6	0.5	1.6	0.7	0.7	1.2	0.0	0.0	0.0	0.3	4.1	0.8	0.4	11.2	0.0	0.0	0.1	0.0	0.4	47.1	1.2	0.0	0.0	0.0	24.0	3.9	5.9	0.5	0.1	3.4	0.1	0.6	10.3	18.7	0.1	0.2	0.0	0.7	2.0	0.2	0.0	0.0	12.1	432.9	3.7	0.0	0.5	9.3	0.0	9.3	4.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	8.1	0.0	0.0	0.0	3.8	84.8	3.4	0.0	0.0	0.2	0.3	0.1	0.2	0.0	0.1	0.1	1.1	0.0	1.8	0.3
SAA2		ENSG00000134339	"Serum amyloid A2"	P0DJI9	11	18239223-18248668	"Disease related genes, Predicted secreted proteins"	"Acute phase"		Amyloidosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 36562.7"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 55342.6"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 150.5"	"Group enriched"	"Detected in some"	6	"hypothalamus: 49.8;white matter: 19.9"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 27.8;EFO-21: 20.2;GAMG: 19.6;HaCaT: 25.0;HBEC3-KT: 55.4;HSkMC: 17.6"														"Secreted to blood"	NA	NA		9200000000				"unprognostic (1.73e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (7.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (1.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	567.4	17.1	0.0	139.1	0.2	0.5	324.2	0.4	0.7	279.3	0.6	7.9	0.9	1.0	0.2	22.3	21.3	14.2	6.3	0.2	49.8	12.4	36562.7	36.0	0.6	0.3	5.6	0.2	1.8	14.1	0.2	31.4	1.8	0.6	38.8	1.3	0.6	1810.9	1.6	223.0	20.6	21.1	6.6	0.0	20.2	18.3	2.1	5.9	16.4	6.7	0.2	6.9	22.6	7.9	19.9	27.8	0.1	0.2	0.2	1.0	0.0	3.6	0.1	0.8	0.1	0.3	0.0	12.1	0.1	20.2	0.2	19.6	25.0	0.0	55.4	0.1	1.2	0.0	1.0	0.5	0.0	7.8	0.8	0.1	17.6	7.4	0.0	8.9	0.6	0.2	0.0	0.0	0.9	1.5	0.0	0.2	0.0	0.5	0.4	0.0	0.2	0.7	0.0	12.4	1.3	0.3	0.0	1.7	8.5	0.1	0.5	0.4	0.5	0.2	0.2	1.2	0.5	1.2	0.5	0.3	1.7	0.1	1.1	0.3	1.0	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.1	0.1	1.1	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.4	0.7	0.2	49.8	0.3	5.6	0.2	0.6	0.0	5.9	19.9	7.6	0.0	1.5	0.0	184.4	1.0	5.6	4629.9	0.6	0.0	56.8	68.5	0.2	1052.3	4596.4	3.7	0.0	0.4	0.8	21.9	0.0	70.3	1.6	12.3	0.9	68.2	0.0	2356.0	0.0	34.4	2.3	2.0	0.0	13.5	0.0	0.0	1442.8	55342.6	0.4	0.0	0.0	1.1	1204.4	1502.7	0.0	0.5	0.0	0.6	8.8	0.0	1.0	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.1	34.5	2.9	0.1	11449.8	0.0	0.0	3.1	400.9	0.3	0.0	5.6	0.1	0.5	144.2	0.0	5.3	65.4
APOC1		ENSG00000130208	"Apolipoprotein C1"	P02654	19	44914247-44919349	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 16364.8"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 33405.9"	"Cancer enriched"	"Detected in all"	21	"liver cancer: 3253.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"myeloid DC: 5.6"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 5.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 576.4;HSkMC: 332.9;K-562: 151.6;SK-MEL-30: 268.0"	"Low region specificity"	"Detected in all"							HPA051518	Supported				"Secreted to blood"	NA	NA	20300000000	15000000000			"HPA051518: AB_2681519"	"unprognostic (3.51e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.15e-7)"	"unprognostic (9.51e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.48e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.65e-1)"	57.2	2014.5	109.4	28.3	147.7	52.6	87.8	109.9	340.9	24.0	103.7	28.6	13.2	11.1	42.3	6.0	21.4	31.3	9.9	98.2	181.1	14.4	16364.8	292.4	141.3	156.0	163.0	91.5	56.9	21.6	16.4	23.8	42.0	130.9	14.5	16.8	15.3	35.8	2.2	22.5	49.1	49.5	4.0	135.3	257.0	22.9	18.8	152.6	37.8	36.6	6.2	34.2	23.7	11.4	149.3	2.7	26.5	12.0	5.0	37.1	38.2	111.5	1.3	1.7	4.8	7.3	55.6	49.9	8.4	9.4	1.0	3.2	1.8	15.6	1.9	2.3	0.4	63.5	36.8	4.2	576.4	32.9	27.5	18.1	332.9	2.8	4.8	1.8	9.2	1.3	1.8	151.6	0.8	1.7	3.6	1.5	2.0	112.4	10.4	5.6	6.2	16.0	0.8	7.3	2.0	5.3	3.3	18.9	0.3	268.0	37.7	2.2	98.4	4.2	0.4	1.7	0.2	1.7	4.5	5.4	8.2	0.7	7.4	2.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.3	109.4	147.7	109.9	340.9	98.2	181.1	156.0	163.0	91.5	130.9	135.3	152.6	149.3	22.9	115.4	214.4	2.3	40.6	17.0	4.1	5.8	6.2	2.5	49.8	92.8	0.8	453.2	55.8	1.8	0.0	31.7	1.6	2.4	49.0	4.6	1.2	6.6	128.4	68.9	2.4	768.8	0.3	4.0	341.3	93.0	19.4	5.0	142.6	30.6	432.6	33405.9	4789.8	0.0	0.5	3.2	4.1	867.7	27.3	22.8	270.9	620.5	30.2	3.7	124.5	276.0	0.0	0.0	0.0	3.2	0.3	259.5	1.3	4.2	0.6	16.6	24.4	9.9	19.7	1628.8	24.4	2.0	3.2	3.7	17.8	71.6	46.7	1226.7	2.1	5.0
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402141-177409564	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	226	"liver: 609.5"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 523.0"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;eosinophil: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.6;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;MCF7: 9.0;PC-3: 6.4;SH-SY5Y: 4.3;U-937: 4.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA003825	Approved				"Secreted to blood"	NA	NA	1040000	7000000000			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"	0.2	0.1	1.0	0.1	1.1	2.6	0.3	0.1	1.3	0.2	0.0	0.4	0.5	0.2	0.0	1.9	0.3	0.1	0.2	1.5	0.8	0.8	609.5	0.6	0.0	0.7	0.5	1.1	0.0	0.6	0.1	0.6	0.1	0.9	0.3	0.1	0.0	0.4	0.0	0.0	0.9	0.5	0.0	0.3	1.0	0.1	1.2	0.6	0.0	0.2	0.0	0.1	0.2	0.8	0.8	0.7	1.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.3	0.0	0.2	1.1	0.5	0.3	0.0	7.1	1.4	1.1	0.3	0.7	0.2	0.6	2.4	0.2	1.0	0.0	0.3	0.1	0.2	1.6	0.3	2.5	0.0	9.0	0.1	2.1	0.0	2.1	6.4	0.5	0.2	1.5	0.9	0.0	2.0	4.3	0.2	0.7	0.6	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.4	0.0	0.0	0.0	4.6	0.5	0.0	1.2	3.6	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.5	0.5	0.0	0.5	1.0	1.1	0.1	1.3	1.5	0.8	0.7	0.5	1.1	0.9	0.3	0.6	0.8	0.5	0.0	0.0	0.3	5.3	33.1	7.7	15.3	35.9	0.6	12.7	17.5	1.0	17.2	3.9	1.8	4.2	0.0	4.0	27.6	0.0	6.5	23.3	2.2	0.9	2.2	10.3	19.6	2.6	4.2	0.4	1.1	3.6	1.7	0.0	0.2	16.8	523.0	0.5	0.0	0.8	12.3	8.2	16.7	6.1	42.1	0.6	1.0	8.8	0.0	1.2	0.7	2.1	1.5	0.6	11.1	22.0	0.0	8.5	7.2	60.7	16.1	3.6	0.9	0.0	0.5	1.1	12.0	23.6	57.5	54.3	0.1	4.0	0.1	34.8	7.6
KRTAP5-6	KRTAP5.6	ENSG00000205864	"Keratin associated protein 5-6"	Q6L8G9	11	1697195-1697755	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 3.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	21	"liver cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"									NA	NA												"prognostic favorable (6.04e-5)"			"unprognostic (3.70e-1)"					"unprognostic (2.93e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LGALS4	GAL4	ENSG00000171747	"Galectin 4"	P56470	19	38801671-38812945	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"intestine: 1127.6"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 4349.4;Intestinal goblet cells: 3767.6;Paneth cells: 3353.0;Proximal enterocytes: 4572.2;Undifferentiated cells: 2684.6"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	205	"OE19: 987.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB025653, HPA031184, HPA031185, HPA031186"	Enhanced		Uncertain	"Plasma membrane"		NA	NA		200000	"Plasma membrane"		"CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.71e-2)"	"prognostic favorable (3.21e-4)"	1.6	0.5	0.3	86.9	0.4	0.5	5.5	0.5	0.6	1.2	0.2	1127.6	819.5	3.2	0.2	1.5	2.4	138.4	0.9	0.3	0.3	3.0	80.1	1.2	1.2	0.3	0.3	0.3	1.7	31.8	0.0	0.8	0.2	0.3	2.3	941.8	0.2	1.1	2.3	1.6	1.4	697.8	55.7	0.2	4.0	136.4	1.0	0.3	0.3	1.8	0.2	0.4	11.3	1.5	0.4	0.0	0.4	0.1	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	1.3	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	2.2	0.0	987.1	0.0	0.1	0.0	2.5	0.1	4.8	0.2	1.4	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.2	1.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.4	1.7	3.2	6.5	0.7	10.3	1.1	3.0	0.6	3.4	1.1	3.6	3.0	1.3	770.7	1.0	0.0	0.0	0.8	0.9	4349.4	0.0	267.1	0.2	1.9	1.8	1.2	649.7	0.0	0.3	103.3	0.5	0.8	310.4	5.7	49.0	0.8	1.8	69.0	0.1	1.7	0.3	3767.6	0.0	1.9	0.3	0.0	0.0	1.2	0.0	1.0	3.0	0.8	1.0	0.0	0.7	492.7	3353.0	0.4	0.7	1.8	4572.2	9.3	0.4	2.3	0.0	3.9	1.1	0.3	0.9	0.9	2.7	0.5	11.1	1.1	2684.6	42.4
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960754-42963880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 298.9;pancreas: 605.1"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 842.9"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 8.5;SCLC-21H: 9.5;T-47d: 6.1"	"Region enriched"	"Detected in some"	4	"cerebellum: 15.7"	"Low region specificity"	"Detected in many"			HPA027501	Enhanced		Approved	Cytosol		NA	NA		390000	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favorable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.8	0.9	2.8	1.3	2.9	3.9	7.1	3.1	2.8	0.8	2.3	0.6	0.2	0.9	2.2	0.6	1.4	0.5	3.2	2.9	2.5	0.9	298.9	2.0	1.0	2.2	1.7	2.8	1.9	605.1	0.2	8.5	0.4	2.4	20.5	0.3	2.2	9.8	1.2	1.9	0.9	1.6	0.5	1.8	2.9	51.2	0.7	2.2	1.8	1.9	0.4	1.2	0.8	0.7	2.8	0.4	0.3	1.4	3.9	0.4	0.1	0.2	0.3	1.6	0.6	0.9	0.0	0.1	1.3	0.1	0.3	0.7	0.4	0.2	0.2	0.2	1.6	1.2	1.0	0.9	8.5	0.0	0.9	1.8	0.3	0.0	0.3	0.1	0.9	0.0	3.0	1.2	1.5	0.2	1.8	1.6	3.0	0.1	0.4	0.4	1.4	1.3	0.8	0.6	0.2	9.5	1.3	0.1	1.3	0.6	0.4	6.1	2.8	0.3	0.7	0.7	0.4	0.8	1.0	1.0	1.1	0.1	1.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.0	0.7	0.0	0.1	2.8	2.9	3.1	2.8	2.9	2.5	2.2	1.7	2.8	2.4	1.8	2.2	2.8	0.3	0.0	2.2	5.5	2.8	0.3	5.2	0.7	0.0	1.7	10.2	14.7	5.4	24.3	0.2	1.8	0.0	0.1	1.7	0.0	3.9	0.5	0.2	1.6	0.2	2.2	0.0	77.9	18.4	0.9	0.1	0.3	0.5	0.8	0.0	2.6	24.3	842.9	0.7	1.7	18.2	0.0	6.1	28.9	0.7	0.1	0.9	1.1	0.0	11.2	0.3	0.2	0.0	7.1	4.7	0.6	0.0	2.6	0.5	17.9	0.3	3.4	4.6	0.3	0.0	0.2	0.6	0.6	0.7	0.0	0.1	0.1	3.0	0.0	0.2	1.9
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346482-38377013	"Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity, Lipid transport, Transport"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 1349.5"	"Cell type enriched"	"Detected in some"	30	"Hepatocytes: 458.3"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Region enhanced"	"Detected in single"		"medulla oblongata: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 10.7;HSkMC: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	NA	NA	25000000000	1300000000			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.62e-12)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	58.8	0.5	0.0	24.4	0.1	0.5	6.6	0.0	0.1	2.6	0.0	0.4	0.0	2.7	0.0	0.1	0.6	0.2	1.9	0.0	0.0	8.5	1349.5	1.2	2.8	1.1	0.0	0.0	0.2	1.7	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.4	0.0	23.0	0.4	0.6	1.5	0.0	0.5	0.6	0.7	0.3	0.1	4.0	2.1	0.3	0.7	0.2	0.3	0.0	0.1	0.1	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	8.6	0.7	0.0	0.0	0.1	0.0	0.0	7.9	0.8	1.0	0.1	0.2	0.5	0.0	10.7	0.3	11.0	0.1	0.8	0.0	0.7	0.0	0.0	9.7	458.3	0.3	0.0	0.3	0.0	0.0	8.5	0.0	0.3	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.1	0.0	15.2	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0
OTC	OTCase	ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352586-38421446	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	124	"intestine: 113.5;liver: 380.9"	"Group enriched"	"Detected in some"	5	"Hepatic stellate cells: 38.9;Hepatocytes: 99.6;Proximal enterocytes: 82.0;Undifferentiated cells: 25.3"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		NA	NA		2200000	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			1.2	0.0	0.2	0.5	0.3	0.0	0.2	0.3	0.4	0.4	0.2	5.0	113.5	0.7	0.0	0.4	0.5	0.4	0.1	0.2	0.3	0.1	380.9	0.9	0.1	0.4	0.3	0.2	0.1	1.7	0.0	0.0	0.0	0.4	0.0	2.5	0.1	0.1	0.1	0.0	0.0	88.1	0.5	0.3	0.0	1.9	0.4	0.3	0.0	0.3	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.4	0.2	0.3	0.4	0.3	0.2	0.4	0.3	0.3	0.4	0.3	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	7.4	0.1	0.0	1.7	1.2	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	38.9	99.6	0.0	0.0	0.5	8.3	0.0	3.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.9	0.0	0.0	0.0	82.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	0.3	0.0	25.3	0.0
RDH16	"RODH-4, SDR9C8"	ENSG00000139547	"Retinol dehydrogenase 16"	O75452	12	56951431-56959374	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	152	"liver: 799.6"	"Cell type enriched"	"Detected in some"	27	"Hepatocytes: 365.1"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 44.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.0;hTCEpi: 4.3;OE19: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038518	Enhanced					NA	NA					"HPA038518: AB_10672713"	"unprognostic (5.42e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (2.16e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.10e-1)"	"unprognostic (7.99e-12)"	"unprognostic (2.24e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	0.3	0.3	1.0	0.0	1.0	0.0	0.3	1.0	1.0	0.9	1.0	0.3	0.0	0.4	0.1	1.4	0.5	0.0	0.3	1.0	0.9	0.5	799.6	0.4	0.1	0.9	0.9	1.0	0.5	0.6	0.0	0.3	0.0	1.0	5.2	0.0	0.4	0.5	2.4	0.2	2.8	0.5	0.0	0.9	2.5	0.3	1.3	1.0	0.2	0.3	0.0	1.4	0.3	1.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	4.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	1.0	1.0	1.0	0.9	0.9	0.9	1.0	1.0	0.9	1.0	1.0	0.1	0.0	0.0	2.0	1.9	0.0	1.2	0.3	0.0	2.2	0.2	0.0	2.0	5.7	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	8.5	0.1	0.1	0.6	0.0	13.5	0.2	0.4	0.0	0.3	0.0	0.1	0.0	0.3	3.6	365.1	0.2	1.7	0.2	0.0	0.0	6.3	0.3	5.8	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	1.8	0.2	0.0	0.0	0.3	5.7	0.0	0.1	0.2	1.0	0.0	0.0	0.1	1.4	0.9	0.8	0.3	0.0	0.6	0.1	0.0	0.3
SMLR1		ENSG00000256162	"Small leucine rich protein 1"	H3BR10	6	130827406-130837135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 57.1"	"Group enriched"	"Detected in some"	11	"Hepatocytes: 243.3;Proximal enterocytes: 144.8"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 16.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 81.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA066060	Uncertain					NA	NA					"HPA066060: AB_2685607"	"unprognostic (1.73e-1)"		"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-2)"		"unprognostic (2.35e-1)"			"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"		"unprognostic (6.43e-3)"	"unprognostic (2.68e-3)"	"unprognostic (3.29e-1)"			0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	57.1	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	10.5	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	81.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	10.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.7	1.4	243.3	0.1	0.0	0.0	3.1	0.0	5.2	0.0	0.2	0.0	0.1	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	144.8	17.5	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	2.0	1.5	0.0
C4BPB	C4BP	ENSG00000123843	"Complement component 4 binding protein beta"	P20851	1	207088860-207099993	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 475.2"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 597.6"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 83.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"CACO-2: 116.4;HeLa: 46.2;Hep G2: 151.6;OE19: 57.1"					"Not detected"	"Not detected"			"HPA000925, HPA051620"	Approved		Uncertain	"Golgi apparatus"	"Secreted to blood"	NA	NA	265000000000	1100000000	"Golgi apparatus"		"HPA000925: , HPA051620: AB_2681554"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.25e-2)"	3.1	0.1	0.0	3.4	0.0	0.0	1.9	0.0	0.1	2.8	0.0	2.8	3.8	0.1	0.0	0.2	0.5	3.1	0.0	0.0	0.0	0.4	475.2	1.5	0.4	0.0	0.0	0.0	44.6	9.2	0.0	0.0	6.3	0.1	0.0	1.8	0.0	0.5	0.0	0.1	0.1	4.4	0.7	0.0	0.4	8.5	0.7	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.4	5.8	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	46.2	151.6	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	12.8	2.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	7.3	2.2	0.5	54.3	3.2	0.0	0.0	1.0	0.2	10.2	1.9	11.4	4.1	0.7	0.1	0.8	1.8	8.0	0.1	88.8	0.3	3.4	5.6	0.8	0.0	0.3	9.7	597.6	2.1	0.0	0.2	5.6	0.0	13.1	0.3	2.8	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	69.2	15.9	0.0	0.1	0.2	4.3	0.0	2.2	0.0	0.0	1.1	0.4	0.1	0.4	0.0	0.0	0.1	1.1	143.8	4.8	0.1
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	329	"liver: 16694.5"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 10221.7"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	56	"Hep G2: 735.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	73000000000	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	1.0	34.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.4	0.0	0.4	0.2	0.6	0.7	25.3	0.9	0.0	0.0	8.5	16694.5	50.6	0.1	0.0	0.0	0.0	1.4	15.9	0.0	0.4	6.4	0.0	0.4	0.0	0.0	0.4	0.3	0.5	0.5	0.6	0.0	0.0	9.1	8.7	3.1	0.1	0.3	0.4	0.0	0.0	0.5	0.6	0.1	0.0	13.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.5	0.4	735.3	0.2	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.3	6.4	0.0	0.0	0.6	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.1	0.1	1.7	0.0	3.6	0.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	19.2	214.4	0.0	31.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	633.4	2.5	0.0	0.0	0.0	0.0	0.1	0.0	21.9	4.3	0.0	0.1	9.2	0.0	157.7	0.0	48.5	0.2	0.5	0.0	0.1	11.4	1.1	202.4	10221.7	0.2	0.0	0.0	0.0	0.0	289.5	0.0	0.5	0.0	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	161.8	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.0	0.4	17.3	0.2	0.0	0.0
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760270-233773300	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"intestine: 203.0;liver: 325.1"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 105.0"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;OE19: 64.5;RT4: 34.7"	"Not detected"	"Not detected"													NA	NA								"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.1	0.5	0.2	0.5	0.5	0.2	1.5	0.7	0.1	0.1	3.0	203.0	0.2	0.4	3.5	0.1	1.0	0.2	0.5	0.4	4.1	325.1	0.2	0.3	0.3	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.8	0.2	2.5	0.9	0.5	0.3	0.1	1.8	79.8	0.1	0.0	0.2	2.4	0.6	0.3	0.1	0.2	0.1	0.3	10.1	0.9	0.6	0.3	1.1	0.2	0.2	0.1	0.1	0.6	0.0	0.0	0.0	0.1	5.4	0.3	0.2	2.5	0.1	0.1	14.0	0.0	0.2	0.0	0.2	0.1	0.1	0.6	1.6	0.0	0.5	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.3	0.2	0.6	0.0	0.8	0.1	0.3	0.5	64.5	6.5	0.1	0.1	0.6	0.0	34.7	0.2	0.4	2.6	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.2	0.1	0.7	0.4	0.2	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	1.4	0.3	0.1	0.1	0.1	0.0	0.5	0.5	1.5	0.7	0.5	0.4	0.3	0.1	0.3	0.8	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	0.0	0.0	1.8	0.0	0.1	2.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	105.0	0.0	0.0	0.0	0.4	0.0	2.4	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.1	6.9	14.6	2.2	1.5	0.0	0.0	0.4	0.1	0.2	0.1	1.5	0.0	0.0	0.1	0.0	0.7	7.3
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 709.5"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 325.5;Proximal tubular cells: 92.4"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 44.7"	"Not detected"	"Not detected"							"HPA067946, HPA069081"	Enhanced					NA	NA		3400000			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.2	0.0	0.3	0.6	0.1	0.0	0.1	0.1	0.1	0.2	0.1	8.3	41.9	0.3	0.0	0.3	9.3	7.8	0.0	0.1	0.2	52.8	709.5	0.2	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	8.7	0.0	0.0	0.1	0.0	1.4	22.8	0.4	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	44.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	9.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.1	0.4	0.0	0.0	0.5	0.0	0.7	0.5	0.1	0.5	0.0	0.0	0.0	0.0	0.3	15.7	1.1	5.5	0.0	0.0	0.0	7.8	7.9	0.3	0.0	11.2	0.3	0.4	12.1	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.0	7.1	325.5	0.0	0.0	0.1	8.9	8.2	5.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	31.1	92.4	15.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	12.7	0.1
CREB3L3	"CREB-H, CREBH"	ENSG00000060566	"CAMP responsive element binding protein 3 like 3"	Q68CJ9	19	4153631-4173054	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	71	"intestine: 259.3;liver: 418.9"	"Group enriched"	"Detected in some"	17	"Hepatocytes: 111.9;Proximal enterocytes: 426.0"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 91.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.0;HDLM-2: 49.0;Hep G2: 15.6;HMC-1: 8.5;U-266/70: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040671, HPA056228"	Enhanced					NA	NA		32000			"HPA040671: AB_2677072, HPA056228: AB_2683072"	"unprognostic (1.86e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.41e-4)"	"unprognostic (1.79e-4)"	"unprognostic (1.88e-1)"	"unprognostic (5.28e-4)"	"unprognostic (3.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.53e-6)"	"unprognostic (3.18e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.35e-2)"	0.0	4.7	0.3	0.3	0.3	0.3	0.0	0.1	0.6	0.0	0.0	2.0	246.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	1.4	418.9	0.0	0.1	0.7	0.4	0.3	0.1	0.5	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	259.3	0.3	0.1	0.2	1.8	0.5	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	7.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	49.0	0.0	0.0	0.0	15.6	0.0	0.1	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	4.0	0.4	0.0	0.1	0.0	2.0	0.0	1.4	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	10.1	4.5	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.6	0.4	0.3	0.7	0.4	0.3	1.0	0.1	0.5	0.5	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	15.1	3.3	111.9	0.0	0.0	0.5	13.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	14.6	0.0	0.0	0.0	426.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	8.2	0.0
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 45.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Early spermatids: 7.5;Excitatory neurons: 3.9;granulocytes: 2.5;Hepatocytes: 6.4;Late spermatids: 3.3;Spermatocytes: 2.4"	"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA066463, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA066463: AB_2685670, HPA072245: , HPA075539: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	45.0	0.1	0.1	0.1	0.1	0.0	0.1	5.8	0.0	0.0	0.0	0.1	0.6	0.1	0.5	0.2	0.1	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.8	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.0	0.3	0.4	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.2	0.0	0.0	3.9	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	6.4	0.1	1.7	1.9	0.0	0.0	0.6	1.9	3.3	0.0	0.2	0.0	1.0	0.0	0.2	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.7	0.1	2.4	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.2
GC	"DBP, hDBP, VDBP"	ENSG00000145321	"GC vitamin D binding protein"	P02774	4	71741696-71804041	"Metabolic proteins, Plasma proteins, Predicted secreted proteins"	Transport	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 8327.9"	"Group enriched"	"Detected in some"	27	"Cholangiocytes: 1552.8;Hepatocytes: 3017.1"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 1016.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 2.0;RH-30: 3.0;SiHa: 1.8;U-698: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001526, CAB008596, HPA019855"	Supported				"Secreted to blood"	NA	NA	143000000000	73000000000			"CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545"							"prognostic favorable (8.08e-4)"				"unprognostic (1.06e-3)"		"prognostic unfavorable (5.81e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.15e-1)"			0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	60.8	0.0	0.6	0.1	0.0	500.0	0.1	0.0	0.0	46.6	8327.9	0.0	0.2	0.0	0.1	0.0	0.0	44.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.1	0.0	0.0	1.8	52.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.4	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.3	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	7.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1552.8	0.0	0.0	0.0	0.0	0.0	0.0	5.9	39.5	0.5	0.1	0.0	2.0	0.0	37.5	0.1	16.2	0.2	0.0	0.0	0.0	0.0	0.0	58.5	3017.1	0.1	0.0	0.1	0.7	0.0	83.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	0.0	0.0
TDO2	"TDO, TPH2"	ENSG00000151790	"Tryptophan 2,3-dioxygenase"	P48775	4	155854738-155920406	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"liver: 804.5"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1174.2"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 35.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 9.6;HDLM-2: 22.0;U-87 MG: 11.3"	"Group enriched"	"Detected in some"	7	"cerebellum: 6.3;hippocampal formation: 5.3;white matter: 1.9"	"Low region specificity"	"Detected in all"			HPA039611	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039611: "	"unprognostic (1.10e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-8)"	"unprognostic (7.99e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.95e-2)"	0.2	1.6	0.5	16.9	0.6	0.0	0.1	0.4	1.4	0.2	0.4	1.2	3.6	0.4	0.7	0.7	0.3	1.9	0.0	0.7	0.5	0.4	804.5	3.3	3.1	0.5	1.3	0.5	0.1	0.3	0.1	4.1	0.6	0.6	0.2	1.4	0.0	0.4	0.2	0.2	0.0	6.0	2.6	0.5	1.9	1.6	0.4	0.5	0.2	0.2	0.0	2.6	7.7	0.1	0.9	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	9.6	0.0	0.2	0.0	0.1	0.0	0.0	22.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	3.5	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	1.6	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.5	0.0	3.4	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	1.4	0.7	0.5	0.5	1.3	0.5	0.6	0.5	0.5	0.9	0.8	0.0	0.0	0.7	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.6	158.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.5	0.1	1.1	2.4	0.0	32.0	4.1	0.0	0.0	1.7	3.6	0.1	0.0	0.0	29.6	1174.2	0.9	0.0	0.4	0.0	0.0	31.7	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.6	0.0	11.3	0.4	1.1	0.0	0.0	0.3	2.3	0.3	0.0	0.1
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	52	"liver: 3042.7"	"Cell type enriched"	"Detected in many"	24	"Hepatocytes: 4816.3"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.5;myeloid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Hep G2: 152.2;OE19: 116.1"	"Low region specificity"	"Detected in all"							HPA055896			Approved	"Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments"	"Secreted to blood"	Yes	No	308000000	410000000	"Nucleoli, Nucleoli rim, Mitotic chromosome"	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favorable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	37.0	3.1	3.6	6.1	3.3	1.0	38.1	3.6	5.0	37.4	5.4	32.9	23.4	23.6	18.1	9.9	30.7	28.8	13.6	3.4	6.1	18.6	3042.7	18.7	3.6	4.3	3.8	2.9	58.6	31.1	5.3	5.0	3.8	4.0	33.0	46.1	2.2	53.0	13.4	6.3	27.5	27.3	10.5	4.5	7.5	58.7	10.3	3.7	1.5	8.9	10.6	4.2	25.0	31.6	4.6	3.7	9.9	2.3	0.0	23.9	27.8	0.3	4.8	8.8	1.1	4.0	5.9	5.1	0.4	1.5	12.0	8.0	3.8	2.8	3.1	1.3	18.4	3.8	0.9	5.1	152.2	5.0	4.0	0.5	22.2	2.5	1.5	5.1	11.8	5.7	4.2	0.2	27.0	3.5	0.7	0.9	1.2	0.7	116.1	10.7	0.7	3.9	11.3	2.3	2.9	0.0	0.4	4.6	1.7	6.5	5.1	4.0	0.7	6.0	1.9	2.8	1.7	0.7	5.9	4.8	0.5	3.2	2.0	5.0	0.0	24.5	0.0	0.6	2.9	0.4	5.8	1.2	1.1	14.5	4.9	0.3	0.2	0.4	0.0	0.1	2.3	0.8	7.1	3.6	3.3	3.6	5.0	3.4	6.1	4.3	3.8	2.9	4.0	4.5	3.7	4.6	9.7	28.9	17.7	0.0	9.7	27.1	43.3	39.2	14.2	0.1	33.8	24.8	0.8	194.5	24.6	11.0	0.0	1.6	0.7	32.5	11.7	40.0	1.0	6.2	9.7	11.0	71.0	27.8	0.0	31.6	5.3	48.8	56.1	24.9	0.0	10.7	62.4	4816.3	15.9	0.0	0.0	171.9	12.2	95.9	18.7	2.9	71.1	13.8	23.2	0.0	4.9	10.1	0.0	0.0	0.0	21.6	33.3	24.0	11.7	43.7	91.3	61.2	76.5	0.6	13.1	29.7	17.7	1.0	1.3	9.4	52.4	9.3	5.6	0.5	51.6	39.2
APOC2		ENSG00000234906	"Apolipoprotein C2"	P02655	19	44946035-44949565	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Disease variant, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	79	"liver: 9720.4"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 1170.2"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 49.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	30	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	30	"NK-cells: 3.2"	"Group enriched"	"Detected in many"	4	"Hep G2: 713.0;THP-1: 1354.4"									HPA055877	Supported				"Secreted to blood"	NA	NA	43000000000	49000000000			"HPA055877: AB_2682953"	"unprognostic (4.28e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.14e-8)"	"unprognostic (1.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.80e-3)"	1.0	5.5	70.1	1.7	63.9	1.1	5.4	64.5	117.2	4.5	53.6	4.4	41.8	1.2	4.9	2.4	4.3	3.8	0.8	59.1	83.1	16.5	9720.4	35.2	16.0	74.7	67.7	54.9	0.4	2.2	6.7	3.0	2.9	77.9	1.4	4.4	2.8	2.4	2.2	1.9	4.3	66.2	0.7	77.5	3.9	2.7	1.1	70.5	3.2	0.9	0.7	9.9	2.2	0.8	122.4	2.9	0.6	0.3	0.4	0.5	0.6	1.3	0.1	0.0	0.0	0.1	2.0	2.8	0.7	0.3	0.0	0.0	2.6	0.0	0.1	0.0	0.7	0.1	123.0	2.7	713.0	0.2	15.4	237.5	0.2	0.3	0.0	0.0	0.3	0.0	0.1	1.7	2.9	0.1	0.8	0.9	126.3	0.5	3.2	0.4	0.8	5.2	1.1	0.0	1.5	0.1	0.1	1.9	0.2	7.7	0.0	0.7	1354.4	0.0	0.3	0.6	0.8	0.8	2.3	0.9	2.2	0.2	3.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	70.1	63.9	64.5	117.2	59.1	83.1	74.7	67.7	54.9	77.9	77.5	70.5	122.4	0.1	0.0	2.3	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.1	11.5	0.0	3.7	0.0	0.1	0.1	0.0	3.9	0.0	0.0	0.0	0.1	0.3	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	13.6	1170.2	33.8	0.0	0.0	0.4	0.0	15.5	1.2	0.0	0.0	24.0	7.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	10.0	0.7	0.0	0.1	17.7	32.3	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.4	0.3	1.8	0.0	1.3	0.0
APOC4-APOC2		ENSG00000224916	"APOC4-APOC2 readthrough (NMD candidate)"		19	44942238-44949565	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	1257	"liver: 2239.2"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 147.1"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 9.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"THP-1: 4.2"									HPA055877	Supported					NA	NA					"HPA055877: AB_2682953"	"unprognostic (1.45e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.01e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.68e-2)"	0.1	0.4	0.5	0.0	0.4	0.0	0.2	0.4	0.6	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.4	0.4	0.2	2239.2	1.7	0.0	0.5	0.5	0.4	0.0	0.3	0.0	0.8	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.5	1.2	0.1	0.4	0.6	0.0	0.2	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.6	0.4	0.4	0.5	0.5	0.4	0.5	0.5	0.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.1	147.1	2.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120952335-121050275	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 437.3"	"Cell type enriched"	"Detected in many"	16	"Hepatocytes: 538.3"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 73.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 28.4;Hep G2: 30.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029339	Supported				"Secreted to blood"	NA	NA	113000000000	39000000000			"HPA029339: AB_10601125"	"unprognostic (2.51e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.52e-3)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.83e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.46e-5)"	"unprognostic (5.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.75e-1)"	3.0	1.7	2.9	1.2	3.5	2.2	2.5	2.6	2.6	3.0	3.5	2.3	3.9	2.8	2.7	1.7	3.0	1.5	1.1	2.2	3.0	4.8	437.3	7.1	2.1	3.3	2.9	2.1	3.3	15.0	2.6	3.2	0.9	3.2	3.2	1.6	3.5	1.4	2.2	0.5	3.8	4.0	2.0	2.9	1.5	5.8	1.7	2.7	1.2	2.0	1.2	1.7	2.6	2.1	4.7	1.6	28.4	6.4	11.3	8.0	9.2	0.2	3.4	3.5	0.9	2.0	0.8	2.8	4.1	0.1	1.8	3.8	11.0	0.3	0.3	1.5	0.9	0.0	1.8	1.5	30.4	1.5	1.0	0.7	4.1	0.5	2.0	3.7	1.8	1.0	1.6	0.7	3.8	2.2	5.6	0.4	0.2	1.7	7.0	10.9	2.5	2.8	0.4	1.7	0.8	1.6	6.5	1.6	0.0	2.7	4.4	2.2	3.7	1.3	2.8	0.2	7.5	3.4	2.3	1.8	1.7	2.2	3.8	6.8	0.0	0.3	0.4	0.0	0.0	0.2	0.3	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	3.5	2.6	2.6	2.2	3.0	3.3	2.9	2.1	3.2	2.9	2.7	4.7	0.8	6.4	28.6	30.0	3.5	1.0	1.0	0.5	1.8	4.8	2.2	1.3	0.8	32.9	7.1	1.8	0.0	0.1	0.1	0.4	1.9	0.2	1.8	1.1	2.2	1.4	0.0	12.0	7.3	0.4	0.0	2.9	2.0	0.8	0.0	3.1	7.5	538.3	1.9	6.7	9.4	1.0	0.0	16.3	1.0	2.8	3.1	3.5	0.0	6.5	2.3	3.2	2.1	25.6	25.4	0.7	3.8	9.1	0.1	0.7	1.0	6.8	3.8	2.6	0.0	4.0	1.6	7.5	2.5	2.0	1.3	0.0	1.4	2.8	2.0	0.6
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120685	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"liver: 161.5"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 149.3"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 11.5;Hep G2: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	NA	NA	351000000	1300000000	Mitochondria		"HPA004826: AB_10602805"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	0.2	0.0	0.4	0.1	0.3	0.0	0.2	0.5	0.7	0.9	0.2	0.0	0.5	0.1	0.6	0.1	0.5	0.0	0.1	0.3	0.8	0.4	161.5	0.1	0.0	0.3	0.4	0.3	0.4	0.1	0.2	0.4	0.1	0.4	0.4	0.0	0.2	0.3	0.0	0.0	0.3	0.8	0.0	0.1	0.1	0.1	1.5	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.5	0.7	0.3	0.8	0.3	0.4	0.3	0.4	0.1	0.5	0.4	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.6	0.3	0.5	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	8.0	0.3	0.2	0.0	0.4	0.0	0.2	0.0	0.3	2.2	149.3	0.1	0.0	0.5	0.4	0.0	2.8	0.7	0.2	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	1.1	0.3	0.0	0.2	0.0	0.5	0.1	3.2	4.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186208979-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 331.1"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 280.5"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 27.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.1;SCLC-21H: 2.1;U-937: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA	28900000000	5300000000				"unprognostic (4.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	0.5	1.8	6.7	0.3	6.8	0.0	0.6	6.4	7.6	1.3	8.8	1.9	2.9	0.6	1.0	0.4	1.3	2.6	2.5	6.7	6.4	5.7	331.1	1.0	0.7	7.2	6.7	6.5	0.7	4.8	1.0	3.6	0.2	7.2	1.7	1.4	13.3	0.7	0.6	2.4	0.2	2.6	0.7	6.7	2.4	0.8	2.0	6.4	0.4	1.9	1.8	0.4	1.5	0.9	6.6	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.8	6.4	7.6	6.7	6.4	7.2	6.7	6.5	7.2	6.7	6.4	6.6	0.1	0.0	0.0	48.3	0.7	0.0	0.1	0.2	0.6	5.1	0.3	0.5	4.3	14.3	0.1	1.8	16.7	0.0	0.5	0.6	0.0	1.8	2.8	0.6	0.2	1.0	3.0	2.7	10.2	0.5	0.0	0.4	0.0	0.4	0.0	0.2	5.7	280.5	0.2	0.0	15.6	0.4	0.0	4.4	0.0	2.2	0.6	0.3	0.0	6.5	0.1	10.6	2.1	8.0	7.7	0.4	1.4	0.0	0.1	0.0	2.6	1.6	1.1	5.1	0.0	0.6	0.3	1.3	1.3	0.1	0.0	0.0	0.6	0.1	0.7	0.1
LEAP2	LEAP-2	ENSG00000164406	"Liver enriched antimicrobial peptide 2"	Q969E1	5	132873444-132875046	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 536.4"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1650.6"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 40.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.4;Hep G2: 4.7;U-266/84: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		790000				"unprognostic (2.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.68e-4)"	0.9	0.9	0.8	0.3	1.0	0.5	1.1	2.2	1.2	1.3	0.5	1.7	12.4	0.8	0.2	1.3	1.2	4.5	1.2	0.9	0.9	12.0	536.4	1.1	0.5	0.9	0.9	0.9	1.2	1.9	0.7	1.1	0.2	1.2	2.4	1.6	1.0	1.3	0.2	1.5	1.4	23.6	0.1	0.7	2.2	2.0	1.1	0.9	0.3	1.9	0.5	0.5	7.9	1.6	1.9	0.1	0.7	0.4	1.5	0.6	0.4	0.4	0.1	0.1	0.4	0.6	3.4	0.5	0.2	0.1	0.1	0.4	0.7	1.4	0.6	0.0	1.2	1.0	0.3	1.2	4.7	0.1	0.5	0.2	0.1	0.5	0.0	0.1	0.3	0.1	1.1	0.5	0.4	0.0	0.3	0.8	0.6	1.1	1.1	0.5	0.0	0.2	1.1	0.0	0.2	0.5	0.3	0.3	0.7	0.5	0.4	0.8	0.4	0.0	0.2	0.3	0.6	0.1	1.1	3.8	1.1	0.0	0.7	0.2	1.3	0.7	0.3	0.6	0.4	0.8	1.0	0.6	0.7	0.6	0.8	1.0	0.8	1.7	1.0	0.3	0.8	1.1	0.3	0.8	1.0	2.2	1.2	0.9	0.9	0.9	0.9	0.9	1.2	0.7	0.9	1.9	2.5	0.0	2.6	1.3	7.9	10.1	10.8	4.1	2.8	17.1	4.9	2.8	1.9	64.3	2.6	0.0	33.3	3.3	7.6	39.2	9.8	2.9	6.2	4.8	3.8	5.2	4.8	9.3	1.1	9.8	7.9	5.8	1.5	10.3	7.0	6.7	14.3	1650.6	1.4	13.5	1.4	12.1	0.0	17.3	14.1	0.5	1.5	4.2	5.4	1.0	2.2	5.2	13.4	2.0	1.8	2.9	30.9	1.9	3.1	14.0	279.9	51.8	1.7	25.2	0.0	13.5	4.8	7.0	2.9	1.4	7.7	7.3	6.2	4.1	8.0	10.2
PAGE4	"CT16.7, GAGEC1, PAGE-4"	ENSG00000101951	"PAGE family member 4"	O60829	X	49829260-49834264	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 879.5;placenta: 1031.7"	"Group enriched"	"Detected in some"	10	"Cytotrophoblasts: 13314.7;Syncytiotrophoblasts: 8524.1"	"Group enriched"	"Detected in some"	17	"liver cancer: 14.8;prostate cancer: 7.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.2;U-266/70: 11.7;U-266/84: 45.1"					"Not detected"	"Not detected"			HPA023880	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA023880: AB_1854930"				"unprognostic (8.56e-2)"			"unprognostic (1.47e-1)"			"unprognostic (1.04e-1)"		"unprognostic (4.82e-3)"			"unprognostic (5.37e-2)"			0.1	5.8	0.1	0.3	0.2	0.0	0.0	0.1	0.5	3.9	0.1	0.2	0.4	51.7	879.5	0.0	21.6	0.0	0.4	0.1	0.1	0.9	0.3	0.2	0.0	0.1	0.1	0.0	3.7	2.5	0.0	1.3	1031.7	0.1	173.2	0.0	0.0	0.6	77.9	2.4	0.0	0.3	24.4	0.0	0.3	0.2	5.7	0.1	0.1	0.0	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.0	0.1	11.7	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13314.7	0.0	0.0	0.0	0.0	4.4	1.9	72.5	25.9	0.0	0.0	0.0	0.0	905.4	72.5	0.0	1.9	0.0	0.0	0.0	0.0	1052.1	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	48.8	20.7	0.0	0.0	8524.1	0.3	0.0	0.0	0.1
PAH	PH	ENSG00000171759	"Phenylalanine hydroxylase"	P00439	12	102836889-102958410	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Phenylalanine catabolism"	"Allosteric enzyme, Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 501.2;liver: 1419.9"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 250.2;Hepatocytes: 807.7;Proximal tubular cells: 344.4"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 94.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	31	"Hep G2: 238.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028407, HPA031642"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		No	NA		40000	"Endoplasmic reticulum, Vesicles"		"HPA028407: AB_10601241, HPA031642: AB_2673974"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.13e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.99e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.68e-2)"	0.1	6.4	2.1	0.0	1.7	0.0	0.2	1.9	3.4	0.1	0.9	0.3	0.1	0.1	0.5	0.0	0.1	80.1	0.0	2.0	3.3	501.2	1419.9	0.0	0.1	2.8	2.1	1.3	0.1	9.3	0.8	3.0	0.0	2.1	1.5	0.0	2.4	0.1	0.1	0.0	0.0	0.1	0.0	2.5	0.3	0.4	3.3	2.8	0.7	0.6	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	238.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.2	1.0	0.1	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.7	1.9	3.4	2.0	3.3	2.8	2.1	1.3	2.1	2.5	2.8	2.7	0.0	0.0	0.0	1.0	2.7	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.5	250.2	0.0	5.5	0.0	0.0	0.0	0.0	21.5	2.4	66.8	0.0	0.1	1.1	1.8	21.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	807.7	0.0	3.3	2.3	0.0	0.0	22.2	0.0	15.7	0.6	1.8	0.0	0.0	0.0	0.6	0.0	4.5	0.0	0.0	0.0	1.2	0.0	0.4	0.0	344.4	0.0	0.2	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.1
UGT2B11		ENSG00000213759	"UDP glucuronosyltransferase family 2 member B11"	O75310	4	69199951-69214748	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"breast: 241.8"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 13.7;Cholangiocytes: 7.2"	"Group enriched"	"Detected in some"	17	"breast cancer: 17.4;liver cancer: 13.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	42	"basophil: 4.7;eosinophil: 3.5"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.7"	"Not detected"	"Not detected"											HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.12e-1)"						"unprognostic (1.18e-3)"			"unprognostic (1.49e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-3)"	0.1	0.0	0.0	0.1	0.0	0.1	241.8	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.9	0.0	0.5	11.5	0.0	0.0	0.0	3.6	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.5	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750087-52763475	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 702.5;liver: 2075.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 201.6;Distal tubular cells: 213.2;Exocrine glandular cells: 239.6;Pancreatic endocrine cells: 334.7;Proximal enterocytes: 367.0;Proximal tubular cells: 1186.6;Respiratory ciliated cells: 435.5"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 25.9;Hep G2: 20.0"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA			Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.4	4.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	150.9	0.0	0.7	0.1	2.5	110.4	0.0	0.0	0.0	702.5	2075.0	4.8	0.1	0.0	0.0	0.0	0.2	301.8	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.5	0.0	0.0	0.0	116.5	0.0	0.0	0.0	11.8	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	25.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.0	20.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.6	0.0	0.0	0.3	0.6	0.5	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	1.7	0.0	0.2	1.5	0.0	0.0	0.1	0.1	0.0	201.6	31.1	16.5	0.0	0.0	0.0	0.1	213.2	8.1	6.9	0.0	0.0	0.6	0.0	0.0	0.0	239.6	0.2	0.5	7.7	0.0	0.0	37.2	0.7	124.2	0.1	0.0	0.0	13.7	2.0	2.2	0.0	14.6	1.2	5.1	0.0	0.0	5.2	0.0	0.0	0.0	0.1	334.7	18.8	0.4	0.0	3.9	367.0	1186.6	435.5	0.0	0.0	0.0	1.5	1.9	0.7	0.0	0.0	0.0	2.6	10.4	30.1	1.3
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406930-39451533	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 19.8;liver: 17.9;pancreas: 6.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 19.6;Enteroendocrine cells: 17.4;Hepatocytes: 51.4;Intestinal goblet cells: 12.1;Spermatocytes: 39.5"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"ASC diff: 6.7;Hep G2: 25.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021136	Uncertain					NA	NA		320000			"HPA021136: AB_1852616"	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	19.8	0.1	0.2	0.2	0.4	0.3	3.5	0.9	0.6	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.2	0.2	0.1	0.2	0.3	0.2	17.9	1.6	0.0	0.4	0.2	0.2	0.0	6.1	0.1	0.0	0.0	0.3	0.1	0.5	0.1	0.4	0.0	0.0	0.6	0.6	0.0	0.1	0.0	1.4	2.8	0.2	0.0	0.0	0.2	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	25.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.4	0.9	0.6	0.2	0.3	0.4	0.2	0.2	0.3	0.1	0.2	0.5	0.6	3.2	19.6	0.0	0.7	0.5	1.1	1.4	0.0	1.6	0.7	1.1	1.2	0.0	1.2	0.0	0.0	0.4	0.5	1.6	0.0	1.1	8.5	4.4	1.5	0.4	17.4	0.0	0.5	4.3	1.5	0.5	2.6	2.2	0.0	0.2	0.4	51.4	0.2	1.7	0.6	12.1	2.0	1.0	0.6	3.2	1.5	0.4	1.8	0.0	0.1	0.4	0.0	0.5	0.2	0.9	4.8	0.7	0.0	1.2	2.1	1.1	0.4	2.3	0.0	1.2	0.5	39.5	0.9	2.0	0.9	1.4	0.8	0.5	1.1	1.1
LGALS14	"CLC2, PPL13"	ENSG00000006659	"Galectin 14"	Q8TCE9	19	39704481-39709444	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"placenta: 66.1"	"Cell type enriched"	"Detected in some"	11	"Syncytiotrophoblasts: 88.7"	"Cancer enriched"	"Detected in single"	16	"liver cancer: 5.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"EFO-21: 4.3;U-266/70: 9.8"									HPA065180			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065180: "										"unprognostic (1.95e-1)"								0.1	0.0	0.7	0.3	0.9	0.6	0.4	2.0	1.4	0.2	0.3	0.1	0.3	0.2	0.3	0.0	0.0	0.1	0.0	0.7	0.5	0.0	0.0	0.2	0.4	1.2	0.8	1.0	0.2	0.5	0.0	0.0	66.1	1.5	0.2	0.1	0.5	0.1	0.0	0.1	0.9	0.1	0.2	0.3	0.4	0.3	0.2	1.1	0.1	0.1	0.2	0.6	0.1	0.0	1.9	0.1	0.0	0.2	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	4.3	0.1	0.1	0.5	0.0	0.0	0.1	1.2	0.1	0.1	0.5	0.2	0.0	0.1	0.7	0.0	0.1	0.1	0.2	0.4	0.0	0.3	0.1	0.8	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.5	0.0	0.1	0.0	0.3	0.4	0.5	0.1	9.8	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.9	2.0	1.4	0.7	0.5	1.2	0.8	1.0	1.5	0.3	1.1	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	88.7	0.2	0.0	0.0	0.0
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323056-114326475	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	192	"liver: 43326.9"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 58657.7"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 2506.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	47	"neutrophil: 193.9"	"Lineage enriched"	"Detected in many"	47	"granulocytes: 193.9"	"Cell line enriched"	"Detected in some"	12	"Hep G2: 1182.7"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	945000000000	61000000000	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (3.85e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.16e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.51e-2)"	8.8	10.3	0.7	12.8	0.2	225.2	6.7	0.1	0.4	2.1	0.2	1.4	0.1	2.7	0.3	2.0	1.9	1.0	3.3	0.2	0.1	5.0	43326.9	24.6	0.7	0.3	0.2	0.0	1.6	8.2	0.0	1.4	1.3	0.2	58.1	0.0	1.1	1.4	0.0	2.0	1.6	2.3	0.3	0.5	51.7	19.4	2.8	0.1	1.2	2.8	0.3	0.1	1.6	2.2	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	2.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	3.4	0.6	1182.7	0.1	5.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.2	0.0	0.2	1.0	0.1	0.0	0.7	7.1	0.0	0.0	0.4	0.0	0.0	5.7	5.5	0.0	0.0	0.4	102.0	1.2	0.0	0.5	0.0	0.0	1.2	0.6	3.5	0.0	4.3	0.1	0.0	4.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.9	0.0	1.0	0.0	0.0	1.8	0.7	0.2	0.1	0.4	0.2	0.1	0.3	0.2	0.0	0.2	0.5	0.1	0.2	0.0	3.2	18.1	0.0	81.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1166.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	1.3	0.2	34.4	0.0	890.4	0.0	4.9	0.3	0.2	0.0	2.5	0.0	0.0	930.9	58657.7	0.1	0.0	0.0	0.0	0.0	1260.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	78.6	0.0	0.0	0.3
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"liver: 260.9"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 168.7"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.4;monocytes: 5.1;T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"MCF7: 8.1;T-47d: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	NA	NA		87000000000	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	260.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	5.7	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.4	0.4	0.2	1.6	1.7	1.6	0.2	0.9	0.8	0.1	0.0	2.2	2.3	1.6	0.5	5.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.2	0.5	0.0	0.0	4.1	1.5	0.2	4.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.9	168.7	0.3	0.0	0.4	0.0	0.0	2.2	0.0	3.1	0.3	1.9	8.8	0.0	1.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	14.1	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.1	0.1	0.0	7.6	0.0	0.0	0.1
SAA1	"PIG4, SAA, TP53I4"	ENSG00000173432	"Serum amyloid A1"	P0DJI8	11	18266260-18269977	"Disease related genes, Predicted secreted proteins"	"Acute phase"	Heparin-binding	Amyloidosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 48539.6"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 99298.7"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 1249.6"	"Group enriched"	"Detected in some"	6	"hypothalamus: 41.8;white matter: 12.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"HBEC3-KT: 716.4"														"Secreted to blood"	NA	NA	300000000	11000000000				"unprognostic (2.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (4.57e-12)"	"unprognostic (5.15e-2)"	"unprognostic (9.78e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.64e-1)"	2058.8	54.9	0.1	163.1	0.1	0.0	1394.3	0.1	0.6	260.1	1.4	31.8	1.4	2.2	0.2	51.5	57.1	34.0	17.0	0.2	41.8	28.5	48539.6	99.4	1.2	0.8	3.0	0.1	3.3	47.1	0.5	67.1	7.2	0.3	67.1	6.5	0.0	2387.4	4.4	515.8	81.3	75.6	19.0	0.1	39.1	42.4	1.7	4.5	52.6	18.3	0.2	15.9	64.4	29.3	12.5	49.2	0.3	0.0	0.3	34.4	0.2	18.9	1.3	1.1	0.2	0.3	0.1	17.2	0.0	38.3	0.0	11.7	45.5	0.0	716.4	0.3	0.6	0.0	0.8	0.0	0.1	148.4	1.1	0.0	60.9	66.7	0.2	76.7	0.1	0.0	0.0	0.1	0.0	9.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	1.7	0.0	28.5	0.9	0.0	0.1	4.2	5.5	0.2	0.0	0.5	0.0	0.0	0.2	5.5	0.0	1.3	0.0	1.3	1.3	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.2	41.8	0.8	3.0	0.1	0.3	0.1	4.5	12.5	107.2	6.4	2.8	0.0	259.8	9.3	64.9	10039.5	10.2	0.0	210.6	1010.4	0.1	1701.5	7604.7	55.2	0.0	1.3	3.0	44.5	0.0	250.4	0.0	12.6	1.6	114.9	1.8	3543.7	0.1	81.1	34.4	8.3	0.0	14.3	2.5	0.0	2568.6	99298.7	1.0	0.0	0.1	5.2	2012.1	2454.9	0.3	0.0	0.0	2.6	51.6	0.0	2.6	0.0	1.0	0.0	0.1	68.8	5.5	0.0	0.1	185.5	3.1	0.2	15716.2	0.0	0.0	31.5	736.1	0.0	0.0	34.1	0.1	2.1	214.7	0.0	36.7	178.8
SLC6A1	"GABATHG, GABATR, GAT1"	ENSG00000157103	"Solute carrier family 6 member 1"	P30531	3	10992186-11039247	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.6;liver: 88.0;retina: 37.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 221.0;Inhibitory neurons: 332.3;Microglial cells: 108.7;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 107.9"	"Group enriched"	"Detected in some"	16	"glioma: 16.1;liver cancer: 24.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013341, CAB022293"	Enhanced					NA	NA					"CAB022293: , HPA013341: AB_1849509"	"unprognostic (1.66e-3)"	"unprognostic (1.30e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (5.05e-6)"	"unprognostic (7.32e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.34e-2)"	1.6	0.8	51.1	0.4	46.2	2.3	1.0	42.2	67.6	3.1	0.0	1.0	0.4	1.2	2.9	9.2	1.2	1.2	3.9	34.4	43.8	1.3	88.0	2.1	0.5	65.3	60.7	29.4	2.1	0.3	16.1	3.6	0.8	62.1	2.4	0.5	37.3	0.4	4.1	2.7	1.2	0.9	0.5	26.7	0.7	0.5	4.2	65.3	17.8	0.7	0.8	0.4	0.9	2.6	39.6	0.2	0.2	0.5	0.3	0.4	0.1	0.3	0.2	0.0	0.2	0.3	0.4	0.3	0.4	0.1	0.1	0.5	0.4	0.6	0.2	0.2	0.0	0.5	0.4	1.6	0.8	0.2	0.6	0.6	0.3	0.0	0.0	0.3	0.1	0.1	0.5	0.3	1.0	0.0	0.3	0.2	0.5	0.2	0.3	0.4	0.3	0.0	0.0	0.1	0.5	0.2	0.0	0.2	0.2	0.0	0.3	0.3	0.3	0.1	0.2	0.1	0.2	0.2	0.3	0.1	0.3	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	51.1	46.2	42.2	67.6	34.4	43.8	65.3	60.7	29.4	62.1	26.7	65.3	39.6	0.3	0.0	0.5	221.0	0.0	0.3	0.0	0.0	6.2	26.6	0.1	0.0	2.1	14.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	2.6	0.0	0.0	3.7	0.0	0.0	1.4	0.0	0.0	2.5	0.2	0.0	25.2	0.0	0.0	332.3	0.0	0.0	0.8	0.0	1.6	5.6	0.2	0.0	108.7	0.0	36.6	0.0	130.2	107.9	0.0	0.0	10.1	0.0	0.0	0.0	0.2	0.0	3.7	13.1	9.4	6.8	3.8	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0
APOC4		ENSG00000267467	"Apolipoprotein C4"	P55056	19	44942237-44945496	"Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	228	"liver: 634.1"	"Cell type enriched"	"Detected in single"	37	"Hepatocytes: 3.8"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 0.7"	"Region enriched"	"Detected in single"	4	"white matter: 2.7"	"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 2.4;TIME: 1.2"	"Not detected"	"Not detected"							HPA062671	Approved				"Secreted to blood"	NA	NA	1000000000	980000000			"HPA062671: AB_2684828"							"unprognostic (1.82e-3)"											0.2	0.3	0.3	0.0	0.6	0.5	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.4	0.7	0.0	0.2	0.3	0.2	0.1	0.1	0.0	634.1	0.2	0.1	0.3	0.2	0.0	0.3	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.1	1.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.1	0.5	0.3	2.4	0.0	0.3	0.0	1.2	0.1	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.0	0.1	0.1	0.4	0.0	0.0	0.3	0.6	0.2	0.6	0.1	0.1	0.3	0.2	0.0	0.3	0.3	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAQR9	FLJ41938	ENSG00000188582	"Progestin and adipoQ receptor family member 9"	Q6ZVX9	3	142949164-142963674	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 13.6;retina: 9.7;testis: 20.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 42.1;Erythroid cells: 28.2;Hepatocytes: 18.4;Late spermatids: 98.3;Syncytiotrophoblasts: 36.5"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.0;AF22: 1.0;U-266/70: 3.3;U-266/84: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA052798	Uncertain					NA	NA					"HPA052798: AB_2681955"		"unprognostic (4.13e-2)"		"unprognostic (2.54e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.12e-1)"		"unprognostic (3.56e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.09e-1)"		"unprognostic (6.91e-2)"	0.0	0.1	1.2	0.0	1.7	5.3	0.0	1.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	2.5	2.0	0.0	13.6	0.0	0.0	1.0	2.0	1.5	0.0	0.0	0.2	0.9	0.2	1.2	0.0	0.0	9.7	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	20.6	3.8	0.1	0.0	1.4	0.0	0.1	0.0	1.9	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	3.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.7	1.0	5.3	2.5	2.0	1.0	2.0	1.5	1.2	0.2	3.8	1.9	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	5.8	0.0	0.0	6.7	1.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	42.1	0.7	0.0	0.2	0.0	28.2	0.8	0.0	0.1	0.3	0.0	0.2	0.0	1.0	0.0	18.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	98.3	1.2	0.0	0.0	0.0	0.0	1.7	0.0	1.0	0.2	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.0	6.8	0.0	0.0	0.1	2.6	5.4	0.0	0.1	36.5	0.0	0.1	0.0	0.0
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684719-6713377	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 417.4"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 381.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	79	"Hep G2: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.2	2.8	4.8	0.0	6.2	0.0	0.3	4.9	8.0	0.3	2.8	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.0	5.4	6.5	0.7	417.4	0.0	0.2	6.8	5.5	4.7	0.6	0.3	0.0	0.8	0.0	6.8	0.0	0.0	1.7	38.3	0.0	0.0	0.0	0.0	0.0	4.4	3.4	0.0	2.3	6.8	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.2	4.9	8.0	5.4	6.5	6.8	5.5	4.7	6.8	4.4	6.8	4.2	0.4	0.0	0.0	24.8	4.8	0.5	0.6	0.6	1.2	0.6	0.1	0.1	0.9	7.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	1.9	0.0	24.0	0.3	0.5	0.1	0.4	0.0	0.1	0.0	0.9	16.8	381.0	0.0	0.0	0.2	0.0	0.0	23.2	1.1	0.4	0.6	0.3	0.0	1.9	0.0	7.0	0.0	1.5	0.1	16.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.6	0.0	0.5	0.5	2.4	2.8	1.2	0.4	0.1	1.0	7.8	0.0	0.3
UGT3A1	FLJ34658	ENSG00000145626	"UDP glycosyltransferase family 3 member A1"	Q6NUS8	5	35951006-36001028	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 51.5;liver: 58.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 49.7;Early spermatids: 125.9;Hepatocytes: 72.1;Late spermatids: 24.5;Proximal tubular cells: 87.0"	"Group enriched"	"Detected in some"	15	"liver cancer: 6.7;renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	42	"RH-30: 28.2"									"HPA047697, HPA056290"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA047697: AB_2680122, HPA056290: AB_2683088"				"unprognostic (2.41e-3)"			"unprognostic (4.47e-1)"			"unprognostic (4.04e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.05e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.76e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.5	58.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.4	0.2	0.0	0.1	0.3	0.0	0.7	0.1	0.2	3.0	0.1	6.8	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.4	0.0	0.0	49.7	0.0	0.0	0.0	0.0	3.9	0.0	125.9	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	72.1	0.1	0.0	0.3	0.7	0.0	2.6	0.0	24.5	0.9	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.5	0.4	0.0	0.0	3.8	87.0	0.0	0.2	6.6	0.0	0.0	4.4	0.8	0.0	0.0	0.0	0.5	0.0	1.8	0.1
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943331-95968720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 61.2;skeletal muscle: 27.6"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 132.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 46.6;HMC-1: 47.7;Karpas-707: 61.2;SiHa: 40.5;SK-BR-3: 46.1;U-266/70: 49.1;U-266/84: 62.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		1400000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.8	11.8	8.0	6.5	9.9	6.2	0.4	5.6	10.1	0.3	7.3	1.5	5.2	3.0	0.4	2.7	0.7	1.8	1.7	8.3	6.1	5.9	61.2	2.4	4.4	15.5	9.1	5.2	1.4	3.4	0.7	0.5	2.0	9.6	2.8	0.2	1.8	2.1	0.2	27.6	5.9	5.1	0.6	3.2	6.0	4.8	13.2	9.2	0.6	0.9	0.9	0.4	0.3	0.2	16.2	46.6	9.5	0.8	5.8	0.0	0.0	10.0	1.5	0.5	0.7	1.4	3.9	5.8	4.0	4.2	0.0	2.6	8.2	0.3	0.0	0.3	16.0	1.7	4.2	7.9	9.4	0.0	5.9	47.7	0.0	0.4	0.8	0.1	0.2	0.3	3.9	2.7	61.2	0.0	6.8	3.7	10.8	4.4	1.8	2.2	7.8	0.3	5.3	0.0	4.3	4.9	6.9	40.5	46.1	5.2	0.2	4.6	8.4	0.0	5.8	19.1	8.0	5.4	49.1	62.8	6.3	3.8	12.2	6.9	0.2	0.6	1.7	0.5	0.6	0.4	0.6	0.2	0.6	0.5	0.3	0.3	0.4	0.4	2.3	1.8	0.2	0.1	0.5	8.0	9.9	5.6	10.1	8.3	6.1	15.5	9.1	5.2	9.6	3.2	9.2	16.2	1.1	0.0	0.5	0.3	2.0	0.4	0.2	0.0	0.0	0.1	1.1	1.0	0.6	1.5	0.6	3.7	0.0	0.9	1.7	0.0	3.9	0.2	0.9	0.1	0.0	0.8	1.8	8.0	0.7	1.1	0.1	0.1	0.0	0.0	0.0	0.2	8.6	132.5	4.4	1.7	0.3	0.1	0.0	5.7	1.3	0.1	0.3	1.8	3.6	0.0	0.7	1.8	2.1	4.0	2.0	0.2	0.0	0.0	0.7	0.0	0.4	31.0	0.0	0.0	0.0	0.8	0.0	1.5	1.9	0.0	0.3	0.3	1.4	0.3	0.4	0.1
BHMT2		ENSG00000132840	"Betaine--homocysteine S-methyltransferase 2"	Q9H2M3	5	79069767-79090069	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"kidney: 336.2;liver: 433.4"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Hepatocytes: 201.2;Proximal tubular cells: 408.6"	"Group enriched"	"Detected in many"	14	"liver cancer: 79.6;renal cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 17.5;Hep G2: 78.2;hTEC/SVTERT24-B: 46.0;U-87 MG: 18.6"	"Not detected"	"Not detected"							HPA044573	Enhanced					NA	NA		1900000			"HPA044573: AB_10795044"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-3)"	31.6	16.8	5.4	3.1	5.8	0.3	15.6	4.7	5.0	8.0	12.8	11.4	1.7	12.2	37.9	7.7	7.7	7.5	9.9	4.7	11.8	336.2	433.4	3.2	1.3	5.0	6.6	4.4	7.9	1.8	0.5	12.4	0.4	5.2	12.1	2.4	1.3	2.1	14.5	10.3	2.2	6.2	13.1	4.4	0.6	9.2	3.8	5.9	0.9	18.9	4.9	1.0	18.2	3.8	4.9	0.0	0.2	0.1	0.1	8.5	6.0	2.8	7.8	17.5	4.0	7.7	0.0	0.1	0.1	0.1	9.7	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.4	0.4	78.2	6.6	0.4	0.1	7.3	0.0	46.0	0.0	7.9	0.0	0.0	0.4	0.4	1.1	0.0	0.1	0.3	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.2	2.2	0.1	0.5	0.0	0.1	0.5	0.1	0.2	0.0	0.3	0.1	0.3	0.1	0.1	0.1	0.3	18.6	0.4	0.1	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.8	0.3	0.0	0.1	0.0	0.0	5.4	5.8	4.7	5.0	4.7	11.8	5.0	6.6	4.4	5.2	4.4	5.9	4.9	1.4	6.4	0.5	6.2	1.2	0.8	0.4	0.1	0.0	1.5	0.2	0.1	4.4	1.5	0.0	46.0	2.1	0.2	0.0	0.0	95.9	0.1	0.5	0.4	11.7	2.9	1.2	2.7	4.1	0.0	0.4	17.3	0.0	0.4	0.0	4.5	2.5	201.2	0.3	0.0	0.6	0.1	0.0	4.4	1.2	1.3	27.4	2.5	0.0	11.2	0.3	4.2	0.0	2.0	0.6	0.0	0.0	37.2	0.1	0.4	0.0	408.6	0.1	1.2	6.6	6.2	3.1	0.4	0.5	0.1	1.0	0.3	2.2	30.0	0.0	1.0
CDHR2	"FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC"	ENSG00000074276	"Cadherin related family member 2"	Q9BYE9	5	176542511-176595974	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 278.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 167.0;Early spermatids: 182.4;Late spermatids: 680.0;Paneth cells: 215.0;Proximal enterocytes: 611.4"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"Hep G2: 22.2"	"Region enriched"	"Detected in single"	6	"hypothalamus: 2.1"	"Low region specificity"	"Detected in all"			"HPA012569, HPA017053"	Enhanced					NA	NA		8800000			"HPA012569: AB_1845298, HPA017053: AB_1845297"	"unprognostic (1.34e-2)"	"unprognostic (8.90e-4)"	"unprognostic (3.82e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.10e-4)"	"unprognostic (4.24e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (9.29e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.42e-1)"	0.0	0.1	1.0	4.5	0.6	0.2	0.0	0.2	0.7	0.0	0.0	23.4	278.3	0.1	0.0	0.1	0.6	5.1	0.0	1.4	0.4	10.2	30.5	0.0	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.2	0.0	12.7	0.3	0.0	0.0	0.0	0.1	240.3	1.1	0.0	0.1	12.5	4.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	0.5	0.0	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.3	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.2	0.7	1.4	0.4	0.0	0.0	0.7	0.2	0.0	0.6	0.2	0.0	0.0	0.0	2.3	1.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	8.6	0.0	1.8	0.0	0.0	0.3	167.0	0.0	4.0	182.4	3.2	0.1	0.2	33.6	0.0	3.9	1.0	0.0	0.0	55.0	0.1	0.0	0.0	0.0	15.3	0.0	0.0	4.2	42.7	0.0	0.6	0.0	680.0	1.5	0.5	0.0	1.0	0.0	1.6	0.0	1.5	0.5	15.3	215.0	2.2	0.1	0.0	611.4	13.7	0.7	0.3	0.0	0.0	0.1	3.8	2.0	0.0	0.0	0.1	0.7	3.5	19.8	0.0
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128062	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"intestine: 5552.3;liver: 13171.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 12424.2;Hepatocytes: 7459.2;Paneth cells: 3975.2;Proximal enterocytes: 15929.5"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 122.1;Hep G2: 393.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		45000000	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		6.7	0.8	0.6	161.7	0.5	0.0	10.7	0.4	1.8	0.6	0.3	5552.3	4794.9	13.1	0.0	2.6	3.9	0.5	0.7	0.5	0.5	734.4	13171.3	0.9	3.8	0.5	0.5	0.4	0.9	1.1	0.3	0.8	0.7	0.5	2.6	3448.7	0.1	0.5	8.5	0.9	0.4	4767.4	232.6	0.4	2.8	15.9	1.1	0.5	0.1	0.5	0.4	0.1	0.6	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	122.1	0.0	1.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	393.9	0.0	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	33.0	0.5	0.0	0.0	0.3	6.4	37.4	0.0	0.5	3.6	24.7	2.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	11.8	0.7	0.4	0.1	2.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4	1.8	0.5	0.5	0.5	0.5	0.4	0.5	0.4	0.5	0.6	0.0	0.0	0.0	0.3	42.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.3	120.1	0.0	60.7	0.0	0.2	0.0	12424.2	156.5	0.0	0.0	0.0	0.0	7.5	261.9	149.7	0.1	0.0	1.2	0.1	2.6	0.0	129.2	0.0	105.3	7459.2	1.5	0.0	0.1	1061.1	0.0	166.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3975.2	0.0	0.0	0.1	15929.5	2014.4	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.0	1.4	29.3	0.0	1708.4	0.0
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569844	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"liver: 172.5"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 161.7"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;NK-cells: 1.5;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;EFO-21: 6.1;Hep G2: 24.4;HMC-1: 6.8;MOLT-4: 5.5;U-2197: 18.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		5500000				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.3	0.1	0.6	0.3	0.6	0.2	1.5	0.9	1.0	0.4	0.1	0.6	1.8	0.2	0.9	0.6	1.0	0.8	0.4	0.7	0.4	6.0	172.5	0.3	0.7	0.8	0.8	0.6	0.8	2.5	0.0	1.5	0.4	0.9	0.2	0.8	0.1	0.2	0.9	0.0	0.6	0.8	0.1	0.7	0.8	0.5	0.1	0.4	2.1	1.3	0.3	0.2	1.6	0.3	1.3	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.1	0.8	0.0	0.0	8.5	0.0	0.0	6.1	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	24.4	0.5	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.2	0.1	5.5	0.8	0.0	0.1	0.0	1.1	0.3	0.0	2.6	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	18.4	0.0	0.1	0.0	0.1	0.2	0.5	0.0	1.6	0.1	0.0	1.3	0.1	1.8	0.0	0.3	0.9	0.1	0.0	0.4	1.3	0.2	1.5	0.2	0.0	0.9	1.1	0.6	0.6	0.9	1.0	0.7	0.4	0.8	0.8	0.6	0.9	0.7	0.4	1.3	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.8	11.5	0.7	3.7	0.0	0.0	0.9	1.2	5.9	7.8	0.0	0.4	0.5	1.2	0.0	2.7	6.1	3.7	0.1	2.9	0.5	2.7	0.0	0.2	4.2	161.7	0.1	0.0	4.3	0.0	0.0	3.8	0.8	0.1	0.3	0.3	1.8	16.9	0.6	0.0	3.1	0.0	12.9	0.2	0.0	0.0	0.0	0.2	0.3	15.7	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.3	0.6	0.0	1.1	1.2	0.0	0.1
SLC22A10	"hOAT5, OAT5"	ENSG00000184999	"Solute carrier family 22 member 10"	Q63ZE4	11	63137867-63369718	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	139	"liver: 101.7"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 6.4;Hepatocytes: 21.0"	"Cancer enriched"	"Detected in single"	14	"liver cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA						"unprognostic (1.17e-2)"				"unprognostic (9.77e-2)"		"unprognostic (7.07e-3)"	"unprognostic (7.46e-4)"			"unprognostic (7.62e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.25e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	101.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	21.0	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SLC30A10	"DKFZp547M236, ZnT-10, ZNT8, ZRC1"	ENSG00000196660	"Solute carrier family 30 member 10"	Q6XR72	1	219685427-219958647	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 24.1;liver: 33.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 20.2;Distal enterocytes: 44.3;Early spermatids: 38.3;Hepatocytes: 21.1;Late spermatids: 36.1;Paneth cells: 14.4;Proximal enterocytes: 13.6"	"Cancer enriched"	"Detected in some"	14	"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.0;HEL: 1.5;K-562: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064547	Enhanced					NA	NA					"HPA064547: AB_2732715"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.47e-7)"	"unprognostic (3.16e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.19e-3)"	"unprognostic (5.72e-2)"	0.0	0.0	5.9	0.0	6.3	0.3	0.0	4.6	7.7	0.0	6.9	3.9	24.1	0.0	0.0	0.0	0.0	0.4	0.0	5.9	5.6	0.0	33.8	0.0	0.0	5.5	5.9	5.5	0.2	0.0	0.0	0.0	0.0	5.8	0.1	5.0	0.4	0.0	0.0	0.7	0.1	9.0	0.0	4.6	0.0	0.0	0.7	6.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.3	0.3	0.2	0.1	0.1	5.9	6.3	4.6	7.7	5.9	5.6	5.5	5.9	5.5	5.8	4.6	6.1	5.6	0.0	0.0	0.0	20.2	0.2	0.3	0.0	0.2	0.0	0.3	0.2	0.0	1.2	1.5	0.1	0.0	0.0	0.1	0.0	44.3	0.0	0.2	38.3	0.0	0.0	1.0	0.0	2.7	4.3	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.4	21.1	0.1	0.0	4.3	0.6	0.0	0.6	0.3	36.1	1.2	0.0	1.8	9.4	0.0	3.1	0.0	3.0	3.3	0.0	14.4	1.5	0.0	0.0	13.6	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.9	0.0	0.1	0.3	0.0	1.3	0.8	0.0
SLC38A4	"ATA3, NAT3, PAAT"	ENSG00000139209	"Solute carrier family 38 member 4"	Q969I6	12	46764761-46832408	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	60	"liver: 614.9"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 289.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 61.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.7;LHCN-M2: 43.2;RH-30: 14.6;RT4: 86.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.81e-2)"	"unprognostic (7.46e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.37e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.21e-2)"	0.8	1.1	0.3	0.4	0.2	0.0	1.2	0.1	0.4	0.5	0.5	5.1	0.4	2.2	0.2	1.7	0.9	0.3	0.3	0.2	0.6	4.5	614.9	0.4	0.2	0.3	0.3	0.1	0.2	6.7	0.2	0.1	2.2	0.4	1.3	1.3	0.2	0.8	0.5	10.2	2.6	0.5	5.5	0.2	1.2	0.2	0.3	0.6	1.4	0.3	2.7	0.8	2.0	0.2	0.4	0.0	0.0	0.1	0.0	17.7	2.2	3.4	2.3	5.6	2.0	1.8	1.1	4.3	0.0	3.5	7.8	0.0	1.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.2	0.7	0.5	0.0	4.2	0.1	0.1	1.4	0.1	0.0	0.0	0.2	0.0	43.2	0.0	0.1	0.0	1.3	0.0	0.0	0.0	14.6	0.0	0.0	86.0	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.2	0.5	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.6	0.3	0.3	0.1	0.4	0.2	0.6	0.4	0.1	0.0	0.0	2.6	0.5	0.8	0.0	2.2	3.4	0.0	0.1	0.0	1.5	11.5	0.2	1.8	0.0	2.5	0.0	1.9	0.0	0.0	0.2	0.4	0.2	1.2	0.0	5.3	0.6	0.0	0.7	1.2	0.0	0.2	0.0	1.6	3.9	289.5	0.5	0.0	2.2	0.4	2.0	6.7	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.2	1.2	0.0	0.0	0.7	0.3	0.4	0.2	0.0	0.0	0.3	0.2	0.0	0.1	2.8	0.6	0.8	0.4	2.7	1.3	0.1
TMPRSS6	"FLJ30744, MT2"	ENSG00000187045	"Transmembrane serine protease 6"	Q8IU80	22	37065436-37109713	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 129.4"	"Group enriched"	"Detected in some"	11	"Early spermatids: 61.0;Hepatocytes: 99.9;Late spermatids: 143.9"	"Group enriched"	"Detected in many"	14	"liver cancer: 51.3;thyroid cancer: 14.1"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Hep G2: 5.0;SCLC-21H: 8.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 3.3"							NA	NA						"unprognostic (3.93e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.29e-5)"	"unprognostic (7.95e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (8.16e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.86e-5)"	0.1	0.1	0.2	0.2	3.6	0.2	0.4	0.1	0.6	0.1	0.0	0.6	2.2	0.1	0.8	0.3	0.5	0.9	0.0	0.2	0.3	0.1	129.4	0.7	0.3	1.9	0.3	0.0	0.1	1.3	0.0	13.1	0.7	0.7	0.2	0.5	0.1	0.0	0.0	0.0	2.3	1.1	0.0	0.1	0.3	3.6	7.8	0.9	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.5	0.2	0.1	5.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.9	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.2	0.0	0.0	8.1	0.3	0.1	0.6	0.0	0.1	0.1	0.0	0.4	0.3	1.0	0.1	0.0	1.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.6	0.1	0.6	0.2	0.3	1.9	0.3	0.0	0.7	0.1	0.9	0.1	0.0	0.0	0.0	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.6	0.3	0.5	2.8	0.0	0.0	0.0	0.0	0.1	8.8	0.0	0.2	61.0	0.0	0.0	0.3	5.3	8.0	0.1	0.0	2.6	0.0	2.6	0.0	0.0	0.0	2.5	99.9	0.1	0.0	0.1	1.5	0.0	3.2	0.0	143.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.1	0.3	0.3	0.1	0.6	0.0
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737402	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 145.6;intestine: 296.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 180.1;Enteroendocrine cells: 44.9;Intestinal goblet cells: 161.1;Paneth cells: 58.1;Proximal enterocytes: 125.2;Undifferentiated cells: 38.5"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A549: 27.8;HDLM-2: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.1	0.0	1.9	1.7	2.7	0.0	0.4	2.8	2.2	0.2	1.4	21.9	296.3	1.5	2.2	0.2	58.9	145.6	0.1	1.3	1.8	7.0	20.3	0.2	0.2	3.9	3.8	1.1	0.4	0.4	0.0	0.0	0.0	3.6	0.5	36.4	4.4	0.1	24.5	0.0	0.1	221.3	2.9	3.9	0.0	0.8	4.2	2.6	0.1	0.0	0.0	0.0	0.5	0.1	5.4	0.0	27.8	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	14.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.0	0.0	0.0	0.0	1.7	1.6	0.0	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.7	2.8	2.2	1.3	1.8	3.9	3.8	1.1	3.6	3.9	2.6	5.4	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.0	0.2	0.1	1.1	0.4	180.1	0.0	0.0	0.0	0.0	0.0	6.2	3.9	1.4	1.1	4.5	3.6	0.2	44.9	2.7	0.9	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.2	0.0	1.0	161.1	0.0	0.0	0.0	1.4	1.2	0.3	0.0	0.0	0.0	0.3	0.0	0.5	1.2	0.1	58.1	0.0	0.0	0.0	125.2	27.6	2.9	10.9	0.0	0.2	0.1	0.0	0.1	0.0	0.6	0.0	0.4	0.1	38.5	0.1
APOM	"G3a, NG20"	ENSG00000204444	"Apolipoprotein M"	O95445	6	31652416-31658210	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 393.9"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 665.9;Proximal tubular cells: 681.1"	"Cancer enriched"	"Detected in all"	13	"liver cancer: 185.9"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 38.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034086, HPA051006"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7400000000	8200000000	"Golgi apparatus"		"CAB034086: AB_1119033, HPA051006: AB_2681307"	"unprognostic (2.76e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.20e-2)"	4.4	5.3	0.5	0.1	0.6	2.5	5.3	1.0	0.9	3.6	0.5	3.7	0.6	4.0	1.0	4.1	4.2	0.5	3.3	0.6	1.0	91.5	393.9	2.6	0.6	0.7	0.6	0.5	6.2	6.1	0.7	4.7	0.1	0.7	3.9	0.4	0.4	3.6	0.5	7.2	6.3	9.0	0.5	0.7	4.2	5.3	16.1	0.6	1.2	5.5	0.7	1.1	3.4	3.3	0.8	0.5	0.3	0.6	0.7	0.6	0.8	0.0	0.4	1.1	0.4	0.9	3.2	1.0	1.4	0.2	1.1	0.2	0.6	0.4	0.6	0.8	0.8	0.7	0.8	0.3	38.2	1.3	1.7	0.1	1.2	0.4	0.3	1.0	0.5	0.3	0.9	1.2	0.4	1.1	1.1	1.1	0.9	0.5	0.6	0.2	0.8	0.4	1.5	1.1	0.6	0.5	0.2	0.4	0.0	0.5	0.2	1.5	1.2	0.4	0.2	0.1	0.3	0.3	1.1	1.2	1.5	0.2	1.8	0.1	3.0	0.6	0.6	0.3	0.3	0.5	1.1	0.4	0.3	0.5	0.5	0.5	0.6	0.4	0.3	0.7	0.3	0.7	0.3	0.5	0.6	1.0	0.9	0.6	1.0	0.7	0.6	0.5	0.7	0.7	0.6	0.8	1.5	0.0	7.4	2.3	9.0	6.4	6.7	6.7	9.1	1.5	6.6	12.4	1.6	12.8	3.0	14.7	4.2	2.0	1.6	4.1	76.3	4.3	60.2	5.2	3.1	2.0	4.2	11.4	0.3	6.9	0.9	4.3	5.1	1.6	5.1	1.8	8.9	665.9	5.4	0.0	0.4	4.9	2.0	14.5	4.2	38.4	9.3	6.1	5.4	0.0	2.5	14.6	1.0	0.5	1.3	6.4	4.9	6.4	7.4	4.2	81.4	681.1	4.6	2.5	0.0	6.2	3.1	33.1	6.6	5.3	6.5	1.2	5.6	4.6	6.5	6.1
ASPDH		ENSG00000204653	"Aspartate dehydrogenase domain containing"	A6ND91	19	50511600-50514690	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.5;kidney: 38.0;liver: 133.5"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 135.8;Proximal tubular cells: 487.2"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 24.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 13.6;MOLT-4: 16.5;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042631, HPA042654"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		200000	Nucleoplasm	Cytosol	"HPA042631: AB_10794530, HPA042654: AB_10794383"	"unprognostic (5.79e-2)"	"unprognostic (9.47e-2)"	"unprognostic (8.97e-3)"	"unprognostic (6.13e-3)"	"unprognostic (5.13e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.70e-3)"	"unprognostic (9.65e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.99e-3)"	0.5	2.5	15.4	1.0	16.8	0.5	0.0	21.2	40.5	0.0	4.9	0.2	6.6	0.2	0.0	0.3	0.0	1.7	0.3	17.4	14.4	38.0	133.5	0.2	1.0	14.8	15.2	14.8	0.0	0.8	0.0	19.8	0.0	16.9	0.3	0.0	5.5	1.6	0.0	0.3	1.1	2.5	0.0	11.4	0.6	0.3	0.2	19.6	2.4	0.9	0.0	0.0	0.1	0.1	19.2	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	13.6	0.0	0.7	3.8	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.4	1.7	0.0	1.6	16.5	0.1	0.0	0.6	0.2	0.4	0.3	1.1	0.0	0.2	1.7	9.2	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	3.6	0.8	1.8	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	16.8	21.2	40.5	17.4	14.4	14.8	15.2	14.8	16.9	11.4	19.6	19.2	0.0	0.0	0.0	3.3	2.0	0.0	0.0	0.0	0.0	29.8	0.0	0.0	0.4	1.5	0.0	9.2	4.2	0.0	0.0	0.1	45.0	0.0	0.7	0.0	0.0	0.1	7.1	10.7	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	135.8	0.0	0.0	4.4	0.1	0.0	1.9	0.0	2.5	0.0	3.4	0.0	2.8	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	8.8	487.2	0.0	4.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"liver: 9465.6"	"Group enriched"	"Detected in some"	16	"Ductal cells: 1087.7;Hepatocytes: 4142.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;HDLM-2: 6.3;U-2 OS: 4.5;U-266/84: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	NA	NA	2920000000	5200000000	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"	3.4	0.7	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.3	0.0	3.1	0.0	0.5	0.4	112.7	0.5	0.0	0.0	0.7	9465.6	0.5	0.1	0.1	0.0	0.0	0.4	119.5	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.4	0.0	0.3	0.5	0.5	0.0	0.0	6.1	0.5	0.4	0.0	0.0	0.3	0.0	0.0	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	6.3	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.8	0.0	11.7	1.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	118.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1087.7	1.4	0.0	0.1	6.3	0.0	163.2	0.0	63.2	0.0	0.0	0.0	0.2	0.0	0.0	89.6	4142.7	0.1	0.0	0.0	0.0	0.0	98.8	0.3	0.7	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	60.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0
CYP4A22		ENSG00000162365	"Cytochrome P450 family 4 subfamily A member 22"	Q5TCH4	1	47137435-47149735	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 216.0"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 143.0"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 20.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.2"															NA	NA						"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"		"unprognostic (3.19e-2)"			"unprognostic (2.88e-3)"	"unprognostic (2.76e-3)"		"unprognostic (1.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.59e-4)"	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.1	0.2	0.0	33.2	216.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	143.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186266189-186289681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 245.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 27.6;Hepatocytes: 75.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"Hep G2: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039808			Approved	Vesicles	"Secreted to blood"	NA	NA		4400000000	Vesicles		"HPA039808: AB_2676693"			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favorable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.2	17.2	0.2	0.1	0.0	0.0	13.2	0.0	0.3	0.0	27.8	245.2	8.4	0.0	0.3	0.3	0.0	0.3	59.4	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.0	0.2	0.7	0.0	8.8	0.0	0.0	0.1	0.8	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.3	0.0	0.3	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	27.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	2.5	1.8	0.0	0.0	0.2	0.3	11.7	2.3	0.0	0.0	0.0	0.1	0.0	5.3	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.7	0.0	0.0	0.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	5.5	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
FMO3	FMOII	ENSG00000007933	"Flavin containing dimethylaniline monoxygenase 3"	P31513	1	171090901-171117819	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	60	"liver: 1132.4"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 412.3"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 94.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 34.6;ASC TERT1: 26.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013750	Enhanced					NA	NA					"HPA013750: AB_1848968"	"unprognostic (1.87e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.31e-3)"	"prognostic favorable (3.46e-4)"	"prognostic favorable (5.60e-5)"	"unprognostic (2.95e-1)"	"unprognostic (9.34e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.27e-2)"	18.6	12.5	2.5	0.9	2.5	0.4	6.9	2.5	3.6	1.2	2.3	1.1	1.8	1.4	3.0	5.2	13.4	1.9	4.1	2.2	2.4	13.5	1132.4	18.9	5.0	4.6	2.4	1.9	0.3	4.6	4.3	4.4	0.2	2.9	1.1	0.7	0.1	5.1	0.4	4.6	3.1	2.3	1.6	3.9	0.4	3.9	0.5	3.0	1.4	2.7	3.1	9.2	1.0	0.9	2.7	0.0	0.0	0.0	0.0	34.6	26.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	7.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.5	2.5	3.6	2.2	2.4	4.6	2.4	1.9	2.9	3.9	3.0	2.7	2.7	12.8	0.5	0.0	0.7	0.4	0.4	2.7	0.0	0.0	0.1	0.3	0.4	7.2	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	4.7	0.0	29.5	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	6.8	412.3	0.0	0.0	0.0	0.0	4.1	9.5	0.8	0.0	0.3	0.1	1.8	1.0	0.0	0.5	0.0	7.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	22.7	0.2	6.6	1.3	6.3	0.4	0.1	0.4	0.4	0.0	0.8	0.2	0.0	0.1
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99564081-99623997	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 277.4;liver: 268.7"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 244.2;Proximal enterocytes: 605.4"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 28.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 10.8;Hep G2: 12.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA051170, HPA054862"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		640000	"Endoplasmic reticulum, Cytosol"		"HPA051170: , HPA054862: AB_2682628"	"unprognostic (1.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.49e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	0.3	0.1	1.4	0.2	0.9	0.0	0.2	1.0	0.8	0.1	0.3	0.8	245.4	0.1	1.1	0.1	0.6	1.3	0.7	0.7	1.7	13.1	268.7	0.3	0.3	1.1	1.1	0.5	2.0	0.0	0.0	0.5	0.0	1.2	0.5	0.3	5.6	0.1	0.2	0.4	0.1	277.4	0.5	1.1	0.0	0.8	9.7	1.1	0.2	0.1	0.3	0.1	0.9	0.0	1.8	0.0	0.2	10.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.2	0.1	12.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.5	0.1	0.2	0.1	0.1	1.0	0.0	0.0	0.7	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.9	1.0	0.8	0.7	1.7	1.1	1.1	0.5	1.2	1.1	1.1	1.8	0.1	0.0	0.0	4.6	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.8	4.3	0.1	1.8	0.0	0.2	0.2	0.2	0.0	0.0	44.2	1.0	0.1	0.1	0.0	2.7	1.6	0.0	0.0	0.8	1.5	0.2	0.0	30.1	3.6	244.2	0.1	0.0	0.7	16.7	2.0	3.5	0.0	12.0	0.9	0.2	0.0	0.0	0.6	0.0	0.0	0.0	2.0	0.2	12.5	0.4	0.1	0.0	605.4	23.5	1.0	0.0	6.6	0.5	0.5	32.1	5.7	0.0	0.0	0.0	0.4	12.0	21.0	0.0
SAA2-SAA4		ENSG00000255071	"SAA2-SAA4 readthrough"		11	18231423-18248635	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	5	"liver: 128.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 20.7"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 39.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.6;EFO-21: 1.5;GAMG: 1.1;HaCaT: 1.0"									HPA060139	Uncertain					NA	NA					"HPA060139: AB_2684210"	"prognostic favorable (4.56e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.96e-1)"		"unprognostic (8.27e-3)"	"unprognostic (3.17e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (2.92e-8)"	"unprognostic (1.92e-1)"			"unprognostic (2.72e-1)"	23.9	1.5	0.0	1.5	0.0	0.0	5.2	0.0	0.3	15.4	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.6	0.0	0.0	0.4	0.2	128.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.5	0.0	0.0	18.9	0.2	5.3	0.3	0.2	0.1	0.0	0.1	0.2	0.2	0.1	0.6	0.0	0.0	0.6	0.3	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.0	1.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	20.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976042	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 2832.6;salivary gland: 3880.0"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 1315.5;Breast myoepithelial cells: 704.8;Hepatocytes: 4270.8;Ionocytes: 901.3;Prostatic glandular cells: 1691.9;Urothelial cells: 674.2"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 56.6;OE19: 158.9;RPMI-8226: 130.4;T-47d: 41.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012582, HPA012876, CAB016087, CAB032276"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	55200000000	74000000000	Vesicles	Nucleoplasm	"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: "	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	129.8	3.9	17.4	2.8	28.0	0.4	1072.2	23.6	22.9	2.5	16.4	6.8	31.1	1.5	2.5	22.2	3.0	39.1	67.4	15.6	23.4	329.8	2832.6	14.9	0.4	22.9	23.6	14.9	6.1	758.5	0.1	1.3	0.5	29.9	1060.6	4.3	3.6	3880.0	40.6	1.7	188.9	28.9	0.3	14.8	1.4	317.7	26.1	23.1	0.8	1.9	2.3	1.5	5.8	7.6	26.1	0.2	0.0	0.0	0.0	11.3	0.0	5.5	0.0	0.0	0.0	0.0	0.1	4.0	14.2	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.3	0.1	56.6	4.9	1.5	0.1	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.3	29.9	0.0	0.0	0.0	5.1	0.2	158.9	0.0	0.0	1.7	130.4	0.0	0.0	0.0	2.0	1.0	25.4	13.0	0.0	41.8	0.0	0.0	0.5	0.1	1.8	0.9	1.9	0.8	0.4	0.0	0.5	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	28.0	23.6	22.9	15.6	23.4	22.9	23.6	14.9	29.9	14.8	23.1	26.1	9.9	22.4	276.8	0.0	14.7	4.2	422.1	25.3	0.0	0.0	1315.5	704.8	115.9	451.8	63.0	5.5	2.1	0.0	10.4	5.5	46.9	11.7	1.9	1.4	1.2	14.2	12.4	85.5	0.1	254.2	0.0	7.7	94.8	5.5	3.8	1.2	65.3	4270.8	0.0	0.0	0.1	13.1	901.3	93.1	0.7	4.2	0.9	14.8	62.2	1.0	2.0	23.7	0.0	7.5	7.3	221.5	6.4	0.0	0.3	1691.9	15.3	596.1	6.3	0.3	0.0	0.0	11.9	7.4	0.4	9.9	9.7	0.0	12.3	0.1	12.6	674.2
BTNL8	"BTN9.2, FLJ21458"	ENSG00000113303	"Butyrophilin like 8"	Q6UX41	5	180899077-180950906	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"intestine: 120.1"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 79.6;Proximal enterocytes: 178.9"	"Group enriched"	"Detected in some"	12	"colorectal cancer: 2.6;liver cancer: 1.5;pancreatic cancer: 2.8;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	12	"neutrophil: 233.4"	"Lineage enriched"	"Detected in many"	221	"granulocytes: 233.4"	"Group enriched"	"Detected in some"	28	"CACO-2: 39.3;OE19: 56.2"									HPA039738	Enhanced					NA	NA					"HPA039738: AB_2676656"	"unprognostic (4.31e-1)"	"unprognostic (6.85e-6)"	"unprognostic (6.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.27e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.43e-1)"	"unprognostic (1.17e-2)"	1.1	0.3	0.2	2.1	0.2	7.3	0.5	0.2	0.4	0.0	0.2	26.9	120.1	0.1	0.0	0.2	1.4	7.0	0.3	0.2	0.6	0.6	0.6	2.6	0.3	0.4	0.3	0.1	0.1	1.7	0.2	0.2	0.2	0.3	0.1	26.0	0.0	0.1	0.0	0.3	0.0	87.2	0.6	0.2	3.1	7.2	5.5	0.3	0.2	1.1	0.5	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	39.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	56.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.0	0.0	1.6	0.0	0.2	0.4	0.0	0.1	1.0	20.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.4	0.0	0.5	0.0	0.4	0.3	0.2	0.2	0.2	0.4	0.2	0.6	0.4	0.3	0.1	0.3	0.2	0.3	0.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	8.6	0.1	0.0	0.0	0.0	0.0	79.6	0.0	0.2	0.3	0.0	0.0	0.6	3.6	0.0	0.3	2.6	0.0	0.2	12.2	0.0	0.0	0.0	11.7	0.1	0.8	0.0	0.1	29.6	0.0	4.5	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	26.3	0.0	0.0	0.0	178.9	0.1	0.8	0.0	0.0	0.9	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	15.6	0.1
CPN1		ENSG00000120054	"Carboxypeptidase N subunit 1"	P15169	10	100042193-100081869	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"liver: 82.3"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 37.2"	"Group enriched"	"Detected in some"	12	"liver cancer: 26.6;melanoma: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SK-MEL-30: 141.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		13000000000						"unprognostic (2.97e-2)"	"unprognostic (2.23e-2)"			"unprognostic (3.93e-2)"		"unprognostic (1.64e-1)"		"unprognostic (6.75e-2)"		"unprognostic (2.93e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.63e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	82.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	141.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	37.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.6	4.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0
CYP2A6	"CPA6, CYP2A, CYP2A3"	ENSG00000255974	"Cytochrome P450 family 2 subfamily A member 6"	P11509	19	40843541-40850447	"Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	171	"liver: 1625.1"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 322.3"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 281.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"									"HPA046713, HPA047262"	Supported				"Intracellular and membrane"	NA	NA					"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (5.38e-5)"	"unprognostic (4.98e-3)"	"unprognostic (4.86e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.55e-1)"	0.6	0.2	0.0	0.0	0.0	0.0	9.4	0.0	0.2	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	1625.1	0.3	0.0	0.2	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.2	5.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	8.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	11.4	322.3	0.0	0.0	0.1	0.0	0.0	14.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	1.5
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997564-79236038	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	18	"kidney: 171.0;liver: 286.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 40.6;Hepatocytes: 104.2;Late spermatids: 33.1;Proximal tubular cells: 83.9"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.6;Hep G2: 7.6;hTEC/SVTERT24-B: 2.2;Karpas-707: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria		NA	NA		680000	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: AB_2686859"	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favorable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	8.4	4.5	1.5	0.3	1.7	0.0	2.2	1.5	1.6	1.4	2.8	1.0	0.2	2.8	12.3	1.4	1.3	2.1	1.4	1.5	2.8	171.0	286.1	0.4	0.2	1.8	1.9	1.5	2.2	1.8	0.6	2.9	0.1	1.7	1.8	0.4	1.5	0.4	1.8	2.4	0.6	0.6	1.7	1.3	0.1	1.0	2.3	2.2	0.3	4.9	1.5	0.3	1.3	0.5	1.6	0.0	0.0	0.0	0.3	0.3	0.8	0.3	0.2	3.6	0.8	1.4	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	7.6	1.9	0.0	0.0	1.7	2.1	2.2	1.6	1.5	0.0	0.8	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.5	1.6	1.5	2.8	1.8	1.9	1.5	1.7	1.3	2.2	1.6	1.3	0.0	1.1	19.9	2.9	0.1	0.5	1.0	1.8	1.9	1.4	1.8	1.0	2.8	0.8	9.2	2.1	0.3	1.9	0.7	19.6	0.4	40.6	2.6	5.0	1.2	1.2	6.1	5.8	0.7	0.1	2.7	3.6	2.7	0.0	4.1	1.8	104.2	0.1	0.0	1.5	1.2	4.1	1.6	0.4	33.1	2.5	1.7	0.0	4.7	0.2	4.3	3.1	4.5	3.3	0.8	1.4	2.6	4.5	0.9	1.6	83.9	4.7	3.7	0.0	1.7	0.7	4.9	5.3	1.8	0.3	0.3	2.9	4.4	0.9	0.8
FETUB		ENSG00000090512	"Fetuin B"	Q9UGM5	3	186635969-186653141	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 236.5"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 47.2"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 44.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035132, HPA035133"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	47500000000	3600000000	Vesicles		"HPA035132: AB_10601650, HPA035133: "		"unprognostic (9.01e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.73e-2)"			"unprognostic (9.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.39e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.4	236.5	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.9	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.9	0.0	5.3	0.2	0.2	0.1	0.0	2.7	0.2	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.7	47.2	0.0	0.0	0.0	0.2	0.0	2.9	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0
HAMP	"HEPC, HFE2B, LEAP-1, LEAP1"	ENSG00000105697	"Hepcidin antimicrobial peptide"	P81172	19	35280716-35285143	"Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hormone"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 2071.6"	"Cell type enriched"	"Detected in many"	17	"Hepatocytes: 3227.7"	"Group enriched"	"Detected in many"	12	"glioma: 6.5;liver cancer: 16.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"myeloid DC: 1.5;plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.6"	"Cell line enriched"	"Detected in some"	440	"Hep G2: 448.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	1900000	10000000				"unprognostic (5.53e-2)"	"unprognostic (5.02e-4)"	"unprognostic (2.10e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-7)"	"unprognostic (4.11e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.77e-2)"	0.8	1.3	16.5	2.1	18.9	5.4	1.5	16.8	30.7	1.4	19.3	0.5	0.9	0.3	0.6	0.5	2.8	0.6	211.1	17.1	70.1	0.3	2071.6	3.2	4.0	48.6	22.6	17.3	3.2	88.7	0.4	5.9	2.3	24.5	2.8	0.0	4.3	1.2	1.3	1.2	1.0	0.5	1.0	19.1	1.1	1.1	0.7	22.3	0.1	0.4	0.2	4.4	1.6	0.2	26.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.7	448.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.7	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.4	0.0	4.6	0.0	0.0	16.5	18.9	16.8	30.7	17.1	70.1	48.6	22.6	17.3	24.5	19.1	22.3	26.8	0.8	0.0	0.0	0.0	5.7	0.5	1.5	0.0	0.0	0.0	26.2	8.0	1.7	30.0	0.6	0.0	0.0	0.9	0.6	0.1	0.0	0.4	0.0	1.9	1.0	13.7	0.0	89.7	0.2	99.0	1.2	0.4	10.7	1.8	75.7	0.7	45.3	3227.7	187.9	0.0	0.0	0.7	0.0	63.2	1.2	0.0	0.0	28.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.6	0.1	0.0	0.1	4.2	0.0	0.1	0.0	0.6	0.0	0.2	0.6	0.0	0.0	0.0	18.6	0.7	4.3	0.5	0.2	2.2
PRAMEF33	PRAMEF33P	ENSG00000237700	"PRAME family member 33"	A0A0G2JMD5	1	13303539-13308907	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	12	"liver: 1.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	12	"liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA												"unprognostic (6.42e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAMEF4	RP5-845O24.6	ENSG00000243073	"PRAME family member 4"	O60810	1	12879212-12886201	"Predicted intracellular proteins"				"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	12	"liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA												"unprognostic (5.41e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996347-171026743	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 842.9"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 457.6"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Region enhanced"	"Detected in single"		"white matter: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"CACO-2: 7.7;Hep G2: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.1	0.0	66.7	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.2	31.1	842.9	0.0	0.0	0.5	0.4	0.0	0.0	2.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	27.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.4	0.2	0.2	0.5	0.4	0.0	0.6	0.3	0.3	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	90.1	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.2	6.7	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	457.6	0.0	0.0	0.1	3.0	0.0	10.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	2.5	0.0	0.0	0.0	105.4	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.8	0.0
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	523	"intestine: 988.7"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 28.0"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"U-138 MG: 50.8;U-87 MG: 141.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"olfactory bulb: 5.0;spinal cord: 1.8"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214"					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.0	0.0	0.9	0.2	0.7	0.0	0.0	1.8	1.7	0.0	0.0	0.1	988.7	0.2	0.0	0.1	0.0	0.1	0.1	0.8	0.3	0.0	0.0	0.0	0.7	0.6	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.2	22.0	0.0	0.0	0.0	0.4	1.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.0	4.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	0.0	0.3	0.0	0.9	0.0	0.2	141.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.7	1.8	1.7	0.8	0.3	0.6	0.6	0.3	0.7	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	4.0	0.0
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401696-87480435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 124.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 256.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.4;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.1"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.9;WM-115: 25.7"	"Low region specificity"	"Detected in many"							"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.7	7.5	1.0	2.5	0.7	0.9	0.5	0.7	1.0	0.3	0.5	0.9	0.4	0.2	0.6	0.6	0.2	0.8	6.7	0.9	0.7	0.6	124.2	0.2	5.9	0.9	0.8	0.7	0.4	0.1	0.0	0.2	0.2	1.1	0.5	1.2	0.4	0.6	0.4	7.5	1.4	2.2	0.3	0.7	5.1	0.6	1.0	0.8	0.7	0.5	4.8	5.2	1.2	0.5	0.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	12.9	0.0	0.6	2.6	0.5	0.2	0.6	0.0	0.2	1.7	0.1	0.0	0.0	0.0	3.2	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.0	0.7	0.7	1.0	0.9	0.7	0.9	0.8	0.7	1.1	0.7	0.8	0.9	1.3	0.0	0.5	0.3	22.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.8	0.0	1.1	0.1	0.2	0.0	0.1	0.6	0.2	0.2	1.0	0.0	0.4	0.6	0.0	0.3	2.0	0.0	0.2	0.0	0.0	3.3	256.1	0.5	38.7	1.8	0.0	0.0	5.0	1.2	0.4	0.0	1.0	10.6	3.7	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.4	0.3	0.0	0.5	0.7	0.0	0.2	0.0	0.6	1.2	1.2	0.2	0.0	0.4	0.1	0.7	0.0	0.2	0.0
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122799-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 161.4"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 113.6;Hepatocytes: 195.1;Leydig cells: 215.9;Peritubular cells: 236.2"	"Cancer enriched"	"Detected in many"	11	"liver cancer: 95.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 14.4;BJ hTERT+: 11.5;CACO-2: 12.7;fHDF/TERT166: 13.1;Hep G2: 59.6;HHSteC: 11.5;SH-SY5Y: 27.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA		13000000000				"unprognostic (4.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.88e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (5.14e-5)"	"unprognostic (6.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.23e-3)"	18.1	8.6	1.2	1.5	1.1	0.0	11.8	2.4	2.0	44.6	1.8	5.3	11.0	13.3	16.6	8.9	24.1	11.0	24.9	1.0	1.7	4.1	161.4	14.5	3.2	2.2	1.4	0.9	28.1	7.1	0.2	4.5	4.4	2.4	12.9	2.0	0.9	5.1	7.2	6.8	17.2	12.0	2.7	1.1	3.3	8.7	10.2	1.4	1.4	8.3	6.7	1.3	12.0	26.1	2.1	0.1	0.0	2.5	0.4	8.0	8.1	0.1	14.4	11.5	0.8	0.3	12.7	0.1	0.1	0.5	13.1	1.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	59.6	11.5	0.0	0.3	8.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	1.5	0.1	0.0	0.3	0.0	1.3	0.2	0.3	0.1	0.0	0.0	0.2	1.0	27.9	0.1	0.5	0.1	0.6	0.6	0.1	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	2.4	2.0	1.0	1.7	2.2	1.4	0.9	2.4	1.1	1.4	2.1	7.0	0.0	0.0	1.3	0.6	15.7	0.1	0.0	0.0	1.1	0.4	0.3	9.1	4.3	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.1	2.9	1.9	45.9	3.8	17.9	2.7	1.3	0.0	0.4	113.6	6.1	1.0	1.3	2.2	7.9	195.1	1.4	6.7	1.4	5.0	0.0	4.8	25.0	9.6	215.9	1.3	19.6	5.6	0.6	4.5	0.0	0.5	0.1	0.3	6.5	236.2	0.0	0.3	28.3	6.4	0.0	1.2	52.6	14.5	40.9	2.3	1.2	0.5	15.3	1.1	1.9	2.4	2.2	0.4
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 46.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 68.8;Excitatory neurons: 62.4;Hepatocytes: 66.8;Inhibitory neurons: 78.3;Oligodendrocyte precursor cells: 33.2"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;U-698: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	NA	NA	103000000000	3100000000			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	4.3	0.9	1.5	0.6	1.7	0.9	1.4	7.7	4.7	0.9	0.1	0.8	0.5	1.6	1.7	1.1	0.9	0.6	0.5	1.4	1.8	0.6	46.5	0.9	0.9	1.8	2.4	1.4	1.2	0.6	2.5	1.7	0.2	3.3	1.8	0.6	6.2	0.4	4.8	1.7	8.6	0.5	1.5	0.2	0.6	0.7	1.4	1.4	5.2	2.5	0.6	1.3	1.1	1.5	3.2	0.5	0.7	0.8	1.2	0.0	0.0	2.0	0.1	0.2	0.2	0.1	3.5	0.1	7.6	0.8	0.1	0.2	0.1	1.2	0.2	0.1	0.9	2.1	1.1	0.9	3.2	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.8	0.0	1.8	0.5	0.3	0.1	0.5	0.7	0.5	2.9	0.5	0.3	1.4	0.2	0.1	0.4	3.4	2.0	2.3	0.9	0.1	0.4	0.6	0.4	0.3	0.1	0.7	0.9	0.1	1.0	2.4	3.4	8.1	0.1	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	1.5	1.7	7.7	4.7	1.4	1.8	1.8	2.4	1.4	3.3	0.2	1.4	3.2	0.4	0.0	3.7	24.8	1.1	0.0	0.7	2.8	0.6	19.6	0.7	0.4	11.6	0.0	1.7	1.8	68.8	0.3	1.6	0.1	0.0	0.4	3.5	0.5	0.6	1.2	1.8	7.4	62.4	0.4	0.3	1.3	0.0	0.3	0.0	2.1	1.4	66.8	0.1	15.2	78.3	0.3	0.0	1.3	0.0	3.4	3.1	0.1	0.0	9.4	0.1	4.0	3.1	33.2	3.1	0.1	0.1	3.4	3.1	0.3	0.1	0.5	1.1	10.9	0.0	3.6	1.4	0.5	5.8	0.3	0.6	0.0	0.5	0.9	0.5	2.6
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 199.8;skin 1: 61.6"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 129.6"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;neutrophil: 73.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 73.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;NB-4: 2.8;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		NA	NA		280000	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	1.4	0.3	0.1	3.0	0.1	11.6	2.2	0.2	0.4	0.8	0.3	0.4	0.6	0.4	0.0	1.0	0.7	0.6	0.3	0.1	0.1	0.3	199.8	2.3	0.5	0.1	0.1	0.0	0.2	0.9	0.1	3.0	0.4	0.1	0.2	0.4	0.0	0.6	0.1	0.2	61.6	0.8	0.5	0.1	7.7	0.4	0.1	0.1	0.5	0.2	0.6	1.4	0.5	1.4	0.1	0.4	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.4	0.4	0.0	0.6	0.3	0.2	0.1	0.2	0.3	0.0	0.1	0.1	0.0	0.1	2.8	0.9	0.1	0.4	0.2	0.1	0.0	0.1	0.6	0.1	0.3	0.3	0.0	0.0	0.0	0.0	11.4	0.1	0.1	0.1	0.1	0.1	0.4	0.5	0.1	0.0	1.7	0.0	56.9	15.1	2.4	0.0	5.7	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	73.3	0.7	13.6	0.3	0.2	4.4	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.0	1.1	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.7	2.8	0.3	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.1	3.2	2.0	0.4	0.0	9.7	0.2	0.2	0.7	0.1	0.5	15.0	0.0	0.1	2.5	129.6	0.3	0.0	0.1	0.1	0.0	7.7	0.8	0.0	0.0	3.5	0.0	0.0	6.3	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.4	0.2	1.2	0.7	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	2.8	0.0	0.6	0.0	0.3	0.1
NR1H4	"FXR, HRR-1, HRR1, RIP14"	ENSG00000012504	"Nuclear receptor subfamily 1 group H member 4"	Q96RI1	12	100473708-100564414	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 39.4;liver: 121.6"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 92.9;Hepatocytes: 105.1;Proximal enterocytes: 331.0;Proximal tubular cells: 153.8"	"Group enriched"	"Detected in some"	11	"liver cancer: 18.7;renal cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"Hep G2: 28.3;HHSteC: 14.1;RPTEC TERT1: 44.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047699			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047699: AB_10965320"			"unprognostic (1.78e-1)"		"unprognostic (1.81e-1)"		"unprognostic (6.68e-2)"	"unprognostic (2.49e-1)"		"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-1)"		"unprognostic (3.77e-3)"	0.2	22.8	0.1	1.4	0.1	0.4	1.0	0.4	0.4	0.1	1.4	7.6	29.9	0.1	0.1	0.3	0.2	12.7	0.4	0.2	0.1	28.5	121.6	0.4	0.3	0.1	0.1	0.1	14.2	3.1	0.0	1.4	0.0	0.1	0.3	1.6	0.3	0.3	0.0	0.3	0.5	39.4	0.8	0.1	0.4	0.5	0.7	0.1	0.1	0.3	0.1	0.2	6.6	0.1	0.5	0.0	0.9	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	28.3	14.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.6	0.1	0.0	0.0	44.9	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	92.9	0.0	22.0	0.0	0.0	0.0	8.0	43.0	11.5	0.7	0.0	0.0	0.3	0.0	2.7	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.6	8.9	105.1	0.0	0.0	1.6	17.0	0.0	3.5	0.0	2.0	0.9	0.8	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.4	19.9	0.0	0.0	0.0	331.0	153.8	0.0	0.0	0.0	0.0	0.1	0.4	1.3	0.0	0.0	0.0	0.9	1.1	30.4	3.7
PFKFB1	PFRX	ENSG00000158571	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1"	P16118	X	54932961-54998534	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 28.6;liver: 50.7;skeletal muscle: 112.6;tongue: 41.1"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 15.9"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 8.5;Hep G2: 3.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.51e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.36e-3)"	"unprognostic (5.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.96e-3)"	28.6	0.5	0.4	0.1	0.5	0.4	9.3	0.4	0.5	0.1	0.2	0.4	0.1	0.1	0.6	1.1	0.1	0.3	0.2	0.4	0.4	1.1	50.7	0.2	0.5	0.5	0.5	0.3	0.0	1.3	0.3	0.5	0.2	0.5	0.3	0.5	0.4	0.7	0.2	112.6	0.8	0.5	0.1	0.4	0.3	0.4	0.4	0.4	0.4	1.0	41.1	0.6	0.2	0.2	0.6	0.2	0.1	0.2	0.4	8.5	0.1	0.6	0.0	0.1	0.1	0.0	0.5	0.1	0.4	0.1	0.0	0.4	0.3	0.1	0.2	0.3	0.3	0.7	0.2	0.1	3.2	0.0	0.0	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.8	0.1	1.4	0.1	0.5	0.4	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.3	1.0	0.1	0.7	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.7	1.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.5	0.4	0.4	0.5	0.5	0.3	0.5	0.4	0.4	0.6	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	15.9	0.1	0.0	1.5	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721167-69787961	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.3;stomach 1: 45.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 298.2;Gastric mucus-secreting cells: 61.7;Paneth cells: 153.4;Proximal enterocytes: 234.3;Undifferentiated cells: 76.4"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 10.7;neutrophil: 32.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.9;OE19: 26.3;TIME: 36.2;U-2197: 31.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	3.0	0.7	2.2	10.8	4.7	5.6	2.1	8.1	7.3	1.6	2.6	70.6	100.3	2.0	2.4	2.0	1.5	1.5	2.0	3.0	2.6	1.9	24.0	2.5	4.3	1.8	1.8	2.7	3.1	0.8	1.0	0.1	1.3	3.6	2.5	62.8	4.0	0.8	1.5	1.2	1.3	96.1	5.1	0.3	9.8	45.3	1.2	1.5	3.0	2.7	2.3	7.6	1.6	0.9	5.9	0.7	0.6	0.8	0.8	1.8	1.9	1.2	0.8	0.4	0.3	0.3	0.7	0.7	1.3	0.7	0.8	1.0	1.1	0.1	0.2	0.7	1.5	1.0	1.0	1.2	0.5	2.7	1.3	1.3	12.3	0.2	0.3	0.5	1.1	110.9	1.6	0.6	2.5	1.0	0.7	0.6	1.0	0.8	26.3	0.4	0.6	3.7	0.8	0.2	1.8	1.3	0.8	0.5	0.3	0.5	0.7	1.6	0.6	36.2	1.0	1.7	31.5	0.6	1.9	1.0	0.6	0.4	3.3	1.3	10.7	4.8	1.4	1.0	2.7	0.3	0.1	1.5	0.4	2.7	0.2	4.9	2.5	32.0	2.9	3.4	0.2	0.9	2.6	2.2	4.7	8.1	7.3	3.0	2.6	1.8	1.8	2.7	3.6	0.3	1.5	5.9	1.3	19.2	20.8	0.3	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	8.4	0.0	0.0	0.0	4.9	298.2	0.0	0.3	0.1	1.2	0.1	2.2	33.7	2.7	0.1	4.4	0.2	1.8	61.7	0.2	16.4	0.2	2.9	45.1	0.3	0.0	0.1	42.6	0.0	24.9	1.8	0.0	0.0	9.4	0.0	3.7	15.4	0.0	11.3	0.0	0.1	18.2	153.4	0.0	1.0	0.2	234.3	1.5	12.8	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.3	6.7	0.1	76.4	0.1
IGSF23		ENSG00000216588	"Immunoglobulin superfamily member 23"	A1L1A6	19	44613563-44636781	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"intestine: 16.0;liver: 24.7"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 5.7;Early spermatids: 7.9;Hepatocytes: 11.9;Late spermatids: 9.9;Proximal enterocytes: 40.8"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 12.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.5;Hep G2: 5.4;SiHa: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051811			Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA051811: AB_2681621"	"unprognostic (1.54e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.20e-6)"	"unprognostic (7.35e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-8)"	"unprognostic (1.26e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.85e-1)"	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.2	14.8	0.1	0.7	0.0	0.0	0.1	0.3	0.2	0.2	0.4	24.7	0.2	0.0	0.4	0.1	0.0	0.0	3.7	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	16.0	0.0	0.1	0.0	0.1	1.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.3	0.0	0.0	0.5	0.3	0.5	0.0	0.4	10.5	0.3	0.0	0.7	0.3	0.2	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.2	5.4	0.0	0.0	0.1	0.3	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	4.7	1.6	0.0	0.0	0.2	0.0	1.9	0.3	0.4	0.4	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.4	0.1	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	7.9	0.3	0.0	0.1	0.0	0.0	0.4	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.7	11.9	0.0	0.0	0.4	1.2	0.0	0.3	0.0	9.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.4	1.2	0.0	0.0	0.0	40.8	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	1.3	0.0
PRG4	"bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP"	ENSG00000116690	"Proteoglycan 4"	Q92954	1	186296279-186314567	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 72.6;liver: 187.3"	"Group enriched"	"Detected in some"	15	"Fibroblasts: 320.6;Hepatocytes: 364.7"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 28.4"	"Region enriched"	"Detected in some"	12	"hypothalamus: 20.7"	"Immune cell enriched"	"Detected in single"	5	"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enriched"	"Detected in some"	6	"ASC diff: 284.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			CAB054258	Supported				"Secreted to extracellular matrix"	NA	NA		4300000000			"CAB054258: "	"unprognostic (8.67e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.87e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.91e-13)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.60e-3)"	"unprognostic (7.05e-3)"	72.6	2.3	0.0	2.3	0.0	0.3	15.3	0.4	1.7	0.4	3.6	1.0	0.0	0.6	0.9	0.3	20.2	0.4	18.7	0.0	20.7	0.2	187.3	26.7	0.4	0.0	0.1	0.1	2.1	1.5	0.0	2.1	0.0	0.1	0.6	0.1	0.1	4.0	0.1	9.6	4.8	0.4	0.3	0.2	0.7	1.4	0.2	0.2	0.3	1.7	8.1	0.3	2.6	0.5	0.1	0.0	0.1	0.0	0.0	284.6	11.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	1.1	0.1	0.2	0.2	0.0	26.2	0.0	44.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.7	1.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	1.7	0.0	20.7	0.0	0.1	0.1	0.1	0.2	0.2	0.1	5.1	22.4	16.2	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	2.7	10.0	21.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.2	3.7	4.1	0.0	2.7	0.0	0.0	0.0	320.6	0.0	0.8	16.4	0.0	6.4	364.7	0.1	0.0	0.1	0.0	0.0	9.4	1.9	0.8	0.0	2.8	1.8	0.0	0.1	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.1	0.1	0.0	0.0	10.9	0.0	0.0	3.5	1.5	0.0	0.3	0.0	1.1	0.0	2.3	0.1	0.0	0.1
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	45	"liver: 34304.0"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 42919.3"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 2482.1;intermediate monocyte: 3411.9;neutrophil: 2823.2;non-classical monocyte: 4518.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 2823.2;monocytes: 4518.8"	"Cell line enriched"	"Detected in many"	10	"Hep G2: 4769.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 130.6"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	2070000000000	140000000000	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favorable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	49.6	9.7	7.8	227.0	11.7	158.6	101.7	10.2	19.9	106.6	14.6	152.4	281.1	42.7	5.3	10.1	22.6	355.5	12.2	7.8	19.1	511.1	34304.0	575.7	37.4	22.4	13.0	6.9	5.5	202.7	5.3	9.1	26.8	16.7	12.7	180.6	2.6	33.9	141.7	3.7	6.1	767.2	76.4	14.1	316.1	284.8	3.0	20.5	15.2	23.2	12.0	25.4	56.4	9.1	29.9	25.9	0.3	0.0	0.5	1.0	0.0	1.5	0.6	1.7	0.6	1.1	187.8	500.8	2.6	15.6	0.0	1.4	1.9	0.0	10.9	1.2	70.1	0.0	4.3	2.0	4769.1	0.3	16.8	2.3	4.1	5.4	0.3	18.5	1.9	0.0	0.0	3.2	0.4	0.0	0.8	1.1	12.1	2.0	5.5	8.0	1.9	16.7	2.4	300.8	3.0	0.6	1.3	6.4	1.6	1.4	0.4	262.1	2.7	1.6	2.1	59.4	1.9	7.1	3.3	1.8	7.0	4.4	41.8	0.6	10.6	2482.1	634.3	5.5	3411.9	6.8	7.7	3.6	4.1	683.6	3.6	4.3	3.6	2823.2	5.3	4518.8	14.9	4.5	2770.7	7.8	11.7	10.2	19.9	7.8	19.1	22.4	13.0	6.9	16.7	14.1	20.5	29.9	2.2	35.3	285.9	0.0	137.4	2.3	1.0	36.3	0.0	0.2	100.8	31.5	5.3	4520.9	165.5	150.8	0.0	1.6	3.9	52.0	68.4	3787.9	0.2	70.0	2.8	57.0	12.1	1227.4	0.0	225.8	4.5	3.6	36.2	51.3	1.3	0.1	938.8	42919.3	167.6	0.0	0.0	742.4	30.5	1454.0	74.1	1.1	0.0	413.3	1.8	1.0	291.7	0.3	9.2	0.0	0.0	2161.6	137.0	0.0	1.5	6.8	5270.0	745.9	108.3	0.2	0.0	0.6	17.4	0.0	0.2	0.6	1.7	6.4	75.5	0.0	83.2	6.7
TAT		ENSG00000198650	"Tyrosine aminotransferase"	P17735	16	71565660-71577092	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Aminotransferase, Transferase"	"Disease variant, Mental retardation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 1283.0"	"Cell type enriched"	"Detected in some"	43	"Hepatocytes: 4164.8"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 152.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.66e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	0.1	0.0	0.0	0.1	0.0	0.1	59.5	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.4	1283.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.1	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.7	6.7	0.0	0.1	0.0	0.0	0.6	95.3	18.7	0.5	72.9	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.3	1.0	0.3	0.0	3.1	0.0	45.5	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.1	49.6	4164.8	0.0	0.0	0.0	0.0	0.0	72.3	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	2.7	0.2	0.3	1.0	0.0	0.0	0.1	1.3	1.3	0.0	0.0	0.0	3.9	0.0	0.1	0.0
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149474697-149503394	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"gallbladder: 954.4;intestine: 656.7;liver: 709.6"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 2070.3;Hepatocytes: 578.1"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 22.7;OE19: 20.3;RPTEC TERT1: 36.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	1.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.5	656.7	0.6	2.3	0.7	0.5	954.4	0.3	0.0	0.0	0.8	709.6	0.3	0.8	0.0	0.0	0.0	0.0	73.1	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	519.1	0.9	0.0	0.1	21.5	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.6	0.3	0.2	4.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.8	0.1	20.3	0.0	0.0	0.5	1.4	36.5	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.1	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	4.1	2070.3	0.6	0.0	0.0	0.0	0.0	0.8	0.0	25.9	1.1	3.1	0.3	0.6	3.0	13.5	0.1	2.0	0.2	0.1	10.7	3.3	0.0	0.0	7.1	578.1	0.1	0.0	0.1	41.6	0.0	11.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	8.2	17.5	0.0	0.3	0.0	76.6	4.8	0.1	0.0	0.0	0.0	0.7	4.1	0.3	0.0	0.0	0.1	0.5	5.6	2.0	0.2
TRIM55	"MURF-2, RNF29"	ENSG00000147573	"Tripartite motif containing 55"	Q9BYV6	8	66126896-66175485	"Predicted intracellular proteins, Predicted membrane proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 62.3;liver: 38.2;skeletal muscle: 29.9;tongue: 34.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 108.9;Endometrial ciliated cells: 64.7;Hepatocytes: 30.4;Skeletal myocytes: 31.0;Spermatocytes: 23.8"	"Group enriched"	"Detected in some"	10	"liver cancer: 12.3;renal cancer: 5.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"LHCN-M2: 426.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038793, HPA053691"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA038793: AB_10673289, HPA053691: AB_2682231"	"unprognostic (5.44e-3)"	"unprognostic (1.25e-2)"		"unprognostic (5.93e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-3)"	1.4	0.0	0.1	0.1	0.0	0.0	0.2	1.5	0.1	0.3	0.0	0.0	0.1	0.1	3.5	0.8	5.3	0.1	62.3	0.0	0.1	4.9	38.2	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.4	0.0	0.4	0.7	0.1	0.0	1.3	0.2	29.9	0.3	0.1	0.1	0.0	0.1	0.0	7.4	0.1	0.2	0.3	34.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	7.2	0.1	0.3	0.1	0.0	0.4	0.5	0.6	0.0	60.5	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.2	426.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.7	1.5	27.6	0.0	2.4	0.0	0.0	0.1	0.0	91.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.1	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.1	0.1	0.1	0.0	2.0	0.0	0.6	0.0	0.1	2.8	0.0	0.0	0.1	0.0	108.9	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.8	64.7	0.2	1.2	0.0	0.0	0.2	0.0	0.1	3.8	0.0	3.5	0.0	0.0	0.7	30.4	0.1	0.0	1.5	0.0	0.0	1.3	0.0	6.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	7.4	15.4	0.0	6.6	31.0	2.9	23.8	1.2	0.0	0.0	3.8	0.3	0.0	0.0	0.3
UGT2B15	UGT2B8	ENSG00000196620	"UDP glucuronosyltransferase family 2 member B15"	P54855	4	68646597-68670652	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"gallbladder: 78.4;liver: 293.6"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 168.7;Hepatocytes: 142.8"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 120.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.86e-1)"		"unprognostic (1.94e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (6.73e-2)"			"unprognostic (3.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"		"prognostic favorable (4.50e-4)"	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	12.0	5.2	0.0	0.0	0.0	0.1	78.4	0.0	0.0	0.0	0.0	293.6	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	13.1	0.0	0.0	0.1	17.2	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	4.4	0.9	0.1	168.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	24.2	3.0	0.2	0.0	0.2	0.0	2.7	0.1	3.6	0.1	0.1	0.0	0.0	0.0	0.0	2.9	142.8	0.0	0.0	0.1	3.3	0.0	3.2	0.0	0.6	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	14.6	1.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.9	0.1	0.6	1.0	0.0	0.0	0.0	0.4	0.0	0.5	0.9
AKR1C8P	AKR1CL1	ENSG00000264006	"Aldo-keto reductase family 1 member C8, pseudogene"	Q5T2L2	10	5154140-5185187	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	9	"choroid plexus: 2.7;epididymis: 3.4;liver: 8.1"	"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.0"	"Cancer enriched"	"Detected in single"	9	"liver cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	41	"HDLM-2: 19.5"															NA	NA						"unprognostic (3.47e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.76e-1)"			"unprognostic (4.20e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.07e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.92e-2)"		"unprognostic (2.66e-2)"	"unprognostic (6.28e-3)"				0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	19.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200586014-200677064	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 303.4;liver: 898.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 749.1"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 377.3;ASC TERT1: 191.5;HSkMC: 78.2;hTERT-HME1: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		3300000			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	74.9	303.4	0.2	3.2	2.3	0.5	50.6	0.1	1.4	15.9	3.8	11.9	0.8	10.9	12.4	8.3	48.6	9.9	9.6	0.6	0.5	104.2	898.3	19.7	4.8	2.7	0.7	0.3	48.4	85.7	1.3	2.9	1.7	4.9	22.5	4.5	0.5	15.5	28.5	13.0	19.6	12.8	7.2	0.1	4.1	14.4	19.6	3.0	2.0	17.8	11.1	1.5	38.9	17.8	2.8	0.6	0.2	0.0	0.0	377.3	191.5	0.2	6.6	12.2	5.4	9.7	0.0	0.1	0.1	0.5	8.4	2.3	0.2	0.1	18.6	22.0	0.2	0.6	0.0	4.6	20.7	25.4	0.9	0.0	78.2	4.6	26.1	81.2	5.4	0.2	0.2	0.2	0.1	18.3	0.5	0.0	0.1	8.0	0.1	5.2	0.0	0.5	0.1	0.2	0.2	0.4	0.3	4.8	0.0	0.3	0.4	0.1	0.2	31.9	13.8	11.2	0.2	2.5	0.2	0.1	2.6	10.7	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.1	1.4	0.6	0.5	2.7	0.7	0.3	4.9	0.1	3.0	2.8	1.0	3.2	1.1	0.7	3.6	1.8	0.5	1.2	1.2	0.1	0.2	0.3	0.9	17.2	0.1	3.7	0.0	0.1	0.0	0.1	11.7	0.7	0.8	0.4	3.0	2.6	3.0	37.5	0.9	26.2	0.2	22.9	0.0	8.2	0.0	0.1	15.4	749.1	0.4	0.0	2.5	0.1	2.0	19.8	3.6	4.4	74.0	1.7	3.6	1.0	0.0	0.6	0.0	5.0	6.9	11.5	0.0	82.0	0.0	7.5	0.1	162.2	0.1	0.1	0.0	5.3	3.0	0.8	1.3	0.1	1.6	0.0	2.0	2.3	0.1	0.4
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 481.8"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 142.4;Hepatocytes: 380.3;Hofbauer cells: 282.7;Kupffer cells: 99.3"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 21.1;non-classical monocyte: 25.9"	"Lineage enriched"	"Detected in single"	35	"monocytes: 25.9"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB016775	Supported				"Secreted to blood"	NA	NA		34000000000			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	36.4	12.2	1.1	27.8	0.9	3.2	11.8	0.9	2.9	8.2	2.3	14.5	16.8	7.1	1.3	7.6	12.1	23.2	6.7	0.7	7.4	22.5	481.8	80.7	28.0	3.3	2.3	0.8	5.3	1.9	0.9	3.8	48.8	2.2	5.5	13.1	0.4	9.2	0.9	2.1	5.3	30.5	23.8	1.8	46.7	12.1	4.2	3.1	5.5	3.3	2.7	12.6	23.8	5.4	10.2	0.3	0.1	0.1	0.6	0.1	0.0	6.8	0.5	0.3	0.4	0.3	0.4	0.3	0.6	3.5	1.0	0.6	0.5	0.1	0.0	0.3	0.2	0.4	0.3	0.4	52.8	1.1	0.1	0.7	2.7	0.3	0.6	0.1	0.6	0.0	0.7	0.5	284.0	0.0	0.0	0.4	0.5	0.3	0.1	0.0	0.2	16.5	3.0	0.0	0.1	0.3	0.3	2.6	0.3	0.2	0.3	0.2	9.5	0.2	0.2	0.7	0.5	0.1	0.9	31.6	2.7	0.8	0.9	0.1	0.1	5.6	0.0	0.1	21.1	0.1	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.5	0.1	25.9	0.0	0.0	2.2	1.1	0.9	0.9	2.9	0.7	7.4	3.3	2.3	0.8	2.2	1.8	3.1	10.2	2.1	25.6	142.4	2.6	1.9	3.3	1.1	2.0	0.6	1.4	1.3	1.3	0.6	25.8	11.2	1.8	0.0	2.1	0.1	1.8	0.0	0.6	0.3	1.5	18.7	1.9	2.4	10.7	6.6	2.7	2.7	19.8	3.1	1.3	3.8	0.2	21.0	380.3	282.7	1.7	6.3	11.3	0.0	99.3	5.0	1.3	6.8	32.6	3.6	7.5	7.3	0.1	0.0	1.0	1.7	4.5	33.1	1.2	0.4	4.0	55.2	35.7	9.4	0.9	0.0	5.6	3.5	0.8	1.4	0.7	2.8	4.0	2.0	0.5	15.8	4.5
CFH	"ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS"	ENSG00000000971	"Complement factor H"	P08603	1	196652043-196747504	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity"		"Age-related macular degeneration, Cancer-related genes, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"liver: 1690.3"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 448.0;Hepatocytes: 1114.8;Leydig cells: 283.9"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 151.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 18.7"	"Lineage enriched"	"Detected in single"	26	"T-cells: 18.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 123.1;HSkMC: 119.5;hTERT-RPE1: 374.9;RT4: 227.0"									"CAB016385, CAB016769, HPA038922, HPA049176, HPA053326"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	396000000000	100000000000	Vesicles		"CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113"	"unprognostic (2.40e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (6.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	98.8	42.5	18.2	33.0	19.1	1.3	67.6	19.4	30.9	77.4	57.9	51.5	30.7	13.0	16.0	64.4	24.4	134.8	170.2	17.4	20.0	25.7	1690.3	71.4	27.6	19.1	18.0	15.8	166.4	14.2	6.5	16.1	26.3	18.8	23.2	81.0	4.3	127.7	24.2	21.3	59.4	52.6	32.8	18.9	14.1	47.4	14.4	20.6	12.2	103.4	84.7	26.1	151.3	27.3	20.6	0.0	64.9	0.0	0.0	96.5	54.7	0.1	25.8	63.1	3.5	13.5	0.1	11.9	0.3	9.6	0.1	0.2	2.2	0.0	23.6	2.6	1.3	0.0	20.0	74.7	0.0	123.1	0.9	0.3	119.5	0.3	18.4	7.9	374.9	79.2	0.0	74.4	2.7	89.4	0.1	0.5	0.1	0.4	0.0	0.1	0.2	89.8	21.0	0.0	227.0	0.0	0.1	0.4	0.0	0.1	0.6	0.1	0.0	5.6	73.6	0.9	0.8	0.8	0.8	0.0	0.3	13.1	0.2	5.8	0.0	0.1	0.0	2.0	0.0	18.7	0.0	6.6	4.0	0.2	0.0	0.4	1.5	0.7	0.0	0.0	0.0	0.0	1.1	18.2	19.1	19.4	30.9	17.4	20.0	19.1	18.0	15.8	18.8	18.9	20.6	20.6	73.9	9.6	17.6	0.7	4.2	44.2	63.6	140.6	14.2	2.4	1.3	3.4	10.9	35.8	141.1	5.5	0.0	0.0	3.1	0.1	0.0	6.2	2.6	2.3	3.8	49.8	0.0	52.6	0.6	0.8	0.0	448.0	8.6	1.9	3.8	6.9	47.8	1114.8	1.1	0.0	1.0	0.0	14.2	43.8	62.1	7.4	283.9	5.7	44.4	38.4	0.3	0.3	0.0	0.0	0.2	5.3	0.0	138.8	2.6	13.0	0.0	0.5	115.6	1.4	6.6	94.2	59.6	1.4	1.0	10.9	38.2	0.1	13.2	26.3	0.0	61.5
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898077	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 80.9;kidney: 41.3;liver: 168.1"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 139.7;Proximal enterocytes: 204.6"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	19	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	4	"Hep G2: 3.8"					"Low region specificity"	"Detected in all"			"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"	NA	NA					"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.0	0.0	0.3	0.1	0.0	1.1	0.2	0.1	0.2	0.0	0.4	2.2	80.6	0.0	26.0	0.2	0.0	3.3	0.0	0.2	0.2	41.3	168.1	0.0	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	6.7	0.9	0.0	0.0	0.1	0.0	0.8	80.9	0.0	0.4	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	12.3	1.9	0.1	5.8	0.0	0.0	0.1	1.8	5.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	1.4	139.7	0.0	0.0	0.0	8.9	0.0	3.8	0.0	18.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.5	204.6	37.7	0.0	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.1	0.0	0.2	0.1	5.6	0.2
DAO	"DAAO, DAMOX"	ENSG00000110887	"D-amino acid oxidase"	P14920	12	108858932-108901043	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 64.1;kidney: 91.1;liver: 151.1"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 46.1;Proximal tubular cells: 86.8"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 13.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.1"	"Group enriched"	"Detected in some"	10	"cerebellum: 66.4;pons and medulla: 20.2"	"Low region specificity"	"Detected in all"			"HPA038653, HPA038654"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA038653: AB_10673016, HPA038654: AB_10673285"	"unprognostic (1.50e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.59e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.13e-2)"	"prognostic favorable (4.11e-4)"	"unprognostic (3.44e-3)"	"unprognostic (8.96e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	0.1	0.0	4.2	0.0	9.9	0.0	0.0	64.1	6.8	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.0	91.1	151.1	0.2	0.0	35.7	16.0	0.1	0.0	0.2	0.0	0.0	0.0	27.3	0.0	2.1	12.1	0.0	0.0	0.0	0.0	0.0	0.1	37.3	0.1	0.1	0.1	5.2	0.0	0.0	0.0	0.0	0.0	0.0	60.9	0.0	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	9.9	64.1	6.8	0.9	3.0	35.7	16.0	0.1	27.3	37.3	5.2	60.9	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.7	0.0	4.6	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	46.1	0.2	0.0	1.2	0.0	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.5	0.1	0.0	1.2	0.0	0.0	0.0	0.0	86.8	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.4	0.0	0.2	0.0
GPR88		ENSG00000181656	"G protein-coupled receptor 88"	Q9GZN0	1	100538139-100542021	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 72.2"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.1;Excitatory neurons: 1.8;Hepatocytes: 2.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 12.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 72.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HSkMC: 1.6;SCLC-21H: 2.0"	"Region enriched"	"Detected in many"	10	"basal ganglia: 718.8"	"Region enriched"	"Detected in many"	42	"basal ganglia: 273.1"	HPA007488		Approved				NA	NA					"HPA007488: AB_2667844"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.37e-3)"	"unprognostic (5.41e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.93e-4)"	"unprognostic (1.85e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-2)"	0.4	0.3	3.5	0.3	72.2	0.0	7.2	0.2	12.0	0.1	0.4	0.6	0.3	0.1	0.0	0.1	0.1	0.0	0.2	2.9	13.0	0.1	8.9	0.1	0.1	21.2	1.4	3.9	2.6	0.0	1.0	1.1	0.0	13.4	0.3	0.3	0.3	0.4	0.0	0.2	0.0	0.4	0.1	0.7	10.6	0.2	0.1	12.5	0.2	0.1	0.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	72.2	0.2	12.0	2.9	13.0	21.2	1.4	3.9	13.4	0.7	12.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRG1	LRG	ENSG00000171236	"Leucine rich alpha-2-glycoprotein 1"	P02750	19	4536402-4540036	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"liver: 952.0"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 793.0"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 160.9"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	19	"neutrophil: 285.2"	"Lineage enriched"	"Detected in many"	44	"granulocytes: 285.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 15.4;SK-BR-3: 15.7;THP-1: 26.2;U-937: 48.7"	"Low region specificity"	"Detected in single"							"HPA001888, HPA001889"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	21000000000	42000000000	Vesicles		"HPA001888: AB_1079276, HPA001889: AB_1079275"	"unprognostic (5.54e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.66e-6)"	"unprognostic (4.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.60e-2)"	5.5	4.6	0.6	17.9	0.5	31.7	4.3	1.1	2.3	8.7	1.2	7.4	6.8	1.9	5.9	22.9	10.1	15.6	1.1	0.6	0.6	7.9	952.0	7.9	0.8	0.7	0.6	0.5	1.6	44.5	0.1	1.6	1.9	1.9	4.4	4.7	0.2	21.1	6.2	1.0	4.3	3.4	2.2	0.4	16.4	13.8	0.3	0.8	1.2	1.3	1.4	6.5	13.4	3.8	1.3	10.8	0.1	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	1.0	8.0	3.6	13.3	0.0	0.5	1.4	0.0	1.7	0.1	13.4	0.4	0.3	0.2	15.4	0.0	0.4	13.9	4.1	0.0	0.0	0.0	0.0	0.1	0.0	9.6	0.2	0.0	0.6	0.0	11.3	0.2	8.2	0.0	0.1	0.3	11.3	1.0	2.0	0.0	0.0	0.1	15.7	0.1	1.3	4.8	26.2	0.3	0.0	0.2	0.1	0.2	0.1	0.1	0.2	0.0	48.7	0.0	2.4	6.4	15.0	0.1	2.0	0.1	0.4	0.3	0.1	1.6	0.4	0.1	0.1	285.2	0.2	1.3	0.2	1.1	2.2	0.6	0.5	1.1	2.3	0.6	0.6	0.7	0.6	0.5	1.9	0.4	0.8	1.3	13.4	12.8	54.3	0.0	3.3	8.0	33.1	56.8	18.2	0.1	14.2	2.5	0.5	60.1	50.2	14.7	0.0	0.8	0.5	44.7	1.9	112.7	0.0	38.0	1.8	24.7	4.9	13.2	0.0	64.1	12.4	3.0	31.6	17.3	12.0	0.2	38.2	793.0	6.7	1.7	0.0	26.3	32.6	19.9	5.0	0.0	0.0	14.7	1.8	0.0	7.3	0.1	0.0	0.0	0.0	40.6	11.9	0.0	1.7	4.5	10.8	4.9	76.1	0.1	0.0	2.3	3.3	0.0	0.2	9.0	5.8	1.4	1.9	3.4	27.6	30.2
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217282-187291980	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 117.2;liver: 185.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cardiomyocytes: 38.1;Cholangiocytes: 20.0;Endometrial stromal cells: 30.6;Fibroblasts: 16.4;Hepatic stellate cells: 23.2;Hepatocytes: 65.8"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 133.3;BJ hTERT+: 498.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1900000000	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	6.3	3.7	9.6	1.3	8.8	0.0	2.8	14.3	8.0	98.7	4.4	39.0	1.9	89.2	3.4	11.2	17.9	5.1	117.2	9.6	23.8	4.8	185.0	6.1	1.0	19.0	15.4	4.7	2.7	0.2	0.3	1.0	9.1	15.5	46.4	5.6	0.0	2.3	52.8	37.8	5.5	7.6	44.8	21.3	0.8	1.6	0.5	13.3	0.2	3.3	19.1	4.3	10.0	62.1	32.8	0.0	0.0	0.3	0.4	15.7	17.3	0.1	133.3	498.3	1.8	0.9	0.0	0.0	0.1	0.0	40.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.2	0.0	0.0	5.4	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	8.8	14.3	8.0	9.6	23.8	19.0	15.4	4.7	15.5	21.3	13.3	32.8	1.1	0.0	1.8	28.1	0.2	2.9	0.1	0.2	0.0	0.0	0.0	0.0	38.1	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.9	0.7	30.6	2.0	0.0	0.0	0.2	0.0	0.3	16.4	0.0	0.7	0.0	0.2	23.2	65.8	0.4	0.0	0.9	0.0	0.0	1.9	3.7	7.5	2.5	0.3	1.8	1.0	0.0	0.0	0.0	10.1	0.2	0.0	0.0	0.7	0.1	0.1	0.0	2.4	0.0	0.0	0.0	5.4	4.5	0.0	0.0	0.2	1.7	0.1	0.5	5.1	0.0	0.1
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 19.7;kidney: 25.4;liver: 93.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.3;Erythroid cells: 22.1;Hepatocytes: 16.3;Late spermatids: 23.0;Proximal enterocytes: 14.8;Proximal tubular cells: 48.9"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"K-562: 107.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected"	"Not detected"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	Cytosol		No	NA		5200000	Cytosol		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.0	0.0	0.1	0.0	0.1	19.7	0.0	0.7	0.2	0.0	0.0	0.4	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	25.4	93.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.8	7.3	0.0	0.0	0.1	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.2	0.0	0.4	0.2	0.2	0.0	0.3	0.0	0.3	0.3	0.1	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.4	1.5	0.0	1.8	0.0	0.0	0.0	0.6	0.0	0.0	9.3	0.2	0.3	0.1	0.0	22.1	1.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.7	16.3	0.2	0.0	1.2	0.9	0.0	0.0	0.0	23.0	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	14.8	48.9	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359872-95396375	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 621.9"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 509.6"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 28.9;CACO-2: 8.6;CAPAN-2: 6.5;Hep G2: 32.6;T-47d: 17.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	NA	NA	1760000000	380000000			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	1.0	3.9	1.9	0.5	1.6	0.0	31.5	1.6	1.7	5.3	1.2	2.0	7.9	0.9	3.7	0.5	1.3	4.5	0.8	1.6	1.9	2.7	621.9	14.3	0.1	2.1	2.2	1.4	12.5	14.4	0.2	25.1	0.8	3.1	0.9	2.9	0.1	26.5	4.0	0.3	7.5	3.1	0.2	1.9	0.3	2.3	9.1	1.9	1.6	7.2	0.3	6.0	1.4	0.9	1.7	3.1	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	6.5	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.1	17.4	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.6	1.6	1.7	1.6	1.9	2.1	2.2	1.4	3.1	1.9	1.9	1.7	2.5	6.4	45.9	24.5	0.6	0.9	0.9	9.3	1.8	0.0	5.4	4.3	0.5	31.5	23.9	3.7	0.0	1.7	0.3	3.2	1.9	0.3	14.5	0.0	0.4	1.9	0.0	8.0	0.1	2.0	2.2	5.2	0.5	0.0	0.0	0.4	10.0	509.6	0.2	0.0	0.2	1.8	12.2	8.1	0.3	4.8	8.1	0.2	14.2	4.7	0.0	3.2	0.0	17.6	0.1	1.2	1.2	3.0	0.0	2.1	6.0	6.7	6.5	0.1	0.0	0.8	2.1	21.4	16.9	0.3	1.3	1.4	0.8	6.6	2.3	0.4
SERPINA11		ENSG00000186910	"Serpin family A member 11"	Q86U17	14	94442464-94452800	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"liver: 494.6"	"Cell type enriched"	"Detected in some"	46	"Hepatocytes: 278.7"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 94.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 17.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		230000000				"unprognostic (2.50e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.00e-2)"	"prognostic favorable (6.30e-4)"		"unprognostic (7.44e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.44e-1)"		"unprognostic (5.14e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.64e-1)"				0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.1	5.3	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	494.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	3.9	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.3	0.0	0.0	4.3	1.8	0.0	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	278.7	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.2
SERPINA6	CBG	ENSG00000170099	"Serpin family A member 6"	P08185	14	94304248-94323389	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 782.8"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 204.5;Hepatocytes: 390.8"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"T-47d: 961.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA017864	Approved				"Secreted to blood"	NA	NA	60800000000	37000000000			"HPA017864: AB_1856721"	"unprognostic (2.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-3)"	"prognostic favorable (6.96e-5)"		"unprognostic (2.93e-3)"	"unprognostic (9.98e-3)"	"unprognostic (4.43e-2)"		"unprognostic (3.11e-1)"	"unprognostic (4.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.14e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	1.9	0.0	3.5	0.1	0.5	0.0	0.0	12.8	35.4	0.0	0.0	0.0	43.9	782.8	0.1	0.0	0.0	0.0	0.0	0.3	17.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	114.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.4	0.4	4.5	0.1	0.4	0.0	0.1	0.7	0.0	0.0	961.9	0.0	0.0	0.5	0.0	0.6	0.0	0.3	0.0	0.5	1.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.1	0.1	0.1	0.7	0.0	0.0	4.4	0.0	0.4	204.5	0.3	0.0	0.0	0.3	0.0	0.4	1.9	33.1	0.0	62.6	0.3	0.4	9.0	16.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.2	9.7	390.8	0.0	0.0	0.0	0.8	2.0	8.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.0	1.2	0.0	0.0	0.0	0.1	43.0	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.8	0.1
SLC38A3	"G17, SN1"	ENSG00000188338	"Solute carrier family 38 member 3"	Q99624	3	50205246-50221486	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"liver: 334.3;retina: 174.4"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 88.3;Cone photoreceptor cells: 187.7;Hepatocytes: 114.6;Muller glia cells: 80.1;Rod photoreceptor cells: 124.0"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 140.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	5	"Hep G2: 49.8;SCLC-21H: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031871			Approved	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA031871: AB_2674080"	"unprognostic (2.14e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.19e-4)"	"unprognostic (7.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.96e-1)"	1.4	0.1	32.1	0.1	33.2	1.0	1.4	40.9	41.5	0.5	27.3	0.2	1.3	0.3	0.4	1.1	0.6	0.4	5.6	30.2	34.2	5.0	334.3	0.2	0.5	37.9	37.7	25.1	6.4	37.5	8.0	4.7	1.2	35.6	0.5	0.1	174.4	1.8	0.1	36.2	0.6	0.6	0.2	32.8	0.2	2.0	1.9	36.3	0.0	1.3	36.1	0.3	0.1	0.4	35.3	0.0	0.0	1.2	7.0	0.1	0.0	1.7	0.0	0.0	1.3	0.6	4.1	0.0	0.1	1.1	0.0	0.3	0.0	1.9	0.0	0.9	0.1	0.6	0.0	1.0	49.8	0.1	0.5	0.0	0.1	0.0	0.1	0.0	5.6	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.5	0.5	0.0	0.2	0.2	15.4	1.3	0.7	0.2	0.0	2.1	2.0	0.3	0.0	0.2	1.2	0.0	1.0	0.3	0.0	0.1	0.2	0.3	0.1	2.9	0.2	0.3	0.2	0.0	0.1	0.3	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.4	0.0	0.2	0.1	0.1	32.1	33.2	40.9	41.5	30.2	34.2	37.9	37.7	25.1	35.6	32.8	36.3	35.3	0.3	0.0	0.0	17.6	0.4	0.0	0.1	0.0	0.6	88.3	3.2	1.7	3.3	17.2	0.0	0.0	187.7	0.2	0.0	0.0	0.0	1.8	0.3	0.4	0.0	3.9	3.5	2.7	0.2	2.2	0.1	0.2	0.0	0.5	0.0	0.1	2.2	114.6	0.1	8.4	0.6	0.2	0.0	2.6	0.0	0.0	2.1	0.1	0.0	7.5	0.6	80.1	0.0	4.5	3.7	0.6	0.0	0.4	0.0	0.0	0.0	4.2	0.0	124.0	0.0	0.6	0.3	2.9	3.3	0.9	0.0	1.4	0.2	0.0	0.2	0.0
TM4SF5		ENSG00000142484	"Transmembrane 4 L six family member 5"	O14894	17	4771884-4783213	"Predicted membrane proteins, Transporters"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 176.3;liver: 206.3"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 115.2;Hepatocytes: 275.4;Intestinal goblet cells: 143.9;Paneth cells: 285.4;Proximal enterocytes: 618.4"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 219.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 53.7;Hep G2: 96.0;OE19: 60.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA055674			Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA055674: "		"unprognostic (1.81e-1)"	"unprognostic (1.61e-1)"				"unprognostic (1.31e-1)"				"unprognostic (4.44e-2)"		"unprognostic (9.33e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.95e-1)"		"unprognostic (5.21e-3)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	176.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	11.7	206.3	0.0	0.2	0.0	0.0	0.0	0.0	1.4	8.2	0.0	0.6	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	159.4	0.0	0.0	0.1	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	53.7	2.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	96.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.7	0.0	60.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.8	0.0	1.8	0.0	0.1	0.0	40.5	5.9	0.9	2.0	0.0	0.0	0.1	115.2	5.3	0.1	8.9	4.6	0.0	57.6	0.0	4.5	0.0	4.6	275.4	0.1	0.0	0.1	143.9	0.0	4.8	0.3	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	285.4	0.0	0.1	0.0	618.4	72.8	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.0	47.8	0.0
TTPA	AVED	ENSG00000137561	"Alpha tocopherol transfer protein"	P49638	8	63048553-63086053	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 166.4"	"Group enriched"	"Detected in some"	4	"Astrocytes: 37.9;Hepatocytes: 72.0"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 21.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.0;SK-BR-3: 6.0;T-47d: 2.1;U-2 OS: 2.9;U-2197: 3.7"	"Low region specificity"	"Detected in all"													NA	NA		10000				"unprognostic (1.48e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.30e-7)"	"unprognostic (1.78e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.57e-2)"	"unprognostic (5.46e-3)"	"unprognostic (6.16e-3)"	1.6	0.2	2.7	0.4	2.4	0.2	0.6	3.0	2.3	0.1	0.7	3.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	2.4	2.3	2.4	166.4	0.7	0.2	2.8	2.9	1.8	0.0	1.2	3.6	0.1	1.7	2.4	0.1	4.3	0.9	0.1	0.1	0.2	0.2	0.3	0.2	2.1	0.0	0.3	0.3	2.7	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.8	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.4	0.0	0.0	0.0	2.0	0.0	1.5	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.1	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.5	6.0	0.6	0.0	2.1	0.2	0.1	0.0	2.9	3.7	0.6	0.2	0.0	0.0	1.3	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	2.4	3.0	2.3	2.4	2.3	2.8	2.9	1.8	2.4	2.1	2.7	2.6	0.0	3.2	1.1	37.9	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.4	0.1	7.2	1.3	0.0	0.0	11.2	0.0	2.1	1.9	1.1	0.0	0.0	0.1	0.2	2.4	0.0	1.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	1.8	72.0	0.6	0.0	2.7	2.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	12.9	0.0	10.6	0.1	0.1	1.2	0.0	0.0	0.1	0.0	5.5	0.0	0.2	0.0	0.7	0.1	0.0	1.0	0.0	0.1	9.9	0.1	0.0	4.9	0.1
ACADL	"ACAD4, LCAD"	ENSG00000115361	"Acyl-CoA dehydrogenase long chain"	P28330	2	210187126-210225447	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.3;pancreas: 28.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 70.9;Early spermatids: 85.6;Late spermatids: 69.4;Leydig cells: 46.9;Peritubular cells: 46.6;Proximal tubular cells: 31.5"	"Group enriched"	"Detected in many"	8	"liver cancer: 2.2;prostate cancer: 6.8;renal cancer: 8.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 2.4;RPTEC TERT1: 2.6;SuSa: 2.3;U-2 OS: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011990	Enhanced	Supported				NA	NA					"HPA011990: AB_1844465"	"unprognostic (6.29e-3)"	"unprognostic (7.61e-2)"		"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (1.58e-11)"	"unprognostic (4.22e-3)"	"unprognostic (1.18e-4)"	"unprognostic (8.81e-3)"	"unprognostic (1.06e-1)"	12.0	1.1	0.7	0.1	0.6	0.0	8.1	0.6	1.1	3.4	0.8	0.5	0.0	0.7	1.1	0.5	4.0	0.6	2.1	0.6	1.1	20.0	28.3	10.1	0.0	0.7	0.6	0.6	12.8	28.6	4.5	2.9	1.0	0.6	20.8	0.1	0.0	6.8	4.9	9.6	2.6	0.4	0.1	0.6	0.0	5.6	3.1	0.6	1.5	23.9	5.1	0.0	1.0	3.8	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.6	0.5	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.6	1.1	0.6	1.1	0.7	0.6	0.6	0.6	0.6	0.6	0.7	0.2	28.9	70.9	1.0	0.0	0.6	1.4	1.1	1.2	0.2	1.3	0.5	1.1	8.6	7.6	22.0	2.1	8.8	0.0	0.0	15.6	4.0	85.6	7.1	0.4	0.2	0.0	0.0	0.2	11.9	0.3	4.9	3.6	5.9	2.5	0.8	0.7	23.0	0.5	0.0	13.3	0.0	0.0	0.3	0.4	69.4	46.9	0.4	0.0	4.7	0.0	0.2	0.0	7.5	0.3	3.9	0.0	46.6	0.0	8.2	0.0	31.5	2.4	0.2	0.0	7.6	13.7	0.7	0.7	0.7	1.0	6.3	0.4	0.1	0.0	0.7
ACSM1	"BUCS1, MACS1"	ENSG00000166743	"Acyl-CoA synthetase medium chain family member 1"	Q08AH1	16	20623237-20698890	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"breast: 227.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 13.2;Late spermatids: 23.2;Theca cells: 8.4"	"Group enriched"	"Detected in many"	8	"liver cancer: 14.7;prostate cancer: 36.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.3;memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"NTERA-2: 15.6"	"Not detected"	"Not detected"							HPA046291	Uncertain					NA	NA					"HPA046291: AB_10960704"	"unprognostic (1.08e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.50e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.01e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.33e-3)"	0.3	0.5	0.3	0.0	0.3	3.6	227.5	0.4	0.4	1.7	0.2	1.0	0.5	2.1	0.4	0.4	2.2	0.4	0.4	0.3	0.3	1.1	10.8	0.5	0.3	0.4	0.3	0.2	2.6	1.6	0.9	0.1	0.0	0.5	3.8	0.6	0.1	1.8	0.6	0.3	1.3	0.7	0.8	0.3	0.5	2.2	4.4	0.4	0.4	0.5	0.2	0.2	1.0	1.4	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.1	15.6	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.5	0.0	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.4	0.3	0.3	0.4	0.3	0.2	0.5	0.3	0.4	0.4	0.1	0.0	0.0	0.3	1.0	0.6	2.6	1.2	1.2	0.0	2.5	2.4	1.0	5.7	1.4	0.0	0.0	0.2	0.2	1.6	1.9	4.2	13.2	1.4	0.2	1.5	1.2	1.3	0.8	2.3	0.1	0.7	2.0	0.8	0.0	2.8	3.6	1.3	0.2	0.0	0.7	2.9	0.0	0.3	2.8	23.2	4.4	0.6	0.0	0.0	1.7	0.0	0.0	1.0	1.3	1.2	3.7	7.2	0.0	2.5	0.6	1.4	3.7	0.0	0.0	0.1	0.2	0.8	0.2	1.1	1.6	0.1	0.3	8.4	2.5	1.4
AGTR1	"AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R"	ENSG00000144891	"Angiotensin II receptor type 1"	P30556	3	148697784-148743008	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 97.4;placenta: 142.8"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 53.1;Hepatocytes: 30.9;Leydig cells: 145.1;Sertoli cells: 144.7;Smooth muscle cells: 71.2"	"Group enriched"	"Detected in many"	8	"breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8"	"Group enriched"	"Detected in some"	6	"hypothalamus: 6.1;medulla oblongata: 2.2;midbrain: 7.3;pons: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 176.8;ASC TERT1: 24.4;BJ hTERT+ SV40 Large T+: 34.8;HBF TERT88: 53.9;HSkMC: 32.2"					"Low region specificity"	"Detected in all"			HPA003596	Enhanced		Uncertain	Vesicles		NA	NA			Vesicles		"HPA003596: AB_1845163"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.48e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.41e-3)"	52.7	38.5	0.3	1.8	0.7	0.0	40.2	0.3	0.4	3.4	0.4	15.3	0.9	3.5	2.8	2.8	9.9	6.3	7.7	0.4	6.1	18.6	97.4	10.5	0.7	2.2	7.3	0.2	3.9	3.5	2.9	3.9	142.8	2.6	5.4	4.4	0.9	4.8	4.2	11.7	12.9	4.3	4.6	0.2	9.1	6.5	2.2	0.5	3.0	14.3	13.9	0.2	14.7	6.2	0.3	0.0	1.0	0.8	0.0	176.8	24.4	0.0	0.2	3.9	34.8	20.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0	53.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	32.2	0.0	3.4	1.8	1.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.3	0.4	0.4	6.1	2.2	7.3	0.2	2.6	0.2	0.5	0.3	20.5	0.0	0.6	0.0	0.0	3.4	0.2	0.0	0.0	0.0	1.3	0.9	6.3	2.8	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.1	0.8	0.0	0.3	3.8	23.5	0.0	0.1	7.6	0.3	53.1	0.5	0.0	0.0	0.0	17.5	30.9	0.7	0.0	0.0	0.2	0.0	0.3	3.5	1.7	145.1	0.5	1.8	2.8	0.0	5.7	0.0	0.0	0.1	0.5	0.0	7.5	0.4	1.1	0.0	0.1	0.0	0.1	144.7	7.6	71.2	0.0	1.8	0.3	1.7	0.3	0.5	0.3	0.0	0.1
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233699-21253850	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 12.4;kidney: 5.9;liver: 13.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 63.4;Enteroendocrine cells: 25.1;Hepatocytes: 28.0;Intestinal goblet cells: 40.0;Paneth cells: 38.2;Proximal enterocytes: 113.0;Proximal tubular cells: 37.5;Undifferentiated cells: 24.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.3;HDLM-2: 3.4;Hep G2: 8.2;OE19: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA043523, HPA061125"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA043523: AB_10966687, HPA061125: "	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.0	0.0	0.1	0.6	0.2	0.1	0.0	1.8	0.2	0.0	0.0	6.9	9.1	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	5.9	13.6	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	7.2	0.2	0.0	0.0	0.7	0.1	12.4	0.2	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	1.8	0.2	0.1	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.8	2.8	0.6	1.8	0.0	0.0	0.0	63.4	0.0	0.2	0.8	0.3	0.1	0.3	25.1	0.0	1.3	1.7	0.0	0.2	0.0	0.1	1.3	0.0	0.4	28.0	0.0	0.0	0.2	40.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	1.3	38.2	0.0	0.0	0.5	113.0	37.5	0.0	0.3	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.1	0.6	0.0	24.7	0.4
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1071.9"	"Cell type enriched"	"Detected in many"	19	"Hepatocytes: 2075.1"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 347.6;SiHa: 65.1;SK-BR-3: 98.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	"Nucleoli,Nucleoli rim"		NA	NA		8300000	"Nucleoli, Nucleoli rim"		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	2.6	0.4	1.1	0.4	9.0	0.1	1.5	5.1	4.1	0.9	0.2	0.8	213.7	1.6	2.8	1.5	0.9	1.6	1.1	0.8	3.3	1.9	1071.9	1.1	0.3	7.3	6.2	0.7	3.0	0.8	0.1	0.9	2.5	7.0	0.8	0.4	0.3	0.5	0.8	0.6	1.3	124.4	2.2	3.7	1.2	0.6	6.0	5.8	0.3	1.8	0.5	0.2	0.6	0.7	6.7	0.9	9.7	14.0	11.7	11.6	16.5	18.0	6.1	6.4	6.3	9.2	1.8	0.0	2.7	0.4	5.3	9.6	3.0	0.5	10.8	15.9	0.0	4.5	10.0	347.6	15.2	2.8	4.0	0.0	9.2	6.2	12.8	13.0	18.7	0.4	4.2	10.3	0.8	10.4	2.8	0.3	0.7	6.3	0.0	1.8	0.7	14.6	1.6	13.2	0.2	0.5	1.1	65.1	98.9	8.1	20.0	0.1	1.6	7.7	17.5	5.8	5.9	13.0	0.0	0.7	0.0	12.5	11.6	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.0	5.1	4.1	0.8	3.3	7.3	6.2	0.7	7.0	3.7	5.8	6.7	0.4	12.8	8.4	6.2	3.6	2.2	0.6	0.9	1.2	1.4	1.3	1.5	1.1	15.7	3.9	1.8	8.4	0.4	0.4	0.1	0.0	0.2	35.5	1.0	2.1	2.0	0.0	18.7	12.1	0.2	0.4	2.6	0.0	1.6	3.8	0.3	16.8	2075.1	0.2	0.0	6.2	13.5	0.0	27.2	2.9	6.5	2.5	0.8	1.8	3.7	0.2	0.7	0.0	3.0	8.8	0.0	2.5	1.2	0.1	1.1	105.6	1.0	1.3	2.3	0.0	1.8	2.3	0.6	1.8	1.5	1.8	20.8	1.8	3.5	41.2	0.4
DIO1	TXDI1	ENSG00000211452	"Iodothyronine deiodinase 1"	P49895	1	53891239-53911086	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	42	"kidney: 146.2;liver: 186.8;thyroid gland: 262.5"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 61.5;Proximal tubular cells: 115.7"	"Group enriched"	"Detected in many"	8	"liver cancer: 44.7;thyroid cancer: 43.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	26	"Hep G2: 33.9;SK-BR-3: 79.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.91e-3)"	"unprognostic (6.96e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.99e-3)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (3.59e-2)"	0.1	0.2	0.2	0.1	0.2	0.2	0.7	0.2	0.3	0.1	0.2	0.1	0.1	0.2	0.0	0.2	4.7	1.0	0.6	0.1	0.1	146.2	186.8	0.4	0.8	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.7	0.2	0.0	262.5	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	1.0	0.3	0.0	33.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.2	0.0	0.3	0.1	0.1	0.2	0.3	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	79.0	0.0	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	0.4	0.1	0.2	0.5	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.8	0.0	0.0	0.9	0.1	15.2	11.5	0.4	0.0	0.0	0.5	0.1	0.0	11.7	0.0	3.6	0.3	0.1	0.4	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	61.5	0.5	0.0	0.5	0.0	0.0	2.2	0.0	5.3	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.2	0.0	115.7	10.2	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	2.3	0.3	0.1	0.0	0.0
ELOVL2	Ssc2	ENSG00000197977	"ELOVL fatty acid elongase 2"	Q9NXB9	6	10980759-11044305	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.9;placenta: 35.6;retina: 28.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 95.0;Cone photoreceptor cells: 29.2;Extravillous trophoblasts: 19.7;Sertoli cells: 19.7;Spermatocytes: 23.0"	"Group enriched"	"Detected in many"	8	"breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 29.9;GAMG: 31.2;HBF TERT88: 29.0;Hep G2: 23.4;RH-30: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"prognostic favorable (6.73e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-5)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-12)"	"unprognostic (9.98e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.47e-2)"	1.2	0.9	9.0	1.5	10.2	0.0	4.9	10.1	14.0	0.1	4.6	0.4	0.2	0.5	2.3	0.4	0.2	0.6	3.2	9.1	22.4	0.2	52.9	0.2	0.5	10.2	9.2	8.6	0.2	2.6	9.8	3.0	35.6	9.5	5.3	0.1	28.1	0.7	0.4	1.0	0.2	0.3	0.7	9.8	0.0	0.1	11.7	9.6	1.1	1.8	1.0	0.9	2.1	0.1	14.5	0.0	5.3	20.1	0.0	0.0	0.0	11.5	0.4	1.0	17.7	29.9	0.0	0.0	0.0	0.0	1.1	31.2	0.0	21.3	0.0	29.0	0.0	18.2	0.1	0.4	23.4	0.9	0.4	4.8	0.2	0.0	13.7	0.0	1.0	0.0	0.9	1.2	0.0	0.4	0.1	12.1	0.2	3.8	0.0	17.4	16.6	31.8	0.0	0.0	0.3	8.0	9.1	0.0	0.0	7.5	16.1	3.7	9.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	10.2	10.1	14.0	9.1	22.4	10.2	9.2	8.6	9.5	9.8	9.6	14.5	0.5	0.0	0.0	95.0	0.1	0.1	0.0	0.0	0.0	2.2	7.8	1.3	1.2	8.6	0.0	0.0	29.2	2.3	0.0	0.0	0.0	7.2	10.1	0.0	0.5	1.9	0.0	0.0	2.5	1.0	19.7	8.0	0.0	0.0	0.0	0.3	0.0	17.5	1.2	0.0	5.9	0.0	0.0	0.0	0.0	14.9	0.9	0.1	0.0	6.5	0.0	4.9	0.0	4.5	16.8	1.0	0.0	0.4	0.0	1.9	0.0	0.1	0.0	11.8	19.7	0.1	3.9	23.0	8.9	0.2	0.0	1.6	0.1	0.0	0.0	0.1
FCN2	"EBP-37, FCNL, ficolin-2, P35"	ENSG00000160339	"Ficolin 2"	Q15485	9	134880810-134887523	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 100.5"	"Cell type enriched"	"Detected in some"	18	"Hepatic stellate cells: 1192.6"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.5;intermediate monocyte: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"Region enriched"	"Detected in some"	23	"spinal cord: 38.6"						"Secreted to blood"	NA	NA	8100000000	1400000000				"unprognostic (1.91e-1)"	"unprognostic (1.07e-1)"			"unprognostic (6.96e-4)"		"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"		"unprognostic (3.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"		"unprognostic (1.05e-1)"	"unprognostic (3.07e-1)"		4.7	24.8	0.3	0.0	0.3	0.1	7.7	0.2	0.5	0.3	0.4	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.2	0.5	0.3	6.2	100.5	0.1	0.1	0.3	0.5	0.2	0.5	0.5	0.2	3.1	0.0	0.3	3.2	0.0	0.0	3.2	0.4	0.1	0.2	0.1	0.0	0.2	3.1	0.2	0.2	0.3	0.0	2.1	0.1	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.1	0.0	2.2	0.0	0.0	9.0	0.3	0.3	0.2	0.5	0.5	0.3	0.3	0.5	0.2	0.3	0.2	0.3	0.3	0.1	0.0	0.0	0.7	3.8	0.0	0.1	0.0	0.0	0.0	3.8	0.4	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	34.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1192.6	12.6	0.0	0.0	0.1	0.0	0.0	64.1	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1
FTCD		ENSG00000160282	"Formimidoyltransferase cyclodeaminase"	O95954	21	46136262-46155579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	"Lyase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 947.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 131.5;Early spermatids: 104.7;Hepatocytes: 444.9;Late spermatids: 124.3;Proximal tubular cells: 395.1"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 87.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"Hep G2: 92.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020073, HPA030928, HPA030929, HPA036114"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	NA		1600000	Cytosol	"Plasma membrane"	"HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.62e-5)"	"unprognostic (2.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.85e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.78e-5)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.78e-4)"	"unprognostic (3.80e-2)"	"unprognostic (3.60e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.10e-1)"	0.3	1.7	4.8	0.2	5.7	0.0	0.4	2.9	8.5	1.3	2.4	1.0	1.3	1.2	0.4	0.3	0.9	0.1	1.3	4.3	3.9	151.3	947.4	0.2	0.3	4.0	3.7	4.3	3.0	4.0	0.0	3.4	0.0	4.9	4.2	0.0	0.0	0.2	0.6	0.5	0.3	1.7	0.0	2.8	0.5	0.5	14.0	3.6	0.0	0.9	0.0	0.0	1.3	1.0	6.5	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.0	92.9	0.0	0.6	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.9	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.4	0.5	0.0	0.3	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	4.8	5.7	2.9	8.5	4.3	3.9	4.0	3.7	4.3	4.9	2.8	3.6	6.5	0.0	0.0	0.0	1.0	8.1	0.1	0.0	0.0	0.0	1.3	0.2	0.5	1.5	131.5	0.0	9.2	0.0	0.0	0.1	0.0	46.9	0.0	104.7	0.1	0.4	1.8	0.0	61.5	10.5	0.0	0.0	0.6	0.0	0.2	0.0	0.6	30.4	444.9	0.1	3.3	5.9	0.1	0.0	28.9	0.0	124.3	3.1	1.6	0.0	1.0	0.0	0.2	0.0	1.0	18.5	0.0	0.1	2.6	0.0	0.5	0.3	395.1	0.0	0.4	0.0	0.2	0.5	39.2	17.9	0.2	0.4	0.0	3.6	0.1	0.2	0.1
GCKR		ENSG00000084734	"Glucokinase regulator"		2	27496839-27523684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	19	"liver: 137.5"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 96.5"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.4;Hep G2: 20.7;HUVEC TERT2: 6.4;TIME: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034098, HPA045855, HPA052227"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"CAB034098: AB_2247323, HPA045855: , HPA052227: "	"unprognostic (3.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.27e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-7)"	"unprognostic (6.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.50e-2)"	0.6	7.2	1.0	0.2	1.4	0.9	0.6	4.0	1.6	0.4	1.2	0.1	0.7	0.5	0.6	1.5	0.2	2.3	0.4	1.1	1.4	0.3	137.5	0.2	0.6	1.8	1.1	1.3	5.9	1.8	0.2	0.4	0.2	2.3	0.5	0.3	0.9	0.4	0.2	0.3	0.8	0.2	0.3	0.5	1.6	6.6	2.7	0.9	0.2	0.1	0.1	0.3	0.3	0.4	1.8	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0.0	0.1	0.3	0.0	0.4	0.1	0.2	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.0	13.4	0.7	20.7	0.8	0.0	0.4	0.3	1.0	0.5	0.1	2.2	6.4	0.1	0.0	0.2	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.5	0.2	4.2	0.1	0.3	0.6	0.2	0.4	0.1	0.2	1.2	0.1	0.2	0.8	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.4	0.3	0.0	0.1	0.0	0.2	1.0	1.4	4.0	1.6	1.1	1.4	1.8	1.1	1.3	2.3	0.5	0.9	1.8	0.3	0.0	0.0	1.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.1	7.9	0.1	0.6	0.6	0.0	0.0	2.0	10.4	0.0	0.2	18.3	0.1	0.0	0.1	0.7	96.5	0.1	0.0	1.6	0.0	0.0	2.1	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	13.7	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	1.7	0.2	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GLYATL1	"FLJ34646, MGC15397"	ENSG00000166840	"Glycine-N-acyltransferase like 1"	Q969I3	11	58905398-59043527	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 581.1"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 234.3;Proximal tubular cells: 797.1"	"Group enriched"	"Detected in some"	8	"liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;Daudi: 4.9;RPTEC TERT1: 1.5;U-2197: 1.2"									HPA039501	Supported		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA039501: AB_2676545"	"unprognostic (9.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-5)"	"unprognostic (3.93e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	1.3	0.3	0.4	0.1	0.3	0.4	1.6	0.1	0.7	0.1	1.3	0.9	0.0	0.1	0.3	142.7	581.1	0.0	0.1	0.9	0.4	0.0	0.0	1.7	2.6	0.0	0.0	1.1	11.2	0.3	0.2	1.9	0.0	0.0	0.5	0.2	0.0	0.3	0.1	2.7	0.1	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.1	0.5	0.4	2.0	0.0	4.9	0.0	0.3	0.4	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.5	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.1	0.3	0.9	0.4	0.0	1.1	0.3	0.2	0.5	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.3	12.8	0.0	14.7	0.0	0.0	0.0	0.1	107.6	0.1	0.0	2.5	0.1	0.5	0.0	8.0	0.7	0.6	0.0	0.1	0.0	0.1	0.0	0.1	5.0	234.3	0.0	0.0	0.8	0.1	0.0	8.1	0.0	0.0	0.0	3.1	1.8	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	1.3	0.0	797.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.9	0.1	0.9	0.2
IL27	"IL-27, IL-27A, IL27A, IL27p28, IL30, MGC71873, p28"	ENSG00000197272	"Interleukin 27"	Q8NEV9	16	28499362-28512051	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antiviral protein, Cytokine"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 26.9"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 18.1;Syncytiotrophoblasts: 23.1"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 4.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 3.6;intermediate monocyte: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"BEWO: 17.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB024722	Approved				"Secreted to blood"	NA	NA	521000				"CAB024722: "	"unprognostic (4.79e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-3)"	"prognostic favorable (1.30e-4)"	"unprognostic (3.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (6.07e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.41e-7)"	"unprognostic (6.44e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-2)"	0.2	0.2	0.2	1.2	0.2	0.9	0.1	0.3	0.4	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.1	26.9	0.5	0.4	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.7	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.2	1.7	0.1	0.7	0.5	0.1	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	3.6	0.8	0.0	3.8	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	2.1	1.5	0.1	0.0	0.2	1.0	0.2	0.2	0.3	0.4	0.3	0.3	0.3	0.2	0.1	0.4	0.2	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	18.1	0.9	0.0	0.4	0.0	0.0	3.5	1.2	0.1	0.0	2.3	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.1	0.0	0.0	0.0
PLA2G12B	PLA2G13	ENSG00000138308	"Phospholipase A2 group XIIB"	Q9BX93	10	72934762-72954806	"Metabolic proteins, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 33.3;kidney: 14.5;liver: 71.6"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 52.2;Proximal enterocytes: 70.0"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 35.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 9.1;Hep G2: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA057745, HPA059562"	Approved				"Secreted to blood"	NA	NA		2300000			"HPA057745: AB_2683514, HPA059562: AB_2684064"			"unprognostic (1.11e-2)"				"unprognostic (2.66e-2)"	"unprognostic (2.02e-3)"			"unprognostic (3.41e-1)"		"unprognostic (1.68e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"		0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.1	27.2	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	14.5	71.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	1.2	0.0	0.0	0.0	0.0	33.3	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.1	0.3	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.1	1.5	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.8	52.2	0.0	0.0	0.3	2.4	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	70.0	13.4	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	6.3	0.0
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7115736-7128889	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 435.6;liver: 326.8"	"Cell type enriched"	"Detected in many"	8	"Proximal tubular cells: 3197.2"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 6.0;Hep G2: 13.4;K-562: 26.3"									HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA038723: AB_2676175"	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favorable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favorable (3.68e-4)"	5.5	11.8	0.1	15.1	0.1	1.6	5.2	0.2	0.3	9.8	0.5	6.2	4.7	8.7	3.2	3.9	8.2	6.0	1.3	0.0	0.8	435.6	326.8	3.8	31.4	0.5	0.2	0.0	5.0	5.2	1.4	6.2	0.3	0.3	10.1	5.0	0.8	3.7	5.0	0.7	2.4	20.8	5.4	0.0	97.9	5.3	2.2	0.2	14.3	8.0	0.0	21.6	7.5	4.6	0.7	0.9	1.3	0.0	0.3	0.0	0.0	0.2	1.1	0.0	0.0	0.2	1.1	1.2	1.0	0.3	0.0	0.1	1.2	0.1	0.0	0.0	1.6	0.0	6.0	3.9	13.4	0.0	0.2	0.9	0.2	0.0	0.0	0.0	2.4	0.0	0.6	26.3	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.1	1.2	0.0	0.2	1.4	0.9	0.0	0.6	0.5	0.7	0.7	0.6	0.5	2.8	0.4	0.3	0.1	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.3	0.0	0.8	0.5	0.2	0.0	0.3	0.0	0.2	0.7	4.9	0.0	0.6	0.7	15.2	1.5	0.5	0.1	0.0	1.2	1.3	1.3	0.1	5.7	0.1	80.9	0.0	0.1	0.3	0.1	352.1	0.2	4.1	0.3	1.7	28.8	0.0	0.0	2.1	0.4	0.0	8.2	0.0	0.5	0.0	0.2	8.9	361.1	0.1	5.0	1.1	0.0	0.0	8.1	2.6	6.7	2.5	16.6	0.0	1.9	0.0	1.4	0.0	0.5	0.1	0.2	0.0	0.4	0.1	0.5	0.0	3197.2	0.9	1.7	0.0	0.1	4.3	0.7	0.4	0.2	2.3	0.0	7.3	2.4	0.1	0.3
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 48.3;liver: 115.3;pancreas: 43.6"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 120.6"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 3.3;naive CD4 T-cell: 6.7;T-reg: 8.8"	"Lineage enriched"	"Detected in single"	16	"T-cells: 8.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.4;Hep G2: 31.1;MOLT-4: 22.5;RH-30: 18.5;RPMI-8226: 39.1;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		NA	NA		230000	Mitochondria		"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	1.0	2.2	3.6	2.5	3.3	0.9	0.8	1.8	4.0	2.3	0.6	1.0	1.8	2.1	48.3	0.6	1.9	1.3	1.6	3.1	2.9	12.2	115.3	2.7	4.1	4.2	2.7	2.9	3.1	43.6	2.1	4.1	0.9	2.9	2.3	0.4	0.6	5.3	1.8	0.6	0.4	1.3	0.9	2.6	1.3	3.0	0.7	3.7	4.3	1.6	0.3	2.4	1.1	1.0	2.8	0.0	0.1	1.4	17.4	0.1	0.5	2.3	0.1	0.7	0.9	1.1	0.3	0.2	0.0	2.4	0.3	2.2	0.1	0.0	0.3	0.7	0.0	0.3	2.5	0.0	31.1	1.9	0.1	0.3	4.2	0.0	2.0	0.1	0.4	0.2	13.1	0.1	0.4	11.1	3.2	22.5	2.4	2.8	1.7	0.2	1.6	18.5	39.1	0.0	0.1	1.7	14.7	0.0	0.4	3.9	0.8	2.4	0.2	0.1	3.3	3.0	0.3	0.0	0.3	0.0	1.3	2.1	1.4	0.1	0.3	0.1	0.1	0.3	0.0	0.8	0.0	3.3	0.8	0.0	0.3	6.7	1.2	0.5	0.1	0.0	0.3	8.8	1.4	3.6	3.3	1.8	4.0	3.1	2.9	4.2	2.7	2.9	2.9	2.6	3.7	2.8	0.1	0.0	1.9	6.8	0.4	0.3	0.4	0.0	1.2	0.1	0.2	0.8	0.8	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.8	1.2	5.7	1.5	1.1	0.1	2.3	0.0	0.3	1.3	0.8	2.9	120.6	0.1	0.0	0.7	0.0	0.0	1.6	0.6	0.8	4.7	0.2	0.0	1.9	0.0	4.2	1.0	0.5	0.3	0.1	0.0	3.0	0.7	0.3	0.0	21.3	0.0	0.3	0.0	1.6	3.5	0.1	0.8	0.0	0.1	0.0	4.2	1.6	0.0	0.2
SLC17A2	NPT3	ENSG00000112337	"Solute carrier family 17 member 2"	O00624	6	25912754-25930691	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	165	"liver: 80.2"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 30.9"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038270	Uncertain					NA	NA					"HPA038270: AB_10672511"							"prognostic favorable (8.54e-4)"						"unprognostic (1.90e-2)"		"unprognostic (4.14e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	30.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SOAT2	ACAT2	ENSG00000167780	"Sterol O-acyltransferase 2"	O75908	12	53103486-53124535	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 19.6"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 14.3"	"Group enriched"	"Detected in some"	8	"liver cancer: 5.2;testis cancer: 5.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 9.5;Hep G2: 22.6;U-266/70: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.53e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.30e-4)"	"unprognostic (3.88e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.58e-3)"	"unprognostic (3.28e-1)"	0.3	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.7	0.0	0.2	11.7	0.4	0.3	0.1	0.6	0.4	0.1	0.0	0.0	0.4	2.9	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.4	0.1	0.0	0.2	19.6	0.0	0.0	2.1	0.2	0.2	0.0	0.1	0.3	0.1	0.2	0.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	9.5	0.1	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.7	0.0	0.0	1.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.4	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.2	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.7	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	1.5	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.2	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	2.5	0.0	0.0	0.0	14.3	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.3	0.0
TRIM50	"FLJ32804, TRIM50A"	ENSG00000146755	"Tripartite motif containing 50"	Q86XT4	7	73312536-73328082	"Enzymes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"pancreas: 29.3;parathyroid gland: 33.6;stomach 1: 49.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.3;Gastric mucus-secreting cells: 17.9;Spermatocytes: 5.2;Spermatogonia: 4.2"	"Group enriched"	"Detected in some"	8	"liver cancer: 2.9;renal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"Hep G2: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA019862, HPA047843"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA019862: AB_1858305, HPA047843: AB_2680176"	"unprognostic (1.93e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.36e-7)"	"unprognostic (3.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.25e-1)"	0.5	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.2	1.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	6.6	0.3	0.1	0.0	0.0	0.0	0.0	0.2	29.3	33.6	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.9	0.0	0.0	0.4	49.1	8.7	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	17.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	5.2	4.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0
UPB1	BUP1	ENSG00000100024	"Beta-ureidopropionase 1"	Q9UBR1	22	24494107-24528390	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 217.7"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 146.5;Proximal tubular cells: 68.5"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 25.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	14	"basophil: 2.1;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	7	"CACO-2: 3.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000728, HPA076321"	Enhanced					NA	NA		1400000			"HPA000728: AB_1080471, HPA076321: "	"unprognostic (7.27e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.09e-4)"	"prognostic favorable (2.30e-7)"	"unprognostic (8.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.89e-6)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.63e-3)"	0.2	0.2	0.3	0.2	0.6	2.0	0.1	0.7	1.7	0.2	0.4	0.1	1.2	0.2	0.2	0.1	0.3	0.1	1.9	0.3	0.2	25.8	217.7	0.8	0.2	0.2	0.2	0.0	0.2	0.1	0.0	0.4	0.0	0.5	0.3	0.1	1.1	0.1	0.1	0.5	0.6	0.4	0.1	0.0	0.8	0.3	3.1	0.4	0.6	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.7	1.7	0.3	0.2	0.2	0.2	0.0	0.5	0.0	0.4	0.2	0.8	0.0	2.0	0.3	0.6	0.6	1.3	0.1	0.0	4.0	0.3	0.3	2.4	4.3	0.0	1.8	10.4	0.1	0.1	0.0	11.7	0.1	1.2	0.2	0.6	1.9	2.4	5.3	0.7	0.4	0.1	1.4	0.0	0.5	0.0	0.6	3.6	146.5	0.1	0.0	1.2	0.0	0.0	5.1	2.7	1.4	0.3	1.0	0.0	0.0	21.3	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.7	1.2	0.0	68.5	0.0	1.8	0.0	2.7	3.7	12.8	6.8	0.0	1.1	0.3	0.9	0.2	0.1	1.1
ABCA6	EST155051	ENSG00000154262	"ATP binding cassette subfamily A member 6"	Q8N139	17	69078702-69141895	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 78.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 62.5;Fibroblasts: 117.6;Hepatocytes: 110.3;Inhibitory neurons: 77.8;Leydig cells: 51.3;Microglial cells: 93.7;Theca cells: 45.4"	"Cancer enriched"	"Detected in some"	7	"liver cancer: 4.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 39.9;ASC TERT1: 56.0;HSkMC: 25.3;HUVEC TERT2: 54.8;RT4: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA064878, HPA067180"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064878: AB_2685380, HPA067180: AB_2685797"	"unprognostic (7.76e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.82e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.35e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.96e-4)"	"unprognostic (1.61e-4)"	"unprognostic (2.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.69e-1)"	21.0	5.6	1.0	2.6	5.1	0.0	16.0	4.9	3.2	9.5	3.4	6.9	2.2	6.0	2.8	6.0	11.4	10.2	14.4	1.2	10.7	3.6	78.6	11.0	5.1	10.5	3.8	0.4	30.1	2.3	1.4	2.1	2.1	8.5	2.9	4.4	0.8	9.1	2.0	5.5	6.1	5.6	3.7	6.5	1.6	5.7	1.8	5.2	1.4	8.6	11.8	3.2	14.3	9.0	20.9	0.0	0.0	0.0	0.0	39.9	56.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	25.3	0.1	3.2	0.9	1.5	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	5.1	4.9	3.2	1.2	10.7	10.5	3.8	0.4	8.5	6.5	5.2	20.9	12.5	0.0	0.0	2.9	2.0	3.1	1.5	0.4	4.0	11.6	1.8	2.2	6.0	4.3	0.9	3.7	6.2	0.0	1.7	1.8	0.0	0.5	3.3	0.7	5.1	3.2	2.4	2.7	62.5	0.2	0.0	117.6	2.0	2.5	0.0	4.0	3.3	110.3	1.6	0.0	77.8	0.7	0.0	2.5	42.1	2.7	51.3	20.3	5.4	93.7	0.7	3.2	0.0	4.5	33.4	0.4	1.1	12.0	1.2	0.1	0.5	0.9	0.7	13.3	0.0	20.0	14.3	2.0	0.9	1.4	2.8	0.0	1.2	45.4	0.3	0.5
ACSM5	FLJ20581	ENSG00000183549	"Acyl-CoA synthetase medium chain family member 5"	Q6NUN0	16	20409534-20441336	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 278.8"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 237.8"	"Group enriched"	"Detected in some"	7	"liver cancer: 20.5;renal cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 5.3;ASC TERT1: 11.5;HSkMC: 13.8;U-87 MG: 8.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041435	Uncertain		Uncertain	Vesicles		NA	NA			Vesicles		"HPA041435: AB_10961121"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.57e-1)"	25.8	2.5	6.4	0.7	4.7	0.6	10.7	4.6	4.7	2.1	2.8	2.9	0.8	1.2	7.1	1.0	1.7	2.3	2.5	5.2	6.6	25.6	278.8	2.2	1.9	7.1	5.9	3.2	0.8	0.6	1.0	0.5	1.4	6.5	0.6	1.3	0.5	0.9	0.9	14.0	2.1	2.0	1.0	6.2	4.6	3.4	0.9	7.5	0.7	4.3	1.7	0.7	1.1	2.2	8.4	0.0	0.0	0.1	0.1	5.3	11.5	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	13.8	0.0	0.8	0.1	0.2	0.0	0.0	0.1	0.5	1.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	8.5	0.1	0.0	0.1	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	6.4	4.7	4.6	4.7	5.2	6.6	7.1	5.9	3.2	6.5	6.2	7.5	8.4	0.4	0.0	0.0	1.0	0.5	0.0	0.1	0.0	0.0	0.0	0.8	0.4	3.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.5	0.5	0.0	0.3	1.2	0.0	13.5	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	6.1	237.8	3.7	0.0	0.2	0.0	0.0	11.7	1.5	0.8	9.3	3.5	0.0	7.5	1.3	0.9	0.0	1.5	0.1	0.0	0.0	6.0	0.0	0.2	0.0	52.1	0.0	0.1	0.0	11.3	0.3	0.2	0.3	0.1	0.6	0.0	0.7	0.9	0.1	0.2
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336497-99352746	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"intestine: 603.5;liver: 2078.8;stomach 1: 575.8"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 699.4;Gastric mucus-secreting cells: 611.2;Hepatocytes: 440.6;Undifferentiated cells: 420.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.1;ASC TERT1: 3.6;HSkMC: 11.9;RPMI-8226: 2.1"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		31000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	17.2	0.8	0.1	30.1	0.1	0.0	19.3	0.1	0.1	4.7	0.1	332.7	603.5	5.2	7.3	5.1	5.8	52.1	4.9	0.1	0.0	19.7	2078.8	2.9	0.6	0.1	0.1	0.1	4.0	16.8	0.1	1.6	0.1	0.1	9.5	193.6	0.0	19.4	6.3	24.1	0.7	192.2	16.4	0.1	0.7	575.8	0.8	0.0	0.5	3.0	31.3	0.5	5.9	3.6	0.1	0.0	2.1	0.0	0.0	1.4	3.6	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	1.1	0.3	11.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.8	0.2	0.0	0.1	0.1	0.8	2.1	0.8	0.0	0.3	1.1	0.5	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.3	0.1	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	2.1	3.2	7.3	0.7	1.3	0.0	4.0	0.0	25.0	0.0	0.1	0.3	1.0	64.3	24.8	29.5	0.0	0.0	0.1	108.4	0.0	159.5	2.3	1.3	0.8	1.2	21.6	29.5	0.3	699.4	0.0	21.1	611.2	1.3	0.0	0.0	13.2	440.6	0.0	0.0	0.2	86.3	0.0	13.2	0.0	1.0	10.5	0.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	66.3	120.8	0.0	0.6	3.1	59.4	1.4	43.7	0.0	0.0	1.3	2.0	0.0	0.7	10.6	0.0	0.0	1.8	1.6	420.5	3.6
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917393-134950115	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"kidney: 72.9;liver: 249.2"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 142.5;Proximal tubular cells: 136.9"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.9;Hep G2: 2.9;K-562: 3.0;RPTEC TERT1: 3.3;U-266/70: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA026292, HPA055414"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		110000	Centrosome	Nucleoplasm	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	1.0	1.3	6.6	0.7	6.4	2.4	1.2	6.8	9.8	1.2	2.5	2.4	0.8	1.3	2.1	0.8	1.0	0.9	0.7	6.9	4.2	72.9	249.2	0.9	0.6	6.0	5.7	7.9	0.5	0.9	0.4	0.8	0.5	7.2	1.7	0.8	2.8	0.8	0.8	3.7	1.7	1.1	0.9	3.4	1.3	1.2	0.5	5.6	0.7	0.7	0.3	0.6	1.9	0.9	10.1	0.1	0.5	0.8	0.5	0.2	0.1	0.6	0.2	0.2	0.0	0.5	0.2	0.3	0.1	0.2	0.0	0.1	0.6	0.6	0.0	0.4	0.6	2.9	2.0	2.1	2.9	0.3	0.8	1.0	0.8	0.9	0.2	0.4	0.6	0.2	0.8	3.0	1.1	0.1	0.0	0.9	1.0	0.2	0.2	0.3	0.0	0.2	0.2	3.3	0.4	0.8	0.2	0.1	0.0	0.5	0.2	0.3	0.2	0.2	0.2	1.6	0.6	0.8	2.8	1.0	0.5	0.3	0.7	0.2	2.5	0.3	0.3	0.4	0.1	0.1	0.4	0.4	0.2	0.0	0.4	0.3	0.3	0.8	0.8	0.1	0.4	0.5	0.3	6.6	6.4	6.8	9.8	6.9	4.2	6.0	5.7	7.9	7.2	3.4	5.6	10.1	0.3	3.2	0.6	3.6	0.8	0.0	0.2	0.2	0.0	2.6	0.7	0.9	0.6	1.5	0.7	31.3	0.0	0.2	0.3	0.1	19.6	0.2	0.1	0.4	0.4	0.7	0.0	0.0	14.3	0.0	1.7	0.4	0.0	1.6	0.0	0.5	2.5	142.5	0.1	3.3	12.9	0.1	0.0	2.5	0.3	0.0	0.0	0.8	0.0	1.0	0.7	0.3	0.0	3.0	9.6	0.0	0.1	0.0	0.3	0.1	0.0	136.9	0.0	1.8	0.0	1.2	0.5	0.0	0.0	0.0	0.4	0.0	0.9	0.5	0.2	0.1
APOL5	APOLV	ENSG00000128313	"Apolipoprotein L5"	Q9BWW9	22	35717872-35729483	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.4;tongue: 2.0"	"Cell type enhanced"	"Detected in single"		"Early spermatids: 1.1"	"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"U-698: 1.7"															NA	NA						"unprognostic (2.23e-1)"				"unprognostic (7.61e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.23e-1)"			"unprognostic (4.18e-2)"		"unprognostic (4.37e-5)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ATF5		ENSG00000169136	"Activating transcription factor 5"	Q9Y2D1	19	49928702-49933935	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"liver: 2500.3"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1412.6"	"Cancer enriched"	"Detected in all"	7	"liver cancer: 200.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 24.0;intermediate monocyte: 22.4;myeloid DC: 14.3;plasmacytoid DC: 38.5"	"Group enriched"	"Detected in all"	9	"dendritic cells: 38.5;monocytes: 24.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 313.2;Karpas-707: 523.4;THP-1: 452.4;U-266/84: 715.6;U-698: 316.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030187	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030187: AB_10601666"	"unprognostic (2.09e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (9.38e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (3.39e-7)"	"unprognostic (3.06e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"	38.0	61.9	13.1	32.0	11.5	21.6	35.9	10.4	15.3	15.0	9.3	17.9	28.6	16.3	9.9	18.1	23.1	14.5	16.7	12.0	12.6	26.1	2500.3	17.2	23.5	14.6	12.7	9.3	14.2	29.4	10.1	14.8	12.4	14.6	23.4	10.4	12.6	21.3	10.4	30.8	17.7	23.4	10.3	12.9	27.5	24.7	44.7	12.3	13.2	119.7	9.6	20.2	24.6	14.4	14.9	68.5	47.3	17.8	12.0	18.3	15.5	17.8	48.6	40.8	49.4	30.2	35.7	36.5	60.7	24.3	28.6	34.0	24.2	22.7	20.0	23.5	313.2	22.6	41.7	14.8	27.4	12.5	162.7	113.6	108.3	31.5	36.5	8.5	12.2	21.4	132.6	38.1	523.4	24.7	64.3	23.5	35.9	8.8	18.6	62.6	194.2	19.1	24.9	56.6	90.9	28.2	20.1	113.2	47.8	34.9	6.6	39.2	452.4	36.6	95.5	61.3	11.3	49.8	13.8	715.6	316.2	75.1	63.6	36.4	0.4	24.0	1.0	1.4	22.4	2.0	1.6	1.4	1.7	14.3	0.8	1.2	1.8	3.6	3.2	6.0	38.5	1.9	4.7	13.1	11.5	10.4	15.3	12.0	12.6	14.6	12.7	9.3	14.6	12.9	12.3	14.9	16.3	12.8	11.9	2.6	41.7	22.6	12.3	11.1	39.9	3.8	31.9	29.3	7.4	38.6	9.4	16.5	6.2	33.9	23.5	22.0	13.7	13.1	260.8	36.5	17.4	21.1	21.5	64.2	1.2	29.8	19.4	27.3	34.1	35.3	6.3	27.1	40.0	1412.6	82.5	92.5	1.8	21.0	2.0	59.4	172.3	134.3	13.4	51.2	40.9	2.8	259.9	17.4	8.2	0.5	1.6	20.0	20.6	16.6	118.1	24.8	49.0	47.9	9.6	7.5	13.1	18.0	24.2	15.0	11.3	37.7	24.0	35.6	15.1	23.4	23.4	18.4
C4BPA	C4BP	ENSG00000123838	"Complement component 4 binding protein alpha"	P04003	1	207104233-207144972	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 1934.6"	"Group enriched"	"Detected in many"	14	"Alveolar cells type 1: 493.6;Alveolar cells type 2: 660.8;Hepatocytes: 1020.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 434.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	137	"neutrophil: 29.5"	"Lineage enriched"	"Detected in single"	137	"granulocytes: 29.5"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 37.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000926, HPA001578"	Enhanced				"Secreted to blood"	NA	NA	30800000000	28000000000			"HPA000926: AB_1078355, HPA001578: AB_1078354"	"unprognostic (3.85e-4)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (6.37e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.51e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-1)"	0.6	0.7	0.3	2.5	0.2	0.1	4.6	0.7	0.2	6.4	0.0	1.7	0.0	4.5	0.0	0.1	1.0	3.2	0.1	0.1	0.3	0.6	1934.6	174.8	0.3	0.4	0.3	0.0	1.5	9.7	0.3	0.1	0.8	0.5	0.1	0.8	0.0	1.1	0.0	0.0	0.0	0.8	0.1	0.1	1.2	0.4	0.3	0.2	0.0	0.1	0.0	1.1	0.1	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	37.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	7.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.7	0.2	0.1	0.3	0.4	0.3	0.0	0.5	0.1	0.2	0.4	0.0	493.6	660.8	0.0	3.7	0.0	0.0	0.2	0.0	0.0	2.7	0.4	0.2	41.5	22.5	0.0	0.0	0.0	0.0	3.2	0.0	11.2	0.3	18.0	7.6	1.9	0.0	21.5	0.7	18.7	0.0	1.1	0.0	48.8	3.8	0.0	22.1	1020.8	0.2	0.0	1.4	0.3	0.0	39.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	5.6	32.0	0.0	0.0	0.3	0.1	0.1	3.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	3.9	16.7	0.2	1.4
C6		ENSG00000039537	"Complement C6"	P13671	5	41142116-41261438	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"liver: 671.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 127.2;Hepatocytes: 376.9;Late spermatids: 54.8;Leydig cells: 120.2;Respiratory ciliated cells: 58.0"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"ASC diff: 4.5;ASC TERT1: 6.2;HSkMC: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"	NA	NA	45000000000	9200000000			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	12.9	1.1	0.2	0.0	0.3	0.0	5.4	0.3	0.3	0.6	1.5	0.8	0.9	0.4	0.9	0.3	44.2	12.1	45.4	0.2	1.0	4.3	671.4	3.2	0.4	0.0	1.0	0.1	6.2	43.1	0.1	0.7	2.8	0.5	0.9	0.6	0.0	0.9	0.6	0.6	0.5	1.4	0.9	0.1	0.3	2.2	4.2	1.2	0.6	2.0	0.7	0.5	0.9	0.6	0.7	0.0	0.0	0.0	0.0	4.5	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.2	1.0	0.0	1.0	0.1	0.5	0.1	1.2	0.7	0.8	0.0	0.0	0.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.9	127.2	7.5	0.0	0.0	0.0	0.1	0.3	0.0	9.3	11.3	37.5	0.8	0.9	0.0	8.0	1.4	0.4	0.0	6.7	0.0	0.7	0.0	0.1	5.0	376.9	0.0	0.0	2.7	1.0	0.0	9.7	0.3	54.8	120.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.5	1.3	0.4	0.0	0.0	11.6	0.8	58.0	0.0	0.0	0.2	0.4	0.4	0.1	0.0	0.0	0.0	0.4	0.5	0.6	0.0
CTXND1	LINC01314	ENSG00000259417	"Cortexin domain containing 1"	A0A1B0GTU2	15	80195481-80252213	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 31.5;liver: 9.4"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 6.3;Proximal tubular cells: 14.0"	"Group enriched"	"Detected in many"	7	"glioma: 3.4;liver cancer: 2.7;melanoma: 9.1;thyroid cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 1.6;WM-115: 4.7"	"Region enriched"	"Detected in all"	4	"hippocampal formation: 35.0"											NA	NA						"unprognostic (4.15e-5)"	"unprognostic (8.42e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.59e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.34e-1)"	0.2	3.7	11.1	0.2	7.5	0.0	0.2	5.3	14.4	0.3	2.8	0.7	0.4	0.1	5.4	0.1	0.3	0.1	2.7	31.5	12.5	2.2	9.4	1.6	0.2	7.2	9.4	6.5	0.4	0.5	0.0	1.4	0.0	8.7	0.3	0.3	1.4	0.1	0.1	0.5	0.8	0.5	0.0	5.1	1.4	2.6	0.4	12.2	0.0	0.4	0.1	0.2	0.5	0.3	6.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	7.5	5.3	14.4	31.5	12.5	7.2	9.4	6.5	8.7	5.1	12.2	6.7	0.0	0.0	6.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	1.9	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CYP4F22	FLJ39501	ENSG00000171954	"Cytochrome P450 family 4 subfamily F member 22"	Q6NT55	19	15508525-15552317	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	Ichthyosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 19.0;skin 1: 55.3;vagina: 23.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 8.8;Breast myoepithelial cells: 5.5;granulocytes: 7.0;Prostatic glandular cells: 4.0;Suprabasal keratinocytes: 3.0"	"Group enriched"	"Detected in many"	7	"breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 6.1;MAIT T-cell: 4.3;non-classical monocyte: 14.1"	"Group enriched"	"Detected in many"	8	"monocytes: 14.1;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.7;T-47d: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058960	Uncertain					NA	NA					"HPA058960: AB_2683862"	"unprognostic (2.32e-3)"	"unprognostic (1.17e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.21e-5)"	"unprognostic (8.10e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.03e-2)"	0.9	0.0	0.0	0.0	0.0	0.1	3.7	0.0	0.0	5.1	0.0	0.0	0.2	0.3	0.0	19.0	0.1	0.1	0.0	0.0	0.0	0.0	7.0	0.3	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	8.5	0.0	0.0	3.2	6.4	0.2	55.3	0.1	0.0	0.0	0.3	1.4	1.0	0.0	0.1	0.0	0.0	1.8	6.3	23.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	6.1	4.3	0.0	0.5	1.5	0.2	0.0	0.0	0.4	0.0	1.1	14.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	8.8	5.5	0.4	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.0	7.0	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.4	0.0	0.3	0.0	0.0	0.5	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	4.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.8	0.0	3.0	0.0	1.8	0.0	0.0	0.3
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	11	"kidney: 145.7;liver: 347.3"	"Group enriched"	"Detected in many"	10	"Hepatocytes: 289.0;Proximal tubular cells: 147.1"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA					"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	10.9	4.3	2.1	3.0	2.9	1.2	4.2	4.1	2.7	3.6	8.0	14.3	21.7	2.8	3.5	5.6	3.6	4.5	10.8	2.1	3.8	145.7	347.3	4.4	2.1	3.1	3.7	1.7	2.7	10.0	7.8	1.5	3.2	2.9	6.3	10.9	1.6	5.8	2.2	1.7	4.6	13.0	3.7	2.5	3.7	10.5	2.8	3.2	2.1	6.5	5.7	2.9	3.6	2.1	3.0	12.3	5.0	1.4	0.0	7.3	6.1	1.5	5.7	1.8	3.7	4.1	21.9	7.5	0.0	22.1	5.7	1.4	5.8	0.0	4.8	7.6	16.2	5.2	8.6	1.3	22.5	4.7	1.0	0.2	8.7	6.0	3.7	3.4	5.0	5.5	0.0	5.7	6.1	7.2	6.4	0.2	5.1	3.0	4.3	6.3	0.0	9.9	0.5	15.4	6.8	4.4	6.4	11.2	6.4	10.5	12.1	23.7	10.1	2.6	2.4	3.6	1.9	0.5	1.7	5.6	0.5	0.8	3.9	4.0	0.1	0.9	0.0	0.6	0.8	0.4	0.5	0.4	0.9	2.4	0.0	0.6	1.0	0.0	1.2	0.8	1.0	0.6	0.4	2.1	2.9	4.1	2.7	2.1	3.8	3.1	3.7	1.7	2.9	2.5	3.2	3.0	4.9	16.0	10.9	20.9	4.5	1.5	1.4	1.9	1.2	0.7	3.2	2.3	19.2	17.2	3.9	20.2	4.2	8.9	0.4	17.8	19.6	2.1	0.2	6.5	5.1	3.9	7.7	9.7	4.9	6.8	2.9	1.6	8.6	3.1	0.0	6.1	13.6	289.0	4.4	0.0	5.7	12.8	0.0	10.5	1.0	0.7	0.6	2.7	3.6	4.7	9.4	1.9	0.0	3.5	8.0	3.7	9.3	0.4	0.8	2.5	15.0	147.1	4.0	1.2	0.0	1.1	2.4	3.7	4.2	4.9	0.4	1.4	2.2	3.6	10.8	1.8
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169511951-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"choroid plexus: 116.7;liver: 177.6;placenta: 47.3"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Cytotrophoblasts: 82.7;Hepatocytes: 253.4;Syncytiotrophoblasts: 59.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.1;eosinophil: 8.1;neutrophil: 7.0;T-reg: 6.2"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.1;monocytes: 4.1;T-cells: 6.2"	"Group enriched"	"Detected in some"	23	"Hep G2: 32.8;OE19: 125.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.7;hippocampal formation: 6.6;pons and medulla: 4.4;thalamus: 5.4"	"Group enriched"	"Detected in all"	7	"amygdala: 39.9;basal ganglia: 35.0;cerebral cortex: 67.9;hippocampal formation: 61.4;olfactory bulb: 27.6"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7670000000	13000000000	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.0	0.8	3.2	1.3	3.7	0.6	4.9	2.4	0.1	116.7	0.3	0.9	0.1	0.2	0.2	3.5	17.8	2.4	4.7	5.0	1.5	177.6	0.9	2.2	1.7	2.9	0.1	0.0	0.8	0.0	1.6	47.3	3.2	1.3	0.6	1.0	6.2	0.0	0.2	1.1	0.3	1.1	0.8	1.8	4.9	0.5	1.9	0.5	0.4	0.2	2.4	3.8	0.1	4.3	0.0	0.6	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.2	1.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	32.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	125.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	4.1	8.1	0.0	0.2	0.0	0.0	1.4	0.2	0.4	0.0	0.3	0.0	7.0	0.0	0.0	0.0	6.2	1.1	0.8	1.3	4.9	2.4	4.7	5.0	1.7	2.9	0.1	3.2	0.8	1.9	4.3	0.0	3.2	0.6	1.6	0.7	0.1	6.1	0.0	0.0	0.3	0.7	0.3	9.4	74.4	1.9	0.0	2.1	82.7	0.1	0.3	0.0	2.4	2.4	0.9	0.0	2.4	25.2	0.0	5.4	0.2	2.3	5.3	4.1	0.2	0.0	2.8	3.6	253.4	5.3	0.0	2.6	0.1	0.0	12.3	0.4	0.3	0.0	7.1	3.6	0.0	18.2	1.0	2.1	0.5	1.0	1.9	0.0	0.0	0.1	1.8	0.0	0.2	3.1	0.1	0.0	2.4	0.2	0.5	0.5	0.0	0.0	59.5	2.5	0.0	0.0	11.8
FMO5		ENSG00000131781	"Flavin containing dimethylaniline monoxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 688.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 64.2;Cholangiocytes: 133.0;Hepatocytes: 265.4;Proximal enterocytes: 108.8;Proximal tubular cells: 69.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	3.1	5.8	2.9	5.2	3.5	2.0	46.6	4.3	4.1	7.9	1.0	41.7	71.9	2.8	6.9	1.2	3.6	16.0	2.2	2.5	3.5	52.0	688.9	27.4	4.0	4.7	4.9	2.0	4.1	48.5	68.9	6.8	2.4	5.4	9.8	47.0	0.9	33.0	4.1	0.8	11.3	74.5	3.6	3.7	4.1	121.0	5.3	3.5	1.1	2.0	1.4	2.5	3.9	1.5	6.2	0.1	1.1	0.6	0.1	2.8	0.8	0.9	0.7	0.5	0.3	0.8	0.7	2.4	0.4	0.8	0.8	0.2	0.4	0.0	0.0	0.0	1.4	0.2	1.6	0.1	41.7	0.9	1.4	9.0	1.3	0.2	0.4	0.0	0.4	0.6	0.2	0.1	0.1	1.5	1.4	0.2	0.7	2.8	5.3	0.8	0.4	0.5	0.4	3.4	0.6	0.5	0.3	0.9	2.8	1.3	1.3	2.1	10.4	1.1	0.0	0.3	0.9	0.0	0.3	0.0	0.3	1.1	0.5	0.3	7.0	12.9	4.1	2.0	5.9	0.3	4.7	0.5	0.6	5.4	8.5	0.3	1.3	1.3	1.2	1.8	2.5	1.6	3.9	2.9	3.5	4.3	4.1	2.5	3.5	4.7	4.9	2.0	5.4	3.7	3.5	6.2	2.8	9.6	64.2	11.1	6.4	1.7	3.9	0.9	1.8	2.0	17.5	6.7	1.9	133.0	10.4	14.7	0.0	1.5	1.7	60.8	7.9	7.5	7.7	2.5	1.8	2.7	6.7	4.8	8.2	5.9	1.1	2.9	24.5	6.1	5.7	9.8	5.0	265.4	4.0	3.3	6.4	34.4	4.1	10.0	2.3	4.5	2.8	4.6	28.4	10.3	5.3	0.2	4.1	10.1	17.5	7.0	29.0	1.5	0.4	5.6	108.8	69.2	18.1	1.3	0.0	2.2	1.0	5.9	0.9	1.3	1.6	1.4	2.6	6.6	20.7	6.4
FNDC5	FRCP2	ENSG00000160097	"Fibronectin type III domain containing 5"	Q8NAU1	1	32862268-32872482	"Predicted membrane proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"skeletal muscle: 326.1;tongue: 482.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 71.3;Cardiomyocytes: 64.9;Early spermatids: 28.1;Granulosa cells: 38.6;Muller glia cells: 44.1"	"Group enriched"	"Detected in many"	7	"glioma: 4.2;liver cancer: 10.0;testis cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RH-30: 48.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051290	Enhanced				"Intracellular and membrane"	NA	NA					"HPA051290: AB_2681422"	"unprognostic (4.36e-2)"	"unprognostic (9.08e-3)"	"unprognostic (7.62e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.07e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.33e-2)"	1.3	12.9	9.5	0.1	4.4	0.2	0.8	20.5	9.7	1.2	36.9	1.1	0.8	3.3	2.4	11.7	4.2	1.8	42.6	6.2	13.6	0.7	18.5	1.1	0.2	8.0	14.5	2.5	4.7	0.5	10.5	5.3	0.5	8.1	3.7	0.5	8.1	25.8	1.1	326.1	0.4	1.3	2.0	3.7	0.2	5.2	2.8	30.8	0.6	1.2	482.6	0.1	1.2	0.8	6.6	0.0	0.1	1.1	0.4	0.0	1.2	0.2	0.5	0.1	0.7	0.1	0.9	0.3	0.2	0.8	0.4	0.2	0.1	4.7	0.1	0.1	0.1	0.3	0.1	0.4	0.2	0.0	0.2	0.0	1.8	0.0	0.3	0.0	0.6	0.0	0.2	0.9	0.1	0.8	0.1	0.1	0.1	1.4	0.0	0.1	0.6	48.2	0.3	0.0	0.1	6.9	1.1	0.5	0.0	0.0	0.5	0.2	0.1	0.2	0.1	0.8	2.2	0.4	0.2	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	4.4	20.5	9.7	6.2	13.6	8.0	14.5	2.5	8.1	3.7	30.8	6.6	1.1	0.0	0.0	7.5	0.0	0.1	0.2	0.0	0.0	71.3	0.6	0.5	64.9	0.0	0.0	1.8	4.2	0.0	0.0	0.0	1.9	0.0	28.1	0.3	4.6	1.4	0.0	0.0	10.3	0.0	0.0	14.5	0.0	0.5	0.0	38.6	0.7	2.0	0.9	0.0	15.8	0.1	0.0	0.0	0.5	5.9	5.3	0.8	0.0	5.6	0.0	44.1	0.0	3.0	0.7	0.1	0.0	5.7	0.0	0.2	0.1	0.2	0.0	7.4	0.0	12.9	1.7	0.5	1.0	0.0	0.0	0.3	0.2	0.5	0.5	0.1
GPT	"ALT1, GPT1"	ENSG00000167701	"Glutamic--pyruvic transaminase"	P24298	8	144502973-144507174	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 181.1;skeletal muscle: 50.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 176.9;Hepatocytes: 237.3;Paneth cells: 88.4;Proximal enterocytes: 139.7;Proximal tubular cells: 164.9"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 38.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;Karpas-707: 2.8;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031059, HPA031060, CAB032997, CAB032999"	Enhanced					NA	NA		17000000			"CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.22e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-2)"	18.8	2.4	2.0	4.7	1.3	2.3	12.6	2.5	4.7	0.7	2.6	20.4	18.5	0.5	0.4	2.4	1.3	2.4	26.7	1.9	0.2	14.1	181.1	0.4	0.3	1.0	0.3	1.7	1.1	10.4	1.4	2.9	0.1	1.9	1.8	5.9	0.6	14.7	1.3	50.6	14.7	18.1	0.4	0.1	0.7	15.2	2.7	0.6	0.0	0.9	24.5	0.2	0.6	1.3	1.1	0.2	0.8	0.2	0.5	0.4	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.9	0.4	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.7	1.3	0.3	1.5	2.5	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.2	2.8	0.0	1.3	0.4	0.4	0.3	0.6	0.5	0.5	0.1	1.5	0.0	0.9	0.5	0.8	0.2	0.7	0.1	0.1	1.9	0.1	0.2	0.1	0.6	0.7	0.1	2.9	0.2	0.2	0.4	0.9	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.0	1.3	2.5	4.7	1.9	0.2	1.0	0.3	1.7	1.9	0.1	0.6	1.1	0.2	0.0	0.0	14.4	5.3	1.7	1.3	1.2	0.6	0.9	14.1	4.6	8.5	34.3	1.8	7.3	0.0	0.0	0.4	176.9	21.5	1.1	16.5	0.5	0.4	1.1	2.4	43.2	0.8	2.4	3.3	0.3	51.0	0.7	8.9	0.3	14.3	237.3	0.1	3.3	0.5	30.4	0.0	14.4	2.1	48.1	0.6	1.2	1.8	1.0	0.1	15.6	0.0	2.0	0.0	1.3	88.4	0.4	0.1	1.2	139.7	164.9	0.5	2.0	0.0	2.0	0.4	1.0	0.6	2.4	4.5	0.0	1.8	0.4	62.1	1.6
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100762	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"intestine: 122.2;kidney: 105.4;liver: 182.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 428.5;Proximal enterocytes: 1858.7;Proximal tubular cells: 1019.7"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 32.8;Hep G2: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Vesicles,Cytosol		NA	NA		620000	Cytosol	Vesicles	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	2.2	4.6	3.8	3.1	4.0	1.7	2.0	6.9	5.9	2.5	1.1	4.2	113.4	3.8	0.7	2.4	4.3	1.3	1.4	4.6	4.0	105.4	182.0	1.6	1.9	5.0	3.8	4.3	3.7	9.5	2.6	1.4	0.6	5.3	1.6	1.2	1.5	4.4	1.4	3.9	2.4	122.2	1.9	3.4	2.0	2.9	3.2	3.8	0.7	1.1	2.0	1.2	1.8	2.4	4.6	25.0	18.5	2.8	11.0	2.0	0.5	2.5	1.7	1.1	2.3	1.4	9.0	5.3	3.7	5.8	0.1	2.6	10.7	9.4	3.1	0.8	8.8	17.2	32.8	5.2	48.0	1.1	4.6	3.7	0.1	1.3	2.7	0.2	1.2	2.1	5.1	5.9	6.1	0.2	16.0	5.4	3.6	4.0	22.3	7.2	18.9	1.4	20.9	2.7	3.0	10.2	15.8	3.6	6.2	6.9	1.0	2.7	2.0	1.9	0.7	3.6	1.6	6.5	7.5	14.4	6.3	3.0	10.7	1.8	0.0	5.4	0.3	4.1	3.1	5.5	3.8	6.6	6.0	4.9	3.6	4.7	5.8	0.5	4.9	1.4	6.1	4.7	4.9	3.8	4.0	6.9	5.9	4.6	4.0	5.0	3.8	4.3	5.3	3.4	3.8	4.6	6.5	3.2	3.7	1.6	6.8	3.6	2.6	0.8	6.8	3.6	4.7	5.8	1.8	20.0	1.0	40.5	2.1	4.1	1.3	7.4	129.1	3.2	1.2	0.1	0.6	5.5	6.0	15.6	3.4	3.0	3.6	2.4	3.6	0.3	4.5	2.9	9.7	428.5	8.3	6.7	2.7	89.6	4.1	11.9	2.0	6.2	1.8	10.8	8.8	0.0	1.9	9.8	4.1	2.5	2.3	2.1	95.7	1.5	8.0	0.7	1858.7	1019.7	0.0	5.4	0.0	5.0	5.0	1.1	5.8	4.6	6.8	9.4	6.8	0.8	82.6	2.2
LEPR	"CD295, OBR"	ENSG00000116678	"Leptin receptor"	P48357	1	65420652-65641559	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 131.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 97.7;Endothelial cells: 80.5;Fibroblasts: 94.2;Hepatocytes: 175.2;Langerhans cells: 66.6;Microglial cells: 129.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 13.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"K-562: 114.7;RPTEC TERT1: 52.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030899	Approved	Supported			"Intracellular and membrane"	NA	NA	8240000	14000000			"HPA030899: AB_10610003"	"unprognostic (1.59e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.73e-1)"	24.5	7.3	5.3	3.9	5.2	5.0	20.8	4.9	6.8	21.7	23.8	6.0	4.0	24.9	6.7	9.3	16.2	14.8	7.0	5.3	9.8	7.9	131.5	22.7	9.6	5.1	5.1	3.9	25.2	3.0	2.9	11.8	5.4	5.1	9.1	5.1	2.5	12.0	7.3	2.1	15.2	5.7	18.9	6.1	3.3	13.8	4.0	7.0	4.7	10.5	32.4	5.8	9.2	4.8	6.7	3.3	2.0	2.6	2.9	11.5	10.6	9.0	14.2	8.1	4.8	4.5	1.5	7.6	1.4	10.1	18.0	1.3	2.7	2.2	12.3	12.7	17.2	3.7	18.8	7.9	0.3	7.0	1.4	1.6	29.7	6.8	2.9	10.8	36.2	13.9	1.4	114.7	2.2	22.5	0.9	1.4	0.4	4.2	2.0	0.2	0.4	2.2	0.8	52.3	1.4	1.6	26.3	3.5	1.5	4.0	14.9	5.0	5.0	5.3	4.9	10.0	1.1	7.8	3.0	2.2	0.5	10.2	5.3	4.8	4.5	0.8	1.2	0.5	0.6	0.4	0.2	0.4	0.4	0.7	0.1	0.3	0.5	0.4	0.4	0.7	0.5	1.0	0.7	5.3	5.2	4.9	6.8	5.3	9.8	5.1	5.1	3.9	5.1	6.1	7.0	6.7	97.7	0.0	11.3	47.0	2.6	35.3	1.9	3.3	2.2	4.0	3.1	3.3	6.6	11.5	4.2	9.2	0.0	1.6	1.6	0.5	3.9	1.5	1.1	2.0	4.4	80.5	0.0	10.3	20.9	1.1	2.6	94.2	2.6	12.8	1.3	2.6	52.5	175.2	2.0	1.7	21.8	0.8	2.0	6.3	66.6	2.3	34.5	6.1	35.6	129.3	3.4	0.4	2.1	29.1	24.5	1.7	1.9	7.5	2.4	7.5	0.7	6.4	2.6	1.0	0.0	41.1	10.3	1.1	1.2	4.1	29.5	2.6	4.7	3.3	0.8	2.1
MCHR1	"GPR24, MCH1R, SLC1"	ENSG00000128285	"Melanin concentrating hormone receptor 1"	Q99705	22	40678750-40682814	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8;endometrium 1: 3.6"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.7;Hepatic stellate cells: 2.2;Inhibitory neurons: 4.3;Leydig cells: 2.8;Melanocytes: 8.8;Microglial cells: 2.8;Oligodendrocyte precursor cells: 2.0"	"Group enriched"	"Detected in some"	7	"glioma: 4.9;liver cancer: 1.5;melanoma: 3.1;renal cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;RH-30: 1.6;SuSa: 4.7;T-47d: 1.4;U-87 MG: 1.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 22.9"							NA	NA						"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.84e-3)"	"unprognostic (4.92e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (1.49e-6)"	"unprognostic (3.07e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.91e-2)"	0.2	0.1	1.6	0.3	2.7	0.0	0.1	2.0	3.8	0.4	0.5	0.1	0.1	3.6	0.4	0.0	0.7	0.0	1.2	2.5	2.9	0.0	1.3	0.2	0.2	1.7	1.6	2.2	2.4	0.0	0.0	2.2	0.0	2.2	0.0	0.0	1.2	0.1	0.0	0.1	0.5	0.1	0.7	1.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.1	0.2	0.1	2.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.7	2.0	3.8	2.5	2.9	1.7	1.6	2.2	2.2	1.0	1.9	2.4	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.1	0.0	0.4	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.2	1.2	0.1	0.0	4.3	0.0	0.0	0.0	0.3	0.0	2.8	0.0	8.8	2.8	0.0	1.6	0.0	2.0	0.6	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MST1	"D3F15S2, DNF15S2, HGFL, MSP, NF15S2"	ENSG00000173531	"Macrophage stimulating 1"		3	49683947-49689501	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in all"	10	"liver: 935.5"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 362.8"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 42.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 84.6;NB-4: 17.3;U-266/70: 21.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024036	Approved				"Secreted to blood"	NA	NA					"HPA024036: AB_1854147"	"unprognostic (5.13e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.42e-3)"	"unprognostic (8.24e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	16.7	28.2	11.2	1.1	11.2	6.3	8.2	11.7	13.0	10.7	11.0	4.7	51.0	8.9	11.4	7.4	10.6	7.5	4.6	11.0	11.9	95.4	935.5	5.9	3.7	11.2	11.3	11.1	12.6	16.6	9.5	29.5	5.9	11.3	13.0	2.1	5.3	8.1	5.2	3.6	15.0	31.4	2.2	11.2	14.0	8.8	35.1	11.1	2.2	36.7	2.9	1.7	6.1	6.9	11.2	0.2	0.4	1.2	2.0	3.7	7.6	3.7	1.1	1.4	0.6	0.8	3.9	1.2	0.3	2.6	1.3	0.5	0.8	0.6	1.5	0.6	1.3	0.7	0.6	2.6	84.6	5.8	0.0	1.6	10.2	2.6	0.7	2.1	14.1	1.4	3.5	0.7	9.9	1.9	0.6	0.5	17.3	0.2	1.1	1.0	0.4	0.5	2.2	4.2	0.6	0.2	2.8	0.0	1.6	0.4	2.5	1.5	5.7	0.9	1.9	0.6	0.1	0.2	21.8	2.9	0.5	2.2	3.2	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.2	11.2	11.7	13.0	11.0	11.9	11.2	11.3	11.1	11.3	11.2	11.1	11.2	3.1	6.4	3.9	10.1	3.5	2.9	4.6	5.8	6.8	8.2	6.1	10.2	2.2	45.8	5.4	27.6	8.4	4.8	1.0	5.1	62.6	6.9	7.6	2.3	3.5	3.4	8.3	29.7	1.1	3.9	19.7	5.2	9.2	3.2	1.3	36.9	10.0	362.8	1.4	1.7	2.0	8.9	6.1	10.7	1.4	2.6	3.1	1.2	3.6	2.8	0.1	8.9	0.0	3.0	2.9	2.1	7.2	1.9	1.6	1.3	57.0	61.9	6.7	6.9	0.0	2.3	10.9	21.8	9.2	2.6	4.7	5.1	2.1	22.8	13.7	3.4
NEU4		ENSG00000204099	"Neuraminidase 4"	Q8WWR8	2	241809065-241817413	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 76.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 74.6;Enteroendocrine cells: 34.4;Hepatocytes: 124.4;Intestinal goblet cells: 38.5;Oligodendrocyte precursor cells: 50.3;Paneth cells: 58.0;Proximal enterocytes: 76.0;Undifferentiated cells: 38.4"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"Hep G2: 57.7;HMC-1: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037394	Enhanced					NA	NA					"HPA037394: AB_2675455"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.68e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.70e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.11e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.55e-2)"	0.6	0.2	2.2	0.1	2.0	3.5	0.2	1.8	4.4	0.3	0.2	9.1	10.8	0.2	0.0	0.0	0.7	0.4	0.3	1.6	2.0	1.5	76.4	0.4	0.0	4.5	2.3	1.2	0.3	0.1	0.0	1.1	0.0	2.3	0.4	2.2	0.1	0.8	0.0	9.1	0.1	9.2	0.0	2.3	0.3	0.1	0.7	2.3	0.0	0.3	0.8	0.0	0.1	0.1	3.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	57.7	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.0	1.8	4.4	1.6	2.0	4.5	2.3	1.2	2.3	2.3	2.3	3.0	0.2	0.0	0.0	1.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.6	1.5	0.7	1.8	0.0	0.0	1.1	74.6	3.9	0.0	0.1	0.0	0.1	0.3	34.4	0.0	0.4	0.0	0.0	0.2	0.5	0.0	1.3	0.1	1.1	124.4	1.5	0.0	0.4	38.5	2.0	4.2	0.7	0.2	0.6	4.0	0.0	0.0	0.0	26.2	0.0	50.3	0.1	0.0	58.0	0.7	0.4	0.0	76.0	23.6	0.2	1.3	0.0	3.6	0.4	0.5	0.5	0.0	0.0	0.0	1.3	0.0	38.4	0.1
ONECUT1	"HNF-6, HNF6, HNF6A"	ENSG00000169856	"One cut homeobox 1"	Q9UBC0	15	52755053-52791078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 6.0;liver: 13.0;pancreas: 13.7;retina: 4.7"	"Cell type enriched"	"Detected in some"	16	"Horizontal cells: 647.8"	"Group enriched"	"Detected in some"	7	"liver cancer: 2.9;pancreatic cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.8;Hep G2: 1.4;MCF7: 1.3;NTERA-2: 1.8;SuSa: 1.9;WM-115: 1.2"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.0"	"Low region specificity"	"Detected in many"			HPA003457	Enhanced					NA	NA					"HPA003457: AB_1079525"		"unprognostic (5.12e-2)"		"unprognostic (2.45e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.82e-2)"	"unprognostic (9.19e-2)"	"unprognostic (7.05e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.03e-1)"		"unprognostic (1.70e-7)"	"unprognostic (9.76e-3)"	"unprognostic (2.11e-1)"		"unprognostic (1.17e-1)"	0.0	0.0	1.0	0.0	0.7	0.5	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.4	1.0	0.0	13.0	0.0	0.0	1.8	1.9	0.1	0.0	13.7	0.0	0.0	0.0	1.8	0.0	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	1.8	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.3	0.0	0.0	1.8	0.1	0.1	0.3	0.0	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.2	1.9	0.3	0.0	0.0	0.6	0.8	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.4	0.3	0.4	1.0	1.8	1.9	0.1	1.8	0.7	0.7	1.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	1.3	40.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	21.1	1.4	0.1	0.0	0.3	0.0	0.0	0.4	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	647.8	0.2	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	15.6	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.2	3.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ONECUT2	OC-2	ENSG00000119547	"One cut homeobox 2"	O95948	18	57435374-57491298	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.1;gallbladder: 10.2;intestine: 10.2;liver: 8.5;retina: 5.5"	"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 964.0"	"Group enriched"	"Detected in many"	7	"liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 7.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.3;HeLa: 14.1;RT4: 6.7;SCLC-21H: 10.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.7;cerebellum: 4.7;cerebral cortex: 5.6;hippocampal formation: 3.2;hypothalamus: 2.5"	HPA057058	Enhanced		Supported	"Nucleoplasm,Actin filaments"		NA	NA			Nucleoplasm	"Actin filaments"	"HPA057058: AB_2683323"	"unprognostic (3.02e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.79e-5)"	"unprognostic (1.13e-2)"	"unprognostic (4.48e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.56e-3)"	"unprognostic (8.66e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.21e-1)"	0.0	0.1	0.2	0.0	7.1	0.0	0.0	0.6	1.9	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	10.2	0.0	0.3	4.2	0.0	8.5	0.0	0.0	2.2	0.3	0.1	0.0	2.4	0.8	0.8	0.0	2.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.0	1.2	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	1.4	0.0	3.4	0.0	0.1	20.3	3.1	0.7	14.1	3.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	2.3	4.0	0.7	0.0	0.5	1.9	0.0	0.1	1.6	0.7	0.0	1.2	0.0	1.6	6.7	10.1	1.7	0.1	0.0	0.2	0.1	0.5	0.7	0.0	1.0	1.3	0.2	0.2	0.3	3.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.1	0.6	1.9	0.3	4.2	2.2	0.3	0.1	2.0	0.0	1.0	0.3	0.3	0.0	0.0	2.3	0.0	0.1	0.2	0.0	0.0	4.5	0.4	1.1	2.8	184.5	0.0	7.3	14.6	0.0	0.0	2.0	0.0	79.7	4.9	0.2	0.1	0.5	8.9	0.0	38.7	8.8	0.1	0.3	0.0	0.3	0.0	0.5	5.3	47.0	1.0	964.0	1.8	0.6	0.0	1.3	0.0	3.2	0.3	0.1	0.0	1.0	0.0	3.0	0.0	3.5	1.0	38.7	3.3	0.0	0.0	0.4	0.1	0.1	0.0	5.6	0.0	0.9	0.7	1.9	2.0	0.0	0.1	0.0	0.1	0.2	0.5	0.0
PLGLB1	"PLGL, PRP-B"	ENSG00000183281	"Plasminogen like B1"	Q02325	2	87002559-87021852	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Tissue enriched"	"Detected in all"	6	"liver: 236.8"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 95.9"	"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"																"Secreted to blood"	NA	NA						"unprognostic (7.25e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-5)"	"unprognostic (7.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-4)"	"unprognostic (9.90e-3)"	"unprognostic (2.96e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.98e-5)"	3.5	5.5	20.4	4.6	21.2	8.6	3.6	32.9	26.7	6.4	21.5	4.5	3.9	6.0	8.2	4.0	4.4	4.8	4.8	20.4	19.7	6.1	236.8	3.3	8.0	18.4	19.3	21.6	6.7	4.1	2.3	9.6	2.3	23.0	6.6	2.7	42.8	4.9	3.2	8.9	14.3	5.4	2.4	15.8	9.5	4.0	4.3	19.6	7.3	5.7	4.4	4.3	4.9	4.9	23.4	2.7	3.7	4.6	2.6	3.6	5.2	4.5	3.2	2.3	1.7	2.6	2.9	6.9	7.3	3.3	1.3	1.3	2.4	1.2	0.5	1.8	8.2	3.1	5.8	6.6	3.1	2.5	3.5	1.5	4.0	4.2	4.7	4.8	7.9	0.8	8.0	3.0	5.9	2.2	3.9	13.3	11.5	5.9	2.4	2.4	3.1	1.7	3.9	4.5	2.9	3.6	4.0	2.9	2.5	2.7	4.6	1.3	7.6	5.0	3.3	2.3	2.3	2.0	6.7	5.1	2.9	1.9	4.7	1.9	1.9	0.3	0.4	0.7	0.1	0.6	1.2	0.7	0.5	0.1	0.8	0.9	0.5	1.0	0.4	0.3	0.6	1.1	0.1	20.4	21.2	32.9	26.7	20.4	19.7	18.4	19.3	21.6	23.0	15.8	19.6	23.4	1.3	0.0	3.4	0.7	1.0	1.1	0.3	0.4	1.2	10.3	1.1	1.0	2.6	1.5	1.5	0.0	6.2	0.2	1.5	0.7	0.0	1.1	0.8	1.0	1.0	1.6	1.2	4.0	0.9	0.2	0.2	1.6	0.5	0.9	0.0	1.0	1.8	95.9	0.2	5.0	1.1	2.5	0.0	1.3	0.4	0.3	1.2	1.1	3.6	0.0	1.6	2.7	1.0	0.0	0.8	0.3	0.3	1.9	0.9	0.5	0.7	1.8	2.3	18.2	0.0	2.5	1.0	0.7	0.5	1.5	1.3	0.0	1.4	0.9	0.9	0.3
RFPL4B	RNF211	ENSG00000251258	"Ret finger protein like 4B"	Q6ZWI9	6	112347330-112351294	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"testis: 1.7"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 15.7"	"Group enriched"	"Detected in some"	7	"liver cancer: 0.6;testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.9;RPTEC TERT1: 2.3;U-266/70: 1.0;U-266/84: 8.0"									"HPA059324, HPA066464"	Uncertain					NA	NA					"HPA059324: , HPA066464: "	"unprognostic (4.26e-1)"				"unprognostic (1.45e-1)"						"unprognostic (6.66e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.80e-3)"		"unprognostic (3.73e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
SLC51A	OSTalpha	ENSG00000163959	"Solute carrier family 51 subunit alpha"	Q86UW1	3	196211487-196243178	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"intestine: 65.1;liver: 71.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 49.1;Leydig cells: 61.5;Peritubular cells: 101.5;Proximal enterocytes: 271.8;Sertoli cells: 144.7"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 15.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 3.9;U-266/84: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045488	Enhanced					NA	NA					"HPA045488: "	"unprognostic (1.63e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.98e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-5)"	1.3	5.2	0.3	1.3	0.3	6.0	1.2	0.1	0.7	1.5	0.0	10.4	30.7	0.8	0.8	1.5	1.6	0.6	1.1	0.3	0.4	5.5	71.9	2.0	0.6	0.3	0.1	0.1	1.4	0.9	2.7	1.2	0.2	0.3	1.1	0.7	0.7	1.2	0.0	1.6	2.4	65.1	0.2	0.1	1.8	0.9	4.1	0.6	0.1	1.5	0.0	0.5	1.0	1.8	0.5	0.5	0.7	0.6	0.7	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.8	0.5	0.0	0.4	0.0	0.0	0.0	0.3	1.3	0.5	0.4	0.8	0.1	0.6	0.6	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.1	1.5	0.0	0.3	0.0	0.6	0.0	0.1	0.9	3.9	0.0	0.2	0.0	0.4	0.1	0.2	0.2	1.4	0.1	0.1	1.1	0.2	0.2	0.7	0.3	0.6	0.4	1.5	2.0	0.2	0.5	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.7	0.3	0.4	0.3	0.1	0.1	0.3	0.1	0.6	0.5	1.1	0.0	0.5	0.3	1.0	3.3	2.5	10.9	0.0	0.5	0.6	0.3	4.1	1.5	18.2	0.0	4.2	0.7	3.0	43.5	3.9	0.2	20.7	2.7	1.6	1.6	0.0	2.7	1.0	0.2	0.4	2.4	0.0	1.6	0.0	2.3	3.9	49.1	0.6	1.7	0.7	8.4	22.4	4.4	7.3	12.9	61.5	1.3	3.6	1.0	0.8	0.4	1.0	0.5	0.2	0.1	12.1	101.5	0.8	1.5	271.8	11.5	18.0	1.1	144.7	2.3	2.6	2.4	1.3	0.0	2.6	1.0	3.0	13.6	11.8	2.8
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869767	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 125.6;kidney: 68.8"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 772.0"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"BEWO: 3.4;CACO-2: 8.2;Hep G2: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced					NA	NA					"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.2	0.1	0.8	0.1	0.8	0.0	0.3	0.8	0.9	0.6	0.6	0.7	79.0	0.4	1.5	0.2	0.5	0.2	0.1	0.7	0.8	68.8	17.4	0.2	0.1	0.7	0.7	0.7	0.6	0.3	0.0	0.7	0.1	0.9	1.0	0.2	1.0	0.2	0.2	0.0	0.2	125.6	0.2	0.7	0.3	0.2	0.4	0.7	0.2	0.8	0.0	0.0	0.3	0.5	0.9	0.0	0.1	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.9	0.7	0.8	0.7	0.7	0.7	0.9	0.7	0.7	0.9	0.1	0.0	0.0	2.3	0.5	0.0	0.1	0.0	0.0	1.3	0.2	0.6	0.4	0.0	0.0	5.5	4.2	0.2	0.1	0.0	1.9	0.1	1.6	0.3	0.2	0.1	0.0	0.0	3.1	7.2	8.8	0.2	0.0	0.2	0.0	0.4	0.0	12.2	0.2	0.0	3.0	18.2	0.0	0.0	0.0	0.1	0.6	0.5	0.0	2.8	0.0	0.2	0.0	0.0	1.7	0.6	27.5	0.0	0.0	0.0	772.0	97.8	1.8	1.2	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.1	11.7	0.0
TTC36	HBP21	ENSG00000172425	"Tetratricopeptide repeat domain 36"	A6NLP5	11	118527472-118531197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 172.9"	"Group enriched"	"Detected in many"	13	"Hepatocytes: 492.9;Proximal enterocytes: 185.5;Proximal tubular cells: 172.9"	"Group enriched"	"Detected in some"	7	"breast cancer: 5.0;liver cancer: 12.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SK-BR-3: 9.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA038731	Enhanced		Uncertain	Nucleoplasm		NA	NA		100000	Nucleoplasm		"HPA038731: AB_10672651"	"unprognostic (1.57e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (1.81e-5)"	"unprognostic (6.32e-2)"	"unprognostic (8.80e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.77e-3)"	"unprognostic (3.38e-2)"	"unprognostic (5.77e-7)"	"unprognostic (5.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-3)"	8.1	1.3	0.7	0.1	0.6	0.0	11.2	0.8	0.7	0.3	0.5	0.5	5.9	0.4	18.6	0.5	0.5	0.1	1.0	0.3	0.5	8.7	172.9	0.3	0.1	1.2	0.7	0.4	0.6	1.2	0.0	1.6	0.1	1.1	1.0	0.0	0.3	0.9	0.0	1.4	0.5	4.2	0.0	0.6	0.3	0.7	0.8	0.5	0.0	0.7	0.4	0.0	0.5	0.3	1.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.5	0.2	0.7	0.0	0.0	0.2	0.0	0.0	9.7	0.0	0.0	0.8	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.6	0.8	0.7	0.3	0.5	1.2	0.7	0.4	1.1	0.6	0.5	1.0	0.3	0.0	0.0	0.3	2.4	0.3	0.6	0.2	0.6	0.1	21.2	11.3	0.3	11.5	0.1	12.9	0.0	1.5	0.1	0.8	17.6	0.2	0.1	1.2	0.6	1.1	2.4	16.4	0.2	0.5	0.2	0.3	2.0	1.7	0.0	0.4	9.7	492.9	0.1	0.0	0.3	9.3	0.0	14.2	0.3	0.2	0.3	0.9	0.0	0.0	0.6	1.1	0.0	0.0	0.1	0.2	7.6	0.0	0.3	1.9	185.5	172.9	0.2	0.8	0.0	0.2	0.2	0.3	0.3	0.3	0.1	2.1	1.1	0.4	11.7	1.3
UGT2B17		ENSG00000197888	"UDP glucuronosyltransferase family 2 member B17"	O75795	4	68537184-68568527	"Enzymes, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 463.8;liver: 137.2"	"Group enriched"	"Detected in some"	6	"Distal enterocytes: 130.1;Paneth cells: 35.1;Undifferentiated cells: 100.6"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.3;liver cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	40	"memory B-cell: 2.8;naive B-cell: 8.8"	"Lineage enriched"	"Detected in single"	61	"B-cells: 8.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;NB-4: 1.1;RPMI-8226: 1.7"									HPA045108	Supported					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.66e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.44e-3)"		"unprognostic (9.67e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.76e-1)"	0.3	0.0	0.0	39.2	0.1	0.0	0.7	0.1	0.1	1.5	0.0	369.1	367.6	1.4	1.5	0.1	0.2	0.6	0.0	0.0	0.1	0.2	137.2	0.2	1.5	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	127.1	0.0	0.2	0.7	0.0	0.0	463.8	9.2	0.1	0.6	0.8	0.0	0.1	0.4	0.0	0.0	2.2	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	1.3	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	130.1	0.0	0.0	0.0	11.1	0.1	0.0	1.8	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	2.8	0.0	0.0	0.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.3	0.1	35.1	0.0	1.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	100.6	0.2
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"kidney: 1311.9;liver: 1625.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 150.6;Glandular and luminal cells: 234.7;Hepatocytes: 550.8;Proximal tubular cells: 1249.5"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RPTEC TERT1: 310.8"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favorable (5.38e-4)"	0.3	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	32.3	0.0	3.8	69.3	9.0	24.4	0.2	50.4	10.5	0.0	0.0	0.0	1311.9	1625.3	0.4	0.0	0.0	0.0	0.0	0.1	10.0	0.0	0.0	0.1	0.0	0.3	7.0	0.0	3.6	27.8	0.0	0.3	67.1	0.3	0.0	0.0	0.9	0.1	0.0	0.9	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.3	0.0	0.0	77.6	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	41.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.1	0.6	0.1	310.8	2.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	43.2	0.0	0.0	0.0	0.2	0.3	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.6	1.6	0.0	0.0	1.2	0.6	0.1	38.6	2.1	125.0	0.0	0.0	0.0	5.7	97.8	6.6	0.3	150.6	14.0	1.0	3.5	2.7	0.4	10.6	0.0	0.1	0.0	234.7	0.0	0.0	8.9	550.8	0.1	0.0	0.3	37.3	0.0	13.8	0.0	0.0	1.8	7.6	3.6	0.0	0.0	0.0	0.0	1.5	0.4	13.0	10.7	0.0	0.0	0.6	70.6	1249.5	0.5	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	6.3	0.1	5.9	2.3
A1CF	"ACF, ACF64, ACF65, APOBEC1CF, ASP"	ENSG00000148584	"APOBEC1 complementation factor"	Q9NQ94	10	50799409-50885675	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 145.2"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 150.2;Distal enterocytes: 71.3;Enteroendocrine cells: 116.5;Hepatocytes: 337.9;Paneth cells: 83.8;Proximal enterocytes: 147.5;Proximal tubular cells: 118.4"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 18.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"CACO-2: 23.5;Hep G2: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037779, HPA044079"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037779: AB_10670529, HPA044079: AB_2678800"	"unprognostic (3.87e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.38e-3)"		"unprognostic (1.30e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.50e-4)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.2	23.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	12.7	145.2	0.0	0.0	0.0	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.0	0.0	0.0	0.0	27.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	60.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	150.2	0.0	3.7	2.1	0.0	0.0	71.3	9.8	1.2	0.0	0.0	0.0	0.6	116.5	5.3	0.4	11.4	0.0	0.0	0.0	0.0	0.0	0.0	6.1	337.9	0.0	0.0	0.3	52.0	0.0	8.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	83.8	0.0	0.0	0.1	147.5	118.4	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	35.1	0.1
ACSL6	"ACS2, FACL6, KIAA0837, LACS2, LACS5"	ENSG00000164398	"Acyl-CoA synthetase long chain family member 6"	Q9UKU0	5	131949973-132012243	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.8;brain: 34.4;retina: 46.2;testis: 20.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 229.2;Cone photoreceptor cells: 229.4;Erythroid cells: 110.5;Inhibitory neurons: 110.6;Rod photoreceptor cells: 130.0"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.8;glioma: 1.9;liver cancer: 0.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.6"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 7.6;U-937: 6.2"									HPA040470	Enhanced					NA	NA					"HPA040470: AB_10794033"	"unprognostic (1.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.89e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.38e-3)"	"unprognostic (5.84e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.57e-2)"	"unprognostic (9.28e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.79e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.70e-1)"	0.1	4.2	18.6	1.4	19.9	22.8	0.2	28.3	34.4	0.0	2.0	0.4	4.7	0.1	0.5	0.3	0.2	0.3	1.4	20.8	13.7	1.9	2.1	0.3	2.4	20.7	20.5	15.7	0.0	1.1	11.4	4.3	0.6	20.9	0.3	0.3	46.2	0.3	18.2	2.3	0.1	2.4	0.1	13.4	1.1	0.6	20.9	26.3	0.6	0.4	1.4	1.0	0.2	0.1	16.3	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.1	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.1	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.4	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.2	6.2	0.3	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.7	1.6	0.0	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	0.3	18.6	19.9	28.3	34.4	20.8	13.7	20.7	20.5	15.7	20.9	13.4	26.3	16.3	0.6	25.6	29.2	229.2	1.4	1.9	1.5	0.0	2.2	65.2	2.1	0.4	0.0	1.5	16.1	1.8	229.4	0.3	3.3	0.6	7.9	0.6	43.7	0.3	0.1	3.9	2.4	110.5	70.6	0.2	0.1	4.2	0.0	0.2	10.1	0.2	1.8	8.4	0.1	21.9	110.6	1.8	0.0	1.0	15.9	7.9	0.3	6.4	0.0	15.9	0.9	24.5	0.0	41.7	9.8	0.3	1.6	1.9	0.8	1.1	1.8	0.4	8.1	130.0	0.0	2.3	1.1	45.3	1.7	0.1	1.3	0.3	15.3	0.1	0.4	1.3
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987400-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 324.5;liver: 485.9;skeletal muscle: 289.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 141.7;Club cells: 128.8;Gastric mucus-secreting cells: 133.5;Hepatocytes: 397.4;Urothelial cells: 271.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 2054.8;ASC diff: 2439.5;Hep G2: 3926.2;OE19: 2684.9;RT4: 1178.9"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (6.77e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.25e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.30e-2)"	324.5	21.0	12.3	10.1	11.0	1.0	207.4	10.9	10.8	11.4	8.8	26.1	29.9	5.7	3.3	204.1	8.7	99.0	54.4	7.2	11.9	16.3	485.9	23.7	2.1	18.2	13.4	7.3	10.4	11.9	1.1	8.2	0.8	17.6	11.8	13.4	15.3	117.4	13.1	289.2	39.3	34.0	9.3	12.6	2.1	138.2	12.0	18.8	4.5	38.6	36.8	9.3	256.4	47.4	18.8	0.0	2054.8	2.4	214.1	2439.5	83.4	0.1	0.7	8.6	0.9	2.0	8.1	0.2	0.4	11.5	14.2	10.0	57.8	0.2	10.7	1.2	0.6	0.2	0.7	516.4	3926.2	4.6	0.4	0.9	218.3	126.4	10.5	10.4	0.7	0.9	0.3	81.9	0.3	20.4	3.3	0.2	0.0	0.7	2684.9	0.8	0.3	0.6	34.6	19.0	1178.9	1.2	0.4	21.2	0.3	0.1	0.4	0.5	4.0	8.6	5.1	1.8	74.6	0.8	0.6	0.6	0.3	25.9	30.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.3	11.0	10.9	10.8	7.2	11.9	18.2	13.4	7.3	17.6	12.6	18.8	18.8	15.2	12.8	2.8	0.0	0.9	11.9	9.5	141.7	20.5	1.9	0.8	1.4	5.5	102.9	128.8	0.0	0.0	0.0	0.0	10.3	0.0	18.3	17.3	0.7	0.5	7.5	1.8	8.0	2.6	103.3	0.1	44.2	133.5	0.8	0.0	0.1	10.8	397.4	0.1	3.3	4.2	5.4	46.8	12.0	7.8	7.8	79.2	1.0	8.8	19.7	0.6	39.6	0.0	5.5	0.3	90.0	6.6	78.6	0.8	23.7	15.9	3.6	40.3	3.0	0.0	5.3	13.9	0.2	0.3	112.9	13.5	0.0	1.3	0.4	8.5	271.9
APOF		ENSG00000175336	"Apolipoprotein F"	Q13790	12	56360568-56362857	"Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	333	"liver: 420.1"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 341.9"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 34.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	18000000000	2200000000				"unprognostic (3.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.4	0.1	0.3	0.2	0.1	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	420.1	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.4	4.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.4	0.3	0.6	0.3	0.2	0.1	0.4	0.2	0.1	0.3	0.0	0.3	1.2	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.3	8.6	0.0	0.0	2.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.4	0.0	16.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	5.0	341.9	0.0	0.0	0.0	0.1	0.0	10.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.1	0.0	0.8	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3
ARID3C		ENSG00000205143	"AT-rich interaction domain 3C"	A6NKF2	9	34621379-34628086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 11.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"liver cancer: 2.2;ovarian cancer: 0.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.0;Karpas-707: 2.6;T-47d: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (4.66e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.05e-3)"	"unprognostic (4.42e-3)"	"unprognostic (6.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.21e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.28e-14)"	"unprognostic (3.06e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.91e-2)"	"unprognostic (4.26e-3)"	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.4	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.9	0.0	11.8	0.0	0.0	1.3	0.5	0.2	0.0	0.1	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.2	0.9	0.1	0.3	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.0	2.0	0.2	0.0	0.3	0.0	0.6	0.0	0.1	0.1	0.4	0.0	0.0	0.2	0.0	0.4	0.0	2.6	0.0	0.0	0.0	0.9	0.0	0.1	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.3	0.1	0.6	0.2	0.0	2.6	0.1	0.0	0.0	0.1	0.5	0.0	0.5	0.4	0.0	0.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.1	0.1	0.9	1.3	0.5	0.2	1.5	0.0	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837462	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 529.4"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 420.3;Oligodendrocyte precursor cells: 210.1"	"Group enriched"	"Detected in many"	6	"glioma: 24.0;liver cancer: 13.7;melanoma: 18.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Karpas-707: 785.6"	"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"	NA	NA		9400000000			"HPA001560: AB_1078271"	"unprognostic (4.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.21e-4)"	"unprognostic (8.19e-8)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.46e-5)"	"unprognostic (2.17e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.26e-4)"	14.6	11.7	9.2	2.7	7.8	0.0	4.7	7.9	12.1	22.2	5.5	25.3	4.7	41.4	24.5	26.0	36.5	6.1	7.9	8.1	7.6	4.9	529.4	11.0	0.2	8.3	9.6	7.4	3.8	2.4	0.1	1.8	0.0	8.1	12.6	16.3	8.9	1.9	32.6	2.8	8.8	10.7	29.9	7.7	6.0	3.6	1.3	12.7	2.9	1.4	5.2	0.1	11.4	5.1	9.8	0.0	2.1	82.1	0.1	0.2	0.0	0.1	0.0	1.5	0.6	7.3	0.0	0.1	0.3	30.7	0.0	0.0	0.5	5.7	0.4	5.8	0.4	0.8	0.0	0.0	0.0	6.3	0.2	0.4	23.5	1.4	0.0	8.1	25.3	3.6	30.0	0.0	785.6	0.0	0.0	0.0	0.1	2.1	0.0	0.8	0.0	28.4	67.3	0.7	0.0	0.0	0.8	0.1	0.0	46.5	0.0	34.0	0.2	0.0	19.3	0.5	0.0	8.3	3.5	0.0	1.6	8.2	0.2	84.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	7.8	7.9	12.1	8.1	7.6	8.3	9.6	7.4	8.1	7.7	12.7	9.8	5.8	0.0	0.0	1.0	0.7	5.5	0.9	0.0	1.8	1.4	0.0	0.1	9.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.7	3.4	0.0	8.0	3.0	0.0	0.0	22.0	0.5	0.0	0.0	0.2	8.9	420.3	0.1	1.7	10.5	0.4	0.0	4.7	1.5	8.7	2.1	0.3	19.6	3.7	0.0	31.7	0.0	210.1	16.1	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	1.2	0.0	0.8	6.5	0.3	0.3	0.6	3.4	0.0	1.1	0.1	0.0	0.1
CDO1		ENSG00000129596	"Cysteine dioxygenase type 1"	Q16878	5	115804733-115816659	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 510.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 329.4;Hepatocytes: 149.5;Leydig cells: 91.0;Syncytiotrophoblasts: 481.9;Theca cells: 104.7"	"Group enriched"	"Detected in many"	6	"glioma: 33.6;liver cancer: 74.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 48.1;ASC diff: 57.9;ASC TERT1: 22.3;GAMG: 17.2;HAP1: 17.1;NTERA-2: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036573, HPA057503"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036573: AB_10696658, HPA057503: AB_2683451"	"unprognostic (2.34e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.91e-5)"	"unprognostic (1.14e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.06e-2)"	120.4	18.3	26.8	3.3	28.7	0.2	36.2	26.4	31.4	9.0	94.8	4.2	0.7	8.4	141.5	3.6	13.8	10.6	18.0	28.0	29.6	3.2	510.9	11.8	6.7	24.3	26.4	27.6	26.1	14.3	0.7	20.8	35.5	25.5	9.1	1.8	16.1	7.2	73.5	8.5	3.0	4.0	6.3	24.6	3.8	4.1	15.7	26.8	1.3	9.7	20.1	3.1	8.1	5.8	26.5	0.0	0.0	48.1	0.0	57.9	22.3	0.2	1.4	0.4	4.6	4.5	0.0	0.0	0.0	0.0	0.6	17.2	0.1	17.1	0.0	6.6	0.1	8.5	1.7	0.0	1.4	0.2	0.1	0.0	8.5	0.0	0.7	0.0	1.2	6.3	0.0	0.0	0.0	5.5	0.0	1.2	0.2	17.8	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	11.0	0.1	0.0	0.0	4.0	0.0	5.4	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	26.8	28.7	26.4	31.4	28.0	29.6	24.3	26.4	27.6	25.5	24.6	26.8	26.5	4.1	0.0	1.3	6.8	0.7	0.8	0.8	0.0	0.6	27.3	1.0	7.1	3.4	0.0	0.0	1.8	6.2	329.4	0.3	0.0	0.0	9.9	6.0	0.3	7.1	3.1	1.8	2.7	12.2	0.2	17.0	27.8	0.0	0.3	0.0	7.5	33.9	149.5	23.4	1.7	16.4	0.0	0.0	5.7	1.6	15.0	91.0	0.6	1.8	1.0	0.6	31.4	0.0	5.5	3.1	0.3	0.0	37.6	0.0	0.9	0.0	2.0	0.0	3.8	13.1	7.3	3.9	1.6	1.4	0.5	1.3	481.9	0.9	104.7	0.0	0.1
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 2537.7"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 613.4;Hepatocytes: 2420.8"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"classical monocyte: 109.6;myeloid DC: 114.5"	"Group enriched"	"Detected in many"	22	"dendritic cells: 114.5;monocytes: 109.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 700.9;THP-1: 688.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	95.7	14.2	0.8	3.3	0.8	27.2	43.9	0.7	1.9	22.8	3.6	62.9	24.2	60.9	7.5	41.4	55.1	275.5	48.1	0.7	3.1	4.8	2537.7	169.3	1.9	2.0	1.0	0.6	20.5	8.9	0.7	3.8	8.6	1.7	39.5	12.4	2.9	41.8	36.7	5.2	13.6	27.6	40.7	0.9	41.4	56.6	7.9	1.0	2.5	9.9	9.5	1.0	58.2	17.9	1.0	0.7	4.4	0.0	0.0	90.8	0.6	3.1	0.3	0.0	0.0	0.0	43.5	0.0	0.0	19.4	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.9	700.9	0.0	1.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	40.8	0.1	0.6	0.0	0.0	1.5	6.7	0.0	0.5	0.0	0.1	3.2	0.1	1.1	0.9	0.0	688.0	0.1	0.0	0.4	0.2	0.5	2.2	0.1	1.0	0.0	151.7	0.0	0.0	109.6	0.5	4.5	6.1	1.5	1.1	0.7	5.0	114.5	1.2	0.7	1.1	0.6	0.3	1.6	6.8	0.4	58.0	0.8	0.8	0.7	1.9	0.7	3.1	2.0	1.0	0.6	1.7	0.9	1.0	1.0	2.0	16.0	67.6	0.0	11.3	16.7	5.3	6.8	1.2	0.0	1.2	8.1	0.8	613.4	31.5	16.5	0.0	0.5	12.2	0.1	0.0	15.4	79.6	1.0	10.6	8.9	37.5	177.7	0.0	18.7	2.2	57.4	1.1	0.2	6.3	0.0	66.0	2420.8	18.1	0.0	0.0	12.2	4.1	107.3	26.7	197.8	18.6	58.7	39.2	1.0	39.6	10.4	7.2	0.0	0.0	0.9	1.3	98.9	1.8	1.5	0.6	0.9	169.0	0.9	0.0	9.8	9.8	1.0	2.3	20.6	11.6	0.8	16.9	0.9	0.7	2.6
CLDN14	DFNB29	ENSG00000159261	"Claudin 14"	O95500	21	36460621-36576569	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 39.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 7.2;Distal tubular cells: 19.6;Ductal cells: 11.8;Exocrine glandular cells: 8.2;Hepatocytes: 22.2;Pancreatic endocrine cells: 21.3"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 7.9"	"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"HDLM-2: 224.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA054707			Uncertain	Vesicles		NA	NA			Vesicles		"HPA054707: "	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.43e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.54e-2)"	"prognostic favorable (1.53e-4)"	"unprognostic (3.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.87e-1)"	"unprognostic (7.44e-4)"	"unprognostic (2.77e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.71e-2)"	0.1	0.0	0.2	0.3	0.1	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.3	0.1	0.1	0.0	7.0	39.8	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.2	0.1	0.0	0.1	0.3	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	224.1	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.7	2.1	0.1	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	2.5	15.8	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.1	7.4	4.2	0.1	0.7	0.4	6.7	15.7	0.0	1.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.4	1.0	0.6	0.0	0.0	0.8	0.4	0.7	7.2	0.1	1.8	0.0	0.1	0.0	0.7	19.6	11.8	0.6	0.3	0.2	3.6	0.0	0.0	0.6	8.2	1.3	0.1	0.0	3.4	0.0	0.0	0.4	22.2	0.1	0.0	0.4	0.6	0.0	0.6	0.0	0.5	0.0	0.2	3.6	0.0	0.6	0.0	0.0	1.5	1.0	21.3	0.0	0.4	6.9	0.6	0.0	0.7	0.0	0.0	0.0	0.0	2.0	1.2	0.0	0.0	0.3	0.8	1.4	0.0	0.3	2.3
ENPP7	"alk-SMase, NPP7"	ENSG00000182156	"Ectonucleotide pyrophosphatase/phosphodiesterase 7"	Q6UWV6	17	79730943-79742219	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 105.5"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 9.1;Proximal enterocytes: 22.7;Proximal tubular cells: 9.7"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 1.2;Karpas-707: 2.1;U-266/70: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024603	Approved				"Intracellular and membrane"	NA	NA		450000			"HPA024603: AB_1848174"	"unprognostic (4.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.01e-1)"		"unprognostic (8.45e-4)"	"unprognostic (4.83e-2)"		"unprognostic (1.18e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	11.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	9.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0
EPHX1	EPHX	ENSG00000143819	"Epoxide hydrolase 1"	P07099	1	225810124-225845563	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 1188.3;liver: 1718.8"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 349.9;Hepatocytes: 757.6;Theca cells: 1042.6"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 1047.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 1161.8;SiHa: 413.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020593, HPA048847"	Enhanced					NA	NA		160000			"HPA020593: AB_10601373, HPA048847: AB_2680538"	"unprognostic (2.85e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (7.02e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (8.10e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.88e-2)"	248.0	1188.3	211.0	23.8	220.7	22.9	165.1	217.0	251.2	189.9	297.3	77.8	103.2	109.0	98.5	160.9	155.1	97.4	92.6	199.0	274.0	111.7	1718.8	148.1	39.4	213.0	203.1	171.9	331.8	540.7	148.8	106.6	33.2	210.3	114.1	53.0	30.9	144.8	129.3	143.7	68.0	53.2	110.6	180.7	56.2	100.8	75.0	223.4	26.1	172.5	96.5	33.7	136.6	141.6	247.2	32.1	202.3	12.3	108.5	1161.8	120.2	24.3	29.7	49.2	28.1	35.1	38.8	293.6	1.3	128.7	147.3	30.6	38.1	32.7	16.8	12.1	7.8	46.5	21.8	83.5	282.7	129.8	12.9	15.1	109.2	40.0	74.6	6.3	116.5	22.1	13.4	14.5	27.3	50.4	30.3	13.5	31.0	61.6	178.1	79.4	27.8	15.2	92.9	91.1	132.5	98.3	13.0	413.0	192.1	51.3	32.1	131.7	43.5	46.8	41.9	35.4	54.5	59.0	9.1	38.9	4.1	63.5	14.2	59.5	0.0	2.6	0.1	0.2	0.7	0.4	0.1	0.3	0.2	0.6	0.2	0.5	0.3	0.2	0.7	0.3	0.9	0.3	0.8	211.0	220.7	217.0	251.2	199.0	274.0	213.0	203.1	171.9	210.3	180.7	223.4	247.2	196.9	0.0	14.0	41.1	5.7	19.6	121.8	244.2	74.0	8.8	29.7	27.4	1.2	102.9	255.5	51.5	29.2	46.6	3.4	34.5	17.6	95.3	10.2	142.9	32.2	82.7	10.8	7.0	3.1	73.0	7.6	175.6	30.5	93.4	5.7	349.9	88.2	757.6	149.1	1.7	5.0	17.5	103.7	30.9	28.7	28.4	311.3	25.8	42.7	23.4	9.6	99.2	0.0	7.1	19.4	45.5	27.2	159.1	9.5	40.4	63.4	128.9	174.3	10.1	223.5	29.3	146.9	4.4	5.1	129.0	17.6	22.8	4.7	1042.6	31.5	108.5
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.3;liver: 27.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Excitatory neurons: 37.6;Inhibitory neurons: 30.2;Late spermatids: 41.7;Oligodendrocyte precursor cells: 34.7"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 36.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 36.4"	"Group enriched"	"Detected in some"	7	"MOLT-4: 13.0;NTERA-2: 17.9;SCLC-21H: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA039051: AB_10673299, HPA039052: AB_10672839"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	2.5	0.2	5.0	6.8	8.0	28.3	0.2	2.0	10.4	1.8	5.4	0.4	0.1	3.7	1.0	0.5	3.0	1.7	0.5	6.7	8.5	0.8	27.8	2.9	0.3	3.2	3.3	6.9	0.2	0.9	0.6	1.4	0.7	5.4	0.8	0.3	5.7	0.2	1.5	9.1	1.0	0.3	3.1	0.8	12.8	0.3	15.7	3.9	0.9	1.7	9.7	0.4	1.4	0.5	7.4	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	1.9	0.0	0.3	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.5	3.6	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	36.4	0.0	2.0	2.3	0.0	1.6	5.0	8.0	2.0	10.4	6.7	8.5	3.2	3.3	6.9	5.4	0.8	3.9	7.4	0.0	0.0	0.0	1.6	0.4	0.9	0.0	0.0	0.0	0.8	0.0	0.5	0.4	0.0	0.0	0.0	2.1	0.0	4.7	0.0	0.0	0.1	14.6	0.6	2.3	0.1	0.0	0.0	37.6	0.0	0.0	0.4	0.0	4.8	0.0	0.1	1.1	10.4	1.4	0.0	30.2	0.0	0.0	8.5	0.0	41.7	0.3	9.4	1.8	6.5	12.4	10.4	1.0	34.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.3	0.0	0.2	0.2	4.0	0.6	0.0	0.3	0.1	0.2	0.0	0.0	0.0
GLYCTK	"HBEBP2, HBEBP4"	ENSG00000168237	"Glycerate kinase"	Q8IVS8	3	52287089-52295257	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 277.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 183.0;Proximal enterocytes: 105.2;Proximal tubular cells: 83.0"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 52.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006913	Approved		Approved	"Golgi apparatus,Cytosol,Rods & Rings"		NA	NA			Cytosol	"Golgi apparatus, Rods & Rings"	"HPA006913: AB_1078993"	"unprognostic (1.51e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.64e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.82e-2)"	"unprognostic (9.00e-3)"	12.7	8.3	0.9	4.5	0.9	6.8	9.3	0.5	1.5	2.8	0.9	7.0	22.6	3.2	0.6	3.8	2.7	2.2	4.1	0.9	0.9	24.6	277.3	4.3	4.7	1.4	0.7	0.7	2.4	5.9	2.6	2.9	2.2	1.6	3.7	3.6	0.6	3.1	1.0	3.6	1.9	21.9	1.6	0.4	9.0	8.6	2.3	1.1	2.3	4.1	1.1	3.2	3.3	2.5	1.1	2.9	5.8	3.4	1.2	15.7	2.4	1.8	2.4	2.6	4.6	3.9	12.1	2.4	6.7	1.6	2.7	3.7	1.6	1.7	7.8	0.8	2.0	1.8	9.3	7.5	16.2	1.7	2.8	5.0	2.4	3.5	7.6	3.2	2.1	10.2	5.2	2.4	4.5	3.6	1.9	5.9	2.7	1.5	14.2	4.2	1.9	2.5	11.1	5.8	3.9	1.9	1.9	2.6	1.4	3.0	1.0	3.2	1.7	3.8	3.5	4.1	2.4	6.1	5.1	3.9	5.4	2.7	4.9	2.2	2.2	5.2	6.6	5.6	2.8	2.6	4.4	4.2	4.9	5.6	2.6	3.3	4.3	4.4	3.6	3.5	3.4	6.6	3.7	0.9	0.9	0.5	1.5	0.9	0.9	1.4	0.7	0.7	1.6	0.4	1.1	1.1	5.4	6.4	3.2	0.7	8.2	0.4	3.2	4.1	1.8	1.6	2.1	1.4	1.6	18.6	3.0	9.2	0.0	7.9	9.2	18.4	19.6	5.4	0.3	4.4	2.7	8.3	23.4	26.5	0.6	6.2	5.3	2.9	27.0	8.6	1.3	3.4	14.6	183.0	13.2	0.0	0.4	15.8	2.0	16.6	2.4	0.0	1.2	9.1	3.6	1.0	7.7	1.2	9.2	0.5	0.7	4.0	40.6	0.0	13.5	2.8	105.2	83.0	2.4	1.5	0.0	2.7	2.7	1.8	8.3	2.1	1.3	11.1	9.3	7.7	24.9	4.3
GOLT1A	"CGI-141, FLJ42654, GOT1, MGC62027, YMR292W"	ENSG00000174567	"Golgi transport 1A"	Q6ZVE7	1	204198163-204213988	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 192.3"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 131.3;Proximal enterocytes: 206.8"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 80.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 18.0;CAPAN-2: 20.0;Hep G2: 25.9;MCF7: 43.5;OE19: 16.1;RT4: 27.7;SK-BR-3: 27.2"	"Region enhanced"	"Detected in many"		"cerebral cortex: 9.0"											NA	NA						"unprognostic (3.43e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (6.20e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.35e-5)"	"unprognostic (1.37e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-3)"	"prognostic favorable (1.51e-4)"	0.1	0.1	6.0	0.4	8.7	0.0	5.4	7.0	5.3	11.0	3.4	5.7	47.9	0.3	10.8	0.5	3.3	1.6	0.1	4.2	9.2	15.8	192.3	8.4	0.1	4.6	5.0	4.3	0.1	22.5	18.5	30.7	3.5	4.3	5.4	5.0	1.5	3.4	2.1	0.3	0.5	45.9	0.3	3.5	0.1	8.3	2.7	8.4	0.8	0.7	0.0	0.2	13.2	0.4	4.9	0.5	8.2	0.0	0.0	0.0	0.0	5.5	0.1	0.1	0.1	0.0	18.0	20.0	0.0	0.7	0.2	0.0	0.6	0.0	0.1	0.1	0.0	0.3	0.1	0.0	25.9	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	43.5	0.0	0.1	4.0	16.1	0.2	0.0	0.1	0.4	8.5	27.7	1.3	1.8	0.8	27.2	0.1	0.7	8.9	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.0	8.7	7.0	5.3	4.2	9.2	4.6	5.0	4.3	4.3	3.5	8.4	4.9	0.1	0.0	19.5	0.3	0.1	0.0	12.7	2.6	2.8	1.7	7.2	4.7	0.2	40.0	5.1	16.5	0.0	13.3	0.1	7.0	13.7	29.2	0.9	0.5	0.1	0.3	10.3	0.0	2.2	19.1	0.5	1.1	8.2	2.0	1.3	1.4	1.8	131.3	1.3	1.7	0.7	7.8	2.0	1.6	0.0	0.4	0.0	0.2	1.8	0.0	0.0	0.0	0.0	4.5	0.1	18.7	5.6	0.0	0.0	15.0	206.8	14.7	0.3	0.2	0.0	0.3	0.3	2.9	0.9	1.4	0.1	26.4	0.5	0.2	12.5	20.5
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 614.7"	"Group enriched"	"Detected in many"	4	"Cholangiocytes: 84.4;Enteroendocrine cells: 90.1;Hepatocytes: 286.6;Proximal enterocytes: 108.9"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 46.5;K-562: 15.2;SCLC-21H: 25.5;T-47d: 11.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA064640: AB_2685309"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"	68.4	85.8	4.0	0.7	4.3	0.2	51.6	14.6	9.4	1.9	0.3	6.3	59.4	0.6	16.5	3.4	13.0	5.6	3.0	5.0	2.0	35.3	614.7	2.7	0.0	5.5	2.2	4.1	4.9	23.3	6.3	13.5	0.0	8.2	3.7	1.6	0.7	8.8	0.8	58.6	4.3	47.2	0.5	1.4	0.3	4.7	31.2	2.5	0.9	7.3	13.9	0.0	2.0	2.7	5.1	0.2	2.5	0.0	5.9	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.3	0.0	0.6	1.2	0.0	0.0	0.0	0.2	6.1	0.0	4.8	46.5	1.3	0.2	1.7	0.8	0.0	0.0	0.0	0.1	0.0	0.0	15.2	0.0	0.1	6.3	0.1	0.0	0.7	8.2	1.0	0.0	0.0	1.2	0.0	0.1	25.5	0.7	1.0	4.4	0.0	0.1	11.4	6.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.3	14.6	9.4	5.0	2.0	5.5	2.2	4.1	8.2	1.4	2.5	5.1	0.6	0.0	16.2	2.3	1.6	1.1	4.8	0.6	0.6	9.9	1.4	1.3	3.4	84.4	4.7	3.7	20.9	0.1	0.3	3.2	1.9	2.9	3.2	0.7	0.2	2.5	90.1	16.0	33.4	1.0	0.1	6.5	4.6	0.8	0.0	0.1	12.8	286.6	0.4	1.7	29.1	19.6	0.0	11.2	1.5	1.2	2.8	2.8	7.2	30.9	0.2	2.0	1.0	2.0	0.9	1.4	13.9	1.2	0.1	2.2	108.9	14.1	3.2	6.5	0.0	23.9	1.0	5.1	1.1	0.5	0.9	0.5	1.7	0.0	31.9	4.0
MROH2B	"DKFZp781F0822, FLJ40243, HEATR7B2"	ENSG00000171495	"Maestro heat like repeat family member 2B"	Q7Z745	5	40998017-41071342	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	304	"testis: 30.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 21.0;Late spermatids: 40.2;Spermatocytes: 10.4"	"Cancer enriched"	"Detected in single"	6	"liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059457	Enhanced					NA	NA					"HPA059457: AB_2684026"							"unprognostic (1.81e-1)"	"unprognostic (3.54e-2)"		"unprognostic (1.08e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.91e-5)"	"unprognostic (2.51e-3)"	"unprognostic (2.53e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	2.7	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	40.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAGE5	"CT16.1, CT16.2, PAGE-5"	ENSG00000158639	"PAGE family member 5"	Q96GU1	X	55220346-55224108	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"testis: 26.7"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 131.0;Spermatogonia: 158.8"	"Group enriched"	"Detected in many"	6	"liver cancer: 5.4;melanoma: 11.8;testis cancer: 6.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.9"	"Group enriched"	"Detected in some"	170	"Karpas-707: 437.8;U-266/84: 992.7"									"HPA052619, HPA055869"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA052619: AB_2681887, HPA055869: "					"unprognostic (4.03e-1)"		"unprognostic (4.51e-2)"	"unprognostic (7.86e-4)"	"unprognostic (1.39e-2)"		"unprognostic (7.21e-2)"		"unprognostic (1.06e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"		"unprognostic (3.44e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.3	26.7	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	437.8	0.0	0.0	1.2	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.5	1.3	1.6	4.2	992.7	0.5	0.1	0.0	0.7	0.0	0.0	0.0	0.3	0.0	1.9	0.1	1.6	0.7	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	19.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	11.9	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.1	0.0	6.6	0.0	0.1	131.0	158.8	0.0	0.1	0.0	1.4	0.0	0.0	0.1
RGN	"RC, SMP30"	ENSG00000130988	Regucalcin	Q15493	X	47078355-47093314	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 186.3;liver: 386.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 58.7;Granulosa cells: 67.8;Hepatocytes: 175.7;Muller glia cells: 54.5;Peritubular cells: 69.6;Proximal tubular cells: 174.4"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 47.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 21.7;fHDF/TERT166: 6.9;Hep G2: 32.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029102, HPA029103, HPA029104"	Enhanced		Approved	Cytosol		NA	NA		280000	Cytosol		"HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: "	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.22e-3)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (2.60e-3)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.10e-10)"	"unprognostic (1.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.82e-2)"	"unprognostic (5.22e-2)"	7.8	186.3	17.8	0.7	19.0	0.0	3.5	21.7	20.0	10.3	22.6	5.9	13.4	7.3	4.6	3.2	5.5	5.1	13.8	17.7	24.4	57.3	386.9	19.1	1.0	20.0	18.1	16.2	21.5	34.3	5.9	8.9	12.2	19.5	13.5	2.1	8.1	14.5	17.5	11.9	1.5	13.7	4.5	19.5	3.7	12.0	3.6	18.0	0.5	19.1	11.4	0.5	7.6	6.0	19.8	0.0	0.0	0.2	0.0	0.0	0.2	0.5	0.4	0.8	0.0	0.0	21.7	0.0	0.0	1.1	6.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	32.8	1.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	19.0	21.7	20.0	17.7	24.4	20.0	18.1	16.2	19.5	19.5	18.0	19.8	0.6	6.4	3.6	16.3	0.6	0.5	4.9	0.2	1.8	9.6	2.4	7.0	27.5	8.6	0.7	14.7	0.0	0.1	0.0	0.2	58.7	13.9	0.4	3.4	7.4	2.4	4.8	2.7	10.8	8.9	0.3	11.2	3.1	0.5	0.0	67.8	11.4	175.7	0.1	5.0	4.9	0.2	0.0	5.3	1.2	2.1	24.8	1.2	1.8	4.7	0.0	54.5	0.0	27.2	13.7	5.0	1.2	69.6	0.7	1.1	0.2	174.4	1.7	3.1	13.1	22.3	11.3	0.2	0.2	0.5	0.3	0.3	0.7	14.5	0.7	1.3
SERPINF2	"A2AP, AAP, ALPHA-2-PI, API, PLI"	ENSG00000167711	"Serpin family F member 2"	P08697	17	1742836-1755265	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 1591.4"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1007.7"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 450.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 44.7"	"Lineage enriched"	"Detected in many"	23	"dendritic cells: 44.7"	"Cell line enriched"	"Detected in some"	24	"Hep G2: 145.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001885, CAB024863"	Approved				"Secreted to blood"	NA	NA	11900	61000000000			"CAB024863: , HPA001885: AB_1079922"	"unprognostic (2.17e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.93e-1)"	10.7	2.0	1.5	4.4	1.6	0.4	18.5	1.3	2.2	6.9	9.2	3.9	0.7	8.7	102.3	3.1	19.8	0.7	2.4	2.0	1.5	72.5	1591.4	13.0	3.0	1.6	1.7	1.2	7.8	9.2	0.1	1.9	0.8	2.5	21.6	0.5	0.5	6.1	32.9	4.3	5.3	11.7	1.8	2.1	7.2	3.8	12.6	1.6	2.6	8.0	0.4	3.5	7.4	5.8	2.1	1.8	6.1	0.0	0.0	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.3	0.9	0.0	0.3	0.9	0.0	3.3	0.0	0.0	0.0	0.1	0.9	145.9	1.1	0.8	0.1	1.6	1.2	0.0	0.7	0.1	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.7	0.1	0.3	0.3	0.1	0.9	1.3	0.0	0.3	0.0	0.2	0.6	0.0	1.1	0.0	0.2	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	1.9	1.4	0.0	0.8	0.0	0.5	0.0	0.0	10.7	0.5	0.0	0.0	0.0	1.2	0.0	44.7	0.0	1.2	1.5	1.6	1.3	2.2	2.0	1.5	1.6	1.7	1.2	2.5	2.1	1.6	2.1	1.6	3.2	19.6	0.3	5.3	1.5	4.9	10.3	8.0	0.2	20.5	8.8	0.7	27.1	7.0	1.8	6.2	0.2	32.1	0.7	9.8	0.0	0.6	0.1	2.7	3.4	4.2	23.6	1.6	4.9	0.3	2.7	0.0	0.3	1.3	0.3	14.6	1007.7	7.7	0.0	1.9	2.1	12.2	32.2	20.1	0.8	33.8	8.2	1.8	1.0	10.9	0.1	0.0	1.0	0.7	3.8	2.7	26.7	3.2	2.8	2.2	87.5	4.4	0.4	0.0	1.3	1.2	0.4	0.5	1.3	1.6	0.3	2.6	0.0	3.3	1.8
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781199	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"gallbladder: 16.4;intestine: 32.1;liver: 47.7;pancreas: 22.9"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 94.4;Distal enterocytes: 133.5;Hepatocytes: 41.8;Paneth cells: 44.1;Proximal enterocytes: 51.2"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 1.5"	HPA055564	Approved					NA	NA					"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	20.8	28.9	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	3.6	47.7	0.0	0.0	0.0	0.2	0.0	0.0	22.9	0.0	0.0	0.1	0.2	0.0	26.9	0.0	0.0	0.0	0.0	0.0	32.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	94.4	0.0	0.0	0.0	0.0	0.0	133.5	0.0	8.3	0.8	0.0	0.0	0.0	13.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	41.8	0.1	0.0	0.0	11.7	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	44.1	0.0	0.0	0.0	51.2	1.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	11.5	0.0
SRD5A2		ENSG00000277893	"Steroid 5 alpha-reductase 2"	P31213	2	31522480-31580938	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"epididymis: 23.8;fallopian tube: 20.6;liver: 61.3;prostate: 16.9;seminal vesicle: 18.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 71.7;Endometrial ciliated cells: 29.6;Hepatocytes: 20.0;Late spermatids: 59.9"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.75e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.92e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-3)"	"unprognostic (6.61e-6)"	"unprognostic (4.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.48e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	23.8	0.0	20.6	0.0	0.0	0.0	0.0	0.3	61.3	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.1	0.0	18.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.2	0.0	0.0	0.0	1.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.7	29.6	0.2	0.2	0.0	0.0	0.9	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.4	20.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	59.9	0.6	0.1	0.0	3.7	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.2	0.0	0.7	0.0	0.3	7.3	0.0	0.0	0.0	0.2	1.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	8.6
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362038-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"intestine: 269.0"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 703.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;RPMI-8226: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.1	0.3	0.2	0.2	0.0	1.2	0.4	0.0	0.3	3.1	269.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.1	3.9	0.3	0.0	0.0	0.0	0.3	145.7	1.6	0.0	0.1	0.5	3.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.1	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	1.2	0.4	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	48.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.4	0.0	0.0	0.0	77.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	157.9	0.7	0.0	0.0	703.0	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	18.8	0.0
UGT1A3	UGT1C	ENSG00000243135	"UDP glucuronosyltransferase family 1 member A3"	P35503	2	233729108-233773299	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 74.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"liver cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HaCaT: 11.4"															NA	NA												"unprognostic (5.15e-2)"	"unprognostic (9.93e-2)"			"unprognostic (2.97e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.04e-4)"	"unprognostic (8.22e-2)"			"unprognostic (2.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	74.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UPP2	"UDRPASE2, UP2, UPASE2"	ENSG00000007001	"Uridine phosphorylase 2"	O95045	2	157876702-158136154	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 46.2;liver: 24.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Distal tubular cells: 13.7;Excitatory neurons: 32.5;Inhibitory neurons: 20.8;Oligodendrocyte precursor cells: 27.6;Proximal tubular cells: 82.1"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035225, HPA035226"			Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Nucleoplasm	"Vesicles, Mitochondria"	"HPA035225: AB_10604002, HPA035226: AB_10696503"	"unprognostic (1.87e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-2)"	0.0	0.1	3.5	0.0	3.1	0.0	0.0	1.9	3.2	0.1	1.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	3.9	1.9	46.2	24.1	0.0	0.1	1.7	1.5	3.0	0.3	0.1	0.0	0.2	0.0	1.8	0.0	0.0	0.9	0.5	0.0	0.0	0.3	0.1	0.0	1.2	0.0	0.0	0.1	1.5	0.0	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.1	1.9	3.2	3.9	1.9	1.7	1.5	3.0	1.8	1.2	1.5	2.6	0.0	0.0	0.0	24.2	0.2	0.0	0.1	0.0	0.0	1.3	0.1	0.3	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	13.7	0.0	0.1	0.2	0.1	0.1	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	8.2	0.0	0.0	20.8	0.0	0.0	0.9	0.0	0.1	0.3	0.5	0.0	2.8	0.0	0.1	0.0	27.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	82.1	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782640-99852594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.6;liver: 122.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 70.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 24.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 204.4;Hep G2: 208.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071145	Enhanced					NA	NA					"HPA071145: "	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	1.3	0.4	0.3	0.7	0.4	0.8	3.1	0.5	0.4	0.5	0.2	0.5	39.4	0.4	0.2	0.3	0.7	24.6	0.2	0.3	0.3	18.7	122.7	0.5	0.7	0.4	0.3	0.2	0.3	1.1	0.1	0.1	0.5	0.4	0.4	0.4	3.9	0.5	0.2	1.1	1.7	40.6	0.2	0.3	1.4	0.7	0.7	0.3	0.8	0.4	0.8	0.5	1.3	0.5	0.6	0.3	204.4	3.5	10.2	15.3	12.0	3.4	0.5	1.3	0.5	0.6	44.6	0.3	0.4	0.3	0.7	0.5	1.3	0.3	0.4	0.6	0.5	0.3	0.0	1.0	208.7	0.5	0.3	0.7	1.9	13.9	1.5	1.4	0.2	0.4	0.6	0.0	0.3	0.2	1.0	0.2	1.4	0.3	39.8	0.3	0.3	0.2	0.4	1.4	0.3	0.1	0.2	0.5	3.4	25.9	0.4	0.1	0.4	0.7	0.6	0.6	0.9	0.6	0.8	0.1	0.2	16.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.4	0.3	0.3	0.4	0.3	0.2	0.4	0.3	0.3	0.6	0.7	0.0	0.0	2.3	0.4	0.0	0.2	0.2	0.0	0.3	0.1	0.0	0.5	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	2.6	2.9	0.2	0.3	0.0	0.4	1.0	0.4	0.0	1.7	0.0	0.6	1.3	0.1	1.4	70.7	0.2	0.0	1.3	0.6	0.0	1.0	0.0	1.1	0.3	0.4	5.4	1.9	0.3	0.1	0.0	1.0	2.2	0.1	0.0	0.0	0.1	0.2	15.5	10.7	2.8	1.5	0.0	0.4	0.5	1.2	0.7	0.1	0.0	1.6	0.4	0.1	0.4	0.0
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16149565-16223522	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 135.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 31.5;Distal tubular cells: 45.0;Hepatocytes: 77.9;Proximal enterocytes: 33.7;Proximal tubular cells: 151.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 16.7;renal cancer: 5.0"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.4"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 68.4"	"Not detected"	"Not detected"							HPA038105			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA038105: AB_2675835"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	5.6	3.6	0.7	0.3	0.7	0.7	3.9	0.7	1.1	1.0	0.8	3.6	13.3	0.3	0.6	0.3	1.6	2.9	1.7	0.6	1.2	26.9	135.3	7.5	0.0	0.8	0.8	0.6	1.0	17.3	2.1	0.9	0.2	0.8	2.9	2.8	0.3	12.8	1.0	4.6	0.4	7.9	0.3	0.8	0.7	6.5	0.4	0.8	0.0	5.7	0.1	0.0	0.4	0.7	0.8	0.0	1.5	0.7	0.0	0.0	0.8	1.8	0.0	0.4	1.0	1.6	7.1	2.3	0.0	0.8	0.0	0.2	0.0	0.7	0.1	0.6	0.0	0.7	1.8	0.2	68.4	0.4	0.0	0.0	2.7	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	1.0	0.0	0.8	0.1	0.3	8.4	5.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.7	1.1	0.6	1.2	0.8	0.8	0.6	0.8	0.8	0.8	0.8	0.3	28.9	31.5	2.9	1.9	0.1	0.5	3.2	0.0	1.0	4.3	3.6	3.3	18.6	8.7	9.2	0.0	0.0	0.0	13.7	45.0	2.2	0.5	4.8	1.0	0.8	3.0	2.7	1.0	7.9	0.0	1.7	13.3	1.0	1.3	1.9	1.8	77.9	1.0	0.0	1.1	10.9	0.0	3.5	0.0	0.7	1.5	1.8	1.8	3.7	3.1	1.5	0.0	1.0	0.4	2.2	8.1	5.7	0.3	2.0	33.7	151.1	25.4	0.6	0.0	0.3	1.2	0.4	0.3	0.2	0.9	0.0	1.4	1.8	11.9	0.7
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15571699-15585051	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Putrescine biosynthesis, Spermidine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 135.1;liver: 62.6;skeletal muscle: 34.5"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 306.8"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.1;T-cells: 8.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 36.7;Hep G2: 92.6;RPMI-8226: 22.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA026443, HPA028321"	Enhanced					NA	NA		240000			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.4	1.1	1.3	3.2	1.2	1.0	0.3	1.4	1.5	0.5	0.9	9.3	18.0	0.5	0.3	0.5	0.3	0.5	0.1	1.0	0.9	135.1	62.6	0.2	4.0	0.8	0.7	1.5	0.1	0.6	2.2	0.3	0.2	1.1	0.5	6.9	0.4	4.6	0.1	34.5	0.4	13.5	0.7	0.4	1.6	1.8	0.8	0.8	2.2	0.5	6.2	4.2	0.8	0.1	1.5	7.7	6.3	0.5	0.3	0.1	0.8	0.2	1.3	1.4	0.8	0.5	36.7	5.1	0.1	0.2	0.9	0.2	0.2	0.0	0.0	0.9	7.6	0.1	5.2	5.1	92.6	0.9	4.0	0.2	0.9	0.4	2.4	0.0	0.6	0.7	0.1	0.1	10.3	1.9	8.6	0.2	4.0	8.1	6.5	3.7	0.1	0.0	22.3	0.2	2.2	1.5	1.1	10.9	0.4	1.3	0.4	1.5	8.2	1.1	0.3	0.3	2.1	0.1	0.3	6.1	5.0	0.4	0.1	0.2	1.2	0.3	0.2	2.1	0.3	2.6	4.1	4.5	2.4	0.2	2.7	8.4	5.0	1.4	0.5	0.2	0.4	6.4	2.0	1.3	1.2	1.4	1.5	1.0	0.9	0.8	0.7	1.5	1.1	0.4	0.8	1.5	0.2	0.0	0.0	1.0	5.9	0.3	1.7	0.5	0.0	1.3	0.5	0.9	0.6	2.8	0.3	3.7	0.0	0.9	0.5	7.4	31.3	1.1	9.4	1.2	1.1	0.6	1.2	2.1	1.9	0.9	0.8	0.7	5.1	2.1	0.0	1.4	1.8	42.5	1.1	3.3	2.2	9.6	2.0	2.9	0.8	4.2	0.3	2.0	1.8	3.7	1.9	1.0	5.2	0.5	0.4	2.3	6.0	0.0	2.0	1.7	27.0	306.8	1.4	2.4	0.0	4.7	0.5	1.6	3.5	1.2	0.6	0.8	5.0	3.4	18.9	3.0
AGMO	"FLJ16237, TMEM195"	ENSG00000187546	"Alkylglycerol monooxygenase"	Q6ZNB7	7	15200317-15562015	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 123.5"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 83.0;Oligodendrocyte precursor cells: 33.7;Oligodendrocytes: 38.5;Proximal enterocytes: 30.5;Proximal tubular cells: 16.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 15.7"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.5;Karpas-707: 7.7;NTERA-2: 3.5;SCLC-21H: 3.2;TIME: 4.0;WM-115: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057900			Uncertain	Vesicles		NA	NA			Vesicles		"HPA057900: "	"unprognostic (2.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	2.8	0.1	0.8	0.6	2.3	0.1	1.8	0.7	1.5	0.1	0.2	1.2	9.8	0.1	14.6	0.2	0.1	3.7	0.4	0.7	1.2	9.0	123.5	0.2	0.5	1.8	1.8	0.9	0.1	0.1	0.0	0.4	0.8	2.0	0.0	0.6	0.1	0.2	0.1	0.3	0.2	15.0	0.1	0.8	0.0	0.3	3.0	1.6	0.2	0.4	0.4	0.1	1.2	0.1	4.2	0.0	2.2	0.0	1.9	0.2	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	1.2	0.0	0.7	3.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.0	1.3	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	15.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.8	2.3	0.7	1.5	0.7	1.2	1.8	1.8	0.9	2.0	0.8	1.6	4.2	10.0	0.0	0.0	6.8	0.3	0.1	0.1	0.7	0.0	0.0	0.2	0.3	0.1	11.5	0.4	3.7	0.0	0.1	0.1	0.5	0.0	0.0	1.3	0.3	0.1	1.2	1.8	2.7	1.3	0.0	0.2	1.2	0.0	0.0	0.0	0.0	1.1	83.0	0.1	0.0	1.7	0.4	0.0	1.6	0.5	1.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	33.7	38.5	0.9	0.1	0.0	0.0	0.0	30.5	16.9	0.3	0.0	6.6	0.4	2.4	1.7	6.4	0.1	0.0	0.1	0.2	0.1	0.6	0.0
ART4	"ARTC4, CD297, DO, DOK1"	ENSG00000111339	"ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)"	Q93070	12	14825569-14843526	"Blood group antigen proteins, CD markers, Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 53.7;lymphoid tissue: 19.2"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Endothelial cells: 12.9;Erythroid cells: 51.3;Hepatic stellate cells: 66.0;Hepatocytes: 30.2"	"Group enriched"	"Detected in some"	5	"liver cancer: 3.8;pancreatic cancer: 1.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;HEL: 12.1;Hep G2: 7.3;HUVEC TERT2: 27.0"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.8"	"Low region specificity"	"Detected in all"			HPA075664			Approved	"Rods & Rings"	"Secreted to blood"	NA	NA		17000000	"Rods & Rings"		"HPA075664: "	"unprognostic (2.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.62e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.71e-1)"	2.3	2.8	0.3	1.1	0.4	4.6	1.9	0.2	1.3	0.9	1.8	0.7	0.0	0.8	0.3	0.9	2.1	9.0	6.1	0.3	0.5	3.7	53.7	3.2	8.7	0.5	0.4	0.2	0.5	2.3	0.3	0.1	7.0	0.6	0.3	0.5	0.3	0.7	0.4	0.3	0.3	0.6	1.1	0.2	19.2	0.3	0.2	0.4	1.9	3.7	0.2	2.4	0.6	0.5	0.6	0.0	0.0	0.2	6.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	7.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.3	0.3	0.5	0.5	0.4	0.2	0.6	0.2	0.4	0.6	0.7	0.0	1.1	0.7	0.2	0.3	0.8	0.0	0.0	2.4	0.2	0.1	1.5	15.7	0.0	1.8	12.5	0.9	0.1	0.0	0.0	0.9	0.4	0.2	0.1	12.9	0.0	51.3	0.2	1.9	2.5	1.9	0.0	0.1	0.0	0.0	66.0	30.2	0.1	0.0	0.2	0.0	0.0	4.7	1.3	0.3	1.8	0.1	1.8	0.0	0.0	0.3	1.0	0.0	0.3	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	11.8	6.6	0.5	1.2	0.1	0.1	0.0	0.1	0.3	0.2	0.0	0.0	0.4
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease variant, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"liver: 4800.7"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 4512.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 1213.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"non-classical monocyte: 13.3"	"Lineage enriched"	"Detected in many"	4	"monocytes: 13.3"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 357.8;EFO-21: 738.6;Hep G2: 795.3;HSkMC: 534.8;SiHa: 209.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	NA	NA	1260000000000	200000000000			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"unprognostic (3.26e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.98e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.99e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.88e-1)"	532.8	288.8	38.7	196.1	49.2	1.5	215.8	48.9	44.2	239.5	34.6	119.9	23.1	83.6	41.4	77.1	353.4	358.2	161.1	33.4	208.8	50.0	4800.7	177.5	68.7	146.6	73.5	21.3	230.0	184.2	18.0	21.9	17.8	107.3	35.7	77.3	11.8	156.9	57.9	36.9	50.8	157.8	124.2	85.4	7.2	108.8	41.5	84.8	34.4	93.2	52.4	127.5	366.8	102.1	170.5	65.0	23.0	0.0	0.1	10.8	36.0	74.7	5.2	357.8	6.8	12.6	3.6	49.5	1.9	738.6	0.3	54.2	46.6	0.2	43.1	6.9	24.0	0.5	3.1	31.2	795.3	16.3	6.2	9.1	534.8	12.8	60.8	27.3	9.5	0.0	0.0	2.1	0.8	0.2	1.0	0.6	1.6	1.5	0.7	0.1	0.4	5.0	0.3	32.1	6.2	0.5	0.5	209.5	0.1	0.5	0.1	17.2	8.8	3.5	5.7	7.4	4.8	3.6	1.6	4.8	4.5	75.1	4.5	0.3	1.7	1.3	0.6	0.3	2.5	0.2	0.5	0.2	0.1	0.7	0.5	0.2	0.2	3.0	1.3	13.3	0.5	0.1	0.9	38.7	49.2	48.9	44.2	33.4	208.8	146.6	73.5	21.3	107.3	85.4	84.8	170.5	36.4	76.9	473.9	0.7	29.4	27.5	14.7	141.5	0.6	0.7	19.5	23.4	14.5	783.5	422.5	16.5	0.0	1.4	2.0	0.2	5.9	494.1	45.9	23.0	63.5	26.2	0.0	209.9	0.4	136.7	1.4	482.2	17.9	57.7	5.1	0.1	124.9	4512.2	34.4	0.0	0.5	0.9	20.3	164.5	44.8	97.5	226.2	45.1	35.6	70.3	14.6	1.2	0.0	0.5	0.6	376.4	0.2	10.9	3.9	13.3	1.9	53.6	177.5	4.6	6.6	20.1	49.1	4.0	7.7	5.2	21.9	2.7	15.0	0.1	0.4	38.2
CD5L	"API6, Spalpha"	ENSG00000073754	"CD5 molecule like"	O43866	1	157830911-157898256	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 578.0"	"Group enriched"	"Detected in some"	36	"Hofbauer cells: 279.0;Kupffer cells: 567.0"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA065686, HPA068384"	Enhanced				"Secreted to blood"	NA	NA	4030000000	4300000000			"HPA065686: AB_2685532, HPA068384: AB_2685979"		"unprognostic (2.96e-1)"		"unprognostic (2.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.56e-1)"		"unprognostic (5.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.63e-1)"		1.4	0.0	0.0	1.5	0.0	17.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	105.6	1.6	9.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	578.0	0.5	0.1	0.1	6.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	6.1	6.1	279.0	0.0	0.0	0.0	0.0	567.0	0.0	1.3	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.3	0.3	0.0	0.0	0.0
CES5A	"CAUXIN, CES4C1, CES5, CES7, FLJ31547"	ENSG00000159398	"Carboxylesterase 5A"	Q6NT32	16	55846154-55956031	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"epididymis: 68.1"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.5;Collecting duct cells: 5.5;Excitatory neurons: 1.4;Hepatocytes: 6.9;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 4.0"	"Cancer enriched"	"Detected in single"	5	"liver cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	46	"U-266/70: 7.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted in male reproductive system"	NA	NA									"unprognostic (2.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.34e-2)"	"unprognostic (4.82e-2)"		"unprognostic (3.78e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.12e-2)"		"unprognostic (1.72e-7)"	"unprognostic (1.55e-2)"	"unprognostic (2.27e-1)"			0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	68.1	0.0	0.0	0.6	0.1	0.2	0.2	0.0	3.9	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHAD	SLRR4A	ENSG00000136457	Chondroadherin	O15335	17	50464496-50468906	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.5;pancreas: 32.8"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 4.6;Breast myoepithelial cells: 2.4;Distal enterocytes: 3.3;Gastric mucus-secreting cells: 4.6;Hepatocytes: 2.4;Intestinal goblet cells: 4.3;Oligodendrocyte precursor cells: 5.5;Paneth cells: 2.5;Proximal enterocytes: 2.6"	"Group enriched"	"Detected in many"	5	"breast cancer: 23.7;liver cancer: 10.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	53	"memory B-cell: 21.5;naive B-cell: 8.0"	"Lineage enriched"	"Detected in single"	76	"B-cells: 21.5"	"Cell line enhanced"	"Detected in some"		"RT4: 4.0;SCLC-21H: 8.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA018241	Enhanced				"Secreted to extracellular matrix"	NA	NA		22000000			"HPA018241: AB_1846612"	"prognostic favorable (7.68e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.06e-3)"	"prognostic favorable (1.59e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.41e-3)"	1.5	14.2	7.2	0.7	8.0	0.3	9.7	16.9	7.4	21.9	5.1	4.1	7.7	0.5	0.1	1.8	0.8	1.5	1.2	6.6	6.8	2.3	36.5	1.7	0.6	7.5	6.7	6.4	3.2	32.8	0.0	1.3	0.5	9.6	1.9	4.0	0.5	21.5	0.2	14.7	8.6	10.4	0.1	6.1	1.2	10.8	1.2	6.7	0.2	4.2	0.9	0.2	1.3	1.6	6.8	1.0	0.8	0.7	0.6	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.5	0.8	0.1	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.6	0.7	1.2	0.7	1.5	0.0	0.4	1.1	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.1	0.3	0.0	0.5	0.0	0.7	0.1	0.1	0.7	0.9	0.1	1.5	0.0	4.0	8.5	0.2	0.1	0.3	0.0	0.3	0.3	0.2	0.9	2.1	0.4	0.1	0.0	1.4	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.2	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	7.2	8.0	16.9	7.4	6.6	6.8	7.5	6.7	6.4	9.6	6.1	6.7	6.8	0.0	0.0	0.0	1.3	1.0	0.3	0.2	0.3	0.0	0.0	4.6	2.4	0.2	1.5	0.2	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.2	4.3	0.0	0.3	0.4	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	5.5	0.1	0.0	2.5	0.0	1.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.4
CIDEC	"CIDE-3, FLJ20871, Fsp27"	ENSG00000187288	"Cell death inducing DFFA like effector c"	Q96AQ7	3	9866711-9880255	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 738.8;breast: 497.0"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 219.4"	"Group enriched"	"Detected in many"	5	"breast cancer: 4.5;colorectal cancer: 1.4;liver cancer: 2.4;pancreatic cancer: 4.6;stomach cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 1683.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA018837, HPA020553"	Uncertain					NA	NA					"HPA018837: AB_1846767, HPA020553: AB_1846769"	"unprognostic (1.83e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-5)"	"unprognostic (9.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.48e-3)"	"unprognostic (8.14e-2)"	"unprognostic (5.37e-5)"	"unprognostic (9.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (2.94e-2)"	738.8	5.6	0.2	1.1	0.3	0.0	497.0	0.1	0.4	0.9	0.0	11.6	69.6	4.7	0.3	0.7	2.2	5.0	7.0	0.1	0.2	2.1	10.1	0.2	1.2	0.2	0.1	0.0	0.4	7.4	0.1	0.2	0.0	0.1	2.3	3.9	0.0	16.3	3.8	6.2	15.5	90.6	1.6	0.1	0.2	7.5	0.9	0.1	1.5	3.9	11.7	0.0	13.4	4.9	0.3	0.0	0.2	0.0	0.0	1683.2	376.0	1.2	0.1	0.0	0.0	0.0	7.5	9.1	0.0	0.2	0.6	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	19.1	2.8	0.0	0.0	228.9	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.3	0.0	0.6	1.6	0.0	0.0	1.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.1	0.4	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.3	2.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	2.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	30.0	1.9	0.0	0.5	0.2	0.1	0.1	3.5	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.1	8.4	0.0	0.0	0.4	1.0	2.5	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	14.5	0.4	0.0	0.4	219.4	1.1	0.0	0.0	0.0	0.5	0.6	0.6	0.4	0.0	0.0	0.0	0.2	0.1	3.8	0.3
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 92.2;gallbladder: 102.5;kidney: 166.7;seminal vesicle: 90.9"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 77.5;Exocrine glandular cells: 49.1;Hepatocytes: 25.9;Pancreatic endocrine cells: 30.9;Proximal enterocytes: 32.9;Proximal tubular cells: 153.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 8.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 296.4"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.5;hippocampal formation: 9.5;pons and medulla: 10.3;thalamus: 8.9"	"Region enhanced"	"Detected in some"		"medulla oblongata: 1.7"	"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (9.76e-2)"	0.7	3.0	0.2	2.2	0.1	0.1	0.6	1.5	1.2	0.0	92.2	2.1	21.1	0.1	34.0	0.1	0.3	102.5	0.0	8.8	0.0	166.7	44.6	1.4	0.0	0.2	1.2	0.1	0.0	13.3	0.0	0.2	0.0	0.3	1.2	4.6	0.7	0.1	90.9	0.2	0.3	24.7	0.2	0.1	0.0	7.8	0.0	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.2	27.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	296.4	0.2	0.0	0.0	0.1	46.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.5	1.2	8.8	0.0	0.2	1.2	0.1	0.3	0.1	1.1	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	14.3	0.0	1.8	0.0	0.0	0.0	0.3	15.6	77.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	49.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.9	0.0	0.0	0.3	2.7	0.0	0.8	0.0	1.4	0.0	0.7	0.0	0.0	1.6	1.6	0.0	1.0	0.2	30.9	3.6	0.0	0.0	0.0	32.9	153.1	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.2	0.0
COX6A2		ENSG00000156885	"Cytochrome c oxidase subunit 6A2"	Q02221	16	31427731-31428360	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	43	"heart muscle: 2939.2;skeletal muscle: 6806.0;tongue: 2114.7"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 4861.8"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	150	"NK-cell: 15.0"	"Lineage enriched"	"Detected in single"	150	"NK-cells: 15.0"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.66e-1)"	"unprognostic (1.73e-3)"			"unprognostic (2.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.68e-2)"		"unprognostic (3.88e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-1)"			1.5	0.9	1.6	0.1	1.0	0.0	2.9	2.1	2.3	0.4	0.2	1.1	1.1	1.1	0.0	75.5	0.9	0.0	2939.2	0.8	1.5	4.4	16.0	3.4	0.4	1.4	1.7	0.7	1.2	3.0	2.9	12.0	0.1	5.2	39.2	0.0	1.0	92.8	0.1	6806.0	2.4	1.2	0.0	0.7	0.5	1.3	1.3	2.4	0.5	2.0	2114.7	0.1	0.3	1.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	1.6	1.0	2.1	2.3	0.8	1.5	1.4	1.7	0.7	5.2	0.7	2.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.4	4861.8	2.8	0.0	3.7	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.1	48.8	0.0	0.0	0.0	0.4	0.0	96.2	0.0	0.1	0.0	0.2	0.4	75.7	2.9	3.3	0.0	0.1	0.0	1.6	0.0	0.8	0.3	1.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.1	1.3	24.9	0.0	4.2	19.7	258.0	53.7	0.2	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0
CTH		ENSG00000116761	"Cystathionine gamma-lyase"	P32929	1	70411218-70439851	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Calmodulin-binding, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 123.9;ovary: 34.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 38.0;Hepatocytes: 141.6"	"Group enriched"	"Detected in all"	5	"liver cancer: 30.0;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 39.7;Karpas-707: 63.8;SK-MEL-30: 85.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021591, HPA023300"	Enhanced					NA	NA		220000			"HPA021591: AB_1847321, HPA023300: AB_1847322"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.76e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.45e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.05e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.26e-1)"	3.4	13.1	3.4	1.3	3.0	3.4	3.0	3.3	4.0	2.4	3.9	5.2	5.2	2.3	1.6	4.5	3.8	1.9	2.1	3.2	6.6	13.6	123.9	3.1	0.9	3.4	3.4	3.2	34.7	17.1	1.4	2.9	1.1	3.2	4.3	6.3	8.2	2.5	2.1	3.6	1.2	5.3	1.3	2.6	1.0	7.5	4.2	3.3	0.6	7.8	3.0	1.3	2.2	1.9	3.2	10.2	1.5	7.1	10.0	8.5	4.8	15.0	4.3	4.1	3.8	15.7	3.2	6.4	5.8	3.4	3.1	9.3	4.9	27.3	3.1	7.2	17.3	5.9	7.0	5.1	9.4	39.7	7.8	1.7	7.5	24.4	7.5	8.8	1.5	3.2	11.9	14.0	63.8	2.2	3.2	2.7	1.9	7.2	4.2	5.9	3.0	3.7	16.2	7.3	0.1	3.9	3.3	6.6	7.7	85.7	13.3	2.6	4.6	1.1	1.2	7.7	5.7	4.1	23.8	15.3	3.1	9.8	16.1	3.1	0.8	0.3	0.1	1.2	0.2	2.1	2.2	1.1	1.7	0.5	1.7	3.2	1.5	0.4	0.2	0.2	0.7	0.3	0.6	3.4	3.0	3.3	4.0	3.2	6.6	3.4	3.4	3.2	3.2	2.6	3.3	3.2	2.8	6.4	5.6	16.6	6.7	2.5	8.0	2.2	6.2	9.4	6.2	5.8	1.9	5.7	2.5	5.5	10.4	0.8	5.5	16.1	11.7	1.8	27.2	38.0	6.4	3.3	3.0	7.4	7.8	4.2	1.8	13.6	14.8	19.7	0.0	1.9	3.9	141.6	1.2	0.0	7.4	7.9	2.0	3.5	5.7	5.2	1.2	4.7	19.6	1.9	0.0	4.4	0.0	7.1	4.2	6.4	12.9	4.1	10.8	4.0	11.1	29.2	0.7	11.6	0.0	2.8	17.7	1.4	0.6	4.8	2.0	0.8	11.2	4.5	9.1	3.8
CYP17A1	"CPT7, CYP17, P450C17, S17AH"	ENSG00000148795	"Cytochrome P450 family 17 subfamily A member 1"	P05093	10	102830531-102837472	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Steroidogenesis	"Lyase, Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	84	"adrenal gland: 8297.2"	"Cell type enriched"	"Detected in some"	17	"Theca cells: 1871.0"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 22.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 3.0;SCLC-21H: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048533	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA048533: AB_2680432"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.39e-4)"	"unprognostic (8.26e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.43e-7)"	"unprognostic (1.07e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.94e-4)"	0.4	8297.2	0.0	2.1	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.5	0.0	0.8	0.1	0.9	1.0	0.4	0.8	0.0	0.0	53.4	6.7	1.4	0.0	0.0	0.1	0.0	16.8	1.8	10.6	0.7	0.0	0.0	0.7	0.0	0.2	3.4	0.0	1.0	0.6	0.6	0.0	0.0	0.9	1.3	99.1	0.0	0.0	2.9	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.2	0.1	0.4	0.1	0.0	0.5	0.0	0.1	0.7	0.0	0.0	1.8	0.0	0.4	0.1	0.1	21.5	0.0	41.6	0.1	0.0	0.7	0.0	2.7	0.1	0.2	0.0	1.3	0.0	0.1	0.0	0.1	0.4	6.1	0.1	1.7	0.1	0.0	0.0	0.6	0.7	10.6	1.8	0.9	0.0	0.0	0.1	0.2	3.1	0.5	0.1	0.7	0.0	0.0	0.0	0.3	0.0	104.3	0.0	1.2	0.0	1.2	0.6	0.3	0.1	0.0	0.0	0.3	0.4	1871.0	0.0	0.1
CYP2A13	"CPAD, CYP2A"	ENSG00000197838	"Cytochrome P450 family 2 subfamily A member 13"	Q16696	19	41088451-41096195	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"liver: 2.0"	"Group enriched"	"Detected in some"	8	"Club cells: 2.0;Early spermatids: 4.2;Late spermatids: 3.7"	"Cancer enriched"	"Detected in single"	5	"liver cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046713, HPA047262"	Supported				"Intracellular and membrane"	NA	NA					"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (9.79e-2)"						"unprognostic (1.00e-1)"	"unprognostic (4.51e-3)"		"unprognostic (4.92e-2)"				"unprognostic (1.99e-1)"	"unprognostic (1.49e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CYP4A11	"CYP4A2, CYP4AII"	ENSG00000187048	"Cytochrome P450 family 4 subfamily A member 11"	Q02928	1	46929177-46941484	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	333	"kidney: 220.8;liver: 864.1"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 563.8"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 73.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (9.05e-2)"	"unprognostic (4.98e-2)"		"unprognostic (4.43e-2)"	"unprognostic (4.11e-1)"	"unprognostic (7.81e-5)"	"unprognostic (5.10e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.59e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.68e-2)"	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.6	0.0	1.4	0.0	0.1	1.1	0.1	0.0	0.4	220.8	864.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	32.9	0.0	7.3	0.0	0.0	0.0	0.0	17.6	0.0	0.5	0.8	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	563.8	0.0	0.0	0.1	0.0	0.0	7.3	0.2	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.1	108.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0
DCXR	"DCR, HCR2, KIDCR, P34H, SDR20C1"	ENSG00000169738	"Dicarbonyl and L-xylulose reductase"	Q7Z4W1	17	82035136-82037709	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Xylose metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 1866.7"	"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 812.0;Hepatocytes: 3510.3;Proximal tubular cells: 2919.4"	"Group enriched"	"Detected in all"	5	"liver cancer: 305.9;prostate cancer: 163.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 365.2;MCF7: 446.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023371, HPA023863"	Enhanced		Uncertain	Nucleoli,Microtubules		NA	NA		4000000	"Nucleoli, Microtubules"		"HPA023371: AB_1847530, HPA023863: AB_1847531"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.70e-4)"	"unprognostic (1.72e-1)"	"prognostic favorable (2.13e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.10e-2)"	100.5	44.3	79.1	15.3	82.3	25.5	108.6	87.2	112.0	46.9	68.5	42.7	29.4	39.8	283.7	97.4	59.7	10.9	101.1	72.5	85.3	242.2	1866.7	61.5	16.8	95.8	84.6	70.1	70.6	72.2	46.5	64.4	20.3	91.2	139.2	21.1	9.8	104.3	33.9	188.8	81.9	44.8	10.5	76.3	36.0	168.3	45.1	90.6	26.3	61.2	81.3	19.8	49.3	62.6	85.2	50.3	68.2	32.8	56.4	123.2	31.8	80.4	25.0	33.9	68.5	48.4	122.0	21.3	100.3	47.4	35.9	9.4	57.4	59.6	52.6	24.1	21.4	145.9	96.9	48.8	365.2	143.2	75.6	114.5	44.6	62.2	22.7	79.8	16.0	41.1	61.1	112.4	76.3	36.5	446.2	63.7	184.1	35.0	242.9	71.3	57.9	42.0	135.3	53.3	71.9	85.5	51.0	35.5	287.5	46.0	19.7	213.4	74.5	20.5	36.6	45.0	48.9	48.2	73.7	56.2	50.2	31.4	83.0	26.7	49.5	92.6	77.9	66.5	92.0	64.1	86.8	83.0	64.7	151.3	99.2	117.7	85.4	47.2	108.9	88.1	121.6	98.9	110.1	79.1	82.3	87.2	112.0	72.5	85.3	95.8	84.6	70.1	91.2	76.3	90.6	85.2	29.0	51.3	198.2	16.6	133.6	58.5	200.3	113.5	109.8	16.0	301.8	269.2	120.7	183.0	123.4	178.4	18.8	372.1	116.6	152.9	812.0	41.4	6.0	67.0	50.9	44.6	54.7	335.7	4.7	42.6	450.6	65.0	151.4	102.3	64.7	62.7	138.5	3510.3	164.7	21.9	9.0	170.4	189.2	165.7	65.6	22.6	70.8	82.3	179.7	1.9	52.8	145.1	78.2	5.5	10.5	30.4	135.7	47.4	98.6	215.2	158.9	2919.4	55.4	26.5	19.7	40.6	79.6	10.3	48.2	219.9	73.2	342.6	135.7	118.6	154.6	178.8
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 167.2;kidney: 317.9;retina: 177.1"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 410.3;Proximal enterocytes: 391.5;Proximal tubular cells: 429.5;Rod photoreceptor cells: 498.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.5;liver cancer: 13.4;pancreatic cancer: 6.4;renal cancer: 18.7;stomach cancer: 9.9"	"Region enhanced"	"Detected in many"		"midbrain: 28.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 54.5;Hep G2: 49.3;OE19: 83.6;SCLC-21H: 130.9;SH-SY5Y: 135.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"midbrain: 74.5;pons: 29.4"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		120000	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.5	49.3	0.4	2.3	0.6	0.0	1.0	0.0	1.3	0.0	0.2	36.9	156.2	0.0	9.2	0.1	0.0	0.2	0.0	0.1	1.9	317.9	55.1	2.1	0.1	6.2	28.5	0.0	0.8	15.9	0.0	0.0	0.0	15.4	0.6	37.8	177.1	0.0	0.0	0.0	0.0	167.2	1.7	0.0	0.1	18.3	1.5	9.6	0.0	0.2	0.0	0.0	0.0	0.1	6.4	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	83.6	0.0	0.0	0.0	0.7	1.3	0.0	130.9	135.9	0.0	4.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	1.3	0.1	1.9	6.2	28.5	0.0	15.4	0.0	9.6	6.4	0.0	0.0	12.2	0.0	2.5	0.0	0.0	0.0	0.0	89.3	0.1	0.1	0.4	2.8	0.6	3.7	41.7	0.0	0.0	34.4	25.4	0.1	6.6	0.1	0.0	1.8	410.3	0.0	0.3	0.9	0.1	0.1	0.0	0.4	0.0	0.0	1.1	67.2	0.1	3.3	0.4	67.8	0.0	1.3	0.0	5.4	0.0	2.5	0.0	0.0	0.0	45.1	0.0	0.0	0.1	0.2	31.8	0.0	0.0	0.3	391.5	429.5	0.0	498.9	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.1	1.3	0.1	88.7	0.2
DPYS	DHPase	ENSG00000147647	Dihydropyrimidinase	Q14117	8	104330324-104467055	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	51	"kidney: 201.4;liver: 481.5"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 459.5;Proximal tubular cells: 518.8"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 57.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024785, HPA070814"	Enhanced					NA	NA		820000			"HPA024785: AB_1847856, HPA070814: "	"unprognostic (1.54e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.16e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-1)"	4.0	2.8	0.6	0.1	0.7	0.0	0.4	0.2	1.7	1.2	0.3	0.2	0.0	0.1	0.6	0.1	0.7	6.6	0.1	0.6	0.5	201.4	481.5	0.6	0.3	0.5	0.7	0.5	0.2	0.1	0.6	0.2	0.6	0.5	4.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.3	0.1	0.9	1.0	5.2	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.2	1.7	0.6	0.5	0.5	0.7	0.5	0.5	0.4	1.0	0.8	0.1	0.0	0.0	1.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	40.0	0.0	20.2	0.0	0.0	0.0	0.0	27.4	0.1	12.8	0.3	0.1	1.0	0.0	16.0	11.2	0.0	0.0	1.8	0.0	0.3	0.0	0.4	11.7	459.5	1.4	0.0	4.6	0.0	0.0	11.1	0.3	13.5	0.9	10.6	0.0	14.0	0.4	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	518.8	0.0	0.1	0.0	0.0	0.0	1.2	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5 (inactive)"	O75356	14	73958010-74019399	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 108.2;kidney: 96.1;liver: 265.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 209.3;Hepatocytes: 134.8;Intestinal goblet cells: 77.1;Proximal enterocytes: 87.0"	"Group enriched"	"Detected in all"	5	"liver cancer: 18.2;prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 18.3;eosinophil: 9.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.3"	"Cell line enhanced"	"Detected in all"		"RT4: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced				"Secreted to blood"	NA	NA		5900000			"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	8.3	7.8	5.3	11.5	7.5	8.1	12.5	7.2	6.4	6.8	6.8	95.5	72.8	6.4	7.8	11.4	5.7	12.2	7.7	5.3	6.4	96.1	265.9	6.6	5.6	7.6	7.7	4.7	6.8	5.0	7.8	5.0	5.6	7.7	38.0	108.2	9.5	10.7	4.4	15.1	8.2	68.9	9.8	7.3	6.0	42.7	8.7	7.1	4.6	6.2	9.2	5.7	17.1	7.2	9.4	9.5	7.8	8.2	15.1	16.5	15.5	9.4	9.6	7.9	6.4	7.1	5.6	10.9	10.6	4.7	12.8	6.0	10.8	8.5	14.1	7.2	8.8	4.0	7.9	5.7	30.9	15.5	4.7	8.8	12.9	14.0	8.7	18.2	8.8	13.1	17.1	8.8	15.4	9.7	13.6	5.4	5.6	2.5	8.5	15.7	6.0	8.0	5.2	11.4	57.1	5.8	6.0	16.6	12.9	9.2	6.4	18.7	4.1	10.8	12.6	12.7	7.5	7.2	10.1	16.9	8.3	8.0	8.8	11.5	18.3	1.2	9.4	2.5	2.3	1.3	1.4	1.3	1.8	1.7	1.5	2.1	2.1	0.1	0.5	1.4	0.9	1.6	1.3	5.3	7.5	7.2	6.4	5.3	6.4	7.6	7.7	4.7	7.7	7.3	7.1	9.4	8.0	16.0	6.7	8.1	4.9	3.7	6.2	8.9	5.2	6.6	15.0	7.9	5.2	10.0	11.3	7.3	4.2	8.2	4.3	209.3	25.4	6.9	19.5	10.0	13.6	7.0	16.2	36.6	5.9	12.9	6.7	7.9	23.0	25.8	1.3	9.6	9.7	134.8	6.2	10.1	8.2	77.1	14.2	9.7	1.9	12.7	2.8	5.2	5.4	11.2	5.4	4.9	8.2	2.0	11.3	9.1	58.4	5.7	3.6	28.5	87.0	63.1	6.4	12.2	13.1	6.0	5.9	27.2	19.1	8.5	3.4	3.3	4.9	10.3	60.9	39.0
EPO	EP	ENSG00000130427	Erythropoietin	P01588	7	100720468-100723700	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted secreted proteins"	"Erythrocyte maturation"	Hormone	"Cancer-related genes, Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 47.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 2.9;Exocrine glandular cells: 4.2;Extravillous trophoblasts: 14.0;Hepatocytes: 19.5;Pancreatic endocrine cells: 3.7;Syncytiotrophoblasts: 2.9"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.7;renal cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 1.6;Hep G2: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010336	Supported				"Secreted to blood"	NA	NA	12300				"CAB010336: AB_2098408"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (2.18e-6)"	"unprognostic (4.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.34e-1)"	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.3	3.0	0.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.2	0.1	0.3	3.0	47.6	0.1	0.0	0.2	0.1	0.2	0.2	8.4	0.0	0.0	0.1	0.2	0.5	0.0	0.2	1.4	0.5	0.0	0.4	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.1	0.3	0.2	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	4.2	14.0	0.0	0.0	0.0	0.0	0.1	1.4	19.5	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	2.9	0.0	0.0	0.0	0.0
FAM151A	"C1orf179, MGC27169"	ENSG00000162391	"Family with sequence similarity 151 member A"	Q8WW52	1	54609181-54623556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 66.8;kidney: 176.1"	"Group enriched"	"Detected in some"	15	"Proximal enterocytes: 478.5;Proximal tubular cells: 294.8"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	44	"CACO-2: 78.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016840	Approved					NA	NA		10000			"HPA016840: AB_2669461"	"unprognostic (1.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.97e-6)"	"unprognostic (1.71e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.91e-3)"	"unprognostic (9.99e-2)"	"prognostic favorable (4.09e-5)"	"unprognostic (5.85e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-3)"	0.6	0.3	1.7	0.7	1.2	0.2	0.1	1.8	1.2	0.0	5.0	2.1	2.4	0.1	0.0	0.3	0.0	0.1	3.1	0.7	0.3	176.1	16.9	0.0	5.4	2.7	2.3	0.0	0.3	0.6	0.0	0.1	0.0	1.5	0.1	1.3	0.3	0.5	0.0	1.0	0.1	66.8	0.0	0.5	0.8	0.7	0.6	2.8	0.2	0.4	0.0	1.9	0.1	0.0	0.8	0.7	0.1	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	78.9	0.9	0.0	0.3	0.0	0.2	1.1	0.0	0.0	0.0	0.5	0.0	1.7	0.4	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	1.5	0.0	0.0	0.8	0.0	0.0	1.6	0.4	0.5	0.1	0.0	0.0	0.3	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	1.8	1.2	0.7	0.3	2.7	2.3	0.0	1.5	0.5	2.8	0.8	0.0	0.0	0.0	3.6	2.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.0	9.3	13.7	0.0	5.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.4	16.8	0.0	0.3	0.0	14.3	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	25.0	0.0	0.0	0.0	478.5	294.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.0	0.1	18.1	0.0
FCAMR	"CD351, FCA/MR, FKSG87"	ENSG00000162897	"Fc fragment of IgA and IgM receptor"	Q8WWV6	1	206957965-206970625	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"kidney: 38.4;lymphoid tissue: 26.4"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 32.9"	"Group enriched"	"Detected in some"	5	"liver cancer: 2.4;renal cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA056505	Enhanced					NA	NA		5300000			"HPA056505: AB_2732604"	"unprognostic (2.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.08e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.26e-1)"	0.2	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	38.4	8.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	2.4	0.6	0.0	0.0	1.0	0.0	0.0	26.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	32.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1
FOXA3	HNF3G	ENSG00000170608	"Forkhead box A3"	P55318	19	45863989-45873797	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"intestine: 17.7;liver: 65.1;pancreas: 48.6;stomach 1: 37.2"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 83.3;Gastric mucus-secreting cells: 152.9;Intestinal goblet cells: 230.1;Paneth cells: 74.7;Undifferentiated cells: 46.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 19.9;liver cancer: 26.4;pancreatic cancer: 20.7;stomach cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.5;Hep G2: 29.1;K-562: 23.5;OE19: 101.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB015154, HPA054034"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB015154: AB_647545, HPA054034: AB_2682349"	"unprognostic (2.88e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.11e-1)"	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	17.7	10.7	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.5	65.1	0.3	0.1	0.0	0.0	0.0	0.0	48.6	1.1	0.0	0.0	0.0	0.5	17.3	0.0	2.1	0.4	0.0	0.0	13.0	0.7	0.0	0.0	37.2	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.6	4.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	12.5	1.1	0.2	0.0	29.1	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.7	23.5	0.0	0.0	0.3	0.1	0.0	11.2	101.2	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	2.5	0.3	0.9	0.3	1.3	0.7	0.0	0.0	2.6	1.5	0.5	15.7	2.5	1.8	0.0	0.0	0.6	40.2	0.0	12.5	0.2	0.1	0.1	0.9	83.3	10.7	0.1	24.5	0.0	0.5	152.9	0.4	4.5	0.1	1.4	29.9	0.0	0.0	0.1	230.1	0.0	2.2	0.7	0.5	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.5	0.1	26.0	74.7	0.0	0.6	6.6	17.8	0.4	0.3	0.0	0.0	0.0	1.1	2.7	5.6	0.2	0.3	0.0	0.4	0.1	46.2	1.7
FUOM	"C10orf125, FLJ26016, FucM, FucU"	ENSG00000148803	"Fucose mutarotase"	A2VDF0	10	133355158-133358025	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 230.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 564.7;Hofbauer cells: 172.0;Proximal enterocytes: 690.7;Proximal tubular cells: 368.1"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 61.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039207	Approved					NA	NA		2000000			"HPA039207: AB_10795033"	"unprognostic (1.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.48e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.82e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.50e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.65e-1)"	13.1	8.9	4.0	11.4	4.4	6.7	13.1	3.8	7.3	6.5	7.5	11.1	52.5	5.6	3.2	8.8	7.9	9.7	13.2	3.9	4.8	45.9	230.1	14.2	16.9	4.9	4.6	3.6	7.4	18.4	8.0	6.0	5.3	5.5	7.1	5.5	0.3	29.0	3.6	3.0	7.4	47.2	3.7	4.8	23.9	8.6	5.7	4.7	6.2	6.6	2.7	8.1	8.0	7.8	4.7	23.3	7.2	13.6	28.4	3.8	9.2	24.8	18.3	20.7	6.5	8.1	46.4	12.4	0.0	20.7	13.8	0.0	1.2	4.9	6.3	0.5	8.4	4.9	22.3	10.3	50.7	20.1	25.2	14.8	9.6	0.2	2.6	1.4	3.0	9.2	22.9	22.2	29.7	13.9	23.0	3.9	33.6	9.5	13.5	3.2	21.8	0.4	13.0	7.5	0.0	1.4	11.0	6.7	20.6	25.3	6.8	0.2	38.3	18.7	0.1	18.4	0.0	0.1	15.5	2.7	16.7	5.5	10.2	7.1	0.1	68.9	6.5	16.0	73.2	14.7	36.0	14.0	13.4	57.2	34.5	14.9	13.1	3.3	17.1	15.7	79.0	10.4	28.6	4.0	4.4	3.8	7.3	3.9	4.8	4.9	4.6	3.6	5.5	4.8	4.7	4.7	20.4	6.4	10.0	0.0	32.7	12.1	9.2	8.5	6.2	0.1	12.2	25.7	10.9	22.8	11.4	9.2	0.0	10.3	25.1	79.2	31.3	13.6	3.7	3.8	9.7	14.1	3.0	24.4	0.6	12.7	9.0	25.6	8.6	7.7	27.3	15.5	25.0	564.7	172.0	0.0	1.2	49.7	6.1	103.0	55.4	10.3	10.2	68.7	26.6	1.9	85.6	3.5	13.4	0.0	1.0	12.5	119.5	3.8	29.6	17.8	690.7	368.1	4.0	1.1	13.1	11.6	14.9	20.2	23.7	10.0	9.9	6.6	21.5	4.1	61.1	12.1
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138824-35143109	"Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1394.5;tongue: 846.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.0"	"Group enriched"	"Detected in many"	4	"B-cells: 11.0;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	129.0	26.4	429.7	9.7	441.5	2.2	126.2	441.8	642.5	267.9	518.6	129.7	14.4	174.7	62.7	71.4	189.0	56.8	562.9	419.3	426.4	28.6	563.2	86.6	6.7	494.7	426.3	396.9	145.9	19.3	3.8	40.1	29.6	438.2	117.0	25.8	36.3	37.5	74.1	1394.5	46.8	67.8	105.3	429.0	20.9	73.2	12.2	474.4	8.2	38.4	846.2	6.8	80.7	196.6	432.9	1.1	0.0	0.0	0.2	46.7	13.5	1.3	5.7	0.1	0.0	0.0	0.0	0.3	3.8	1.5	0.0	0.1	1.0	1.1	0.7	0.0	3.4	1.3	0.7	0.0	1.9	5.2	0.3	0.4	19.3	0.0	0.1	0.5	0.5	0.2	0.1	1.0	3.7	0.1	0.0	0.1	0.8	0.2	2.8	0.6	0.0	0.2	1.1	0.0	0.0	0.3	0.2	0.7	0.2	1.8	0.3	0.2	6.1	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.4	0.9	0.6	7.7	1.6	0.3	0.0	1.3	0.7	0.8	11.0	3.6	1.5	0.3	6.9	0.7	0.9	0.5	2.1	0.8	0.6	6.9	0.6	429.7	441.5	441.8	642.5	419.3	426.4	494.7	426.3	396.9	438.2	429.0	474.4	432.9	46.1	0.0	0.0	44.4	15.8	29.4	3.7	2.7	8.0	1.8	4.4	18.0	0.3	11.5	0.8	25.8	4.2	1.2	9.5	42.2	0.0	0.1	1.9	2.2	47.4	13.3	0.0	8.4	3.7	4.9	1.6	225.1	2.0	1.2	0.0	0.1	36.0	651.7	4.4	0.0	0.4	0.8	2.0	14.4	49.0	12.0	430.3	5.3	53.4	2.8	1.0	343.4	1.0	1.5	0.5	1.1	5.3	128.2	2.5	3.3	0.4	0.2	12.6	8.6	118.3	188.7	205.7	10.7	21.7	3.0	27.3	2.9	18.8	0.1	0.7	2.5
GAMT	"PIG2, TP53I2"	ENSG00000130005	"Guanidinoacetate N-methyltransferase"	Q14353	19	1397026-1401570	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 620.1;skeletal muscle: 1246.7;tongue: 470.5"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 718.3;Proximal tubular cells: 417.4"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 173.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 176.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051806	Approved					NA	NA		420000			"HPA051806: AB_2681619"	"unprognostic (3.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-2)"	13.4	26.8	65.9	4.6	67.8	8.9	15.7	62.9	79.8	14.8	49.1	9.0	3.3	10.1	143.1	23.2	14.8	10.0	84.7	62.5	63.8	70.7	620.1	8.2	7.8	68.1	64.8	60.3	23.0	231.7	38.1	37.7	5.0	69.1	36.8	2.2	15.2	43.0	17.6	1246.7	29.4	6.5	4.6	64.8	10.8	32.1	55.4	65.8	25.0	22.4	470.5	4.4	13.0	15.4	90.3	21.6	24.1	25.2	56.9	30.9	37.3	34.3	25.2	41.2	31.8	28.7	54.8	15.1	11.3	17.2	30.0	3.8	9.1	39.8	15.5	8.5	81.5	46.2	34.9	20.3	176.7	18.2	0.7	11.5	41.8	5.5	33.8	0.1	44.0	6.9	43.0	50.6	26.6	52.6	22.1	103.9	12.0	28.6	10.7	75.4	103.1	22.3	81.4	38.1	19.5	8.4	58.5	1.9	14.3	32.0	16.1	65.3	48.1	12.2	34.6	35.6	1.9	11.6	119.0	24.8	19.5	32.2	46.1	40.7	3.7	2.5	15.3	18.8	3.4	27.3	22.0	26.3	23.8	11.2	32.3	40.6	30.8	1.5	18.2	6.1	47.3	15.8	14.9	65.9	67.8	62.9	79.8	62.5	63.8	68.1	64.8	60.3	69.1	64.8	65.8	90.3	9.2	0.0	7.2	5.5	18.0	58.9	42.1	57.8	116.7	41.0	60.3	99.9	99.3	127.2	12.9	16.5	56.3	35.7	15.4	0.8	92.0	39.9	5.2	6.5	7.4	9.2	7.2	35.8	7.4	33.6	41.2	30.9	10.2	4.0	4.5	43.3	18.9	718.3	81.7	18.5	10.1	1.5	6.1	29.5	13.3	16.0	83.9	13.9	32.0	3.7	4.7	57.3	10.3	4.0	36.7	13.5	0.1	139.5	12.5	24.1	0.1	417.4	6.1	61.7	32.9	77.8	47.1	4.3	22.6	42.1	42.9	12.0	19.7	31.1	3.3	23.2
GLTPD2		ENSG00000182327	"Glycolipid transfer protein domain containing 2"	A6NH11	17	4788964-4790589	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 74.4"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 83.7;Proximal tubular cells: 135.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 25.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 3.4;CACO-2: 9.2;Hep G2: 13.7;MCF7: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058295, HPA065267"	Uncertain		Approved	Vesicles	"Secreted - unknown location"	NA	NA		150000	Vesicles		"HPA058295: AB_2683671, HPA065267: AB_2685451"	"unprognostic (4.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (5.62e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.25e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.71e-4)"	"unprognostic (7.59e-3)"	0.5	0.5	1.1	0.5	1.1	1.5	0.3	1.7	2.6	0.4	0.0	0.5	10.1	0.5	0.0	0.8	0.4	0.3	0.2	1.0	1.6	11.7	74.4	0.4	0.1	3.2	1.4	1.3	0.3	0.7	0.2	0.8	0.1	1.6	0.4	0.0	0.3	1.0	0.0	1.3	1.7	6.2	0.0	0.3	1.2	1.1	0.1	1.2	0.0	0.2	0.0	0.0	0.5	0.5	1.2	0.5	1.8	0.1	1.5	0.0	0.0	3.4	0.4	0.0	0.0	0.0	9.2	0.6	0.8	0.9	0.0	0.3	1.7	0.0	0.0	0.0	1.7	1.2	0.1	0.7	13.7	0.1	0.2	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.5	0.4	0.0	4.1	0.1	0.1	0.2	0.6	0.7	0.7	0.5	0.2	0.0	0.7	1.1	0.7	1.6	0.3	0.4	0.0	1.0	0.1	1.7	0.5	0.7	0.4	0.3	0.1	0.5	0.1	0.2	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	1.1	1.7	2.6	1.0	1.6	3.2	1.4	1.3	1.6	0.3	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.3	0.2	1.5	0.5	0.0	0.0	0.0	0.1	0.4	17.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.2	0.0	0.0	2.2	83.7	0.1	0.0	0.2	0.6	0.0	1.3	0.4	0.2	0.6	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.6	0.3	21.1	135.8	0.3	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.1	0.3	0.3	0.1	0.3	0.4
GPAM	"GPAT1, KIAA1560, MGC26846"	ENSG00000119927	"Glycerol-3-phosphate acyltransferase, mitochondrial"	Q9HCL2	10	112149865-112215377	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 308.5;liver: 145.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 90.8;Hepatocytes: 184.5;Horizontal cells: 45.4"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 250.3;Hep G2: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046339, HPA060090"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046339: AB_2679627, HPA060090: AB_2684202"	"unprognostic (1.82e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.59e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.44e-2)"	"prognostic favorable (4.54e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.37e-1)"	308.5	34.2	15.2	4.8	15.8	3.5	68.2	12.4	13.9	3.0	7.2	6.4	4.0	4.2	75.8	2.9	3.1	6.0	12.4	12.7	12.4	4.4	145.3	4.1	4.7	14.9	15.0	11.3	5.3	5.0	4.3	2.1	3.0	13.8	3.9	4.7	5.1	17.3	5.4	8.4	3.1	6.1	4.9	11.2	3.0	4.9	5.7	15.8	3.7	12.5	8.9	4.3	4.9	2.6	11.5	9.9	7.4	9.7	12.9	250.3	9.1	12.7	9.2	10.5	6.6	5.1	17.3	5.7	6.9	5.0	6.5	6.1	12.3	15.5	7.9	12.3	5.0	8.4	6.4	7.9	71.8	7.7	11.2	3.4	43.8	13.1	11.7	23.6	49.7	5.8	9.7	8.5	6.1	7.7	5.6	9.6	8.8	8.1	5.6	10.1	9.7	25.4	5.1	4.3	6.8	4.1	12.1	12.8	6.1	14.5	8.9	6.3	4.0	4.4	7.5	4.6	9.4	14.8	6.1	7.3	14.3	8.8	9.8	5.8	0.0	0.3	0.1	0.7	0.4	0.9	0.5	0.5	0.5	0.4	1.1	0.5	0.9	0.0	0.3	0.3	0.6	0.6	0.3	15.2	15.8	12.4	13.9	12.7	12.4	14.9	15.0	11.3	13.8	11.2	15.8	11.5	9.1	9.6	27.1	90.8	5.2	0.4	0.8	1.6	4.6	5.3	8.1	8.4	18.9	20.0	4.3	5.5	10.4	5.2	4.3	1.7	1.9	2.7	0.5	5.1	10.0	5.0	1.2	12.2	8.2	3.3	2.9	5.1	3.6	4.2	2.5	12.7	6.4	184.5	3.1	45.4	9.4	3.0	0.0	9.3	1.0	0.9	5.3	1.9	1.8	10.3	1.4	6.1	3.1	10.1	10.1	3.4	2.7	12.0	6.4	1.1	3.7	3.3	4.7	9.1	6.6	4.3	6.6	4.0	3.2	5.4	0.1	1.9	3.3	8.6	5.0	0.6
HAAO		ENSG00000162882	"3-hydroxyanthranilate 3,4-dioxygenase"	P46952	2	42767089-42792593	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 298.2"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 209.8;Proximal enterocytes: 236.8;Proximal tubular cells: 162.7"	"Group enriched"	"Detected in all"	5	"liver cancer: 46.5;renal cancer: 13.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 23.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 23.2;granulocytes: 19.2;monocytes: 17.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;Hep G2: 49.4;REH: 9.9;THP-1: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036394, HPA042024"	Enhanced					NA	NA		580000			"HPA036394: AB_10673131, HPA042024: AB_2677803"	"unprognostic (6.97e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (5.77e-4)"	"unprognostic (6.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-1)"	8.8	5.4	1.7	5.9	1.9	4.1	13.0	2.0	2.5	15.1	3.2	13.3	23.3	10.6	14.6	6.0	10.7	6.2	6.3	1.7	3.8	42.2	298.2	5.8	6.2	2.0	2.3	1.5	14.2	26.5	2.9	4.5	8.6	2.1	10.2	11.7	0.3	3.8	11.4	2.4	4.7	41.1	4.8	2.0	5.4	9.7	1.8	2.1	4.1	5.8	3.2	4.6	15.9	9.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.4	4.6	14.0	0.1	0.0	0.1	0.6	0.0	0.0	4.7	0.0	0.8	0.0	1.4	5.6	0.0	49.4	0.4	1.9	0.1	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	2.6	0.2	0.0	9.9	1.1	0.3	0.0	0.0	0.1	0.0	0.6	1.0	0.0	1.3	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	7.9	17.4	19.2	0.0	10.5	0.0	3.5	0.0	0.0	23.2	3.9	0.0	0.1	5.5	0.7	2.9	7.7	0.0	5.6	1.7	1.9	2.0	2.5	1.7	3.8	2.0	2.3	1.5	2.1	2.0	2.1	2.3	2.5	0.0	1.1	3.6	3.5	4.0	6.3	2.3	14.8	0.1	2.9	7.6	0.6	14.3	1.6	1.8	0.0	1.1	2.9	18.3	17.6	7.4	0.0	0.6	8.1	1.9	6.7	12.0	3.4	13.3	0.5	18.0	1.5	0.3	30.4	1.2	4.6	209.8	21.3	0.0	2.2	14.9	0.0	13.5	4.9	0.2	12.5	8.7	5.4	8.4	8.4	3.6	1.0	5.5	1.0	4.8	28.7	10.5	0.5	2.1	236.8	162.7	0.5	0.3	13.1	37.7	13.8	0.4	0.7	6.0	4.8	1.2	1.2	2.2	25.5	2.7
HABP2	"FSAP, HABP, HGFAL, PHBP"	ENSG00000148702	"Hyaluronan binding protein 2"	Q14520	10	113550837-113589602	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 440.9"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 124.4;Hepatocytes: 221.4"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 92.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"OE19: 64.7;RPTEC TERT1: 50.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019518	Uncertain				"Secreted to blood"	NA	NA	20200000000	4400000000			"HPA019518: AB_1850467"	"unprognostic (3.89e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.05e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.5	0.0	0.0	3.1	2.9	1.7	0.0	2.3	36.3	2.1	0.2	0.0	13.9	440.9	0.8	0.0	0.0	0.0	0.1	0.0	17.5	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.1	12.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	64.7	0.0	0.0	0.1	0.0	50.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	2.3	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	124.4	0.0	1.8	0.0	0.0	0.0	0.0	3.9	31.4	0.5	10.8	0.8	0.4	0.0	5.3	1.0	3.9	0.0	0.0	17.9	6.5	0.0	0.0	5.3	221.4	1.0	0.0	0.0	0.2	0.0	5.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	12.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.1
HHEX	"HEX, HOX11L-PEN, PRHX"	ENSG00000152804	"Hematopoietically expressed homeobox"	Q03014	10	92689955-92695647	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 85.5;liver: 92.0;thyroid gland: 102.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 77.2;Cholangiocytes: 125.8;dendritic cells: 57.6;Ductal cells: 107.9;Endothelial cells: 80.0;Hepatic stellate cells: 88.9;Hepatocytes: 58.3;Hofbauer cells: 72.6;Kupffer cells: 63.5"	"Group enriched"	"Detected in all"	5	"liver cancer: 20.1;thyroid cancer: 56.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	43	"basophil: 28.0;classical monocyte: 41.5;eosinophil: 61.8;intermediate monocyte: 45.7;memory B-cell: 59.3;myeloid DC: 30.8;naive B-cell: 65.8;neutrophil: 31.4;non-classical monocyte: 50.7;plasmacytoid DC: 36.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 87.7;HEL: 99.9;HMC-1: 105.6;HUVEC TERT2: 106.1;K-562: 154.8;NB-4: 101.8;U-937: 79.7"					"Low region specificity"	"Detected in many"			"HPA003257, HPA051894"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA003257: , HPA051894: AB_2681653"	"prognostic favorable (8.83e-4)"	"prognostic favorable (3.91e-5)"	"unprognostic (2.98e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.50e-2)"	14.6	18.7	5.0	22.4	4.8	85.5	11.3	5.2	8.9	6.4	5.5	7.4	6.5	6.4	3.5	4.2	6.2	27.6	5.3	4.5	5.1	6.2	92.0	17.1	39.4	5.6	5.1	3.5	3.0	38.5	1.9	2.3	14.7	5.9	4.8	6.5	0.3	3.5	4.0	3.0	4.7	19.1	5.8	5.9	40.2	5.3	2.4	7.0	4.5	102.9	6.3	30.7	12.8	5.1	6.2	11.2	20.6	10.5	0.1	0.9	0.7	0.2	5.6	46.4	7.4	6.6	4.0	2.6	10.7	87.7	0.7	0.0	2.1	9.5	0.3	9.1	0.1	11.1	99.9	8.8	67.4	21.0	58.6	105.6	0.3	0.2	6.5	0.0	3.7	106.1	0.3	154.8	0.1	0.5	3.2	0.4	101.8	0.2	30.2	11.8	34.0	3.0	0.1	0.9	4.3	4.9	1.0	6.2	0.0	0.1	0.5	3.3	30.6	37.2	0.0	0.6	0.1	0.1	2.6	1.8	21.2	0.0	79.7	51.4	28.0	41.5	61.8	0.8	45.7	0.3	59.3	0.0	0.1	30.8	65.8	0.1	0.1	31.4	1.0	50.7	36.3	0.4	15.5	5.0	4.8	5.2	8.9	4.5	5.1	5.6	5.1	3.5	5.9	5.9	7.0	6.2	31.9	0.0	3.0	0.0	77.2	6.4	2.1	0.9	2.2	0.0	3.0	3.2	3.6	125.8	1.6	0.0	0.0	0.7	57.6	0.4	0.0	107.9	0.3	0.8	0.5	80.0	5.3	28.2	0.0	12.0	0.7	2.2	0.5	1.0	7.0	0.0	88.9	58.3	72.6	0.0	0.0	1.6	0.0	63.5	29.1	1.1	0.3	51.7	7.2	5.6	50.4	0.0	9.2	0.5	0.0	10.5	0.0	1.2	1.6	3.2	0.0	0.2	0.9	0.2	0.0	1.9	2.1	0.3	6.3	1.0	3.7	1.1	8.3	3.4	0.7	1.3
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119748002-119768905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 2453.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 327.2;Hepatocytes: 1118.3;Intestinal goblet cells: 226.8;Paneth cells: 177.7;Undifferentiated cells: 282.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 113.6;RT4: 201.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027423, HPA027442, CAB032906"	Enhanced		Approved	Mitochondria		NA	NA		830000	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favorable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	1.1	0.3	0.0	7.4	0.0	0.0	224.6	0.0	0.0	0.1	4.2	370.2	167.1	1.4	0.4	4.4	0.4	4.3	21.7	0.0	0.0	65.5	2453.9	2.2	0.1	0.0	0.1	0.0	0.1	20.3	0.1	0.1	0.4	0.0	34.3	230.1	0.1	51.2	0.6	7.0	14.1	153.0	23.9	0.0	0.6	102.1	35.9	0.0	0.5	0.6	3.2	0.0	36.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	113.6	0.1	0.2	0.7	0.7	0.0	201.6	0.1	0.8	0.6	0.0	0.0	0.1	7.6	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	10.8	0.0	2.4	0.1	3.7	0.0	1.2	0.0	18.8	5.6	8.7	42.9	0.1	31.3	0.0	0.8	0.0	327.2	0.0	0.0	1.9	0.6	0.1	1.1	73.1	24.0	0.0	0.0	0.2	0.2	66.8	1.4	4.5	19.5	16.4	1118.3	0.2	0.0	0.0	226.8	0.0	26.1	0.7	3.9	1.5	0.2	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	177.7	0.0	0.0	6.3	12.4	0.9	0.0	0.0	6.6	0.0	0.1	0.4	0.5	1.9	0.3	9.4	2.2	0.1	282.3	26.5
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566834	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 115.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.8;Distal enterocytes: 51.0;Intestinal goblet cells: 32.3;Paneth cells: 54.3;Proximal enterocytes: 165.3;Undifferentiated cells: 36.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 8.5;liver cancer: 2.8;pancreatic cancer: 4.0;renal cancer: 4.6;stomach cancer: 10.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.3;CAPAN-2: 16.1;Karpas-707: 4.5;OE19: 10.0;PC-3: 4.8;THP-1: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	NA			Nucleoplasm	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.0	0.4	2.5	0.4	0.0	1.0	0.3	0.3	2.3	0.1	20.8	101.4	0.4	1.2	0.3	1.0	12.3	0.0	0.3	0.3	17.5	13.0	0.2	0.1	0.5	0.4	0.2	0.0	5.6	0.0	0.0	0.1	0.3	0.6	19.8	0.0	0.4	0.4	0.0	0.0	115.6	0.9	0.4	0.1	8.2	3.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.4	1.1	4.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	16.1	0.0	2.2	0.0	1.8	0.0	2.0	0.0	0.0	0.0	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.3	10.0	4.8	0.0	0.0	0.3	2.7	0.1	0.3	1.6	0.3	0.1	0.0	0.2	0.2	5.5	0.0	0.3	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.3	0.3	0.3	0.5	0.4	0.2	0.3	0.4	0.3	0.4	0.0	0.0	1.1	39.8	0.5	0.0	0.6	0.4	2.2	0.0	1.3	0.5	0.2	17.2	1.5	3.7	0.0	0.0	0.0	51.0	5.9	3.2	3.1	3.6	0.2	0.0	16.3	0.0	0.5	4.3	0.0	0.1	8.2	3.2	0.0	0.0	0.0	10.7	0.0	0.0	0.6	32.3	2.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.2	0.6	5.6	54.3	0.0	0.0	1.6	165.3	18.5	8.1	0.0	0.0	0.1	0.4	4.8	0.0	0.4	0.0	0.0	0.2	0.0	36.9	2.9
HOGA1	"C10orf65, DHDPS2, DHDPSL, FLJ37472, NPL2"	ENSG00000241935	"4-hydroxy-2-oxoglutarate aldolase 1"	Q86XE5	10	97584323-97612802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 52.3;liver: 55.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 35.8;Distal tubular cells: 29.4;Hepatocytes: 43.3;Late spermatids: 18.4;Proximal tubular cells: 98.0"	"Group enriched"	"Detected in many"	5	"liver cancer: 4.5;renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.8;EFO-21: 9.7;Hep G2: 26.1;RPTEC TERT1: 31.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039466	Approved					NA	NA		16000			"HPA039466: AB_2676522"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-3)"	"unprognostic (4.72e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.80e-2)"	"prognostic favorable (9.08e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.94e-3)"	"unprognostic (7.20e-4)"	4.2	8.4	5.4	0.2	7.0	0.4	1.9	9.3	5.1	0.7	9.9	0.2	0.3	1.1	3.8	1.0	2.0	2.5	14.9	4.4	6.3	52.3	55.3	1.4	0.3	9.6	9.1	3.4	0.2	15.5	5.8	3.7	0.1	8.7	1.1	0.1	0.8	1.7	2.1	3.4	1.4	0.3	0.5	7.3	0.4	0.2	0.9	7.9	0.3	1.8	12.2	0.2	0.4	0.9	10.3	0.3	3.7	0.1	7.8	1.5	0.3	0.1	0.1	0.2	0.0	0.0	3.0	0.2	0.3	9.7	0.2	0.5	2.6	0.0	0.2	0.1	0.1	4.0	0.1	1.4	26.1	1.1	0.2	0.1	0.3	0.7	0.1	0.1	1.9	0.4	0.1	0.0	0.4	0.6	1.6	0.1	0.1	0.2	0.2	0.0	0.1	0.6	0.4	31.5	0.6	0.6	1.0	0.1	1.3	0.5	0.2	2.8	0.0	0.2	0.8	0.2	0.3	0.2	0.5	0.9	0.1	2.0	0.1	0.1	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.1	0.4	0.2	0.2	1.0	0.2	0.2	0.3	0.2	0.1	5.4	7.0	9.3	5.1	4.4	6.3	9.6	9.1	3.4	8.7	7.3	7.9	10.3	0.0	0.0	0.0	7.2	1.5	0.1	0.7	0.5	1.8	0.4	0.1	0.4	6.0	35.8	0.2	9.2	0.0	0.1	0.0	0.1	29.4	5.9	3.8	1.8	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.2	0.0	0.5	0.0	0.1	0.4	43.3	0.1	1.7	1.2	0.0	0.0	1.3	0.0	18.4	0.0	0.8	1.8	1.0	0.0	2.0	0.0	1.5	12.3	0.5	0.1	0.0	0.0	0.1	0.0	98.0	3.2	0.3	0.0	4.5	0.9	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.2
HSD17B6	"HSE, RODH, SDR9C6"	ENSG00000025423	"Hydroxysteroid 17-beta dehydrogenase 6"	O14756	12	56752161-56787790	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"liver: 1819.2"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 1969.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 170.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 13.4;U-266/84: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059141: AB_2683922"	"unprognostic (7.70e-2)"	"unprognostic (8.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.50e-10)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-1)"	5.4	2.5	12.6	7.0	14.0	0.5	0.7	12.9	19.1	25.7	9.2	16.0	3.3	21.0	1.6	10.0	6.6	9.1	0.5	11.7	12.0	2.5	1819.2	63.7	0.8	12.2	13.5	12.0	6.0	0.6	0.5	0.7	5.4	14.0	51.7	7.6	0.8	0.4	69.8	0.4	1.0	4.8	13.2	11.5	47.9	5.8	23.5	13.2	0.9	31.7	0.5	0.9	37.0	14.7	12.2	0.3	0.8	1.9	0.4	1.9	1.4	2.3	4.1	3.5	1.9	1.9	0.4	0.4	12.0	1.7	0.5	0.5	0.3	6.1	1.1	1.1	7.7	2.2	3.7	1.2	0.6	1.2	1.9	6.0	1.0	0.4	1.2	0.6	0.6	0.0	10.3	1.1	13.4	0.9	2.4	5.6	1.3	7.5	0.7	0.7	7.4	0.8	2.9	0.2	1.4	11.0	2.3	2.0	3.6	0.9	0.7	0.6	1.5	0.3	0.9	0.8	4.0	1.0	11.7	18.0	7.8	1.3	6.9	0.6	0.0	0.0	0.0	1.0	0.2	1.2	0.7	0.8	0.8	0.2	0.3	1.1	0.7	0.0	0.0	0.5	0.7	1.0	0.3	12.6	14.0	12.9	19.1	11.7	12.0	12.2	13.5	12.0	14.0	11.5	13.2	12.2	0.4	173.1	130.6	21.2	6.1	1.3	3.1	0.6	0.6	0.4	0.7	0.6	0.2	27.1	9.3	0.0	0.0	1.4	0.4	0.0	0.0	0.1	4.6	0.7	3.5	1.3	0.0	29.5	1.4	0.0	2.6	5.0	0.0	0.1	0.0	1.6	26.0	1969.3	0.4	0.0	2.1	0.4	0.0	40.2	0.3	4.5	12.5	0.5	0.0	1.0	1.0	1.3	0.0	3.0	5.5	0.1	0.0	1.5	0.8	16.1	0.0	0.3	1.5	0.6	13.1	0.6	3.5	16.4	11.4	1.2	1.6	0.4	2.2	36.0	0.7	1.1
INSIG1	"CL-6, MGC1405"	ENSG00000186480	"Insulin induced gene 1"	O15503	7	155297776-155310235	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 568.2"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 4121.3"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 142.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"intermediate monocyte: 272.8;non-classical monocyte: 500.8"	"Lineage enriched"	"Detected in all"	6	"monocytes: 500.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 1228.9;RPMI-8226: 605.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071524			Uncertain	Vesicles		NA	NA			Vesicles		"HPA071524: "	"unprognostic (8.11e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.62e-4)"	"unprognostic (4.97e-2)"	80.0	37.6	31.1	35.7	38.6	45.9	37.7	46.3	43.3	18.9	54.1	30.1	53.5	19.7	32.0	40.4	17.7	31.9	19.9	31.5	38.8	32.2	568.2	43.6	31.1	60.9	55.1	26.5	24.2	112.6	17.5	19.0	34.4	64.1	63.1	26.6	40.9	71.6	11.4	9.1	35.5	35.5	20.5	40.8	19.1	61.6	34.7	41.8	40.7	12.6	12.1	25.5	37.0	23.4	88.6	158.9	29.0	76.8	48.1	200.6	265.5	41.9	12.5	179.1	36.9	242.6	18.1	225.2	104.0	35.7	98.2	282.2	83.9	53.1	92.6	43.3	32.3	155.5	28.6	51.7	0.0	99.0	49.3	448.7	165.6	50.4	281.8	25.8	27.3	49.8	202.8	53.2	1228.9	47.9	82.2	238.7	128.6	80.0	30.4	20.4	43.5	0.2	605.1	291.6	77.8	57.2	45.5	41.6	29.9	67.8	28.7	29.0	162.0	56.3	40.5	11.8	77.2	33.3	296.8	57.4	93.3	177.6	187.2	38.2	21.3	29.7	13.4	49.3	272.8	25.5	46.5	32.8	41.9	78.5	60.2	32.6	36.7	62.6	27.5	500.8	44.7	77.0	85.2	31.1	38.6	46.3	43.3	31.5	38.8	60.9	55.1	26.5	64.1	40.8	41.8	88.6	91.4	41.7	121.5	39.8	100.5	140.2	59.4	148.2	74.6	16.5	58.0	31.6	43.6	35.8	114.4	40.5	10.4	47.7	79.0	129.1	17.6	52.0	21.2	30.8	11.6	135.6	126.8	38.3	11.1	140.4	189.0	120.4	57.6	67.4	60.4	18.1	33.2	828.9	46.9	38.7	16.9	91.5	185.1	63.6	4121.3	9.7	15.8	381.0	247.3	7.5	29.6	88.7	34.0	17.1	61.8	53.6	86.6	18.4	100.1	180.4	29.1	9.4	68.3	18.1	19.7	36.3	62.0	33.6	45.0	135.8	155.3	130.4	108.2	20.6	48.0	158.5
MCCD1		ENSG00000204511	"Mitochondrial coiled-coil domain 1"	P59942	6	31528962-31530232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	71	"kidney: 80.3"	"Group enriched"	"Detected in some"	44	"Distal tubular cells: 401.1;Proximal tubular cells: 414.8"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.7;endometrial cancer: 0.8;liver cancer: 2.4;renal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (1.34e-1)"			"unprognostic (2.39e-2)"			"unprognostic (2.71e-1)"			"unprognostic (3.22e-2)"			"prognostic favorable (1.73e-4)"					0.0	0.0	0.1	0.0	0.2	0.1	1.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	80.3	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.1	0.2	0.4	0.2	0.1	0.4	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	401.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	414.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1
MOGAT3	"DC7, DGAT2L2, MGAT3"	ENSG00000106384	"Monoacylglycerol O-acyltransferase 3"	Q86VF5	7	101195007-101201038	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 24.6;liver: 19.0"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 81.9;Paneth cells: 56.3;Proximal enterocytes: 88.9;Undifferentiated cells: 26.3"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 11.0;liver cancer: 11.1;stomach cancer: 3.2"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"CACO-2: 2.9;Hep G2: 10.7"									HPA011940	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA011940: AB_1854057"		"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.20e-1)"	"unprognostic (9.54e-3)"		"unprognostic (9.36e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-1)"		"unprognostic (2.59e-2)"	0.1	0.1	0.5	1.7	0.5	0.9	0.1	1.3	0.8	0.0	0.4	9.1	24.6	0.2	0.2	0.2	0.1	0.2	0.1	0.5	0.2	1.2	19.0	0.1	0.2	0.3	0.2	0.7	0.0	0.2	0.0	0.0	0.1	0.7	0.1	7.3	0.4	0.1	0.1	0.5	0.4	24.0	0.8	0.2	0.2	0.2	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.0	1.2	0.4	0.1	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	2.9	0.8	0.1	0.4	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.4	10.7	0.1	0.2	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.3	0.0	0.1	0.2	0.3	0.1	0.3	0.4	0.1	0.0	0.3	0.4	0.4	0.1	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.6	0.6	0.1	0.6	0.3	0.2	0.1	0.0	0.6	0.3	0.8	0.8	0.2	0.3	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.4	0.2	0.3	1.6	0.5	0.2	0.3	0.1	0.1	0.5	0.5	1.3	0.8	0.5	0.2	0.3	0.2	0.7	0.7	0.2	0.3	1.2	0.3	0.0	0.5	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	81.9	0.0	0.1	0.0	0.1	0.2	0.1	1.8	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	1.1	7.4	0.0	0.0	0.0	14.7	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.3	0.0	0.0	0.2	88.9	5.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.1	0.1	0.5	0.1	26.3	0.4
NPC1L1	SLC65A2	ENSG00000015520	"NPC1 like intracellular cholesterol transporter 1"	Q9UHC9	7	44512535-44541330	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 54.7;liver: 48.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 12.3;Hepatocytes: 44.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 6.8;Hep G2: 17.9;SCLC-21H: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB070127, CAB070128"	Enhanced					NA	NA					"CAB070127: AB_10002744, CAB070128: AB_10000815"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.59e-2)"	"unprognostic (8.08e-10)"	"unprognostic (1.64e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.83e-2)"	0.5	0.1	0.7	0.0	0.4	0.0	0.4	0.8	1.2	0.5	0.2	1.1	54.7	0.4	0.0	0.4	0.5	5.9	0.1	0.8	0.3	0.9	48.5	0.2	0.0	1.2	0.3	0.3	0.6	0.6	0.0	0.0	0.0	1.4	0.4	0.1	0.0	0.1	0.1	0.1	0.2	50.9	0.1	0.6	0.0	1.5	1.1	0.4	0.0	0.0	0.0	0.0	0.5	0.5	1.1	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	14.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.8	1.2	0.8	0.3	1.2	0.3	0.3	1.4	0.6	0.4	1.1	0.2	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.8	0.8	5.7	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.3	12.3	0.3	0.1	0.2	1.8	2.7	0.3	0.5	0.0	0.2	0.0	0.5	0.0	0.0	1.4	44.7	0.0	0.0	0.1	0.3	0.0	1.0	0.3	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.2	3.4	1.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.3	0.1	0.3	0.7	0.2	0.1
NR0B2	SHP	ENSG00000131910	"Nuclear receptor subfamily 0 group B member 2"	Q15466	1	26911489-26913975	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Receptor, Repressor"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 77.6;liver: 143.6"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 97.2;Distal tubular cells: 52.8;Exocrine glandular cells: 42.4;Gastric mucus-secreting cells: 90.2;Hepatocytes: 173.4;Proximal enterocytes: 49.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 52.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	33	"Hep G2: 78.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 1.7"	"Not detected"	"Not detected"			HPA003983			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA003983: "	"unprognostic (2.99e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.68e-3)"	"unprognostic (9.21e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.44e-2)"		"unprognostic (1.83e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.10e-2)"	0.0	21.5	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.5	77.6	0.0	0.0	0.0	0.0	10.2	13.0	0.0	0.0	33.2	143.6	2.5	0.0	0.0	0.1	0.0	0.0	30.9	1.6	0.3	0.0	0.1	0.0	0.4	0.2	0.0	0.0	2.7	0.0	26.7	0.0	0.1	11.6	26.6	1.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	78.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.3	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	3.2	15.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	8.4	97.2	0.7	12.9	0.0	0.0	0.0	0.9	52.8	31.3	0.4	0.1	0.0	0.2	24.4	8.0	0.0	42.4	0.0	0.3	90.2	0.0	0.0	3.0	2.5	173.4	0.1	28.6	0.0	7.6	16.2	3.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	15.2	0.3	0.0	0.2	0.0	49.8	0.1	0.0	0.4	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.3	0.1	11.0	0.2
NUGGC	"C8orf80, HMFN0672, SLIP-GC"	ENSG00000189233	"Nuclear GTPase, germinal center associated"	Q68CJ6	8	28021964-28083936	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"liver: 20.8;lymphoid tissue: 23.1"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 15.7;Plasma cells: 35.1;Proximal tubular cells: 7.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 3.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 116.5;Karpas-707: 38.6;U-698: 84.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.23e-2)"	"unprognostic (2.17e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.83e-4)"	"unprognostic (2.08e-3)"	"unprognostic (6.19e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.14e-2)"	0.3	0.3	1.3	6.3	0.7	0.9	0.9	1.1	1.8	0.1	2.9	1.9	1.9	0.2	0.2	0.4	0.3	0.4	0.2	1.2	1.0	5.1	20.8	0.8	18.8	1.9	1.2	0.7	0.5	0.2	0.0	0.0	0.1	1.7	0.3	1.5	0.3	1.3	0.2	0.3	0.5	2.3	0.1	0.2	2.7	2.6	0.4	0.7	0.6	2.1	0.0	23.1	1.6	0.1	3.8	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	1.0	0.3	116.5	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.2	0.3	1.1	0.0	0.2	0.5	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	38.6	0.0	0.1	2.4	0.2	0.1	0.3	0.0	1.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.3	0.6	0.0	0.1	0.3	0.1	0.1	15.2	1.4	84.8	0.2	0.2	0.0	1.0	0.4	0.2	4.0	0.3	0.5	1.6	1.8	2.6	0.1	0.6	0.3	1.0	0.8	0.5	0.1	0.3	0.1	0.5	1.3	0.7	1.1	1.8	1.2	1.0	1.9	1.2	0.7	1.7	0.2	0.7	3.8	0.2	0.0	2.2	0.0	5.0	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.7	0.0	3.7	1.8	0.0	0.0	2.2	0.0	1.9	0.0	1.1	0.1	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.5	3.1	0.1	1.3	0.0	0.0	15.7	0.0	0.0	0.5	0.0	0.0	0.6	1.1	1.5	0.0	0.4	0.0	0.0	0.1	0.1	2.1	0.5	0.2	0.0	0.0	0.0	35.1	0.2	0.0	7.8	0.0	0.3	0.0	0.4	0.3	0.1	0.0	0.0	1.0	0.0	4.6	0.1	0.0	0.3
OGDHL	FLJ10851	ENSG00000197444	"Oxoglutarate dehydrogenase L"	Q9ULD0	10	49734641-49762379	"Citric acid cycle related proteins, Enzymes, Metabolic proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 79.6;kidney: 122.9;liver: 80.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 30.4;Collecting duct cells: 29.5;Cone photoreceptor cells: 31.3;Distal tubular cells: 92.0;Hepatocytes: 55.3;Horizontal cells: 30.3;Proximal tubular cells: 84.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.7;renal cancer: 44.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.3;RPTEC TERT1: 43.4;SH-SY5Y: 16.3;SK-BR-3: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043716, HPA052497"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA043716: , HPA052497: AB_2681853"	"unprognostic (9.05e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-3)"	"unprognostic (4.60e-1)"	"prognostic favorable (1.21e-14)"	"unprognostic (3.25e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.38e-2)"	0.1	11.7	20.4	0.3	22.4	0.0	0.0	22.5	41.3	0.7	79.6	1.3	1.0	2.2	0.6	0.1	1.0	0.4	5.9	23.9	34.1	122.9	80.7	0.0	0.2	34.4	26.7	20.3	1.7	4.4	51.0	29.6	0.1	38.3	1.6	0.3	18.8	17.2	6.4	0.1	0.1	1.1	0.7	13.1	0.3	1.0	2.3	30.7	0.5	23.1	0.8	0.6	0.5	0.5	44.4	0.0	0.0	4.7	21.3	0.0	0.0	2.7	0.1	0.1	1.1	0.2	10.5	2.3	0.0	11.4	0.0	3.4	0.4	7.4	0.2	0.4	0.0	0.4	0.0	0.2	5.3	0.2	0.0	1.6	0.3	0.0	0.0	0.0	0.6	0.0	5.4	0.5	0.0	0.0	3.2	8.2	7.3	2.0	0.8	1.0	0.0	0.0	0.0	43.4	0.7	12.0	16.3	0.1	16.2	1.1	6.1	4.5	2.9	0.0	0.0	10.6	0.0	0.7	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	22.4	22.5	41.3	23.9	34.1	34.4	26.7	20.3	38.3	13.1	30.7	44.4	0.0	0.0	0.0	20.2	0.8	0.0	0.9	0.4	0.0	30.4	0.1	0.1	4.4	2.8	0.1	29.5	31.3	0.0	0.0	0.4	92.0	1.1	0.2	0.9	0.2	0.3	4.8	0.0	16.8	0.0	0.1	0.3	0.0	1.6	0.0	0.7	1.4	55.3	0.1	30.3	21.4	0.5	2.0	1.3	0.0	0.5	0.0	0.5	0.0	1.0	0.0	5.4	0.0	3.5	1.8	0.1	1.1	0.0	0.0	0.3	0.0	84.7	0.0	18.1	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.1	0.6	0.4	0.3	0.3
OPRPN	"BPLP, PRL1, PROL1"	ENSG00000171199	"Opiorphin prepropeptide"	Q99935	4	70397931-70410195	"Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"salivary gland: 147.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 12.5;Breast myoepithelial cells: 3.3;Glandular and luminal cells: 2.1"	"Group enriched"	"Detected in some"	5	"breast cancer: 7.4;liver cancer: 4.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA065711	Approved				"Secreted in other tissues"	NA	NA		63000			"HPA065711: AB_2685541"	"unprognostic (3.11e-3)"						"unprognostic (2.22e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	147.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
OSGIN1	"BDGI, OKL38"	ENSG00000140961	"Oxidative stress induced growth inhibitor 1"	Q9UJX0	16	83931311-83966332	"Predicted intracellular proteins"	"Differentiation, Growth regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 148.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 56.2;Hepatocytes: 78.4;Late spermatids: 261.1;Proximal enterocytes: 99.0"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 65.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 12.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.2;monocytes: 12.6"	"Cell line enhanced"	"Detected in many"		"A549: 66.8;Hep G2: 103.7;T-47d: 73.3;WM-115: 62.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA019239			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA019239: AB_1854779"	"unprognostic (8.36e-2)"	"unprognostic (9.44e-2)"	"unprognostic (4.28e-2)"	"prognostic favorable (4.89e-5)"	"unprognostic (3.31e-3)"	"unprognostic (9.14e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.89e-1)"	8.0	26.7	9.2	4.9	7.3	0.8	7.2	7.0	7.5	3.4	3.8	7.1	31.6	3.4	1.2	12.4	4.5	8.4	9.0	5.1	6.1	13.9	148.6	9.4	1.3	10.7	8.1	4.4	4.3	8.6	3.0	3.7	1.6	14.4	5.6	2.5	2.0	5.2	2.2	22.6	3.0	18.8	1.6	8.6	10.6	14.0	15.3	8.6	0.8	13.3	9.7	1.2	13.0	5.7	16.0	4.7	66.8	0.8	2.9	4.1	5.9	5.0	7.7	7.5	7.0	2.5	16.9	24.0	0.1	18.0	6.7	31.5	12.6	3.2	4.9	2.6	1.1	0.8	1.2	15.5	103.7	15.0	2.3	25.7	3.6	3.9	18.1	4.1	3.9	7.2	4.8	6.5	6.5	9.1	31.9	0.9	0.9	0.6	16.5	15.8	2.3	6.7	3.3	4.8	5.9	0.4	1.5	16.0	5.1	32.6	1.7	73.3	2.7	23.1	10.6	16.0	15.7	5.3	2.7	1.2	0.2	35.6	3.6	62.8	0.1	2.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	4.2	0.0	12.6	0.0	0.0	1.0	9.2	7.3	7.0	7.5	5.1	6.1	10.7	8.1	4.4	14.4	8.6	8.6	16.0	2.2	16.0	3.9	0.0	0.6	1.5	8.1	15.7	5.2	0.8	7.9	4.3	9.0	8.6	18.5	1.8	0.0	1.4	0.5	41.8	5.9	11.3	56.2	6.1	1.0	5.4	4.2	0.0	0.1	6.6	0.4	5.4	26.0	5.3	1.3	2.7	6.1	78.4	10.5	0.0	0.1	12.9	12.2	9.4	3.0	261.1	4.1	7.3	7.2	0.0	3.0	8.6	0.0	0.0	0.2	13.2	23.5	12.0	1.3	11.8	99.0	11.7	5.0	0.6	13.1	4.7	5.1	2.3	1.3	6.0	1.7	1.4	0.6	4.6	10.5	5.9
PCK1	PEPCK-C	ENSG00000124253	"Phosphoenolpyruvate carboxykinase 1"	P35558	20	57561080-57568121	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Kinase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 436.1;liver: 687.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 703.8;Distal tubular cells: 588.9;Hepatocytes: 1184.0;Proximal enterocytes: 2209.9;Proximal tubular cells: 3547.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 99.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"ASC diff: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006277, HPA006507, CAB017027"	Approved					NA	NA		840000			"CAB017027: , HPA006277: AB_1079579, HPA006507: AB_1079578"	"unprognostic (3.50e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.60e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.43e-2)"		"unprognostic (1.84e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.47e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-1)"	59.7	1.2	0.8	1.7	0.7	0.0	30.0	0.7	1.6	0.0	0.6	58.3	111.4	1.2	0.2	0.4	0.9	5.0	0.7	0.7	2.5	436.1	687.0	0.2	0.3	0.8	1.1	0.6	1.6	0.4	0.0	21.3	0.3	0.7	0.2	80.6	0.5	1.2	0.2	0.4	0.8	145.2	2.9	0.6	0.3	0.9	0.0	1.2	0.1	0.8	6.6	0.0	0.8	0.1	0.8	0.0	0.0	0.0	0.0	20.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.7	1.6	0.7	2.5	0.8	1.1	0.6	0.7	0.6	1.2	0.8	0.7	0.0	0.0	0.0	21.3	0.1	0.0	0.0	15.9	0.3	0.7	0.6	1.0	61.5	0.6	90.1	0.0	0.1	0.1	703.8	588.9	0.6	0.1	1.3	1.5	2.7	53.9	40.2	0.0	0.0	0.0	2.3	19.9	8.5	8.9	0.1	29.6	1184.0	0.0	3.3	0.0	293.6	0.0	22.6	0.0	0.0	0.0	12.8	0.0	1.9	0.0	9.9	0.0	0.0	0.0	0.1	285.5	0.0	0.0	0.0	2209.9	3547.9	0.0	0.4	0.0	0.3	6.0	0.0	0.1	10.3	0.3	0.3	10.2	1.5	348.5	0.1
PIPOX	LPIPOX	ENSG00000179761	"Pipecolic acid and sarcosine oxidase"	Q9P0Z9	17	28950513-29057216	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"kidney: 147.4;liver: 510.7"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 225.4;Proximal tubular cells: 163.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 73.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"AF22: 36.7;Hep G2: 120.2;NTERA-2: 68.4;RH-30: 90.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA		380000				"unprognostic (8.02e-2)"	"unprognostic (3.50e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.45e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.22e-1)"	0.4	0.6	13.6	0.6	15.9	0.3	0.3	17.2	15.7	0.7	10.8	2.7	13.7	1.6	24.6	1.8	8.9	3.4	0.4	13.1	14.3	147.4	510.7	1.2	1.0	14.9	14.9	11.9	0.9	0.7	1.7	0.8	4.3	15.3	2.0	1.1	4.4	0.5	3.5	0.3	0.7	4.4	2.1	12.2	1.0	0.9	0.3	16.2	0.4	0.2	0.1	0.5	1.3	0.5	13.6	0.0	0.0	36.7	0.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.8	0.0	0.1	0.2	0.6	0.0	0.1	0.5	0.5	0.5	0.2	120.2	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	1.1	0.0	0.2	0.0	0.7	68.4	2.4	0.0	0.3	90.7	2.2	0.0	0.1	11.2	3.8	0.3	0.2	0.5	5.9	0.2	4.4	0.0	0.1	0.2	0.1	4.3	0.9	11.4	0.4	0.0	0.6	3.6	1.0	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.4	1.8	0.2	0.1	0.8	1.4	0.3	0.1	0.1	0.4	0.3	13.6	15.9	17.2	15.7	13.1	14.3	14.9	14.9	11.9	15.3	12.2	16.2	13.6	0.4	0.0	0.6	12.4	1.4	0.3	0.3	0.2	0.0	2.9	0.2	0.3	0.5	5.7	0.1	0.0	4.2	0.2	0.7	0.2	9.8	0.0	1.5	0.2	0.3	0.8	1.2	5.3	0.2	0.2	7.7	0.7	1.5	0.2	5.7	1.3	5.3	225.4	1.2	0.0	0.5	0.0	0.0	6.0	2.1	2.1	0.3	2.2	0.0	1.0	2.2	29.0	0.0	1.0	0.1	0.0	0.0	1.2	0.2	0.3	1.9	163.7	0.0	1.4	0.0	0.7	0.4	0.1	1.0	0.0	0.1	0.4	1.2	0.1	0.1	0.1
PLA1A	ps-PLA1	ENSG00000144837	"Phospholipase A1 member A"	Q53H76	3	119597875-119629811	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 139.6;parathyroid gland: 66.3;seminal vesicle: 67.8"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 14.7;Endothelial cells: 14.3;Hepatocytes: 26.0;Langerhans cells: 15.6;Peritubular cells: 14.3"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"SK-MEL-30: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059740			Approved	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"	"Secreted in other tissues"	NA	NA		420000	"Nuclear speckles, Cytoplasmic bodies"	Nucleoplasm	"HPA059740: AB_2684118"	"unprognostic (1.35e-1)"	"prognostic favorable (2.81e-7)"	"unprognostic (2.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-1)"	4.9	0.7	12.1	3.5	10.3	0.3	3.5	10.4	16.5	4.7	23.7	2.8	1.1	4.8	139.6	1.5	5.7	2.8	4.3	11.2	10.7	7.8	39.9	21.4	15.7	12.0	11.0	9.2	1.1	3.8	66.3	1.7	9.9	11.9	9.1	2.5	1.1	3.6	67.8	16.4	0.7	3.6	8.9	12.2	1.0	4.5	3.8	14.1	1.6	6.9	3.1	8.7	4.0	1.9	15.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.8	0.3	0.5	0.1	0.0	0.2	0.0	0.0	25.0	0.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	12.1	10.3	10.4	16.5	11.2	10.7	12.0	11.0	9.2	11.9	12.2	14.1	15.3	6.5	0.0	1.7	0.0	0.0	0.6	0.5	0.4	0.6	0.0	0.1	0.1	2.8	2.8	1.0	14.7	0.0	0.2	0.1	0.0	1.9	4.7	6.6	0.1	0.1	14.3	1.8	0.0	0.2	2.2	0.0	1.6	0.0	0.9	1.3	0.7	7.9	26.0	1.6	0.0	0.1	0.1	0.0	1.0	15.6	3.2	0.3	5.4	1.8	4.7	4.2	0.0	0.0	0.0	0.0	1.3	0.6	14.3	0.0	0.5	0.0	5.1	7.5	0.1	0.0	0.9	5.9	0.0	0.2	0.0	0.6	1.9	0.1	0.0	0.1	0.2
PLIN1	PLIN	ENSG00000166819	"Perilipin 1"	O60240	15	89664367-89679427	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"adipose tissue: 964.8;breast: 466.9"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 59.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 8.4;liver cancer: 2.3;pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	171	"ASC diff: 208.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024299, CAB033821, CAB037333"	Enhanced		Uncertain	Peroxisomes		NA	NA		22000	Peroxisomes		"CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467"	"unprognostic (4.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.62e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.85e-2)"	964.8	11.4	12.4	3.5	12.2	0.3	466.9	7.7	10.7	1.3	5.2	9.3	0.5	0.7	0.4	1.3	1.4	6.6	8.3	10.3	10.1	2.7	41.2	0.7	1.7	9.4	10.5	7.3	2.1	6.2	0.2	1.3	0.2	11.8	2.6	3.8	0.6	21.0	0.6	9.6	13.7	14.0	1.5	6.3	1.1	5.5	13.3	9.3	2.3	5.3	17.5	0.1	8.0	3.1	8.4	0.0	0.2	0.2	0.0	208.2	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.7	0.5	0.1	0.7	0.2	0.0	0.2	0.6	0.7	0.0	0.1	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.1	0.3	0.2	0.1	0.3	1.2	0.1	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.4	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	12.2	7.7	10.7	10.3	10.1	9.4	10.5	7.3	11.8	6.3	9.3	8.4	2.6	0.0	0.0	4.2	0.2	0.1	0.3	0.1	0.0	0.3	0.7	3.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	7.5	0.1	0.2	0.2	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.2	0.0	0.1	1.1	59.0	0.0	0.0	0.3	0.3	0.0	1.0	0.3	7.5	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	1.3	0.0	0.0	0.6	0.3	0.1	0.1	0.1	0.0	1.3	1.3	4.8	0.2	0.0	0.4	0.0	0.1	0.1	0.5	0.9
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 619.5;liver: 912.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 743.3;Hepatocytes: 527.0;Syncytiotrophoblasts: 1815.2"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Region enriched"	"Detected in all"	7	"hypothalamus: 289.4"	"Group enriched"	"Detected in all"	4	"basophil: 776.5;eosinophil: 581.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 776.5"	"Group enriched"	"Detected in many"	5	"ASC diff: 2345.1;HHSteC: 2025.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"		NA	NA			"Lipid droplets"		"CAB037331: , HPA016607: AB_2669403"	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.77e-1)"	619.5	128.5	15.4	45.2	17.1	120.3	464.0	15.4	41.3	77.1	17.4	50.2	187.8	56.6	13.7	20.7	60.5	71.9	180.0	15.2	289.4	171.0	912.8	127.3	38.7	18.2	15.8	12.7	44.6	29.8	18.9	34.7	157.2	19.2	30.8	23.4	13.2	47.7	28.2	439.1	101.9	165.7	35.8	17.8	44.3	44.6	24.5	43.4	34.1	32.7	128.5	32.7	108.5	62.4	27.8	0.5	35.0	39.3	28.9	2345.1	318.3	434.8	113.5	87.6	67.7	76.5	54.1	8.3	0.4	2.0	232.9	432.1	4.7	39.1	0.3	115.1	146.9	0.8	191.8	5.4	205.2	2025.0	23.3	336.2	338.2	39.7	165.7	0.4	54.4	84.8	0.1	35.3	40.6	266.2	10.0	53.5	79.4	52.6	1.1	69.5	127.0	18.4	1.3	0.2	133.2	3.0	64.7	52.8	13.2	113.6	49.6	27.0	50.8	134.1	0.1	20.6	105.6	0.5	24.4	26.7	76.2	0.6	39.0	10.9	776.5	111.0	581.9	80.7	149.5	69.9	23.6	69.8	57.9	63.8	25.8	67.3	57.6	6.7	17.2	169.0	7.9	74.7	106.5	15.4	17.1	15.4	41.3	15.2	289.4	18.2	15.8	12.7	19.2	17.8	43.4	27.8	280.4	19.2	51.4	7.5	43.9	206.2	507.2	69.5	42.1	2.4	213.3	24.1	62.3	91.5	62.1	12.9	0.0	173.6	77.5	43.3	27.4	105.6	3.6	83.5	188.1	91.2	14.9	78.5	0.6	16.0	743.3	182.0	24.5	232.5	422.1	8.1	94.9	527.0	410.7	11.8	0.8	26.1	26.4	214.1	81.1	12.3	39.7	277.1	87.2	10.3	50.2	44.4	30.9	3.5	2.6	37.4	45.7	69.2	45.3	109.0	382.5	267.9	16.9	4.8	13.1	36.1	68.8	8.0	25.9	12.3	108.5	1815.2	123.3	21.4	44.3	263.3
PLPPR1	"FLJ20300, LPPR1, MGC26189, PRG-3"	ENSG00000148123	"Phospholipid phosphatase related 1"	Q8TBJ4	9	101028727-101325135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.8;choroid plexus: 5.9;kidney: 15.8"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 37.2;Early spermatids: 12.3;Proximal tubular cells: 39.0"	"Group enriched"	"Detected in some"	5	"glioma: 11.1;liver cancer: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Hep G2: 3.7;SCLC-21H: 9.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014760, HPA014968, HPA014979"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA014760: AB_2669084, HPA014968: AB_1855702, HPA014979: AB_2669130"	"unprognostic (1.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.37e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.86e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.65e-6)"	"unprognostic (3.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.83e-2)"	0.0	0.1	10.0	0.0	12.8	0.0	0.7	7.2	11.9	0.1	5.9	0.2	0.0	0.0	2.8	0.0	0.2	0.0	0.0	10.4	9.9	15.8	3.6	1.4	0.0	10.4	9.7	8.8	0.0	0.3	0.0	0.1	0.0	10.2	0.2	0.1	1.5	0.3	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.1	0.6	10.6	0.4	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	9.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.8	7.2	11.9	10.4	9.9	10.4	9.7	8.8	10.2	10.9	10.6	11.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.3	2.3	0.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	37.2	0.0	12.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	39.0	0.0	1.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0
PPP4R3C	"FLFL3P, FLJ32867, PPP4R3CP, SMEK3P, smk1"	ENSG00000224960	"Protein phosphatase 4 regulatory subunit 3C"	Q6ZMV5	X	27460207-27463341	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"testis: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"liver cancer: 0.6;testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	140	"U-2197: 20.4"					"Not detected"	"Not detected"									NA	NA																				"unprognostic (8.74e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRAP1	UPA	ENSG00000165828	"Proline rich acidic protein 1"	Q96NZ9	10	133347368-133352683	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 1144.8;liver: 680.6"	"Cell type enriched"	"Detected in some"	9	"Proximal enterocytes: 17736.9"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 348.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 34.2;Hep G2: 128.3"									"HPA038713, HPA052451"	Supported				"Secreted to digestive system"	NA	NA		210000000			"HPA038713: AB_10673117, HPA052451: AB_2681839"	"unprognostic (1.63e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.91e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.22e-3)"	0.6	0.5	0.7	4.2	0.7	0.5	0.3	0.4	0.7	0.2	5.3	75.3	1063.3	0.8	0.1	0.4	0.7	2.7	0.3	0.6	0.4	146.7	680.6	0.3	1.5	1.2	0.5	0.4	0.4	0.1	0.1	0.8	0.1	1.3	0.3	36.0	0.0	1.7	0.3	0.2	1.4	1144.8	1.7	0.6	0.8	2.8	12.3	0.6	0.4	0.2	0.3	0.1	0.3	0.2	0.6	0.2	0.5	0.1	1.2	0.1	0.0	14.6	0.0	0.0	0.0	0.0	34.2	0.6	0.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.5	128.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.0	3.5	0.4	5.0	0.0	0.2	0.9	2.9	0.0	0.0	0.9	4.6	0.4	0.0	0.0	0.8	0.0	0.2	0.0	0.0	1.4	1.3	0.0	1.4	0.1	0.4	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.7	0.4	0.7	0.6	0.4	1.2	0.5	0.4	1.3	0.6	0.6	0.6	0.0	0.0	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.6	0.0	9.2	0.0	0.2	0.0	773.7	33.2	0.1	1.9	0.6	0.0	0.6	18.4	13.5	0.1	0.2	0.2	0.2	1.5	0.1	8.9	0.0	12.5	1021.3	0.2	0.0	0.0	676.2	0.0	20.9	0.0	7.3	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1815.7	1.5	0.0	0.1	17736.9	412.0	0.1	0.0	0.0	0.0	0.1	140.2	38.2	0.0	0.0	0.3	3.5	0.0	607.1	0.1
PRODH2	HSPOX1	ENSG00000250799	"Proline dehydrogenase 2"	Q9UF12	19	35799988-35813299	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"kidney: 140.3;liver: 175.0"	"Group enriched"	"Detected in some"	13	"Hepatocytes: 157.6;Proximal tubular cells: 559.9"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 28.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"Hep G2: 33.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA051287	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA051287: AB_2681420"							"unprognostic (2.58e-1)"				"unprognostic (3.41e-3)"		"unprognostic (2.75e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.73e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.3	175.0	0.0	0.4	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.9	1.5	0.0	12.9	0.0	0.0	0.0	0.0	27.4	0.0	2.8	0.3	0.0	0.3	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	157.6	0.1	0.0	0.1	0.0	0.0	4.7	0.0	0.9	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	559.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0
PRR18	MGC35308	ENSG00000176381	"Proline rich 18"	Q8N4B5	6	166305300-166308448	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 126.7"	"Cell type enriched"	"Detected in some"	5	"Oligodendrocytes: 27.3"	"Group enriched"	"Detected in some"	5	"glioma: 3.1;liver cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 4.3;SH-SY5Y: 2.5"	"Low region specificity"	"Detected in all"							HPA077250	Enhanced					NA	NA					"HPA077250: AB_2732336"	"unprognostic (2.91e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.65e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.35e-3)"	"unprognostic (9.49e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.07e-1)"	0.3	0.0	28.4	0.0	73.4	0.0	0.1	35.0	71.3	0.1	7.2	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	29.4	37.1	0.0	3.4	0.2	0.0	90.4	59.1	17.8	0.0	0.2	1.2	0.9	0.0	101.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	31.2	0.0	0.1	0.0	54.7	0.0	0.1	0.0	0.0	0.0	0.0	126.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	2.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	73.4	35.0	71.3	29.4	37.1	90.4	59.1	17.8	101.1	31.2	54.7	126.7	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.6	2.8	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	27.3	0.1	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein"	Q9H310	1	156369211-156385219	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 9.6"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 89.9;Theca cells: 91.3"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enhanced"	"Detected in single"		"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 2.9;Hep G2: 3.0;RT4: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.6	1.9	0.0	0.0	0.0	0.2	0.0	2.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	22.0	0.0	0.0	0.0	0.0	19.6	0.3	10.3	0.3	0.0	0.1	0.0	0.0	0.2	0.6	0.1	1.3	0.0	0.1	0.0	89.9	0.0	10.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.8	2.3	0.4	0.0	0.4	0.0	0.0	91.3	0.0	0.1
RIDA	"HRSP12, P14.5, PSP, UK114"	ENSG00000132541	"Reactive intermediate imine deaminase A homolog"	P52758	8	98102344-98117171	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"kidney: 500.8;liver: 1549.6"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1579.1"	"Group enriched"	"Detected in all"	5	"liver cancer: 162.2;renal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 191.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022856, HPA023489"	Enhanced					NA	NA		5000000			"HPA022856: AB_1858253, HPA023489: AB_1858252"	"unprognostic (1.67e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.20e-2)"	"prognostic favorable (9.61e-6)"	"unprognostic (6.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-2)"	50.6	48.8	92.0	11.5	95.0	7.6	19.2	95.1	132.8	11.3	82.8	24.7	30.8	8.4	22.9	14.4	9.5	22.9	32.6	88.7	93.9	500.8	1549.6	9.6	10.2	96.5	94.5	87.4	23.6	27.2	24.8	10.1	10.9	93.7	19.5	24.9	26.8	16.5	11.7	40.4	10.7	22.0	10.9	91.4	7.5	25.0	17.3	97.4	11.3	16.0	41.3	12.4	15.6	8.0	90.3	44.0	37.5	29.3	36.6	65.5	50.4	33.0	39.7	28.0	26.4	31.0	51.4	28.4	62.5	49.6	29.4	34.5	30.8	65.4	56.9	52.5	22.3	28.6	45.0	25.6	55.6	29.9	17.6	7.0	44.4	19.5	36.6	39.9	32.4	34.2	65.3	82.7	12.9	35.5	57.8	35.6	50.1	47.0	191.4	67.8	41.0	21.7	18.4	64.6	31.6	32.2	15.7	25.5	17.4	29.2	37.4	44.5	23.5	20.9	20.6	12.5	33.7	16.3	31.2	46.1	30.9	35.0	39.0	13.2	0.2	9.0	5.6	6.6	7.8	8.7	13.8	9.4	10.1	11.1	11.5	12.0	13.0	1.9	10.3	8.3	8.5	13.9	8.1	92.0	95.0	95.1	132.8	88.7	93.9	96.5	94.5	87.4	93.7	91.4	97.4	90.3	7.8	25.6	22.4	0.0	7.4	0.0	0.0	0.0	0.0	0.0	13.8	15.1	0.0	0.0	1.8	47.8	0.0	31.1	3.2	0.0	285.7	19.7	0.0	25.1	12.3	5.0	0.0	0.0	0.0	8.5	29.9	7.9	0.0	9.4	2.5	17.7	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.8	0.0	0.0	1579.1	5.8	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	14.4	6.3	22.3	0.0	0.0
RTP3	"LTM1, TMEM7, Z3CXXC3"	ENSG00000163825	"Receptor transporter protein 3"	Q9BQQ7	3	46497976-46500950	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	130	"liver: 120.5"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 89.6"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 22.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SiHa: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075932			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA075932: "		"unprognostic (2.09e-1)"				"unprognostic (1.64e-1)"	"prognostic favorable (3.11e-6)"								"unprognostic (1.08e-1)"	"unprognostic (1.58e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	120.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	89.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.4	1.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SERPINA12	"OL-64, Vaspin"	ENSG00000165953	"Serpin family A member 12"	Q8IW75	14	94487274-94517844	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skin 1: 344.3"	"Cell type enriched"	"Detected in some"	4	"Suprabasal keratinocytes: 20.9"	"Group enriched"	"Detected in some"	5	"liver cancer: 1.8;melanoma: 2.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"Hep G2: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		6500000				"unprognostic (1.82e-3)"				"unprognostic (6.44e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.00e-2)"		"unprognostic (5.98e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.64e-3)"				"unprognostic (6.67e-2)"			0.2	0.0	0.0	0.0	0.0	0.1	28.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	344.3	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0
SLC23A1	"SLC23A2, SVCT1, YSPL3"	ENSG00000170482	"Solute carrier family 23 member 1"	Q9UHI7	5	139367196-139384553	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"fallopian tube: 54.6;intestine: 65.8;kidney: 40.6;liver: 22.6"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 65.2;Hepatocytes: 19.3;Proximal enterocytes: 131.7;Proximal tubular cells: 27.0"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.4;HDLM-2: 8.3;Hep G2: 13.6;JURKAT: 15.5;Karpas-707: 10.9;RPMI-8226: 10.9;U-266/70: 16.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047612	Enhanced					NA	NA					"HPA047612: AB_2680102"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.36e-6)"	"unprognostic (7.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.65e-3)"	0.1	0.1	0.2	1.2	0.5	2.8	0.2	1.0	0.3	1.7	0.1	3.3	26.6	0.7	0.0	0.3	54.6	2.4	0.1	0.3	0.4	40.6	22.6	0.9	1.7	0.8	2.1	0.0	0.4	1.2	0.3	0.2	0.1	0.7	6.3	1.5	0.6	3.2	0.6	0.4	1.9	65.8	0.2	0.2	1.3	1.5	0.2	0.8	5.5	0.2	0.0	1.3	0.4	0.3	0.6	0.3	2.1	0.4	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.4	1.3	5.8	3.0	0.0	0.1	0.3	0.0	0.0	0.1	8.3	0.1	0.2	0.8	13.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	15.5	0.1	10.9	0.0	0.2	5.7	1.0	0.1	0.8	0.1	6.8	0.3	10.9	0.5	0.4	0.3	0.3	0.3	1.9	0.0	0.7	5.0	0.1	0.3	0.3	0.3	0.1	0.0	16.6	2.2	7.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.2	0.5	1.0	0.3	0.3	0.4	0.8	2.1	0.0	0.7	0.2	0.8	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.3	1.5	2.0	0.0	4.2	0.4	0.4	1.9	5.9	0.2	0.0	65.2	0.7	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	1.5	0.0	0.1	0.4	19.3	0.1	0.0	1.2	3.6	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.1	3.1	0.0	0.4	0.9	131.7	27.0	13.4	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	4.2	0.2
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563450-17590995	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 142.2;choroid plexus: 84.7;liver: 112.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 195.2;Hepatocytes: 72.8"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.8;BEWO: 8.5"	"Low region specificity"	"Detected in all"							HPA068110			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA068110: "	"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	14.5	1.0	123.3	0.3	120.0	0.1	7.2	111.4	142.2	2.3	84.7	2.4	0.3	2.9	0.2	0.3	3.8	0.9	2.2	116.2	113.3	1.9	112.4	1.2	0.3	121.4	121.9	104.2	1.2	1.1	0.2	1.6	0.1	124.3	7.8	0.1	1.9	0.5	0.4	6.3	0.9	1.9	0.6	98.6	4.9	1.5	4.2	132.2	0.3	0.6	4.0	0.1	0.8	1.4	104.6	0.3	0.6	2.2	0.4	3.8	0.0	8.5	0.3	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	2.5	0.7	0.0	0.0	0.0	0.3	1.0	0.3	0.3	0.5	1.5	0.3	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.3	0.0	0.4	0.1	0.5	2.0	0.9	1.4	2.9	0.8	0.0	0.1	0.4	0.8	0.3	0.2	0.4	0.7	1.6	2.5	1.0	0.1	0.1	0.3	0.2	0.3	0.9	1.2	0.0	1.8	0.2	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	123.3	120.0	111.4	142.2	116.2	113.3	121.4	121.9	104.2	124.3	98.6	132.2	104.6	1.0	28.9	10.3	195.2	0.3	0.0	0.3	0.1	0.6	0.6	0.3	0.0	1.5	5.7	7.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.6	0.4	0.9	1.7	0.0	10.7	2.0	0.0	0.3	4.7	0.0	0.7	6.3	8.5	3.6	72.8	0.3	0.0	3.0	0.3	0.0	4.1	0.3	0.6	0.9	3.9	0.0	10.3	0.1	2.2	1.0	13.0	11.5	0.0	0.0	2.6	0.1	4.3	0.1	0.8	15.8	3.4	0.0	2.7	2.5	4.8	5.9	0.0	0.1	1.8	2.6	2.6	0.0	0.2
THPO	"MGDF, MPLLG, TPO"	ENSG00000090534	Thrombopoietin	P40225	3	184371935-184381968	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 35.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.3;Hepatocytes: 12.7;Late spermatids: 4.0;Proximal tubular cells: 9.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.0;Hep G2: 15.6;K-562: 2.8;RPMI-8226: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	1070000					"unprognostic (5.57e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.48e-6)"	"unprognostic (1.40e-3)"	"unprognostic (4.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.25e-2)"	1.6	2.6	5.1	0.5	3.8	0.0	1.4	4.6	4.8	3.5	2.3	0.7	0.2	3.8	1.3	0.4	2.1	0.4	1.2	4.2	2.8	4.5	35.7	0.8	0.2	3.3	2.7	3.9	2.9	1.7	0.1	0.8	0.5	3.5	1.3	0.3	0.0	0.5	0.5	1.9	0.5	0.7	1.5	2.8	1.3	0.9	4.0	2.7	0.0	0.8	0.9	0.1	1.0	1.9	3.4	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	15.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.3	0.6	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	3.8	4.6	4.8	4.2	2.8	3.3	2.7	3.9	3.5	2.8	2.7	3.4	0.1	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	1.6	0.1	0.0	0.0	2.2	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	12.7	0.6	0.0	1.3	0.0	0.0	0.8	0.0	4.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	1.1	0.8	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226638-55228784	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 11.1;liver: 17.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 37.1;Erythroid cells: 66.5;Hepatocytes: 33.3"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 7.6;RPMI-8226: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome		Yes	No			Centrosome	Midbody	"HPA057689: AB_2683504"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	0.9	2.1	4.1	2.4	4.5	7.0	0.9	4.0	6.8	1.3	3.2	1.5	9.8	1.6	0.1	1.0	1.8	11.1	0.6	4.2	3.3	1.2	17.0	1.3	1.7	4.1	3.5	3.7	1.2	0.7	0.5	2.9	0.7	4.2	1.8	0.3	0.7	0.9	0.6	1.5	1.6	10.3	0.3	2.9	3.7	4.1	3.0	3.5	1.6	2.3	0.4	1.3	1.2	1.0	4.2	1.7	0.0	0.9	1.1	0.1	0.0	3.0	1.2	0.3	0.9	0.9	5.4	1.4	2.4	0.4	0.4	0.3	0.7	0.1	0.2	0.0	0.3	4.0	1.9	0.4	7.6	0.9	1.6	0.9	0.7	1.5	0.5	0.0	0.4	0.0	3.8	3.8	1.4	0.4	1.0	3.8	5.3	0.2	0.6	1.7	3.8	0.5	8.1	0.8	1.6	0.7	1.7	0.0	0.9	4.4	0.7	1.0	1.9	1.2	1.9	1.1	1.1	0.9	1.4	1.5	4.1	1.0	5.2	0.4	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.5	0.3	0.2	0.0	0.6	0.0	0.2	4.1	4.5	4.0	6.8	4.2	3.3	4.1	3.5	3.7	4.2	2.9	3.5	4.2	1.5	6.4	2.7	4.9	1.3	3.3	0.4	1.0	1.8	6.0	1.9	1.1	0.6	37.1	1.5	0.0	2.1	0.4	1.9	2.0	0.0	1.1	3.0	2.5	1.0	1.9	10.7	66.5	5.2	0.2	0.3	0.9	12.8	1.8	0.0	2.5	1.4	33.3	1.0	10.1	4.5	2.8	4.1	5.9	2.8	4.5	0.9	2.5	3.6	0.0	3.1	1.2	2.1	2.5	3.3	1.1	0.3	0.4	2.9	1.2	14.5	1.0	3.8	3.9	0.0	0.8	1.3	1.8	1.2	0.8	2.3	0.3	3.3	1.9	2.7	2.4
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 72.0;liver: 144.4;urinary bladder: 89.6"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 12.5;Early spermatids: 52.4;Gastric mucus-secreting cells: 14.3;Late spermatids: 23.3;Squamous epithelial cells: 17.3"	"Group enriched"	"Detected in many"	5	"liver cancer: 7.2;lung cancer: 3.1;renal cancer: 7.6;urothelial cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 1194.0"	"Not detected"	"Not detected"							"CAB009819, HPA054065, HPA056023"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Endoplasmic reticulum"	"CAB009819: AB_2241481, HPA054065: AB_2682367, HPA056023: "		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.9	0.0	1.8	5.9	0.1	2.6	16.2	0.0	3.5	0.0	0.0	0.0	72.0	144.4	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	1.4	0.0	2.6	3.6	0.0	11.2	2.6	0.0	0.0	0.0	17.5	0.4	0.0	1.2	0.5	0.0	5.8	89.6	5.6	0.0	4.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	53.8	1.6	0.0	80.2	0.1	0.8	294.5	0.1	4.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.3	0.0	31.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.0	1194.0	0.0	0.1	0.2	0.1	3.2	149.0	0.0	0.0	7.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	1.2	12.5	0.0	0.0	0.0	0.3	0.0	2.9	1.8	0.0	0.0	0.0	0.4	0.0	0.0	52.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.5	0.0	0.0	0.4	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.5	1.8	0.1	0.0	0.0	0.0	0.0	1.2	0.2	17.3	1.1	0.0	0.0	0.0	0.1	3.0
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"liver: 3.7"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 107.5;Proximal tubular cells: 101.6"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 208.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	192	"Hep G2: 2165.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	NA	NA	3010000	150000000	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2165.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	9.7	5.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.7	2.8	0.3	0.0	0.1	0.0	0.1	2.5	107.5	2.3	0.0	0.1	0.1	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	101.6	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	1.5	0.2	0.1	0.2	0.0
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230690776-230745576	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1616.8"	"Group enriched"	"Detected in many"	9	"Cholangiocytes: 985.1;Hepatocytes: 2244.9"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 1163.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 646.2;THP-1: 243.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025798	Supported				"Secreted to blood"	NA	NA	5940000	65000000000			"CAB025798: "	"unprognostic (7.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.70e-2)"	"unprognostic (9.28e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	8.2	14.7	229.9	2.6	232.1	0.4	4.5	265.2	245.5	9.8	121.2	4.6	2.5	3.2	1.9	2.6	6.1	93.5	142.6	218.4	230.1	51.3	1616.8	5.1	1.0	326.7	249.7	164.9	3.5	8.0	6.1	26.0	0.7	277.5	16.4	3.6	26.6	4.9	2.3	44.0	1.6	9.8	5.9	310.3	1.3	5.0	4.2	265.3	1.7	13.3	26.0	0.1	7.1	4.6	299.1	0.2	0.4	0.2	0.2	15.6	0.0	0.9	0.6	0.2	0.0	0.0	80.6	0.1	0.3	0.7	0.2	0.7	0.7	0.0	0.0	0.0	11.4	0.2	0.2	0.3	646.2	1.9	1.0	0.5	26.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	5.5	0.7	0.0	0.2	0.6	0.6	0.1	0.2	0.3	2.4	0.1	0.1	0.3	0.9	0.6	0.4	0.1	5.5	0.1	0.0	243.6	0.1	0.4	1.3	0.4	1.2	3.5	47.0	0.4	0.4	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	229.9	232.1	265.2	245.5	218.4	230.1	326.7	249.7	164.9	277.5	310.3	265.3	299.1	0.8	0.0	1.7	140.0	11.3	0.6	1.1	0.0	0.0	4.7	0.8	0.3	60.0	985.1	0.6	3.7	35.5	0.1	0.0	0.0	25.4	169.8	62.2	0.3	0.4	5.5	0.0	50.8	0.3	10.0	0.2	27.2	0.5	0.1	0.0	0.0	39.3	2244.9	2.1	3.3	1.5	1.1	0.0	56.9	0.4	48.5	4.1	0.9	8.8	5.6	0.6	75.1	0.0	3.5	6.8	13.7	1.2	3.4	0.0	26.2	24.2	146.9	0.1	49.8	13.1	7.2	94.1	0.4	0.4	0.0	0.0	0.7	3.9	0.0	0.4	1.9
ALDH1L1	"10-fTHF, FDH, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 372.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 633.3;Proximal tubular cells: 197.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.5;Hep G2: 78.1;Karpas-707: 82.0;RPMI-8226: 45.0;RT4: 219.1;U-266/70: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		No	No		3000000	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	77.1	37.5	50.2	2.0	52.4	0.4	29.1	52.7	64.1	15.8	33.7	9.7	0.2	7.3	2.5	6.7	16.2	2.3	18.5	44.3	49.0	117.7	372.7	3.1	0.3	52.6	48.8	42.1	45.7	44.7	15.3	4.5	0.0	50.2	14.7	5.4	8.8	89.4	7.0	91.5	3.2	5.6	2.1	41.5	0.4	9.5	15.1	48.1	3.7	2.6	60.5	4.6	28.6	6.5	42.1	1.3	0.0	0.0	0.0	36.5	0.0	0.4	0.3	1.5	0.4	0.6	0.0	3.2	2.6	10.2	0.0	2.1	0.4	0.6	1.5	0.7	0.0	0.2	0.1	0.3	78.1	10.6	10.6	0.2	0.3	0.8	0.0	0.0	0.3	0.0	0.0	0.0	82.0	1.6	0.0	0.0	0.2	0.3	1.1	0.0	0.1	0.2	45.0	0.7	219.1	0.4	0.3	1.3	10.6	0.0	0.6	0.1	0.0	0.3	1.4	6.2	0.0	0.1	44.8	14.8	0.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	52.4	52.7	64.1	44.3	49.0	52.6	48.8	42.1	50.2	41.5	48.1	42.1	0.8	0.0	6.0	92.7	4.6	0.1	53.5	9.1	1.8	0.2	14.4	2.2	16.1	38.6	44.0	12.9	0.0	0.0	0.1	7.2	72.4	2.9	22.3	57.2	5.2	4.6	1.2	34.7	0.6	5.6	0.2	9.1	0.0	3.6	27.8	12.4	17.2	633.3	0.1	0.0	3.0	17.6	2.0	24.5	1.9	35.0	26.4	9.3	3.6	3.7	0.0	40.0	0.0	11.1	0.2	2.2	0.4	22.6	0.0	12.2	0.8	197.4	32.2	1.4	6.6	10.5	5.3	1.6	4.3	1.7	0.0	0.1	2.8	0.9	5.6	61.7
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986165-34008104	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 135.5;liver: 182.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.7;Hepatocytes: 21.6;Late spermatids: 21.6;Proximal tubular cells: 38.5"	"Group enriched"	"Detected in all"	4	"liver cancer: 8.8;prostate cancer: 34.5;renal cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 175.4;U-266/84: 98.0"	"Low region specificity"	"Detected in all"							"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		70000	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favorable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	8.7	15.1	5.9	5.0	5.3	3.1	6.4	4.7	6.1	6.6	4.5	40.4	18.1	4.7	9.7	15.8	6.2	20.7	10.2	5.1	6.6	135.5	182.0	9.3	3.6	5.9	5.9	5.8	7.8	13.9	13.1	5.7	7.8	6.0	39.6	43.3	12.1	61.2	12.6	19.4	4.7	16.0	7.1	5.1	5.4	35.1	4.4	6.7	4.8	8.3	15.1	5.7	8.9	8.6	7.0	12.7	20.2	11.1	14.3	7.7	11.9	19.1	16.6	12.2	7.6	5.7	66.1	15.1	4.1	8.7	23.6	28.6	5.8	2.8	12.0	7.7	12.7	10.9	9.8	13.7	19.0	5.4	6.0	3.0	18.1	6.0	9.7	3.6	10.7	8.5	8.3	3.8	14.7	22.4	9.6	5.0	7.6	10.0	9.4	32.9	6.0	18.6	6.5	33.2	62.4	6.1	8.7	27.6	19.3	16.9	9.1	14.9	5.9	15.6	24.6	5.4	6.2	13.6	175.4	98.0	7.4	7.0	12.1	18.8	0.3	6.0	9.3	8.3	8.0	7.0	7.1	7.2	6.4	8.9	5.2	6.6	4.8	10.0	8.7	14.2	4.6	7.9	6.0	5.9	5.3	4.7	6.1	5.1	6.6	5.9	5.9	5.8	6.0	5.1	6.7	7.0	0.8	3.2	4.1	0.0	2.2	0.4	0.4	0.9	1.8	4.3	1.4	0.9	1.1	8.6	3.7	1.8	0.0	1.0	2.2	19.7	5.9	0.8	8.9	2.3	1.2	3.0	4.2	2.1	0.0	3.8	1.0	2.9	4.1	1.5	0.0	1.2	1.1	21.6	1.1	5.0	0.0	5.1	4.1	0.9	0.2	21.6	0.6	1.2	0.0	0.0	1.5	9.3	3.1	0.0	0.0	2.6	4.5	2.2	1.6	0.6	4.7	38.5	3.1	0.9	0.0	1.7	3.7	0.7	0.7	3.4	0.6	0.3	1.5	1.2	4.4	0.4
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111809-79132288	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	83	"kidney: 786.1;liver: 1151.3"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 604.2;Proximal tubular cells: 996.1"	"Group enriched"	"Detected in some"	4	"liver cancer: 90.6;renal cancer: 50.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.6;NTERA-2: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol		No	NA		10000000	Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favorable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.6	0.3	0.3	0.0	0.7	0.0	0.5	0.1	0.6	0.2	0.2	0.6	1.2	0.2	1.8	0.1	0.2	0.2	0.1	0.5	0.3	786.1	1151.3	0.1	0.0	0.3	0.2	0.3	0.1	0.1	0.0	0.5	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.1	3.2	0.3	0.3	0.5	0.4	0.0	0.0	11.7	0.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.6	0.5	0.3	0.3	0.2	0.3	0.3	0.2	0.3	0.4	0.1	0.0	0.0	1.0	5.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	4.3	0.0	16.5	0.0	0.0	0.0	0.0	78.2	0.0	0.5	0.1	0.8	0.8	0.0	13.5	0.9	0.0	0.1	0.1	8.2	0.2	0.0	0.1	8.9	604.2	0.0	0.0	0.2	0.4	0.0	12.2	0.0	0.5	0.9	3.5	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	2.6	0.0	0.0	0.0	996.1	0.0	0.4	0.0	0.2	0.1	0.2	1.0	0.0	0.0	0.1	4.2	0.5	0.1	0.3
CCL25	"Ckb15, SCYA25, TECK"	ENSG00000131142	"C-C motif chemokine ligand 25"	O15444	19	8052318-8062660	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	1031	"intestine: 586.3;lymphoid tissue: 778.4"	"Cell type enhanced"	"Detected in some"		"Intestinal goblet cells: 149.1;Proximal enterocytes: 774.7;Undifferentiated cells: 399.3"	"Group enriched"	"Detected in many"	4	"liver cancer: 25.4;stomach cancer: 33.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 3.5"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;HEL: 2.1;NB-4: 2.6;REH: 6.1;RPMI-8226: 1.8;SH-SY5Y: 1.9"									HPA055883	Approved				"Secreted to blood"	NA	NA	183000000				"HPA055883: AB_2682955"	"unprognostic (9.22e-3)"	"unprognostic (3.13e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-4)"	"unprognostic (6.43e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.2	0.5	0.0	0.1	0.8	517.0	0.3	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.3	0.0	1.4	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	586.3	0.0	0.1	0.5	0.5	0.6	0.2	778.4	0.2	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	2.6	0.1	0.0	0.3	6.1	0.0	1.8	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.5	0.2	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.2	1.6	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	149.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	57.6	0.0	1.5	0.0	774.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	399.3	0.0
CHST13	C4ST3	ENSG00000180767	"Carbohydrate sulfotransferase 13"	Q8NET6	3	126524155-126543291	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 60.1;testis: 18.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 104.0;Hepatocytes: 40.3;Spermatocytes: 126.2"	"Group enriched"	"Detected in many"	4	"liver cancer: 25.0;renal cancer: 6.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 155.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 155.2"	"Group enriched"	"Detected in some"	8	"CACO-2: 15.6;Hep G2: 28.4;NB-4: 19.0;THP-1: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA067960			Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA067960: "	"unprognostic (5.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.42e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-2)"	0.3	0.4	0.2	0.4	0.2	0.6	0.1	0.1	0.4	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.3	3.2	60.1	0.6	0.1	0.2	0.4	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.4	3.6	0.4	18.5	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.7	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.7	0.3	28.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.9	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.1	33.0	155.2	0.0	20.5	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	30.7	0.0	17.5	0.0	0.0	13.1	0.2	0.2	0.1	0.4	0.2	0.3	0.2	0.4	0.2	0.2	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	104.0	0.6	0.0	0.1	1.2	5.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.7	40.3	13.1	0.0	0.0	1.0	0.0	7.5	1.3	16.9	1.5	6.2	0.0	1.9	7.2	0.0	0.0	0.0	0.1	0.0	2.8	1.2	0.3	0.0	8.5	9.9	0.1	0.0	0.0	0.0	0.0	126.2	2.8	0.0	0.0	0.3	0.2	0.0	1.8	0.0
CUX2	"CDP2, CUTL2, KIAA0293"	ENSG00000111249	"Cut like homeobox 2"	O14529	12	111034165-111350554	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 21.7;choroid plexus: 21.6;liver: 20.5;prostate: 11.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 28.1;Excitatory neurons: 175.4;Hepatocytes: 50.9;Horizontal cells: 26.9;Inhibitory neurons: 72.5"	"Group enriched"	"Detected in some"	4	"liver cancer: 5.2;prostate cancer: 11.2"	"Region enhanced"	"Detected in many"		"cerebral cortex: 21.7"	"Immune cell enriched"	"Detected in single"	70	"plasmacytoid DC: 6.9"	"Lineage enriched"	"Detected in single"	70	"dendritic cells: 6.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 6.6;HDLM-2: 2.9;hTERT-HME1: 3.5;SCLC-21H: 6.5;SH-SY5Y: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.87e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.83e-5)"	"unprognostic (2.67e-1)"	"unprognostic (3.54e-3)"	"unprognostic (4.31e-2)"	"unprognostic (9.03e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.90e-2)"	0.0	0.0	3.7	0.2	1.5	0.2	1.8	0.0	21.7	0.8	21.6	0.3	0.1	0.1	0.3	0.1	0.0	0.0	0.0	4.1	1.6	0.0	20.5	0.0	0.5	0.7	1.6	4.9	0.0	0.1	0.0	2.1	0.0	4.3	11.5	0.0	2.3	0.0	2.9	0.1	0.2	0.2	0.0	0.0	0.2	1.6	0.5	7.9	0.2	4.2	0.1	0.4	0.1	0.0	2.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	6.6	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	6.5	14.0	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	3.7	1.5	0.0	21.7	4.1	1.6	0.7	1.6	4.9	4.3	0.0	7.9	2.9	0.0	0.0	0.0	7.2	0.5	0.0	3.5	0.7	0.0	6.4	2.6	3.0	1.0	2.8	0.1	0.0	0.0	0.0	28.1	0.1	0.0	0.0	1.2	3.7	0.1	0.1	0.0	2.7	175.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.4	50.9	0.7	26.9	72.5	0.0	0.0	0.6	0.0	0.6	0.0	0.5	0.0	1.9	0.0	0.1	0.0	20.1	1.8	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.9	0.0	0.3	0.1	0.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.6
CYP27A1	"CP27, CTX, CYP27"	ENSG00000135929	"Cytochrome P450 family 27 subfamily A member 1"	Q02318	2	218781749-218815293	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 599.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 404.3;Hofbauer cells: 148.9;Proximal enterocytes: 206.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 176.9;melanoma: 85.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 151.5;neutrophil: 126.3"	"Group enriched"	"Detected in many"	21	"granulocytes: 126.3;monocytes: 151.5"	"Cell line enhanced"	"Detected in many"		"Hep G2: 299.6;HSkMC: 54.7;RPTEC TERT1: 78.5;SK-MEL-30: 103.6;WM-115: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059155	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA059155: AB_2683933"	"prognostic favorable (1.05e-4)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.71e-3)"	"unprognostic (1.31e-2)"	"prognostic favorable (8.62e-6)"	"unprognostic (6.04e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	22.6	50.7	45.5	15.8	57.6	1.3	22.0	58.4	59.8	26.8	71.5	26.5	78.5	20.0	11.7	12.0	34.3	19.2	24.7	42.8	52.2	46.9	599.2	72.4	24.8	64.1	57.4	39.5	32.9	8.4	18.7	29.8	6.3	61.0	42.2	20.9	22.7	40.7	29.8	38.3	17.4	82.6	13.3	58.4	13.1	13.9	12.7	55.1	23.8	12.7	49.6	28.2	24.5	23.4	70.8	0.2	0.0	2.7	0.2	4.6	3.3	0.4	1.9	11.7	3.9	7.8	13.7	0.8	0.0	4.3	7.6	0.2	0.1	0.0	0.0	1.7	1.4	1.0	0.0	0.4	299.6	16.2	0.4	0.3	54.7	0.5	0.1	0.0	12.8	5.9	0.0	0.3	0.1	8.3	0.0	0.0	0.2	2.3	0.3	0.5	0.1	2.4	0.5	78.5	0.2	0.2	0.2	0.1	0.0	103.6	2.4	1.6	2.2	5.9	0.0	0.2	0.1	6.0	0.0	0.0	0.1	0.1	0.3	42.9	0.0	151.5	0.4	0.2	17.1	0.3	0.7	0.2	0.5	6.5	0.0	0.1	0.0	126.3	0.0	1.2	0.8	0.0	44.1	45.5	57.6	58.4	59.8	42.8	52.2	64.1	57.4	39.5	61.0	58.4	55.1	70.8	10.6	3.2	28.9	33.6	0.9	5.2	52.4	8.5	21.6	15.3	12.7	18.8	5.1	17.2	11.3	3.7	27.1	0.7	0.5	37.0	9.8	12.1	1.0	12.6	4.3	10.3	24.5	8.4	2.2	12.0	0.7	35.4	2.6	14.8	2.5	1.9	19.6	404.3	148.9	10.1	3.9	20.0	4.1	18.2	5.1	1.0	47.5	104.3	49.8	15.0	92.4	28.7	0.0	26.7	108.5	9.7	44.0	26.7	0.0	43.3	206.3	76.9	21.4	14.1	0.0	12.8	7.2	0.7	0.1	3.2	3.1	1.2	2.3	1.2	30.3	20.4
DEFB132	"DEFB32, RP5-1103G7.6"	ENSG00000186458	"Defensin beta 132"	Q7Z7B7	20	257724-261096	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"epididymis: 273.5"	"Cell type enriched"	"Detected in some"	7	"Collecting duct cells: 11.0"	"Group enriched"	"Detected in some"	4	"liver cancer: 0.8;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046399	Approved				"Secreted in male reproductive system"	NA	NA					"HPA046399: AB_10960992"	"unprognostic (9.27e-3)"						"unprognostic (1.61e-2)"					"unprognostic (2.54e-2)"						26.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	273.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.5	0.0	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
GCGR	GGR	ENSG00000215644	"Glucagon receptor"	P47871	17	81804132-81814008	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 171.0"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 74.6"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 10.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.0;MCF7: 1.4;SK-BR-3: 1.2;U-87 MG: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071228			Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA071228: AB_2686368"	"unprognostic (3.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.36e-3)"	0.2	2.6	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.7	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	35.7	171.0	0.0	0.1	0.2	0.1	0.0	0.0	1.5	6.3	0.2	0.0	0.2	0.2	0.0	0.7	0.1	0.0	0.0	1.2	0.6	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.2	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.9	0.0	0.6	0.0	0.5	0.0	0.3	0.6	0.0	0.3	3.7	2.1	0.0	0.0	0.1	3.9	0.2	0.1	0.4	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.4	74.6	0.1	0.0	0.5	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.6	0.4	0.0	0.0	0.0	0.2	0.4	0.5	0.4	0.0	0.2	0.0	0.1	0.0
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423439-42721878	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 85.5;liver: 215.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 53.3;Hepatocytes: 141.3;Inhibitory neurons: 115.7;Oligodendrocyte precursor cells: 181.0"	"Group enriched"	"Detected in many"	4	"breast cancer: 2.8;liver cancer: 7.6;prostate cancer: 8.1;renal cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 21.2;T-47d: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	2200000	24000000	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (2.18e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (2.73e-6)"	"unprognostic (1.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.73e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.67e-3)"	"unprognostic (4.29e-4)"	"unprognostic (7.82e-2)"	"unprognostic (7.33e-4)"	"unprognostic (8.35e-6)"	85.5	5.6	1.6	1.7	2.3	0.2	30.3	1.9	1.7	5.1	2.4	5.3	1.1	4.5	4.6	3.9	5.4	5.2	9.0	1.8	4.2	11.9	215.0	4.0	1.3	1.1	1.9	1.5	7.6	2.2	5.5	1.2	4.9	1.4	11.2	5.7	0.4	3.8	4.7	46.1	5.6	4.3	4.0	1.1	4.1	6.1	1.7	2.6	2.3	4.7	11.7	0.9	5.0	5.9	1.5	0.0	0.0	0.6	5.0	3.3	0.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.3	4.3	0.0	0.0	2.6	0.0	0.1	0.0	0.6	0.0	0.0	21.2	7.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	1.8	0.2	0.0	0.0	0.3	0.0	0.7	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.3	0.1	3.5	0.6	56.0	0.1	3.0	4.8	2.1	2.6	0.5	0.5	0.0	0.0	0.5	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	2.3	1.9	1.7	1.8	4.2	1.1	1.9	1.5	1.4	1.1	2.6	1.5	17.2	0.0	0.5	14.7	0.4	4.7	4.5	17.8	10.2	0.6	9.7	16.0	18.6	1.5	1.9	1.8	0.0	17.4	0.5	2.8	1.9	0.0	5.1	0.5	9.4	4.8	3.0	5.3	53.3	0.2	2.2	23.8	0.5	0.3	0.0	1.1	6.1	141.3	1.9	0.0	115.7	1.9	0.0	3.0	1.8	2.8	18.6	0.7	1.8	36.5	0.0	0.7	0.0	181.0	3.6	0.2	1.7	12.0	0.0	5.2	0.0	9.6	0.6	0.4	13.1	18.7	15.1	0.7	0.3	2.9	3.7	40.2	0.5	49.4	2.2	0.9
GLS2	"GA, GLS, hLGA, LGA"	ENSG00000135423	"Glutaminase 2"	Q9UI32	12	56470944-56488414	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 206.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 41.3;Hepatocytes: 54.9;Inhibitory neurons: 31.6"	"Cancer enriched"	"Detected in single"	4	"liver cancer: 1.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Lineage enhanced"	"Detected in single"		"T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"A-431: 7.6;Daudi: 42.8;Hep G2: 7.4;SCLC-21H: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038608	Uncertain					NA	NA					"HPA038608: AB_10673176"	"unprognostic (5.59e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.73e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.98e-6)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.65e-5)"	"unprognostic (1.42e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.44e-2)"	0.2	1.6	3.0	0.2	3.8	0.1	1.3	5.1	12.2	0.4	0.1	0.6	0.3	0.9	2.3	1.5	4.1	0.2	0.2	3.7	4.3	2.0	206.6	1.4	0.9	5.1	2.4	5.6	0.8	21.4	5.6	5.8	0.0	6.0	1.4	1.6	11.3	1.5	2.3	0.0	2.8	0.6	0.5	0.4	0.5	1.5	0.6	1.8	1.3	1.4	0.0	1.5	0.6	0.7	8.9	7.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	4.3	1.2	42.8	0.5	0.0	0.0	0.8	0.0	6.5	0.0	0.0	6.0	0.0	0.4	7.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	3.2	1.2	0.5	0.0	0.1	6.6	3.9	3.4	12.6	0.5	1.3	0.3	0.0	1.0	4.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.8	1.7	0.4	0.0	0.3	1.8	2.2	0.0	0.0	0.0	0.0	0.5	0.7	3.0	3.8	5.1	12.2	3.7	4.3	5.1	2.4	5.6	6.0	0.4	1.8	8.9	0.2	0.0	2.7	5.5	2.3	1.7	4.8	4.6	10.8	10.7	0.9	1.7	0.0	0.0	4.5	0.0	6.2	0.2	0.1	0.1	7.9	0.5	0.0	0.3	0.2	0.5	1.2	8.0	41.3	2.0	0.0	0.5	1.1	0.2	1.3	0.3	2.5	54.9	0.1	3.3	31.6	0.1	0.0	1.6	0.7	0.0	0.9	0.1	1.8	3.7	0.2	3.1	0.0	8.0	3.3	0.7	0.1	0.0	0.9	1.3	0.0	0.6	1.7	10.2	0.0	0.3	0.2	0.6	1.5	5.5	1.1	0.3	1.1	0.0	0.3	1.3
GPC3	"DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1"	ENSG00000147257	"Glypican 3"	P51654	X	133535745-133985594	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 579.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.1;Extravillous trophoblasts: 61.0;Fibroblasts: 404.2;Muller glia cells: 88.9;Syncytiotrophoblasts: 148.6"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 269.0"	"Region enhanced"	"Detected in many"		"hypothalamus: 8.2"	"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.8"	"Group enriched"	"Detected in some"	5	"HAP1: 514.3;Hep G2: 1825.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006316			Supported	"Plasma membrane"		NA	NA		27000	"Plasma membrane"		"HPA006316: AB_1078994"	"unprognostic (2.06e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.51e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.92e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.81e-3)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	80.1	23.0	0.7	3.5	1.0	0.0	62.4	0.5	0.3	10.0	0.3	6.4	1.7	9.3	41.5	6.8	14.0	13.9	16.3	0.2	8.2	87.8	5.1	124.0	2.5	1.8	2.1	0.2	15.6	21.4	4.1	47.4	579.7	1.7	8.4	4.2	6.3	13.8	9.3	4.5	14.7	5.7	7.4	1.5	3.7	13.7	2.8	1.8	8.1	22.6	28.8	11.0	14.8	9.4	1.1	0.0	0.0	21.8	1.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	154.0	0.0	0.0	0.1	0.1	0.0	0.0	514.3	0.4	0.0	0.0	22.6	0.0	0.9	1825.2	0.3	0.0	0.5	12.9	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.5	0.1	132.1	0.1	0.0	0.0	0.0	0.1	122.4	6.1	15.3	40.3	0.0	0.0	0.4	233.8	0.5	23.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.8	1.2	0.0	0.7	0.0	0.0	0.0	0.1	0.7	1.0	0.5	0.3	0.2	8.2	1.8	2.1	0.2	1.7	1.5	1.8	1.1	28.5	0.0	1.7	0.3	1.0	10.5	4.8	17.0	0.0	0.4	5.0	10.4	0.5	1.5	20.0	5.5	0.0	65.1	0.8	0.5	19.6	0.3	0.9	0.2	0.4	1.8	1.8	0.0	2.5	1.6	61.0	404.2	0.5	1.5	0.0	1.0	2.2	0.0	26.7	0.0	2.5	3.1	2.0	0.0	6.1	2.4	10.5	1.0	3.6	23.4	0.0	88.9	0.0	3.5	1.4	1.7	2.6	3.0	0.4	2.7	1.2	40.7	24.3	3.1	0.0	21.7	21.3	6.9	7.1	0.2	4.0	148.6	1.1	7.6	4.1	0.6
GPR37	"EDNRBL, hET(B)R-LP, PAELR"	ENSG00000170775	"G protein-coupled receptor 37"	O15354	7	124743885-124765792	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 109.0;retina: 39.4"	"Group enriched"	"Detected in many"	8	"Muller glia cells: 616.6;Oligodendrocytes: 324.9"	"Group enriched"	"Detected in many"	4	"glioma: 19.2;liver cancer: 5.7;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 7.5;fHDF/TERT166: 17.7;hTCEpi: 7.7;SK-BR-3: 6.8;SuSa: 8.0;TIME: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042903, HPA068009"	Approved		Approved	"Nuclear membrane,Cytosol"		No	No		900000	"Nuclear membrane, Cytosol"		"HPA042903: AB_2678219, HPA068009: AB_2685940"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-4)"	0.5	0.1	28.9	0.1	59.6	0.0	0.5	51.2	46.3	0.3	7.1	0.5	0.0	1.6	0.2	3.7	0.6	0.3	0.0	30.3	44.0	0.3	10.1	0.2	0.1	60.7	58.2	22.4	0.0	1.5	0.1	0.2	5.2	57.6	0.5	0.3	39.4	0.9	0.5	0.6	2.2	0.6	1.2	51.5	2.1	1.3	10.7	47.3	0.0	0.0	0.1	0.0	1.4	0.6	109.0	0.1	1.4	7.5	0.0	0.0	0.0	2.1	0.5	1.9	1.9	0.4	0.3	0.7	0.0	0.0	17.7	0.2	0.1	2.2	0.0	0.4	0.3	1.0	0.1	4.4	0.0	2.2	0.0	0.3	0.0	7.7	0.0	0.1	0.0	3.6	0.0	0.0	3.4	0.0	0.4	0.0	0.0	1.1	0.0	3.5	0.0	0.0	0.0	0.0	0.1	1.7	2.7	0.0	6.8	2.6	8.0	1.7	0.0	12.7	1.5	0.6	0.0	0.0	1.1	0.0	0.0	0.7	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	59.6	51.2	46.3	30.3	44.0	60.7	58.2	22.4	57.6	51.5	47.3	109.0	0.1	0.0	0.0	5.9	0.0	4.6	0.5	4.4	6.8	55.8	4.6	3.0	0.6	7.2	1.8	1.8	6.2	10.1	0.0	0.1	0.0	5.1	0.4	2.0	0.4	0.7	0.0	0.0	6.0	0.6	19.7	1.9	0.0	3.4	0.0	0.3	0.4	22.4	1.2	18.5	1.1	1.1	2.0	0.3	0.7	1.7	2.8	0.2	3.6	1.0	0.6	616.6	0.0	1.5	324.9	0.4	0.2	0.7	0.0	3.2	0.0	0.0	1.4	22.5	0.0	4.8	0.7	0.6	2.2	4.6	10.2	3.0	0.5	0.1	0.0	0.4
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791371-52803860	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 924.0;kidney: 951.8;liver: 2632.1"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1652.6;Granulosa cells: 3177.1;Proximal enterocytes: 4294.8;Proximal tubular cells: 3190.6;Theca cells: 4578.2"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 555.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 263.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000		Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.5	924.0	0.0	2.5	0.0	0.0	4.3	0.0	0.2	2.0	0.0	7.3	678.0	0.4	7.0	5.3	86.8	120.6	0.2	0.0	0.0	951.8	2632.1	12.3	0.5	0.0	0.0	0.0	79.6	149.9	0.0	0.2	0.5	0.0	18.9	8.2	0.0	21.7	0.6	0.1	0.9	680.2	0.3	0.1	0.2	136.8	339.7	0.2	0.1	0.1	0.0	11.6	2.2	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	19.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.1	263.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.2	1.5	2.1	0.3	0.0	0.0	1.1	0.0	0.2	0.5	0.5	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	6.4	7.7	0.0	13.5	0.0	5.0	35.7	0.0	0.0	7.0	1.5	0.0	453.2	159.9	73.5	0.0	0.1	0.1	5.8	536.1	71.3	11.8	0.4	0.1	3.1	3.0	45.5	0.0	1652.6	0.2	7.3	116.7	0.5	2.5	3177.1	26.4	1013.9	0.1	0.0	0.0	165.6	42.7	31.5	0.0	43.0	65.6	25.3	0.0	0.0	13.3	0.0	1.0	0.0	0.1	629.1	187.4	4.5	0.2	27.6	4294.8	3190.6	533.5	0.0	0.0	0.0	98.6	36.8	3.4	6.8	0.0	0.5	10.4	4578.2	295.3	58.7
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628172-120682269	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"kidney: 202.2;liver: 758.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 103.7;Endometrial ciliated cells: 113.9;Glandular and luminal cells: 127.8;Hepatocytes: 534.7;Proximal tubular cells: 477.5"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 119.8"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 55.8;EFO-21: 82.7;Hep G2: 186.6;OE19: 328.0;RPTEC TERT1: 212.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"		NA	NA		700000	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.4	0.3	0.4	2.5	1.2	0.5	12.6	0.5	0.8	27.6	1.2	16.9	31.9	3.2	13.2	0.4	4.2	62.3	0.3	0.5	0.4	202.2	758.9	0.8	0.4	1.1	0.4	0.5	0.2	31.4	7.1	0.2	0.2	0.4	44.9	20.5	0.7	4.3	4.3	0.1	0.6	25.8	0.5	0.4	0.6	25.7	0.1	0.4	0.7	55.6	0.2	0.1	0.2	0.1	0.6	0.0	12.3	4.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	55.8	10.7	0.1	82.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.2	186.6	0.0	0.4	1.0	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.5	0.0	0.0	0.2	0.3	328.0	0.0	0.1	0.3	0.1	212.2	0.0	0.2	0.2	0.2	0.9	0.0	0.0	0.2	1.0	0.6	0.1	0.9	0.2	0.1	0.0	0.3	0.5	0.2	0.8	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.4	1.2	0.5	0.8	0.5	0.4	1.1	0.4	0.5	0.4	0.4	0.4	0.6	0.1	0.0	2.0	0.3	5.9	0.0	0.4	0.6	0.0	0.3	7.5	1.7	0.3	81.5	4.9	27.6	2.1	0.0	0.3	18.5	103.7	7.2	0.2	113.9	17.1	1.2	43.8	24.0	3.2	17.8	0.0	0.4	19.4	127.8	1.3	0.0	16.4	534.7	0.2	0.0	0.6	16.0	2.0	16.1	0.0	0.0	0.0	21.3	0.0	1.9	2.0	4.2	0.0	0.0	0.5	12.1	35.6	0.0	0.0	12.9	54.6	477.5	4.1	0.2	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	3.8	0.4	9.1	0.4
HNF1A	"HNF1, LFB1, MODY3, TCF1"	ENSG00000135100	"HNF1 homeobox A"		12	120978543-121002512	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"			"Group enriched"	"Detected in some"	4	"intestine: 15.5;kidney: 16.2;liver: 35.0;pancreas: 9.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 14.5;Hepatocytes: 15.8;Intestinal goblet cells: 9.4;Paneth cells: 14.8;Proximal enterocytes: 33.4;Proximal tubular cells: 16.0;Undifferentiated cells: 10.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 4.5;liver cancer: 3.6;pancreatic cancer: 1.4;renal cancer: 3.6;stomach cancer: 4.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 8.9;CACO-2: 29.4;Hep G2: 32.5;OE19: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010430, HPA035231"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB010430: AB_2116746, HPA035231: AB_2674528"	"unprognostic (5.92e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.12e-3)"	"unprognostic (6.18e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.77e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.48e-1)"		"unprognostic (6.93e-3)"	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.1	4.3	15.5	0.2	0.0	0.1	1.1	0.8	0.0	0.1	0.1	16.2	35.0	0.0	0.0	0.1	0.1	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.2	14.4	0.1	0.0	0.0	4.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.6	0.2	0.0	1.2	4.3	0.0	1.8	0.0	0.1	0.4	14.5	0.0	2.6	0.0	1.3	0.2	0.3	4.8	0.0	0.2	5.3	0.1	0.2	4.6	0.5	0.0	0.1	0.4	15.8	0.1	0.0	0.2	9.4	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.5	0.0	0.5	0.0	3.9	14.8	0.0	0.1	0.5	33.4	16.0	0.0	0.3	0.0	0.8	0.3	0.1	0.3	0.0	0.3	0.0	0.5	0.0	10.8	0.4
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 432.9;liver: 219.6;placenta: 384.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 155.8;Distal enterocytes: 203.4;Hepatocytes: 121.9;Paneth cells: 284.2;Proximal enterocytes: 390.7"	"Group enriched"	"Detected in many"	4	"liver cancer: 10.9;pancreatic cancer: 6.5;stomach cancer: 4.2;urothelial cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 57.9;Hep G2: 47.5;hTERT-HME1: 27.1;OE19: 87.1;RT4: 96.8;TIME: 54.0"	"Group enriched"	"Detected in some"	5	"midbrain: 2.2;pons and medulla: 3.4"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.83e-4)"	0.9	0.0	0.4	4.3	0.3	0.7	26.6	0.9	0.5	4.3	0.2	75.5	432.9	1.2	0.1	9.7	0.1	21.3	0.2	0.3	0.2	5.0	219.6	2.3	0.3	0.1	0.1	0.2	0.3	23.4	0.0	1.2	384.9	0.5	2.0	57.4	17.5	22.3	0.2	0.1	3.1	190.1	2.4	0.0	0.2	20.3	0.3	0.1	0.4	0.1	0.0	3.4	79.3	1.4	0.5	0.4	0.1	0.4	0.0	0.0	0.7	0.7	0.2	57.9	0.0	0.0	10.9	1.7	0.1	11.4	0.0	0.1	0.4	0.0	2.4	0.0	0.1	0.1	0.3	0.3	47.5	0.4	0.3	0.3	0.0	3.1	0.0	27.1	0.6	0.9	0.1	0.1	0.4	8.6	0.1	0.0	0.9	0.2	87.1	21.4	0.1	0.2	1.3	1.0	96.8	0.4	1.5	0.0	2.7	0.2	0.0	0.1	0.1	54.0	0.6	0.5	0.3	0.0	0.2	0.2	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.2	0.0	0.0	0.4	0.3	0.9	0.5	0.3	0.2	0.1	0.1	0.2	0.5	0.0	0.1	0.5	1.0	3.2	3.9	0.3	0.7	0.4	2.7	16.4	2.2	0.5	45.7	12.3	0.6	155.8	21.4	0.0	0.0	2.7	0.3	203.4	0.0	73.6	0.5	5.9	5.4	21.3	3.0	2.7	0.1	6.0	1.8	38.3	15.3	41.3	0.0	0.0	2.5	121.9	3.5	0.0	0.1	26.3	6.1	3.1	0.0	0.9	0.0	0.4	1.8	0.0	0.0	45.1	0.0	0.0	0.1	20.1	284.2	0.0	0.1	2.7	390.7	1.4	5.6	0.7	0.0	0.4	2.0	0.0	0.1	0.8	1.1	6.4	0.7	0.0	47.1	14.8
KMO		ENSG00000117009	"Kynurenine 3-monooxygenase"	O15229	1	241532134-241595642	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Pyridine nucleotide biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 31.8;liver: 92.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 33.8;Hepatocytes: 46.9;Langerhans cells: 49.4;Macrophages: 33.0;Proximal tubular cells: 63.2;Syncytiotrophoblasts: 180.1"	"Group enriched"	"Detected in many"	4	"breast cancer: 1.6;liver cancer: 3.3;renal cancer: 3.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.8"	"Group enriched"	"Detected in many"	79	"classical monocyte: 11.0;intermediate monocyte: 32.3;memory B-cell: 36.1;myeloid DC: 11.3;naive B-cell: 42.0;non-classical monocyte: 33.8;plasmacytoid DC: 24.3"	"Group enriched"	"Detected in many"	97	"B-cells: 42.0;dendritic cells: 24.3;monocytes: 33.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.2;RPMI-8226: 9.1;RPTEC TERT1: 21.9;SK-BR-3: 10.9;U-698: 9.4"	"Region enriched"	"Detected in single"	4	"thalamus: 1.1"	"Low region specificity"	"Detected in many"			"HPA031115, HPA056942"	Enhanced					NA	NA					"HPA031115: AB_10601924, HPA056942: AB_2683281"	"unprognostic (4.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.95e-2)"	"unprognostic (7.48e-3)"	"unprognostic (8.37e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.49e-8)"	"unprognostic (1.60e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.81e-2)"	1.4	0.8	0.1	5.2	0.4	1.4	5.3	0.1	1.8	0.6	2.1	0.9	0.6	5.4	0.2	0.2	0.2	1.6	0.4	0.4	0.2	31.8	92.4	5.1	8.9	0.1	0.1	0.2	0.2	0.1	0.1	0.2	6.9	0.2	0.3	1.1	0.2	0.3	0.2	0.1	0.2	1.2	0.8	0.0	8.4	1.2	1.3	0.7	1.6	0.2	0.0	11.3	5.6	0.1	0.4	0.2	1.8	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.2	0.4	0.0	0.2	6.2	0.4	0.0	0.2	2.5	0.0	0.2	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.6	0.2	0.2	0.7	0.1	0.2	0.5	0.0	0.4	0.1	0.9	0.0	0.2	0.0	2.4	1.0	0.9	0.4	1.6	0.1	9.1	21.9	4.5	0.3	0.1	0.0	10.9	0.1	2.1	4.3	2.1	0.0	0.0	0.1	0.1	1.6	0.4	0.6	9.4	0.2	2.7	1.8	0.1	11.0	0.2	0.0	32.3	0.0	36.1	0.0	0.0	11.3	42.0	0.0	0.1	0.3	0.0	33.8	24.3	0.0	6.1	0.1	0.4	0.1	1.8	0.4	0.2	0.1	0.1	0.2	0.2	0.0	0.7	0.4	0.1	0.0	0.5	0.0	33.8	1.0	0.1	13.3	2.2	0.0	1.8	0.8	0.4	2.8	11.1	0.0	0.0	3.6	5.5	0.1	5.9	4.8	4.9	9.5	1.5	0.3	0.0	5.2	6.6	0.2	2.3	0.4	2.0	26.6	0.0	0.1	0.7	46.9	7.0	0.0	30.0	0.0	4.1	22.7	49.4	1.8	0.0	33.0	0.0	0.0	5.5	0.0	1.0	1.0	0.6	1.5	0.0	0.0	11.7	0.2	0.2	63.2	2.3	0.0	0.0	0.1	1.3	1.6	0.3	3.1	1.4	180.1	1.6	0.1	0.0	0.1
LRCOL1		ENSG00000204583	"Leucine rich colipase like 1"	A6NCL2	12	132603150-132610582	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"epididymis: 50.5"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 33.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 0.8;liver cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA						"unprognostic (5.09e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.50e-6)"	"unprognostic (1.46e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.00e-3)"	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.2	50.5	0.1	0.4	0.0	0.0	0.0	0.0	0.1	2.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.6	1.9	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.0	0.1	3.3	33.2	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	1.5	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.1	0.0	0.2	0.4	0.0	0.0
MLIP	"C6orf142, CIP, MGC18257"	ENSG00000146147	"Muscular LMNA interacting protein"	Q5VWP3	6	53929982-54266280	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"heart muscle: 166.4;liver: 132.4;skeletal muscle: 248.7;tongue: 150.8"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 224.9;Excitatory neurons: 244.1"	"Group enriched"	"Detected in some"	4	"glioma: 0.8;head and neck cancer: 0.5;liver cancer: 1.9;melanoma: 1.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 19.6;SK-MEL-30: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029252, HPA046654"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029252: AB_2732446, HPA046654: "	"unprognostic (7.95e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.91e-5)"	"unprognostic (7.49e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.29e-3)"	3.8	4.3	2.2	0.1	5.3	0.0	3.5	0.0	15.8	1.5	0.0	0.9	0.3	0.3	0.9	12.7	0.7	1.6	166.4	7.6	1.6	0.9	132.4	0.4	0.2	0.0	0.0	3.3	0.2	0.8	0.3	0.5	0.1	1.5	1.6	0.7	0.9	7.0	0.3	248.7	17.5	2.6	0.5	0.0	0.1	0.3	1.0	0.0	0.3	6.9	150.8	5.2	1.3	2.6	2.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.4	2.2	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	2.4	0.0	0.0	0.0	19.6	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	1.2	0.0	0.1	0.6	1.4	0.0	0.0	0.5	19.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	5.3	0.0	15.8	7.6	1.6	0.0	0.0	3.3	1.5	0.0	0.0	2.0	0.5	0.0	0.0	4.9	0.0	0.4	0.1	0.5	0.6	0.1	0.2	0.0	224.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	15.7	0.5	0.5	2.6	0.0	2.7	244.1	0.0	0.0	4.9	0.0	0.4	0.0	0.1	0.7	20.0	0.0	13.5	4.6	3.7	0.0	0.8	0.6	12.9	0.3	0.2	7.2	16.9	0.0	0.0	0.0	5.0	4.2	0.0	0.0	0.0	0.0	0.1	1.0	1.9	0.6	0.1	0.0	17.8	1.9	1.5	0.4	4.1	2.0	0.0	0.1	0.1	0.1	0.1
MT1A	"MT1, MT1S"	ENSG00000205362	"Metallothionein 1A"	P04731	16	56638666-56640087	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 315.8;liver: 434.3"	"Group enriched"	"Detected in many"	6	"Adipocytes: 797.9;Fibroblasts: 244.1;Hepatocytes: 343.8;Skeletal myocytes: 561.9;Smooth muscle cells: 889.5"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 33.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.4;ASC TERT1: 27.9;HHSteC: 19.7;HMC-1: 29.5;hTEC/SVTERT24-B: 80.2;NTERA-2: 40.1"					"Low region specificity"	"Detected in single"			"CAB002161, CAB013056"	Approved					NA	NA					"CAB002161: AB_563878, CAB013056: "	"unprognostic (1.36e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.35e-2)"	315.8	64.9	9.4	10.9	11.3	0.0	209.9	9.3	15.4	48.6	7.7	25.4	7.8	13.7	1.3	33.7	69.3	30.5	54.1	8.8	28.1	34.8	434.3	116.2	0.6	9.9	10.4	8.4	20.0	91.1	2.1	26.1	0.8	10.8	33.3	13.3	4.4	19.1	2.9	100.8	25.1	23.5	17.1	10.9	3.4	43.3	8.5	11.9	6.1	68.3	6.2	0.7	34.2	22.8	13.1	0.0	6.2	0.0	0.1	18.4	27.9	0.4	1.9	7.9	1.2	1.5	2.3	4.8	0.0	2.4	1.1	0.0	0.5	0.0	0.4	2.9	0.0	0.0	0.0	2.5	9.9	19.7	0.2	29.5	8.2	0.0	80.2	0.0	0.0	7.7	0.0	0.7	0.0	5.5	0.0	0.0	0.1	40.1	0.0	0.0	0.0	0.0	3.6	0.5	0.0	0.3	0.1	0.0	0.3	0.0	0.9	0.0	0.3	6.3	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	9.4	11.3	9.3	15.4	8.8	28.1	9.9	10.4	8.4	10.8	10.9	11.9	13.1	797.9	9.6	1.7	0.7	1.8	27.4	11.3	1.9	5.7	0.0	11.7	15.4	5.4	8.6	5.1	0.0	0.0	1.1	1.0	11.1	13.7	2.7	0.1	11.9	6.9	63.2	3.6	29.5	0.0	1.8	12.8	244.1	5.1	23.8	3.8	0.3	15.7	343.8	0.3	0.0	0.0	32.3	0.0	10.4	39.6	0.7	55.0	12.4	33.8	0.0	0.0	0.0	0.0	0.0	0.0	3.0	18.6	12.8	1.2	27.9	86.5	16.1	3.0	0.0	26.3	561.9	889.5	0.0	0.3	2.1	19.5	0.5	6.6	0.4	34.7	13.7
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666730-56668065	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 3506.9;liver: 7016.2;thyroid gland: 2912.8"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 77919.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 320.1;ovarian cancer: 106.9;prostate cancer: 103.9;testis cancer: 269.9;thyroid cancer: 369.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"U-937: 1103.8"														"Intracellular and membrane"	NA	NA						"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	124.7	21.7	342.2	106.7	413.9	2.9	28.3	393.5	919.5	12.4	301.5	828.7	518.4	8.4	2.4	257.4	76.2	12.1	6.8	338.0	346.5	3506.9	7016.2	50.3	5.6	403.6	361.9	358.6	3.2	1822.1	0.3	21.8	2.1	372.5	428.9	521.1	43.0	44.5	5.9	8.5	56.7	1105.7	77.0	331.0	3.9	1272.7	4.0	363.1	0.9	2912.8	1.0	2.6	14.3	26.1	402.5	0.4	0.0	0.0	0.0	0.0	0.0	4.4	8.6	1.7	1.1	0.4	0.0	0.0	0.1	16.2	0.0	0.1	1.8	0.2	1.2	0.9	0.8	0.0	4.3	0.0	3.5	4.5	1.0	0.6	1.7	0.0	11.4	0.0	0.1	0.0	0.0	0.3	1.2	0.7	0.0	3.7	251.3	0.5	0.0	0.0	0.0	0.8	70.8	40.8	0.0	21.8	3.0	0.5	1.3	1.1	10.8	0.0	107.8	0.0	0.0	0.8	1.7	0.3	0.6	1.9	0.6	2.0	1103.8	0.0	0.2	0.3	0.1	0.3	0.3	0.3	0.0	0.4	0.6	0.3	0.0	0.4	0.7	0.0	0.0	0.1	0.1	0.7	0.5	342.2	413.9	393.5	919.5	338.0	346.5	403.6	361.9	358.6	372.5	331.0	363.1	402.5	10.6	28.9	8.7	38.5	338.7	57.9	26.0	4.5	46.1	0.0	87.0	116.2	11.7	330.3	9.1	2302.6	0.0	3.9	9.8	3657.8	6849.7	74.4	0.3	2960.7	777.1	49.2	246.7	878.6	0.1	283.4	403.2	50.7	443.9	8167.8	17.2	16.8	310.2	16307.3	26.3	0.0	0.1	3688.0	0.0	379.5	4.9	0.9	23.3	765.6	30.2	2.8	10.6	0.0	2.1	2.0	0.1	339.8	10431.2	2.2	26.3	823.7	8631.3	77919.3	3.9	0.0	0.0	25.1	42.9	0.3	0.8	42.2	77.9	132.7	247.5	4.7	3786.7	21.1
NLRP6	"CLR11.4, NALP6, PAN3, PYPAF5"	ENSG00000174885	"NLR family pyrin domain containing 6"	P59044	11	278407-285388	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 40.2"	"Group enriched"	"Detected in some"	4	"Proximal enterocytes: 9.9;T-cells: 2.6"	"Group enriched"	"Detected in some"	4	"colorectal cancer: 0.9;liver cancer: 1.2;renal cancer: 1.5;stomach cancer: 1.8"	"Region enhanced"	"Detected in some"		"cerebral cortex: 3.1"	"Group enriched"	"Detected in many"	4	"neutrophil: 15.4;non-classical monocyte: 4.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 15.4;monocytes: 4.6"	"Cell line enhanced"	"Detected in some"		"REH: 2.0;U-266/70: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043681, HPA048500"	Supported					NA	NA					"HPA043681: AB_2678614, HPA048500: AB_2680422"	"unprognostic (6.37e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.18e-2)"	"prognostic favorable (4.23e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.69e-2)"	0.7	0.0	0.1	2.2	0.2	0.6	0.2	0.2	3.1	0.1	0.6	0.4	40.2	0.2	0.1	0.1	0.6	0.3	0.1	0.1	0.9	1.3	2.6	0.9	1.2	0.9	0.3	0.0	0.0	0.5	0.0	0.1	0.1	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	38.4	0.1	0.3	3.6	0.3	0.2	0.2	0.3	0.1	0.1	0.3	0.3	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.6	0.0	0.2	0.2	0.4	0.1	0.0	0.0	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	1.4	0.3	1.6	1.1	0.1	0.1	1.8	2.3	15.4	1.0	4.6	0.0	0.0	0.7	0.1	0.2	0.2	3.1	0.1	0.9	0.9	0.3	0.0	1.0	0.3	0.2	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.7	0.0
OIT3	"FLJ39116, LZP"	ENSG00000138315	"Oncoprotein induced transcript 3"	Q8WWZ8	10	72893584-72933036	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 111.7"	"Cell type enriched"	"Detected in some"	11	"Hepatic stellate cells: 372.3"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 4.6"	"Region enhanced"	"Detected in single"		"cerebellum: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 2.3;Hep G2: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		52000000				"unprognostic (2.42e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.98e-4)"	"unprognostic (9.26e-2)"	"unprognostic (9.47e-4)"	"unprognostic (3.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.19e-1)"	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.4	0.5	0.0	0.1	0.3	5.3	0.0	0.0	0.0	0.0	0.3	2.4	0.2	0.1	1.5	111.7	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	6.2	0.0	0.1	7.9	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.5	0.2	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	14.6	0.0	10.7	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	372.3	10.6	0.0	0.0	0.9	0.0	0.0	31.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0
PAGE1	"CT16.3, GAGE-9, GAGEB1, PAGE-1"	ENSG00000068985	"PAGE family member 1"	O75459	X	49687447-49695984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	151	"testis: 17.3"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 166.9;Spermatogonia: 206.5"	"Group enriched"	"Detected in many"	4	"liver cancer: 10.5;melanoma: 5.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 188.0;Karpas-707: 139.8;U-266/84: 230.7"									HPA003473	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoli fibrillar center"	"Nucleoplasm, Mitochondria"	"HPA003473: AB_1079558"				"unprognostic (3.00e-1)"										"unprognostic (1.99e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	188.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	17.7	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	139.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.4	0.3	0.2	0.3	1.6	0.6	2.8	230.7	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	32.9	0.0	0.0	166.9	206.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 601.3"	"Group enriched"	"Detected in many"	5	"Proximal enterocytes: 280.0;Proximal tubular cells: 1113.8"	"Group enriched"	"Detected in many"	4	"liver cancer: 27.6;renal cancer: 44.3"	"Group enriched"	"Detected in many"	4	"cerebellum: 13.5;pons: 4.7"	"Immune cell enriched"	"Detected in single"	5	"NK-cell: 4.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 4.2"	"Group enriched"	"Detected in many"	4	"RPTEC TERT1: 250.0;T-47d: 653.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favorable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.6	3.5	0.8	0.5	1.0	0.6	19.8	13.5	2.1	2.4	1.5	4.8	75.5	0.7	15.9	0.2	1.0	22.2	0.4	1.1	0.7	601.3	129.2	0.3	0.7	1.5	1.9	0.6	0.3	16.7	0.0	0.6	0.5	4.7	0.3	8.3	3.0	0.4	0.8	0.3	1.7	125.9	0.8	0.6	0.7	2.8	0.6	1.0	0.3	0.3	0.1	0.2	0.3	0.3	1.6	7.6	1.2	0.8	0.8	0.3	0.4	3.0	1.2	0.3	0.2	1.0	106.6	1.0	0.7	1.3	5.9	0.5	3.4	0.2	0.6	0.6	10.3	2.0	0.9	2.8	45.7	0.0	1.1	0.9	0.3	0.7	0.4	0.2	0.8	0.0	0.4	0.8	1.6	0.8	6.0	0.7	1.4	1.2	1.5	3.6	0.4	7.3	1.6	250.0	0.3	0.6	6.7	1.7	1.8	0.2	6.4	653.8	0.9	0.5	1.3	1.3	0.9	1.1	8.8	1.2	0.6	1.0	0.6	0.5	0.1	0.1	0.0	0.7	0.1	0.2	0.6	0.2	0.8	0.0	0.4	0.2	0.3	0.1	4.2	0.0	0.5	0.0	0.3	0.8	1.0	13.5	2.1	1.1	0.7	1.5	1.9	0.6	4.7	0.6	1.0	1.6	0.2	0.0	0.0	2.0	4.1	0.1	0.0	0.1	0.0	0.4	20.2	3.3	0.5	72.9	0.0	57.0	0.0	0.0	0.9	27.4	138.9	1.2	8.6	1.1	0.5	0.4	6.6	0.0	2.8	2.0	0.1	0.5	0.5	4.9	0.0	0.2	1.1	47.9	0.2	0.0	1.9	7.8	0.0	0.9	0.3	9.0	0.0	4.9	0.0	1.9	0.0	0.3	2.1	3.0	0.7	1.5	7.4	0.0	0.0	0.1	280.0	1113.8	0.1	0.5	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.1	4.1	4.3	6.5	0.1
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 2105.2;liver: 6319.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 448.7;Alveolar cells type 2: 529.3;Granulosa cells: 458.1;Hofbauer cells: 858.5;Macrophages: 373.3;Proximal tubular cells: 1044.7"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Hep G2: 567.4;HSkMC: 451.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	2220000000	1800000000	"Nucleoplasm, Golgi apparatus"		"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	725.6	428.3	175.3	181.6	329.4	40.4	623.7	382.8	292.5	463.9	184.2	650.1	625.6	339.0	463.7	242.9	379.9	676.3	239.3	168.0	247.7	861.5	6319.6	516.6	557.0	518.9	332.0	147.7	707.5	230.9	248.0	109.2	981.2	448.7	216.1	721.0	59.7	172.3	377.6	157.8	173.2	2105.2	235.2	356.2	957.0	259.4	88.6	298.2	172.0	148.4	267.9	178.9	418.2	214.9	549.3	0.7	1.7	7.7	1.0	43.6	12.2	7.3	4.1	10.9	0.0	0.0	12.5	65.3	2.0	36.3	1.5	1.4	1.7	0.2	0.1	0.0	2.4	52.7	3.1	0.2	567.4	25.9	3.2	0.4	451.1	0.7	0.0	0.1	1.9	0.1	1.5	6.4	12.9	23.5	1.3	1.1	6.4	30.6	17.0	0.9	1.3	2.0	100.8	12.5	8.0	2.2	2.7	2.7	16.7	1.6	54.6	125.4	0.7	0.7	3.2	1.7	5.2	1.0	8.4	1.5	2.0	1.7	5.9	1.5	0.1	0.1	0.5	0.5	0.1	0.6	0.4	0.3	0.3	0.3	0.5	0.4	0.4	0.5	0.6	0.2	0.9	0.3	0.3	175.3	329.4	382.8	292.5	168.0	247.7	518.9	332.0	147.7	448.7	356.2	298.2	549.3	312.7	448.7	529.3	0.0	15.2	0.0	0.0	0.0	0.0	0.0	312.0	271.1	0.0	0.0	102.1	125.0	0.0	223.4	9.4	0.0	197.6	73.4	0.0	83.8	231.0	75.8	0.0	0.0	0.0	52.8	17.5	358.7	0.0	116.1	26.5	458.1	0.0	0.0	858.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	373.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	4.9	0.0	0.0	1044.7	52.5	0.0	0.0	0.0	133.1	0.0	0.0	0.0	0.0	112.9	10.0	361.8	0.0	0.0
SERPINA4	"KAL, kallistatin, KLST, KST, PI4"	ENSG00000100665	"Serpin family A member 4"	P29622	14	94561442-94569913	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 554.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 245.9;Exocrine glandular cells: 93.8;Hepatocytes: 478.5;Pancreatic endocrine cells: 62.1"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 94.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 28.4"					"Not detected"	"Not detected"			"HPA003607, HPA068939"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA	14500000000	14000000000	Vesicles		"HPA003607: AB_1079914, HPA068939: "	"unprognostic (1.65e-3)"		"unprognostic (4.13e-2)"	"prognostic favorable (2.95e-4)"			"unprognostic (2.09e-3)"	"unprognostic (1.99e-3)"		"unprognostic (2.82e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.45e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.9	0.4	41.3	0.0	1.5	53.9	0.0	0.0	0.0	7.3	554.4	0.0	0.0	0.0	0.0	0.0	0.0	117.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.3	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	245.9	0.0	3.7	0.0	0.0	0.0	0.0	11.7	30.0	0.0	3.3	0.3	0.3	0.0	2.7	0.0	93.8	0.0	0.0	5.1	4.5	0.0	0.2	5.3	478.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 267.3"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 203.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 65.3;A549: 17.5;CAPAN-2: 12.6;GAMG: 13.6;HeLa: 14.2;PC-3: 17.3;U-2 OS: 14.7"									"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: AB_2681265"		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.1	13.1	0.3	0.2	0.1	0.4	0.3	0.0	0.3	0.0	0.5	0.0	0.0	267.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	65.3	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	12.6	0.0	4.3	0.0	13.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	14.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	203.4	0.0	0.0	0.5	0.0	0.0	1.6	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.2
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023147-45077185	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 165.2;liver: 249.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 138.7;Hepatocytes: 649.4;Prostatic glandular cells: 218.8;Proximal tubular cells: 270.2"	"Group enriched"	"Detected in all"	4	"liver cancer: 30.3;prostate cancer: 72.5;thyroid cancer: 30.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"basophil: 86.3;eosinophil: 55.9"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 86.3"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol		NA	NA		2800000	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favorable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	1.9	15.9	4.9	3.1	3.7	2.9	54.3	8.3	8.5	165.2	1.7	5.4	7.6	4.3	6.9	10.3	6.8	8.3	5.7	5.0	3.4	50.8	249.0	3.2	2.6	4.5	3.7	2.9	2.4	5.7	4.5	3.2	2.5	4.3	88.6	7.8	4.9	5.4	27.3	2.2	16.7	7.3	3.5	3.9	2.4	9.3	12.3	3.8	3.8	90.2	2.8	3.5	9.2	7.0	6.1	12.3	12.2	4.7	20.8	4.4	5.3	5.9	1.8	3.5	12.2	7.0	12.2	5.8	2.7	8.0	5.4	4.1	17.6	19.9	19.1	9.2	29.9	12.3	13.5	12.1	50.3	0.2	18.0	25.5	6.7	18.0	6.6	9.5	5.4	12.5	15.1	11.7	10.6	14.9	8.1	18.4	38.3	39.0	29.4	13.8	0.9	16.6	6.4	16.8	12.1	25.1	12.2	2.1	57.3	5.9	5.2	16.4	22.5	4.7	3.5	38.0	1.6	5.8	8.7	4.5	4.4	14.2	18.6	10.6	86.3	1.7	55.9	1.6	1.5	1.7	5.4	1.3	1.6	1.7	6.9	1.6	1.4	3.8	1.1	2.1	2.4	2.5	2.0	4.9	3.7	8.3	8.5	5.0	3.4	4.5	3.7	2.9	4.3	3.9	3.8	6.1	3.9	0.0	3.1	5.5	11.9	7.8	26.5	14.8	17.6	10.8	24.7	17.5	3.2	25.8	28.1	33.1	0.0	1.3	2.3	15.0	29.4	68.2	31.7	40.2	17.4	4.9	84.8	37.5	4.8	138.7	5.1	7.5	31.1	43.7	8.8	11.5	15.7	649.4	16.0	3.3	5.4	32.5	22.4	24.2	6.4	24.1	3.7	12.2	16.0	1.0	13.3	9.0	2.1	7.1	8.9	89.0	18.1	6.0	7.9	218.8	8.0	270.2	42.5	4.7	0.0	8.9	8.9	7.4	2.8	35.1	20.3	1.0	6.5	15.3	39.4	131.2
TRIM15	"RNF93, ZNF178, ZNFB7"	ENSG00000204610	"Tripartite motif containing 15"	Q9C019	6	30163206-30172693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 17.2;kidney: 5.9;liver: 14.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 139.1;Intestinal goblet cells: 41.5;Paneth cells: 332.0;Proximal enterocytes: 80.0"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 14.4;liver cancer: 5.6;pancreatic cancer: 7.7;renal cancer: 4.4;stomach cancer: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 16.5;Hep G2: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047527			Approved	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA047527: "	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.36e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.57e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"		"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.7	17.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	5.9	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.7	12.3	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	11.5	0.0	0.0	0.0	0.0	0.0	139.1	1.9	1.8	0.0	0.0	0.1	0.0	0.0	2.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	332.0	0.0	0.0	0.0	80.0	21.5	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.5	0.0	29.1	0.0
TTBK1	KIAA1855	ENSG00000146216	"Tau tubulin kinase 1"	Q5TCY1	6	43243481-43288258	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 20.6;pituitary gland: 9.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Bipolar cells: 6.6;Excitatory neurons: 12.1;Inhibitory neurons: 13.0;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 12.4"	"Group enriched"	"Detected in some"	4	"glioma: 3.0;liver cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 20.3;SH-SY5Y: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031735, HPA031736"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA031735: AB_2674019, HPA031736: AB_10670294"	"unprognostic (1.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.24e-4)"	"unprognostic (2.46e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.12e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.04e-4)"	0.0	1.3	11.7	0.2	10.0	0.0	0.0	2.9	20.6	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.1	12.1	2.5	0.4	1.9	0.0	0.1	5.5	2.5	11.6	0.0	0.2	0.3	9.3	0.0	7.6	0.1	0.1	3.0	0.0	0.1	0.0	0.0	2.8	0.0	0.4	0.1	0.1	0.9	6.3	0.0	0.0	0.0	0.2	0.0	0.0	11.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	20.3	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	10.0	2.9	20.6	12.1	2.5	5.5	2.5	11.6	7.6	0.4	6.3	11.0	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	12.1	0.2	0.0	0.1	0.0	0.0	0.0	2.2	0.4	2.5	0.1	5.0	13.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	2.8	0.0	1.4	0.0	12.1	12.4	0.0	1.1	0.0	0.0	0.0	3.8	3.5	0.0	0.5	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0
TTC39C	"C18orf17, FLJ33761, HsT2697"	ENSG00000168234	"Tetratricopeptide repeat domain 39C"	Q8N584	18	23992773-24135610	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.0;retina: 144.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.8;Hepatocytes: 169.3;Late spermatids: 320.0;Rod photoreceptor cells: 241.5"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 19.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 115.9"	"Lineage enriched"	"Detected in all"	4	"T-cells: 115.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065705, HPA065713"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA065705: AB_2685538, HPA065713: AB_2685542"	"prognostic favorable (1.48e-4)"	"unprognostic (6.37e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (2.32e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.94e-3)"	"unprognostic (4.48e-3)"	19.0	30.7	7.2	12.4	7.1	36.7	19.1	3.8	27.1	20.1	10.0	10.2	9.2	15.8	7.4	16.2	18.7	23.8	6.4	17.9	4.1	5.9	95.0	15.2	19.2	2.0	4.6	6.5	10.3	15.9	1.9	20.2	2.7	4.3	20.2	7.5	144.4	25.4	5.4	10.3	54.0	13.5	8.4	1.9	13.3	12.9	33.6	3.3	15.5	7.2	1.6	21.5	13.4	19.8	7.0	12.6	10.4	6.1	3.7	38.3	39.8	22.9	16.4	39.0	13.9	13.5	1.3	6.8	19.7	16.8	30.4	11.1	15.8	12.3	16.5	10.9	28.7	13.1	6.6	50.6	26.3	7.7	31.4	15.3	33.4	21.8	8.4	11.7	26.9	1.1	14.6	0.1	0.2	8.7	10.7	4.9	10.0	14.5	5.5	25.1	28.1	9.5	7.8	14.7	19.7	15.9	12.4	34.5	10.6	11.4	6.5	8.2	10.6	8.3	11.8	9.6	8.7	8.7	0.4	0.1	32.0	16.0	32.9	8.3	2.4	5.4	0.2	32.8	6.1	84.0	16.4	71.7	40.3	7.8	10.0	30.0	25.0	1.5	18.5	5.2	27.8	115.9	13.1	7.2	7.1	3.8	27.1	17.9	4.1	2.0	4.6	6.5	4.3	1.9	3.3	7.0	6.9	0.0	3.4	13.7	23.0	46.0	17.1	10.1	30.1	14.7	28.6	24.1	3.0	64.3	5.0	7.3	45.9	0.7	52.0	2.0	0.0	14.2	149.8	72.9	34.9	7.0	4.2	20.6	114.3	11.5	15.2	16.5	15.8	30.0	2.5	11.5	4.6	169.3	12.6	13.5	80.3	9.4	18.3	26.6	44.5	320.0	11.1	21.5	14.2	20.6	18.9	27.8	38.1	41.7	2.3	8.9	1.5	7.9	7.1	20.8	11.4	1.3	16.7	241.5	0.0	5.2	6.7	42.4	8.0	26.8	86.1	0.5	95.9	9.2	9.0	20.1
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132736935	"Enzymes, Metabolic proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 35.2;liver: 35.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 20.7;Club cells: 42.5;Gastric mucus-secreting cells: 15.8;Respiratory ciliated cells: 86.1"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 3.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 76.2"	"Lineage enriched"	"Detected in many"	33	"granulocytes: 76.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	150000000					"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.2	0.1	0.1	2.2	0.1	35.2	0.2	0.1	0.4	1.6	0.3	0.1	0.0	0.1	0.0	0.8	1.9	1.0	0.4	0.1	0.1	0.2	35.0	4.5	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.1	1.3	0.2	0.3	0.0	0.0	1.0	0.1	0.1	0.2	0.2	0.3	0.1	5.5	0.4	0.1	0.1	0.4	0.1	1.1	0.4	0.5	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.1	20.7	0.0	0.0	0.2	0.0	0.4	0.0	42.5	0.0	0.0	0.0	0.1	0.2	0.0	3.7	0.2	2.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	15.8	1.7	0.0	0.0	0.4	10.0	0.1	0.0	0.0	0.0	6.1	5.8	0.0	0.2	0.0	3.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	0.0	0.1	86.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.3	4.1
XAGE5	"CT12.5, GAGED5, XAGE-5"	ENSG00000171405	"X antigen family member 5"	Q8WWM1	X	52812204-52818301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"testis: 1.1"	"Cell type enhanced"	"Detected in some"		"Spermatocytes: 3.8;Spermatogonia: 9.0;Syncytiotrophoblasts: 1.9"	"Cancer enriched"	"Detected in single"	4	"liver cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"U-2 OS: 22.0"									"HPA052507, HPA055941"	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			"Nucleoplasm, Vesicles"		"HPA052507: AB_2681855, HPA055941: AB_2682978"															"unprognostic (1.89e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	9.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0
ABAT	"GABA-T, GABAT"	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674596-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 134.6;liver: 348.5;pancreas: 139.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 268.2;Inhibitory neurons: 95.0;Oligodendrocyte precursor cells: 76.9;Proximal tubular cells: 94.9"	"Cancer enhanced"	"Detected in all"		"glioma: 27.3;liver cancer: 26.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 127.5;MCF7: 81.9;RH-30: 67.4;T-47d: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		2100000	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	3.3	28.0	93.4	4.7	99.1	2.2	5.2	86.6	101.8	3.9	60.9	7.7	44.0	3.9	9.7	7.7	6.2	4.5	14.3	82.4	121.6	134.6	348.5	4.5	5.0	87.6	103.0	78.6	10.6	139.5	8.3	56.2	3.4	102.7	21.9	7.9	29.9	6.5	3.6	1.6	2.7	20.2	2.7	75.3	4.1	7.5	13.5	115.9	4.2	29.6	1.5	6.0	10.0	4.2	67.7	0.7	0.2	32.1	18.7	5.0	1.7	2.0	4.2	2.2	1.8	0.7	12.7	0.9	4.0	1.4	2.3	1.2	8.3	2.1	7.7	2.4	2.3	2.1	5.5	0.1	127.5	8.1	1.3	8.3	6.5	3.4	3.2	1.4	0.9	0.6	10.7	1.1	2.6	0.6	81.9	2.1	0.6	2.8	23.2	0.3	9.7	67.4	1.8	1.2	20.9	5.1	15.7	1.9	1.0	0.2	6.2	42.6	3.4	0.6	0.8	5.7	2.7	0.1	3.0	0.3	0.8	0.8	5.7	4.2	0.7	1.9	2.7	1.5	2.2	0.7	0.6	1.0	1.1	1.2	1.2	0.7	1.1	6.1	1.2	4.2	0.2	1.1	1.2	93.4	99.1	86.6	101.8	82.4	121.6	87.6	103.0	78.6	102.7	75.3	115.9	67.7	1.7	0.0	6.9	39.5	6.1	1.5	4.0	3.3	2.2	27.3	9.1	5.0	10.8	20.0	5.8	1.8	4.2	1.4	5.3	8.9	23.5	1.6	13.0	12.9	6.2	2.4	15.6	13.9	41.8	6.2	1.5	3.2	5.6	12.9	1.3	59.5	7.1	268.2	5.2	35.3	95.0	3.9	2.0	15.7	7.4	8.7	3.7	8.2	1.8	19.7	6.5	48.6	9.2	76.9	17.7	6.8	6.1	4.5	1.0	7.4	15.7	94.9	3.6	5.8	0.0	4.3	3.8	3.7	0.9	9.5	0.6	1.4	6.3	2.3	6.9	5.0
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 363.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 499.5;Proximal tubular cells: 137.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041458, HPA063555"	Enhanced		Supported	Mitochondria		NA	NA		37000	Mitochondria		"HPA041458: AB_2677491, HPA063555: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favorable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	14.9	27.7	7.9	7.2	8.7	3.8	24.1	14.1	10.5	7.5	11.0	16.0	52.8	10.0	7.8	12.8	9.8	7.7	38.8	8.3	7.5	91.1	363.0	12.8	8.3	7.0	8.0	7.9	12.9	15.9	33.7	8.8	5.1	8.2	22.9	17.0	12.5	15.9	11.3	42.7	9.8	11.1	8.5	4.2	6.4	14.1	8.4	7.1	7.5	12.4	69.7	10.4	10.9	8.2	8.6	15.4	10.9	7.9	14.5	10.6	13.1	7.0	9.3	18.8	9.2	9.1	9.6	4.9	16.0	6.3	7.9	5.6	6.3	12.5	6.5	15.1	10.6	12.9	8.3	3.3	54.8	7.5	12.0	7.6	9.7	6.5	5.8	5.3	13.5	9.0	13.2	8.1	11.5	11.5	7.1	11.4	9.8	4.8	8.5	6.7	13.4	16.6	5.1	13.1	16.9	1.4	9.1	14.3	4.2	14.4	7.5	12.9	5.8	9.5	4.9	4.4	11.4	11.4	12.9	15.5	8.5	7.6	11.1	3.8	17.4	4.5	11.8	8.8	4.7	10.2	5.5	8.1	7.6	6.4	5.7	7.4	8.3	2.9	8.5	2.9	3.8	7.1	5.7	7.9	8.7	14.1	10.5	8.3	7.5	7.0	8.0	7.9	8.2	4.2	7.1	8.6	7.7	28.9	53.1	29.4	11.6	9.3	9.2	8.2	14.2	17.4	58.6	27.8	80.7	37.1	21.1	11.0	10.4	20.1	8.7	11.2	46.9	7.3	7.0	6.8	9.1	8.2	12.1	21.4	39.8	4.8	3.5	10.6	10.7	18.8	3.8	29.1	15.4	499.5	7.3	21.9	49.6	13.7	26.4	17.4	5.9	8.1	13.4	7.1	7.2	12.2	7.9	12.0	7.2	15.6	38.3	4.6	13.1	10.9	9.1	19.8	9.2	137.9	15.2	7.7	19.7	12.3	11.0	8.5	3.7	14.7	13.8	30.1	13.3	18.9	18.3	12.0
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537283	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 178.7"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 89.0;Proximal enterocytes: 27.9;Proximal tubular cells: 51.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.4;ASC TERT1: 25.9;fHDF/TERT166: 9.2;Hep G2: 10.8;HSkMC: 17.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		No	No		29000	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	8.8	8.4	3.8	2.1	3.9	0.1	5.9	4.1	4.5	8.0	14.2	10.5	25.7	9.5	5.9	6.4	10.9	8.2	16.9	4.0	5.3	42.5	178.7	6.3	1.7	5.1	4.0	3.0	11.3	4.7	9.7	4.7	3.4	4.0	10.9	8.4	1.8	7.3	9.9	8.2	2.5	21.8	11.3	4.0	1.4	4.1	4.9	4.1	4.0	16.3	17.1	1.2	8.8	6.1	4.0	0.0	0.0	0.2	0.0	16.4	25.9	4.7	3.1	0.2	0.0	0.4	0.8	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	2.3	0.0	0.0	17.4	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	3.9	4.1	4.5	4.0	5.3	5.1	4.0	3.0	4.0	4.0	4.1	4.0	1.9	3.2	5.8	11.1	0.6	0.6	7.6	0.5	5.7	0.3	1.3	3.8	14.3	4.3	0.9	3.7	0.0	0.7	0.0	4.2	15.6	0.3	0.1	0.4	1.3	1.6	3.0	2.7	0.6	1.9	0.4	8.6	2.0	0.2	1.3	8.6	6.1	89.0	5.2	1.7	0.6	5.1	0.0	1.9	0.4	1.8	10.8	1.7	0.0	1.0	0.5	10.8	0.0	0.5	0.0	0.4	0.8	8.6	0.1	0.6	27.9	51.0	0.0	0.8	6.6	7.0	5.2	0.4	0.4	3.0	0.3	0.8	0.3	9.6	4.6	3.8
ADCY10	"HCA2, RP1-313L4.2, SAC, SACI, Sacy"	ENSG00000143199	"Adenylate cyclase 10"	Q96PN6	1	167809386-167914215	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"liver: 6.1;testis: 17.8"	"Group enriched"	"Detected in some"	7	"Early spermatids: 87.5;Late spermatids: 85.4"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"T-47d: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015243, HPA017749"	Approved					NA	NA					"HPA015243: AB_1856540, HPA017749: AB_1856541"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.43e-2)"	"unprognostic (7.83e-5)"	"unprognostic (5.86e-7)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.59e-1)"	0.1	0.2	1.3	0.0	1.2	0.0	1.0	2.5	2.4	0.1	0.6	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.2	1.5	0.8	0.4	6.1	0.2	0.0	0.6	1.0	1.3	0.1	0.4	0.0	0.1	0.1	1.6	0.4	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.7	0.1	0.3	17.8	1.6	0.1	0.1	0.0	0.0	0.1	0.1	1.7	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.2	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.4	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.5	2.4	1.5	0.8	0.6	1.0	1.3	1.6	0.7	1.6	1.7	0.1	0.0	0.0	2.0	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.3	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	87.5	0.3	0.2	0.1	0.0	0.0	9.9	0.0	0.7	0.3	0.0	0.1	0.0	0.9	0.7	7.6	0.1	0.0	7.6	0.0	0.0	0.0	0.4	85.4	0.6	0.1	0.0	1.0	0.0	0.0	0.0	3.5	3.6	0.0	0.0	0.4	0.0	0.2	1.1	0.2	0.0	0.0	0.0	0.2	0.4	11.3	0.6	0.1	0.4	1.8	0.0	0.8	0.2	0.2
ADHFE1	FLJ32430	ENSG00000147576	"Alcohol dehydrogenase iron containing 1"	Q8IWW8	8	66432492-66468907	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 31.4;skeletal muscle: 29.5;tongue: 31.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 76.4;Cardiomyocytes: 41.6;Syncytiotrophoblasts: 116.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.2;RPTEC TERT1: 1.5"					"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA023062: AB_1844611"	"prognostic favorable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	7.0	2.3	8.7	0.3	8.6	0.0	3.9	7.3	10.5	2.3	9.8	3.3	0.6	2.1	1.4	1.3	5.7	0.7	20.9	8.1	7.5	6.7	31.4	2.1	0.3	9.2	8.4	7.4	5.1	9.5	5.1	2.7	1.1	9.9	5.3	0.8	1.5	2.3	1.5	29.5	1.1	2.5	0.2	7.6	1.8	11.1	1.7	8.7	0.3	2.8	31.6	0.3	4.4	1.8	8.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.2	0.0	0.5	0.1	0.0	0.3	0.0	0.4	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.0	8.7	8.6	7.3	10.5	8.1	7.5	9.2	8.4	7.4	9.9	7.6	8.7	8.5	1.5	9.6	20.1	76.4	1.8	1.0	4.1	2.7	3.4	1.7	4.6	4.6	41.6	14.3	9.6	9.2	10.4	8.8	6.5	1.0	11.7	1.5	0.5	2.5	1.6	3.3	3.6	2.5	8.3	0.6	0.9	5.3	8.6	2.5	8.8	6.1	6.1	27.1	2.5	0.0	13.2	2.0	4.1	2.1	2.8	1.6	23.9	2.1	0.0	14.0	2.0	7.6	6.2	21.6	19.2	0.9	5.8	27.1	3.0	3.5	4.1	14.8	14.3	8.5	0.0	7.8	5.2	0.5	0.6	1.9	1.0	116.4	10.0	2.5	2.4	2.5
ADRA1A	"ADRA1C, ADRA1L1"	ENSG00000120907	"Adrenoceptor alpha 1A"	P35348	8	26748150-26867278	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 22.0;brain: 43.4;liver: 60.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 105.4;Early spermatids: 51.3;Inhibitory neurons: 123.2;Late spermatids: 28.3;Oligodendrocyte precursor cells: 114.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.9;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029678, HPA029679, HPA076693"	Approved	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles"	"HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: "	"unprognostic (1.27e-1)"		"unprognostic (1.68e-2)"		"unprognostic (1.99e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.04e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.30e-1)"	22.0	0.5	13.7	1.1	11.5	0.0	3.7	4.2	23.3	0.5	0.0	1.1	0.9	1.5	0.6	0.8	0.2	0.3	6.1	43.4	16.3	0.7	60.6	3.9	1.8	8.3	4.9	3.4	0.9	0.0	0.0	0.1	0.0	11.5	12.5	0.5	0.3	6.2	13.7	0.2	0.5	1.1	2.9	1.6	9.3	0.9	0.1	3.6	0.1	0.1	1.4	0.4	0.4	0.3	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	11.5	4.2	23.3	43.4	16.3	8.3	4.9	3.4	11.5	1.6	3.6	7.5	0.0	0.0	0.0	105.4	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.3	0.0	0.0	0.1	0.0	0.0	15.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	16.2	0.0	0.0	123.2	0.0	0.0	0.0	0.5	28.3	0.6	0.0	0.0	9.4	0.0	0.0	0.0	114.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527567-134541412	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 226.3;intestine: 620.4;stomach 1: 436.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 193.0;Distal enterocytes: 201.0;Gastric mucus-secreting cells: 542.3;Proximal enterocytes: 327.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	104	"A549: 2959.1;Hep G2: 835.6;OE19: 3141.0"	"Low region specificity"	"Detected in all"							"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted to digestive system"	NA	NA		67000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.9	5.5	0.1	8.0	0.1	0.2	0.4	0.3	0.1	35.6	0.0	74.0	620.4	0.5	0.1	226.3	0.9	177.8	0.1	0.1	0.1	11.8	40.3	0.4	0.3	0.0	0.0	0.1	0.2	0.7	0.0	4.8	0.1	0.1	1.3	46.0	0.1	32.7	0.2	3.8	7.6	357.7	3.3	0.0	0.1	436.4	0.6	0.0	5.6	0.6	5.9	7.8	66.3	146.8	0.1	0.0	2959.1	0.0	0.0	0.7	2.3	9.0	0.3	1.1	0.2	0.0	5.9	0.9	0.0	1.1	1.6	4.6	6.2	0.0	4.0	0.2	0.1	0.0	0.0	1.9	835.6	0.7	0.0	0.6	0.1	13.8	0.7	0.0	4.0	0.5	0.0	0.0	0.0	0.6	5.4	0.1	1.3	0.5	3141.0	2.3	0.3	0.0	2.7	1.5	2.7	1.0	1.5	1.8	1.3	0.1	0.1	0.0	0.1	1.9	1.2	1.2	0.2	1.0	0.4	0.1	0.0	22.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.0	2.8	2.1	52.1	3.4	0.0	0.1	0.0	0.7	193.0	13.5	0.0	0.0	0.3	0.0	201.0	0.0	31.5	0.7	2.9	0.1	0.2	3.5	2.7	0.0	27.5	0.1	4.4	542.3	1.0	0.0	0.0	2.2	62.9	0.0	0.0	0.1	29.5	4.1	0.6	0.3	0.7	3.4	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	66.9	42.5	1.9	1.7	1.0	327.1	3.8	4.8	0.0	0.0	3.7	1.5	0.0	0.1	96.0	10.4	0.3	0.5	0.0	73.0	11.4
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 628.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 253.8;Basal squamous epithelial cells: 262.4;Cholangiocytes: 284.5;Exocrine glandular cells: 328.0;Hepatocytes: 597.7;Squamous epithelial cells: 229.3;Urothelial cells: 306.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2;lung cancer: 53.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	8	"ASC diff: 2988.3;Hep G2: 5415.7;OE19: 2297.1"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	151.9	14.5	12.8	13.6	13.9	5.8	117.2	14.6	11.6	9.7	7.2	22.0	25.6	6.7	6.6	104.7	11.6	66.3	84.5	9.8	26.9	45.2	628.3	29.1	4.8	21.3	18.5	7.8	15.7	23.5	0.8	9.8	1.7	24.4	17.4	12.3	11.6	74.3	12.6	121.4	33.4	23.6	8.8	18.6	4.1	144.0	13.1	17.5	4.6	47.1	27.6	7.9	71.7	31.5	19.8	0.0	429.6	2.4	426.7	2988.3	358.2	0.2	13.7	95.9	5.4	4.1	8.4	0.5	0.0	6.1	97.7	72.5	3.6	1.6	22.4	2.5	0.1	0.2	12.6	65.6	5415.7	30.0	1.8	0.0	183.9	27.3	44.2	26.7	0.4	10.2	2.9	95.8	0.4	74.7	2.4	0.1	0.4	1.2	2297.1	1.5	0.1	0.8	4.2	24.3	81.4	0.4	1.7	23.8	0.7	0.8	1.3	0.5	7.8	85.3	36.0	2.3	97.6	4.5	1.6	0.5	0.3	129.3	12.1	0.9	1.5	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.3	0.1	0.0	0.2	0.1	0.2	12.8	13.9	14.6	11.6	9.8	26.9	21.3	18.5	7.8	24.4	18.6	17.5	19.8	21.6	67.3	34.4	2.0	2.4	21.2	27.8	253.8	262.4	3.1	7.6	1.0	3.2	284.5	144.5	62.5	0.0	0.1	0.2	5.9	13.7	67.0	24.0	3.3	1.7	17.1	1.8	52.6	3.4	328.0	0.1	176.3	139.1	4.6	4.5	0.8	21.0	597.7	0.4	0.0	3.1	6.8	20.3	16.1	15.6	9.9	151.6	3.3	106.7	13.1	4.6	51.5	0.0	4.5	0.5	120.2	3.6	147.4	0.4	41.3	20.2	61.9	72.2	4.5	0.0	16.4	24.3	1.9	1.1	229.3	20.5	0.1	2.1	6.4	20.3	306.0
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 445.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 393.1;Exocrine glandular cells: 722.5;Proximal enterocytes: 576.9;Proximal tubular cells: 601.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 83.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 244.0;gdT-cell: 102.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 244.0;T-cells: 102.6"	"Cell line enhanced"	"Detected in many"		"A549: 1615.1;ASC diff: 811.9;Hep G2: 699.6;OE19: 3025.3;RT4: 639.2"									"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		19000000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	165.9	50.6	29.4	25.6	30.5	42.7	116.2	31.1	42.7	22.1	28.6	129.0	445.3	26.1	4.4	53.6	42.4	263.5	35.9	29.2	42.7	179.3	270.2	48.7	7.6	31.1	30.8	27.7	18.0	36.7	22.7	10.5	4.8	31.3	10.4	98.9	19.3	40.8	19.6	117.9	24.8	273.1	39.5	28.2	3.8	239.6	10.1	31.5	37.8	26.6	35.1	6.7	85.5	22.3	32.8	0.1	1615.1	1.1	413.0	811.9	292.2	1.0	0.0	21.4	0.4	1.4	47.6	24.5	0.2	78.7	19.4	45.0	11.5	1.5	28.8	1.1	3.0	0.5	3.2	438.4	699.6	4.3	0.7	0.2	160.9	57.1	20.0	0.7	25.8	28.1	3.4	10.8	0.0	42.6	3.8	9.8	2.6	0.7	3025.3	4.3	3.3	9.6	43.7	149.0	639.2	1.0	2.9	232.2	0.0	0.3	0.9	0.5	0.2	221.7	5.2	4.7	87.8	3.1	0.7	0.7	0.3	45.8	62.8	4.4	244.0	2.9	4.8	102.6	0.9	6.9	0.0	19.0	18.7	2.1	0.5	11.6	8.9	7.3	21.1	1.4	39.6	21.4	42.4	29.4	30.5	31.1	42.7	29.2	42.7	31.1	30.8	27.7	31.3	28.2	31.5	32.8	144.2	44.8	5.3	4.9	4.3	12.0	3.7	393.1	2.8	2.0	15.8	5.5	3.9	0.0	172.9	36.8	0.0	0.4	64.4	133.8	43.0	114.6	3.3	67.5	4.5	67.5	19.2	34.9	2.5	722.5	0.0	44.3	158.0	66.4	5.7	0.1	0.0	0.0	1.6	1.7	3.2	65.9	61.1	0.0	14.0	4.9	78.3	14.8	21.4	7.5	4.1	132.7	202.9	14.6	0.0	266.1	219.6	106.8	3.1	1.3	576.9	601.8	112.8	5.3	26.3	15.5	20.3	0.5	4.3	20.2	10.7	0.0	14.4	7.8	196.9	46.4
AKR7A3		ENSG00000162482	"Aldo-keto reductase family 7 member A3"	O95154	1	19282573-19288770	"Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 251.2;liver: 155.9;pancreas: 290.9;stomach 1: 226.2"	"Group enriched"	"Detected in many"	5	"Gastric mucus-secreting cells: 348.1;Proximal enterocytes: 1132.3;Proximal tubular cells: 766.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 36.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 15.9;SK-BR-3: 25.0"									HPA064638			Supported	"Golgi apparatus,Cytosol"		NA	NA		1900000	Cytosol	"Golgi apparatus"	"HPA064638: AB_2685307"	"unprognostic (7.78e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.80e-7)"	"unprognostic (4.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-1)"	1.5	4.0	2.2	2.6	2.0	0.3	4.2	2.5	3.3	2.3	13.5	24.5	251.2	1.4	0.4	1.8	1.8	38.4	0.6	3.1	2.1	71.8	155.9	1.0	0.4	2.5	2.6	1.7	2.6	290.9	0.3	2.3	0.2	2.4	1.9	17.5	1.5	3.5	0.3	0.4	2.5	146.0	1.5	2.2	1.3	226.2	2.1	2.5	0.1	1.8	0.1	0.2	1.0	1.6	2.3	0.5	0.0	0.5	0.3	0.5	0.2	1.8	0.1	0.1	0.2	0.1	0.5	1.9	0.2	0.3	0.4	0.0	0.8	0.0	0.0	0.0	0.2	0.5	0.2	0.7	0.8	0.2	0.2	0.2	0.3	0.3	0.3	0.0	0.2	0.0	0.3	0.2	0.3	0.1	0.7	0.5	1.7	0.3	15.9	0.6	0.7	0.1	1.6	0.0	0.1	0.9	1.4	0.3	25.0	0.6	0.1	4.1	0.5	0.4	0.3	0.2	0.9	0.3	1.2	0.3	0.3	0.5	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	2.0	2.5	3.3	3.1	2.1	2.5	2.6	1.7	2.4	2.2	2.5	2.3	0.4	0.0	0.0	7.5	3.3	0.8	0.7	0.2	0.6	1.0	13.8	9.5	0.8	140.2	0.3	29.5	0.0	0.5	0.5	133.3	119.3	3.9	3.5	0.5	0.4	0.8	20.8	11.2	4.1	31.8	0.3	0.5	348.1	0.4	4.5	0.9	4.2	119.0	0.3	0.0	3.6	87.6	4.1	3.5	0.0	4.7	0.3	4.4	0.0	1.9	0.1	3.6	0.0	2.5	1.9	18.3	125.0	0.4	0.8	1.2	1132.3	766.6	3.2	1.1	0.0	0.7	0.4	1.8	1.1	1.1	0.6	0.5	3.0	0.7	130.2	0.4
AL163636.1		ENSG00000259171	"Novel protein, ANG-RNASE4 readthrough"		14	20684587-20700576	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"liver: 116.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"liver cancer: 0.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 9.9;memory B-cell: 3.6;myeloid DC: 5.8"	"Group enriched"	"Detected in many"	12	"B-cells: 3.6;dendritic cells: 5.8;monocytes: 9.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 17.2;ASC TERT1: 38.5;Hep G2: 26.0;HSkMC: 16.9;OE19: 75.0"															NA	NA						"unprognostic (1.88e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.34e-1)"		"unprognostic (1.08e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.61e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.58e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.11e-2)"	45.6	5.8	0.7	6.9	0.6	0.1	35.0	0.6	1.6	29.6	1.3	29.8	26.8	25.3	10.7	11.9	27.6	48.5	11.2	0.6	2.0	15.8	116.0	24.0	5.5	1.0	0.7	0.4	70.3	19.6	3.4	3.2	2.6	1.3	41.8	35.4	0.3	35.4	16.7	6.8	17.4	31.9	18.0	1.2	3.7	58.9	7.2	0.6	1.5	8.3	14.7	5.1	24.9	25.9	1.4	2.6	0.8	2.0	0.0	17.2	38.5	0.0	2.4	6.4	0.0	1.7	0.0	2.7	0.0	0.0	10.2	2.7	0.8	0.6	0.2	0.0	6.4	0.4	0.4	0.0	26.0	1.3	0.0	0.0	16.9	1.4	0.0	0.9	12.1	0.5	1.8	0.0	11.6	2.9	0.0	0.2	0.5	0.0	75.0	0.3	0.3	1.4	2.1	0.1	0.9	0.0	0.2	4.0	1.6	2.0	0.0	1.9	0.2	1.8	3.3	0.6	2.0	0.4	2.2	1.6	0.0	3.2	0.4	3.8	0.0	9.9	0.0	0.0	0.5	0.3	3.6	0.4	0.2	5.8	1.2	0.2	0.0	0.1	0.0	0.0	1.0	0.5	2.4	0.7	0.6	0.6	1.6	0.6	2.0	1.0	0.7	0.4	1.3	1.2	0.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900671-73080442	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1513.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 389.4;Hepatocytes: 624.4;Leydig cells: 406.4;Proximal tubular cells: 375.4;Respiratory ciliated cells: 583.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"classical monocyte: 87.3"	"Lineage enriched"	"Detected in many"	33	"monocytes: 87.3"	"Cell line enhanced"	"Detected in many"		"A549: 4019.8;Hep G2: 1269.3;RPTEC TERT1: 710.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"midbrain: 378.3"	"HPA002123, CAB020690"	Enhanced	Approved	Enhanced	Cytosol		NA	NA		58000000	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favorable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	110.4	184.2	56.7	28.7	75.8	32.0	64.9	128.3	74.7	119.2	43.9	180.4	554.6	140.7	588.5	41.7	185.9	177.0	35.8	67.1	65.5	338.6	1513.1	143.9	31.5	96.3	331.0	45.7	224.7	502.3	24.5	165.7	32.3	88.3	57.7	89.7	0.4	105.4	247.7	67.3	15.5	306.9	118.1	109.8	78.1	573.8	150.8	78.7	20.0	213.6	83.8	21.8	31.9	91.5	116.0	0.0	4019.8	0.4	0.0	22.4	0.2	1.4	139.6	0.0	0.1	0.1	136.2	0.0	0.1	50.5	0.0	0.3	2.6	0.0	0.2	0.1	0.4	0.1	232.1	0.6	1269.3	13.7	0.6	0.3	6.7	0.1	0.0	0.0	0.3	143.0	0.0	16.9	0.0	153.3	7.2	0.2	1.8	0.7	7.2	0.4	0.5	44.0	1.8	710.6	1.1	0.3	1.4	0.3	0.4	2.9	0.2	0.0	0.5	0.7	0.0	3.5	0.5	0.3	0.4	0.2	1.0	0.0	1.7	0.4	0.0	87.3	1.4	0.0	14.9	0.0	0.0	0.2	0.1	1.4	0.7	0.0	0.0	2.6	0.0	1.1	1.0	0.0	30.3	56.7	75.8	128.3	74.7	67.1	65.5	96.3	331.0	45.7	88.3	109.8	78.7	116.0	4.9	96.1	107.6	31.3	6.9	2.7	18.3	168.3	1.2	0.4	12.6	1.7	4.3	187.3	361.1	115.8	0.0	1.7	0.1	20.2	389.4	71.6	12.6	6.3	125.2	26.4	54.9	96.1	3.5	349.7	1.0	102.7	258.4	8.1	158.9	0.2	133.5	624.4	134.4	0.0	0.5	168.9	138.4	109.6	5.1	37.8	406.4	61.7	7.2	17.8	46.0	0.0	2.1	0.0	0.7	128.4	77.4	207.3	1.3	2.0	267.4	375.4	583.7	0.3	26.3	334.2	28.6	8.6	4.6	21.5	3.1	2.5	8.8	129.6	131.7	26.5
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family member"	P05091	12	111766887-111817532	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 864.8"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 857.0;monocytes: 940.8;Proximal tubular cells: 882.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 71.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 212.0;myeloid DC: 213.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 213.2;monocytes: 212.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 86.8;HHSteC: 97.0;OE19: 152.2;SK-BR-3: 201.0;THP-1: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051065	Approved					NA	NA		2200000			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	306.5	103.3	129.6	40.1	132.7	29.4	77.8	129.1	164.8	25.2	113.0	74.0	74.3	30.4	21.5	74.3	32.5	37.8	112.4	123.8	127.2	179.4	864.8	112.6	18.9	138.5	132.2	116.2	42.4	23.5	2.7	23.5	7.0	134.3	34.9	73.0	29.4	32.7	29.7	132.1	128.9	75.4	30.5	131.7	20.8	102.4	13.1	140.1	27.3	31.1	167.1	53.4	50.5	29.2	134.4	8.8	13.1	18.7	31.9	86.8	13.0	60.9	9.3	16.8	4.3	3.1	23.5	12.1	0.5	45.3	20.8	11.9	16.2	0.1	4.6	2.7	0.6	6.1	0.7	8.4	64.7	97.0	0.9	0.9	23.9	22.6	14.8	0.3	17.7	26.9	0.9	17.9	3.0	4.1	0.5	1.0	23.4	24.8	152.2	2.1	0.6	0.4	1.9	31.4	0.6	7.5	23.1	22.8	201.0	0.2	33.7	20.3	92.1	1.1	0.4	16.5	0.6	0.4	5.5	3.0	25.7	22.0	0.8	0.4	6.5	212.0	51.1	0.7	93.0	0.9	6.2	0.3	0.7	213.2	5.2	0.7	0.5	10.7	3.4	25.4	70.6	0.5	123.5	129.6	132.7	129.1	164.8	123.8	127.2	138.5	132.2	116.2	134.3	131.7	140.1	134.4	27.7	147.4	242.7	51.2	22.6	60.0	205.2	311.1	80.8	78.7	35.0	23.7	378.9	165.8	243.1	66.2	18.8	62.4	48.6	260.3	399.2	127.5	4.3	27.8	24.5	66.2	55.2	42.1	11.7	218.0	127.5	103.1	200.3	47.7	30.9	29.0	139.6	857.0	129.2	35.3	18.2	231.0	101.7	278.5	124.1	10.6	79.9	189.3	35.6	26.2	940.8	130.2	8.2	14.1	6.8	130.2	366.5	149.0	12.5	84.4	384.3	882.0	89.4	42.6	46.0	46.0	67.6	3.0	3.9	105.1	124.7	42.1	13.1	81.0	272.6	150.4
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902724	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 202.2;liver: 440.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 78.0;Hepatocytes: 385.1;Proximal tubular cells: 279.4;Syncytiotrophoblasts: 86.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Hep G2: 83.7;SK-BR-3: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401, HPA072759"	Enhanced		Supported	Mitochondria		NA	NA		58000	Mitochondria		"CAB004645: AB_425775, HPA006401: AB_1844731, HPA072759: "	"unprognostic (1.17e-1)"	"prognostic favorable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	71.4	16.2	63.4	4.0	73.4	11.8	21.8	66.2	96.7	9.3	90.5	6.2	1.6	9.9	4.8	36.6	8.4	5.5	33.3	59.4	64.2	202.2	440.2	6.3	3.4	63.2	73.2	54.8	7.4	4.7	23.2	9.8	13.3	63.7	29.7	2.7	6.5	9.2	27.3	74.9	19.3	4.7	7.1	54.1	7.6	12.6	3.2	76.8	11.8	7.2	75.4	4.3	19.4	16.9	59.7	12.7	17.8	9.5	29.2	40.0	5.7	25.2	13.1	7.1	11.8	9.5	13.7	8.9	8.8	16.6	15.6	5.7	34.0	16.7	35.4	4.5	4.8	15.9	5.9	5.0	83.7	12.6	4.4	15.1	15.6	19.2	6.5	6.6	9.0	13.5	14.0	21.0	5.7	8.1	32.3	4.3	20.2	4.7	26.0	10.1	27.9	8.4	10.0	12.1	32.0	19.6	7.6	21.9	85.0	16.1	14.7	38.7	6.3	11.3	10.2	14.0	12.2	4.5	7.1	17.9	2.5	3.4	33.7	13.5	0.0	2.7	1.5	0.6	3.6	0.5	0.8	0.3	0.8	4.4	0.7	0.2	0.5	0.3	0.1	2.0	1.5	0.6	1.5	63.4	73.4	66.2	96.7	59.4	64.2	63.2	73.2	54.8	63.7	54.1	76.8	59.7	2.6	0.0	2.8	27.1	4.3	7.5	17.9	12.5	17.6	3.7	9.8	8.5	20.9	34.3	2.9	46.0	10.4	78.0	2.0	2.0	46.9	6.5	0.5	1.1	1.7	3.1	2.4	32.2	1.2	0.9	12.6	3.2	7.7	3.9	4.5	2.1	15.4	385.1	13.8	20.2	1.6	3.6	6.1	17.2	1.4	0.6	1.2	4.7	3.6	1.9	10.9	14.0	1.0	5.5	1.3	2.5	1.8	2.6	4.4	12.0	0.3	279.4	1.7	4.8	6.6	2.6	4.7	2.2	3.9	21.7	5.4	86.6	2.6	4.5	4.0	9.5
ALPI	IAP	ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456125-232460753	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	138	"intestine: 142.5"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 290.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"CACO-2: 4.8"									"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA		130000	"Plasma membrane"		"HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	142.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	129.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	290.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0
APOE	AD2	ENSG00000130203	"Apolipoprotein E"	P02649	19	44905791-44909393	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Hyperlipidemia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 3482.3;liver: 6646.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 9363.4;Hofbauer cells: 6072.6;Muller glia cells: 9454.8;Peritubular cells: 4958.2;Proximal tubular cells: 8155.9;Theca cells: 7201.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 3183.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1867.0;CACO-2: 466.1;Hep G2: 935.3;HSkMC: 1374.2;SK-MEL-30: 1956.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008363, HPA065539, HPA068768, CAB069921"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	51800000000	29000000000	Vesicles		"CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029"	"unprognostic (8.98e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.22e-3)"	"unprognostic (6.13e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.13e-2)"	526.6	3482.3	694.8	93.7	893.7	67.0	327.8	680.0	950.9	183.0	246.0	99.4	40.6	82.2	20.1	37.5	72.9	101.1	126.3	514.4	1127.5	1037.7	6646.6	261.1	355.2	869.7	859.4	381.4	512.4	42.2	34.8	111.7	103.1	751.5	45.8	23.1	88.4	81.1	10.9	31.4	328.9	167.3	12.7	836.0	625.9	84.1	141.6	843.8	58.3	147.6	10.5	46.4	94.3	136.7	762.5	3.2	5.2	9.5	2.6	1867.0	76.3	69.4	1.5	4.3	8.4	1.4	466.1	2.8	2.0	9.9	0.3	9.1	6.4	12.6	2.1	0.7	1.7	4.0	3.3	1.7	935.3	192.4	6.8	2.3	1374.2	2.5	14.8	1.3	15.6	1.0	0.7	124.9	2.8	1.2	3.3	1.9	2.5	243.2	3.0	1.3	2.6	8.0	1.8	2.8	0.9	5.6	2.4	4.5	1.4	1956.0	131.6	165.3	52.8	3.3	13.2	3.1	1.4	1.6	5.9	8.6	3.8	5.9	4.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	694.8	893.7	680.0	950.9	514.4	1127.5	869.7	859.4	381.4	751.5	836.0	843.8	762.5	136.7	0.0	8.2	444.0	66.1	935.2	12.3	18.3	67.7	81.7	86.7	565.8	2.2	450.4	5.2	228.1	41.7	46.3	6.0	2.2	682.9	1.8	73.6	33.8	936.6	140.2	0.0	331.6	1.1	0.7	43.8	860.7	3.6	22.9	174.4	103.6	208.9	9363.4	6072.6	38.7	2.1	0.6	4.1	718.0	292.6	355.3	2629.4	940.6	2481.3	60.9	70.3	9454.8	0.0	12.1	2.2	0.6	0.3	4958.2	7.2	15.0	0.2	8155.9	1.0	311.4	223.5	2958.4	345.5	14.8	12.8	15.1	1684.9	74.3	60.6	7201.0	1.7	4.7
ARSL	"ARSE, CDPX, CDPX1"	ENSG00000157399	"Arylsulfatase L"	P51690	X	2934521-2968475	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 37.0;liver: 87.0;pancreas: 106.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"liver cancer: 34.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 68.9;CACO-2: 42.7;GAMG: 30.8;Hep G2: 64.1;NTERA-2: 33.6"					"Low region specificity"	"Detected in all"			"HPA060518, HPA070651"	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA060518: AB_2684301, HPA070651: AB_2732160"	"unprognostic (2.07e-1)"	"unprognostic (6.60e-3)"	"prognostic favorable (8.95e-4)"	"unprognostic (8.74e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.94e-2)"	"unprognostic (4.76e-2)"	0.4	0.7	2.2	2.2	2.3	0.3	1.1	2.0	2.8	1.7	4.2	21.0	18.0	3.2	2.2	0.4	4.2	8.3	1.0	2.4	5.5	37.0	87.0	2.7	0.1	2.5	2.4	1.8	7.2	106.1	0.0	0.8	0.7	2.8	0.5	16.8	0.3	1.3	2.9	0.2	0.2	13.7	1.9	2.1	0.0	2.9	0.4	2.3	0.0	0.2	0.3	0.1	0.5	1.6	2.1	4.5	68.9	8.2	0.0	3.3	4.0	1.3	3.9	6.4	4.0	4.0	42.7	0.0	0.0	13.7	0.1	30.8	0.0	0.0	0.9	2.3	0.0	4.5	0.0	0.0	64.1	1.8	0.0	0.1	9.6	0.0	3.8	0.0	7.3	3.8	0.0	0.0	0.1	10.5	0.1	0.0	0.0	33.6	2.4	0.2	2.8	1.1	0.3	7.1	0.0	0.1	0.2	0.0	0.0	2.6	13.7	0.0	0.2	5.0	0.1	0.2	0.0	7.4	0.0	0.0	0.1	9.1	0.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.3	2.0	2.8	2.4	5.5	2.5	2.4	1.8	2.8	2.1	2.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AS3MT	CYT19	ENSG00000214435	"Arsenite methyltransferase"	Q9HBK9	10	102869470-102901899	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"adrenal gland: 304.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Basal squamous epithelial cells: 1.2;Proximal tubular cells: 1.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.8;REH: 54.6;SH-SY5Y: 27.8;T-47d: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017856	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA017856: AB_1847420"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.02e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.83e-10)"	"unprognostic (1.04e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-2)"	5.1	304.9	8.0	1.3	8.1	0.8	6.3	11.8	8.7	7.1	9.1	5.0	3.0	7.8	4.4	3.6	5.9	6.8	27.0	7.4	8.8	19.4	59.7	4.0	2.0	8.6	8.5	7.7	8.8	11.8	66.2	6.6	1.0	9.8	9.2	1.8	4.8	4.8	5.2	11.6	4.3	3.3	4.0	7.1	18.5	4.7	8.8	7.7	3.8	7.8	15.3	1.6	3.2	5.1	8.6	0.0	7.6	26.8	17.4	0.6	0.6	5.1	8.1	6.7	11.9	14.3	21.3	1.2	0.0	2.4	10.7	0.6	0.4	23.8	1.4	12.4	0.3	6.7	0.0	3.2	20.9	7.7	0.2	0.6	3.7	3.1	1.6	0.0	21.3	0.5	25.3	0.0	0.4	10.8	0.1	4.9	0.7	13.2	0.1	1.0	54.6	0.0	0.2	2.7	0.0	0.4	27.8	0.0	0.4	3.7	8.8	43.9	0.6	0.1	2.6	0.0	3.9	0.0	0.2	0.4	0.0	8.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.0	8.1	11.8	8.7	7.4	8.8	8.6	8.5	7.7	9.8	7.1	7.7	8.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0
ASL	ASAL	ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075800-66094697	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"liver: 399.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 294.6;Exocrine glandular cells: 218.6;Hepatocytes: 578.0;Paneth cells: 240.4;Proximal enterocytes: 259.9;Proximal tubular cells: 243.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 52.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB003696, HPA016646"	Enhanced		Approved	Cytosol		NA	NA		12000000	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	20.5	16.2	5.5	16.8	5.4	24.1	22.2	5.9	8.6	18.1	7.4	54.4	61.3	17.1	6.7	28.9	18.2	28.0	15.3	5.2	6.8	60.8	399.7	27.6	10.4	6.8	6.7	5.4	19.9	37.4	15.2	20.0	9.2	7.7	19.6	36.0	2.4	18.5	9.9	8.8	14.6	46.0	10.2	5.5	30.7	44.3	4.6	6.5	5.4	25.1	7.0	8.9	19.5	19.9	6.4	48.4	18.9	11.2	36.7	26.3	18.1	22.1	34.0	31.8	49.5	43.6	43.7	59.0	15.9	53.7	48.5	36.6	13.4	7.1	59.1	11.1	10.5	8.9	18.8	17.9	77.2	48.8	24.0	51.3	38.3	19.5	31.8	51.8	12.5	48.1	11.3	34.4	27.8	25.4	36.6	4.8	28.9	15.8	65.5	26.1	12.1	11.0	51.6	31.9	31.6	18.4	24.3	32.3	109.7	12.3	11.4	46.0	19.7	55.1	53.7	30.8	23.5	45.2	30.2	16.9	19.0	55.0	41.5	49.5	34.2	42.6	50.8	16.9	46.6	15.1	21.8	11.5	13.4	46.2	13.8	8.2	8.5	7.3	73.7	36.1	2.5	23.4	27.3	5.5	5.4	5.9	8.6	5.2	6.8	6.8	6.7	5.4	7.7	5.5	6.5	6.4	34.5	19.2	61.4	5.2	20.4	5.5	21.4	24.2	9.1	12.7	24.5	20.4	9.2	124.4	25.8	31.3	22.9	20.7	25.4	294.6	52.8	73.7	4.0	41.2	12.1	30.7	54.0	47.1	9.4	218.6	45.7	14.4	115.7	34.1	44.5	12.0	42.8	578.0	46.0	15.2	9.7	126.5	16.2	41.2	17.6	6.3	9.3	22.3	8.8	1.9	48.3	7.2	34.0	2.5	4.8	118.3	240.4	8.2	23.4	14.9	259.9	243.1	42.8	13.2	13.1	16.9	17.5	3.2	5.7	19.5	4.3	22.3	18.0	13.5	189.4	22.0
ASPG	C14orf76	ENSG00000166183	Asparaginase	Q86U10	14	104085686-104115582	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 58.2;liver: 152.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 21.4;Distal enterocytes: 21.2;Granulosa cells: 66.8;Hepatocytes: 93.9;Proximal tubular cells: 49.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA069761	Enhanced					NA	NA					"HPA069761: AB_2686191"	"unprognostic (1.45e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.75e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.32e-2)"	1.2	1.4	0.2	0.2	0.2	0.0	0.7	0.0	0.4	3.3	0.2	4.7	1.5	2.3	1.1	34.3	6.3	0.1	58.2	0.3	0.5	12.9	152.4	2.3	0.0	0.4	0.6	0.1	11.5	0.2	0.8	2.3	1.8	0.2	0.3	1.9	0.3	2.9	0.1	0.5	10.0	0.5	1.2	0.0	0.2	3.1	1.1	0.7	0.1	6.0	0.0	3.8	2.3	9.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.5	0.4	0.3	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.3	0.5	0.4	0.6	0.1	0.2	0.0	0.7	0.2	0.0	6.4	1.7	0.3	0.5	1.8	0.2	0.7	0.0	1.1	0.6	0.8	21.4	2.8	2.4	0.0	0.0	0.2	0.0	21.2	3.9	0.0	0.4	0.7	0.1	0.5	1.8	0.0	0.1	0.2	0.2	4.3	4.6	0.7	0.0	66.8	3.6	93.9	0.2	5.0	0.1	16.0	0.0	1.6	0.3	0.7	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	7.6	1.2	0.0	0.1	0.9	49.7	1.6	0.3	0.0	0.0	0.6	0.3	1.5	8.4	9.1	0.5	0.3	3.9	5.4	3.0
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 102.2;choroid plexus: 33.7;salivary gland: 33.5;skeletal muscle: 37.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 117.5;Bipolar cells: 87.7;Excitatory neurons: 323.2;Horizontal cells: 104.3;Inhibitory neurons: 230.5;Oligodendrocyte precursor cells: 58.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.7"	"Region enhanced"	"Detected in many"		"cerebral cortex: 102.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 4.0;RPMI-8226: 11.9;SCLC-21H: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced					NA	NA					"CAB005606: AB_2243199"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.65e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.34e-2)"	"unprognostic (7.95e-3)"	0.0	0.6	9.0	0.0	12.9	0.0	0.1	39.3	102.2	2.0	33.7	0.1	0.0	2.2	0.2	0.1	3.7	0.0	0.0	17.8	4.3	0.2	20.5	0.0	0.0	2.8	11.1	9.5	0.0	0.2	2.0	3.5	0.0	23.1	0.0	0.0	13.6	33.5	0.0	37.8	0.4	0.1	1.4	0.0	0.1	0.1	0.6	17.3	0.5	0.0	5.0	0.1	0.0	0.1	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	4.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	12.9	39.3	102.2	17.8	4.3	2.8	11.1	9.5	23.1	0.0	17.3	30.2	0.1	0.0	0.0	117.5	0.1	0.5	0.0	0.0	0.0	87.7	3.6	0.3	12.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	7.7	0.8	0.7	0.0	0.0	323.2	0.0	0.0	0.5	0.0	14.1	2.5	0.1	0.4	27.1	0.0	104.3	230.5	0.0	0.0	0.8	0.7	7.5	0.0	0.1	3.6	14.0	0.0	16.4	0.0	58.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.2	0.0	2.3	0.5	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0
BCL2L10	"BCL-B, Boo, Diva"	ENSG00000137875	"BCL2 like 10"	Q9HD36	15	52109263-52112775	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 9.6;skin 1: 6.3"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 13.7;Proximal enterocytes: 11.4;Proximal tubular cells: 9.8;Squamous epithelial cells: 7.9;Suprabasal keratinocytes: 8.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"NB-4: 34.1"	"Not detected"	"Not detected"							HPA042222	Approved					NA	NA					"HPA042222: AB_10794271"	"unprognostic (5.33e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.86e-2)"	"unprognostic (3.47e-2)"	"unprognostic (9.52e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.18e-9)"	"unprognostic (9.59e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.20e-2)"	0.2	2.7	1.3	0.3	1.6	0.1	1.0	0.9	1.2	1.6	0.5	1.0	2.0	0.8	0.0	3.6	0.6	1.0	0.0	0.9	1.3	3.2	9.6	0.0	0.2	0.7	0.8	1.0	0.4	0.6	0.2	1.2	0.0	0.8	0.5	0.8	0.4	0.8	0.1	0.1	6.3	2.1	0.2	0.6	0.6	0.9	0.2	1.4	0.1	0.3	0.0	0.2	1.2	3.6	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.7	0.4	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	4.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.3	1.6	0.9	1.2	0.9	1.3	0.7	0.8	1.0	0.8	0.6	1.4	1.1	0.1	0.0	0.0	0.0	0.6	6.1	5.3	2.5	4.6	1.0	1.7	2.5	0.3	4.3	0.7	0.0	0.0	0.1	0.2	2.8	13.7	2.2	0.0	1.4	1.4	0.3	0.0	0.8	0.4	1.5	0.2	0.3	0.0	5.2	0.0	0.1	0.0	4.5	0.1	0.0	0.2	2.1	6.1	0.0	0.7	0.1	0.3	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.7	0.4	1.1	2.0	11.4	9.8	0.4	0.2	0.0	0.2	0.3	0.0	0.1	7.9	8.7	0.1	0.2	0.1	3.1	5.4
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 2939.4"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 687.0;Hepatocytes: 2795.1;Leydig cells: 1193.2;Peritubular cells: 640.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 276.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 769.5;ASC TERT1: 1012.7;BJ hTERT+: 336.1;HSkMC: 540.2"	"Not detected"	"Not detected"							"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	93000000000	14000000000	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	420.2	137.4	26.2	209.6	27.5	1.7	254.6	27.1	44.7	311.8	56.6	175.2	85.4	210.7	148.5	154.3	318.2	548.6	124.8	24.6	45.9	60.8	2939.4	226.8	211.0	45.3	30.5	23.7	490.2	62.6	22.0	33.4	53.3	33.3	176.0	217.4	9.8	97.7	140.4	57.5	91.8	155.5	254.1	30.5	170.0	151.4	90.8	31.9	88.9	140.2	156.1	194.1	460.0	191.4	37.0	0.2	18.6	1.2	10.2	769.5	1012.7	4.5	143.3	336.1	74.7	135.7	0.9	2.0	0.5	19.7	179.6	20.2	1.1	0.3	2.1	6.7	0.7	0.7	0.5	5.6	48.2	230.3	1.8	0.9	540.2	2.8	60.2	4.4	94.2	0.1	0.2	0.4	0.1	9.9	0.0	0.4	1.6	10.3	0.0	0.6	0.2	1.1	1.5	3.1	2.5	0.8	0.9	86.6	1.8	2.1	17.4	0.1	0.0	0.5	34.2	2.6	133.8	0.2	0.6	0.5	0.8	73.6	1.2	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	26.2	27.5	27.1	44.7	24.6	45.9	45.3	30.5	23.7	33.3	30.5	31.9	37.0	37.6	16.0	41.0	9.4	5.7	76.2	18.9	22.2	23.9	0.9	4.5	15.4	21.5	171.6	15.5	3.7	0.0	3.7	0.7	0.1	1.9	285.2	6.6	8.7	272.4	30.6	0.0	112.2	2.9	42.9	2.5	687.0	11.2	7.3	5.1	25.7	93.5	2795.1	8.1	5.0	1.7	0.0	2.0	62.8	103.7	29.9	1193.2	6.4	88.9	19.7	1.0	15.2	0.0	1.5	0.6	31.7	0.1	640.1	1.8	9.7	0.0	7.1	4.6	1.1	138.1	34.9	127.6	6.3	5.3	6.3	53.8	2.6	12.8	30.7	0.2	5.2
C2orf72	LOC257407	ENSG00000204128	"Chromosome 2 open reading frame 72"	A6NCS6	2	231037523-231049719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.9;liver: 18.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 163.2;Cholangiocytes: 47.1;Hepatocytes: 129.1;Oligodendrocyte precursor cells: 45.8;Paneth cells: 51.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.9;CACO-2: 2.2;EFO-21: 3.3;OE19: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044962	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA044962: AB_10960863"	"unprognostic (4.90e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.27e-4)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (2.78e-1)"	"unprognostic (7.23e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-2)"	0.0	0.0	6.8	0.0	6.2	0.0	0.3	5.0	9.4	0.0	0.0	3.1	0.6	0.0	0.1	0.0	0.0	0.4	0.0	8.2	6.8	0.2	18.8	0.1	0.0	8.9	11.9	4.1	0.0	1.4	0.2	1.1	0.9	7.5	0.5	0.7	0.0	0.1	0.0	0.0	0.1	1.1	0.0	4.8	0.0	1.5	0.1	10.6	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.5	0.4	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	4.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	1.5	0.1	1.0	0.5	0.5	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	6.2	5.0	9.4	8.2	6.8	8.9	11.9	4.1	7.5	4.8	10.6	5.8	0.0	0.0	0.0	163.2	0.5	0.1	0.1	0.0	0.0	1.9	5.9	6.0	0.5	47.1	0.0	0.0	0.0	1.8	0.2	32.8	1.9	3.9	13.6	0.1	0.2	0.2	4.9	10.7	33.4	2.0	11.9	0.2	4.6	0.1	0.0	0.1	3.6	129.1	0.6	0.0	15.0	14.8	0.0	2.9	0.0	30.8	0.3	0.2	1.8	6.5	0.0	15.7	0.0	45.8	20.1	0.8	51.3	4.1	0.2	0.7	10.7	1.8	0.0	0.3	0.0	0.0	0.1	0.5	0.9	0.0	0.0	5.2	0.3	0.0	28.8	0.3
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982057-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 116.8;liver: 339.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 46.4;Cardiomyocytes: 8.3;Club cells: 13.6;Fibroblasts: 19.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 58.5;HSkMC: 72.8;U-266/70: 17.1;U-266/84: 33.9"									"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	NA	NA	342000000	120000000000			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (2.13e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.63e-2)"	15.4	116.8	3.2	10.7	1.2	0.4	15.8	0.5	2.5	9.2	0.4	23.6	7.6	17.1	11.9	2.6	30.2	2.3	18.7	0.7	1.8	41.9	339.6	15.1	4.6	6.5	1.8	1.0	58.0	23.2	0.6	20.8	0.5	6.6	11.2	3.8	5.6	14.3	0.0	1.7	1.6	17.1	0.0	0.7	15.4	11.8	4.2	1.8	4.2	44.9	0.0	2.9	23.3	4.1	1.7	0.0	0.3	0.0	0.0	1.0	5.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.7	0.2	0.1	0.1	0.4	0.0	58.5	0.5	0.0	0.3	1.0	0.0	0.0	0.0	72.8	0.0	0.0	0.0	0.5	0.0	0.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.2	17.1	33.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.2	0.5	2.5	0.7	1.8	6.5	1.8	1.0	6.6	0.7	1.8	1.7	0.0	9.6	46.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	8.3	2.8	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.5	4.4	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014795-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 223.3;liver: 388.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 103.9;Cardiomyocytes: 71.8;Club cells: 22.9;Fibroblasts: 53.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 33.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 129.8"									"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"	NA	NA		120000000000			"HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (1.29e-1)"	"unprognostic (2.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.11e-2)"	15.6	223.3	2.9	0.4	7.6	0.6	16.1	3.8	23.8	7.0	1.2	21.1	2.0	16.8	0.0	2.2	24.2	5.9	17.3	1.5	19.7	38.8	388.4	13.7	2.7	10.2	7.0	0.3	57.0	25.3	1.1	20.2	1.6	9.2	10.2	6.1	2.5	21.2	1.2	1.3	1.0	16.7	9.8	7.0	16.5	10.4	3.1	32.4	7.6	49.5	0.2	4.3	18.6	3.7	27.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	21.0	7.8	0.5	0.0	26.2	0.1	0.0	0.0	2.6	0.0	0.0	0.0	129.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.6	3.8	23.8	1.5	19.7	10.2	7.0	0.3	9.2	7.0	32.4	27.3	0.0	3.2	103.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	71.8	1.5	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.6	0.0	0.0	0.0	0.2	0.0	53.9	0.0	0.0	1.3	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.1	0.0	0.5	8.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CCDC152	LOC100129792	ENSG00000198865	"Coiled-coil domain containing 152"	Q4G0S7	5	42756818-42802439	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 179.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 43.4;Spermatocytes: 103.0;Spermatogonia: 37.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 3.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 13.6;JURKAT: 13.3;U-2 OS: 23.5;U-266/84: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036240	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036240: AB_10671242"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (6.25e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.40e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.14e-3)"	7.0	5.7	2.7	2.2	5.1	1.5	6.6	4.6	3.3	6.0	2.9	4.2	3.9	3.0	0.6	2.3	4.2	4.9	6.6	2.2	4.1	8.4	179.5	6.1	7.4	6.1	4.9	1.6	8.4	4.1	0.0	7.8	2.3	6.1	4.7	0.3	2.2	2.7	0.3	1.8	2.9	13.4	0.4	5.0	15.0	4.5	5.0	4.5	4.0	3.3	0.6	2.6	2.7	5.0	7.3	0.4	0.1	1.0	0.1	3.2	4.1	0.0	5.7	0.1	0.0	0.4	0.0	0.3	0.0	0.3	2.6	4.3	4.6	0.0	0.0	0.5	0.1	0.4	0.2	13.6	5.5	3.2	0.1	0.0	5.3	0.0	2.3	0.0	8.5	1.8	13.3	0.6	1.2	0.1	0.0	0.1	0.2	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.4	6.5	0.0	0.1	0.0	4.7	0.4	0.1	0.1	0.2	23.5	5.2	0.2	0.1	16.8	0.2	6.9	0.2	0.1	0.0	0.1	0.1	3.1	0.6	3.7	2.0	2.3	3.9	0.6	2.7	3.0	4.7	0.2	5.1	0.3	8.3	1.6	1.0	2.7	5.1	4.6	3.3	2.2	4.1	6.1	4.9	1.6	6.1	5.0	4.5	7.3	4.9	60.9	43.4	3.9	10.2	3.7	0.3	0.7	2.2	15.8	1.9	1.5	11.7	2.8	7.6	1.8	0.0	1.6	6.0	2.4	0.0	0.8	14.9	2.3	11.1	4.3	1.2	10.3	2.6	1.1	1.0	17.7	0.0	3.1	9.5	5.3	7.1	5.1	2.6	33.7	9.3	2.9	2.0	14.4	5.6	7.4	6.5	8.0	3.6	1.0	0.9	34.2	21.6	7.5	13.0	1.9	3.0	7.5	3.4	0.3	6.4	0.7	3.9	2.7	0.0	13.0	5.0	103.0	37.8	3.5	4.0	1.8	9.1	10.5	1.3	0.3
CCL15	"HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3"	ENSG00000275718	"C-C motif chemokine ligand 15"	Q16663	17	35996440-36001553	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 83.8;liver: 31.9"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 262.6;Intestinal goblet cells: 208.3;Paneth cells: 380.6;Proximal enterocytes: 461.4;Undifferentiated cells: 138.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 35.4;OE19: 28.7"									HPA058608			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	3270000	11000000	"Golgi apparatus"	Vesicles	"HPA058608: AB_2683776"	"unprognostic (1.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.40e-1)"			"unprognostic (8.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.63e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-2)"	"prognostic favorable (3.02e-4)"	0.2	0.4	0.1	7.9	0.1	0.1	0.4	0.1	0.3	0.2	0.1	60.2	38.0	0.2	0.0	0.2	9.7	9.3	0.0	0.1	0.1	9.8	31.9	2.1	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	83.8	0.0	0.1	0.1	0.0	0.1	62.5	1.4	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	5.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	28.7	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.5	0.0	0.5	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.1	7.2	5.0	0.0	0.0	0.0	0.0	262.6	0.0	0.0	0.0	12.2	0.1	0.7	71.8	0.0	0.0	0.7	0.0	0.0	0.0	0.1	8.9	0.0	2.5	40.2	0.1	0.0	0.0	208.3	2.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	380.6	0.0	0.0	0.0	461.4	61.3	76.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	138.2	0.2
CDHR5	"FLJ20219, MU-PCDH, MUCDHL, MUPCDH"	ENSG00000099834	"Cadherin related family member 5"	Q9HBB8	11	616577-626078	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 299.3;liver: 130.9"	"Group enriched"	"Detected in some"	7	"Distal enterocytes: 811.5;Paneth cells: 732.4;Proximal enterocytes: 2545.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 61.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"OE19: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009081, HPA009173, CAB025004"	Enhanced				"Intracellular and membrane"	NA	NA		190000000			"CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429"	"unprognostic (7.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-2)"	0.1	0.9	0.2	4.0	0.4	0.1	0.4	0.4	0.4	0.1	1.7	58.4	243.3	0.2	0.1	0.3	0.3	3.9	0.0	0.2	0.0	43.7	130.9	0.2	0.2	0.3	0.1	0.1	0.2	1.8	0.0	0.6	0.0	0.7	0.1	52.4	0.1	0.0	0.1	0.1	0.1	299.3	2.7	0.0	0.1	4.3	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.0	0.3	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	13.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.4	0.2	0.0	0.3	0.1	0.1	0.7	0.0	0.2	0.7	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	11.5	0.0	1.8	0.0	0.0	1.4	811.5	13.7	0.3	2.8	0.1	0.2	0.1	92.8	0.0	0.0	1.3	0.0	0.0	33.6	0.4	13.4	0.0	4.6	126.1	0.1	0.0	0.1	193.2	0.0	4.3	0.0	18.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	732.4	0.0	0.0	0.0	2545.8	107.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	154.6	0.0
CEBPA	"C/EBP-alpha, CEBP"	ENSG00000245848	"CCAAT enhancer binding protein alpha"	P49715	19	33299934-33302534	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 99.5;liver: 196.3;skin 1: 110.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 91.6;Hepatocytes: 106.5;Hofbauer cells: 87.0;Suprabasal keratinocytes: 171.8;Syncytiotrophoblasts: 212.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 70.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 16.0;classical monocyte: 7.1;intermediate monocyte: 12.3;myeloid DC: 5.1;non-classical monocyte: 15.7"	"Group enriched"	"Detected in many"	15	"dendritic cells: 5.1;granulocytes: 16.0;monocytes: 15.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 196.9;Hep G2: 110.9;NB-4: 114.1;THP-1: 407.7;U-937: 130.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052734, HPA065037, HPA067937"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA052734: AB_2681931, HPA065037: AB_2685410, HPA067937: AB_2685927"	"unprognostic (1.80e-1)"	"unprognostic (7.62e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.43e-3)"	"unprognostic (5.95e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.09e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.02e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.72e-2)"	99.5	2.9	18.2	5.7	17.8	22.8	68.3	19.3	27.1	7.4	11.2	21.2	21.4	2.9	0.8	21.0	4.4	3.0	2.8	15.4	18.9	3.6	196.3	25.7	9.2	21.9	20.6	12.4	1.3	9.8	27.0	2.6	16.1	26.4	8.9	11.6	0.6	9.9	3.4	19.3	110.1	20.9	2.5	31.2	7.8	12.6	1.0	19.6	4.2	6.6	4.5	6.3	8.7	14.9	25.1	2.5	5.1	0.1	7.1	55.8	0.0	196.9	0.1	1.5	0.1	0.0	24.8	0.1	0.0	3.0	0.0	1.1	9.4	5.8	0.6	0.0	35.8	7.2	0.1	0.1	110.9	0.9	36.6	42.1	2.2	25.4	0.0	0.2	0.0	0.0	2.8	2.4	0.0	0.0	12.7	0.2	114.1	5.0	61.8	2.7	0.0	0.4	1.1	0.2	17.7	0.4	1.7	0.7	0.5	0.8	6.2	13.7	407.7	0.1	0.1	0.8	0.1	0.9	0.4	0.0	0.2	0.0	130.9	0.0	16.0	7.1	0.0	0.8	12.3	0.7	0.0	0.1	0.5	5.1	0.1	0.2	0.4	2.5	0.0	15.7	0.2	0.0	2.1	18.2	17.8	19.3	27.1	15.4	18.9	21.9	20.6	12.4	26.4	31.2	19.6	25.1	5.4	16.0	37.8	0.0	2.8	37.3	20.8	3.3	22.2	0.7	6.2	12.2	0.4	57.2	5.1	0.0	0.0	40.3	14.4	91.6	3.9	0.5	0.0	0.8	0.8	4.9	4.2	5.7	1.9	5.8	44.3	9.5	12.8	1.3	1.3	0.0	2.2	106.5	87.0	0.0	0.3	24.8	4.1	35.0	27.4	0.2	3.1	42.9	5.4	17.8	28.2	8.4	6.2	1.0	0.4	1.9	30.6	1.5	2.0	15.1	42.5	4.9	5.1	0.5	0.0	4.1	3.1	0.2	0.7	29.7	171.8	212.3	5.0	0.3	51.5	12.2
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 709.6;liver: 348.6"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 794.4;Hepatocytes: 518.5;Paneth cells: 519.2;Proximal enterocytes: 2529.8;Undifferentiated cells: 499.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 104.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA018897, HPA074629"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		6400000	"Golgi apparatus"	"Endoplasmic reticulum, Cytosol"	"HPA018897: AB_1846558, HPA074629: "	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	18.9	38.4	21.2	18.2	20.5	6.3	13.6	23.8	23.1	17.5	24.2	193.0	709.6	14.8	14.5	133.8	18.1	19.7	37.2	22.4	20.8	97.3	348.6	15.7	12.0	22.2	21.2	19.6	17.1	14.5	38.3	15.8	10.2	21.9	16.8	180.5	16.3	33.1	15.1	34.0	32.9	581.3	19.9	19.8	12.5	42.0	9.3	20.9	13.2	28.1	14.5	21.0	13.9	33.8	21.6	11.6	16.6	18.4	25.9	19.5	17.9	14.5	15.9	25.8	17.6	22.1	17.3	23.5	15.7	14.3	20.9	13.3	35.4	14.2	39.8	15.3	10.7	18.9	14.4	9.6	44.2	26.3	21.6	26.3	25.4	82.5	26.0	46.7	24.6	14.1	11.3	22.2	10.9	35.7	9.1	17.7	21.4	10.8	16.3	18.8	20.9	19.1	19.8	60.7	18.6	11.6	16.0	50.9	12.6	14.5	8.1	21.0	26.5	17.5	22.4	12.6	15.3	11.1	23.3	24.0	18.4	36.7	17.3	17.4	4.1	5.4	1.6	5.1	3.8	4.5	3.0	4.1	5.8	4.5	3.1	4.8	4.5	1.6	4.3	4.1	4.3	3.2	3.1	21.2	20.5	23.8	23.1	22.4	20.8	22.2	21.2	19.6	21.9	19.8	20.9	21.6	13.2	32.1	24.6	8.8	18.8	19.5	13.5	32.8	39.3	31.2	12.4	18.3	33.6	115.8	19.8	53.3	20.9	16.1	12.9	794.4	37.2	24.6	2.1	26.9	15.0	14.1	24.1	7.8	7.0	33.8	5.7	15.3	60.6	33.7	27.3	80.7	28.5	518.5	19.6	28.6	9.7	196.0	18.3	37.0	9.6	2.3	18.6	15.3	10.6	10.3	19.5	19.0	21.6	8.0	5.9	51.8	519.2	18.0	8.5	19.1	2529.8	176.0	85.4	24.2	32.9	19.5	15.2	47.2	19.7	116.1	20.5	13.5	13.0	22.1	499.5	16.7
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"liver: 2634.7"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 873.6;Exocrine glandular cells: 197.3;Hepatocytes: 284.0;Pancreatic endocrine cells: 318.0;Proximal enterocytes: 139.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;ASC TERT1: 23.0;EFO-21: 25.1;fHDF/TERT166: 14.1;HSkMC: 19.1;U-87 MG: 10.1"					"Low region specificity"	"Detected in all"			"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	120000000000	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	77.5	18.2	3.4	33.1	3.3	0.1	28.8	3.2	10.0	11.7	3.8	19.2	28.4	8.3	14.4	24.3	54.1	0.8	25.6	3.4	3.2	58.4	2634.7	39.5	4.2	4.1	3.3	3.1	9.9	52.3	0.2	17.8	5.0	3.5	60.8	14.7	1.4	43.6	0.0	3.1	7.6	73.7	48.8	3.1	13.0	54.9	2.1	3.5	1.9	15.7	0.7	6.8	17.9	9.3	3.4	0.5	1.9	0.1	0.0	15.0	23.0	0.1	0.0	0.2	1.1	0.0	0.1	8.6	0.1	25.1	14.1	0.6	6.0	0.0	1.8	1.2	1.0	0.3	0.7	0.4	0.5	0.0	1.0	0.4	19.1	0.4	0.6	0.5	1.3	0.2	0.1	0.3	0.7	0.1	0.2	0.1	0.3	0.4	0.0	0.4	0.3	0.3	1.3	1.7	0.5	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	3.4	1.2	0.4	0.4	0.7	2.1	1.0	10.1	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.4	3.3	3.2	10.0	3.4	3.2	4.1	3.3	3.1	3.5	3.1	3.5	3.4	1.0	0.0	16.9	0.0	2.6	0.8	0.9	64.8	11.4	0.3	4.9	0.9	0.4	44.3	127.3	5.5	0.0	0.1	0.0	3.7	3.9	873.6	0.0	1.9	0.4	3.9	2.4	16.0	0.2	197.3	0.2	34.6	20.9	1.2	0.0	0.0	11.7	284.0	1.0	0.0	0.2	8.5	18.3	19.7	1.0	0.0	2.8	1.1	0.0	5.6	18.1	0.4	0.0	0.0	0.0	318.0	10.6	0.0	0.1	8.6	139.7	17.1	75.4	0.7	0.0	1.0	12.6	0.1	0.1	3.9	1.8	1.6	1.6	0.0	12.4	4.5
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109801999	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1108.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 108.7;Hepatocytes: 592.5;Muller glia cells: 147.8;Proximal tubular cells: 223.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 90.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 106.1;Hep G2: 179.8;HSkMC: 67.4;RPTEC TERT1: 190.6"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		12000000000			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"	29.8	50.7	7.1	12.7	7.3	0.1	17.5	7.3	13.3	37.1	10.7	7.5	38.3	39.5	81.0	9.4	74.6	73.6	18.4	7.3	10.7	226.9	1108.0	51.2	9.0	15.0	7.9	6.6	32.4	26.2	3.1	8.5	24.4	9.4	8.4	6.4	53.4	15.1	26.9	4.0	2.7	22.5	24.6	10.0	33.3	14.6	8.9	9.4	2.3	14.6	4.6	7.6	34.5	8.4	9.8	0.0	0.6	0.0	0.3	0.0	0.2	0.1	1.5	1.4	0.1	0.2	0.0	106.1	0.0	32.9	0.0	0.5	0.0	0.0	0.0	0.0	34.8	0.7	0.0	0.4	179.8	6.2	0.3	0.0	67.4	0.0	0.1	0.0	3.6	4.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	190.6	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.1	18.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	7.3	7.3	13.3	7.3	10.7	15.0	7.9	6.6	9.4	10.0	9.4	9.8	48.1	12.8	50.9	3.6	4.0	1.0	12.2	15.2	0.6	3.4	2.1	5.6	2.3	108.7	36.2	64.4	2.1	0.1	0.3	1.7	31.3	69.3	0.2	34.1	46.4	57.7	0.0	2.7	0.3	30.9	0.2	34.3	8.2	33.6	3.8	72.1	55.0	592.5	0.7	1.7	0.2	1.9	0.0	16.7	1.5	0.8	16.8	2.0	0.0	4.7	1.6	147.8	0.0	0.0	0.3	30.8	2.4	0.0	0.0	3.8	17.0	223.6	8.4	7.3	0.0	1.3	9.4	1.6	0.5	1.9	1.1	0.3	3.4	18.5	4.1	12.6
CHRNA4	"BFNC, EBN, EBN1"	ENSG00000101204	"Cholinergic receptor nicotinic alpha 4 subunit"	P43681	20	63343223-63378401	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 25.5;liver: 58.5;parathyroid gland: 12.8"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 42.0;Horizontal cells: 139.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-2 OS: 2.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"midbrain: 21.8;pons: 20.5;thalamus: 33.5"	CAB034064	Uncertain					NA	NA					"CAB034064: AB_2080535"	"unprognostic (3.40e-1)"	"unprognostic (1.71e-1)"		"unprognostic (2.87e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.10e-3)"	"unprognostic (5.72e-4)"	"unprognostic (9.02e-3)"	"unprognostic (9.79e-4)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.81e-2)"		0.0	0.2	5.8	0.0	5.2	0.0	0.0	0.6	6.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.4	5.5	3.3	58.5	0.0	0.0	4.5	13.9	4.4	0.1	0.0	12.8	0.8	0.0	5.8	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	1.6	25.5	0.0	0.5	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.2	0.6	6.3	6.4	5.5	4.5	13.9	4.4	5.8	0.4	25.5	6.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	4.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	42.0	0.0	139.7	8.8	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.9	0.0	7.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	2.7	0.0	1.7	0.1	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
COLEC10	CL-L1	ENSG00000184374	"Collectin subfamily member 10"	Q9Y6Z7	8	118995452-119108455	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 66.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 6.9;Hepatic stellate cells: 10.4;Inhibitory neurons: 5.4;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 4.8"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 3.4;SK-BR-3: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		30000000				"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.79e-4)"	"unprognostic (6.25e-3)"	"unprognostic (1.80e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (5.79e-4)"	"unprognostic (1.05e-1)"		"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.02e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-5)"	"unprognostic (7.12e-2)"	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.4	0.1	0.4	0.4	66.2	1.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	11.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	6.9	0.0	0.2	1.0	0.0	0.0	0.0	0.0	10.4	0.4	0.3	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.8	0.1	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.4
COLEC11	"CL-K1, MGC3279"	ENSG00000118004	"Collectin subfamily member 11"	Q9BWP8	2	3594832-3644644	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 54.6;liver: 144.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 37.4;Hepatic stellate cells: 89.3;Peritubular cells: 52.3;Proximal tubular cells: 127.1;Sertoli cells: 72.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HHSteC: 135.7;SH-SY5Y: 111.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA035241	Uncertain				"Secreted to blood"	NA	NA		130000000			"HPA035241: AB_10600701"	"unprognostic (3.35e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.95e-3)"	"unprognostic (5.85e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.27e-3)"	"unprognostic (7.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.60e-1)"	9.4	40.9	1.2	0.9	1.0	1.9	3.3	4.0	1.9	1.5	5.7	2.5	3.5	1.2	0.4	1.6	4.5	54.6	28.8	1.4	1.0	24.2	144.3	2.5	2.0	1.1	0.7	1.2	46.8	13.9	1.3	5.9	2.4	2.0	3.3	0.6	0.5	0.6	1.1	0.6	1.4	3.9	1.2	0.6	3.8	3.1	7.5	0.9	4.1	17.1	0.9	0.2	7.2	1.0	1.4	0.2	1.4	0.7	2.5	0.0	0.0	11.7	0.7	0.0	0.3	0.2	0.7	0.2	0.3	4.0	0.1	0.4	0.4	0.1	0.4	0.3	0.2	0.8	0.6	1.4	5.0	135.7	0.2	1.0	1.6	0.1	0.2	0.0	0.4	0.1	0.8	11.1	0.8	0.0	0.1	0.0	0.8	0.6	0.2	0.9	0.0	0.0	0.5	0.0	0.3	2.1	111.7	1.6	1.1	0.8	0.3	0.5	1.0	0.0	0.0	0.7	0.6	0.5	3.2	26.2	1.5	0.3	1.3	0.6	0.7	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.2	0.9	0.3	0.1	0.2	0.1	0.0	1.2	1.0	4.0	1.9	1.4	1.0	1.1	0.7	1.2	2.0	0.6	0.9	1.4	7.3	0.0	0.0	0.7	0.6	1.0	0.0	0.0	2.8	0.5	0.1	0.3	1.2	0.0	0.0	0.0	0.0	1.6	0.0	0.1	17.6	0.0	0.3	1.1	22.0	4.2	0.0	0.0	2.2	0.0	1.4	37.4	0.0	0.6	0.0	1.3	89.3	7.9	2.5	0.0	0.9	0.1	0.0	1.9	0.3	0.5	7.5	0.8	3.6	1.0	0.0	1.4	0.0	0.5	0.2	0.1	0.0	52.3	0.0	0.2	0.0	127.1	0.0	0.1	72.3	0.3	18.0	1.3	11.6	0.6	0.9	1.2	0.7	27.0	0.0	0.1
COX7B2		ENSG00000170516	"Cytochrome c oxidase subunit 7B2"	Q8TF08	4	46734827-46909245	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	70	"testis: 86.4"	"Group enriched"	"Detected in some"	9	"Early spermatids: 519.2;Late spermatids: 211.0;Spermatocytes: 391.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Karpas-707: 33.9"	"Low region specificity"	"Detected in many"													NA	NA												"unprognostic (2.82e-1)"								"unprognostic (2.42e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	86.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	33.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	519.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	211.0	9.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	391.5	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149221829	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 1886.9"	"Cell type enhanced"	"Detected in many"		"Club cells: 558.1;Glandular and luminal cells: 406.0;Hepatocytes: 1687.2;Muller glia cells: 720.5;Respiratory ciliated cells: 318.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"EFO-21: 318.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	NA	NA	160000000000	440000000000			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	10.6	2.3	16.8	2.2	16.7	0.9	21.0	18.2	30.1	70.8	114.4	13.1	9.9	14.9	0.0	5.6	8.4	1.1	21.8	16.1	45.8	9.3	1886.9	13.6	19.1	27.4	21.9	13.5	0.8	6.5	3.9	28.8	3.4	24.5	7.9	16.5	248.7	40.2	0.9	2.7	10.4	21.0	2.5	18.7	23.3	3.0	1.5	20.3	0.5	16.3	8.3	20.2	24.1	2.3	26.3	0.2	18.8	15.6	0.0	3.3	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	318.8	0.0	29.4	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.4	32.7	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	2.5	5.4	0.0	0.0	0.0	0.4	6.7	16.2	0.0	0.2	0.3	1.0	0.1	0.4	0.0	0.4	0.0	0.2	1.7	0.2	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.8	16.7	18.2	30.1	16.1	45.8	27.4	21.9	13.5	24.5	18.7	20.3	26.3	2.3	19.2	76.6	3.3	10.6	3.3	8.3	28.6	0.6	6.9	14.0	0.6	0.6	65.8	558.1	9.2	6.2	0.1	0.3	0.1	0.0	83.4	0.9	190.5	51.0	12.6	0.0	34.7	1.5	21.4	0.2	16.3	0.0	406.0	2.5	0.1	34.6	1687.2	0.6	5.0	1.4	0.2	8.2	44.6	6.9	1.2	0.3	4.0	0.0	6.5	1.6	720.5	1.0	0.5	2.0	69.3	0.0	0.4	0.3	19.5	0.0	0.3	318.4	24.8	0.0	0.8	15.3	0.0	0.1	0.8	2.6	0.3	4.9	0.1	0.1	79.0
CPLX2	"CPX-2, DKFZp547D155"	ENSG00000145920	"Complexin 2"	Q6PUV4	5	175796310-175884021	"Predicted intracellular proteins"	"Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 310.8;epididymis: 129.7;pituitary gland: 66.2"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 36.6;Excitatory neurons: 44.7;Horizontal cells: 95.9;Inhibitory neurons: 35.9;Late spermatids: 32.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"A549: 496.4;Hep G2: 323.4;SCLC-21H: 201.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles		NA	NA			Vesicles		"HPA071191: , HPA074390: "	"unprognostic (1.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.49e-3)"		"unprognostic (6.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.90e-5)"	"unprognostic (6.88e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	0.7	28.6	240.0	1.0	109.5	0.0	0.1	84.1	288.6	0.0	0.0	2.7	2.1	0.0	129.7	0.1	0.0	0.0	0.2	310.8	48.4	0.1	0.2	1.3	0.0	54.2	119.2	149.1	0.2	9.1	0.1	66.2	0.0	84.9	0.2	1.4	19.5	0.1	0.0	0.2	0.1	1.6	0.3	0.0	0.0	5.0	3.0	23.5	0.1	0.2	0.0	0.0	0.1	0.5	157.4	0.0	496.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	323.4	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.3	2.1	15.2	0.1	0.0	0.0	0.6	0.0	0.2	201.3	16.3	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	240.0	109.5	84.1	288.6	310.8	48.4	54.2	119.2	149.1	84.9	0.0	23.5	157.4	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.2	36.6	0.0	44.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	35.9	1.0	0.0	0.0	0.0	32.9	0.9	0.0	0.0	4.7	0.0	1.1	0.0	5.5	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRIP3	"bA480N24.2, TLP, TLP-A"	ENSG00000146215	"Cysteine rich protein 3"	Q6Q6R5	6	43299710-43308826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 24.6;testis: 25.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Distal tubular cells: 9.8;Granulosa cells: 12.5;Late spermatids: 7.9;Oligodendrocyte precursor cells: 6.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	16	"myeloid DC: 44.6"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 44.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.8;HEK 293: 3.3;HeLa: 3.5;Hep G2: 6.5;NTERA-2: 5.7;RPMI-8226: 4.6;THP-1: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036198	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA036198: AB_10670791"	"unprognostic (8.35e-3)"	"unprognostic (4.14e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-3)"	"unprognostic (5.02e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.80e-4)"	0.8	0.6	11.5	1.7	11.6	2.6	0.9	12.7	14.6	2.3	9.6	1.0	2.0	1.3	1.6	0.7	2.0	0.6	24.6	11.5	11.3	5.3	10.5	0.6	5.5	10.8	10.8	11.6	2.1	1.7	2.1	2.4	0.2	11.2	5.8	0.4	2.5	0.8	8.1	0.4	1.8	3.5	0.6	10.5	8.0	0.8	25.9	11.1	1.6	2.1	0.0	5.9	1.1	1.4	11.9	0.0	0.8	0.2	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.1	0.6	2.8	0.1	0.0	0.0	3.3	0.0	3.5	6.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.6	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.7	0.9	0.0	1.7	0.0	2.3	0.0	0.0	44.6	2.6	0.0	0.0	0.8	0.3	2.3	0.4	0.0	1.8	11.5	11.6	12.7	14.6	11.5	11.3	10.8	10.8	11.6	11.2	10.5	11.1	11.9	0.2	0.0	0.0	9.4	2.8	0.6	0.3	0.0	0.0	0.9	0.1	0.8	3.2	5.7	0.1	0.0	0.0	0.0	0.1	0.3	9.8	1.1	3.9	1.1	0.2	0.2	0.0	0.8	4.7	0.2	0.0	0.2	0.0	0.1	0.0	12.5	0.0	2.9	0.2	0.0	3.5	0.1	0.0	0.9	3.4	7.9	1.2	0.7	0.0	1.0	1.4	0.5	1.0	6.6	3.4	0.3	0.1	0.0	0.1	0.1	0.7	4.5	0.3	0.8	0.0	0.3	0.4	5.3	1.6	0.0	0.0	0.0	0.3	1.0	0.4	0.1
CYB5A	CYB5	ENSG00000166347	"Cytochrome b5 type A"	P00167	18	74250846-74291973	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 897.9;liver: 2492.4"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 1371.0;Distal tubular cells: 2156.1;Hepatocytes: 3376.3;Proximal enterocytes: 1856.4;Proximal tubular cells: 3630.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 43.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 1117.0;RT4: 513.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006333, HPA047548, HPA058547"	Enhanced		Enhanced	Vesicles,Cytosol		No	No		1400000	"Vesicles, Cytosol"		"CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750"	"unprognostic (1.88e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (7.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.54e-2)"	312.3	110.5	37.1	31.5	37.7	25.6	255.6	40.7	45.6	86.7	37.2	133.0	442.2	45.3	177.7	78.7	82.6	304.0	72.9	36.0	37.0	897.9	2492.4	359.7	44.1	41.8	37.4	35.6	225.7	465.2	238.0	58.9	82.5	40.0	96.7	104.4	10.4	59.5	124.0	41.8	102.3	384.9	47.1	40.1	76.2	196.4	58.4	38.7	52.1	42.8	42.5	35.5	156.8	68.9	42.3	78.8	130.8	67.4	0.6	1117.0	198.2	89.5	52.6	113.8	111.0	163.8	156.2	82.7	95.6	36.7	97.6	54.4	170.6	0.1	73.1	86.9	179.8	91.7	34.9	65.6	418.1	174.6	67.3	44.1	334.1	57.4	63.0	32.3	66.0	63.6	85.8	58.6	35.0	93.7	140.9	38.3	80.5	30.4	110.0	86.8	93.6	21.9	2.3	111.9	513.2	190.4	79.7	51.4	137.1	65.8	56.6	271.5	63.7	57.9	0.6	85.8	26.6	68.1	24.6	109.2	30.3	67.0	19.2	64.3	4.1	29.5	7.5	51.3	36.3	116.2	93.7	55.6	60.2	53.7	112.7	54.5	68.6	3.7	36.3	45.7	47.8	48.8	43.2	37.1	37.7	40.7	45.6	36.0	37.0	41.8	37.4	35.6	40.0	40.1	38.7	42.3	169.7	637.8	1371.0	11.4	76.0	98.0	82.1	368.6	50.7	9.9	345.8	213.2	90.7	836.4	1053.2	842.4	4.2	229.3	29.4	197.0	2156.1	239.4	7.5	163.1	76.6	119.9	164.2	180.0	13.1	504.6	169.8	141.4	208.9	345.6	39.9	55.0	177.4	3376.3	97.4	8.4	12.6	236.5	457.7	128.6	72.9	26.7	158.1	60.8	90.7	10.3	224.1	39.2	32.0	14.1	22.7	266.7	358.9	149.7	33.4	142.0	1856.4	3630.6	619.5	14.0	52.6	49.6	85.0	15.3	42.0	141.2	223.9	44.5	52.6	1123.6	329.9	220.7
CYP21A2	"CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B"	ENSG00000231852	"Cytochrome P450 family 21 subfamily A member 2"	P08686	6	32038327-32041644	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Steroidogenesis	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"adrenal gland: 2058.4"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048979, HPA053371"	Enhanced					NA	NA					"HPA048979: AB_2680584, HPA053371: AB_2682131"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.67e-7)"	"unprognostic (7.39e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-1)"	1.4	2058.4	0.0	0.0	0.0	0.0	1.5	0.0	0.6	1.6	0.0	1.9	0.0	1.5	0.6	0.6	2.5	0.0	2.2	0.0	0.0	6.9	45.1	0.8	0.0	0.0	0.0	0.0	4.4	0.9	0.0	1.9	0.0	0.0	1.9	0.0	0.0	4.0	0.0	0.3	0.6	1.2	0.0	0.0	5.6	0.8	0.8	0.0	0.0	2.4	0.0	0.0	2.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	2.4	0.5	0.3	1.5	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.8	0.9	1.8	0.0	0.1	0.0	0.0	1.6	0.0	0.2	1.3	0.4	0.0	15.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.6	0.1	1.8	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	2.0	1.2	0.6	0.0	0.3	0.6	0.6	0.4	0.0	0.0	0.0	0.3	1.0	0.0	0.0
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991282-41018398	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"liver: 538.2"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 420.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;OE19: 1.8"					"Region enhanced"	"Detected in single"		"spinal cord: 2.3"	"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.0	0.0	0.3	0.2	0.2	0.5	0.1	0.6	0.3	0.0	0.3	4.8	5.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.3	15.2	538.2	0.4	0.1	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.0	1.8	0.9	0.0	0.1	0.2	0.0	6.8	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.0	2.6	0.1	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.2	1.8	0.1	0.0	0.1	0.1	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.1	0.3	0.3	0.0	0.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.1	0.0	0.4	0.1	0.0	0.3	0.2	0.6	0.3	0.2	0.3	0.3	0.2	0.1	0.4	0.1	0.2	0.4	0.0	0.0	1.1	0.0	0.8	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.2	7.2	1.4	1.8	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	16.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.4	420.9	0.0	0.0	0.1	1.6	0.0	11.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	0.0	0.0	0.1	38.3	16.9	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.1	4.3	0.7
CYP2C18	"CPCI, CYP2C, CYP2C17, P450IIC17"	ENSG00000108242	"Cytochrome P450 family 2 subfamily C member 18"	P33260	10	94683729-94736190	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 103.7;liver: 198.7;stomach 1: 67.8"	"Cell type enhanced"	"Detected in some"		"Gastric mucus-secreting cells: 68.8;Hepatocytes: 124.0;Proximal enterocytes: 62.5;Squamous epithelial cells: 22.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.2;OE19: 1.9"	"Not detected"	"Not detected"							HPA074424			Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			Vesicles	"Plasma membrane"	"HPA074424: "	"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-2)"		"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.22e-3)"		"unprognostic (1.62e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"		"unprognostic (6.81e-3)"	0.3	0.0	0.1	1.6	0.1	0.0	0.3	0.2	0.1	2.5	0.0	6.0	103.7	0.1	0.0	31.2	0.0	16.4	0.0	0.1	0.1	0.3	198.7	0.8	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	2.5	0.0	5.4	0.0	0.0	4.4	83.8	0.1	0.2	0.0	67.8	0.1	0.1	0.3	0.0	0.0	7.1	0.2	9.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.9	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.2	0.0	0.0	3.3	0.0	0.3	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.1	17.2	3.2	0.0	0.0	0.1	0.0	6.7	0.0	1.5	0.0	0.6	0.1	0.0	0.0	2.7	0.5	6.9	0.2	0.1	68.8	1.3	0.0	0.0	1.8	124.0	0.0	0.0	0.8	2.1	2.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	9.1	3.9	0.0	0.3	0.0	62.5	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.3	22.8	1.7	1.5	0.1	0.1	5.7	0.0
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99679998	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 179.2;liver: 278.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 377.4;Distal enterocytes: 382.7;Gastric mucus-secreting cells: 506.6;Hepatocytes: 454.5;Paneth cells: 451.6;Proximal enterocytes: 1074.6;Urothelial cells: 380.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 9.7;Hep G2: 7.9;OE19: 28.3"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	3.2	14.5	0.2	3.8	0.5	0.6	6.5	0.8	0.9	3.7	0.3	28.7	128.4	3.2	3.0	22.3	3.1	33.0	1.0	0.3	0.0	10.2	278.4	9.3	1.4	0.5	0.1	0.2	0.8	47.4	0.0	0.9	0.4	0.5	21.7	21.2	0.7	3.0	5.8	0.9	19.0	179.2	1.1	0.0	0.8	87.3	0.4	0.1	2.1	1.0	0.0	3.2	10.5	13.2	0.9	1.6	3.3	1.6	1.9	0.4	0.6	0.5	1.5	0.0	0.0	0.0	9.7	7.4	1.0	1.5	0.0	1.2	1.2	0.0	0.0	0.0	1.8	1.2	1.2	0.7	7.9	0.1	2.0	0.6	0.0	2.1	0.0	0.0	1.4	0.0	0.9	3.3	2.0	0.0	0.3	2.6	3.8	0.4	28.3	0.8	0.6	1.6	2.2	0.4	1.5	1.2	1.7	0.9	0.8	3.2	1.6	0.5	0.7	1.2	1.8	1.6	1.6	1.2	1.0	2.6	1.7	1.6	2.6	1.5	0.4	0.3	0.4	0.4	0.3	0.9	0.2	0.6	0.6	0.2	0.1	0.4	0.5	0.5	0.4	0.2	0.3	0.5	0.2	0.2	0.5	0.8	0.9	0.3	0.0	0.5	0.1	0.2	0.5	0.0	0.1	0.9	0.9	12.8	14.8	1.3	4.8	46.1	112.7	31.0	59.7	13.7	1.1	0.4	1.3	377.4	27.3	3.7	12.5	1.7	1.7	382.7	0.0	63.4	2.0	3.1	2.2	6.3	54.6	21.7	8.6	50.7	1.2	8.5	506.6	10.3	10.1	1.8	8.2	454.5	0.6	8.4	11.0	140.5	6.1	9.5	4.5	0.5	2.5	4.1	3.6	2.8	4.9	4.0	10.3	7.1	6.5	80.1	451.6	2.6	6.4	156.3	1074.6	10.8	12.1	21.6	0.0	2.5	3.4	15.1	6.4	107.3	59.0	1.5	7.5	3.1	139.8	380.4
CYP4F11		ENSG00000171903	"Cytochrome P450 family 4 subfamily F member 11"	Q9HBI6	19	15912367-15934867	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.1;liver: 72.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 15.6;Hepatocytes: 62.9;Prostatic glandular cells: 36.3;Urothelial cells: 26.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 13.1;CAPAN-2: 50.4;EFO-21: 18.5;Hep G2: 25.0;RPMI-8226: 13.5;RT4: 15.2"									"HPA017265, CAB033648, HPA058960"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862"	"prognostic favorable (4.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (4.44e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.64e-2)"	0.2	2.9	5.3	0.6	4.6	0.6	2.2	5.9	6.5	1.3	0.0	3.5	10.8	0.5	16.5	13.1	3.1	18.9	0.2	4.6	5.3	6.5	72.9	0.6	0.4	8.7	7.3	3.2	0.1	5.2	0.1	0.5	0.1	6.1	3.8	2.6	1.6	3.8	4.3	0.5	1.0	24.1	0.1	4.4	1.0	4.1	1.1	6.5	0.0	3.0	0.0	0.9	5.8	3.4	5.0	13.1	2.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	50.4	0.1	18.5	0.0	10.5	1.5	0.0	6.6	0.0	0.0	0.1	0.1	4.2	25.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	10.0	0.0	1.9	0.1	0.3	0.1	11.4	0.0	0.1	0.1	13.5	3.4	15.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	1.8	0.2	0.2	0.1	0.6	0.2	0.4	1.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.6	5.9	6.5	4.6	5.3	8.7	7.3	3.2	6.1	4.4	6.5	5.0	0.1	0.0	0.0	9.1	0.2	0.1	7.7	5.3	0.0	0.0	1.4	1.7	0.4	10.0	4.4	9.2	0.0	0.0	0.0	6.9	1.9	15.6	0.0	2.8	0.6	0.3	1.2	2.7	0.0	11.5	0.0	0.3	0.0	4.4	0.0	0.3	0.4	62.9	0.0	0.0	0.0	2.0	2.0	2.4	0.0	0.1	0.3	0.4	0.0	0.0	0.0	3.0	0.0	0.0	0.8	9.2	3.2	0.0	0.0	36.3	11.7	8.3	7.6	0.1	0.0	0.6	0.6	0.0	0.0	0.5	0.3	0.0	0.1	0.1	2.7	26.1
CYP4F3	"CYP4F, LTB4H"	ENSG00000186529	"Cytochrome P450 family 4 subfamily F member 3"	Q08477	19	15640897-15662825	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 81.0;liver: 237.7"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 562.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	63	"neutrophil: 84.1"	"Lineage enriched"	"Detected in single"	177	"granulocytes: 84.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 33.0;HaCaT: 14.9;Hep G2: 18.3;OE19: 49.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (1.73e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.07e-1)"	1.6	0.1	0.9	1.2	3.0	81.0	0.2	2.7	1.5	3.4	0.5	2.1	9.5	0.1	0.8	26.9	1.1	15.6	0.2	1.9	2.0	27.6	237.7	2.3	0.1	2.4	2.1	0.7	0.1	0.6	0.0	0.5	0.4	2.6	0.6	1.8	0.1	3.5	0.6	0.1	3.9	15.1	0.3	2.0	7.8	5.2	0.3	1.7	0.7	0.1	0.6	0.7	2.9	9.0	4.3	0.3	7.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	33.0	0.1	0.2	0.0	0.1	14.9	0.0	0.2	0.0	0.6	0.0	0.1	3.5	18.3	0.0	0.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	49.3	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.2	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	84.1	0.0	0.1	0.0	0.0	0.1	0.9	3.0	2.7	1.5	1.9	2.0	2.4	2.1	0.7	2.6	2.0	1.7	4.3	0.0	9.6	3.7	0.7	2.0	1.0	2.1	2.5	1.2	0.0	0.1	0.1	0.9	62.9	5.0	0.0	0.0	0.0	1.4	10.0	0.0	2.3	0.1	0.9	0.2	0.7	53.1	17.3	0.0	0.2	0.2	0.8	7.7	3.1	1.3	0.0	8.2	562.4	0.0	0.0	0.0	14.4	8.2	11.4	0.3	0.7	0.0	1.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.0	7.4	0.0	0.0	3.2	69.9	32.1	1.9	0.0	0.0	0.7	1.3	0.0	0.3	25.7	6.5	0.0	1.1	0.0	10.9	13.1
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636363-133659329	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adrenal gland: 275.3;brain: 130.0"	"Cell type enriched"	"Detected in some"	6	"Hepatic stellate cells: 10.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.7"	"Group enriched"	"Detected in many"	7	"midbrain: 48.9;pons: 130.0;white matter: 35.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	346	"SH-SY5Y: 1826.4"	"Region enriched"	"Detected in some"	6	"pons and medulla: 22.1"	"Region enriched"	"Detected in single"	26	"pons: 18.5"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		1600000000	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	2.8	275.3	1.2	1.1	1.8	0.2	0.1	0.0	3.5	0.4	0.0	0.1	0.4	0.3	0.2	0.1	0.3	0.4	0.3	0.3	0.3	1.3	36.4	0.8	2.3	9.7	48.9	0.1	0.4	4.3	0.0	1.4	1.4	130.0	0.4	0.0	0.1	0.7	0.2	0.1	0.2	0.6	0.0	0.1	0.9	0.4	0.2	0.6	0.2	0.4	0.0	0.0	0.4	1.1	35.7	0.0	0.0	0.1	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	3.2	0.9	0.1	0.0	0.0	0.3	5.2	4.7	0.0	0.0	2.1	1826.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.8	0.0	3.5	0.3	0.3	9.7	48.9	0.1	130.0	0.1	0.6	35.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0
DEPDC7		ENSG00000121690	"DEP domain containing 7"	Q96QD5	11	33015876-33033582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 29.3;kidney: 19.7;liver: 74.7;testis: 28.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 34.8;Early spermatids: 153.3;Extravillous trophoblasts: 47.0;Proximal enterocytes: 33.2;Spermatocytes: 42.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 53.7;RH-30: 40.1;SiHa: 37.3;SK-MEL-30: 34.4;U-2197: 34.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA015800			Approved	Nucleoplasm,Nucleoli,Cytosol		Yes	No			Nucleoli	"Nucleoplasm, Cytosol"	"HPA015800: AB_1847610"	"unprognostic (2.34e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.26e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.94e-2)"	0.6	0.8	2.6	1.9	3.3	1.8	0.9	3.0	3.6	2.2	2.9	4.6	24.9	1.0	2.2	4.4	0.9	4.4	0.8	2.8	2.8	19.7	74.7	0.9	0.8	3.3	3.0	2.4	1.6	3.9	2.3	0.9	1.5	3.2	1.9	5.2	0.1	2.0	1.5	5.0	6.0	29.3	1.7	2.9	0.3	3.1	28.5	2.9	2.9	0.5	0.9	1.5	1.2	3.4	5.2	9.4	5.2	7.3	3.3	3.8	3.6	4.9	16.2	5.4	9.8	13.0	13.5	0.9	0.0	3.7	16.2	4.5	9.4	10.8	3.8	11.5	0.0	14.9	2.5	16.1	19.3	3.2	9.1	10.9	4.6	5.7	5.7	4.2	5.3	0.0	0.0	6.2	0.0	53.7	1.0	0.0	14.6	4.8	7.7	0.0	0.0	40.1	0.1	3.2	1.3	1.6	4.2	37.3	6.6	34.4	5.1	1.7	4.7	0.0	6.3	10.4	34.1	10.6	0.0	0.0	0.1	2.3	0.0	31.5	4.1	0.5	6.7	0.2	0.1	0.0	0.0	0.4	0.2	3.2	0.0	1.9	2.1	0.0	2.4	0.0	1.2	0.0	0.4	2.6	3.3	3.0	3.6	2.8	2.8	3.3	3.0	2.4	3.2	2.9	2.9	5.2	0.2	0.0	0.0	1.0	0.0	34.8	12.8	4.5	12.5	0.0	0.2	0.6	0.1	1.5	0.9	0.0	0.0	0.5	0.5	6.0	3.9	0.9	153.3	0.2	0.2	0.3	3.5	3.2	0.1	0.6	47.0	1.6	0.0	0.1	2.5	0.1	1.4	22.6	3.1	0.0	0.4	2.4	0.0	0.6	9.5	16.3	1.5	1.7	1.8	3.7	1.2	0.0	0.0	3.5	10.4	0.8	0.6	1.2	0.1	2.4	33.2	18.4	0.9	0.0	0.0	4.5	1.4	42.3	6.5	6.6	7.4	1.5	0.7	0.2	2.4	1.6
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 480.3;breast: 134.7;liver: 334.5;skin 1: 150.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Hepatocytes: 116.4;Late spermatids: 64.1;Spermatocytes: 53.9;Spermatogonia: 53.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"eosinophil: 137.7;neutrophil: 348.6"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 348.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 80.4;HDLM-2: 62.5;Hep G2: 64.9;OE19: 124.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 22.0"	HPA013351			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	480.3	5.1	5.5	19.5	10.5	7.3	134.7	3.4	6.1	1.5	5.1	9.1	14.7	1.2	1.8	24.3	2.1	5.9	10.1	5.8	5.8	3.4	334.5	5.6	4.0	6.5	4.9	6.3	1.8	4.6	2.1	1.6	1.5	5.0	2.2	5.0	0.6	10.6	1.6	4.1	150.7	16.6	2.8	3.5	15.2	12.9	38.4	6.3	4.3	8.9	5.7	18.3	21.5	12.7	6.2	13.3	6.4	0.4	11.2	80.4	6.4	1.0	1.3	1.7	1.6	1.0	46.6	13.5	21.1	16.8	0.3	11.9	0.5	1.8	6.5	4.4	62.5	1.2	1.5	4.0	64.9	0.9	7.4	7.2	26.8	33.6	7.3	10.6	4.4	1.2	20.9	1.2	27.6	0.7	8.5	5.1	16.7	3.6	124.0	31.5	0.0	0.1	24.8	1.2	35.8	22.6	1.4	12.3	1.9	2.9	2.7	4.4	26.6	1.6	14.1	7.0	0.3	9.1	16.3	40.0	28.8	10.2	23.7	25.3	19.4	22.1	137.7	0.0	4.4	0.4	7.4	0.4	0.0	6.1	7.6	0.1	0.2	348.6	0.0	5.0	1.8	0.0	5.7	5.5	10.5	3.4	6.1	5.8	5.8	6.5	4.9	6.3	5.0	3.5	6.3	6.2	3.2	6.4	5.4	0.3	5.0	1.1	0.9	3.0	0.6	0.9	5.2	7.0	3.5	0.0	2.7	0.0	2.1	0.5	0.3	0.6	0.0	1.7	259.3	3.3	0.2	0.5	1.2	2.7	2.9	0.5	0.1	0.7	10.7	0.2	0.0	2.1	2.9	116.4	2.2	1.7	1.3	4.8	0.0	4.1	13.1	64.1	2.1	4.2	1.8	0.0	4.0	0.4	0.0	0.0	1.0	3.7	2.2	0.7	0.9	2.8	1.2	2.2	3.4	0.0	6.6	0.6	1.0	53.9	53.5	0.3	8.0	0.8	0.5	0.2	3.0	15.7
DLK1	"Delta1, FA1, pG2, Pref-1, ZOG"	ENSG00000185559	"Delta like non-canonical Notch ligand 1"	P80370	14	100725705-100738224	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 1341.7;pituitary gland: 778.9;placenta: 1644.9"	"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 576.5;Fibroblasts: 699.3;Leydig cells: 1357.0;Skeletal myocytes: 2360.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.1;testis cancer: 25.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 119.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 120.0;Hep G2: 419.1;SH-SY5Y: 473.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 111.7"	"Group enriched"	"Detected in many"	5	"hypothalamus: 41.2;midbrain: 156.8"	"CAB005872, HPA062262"	Enhanced		Approved	"Golgi apparatus"		NA	NA		2600000	"Golgi apparatus"		"CAB005872: AB_731965, HPA062262: AB_2684729"	"unprognostic (2.16e-2)"			"prognostic unfavorable (2.31e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.89e-3)"	"unprognostic (5.75e-2)"		"unprognostic (1.87e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.24e-1)"		"unprognostic (3.11e-2)"	"unprognostic (6.57e-2)"			3.2	1341.7	7.4	6.1	2.0	0.1	7.1	0.1	12.4	6.2	0.2	0.2	1.8	0.7	0.2	2.6	3.1	2.3	23.5	0.5	119.2	0.6	1.8	0.9	0.5	16.0	38.8	0.2	279.6	21.4	0.0	778.9	1644.9	52.4	1.4	0.0	0.0	27.1	0.0	17.7	1.0	1.3	0.2	2.2	1.1	1.0	41.2	15.4	1.7	0.2	83.8	0.0	1.1	1.5	36.9	0.0	0.0	120.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	12.6	0.3	419.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.0	1.4	0.1	0.0	0.5	33.7	473.8	0.0	0.1	0.0	2.9	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.4	2.0	0.1	12.4	0.5	119.2	16.0	38.8	0.2	52.4	2.2	15.4	36.9	0.4	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	1.3	1.0	2.6	0.0	0.0	0.0	0.0	55.2	0.2	0.0	0.0	4.8	7.1	0.0	0.0	6.7	0.0	0.0	0.0	576.5	45.3	699.3	0.0	0.0	0.0	0.8	0.0	0.0	84.3	0.0	0.0	0.0	0.0	0.0	0.3	35.0	1357.0	4.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.0	0.0	172.6	0.0	1.3	0.0	0.2	0.0	0.0	59.2	2360.1	3.0	13.5	69.9	0.0	0.4	105.8	0.8	63.2	0.0	0.2
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 27.4;placenta: 73.2"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 1171.5;Distal tubular cells: 727.8;Syncytiotrophoblasts: 1735.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Hep G2: 372.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.1	0.0	4.1	0.0	2.9	0.0	0.2	1.7	3.8	0.0	1.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	4.0	2.0	27.4	1.1	0.0	0.0	2.2	2.5	3.1	0.8	0.5	0.7	0.0	73.2	2.6	0.1	0.0	0.0	0.6	0.3	0.0	0.1	0.1	0.0	1.8	0.0	0.0	1.6	2.7	0.0	0.0	0.0	0.0	0.7	0.1	2.9	1.6	0.8	0.1	32.6	0.0	0.0	10.3	0.1	0.0	0.0	0.0	6.5	2.0	0.0	15.8	0.0	1.2	7.5	39.9	1.0	0.0	1.1	7.3	0.0	3.0	372.7	0.0	0.0	5.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	9.7	0.0	0.0	2.1	0.1	0.8	1.1	1.8	14.8	0.0	0.0	0.0	0.1	9.4	0.4	1.2	2.3	2.8	1.6	0.9	0.6	3.9	0.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	2.9	1.7	3.8	4.0	2.0	2.2	2.5	3.1	2.6	1.8	2.7	2.9	0.0	0.0	0.0	3.6	0.5	0.6	1.0	0.6	2.8	0.0	0.2	3.4	2.3	1.5	0.0	11.0	0.0	1171.5	0.0	0.0	727.8	0.1	0.0	0.1	0.1	3.1	0.0	0.0	0.7	0.0	84.0	6.1	0.0	0.0	0.0	3.8	0.0	0.9	84.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	0.0	0.8	0.0	3.2	0.4	0.0	0.0	0.0	0.4	0.8	8.9	0.2	0.0	1735.1	0.2	10.8	0.1	1.1
ECHDC3	FLJ20909	ENSG00000134463	"Enoyl-CoA hydratase domain containing 3"	Q96DC8	10	11742366-11764070	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 162.9;skeletal muscle: 129.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 81.2;Distal tubular cells: 144.8;Hepatocytes: 152.0;Proximal tubular cells: 209.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 35.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"eosinophil: 15.4"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 15.4"	"Cell line enhanced"	"Detected in many"		"A-431: 52.9;BEWO: 28.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038306	Enhanced					NA	NA		120000			"HPA038306: AB_10672586"	"unprognostic (8.74e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-1)"	"prognostic favorable (3.43e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (3.91e-4)"	72.3	29.5	2.4	3.3	2.2	7.0	53.3	2.3	2.5	12.9	14.8	5.8	1.8	11.1	2.3	23.0	11.2	1.8	52.9	2.4	4.0	62.3	162.9	17.6	3.8	2.9	2.5	2.3	10.6	30.0	1.8	10.9	8.0	2.7	13.9	3.7	2.0	28.9	13.8	129.4	21.3	6.1	4.5	2.5	15.8	26.8	14.4	3.0	2.9	18.0	60.6	5.5	9.4	18.0	3.5	52.9	7.6	0.1	0.0	0.0	0.0	28.7	6.3	0.0	4.6	4.0	19.1	0.4	0.0	5.8	14.1	1.3	12.5	11.9	1.9	2.0	0.1	0.5	0.0	7.6	0.0	20.5	0.0	7.4	14.1	11.8	4.8	0.0	0.4	9.3	0.0	19.6	0.0	1.4	7.3	0.0	0.2	13.3	0.1	0.0	16.3	0.0	0.0	3.6	0.0	5.5	8.4	0.0	13.1	0.0	16.5	20.5	2.6	2.8	0.0	5.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	3.6	2.9	1.7	15.4	0.0	0.6	0.0	0.2	0.1	0.5	1.7	1.7	0.3	0.0	3.6	0.5	0.7	0.6	0.0	0.3	2.4	2.2	2.3	2.5	2.4	4.0	2.9	2.5	2.3	2.7	2.5	3.0	3.5	2.7	19.2	11.8	0.0	3.6	4.5	13.8	2.7	0.0	0.9	16.7	27.2	42.2	17.2	6.4	16.5	2.1	81.2	0.1	1.3	144.8	33.6	4.0	2.3	5.9	3.5	0.0	1.7	0.3	29.8	32.9	6.0	16.3	4.6	0.0	49.5	4.6	152.0	13.1	0.0	0.2	0.6	6.1	14.1	2.2	6.3	2.8	10.6	8.8	1.0	6.8	13.1	0.0	0.0	0.5	13.6	1.2	3.4	6.4	26.1	0.9	209.9	0.4	2.7	19.7	12.0	12.0	22.1	9.6	0.4	5.7	28.9	1.5	4.9	1.9	6.8
ERICH5	"C8orf47, FLJ39553"	ENSG00000177459	"Glutamate rich 5"	Q6P6B1	8	98064522-98093610	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 100.1;Ductal cells: 57.6;Endometrial ciliated cells: 27.8;Proximal tubular cells: 24.5;Respiratory ciliated cells: 39.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 23.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"myeloid DC: 2.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 2.2"	"Cell line enhanced"	"Detected in some"		"A549: 7.3;HAP1: 8.0;HEK 293: 11.5;JURKAT: 14.7;RPTEC TERT1: 7.5;RT4: 18.2"	"Not detected"	"Not detected"							"HPA025070, HPA025293, HPA027233"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA025070: AB_1845778, HPA025293: AB_1845779, HPA027233: AB_1845780"	"unprognostic (2.88e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.73e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (4.36e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.17e-2)"	"prognostic favorable (9.38e-4)"	0.2	0.1	1.3	0.3	2.2	0.0	1.0	0.8	1.3	2.5	1.0	1.9	5.3	1.4	0.6	0.7	11.2	12.4	2.9	1.0	2.0	5.6	10.3	1.0	1.0	1.6	1.7	0.9	0.9	34.4	2.2	1.3	0.2	1.8	2.7	3.3	2.3	1.3	2.4	0.0	0.7	1.5	0.5	1.1	0.2	12.7	2.4	3.4	0.7	0.7	0.0	0.7	1.9	0.5	1.7	0.0	7.3	0.0	0.0	0.1	0.0	4.7	4.6	1.8	2.3	1.8	0.1	2.4	0.0	6.0	1.2	3.6	0.4	8.0	0.2	2.8	0.0	11.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.3	0.0	14.7	0.0	0.0	0.1	0.2	0.0	0.8	1.6	0.2	2.8	0.0	0.0	0.2	7.5	18.2	4.1	0.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	2.2	0.8	1.3	1.0	2.0	1.6	1.7	0.9	1.8	1.1	3.4	1.7	0.0	3.2	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.2	2.1	1.3	8.0	100.1	3.1	7.3	0.0	0.3	0.0	1.6	0.0	57.6	0.3	27.8	0.6	0.8	18.0	0.0	1.1	18.4	1.8	0.2	7.7	7.7	0.0	4.3	0.4	2.6	0.1	0.0	1.6	2.4	0.0	0.3	0.0	0.0	0.3	0.7	0.0	0.0	0.1	8.0	0.0	0.5	0.1	14.8	1.6	0.0	0.0	2.5	0.7	24.5	39.4	0.1	0.0	0.2	1.0	0.2	4.7	1.1	0.0	0.1	0.2	0.7	3.6	2.6
ETFB		ENSG00000105379	"Electron transfer flavoprotein subunit beta"	P38117	19	51345169-51366388	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease variant, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 497.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1105.3;Proximal enterocytes: 710.7;Proximal tubular cells: 1118.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 53.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1693.9;OE19: 770.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria		NA	NA		170000	Mitochondria		"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favorable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	160.5	172.9	111.8	44.4	123.0	70.8	116.3	125.3	146.6	47.9	111.0	91.3	137.5	49.3	17.1	141.8	53.8	63.3	319.9	104.2	111.7	143.3	497.6	50.8	58.6	121.4	116.1	102.8	55.7	82.6	107.3	73.7	39.4	121.9	55.7	41.6	24.3	173.7	38.2	283.4	78.0	130.8	32.0	112.6	65.1	90.7	54.1	121.6	82.2	70.9	282.8	37.2	66.2	69.6	128.3	118.9	304.3	41.3	113.9	129.4	150.4	65.6	82.4	61.0	63.5	63.1	257.3	192.1	121.5	80.2	129.8	33.8	104.0	83.3	171.1	19.2	182.0	323.3	98.1	188.9	1693.9	141.8	92.1	67.6	235.3	50.3	86.1	88.2	79.2	54.9	115.0	146.6	130.2	83.2	243.7	95.2	86.2	26.7	770.2	372.0	104.5	114.4	224.6	88.5	135.7	91.7	44.5	184.5	49.9	94.4	29.4	130.3	86.3	77.8	65.9	67.6	71.4	73.3	195.8	130.0	109.8	335.0	135.1	172.5	127.7	190.1	119.6	104.3	212.3	137.4	281.6	156.0	134.2	225.3	303.1	163.6	136.0	97.8	205.3	165.7	265.1	225.7	140.5	111.8	123.0	125.3	146.6	104.2	111.7	121.4	116.1	102.8	121.9	112.6	121.6	128.3	90.9	80.1	93.8	15.3	75.6	65.0	114.9	196.4	55.2	77.1	129.9	170.1	243.8	234.4	122.5	121.4	31.3	240.7	58.7	440.9	571.3	188.0	139.2	67.5	70.2	76.2	168.4	120.0	4.1	140.5	206.6	93.8	128.9	48.2	88.8	63.2	144.9	1105.3	217.5	43.7	4.2	335.2	158.7	147.7	73.4	354.4	107.5	86.9	286.4	5.6	95.2	158.8	50.4	7.1	18.9	155.4	339.4	114.3	69.9	74.9	710.7	1118.7	118.8	67.9	98.6	87.4	144.5	71.0	52.8	135.3	63.6	160.1	74.0	217.3	354.4	140.3
ETNK2	"EKI2, FLJ10761"	ENSG00000143845	"Ethanolamine kinase 2"	Q9NVF9	1	204131062-204152044	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 109.1;liver: 237.4;testis: 126.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 417.0;Late spermatids: 1337.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 53.8;MCF7: 55.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 22.6"	HPA057167	Enhanced					NA	NA					"HPA057167: AB_2683358"	"unprognostic (1.64e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.56e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.28e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.35e-2)"	"prognostic favorable (6.50e-4)"	"unprognostic (5.50e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.20e-1)"	12.4	6.1	12.1	2.1	11.4	2.8	17.5	7.6	12.1	16.4	24.3	5.0	1.9	10.9	30.2	24.1	13.2	5.3	5.5	9.8	11.5	109.1	237.4	3.3	2.1	10.2	11.6	10.1	36.4	9.6	18.7	25.8	4.3	10.5	13.8	2.1	5.8	28.0	16.3	2.0	19.3	3.8	6.5	7.2	7.2	4.9	126.0	11.8	3.7	10.7	4.2	9.4	10.1	26.2	7.6	11.3	3.8	11.0	20.9	4.0	1.3	10.9	11.4	25.2	15.6	6.8	19.2	5.4	0.4	18.4	2.8	18.2	9.9	19.7	15.9	10.7	0.4	17.3	0.2	2.5	30.6	16.2	0.5	0.7	5.4	53.8	3.2	0.7	8.0	11.1	11.9	1.6	0.4	2.0	55.1	3.2	0.3	23.0	0.4	8.4	0.8	13.0	0.4	13.4	4.3	2.9	15.4	7.2	33.6	5.4	35.1	32.5	0.7	0.7	4.4	23.8	1.0	8.4	0.5	0.2	0.5	0.3	0.6	6.3	0.0	0.1	0.0	2.2	0.0	2.1	0.0	0.5	1.3	0.0	0.1	1.3	1.6	0.1	0.8	0.0	0.0	0.3	0.6	12.1	11.4	7.6	12.1	9.8	11.5	10.2	11.6	10.1	10.5	7.2	11.8	7.6	1.3	0.0	0.0	1.3	1.0	4.1	13.8	8.2	1.8	4.2	12.3	11.6	1.1	4.3	2.5	3.7	4.2	6.1	1.6	0.1	39.2	9.5	417.0	4.5	1.9	2.1	1.2	13.5	1.2	6.3	9.2	6.4	1.1	3.2	8.9	47.4	6.8	196.9	0.8	0.0	2.9	0.1	2.0	6.5	1.1	1337.3	29.2	1.6	10.6	0.0	0.0	3.8	1.0	2.5	0.2	4.5	0.0	42.2	0.0	14.9	0.3	147.2	3.1	0.8	0.0	4.1	4.4	11.0	7.4	16.1	2.4	9.4	2.9	34.1	0.2	13.5
EXOC3L4	C14orf73	ENSG00000205436	"Exocyst complex component 3 like 4"	Q17RC7	14	103100144-103110559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 19.3;liver: 41.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 8.6;Gastric mucus-secreting cells: 21.9;Hepatocytes: 25.1;Proximal enterocytes: 30.2;Proximal tubular cells: 12.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.4;HEL: 3.8;Hep G2: 2.7;RPMI-8226: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043661	Approved					NA	NA					"HPA043661: AB_10965693"	"unprognostic (8.71e-2)"	"unprognostic (7.42e-3)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.12e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.81e-4)"	0.6	0.3	0.0	2.8	0.0	0.2	0.2	0.0	0.1	0.5	0.1	1.8	19.3	0.2	0.0	0.5	0.4	3.1	0.8	0.0	0.0	3.8	41.4	1.8	6.5	0.0	0.0	0.0	0.3	1.6	0.0	0.2	0.9	0.0	1.3	1.4	0.0	0.7	0.3	0.3	0.1	9.8	0.2	0.0	5.1	4.6	0.2	0.0	3.8	0.3	0.0	2.9	0.8	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	3.8	0.0	2.7	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.2	1.3	0.0	0.0	0.2	0.1	1.1	8.6	0.6	0.0	0.0	0.0	0.0	6.3	0.0	2.3	0.1	0.3	0.2	0.3	1.2	0.0	0.0	4.1	3.2	2.2	21.9	0.3	0.0	0.8	0.4	25.1	0.2	0.0	0.0	5.3	0.0	0.8	0.3	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.6	1.5	2.1	0.2	30.2	12.3	1.5	0.0	0.0	6.4	0.8	0.1	2.0	0.0	0.4	0.3	0.2	2.2	5.1	0.7
FADS6		ENSG00000172782	"Fatty acid desaturase 6"		17	74877302-74893781	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"brain: 10.9;epididymis: 18.3;intestine: 14.9"	"Cell type enriched"	"Detected in some"	13	"Proximal enterocytes: 72.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016802	Uncertain					NA	NA					"HPA016802: AB_2669448"	"unprognostic (2.41e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.98e-4)"	"unprognostic (3.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.79e-1)"	0.2	7.1	3.2	0.5	3.5	1.5	0.5	5.4	9.0	0.2	0.0	0.6	7.6	0.2	18.3	3.2	0.1	0.0	0.2	2.1	2.3	1.1	6.2	0.2	0.6	8.8	2.5	3.5	0.3	0.4	0.6	0.1	0.2	10.9	0.1	0.7	1.2	0.3	0.3	0.5	7.5	14.9	0.2	0.8	4.2	0.2	0.7	6.4	0.4	0.4	0.2	0.8	1.2	1.1	10.7	0.2	0.3	0.5	0.4	0.0	1.0	0.7	0.5	0.0	0.1	0.2	0.8	0.3	0.3	0.1	0.5	0.3	0.3	0.7	0.0	0.2	0.1	0.0	0.5	1.6	0.6	0.3	0.4	0.4	0.3	0.0	1.1	0.4	0.2	0.0	0.4	0.4	1.4	0.6	0.6	0.3	1.1	0.3	0.2	0.5	0.2	0.1	0.5	0.3	0.3	0.4	0.4	0.5	0.2	0.1	0.5	0.2	0.5	0.3	0.3	0.7	0.6	0.5	0.5	0.2	0.3	1.0	0.3	0.5	1.1	0.6	0.4	0.2	0.6	0.2	0.3	0.3	0.3	0.1	0.5	0.3	0.4	2.0	0.8	1.5	0.5	0.2	0.0	3.2	3.5	5.4	9.0	2.1	2.3	8.8	2.5	3.5	10.9	0.8	6.4	10.7	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	1.8	1.5	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.0	3.7	0.0	0.0	0.8	0.0	0.1	0.3	0.0	0.0	5.2	0.2	0.1	0.3	0.0	0.2	0.0	1.1	0.4	4.0	0.3	1.7	5.4	1.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.2	0.0	5.1	0.0	0.0	1.1	72.2	1.9	0.0	0.5	0.0	1.1	0.4	0.0	2.0	1.7	0.6	3.8	0.2	0.4	0.7	1.3
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 304.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 266.8;Proximal tubular cells: 305.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 23.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041370, HPA044093"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000000	Cytosol	Nucleoplasm	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	100.0	66.0	13.9	7.1	14.2	20.2	59.5	14.8	21.3	18.4	12.9	13.9	14.7	19.4	50.8	15.4	23.2	9.8	19.0	14.2	15.7	65.7	304.0	20.2	5.8	15.6	16.2	12.2	26.6	10.0	18.5	16.9	7.8	14.8	16.8	12.0	1.7	14.9	13.7	31.3	10.7	17.0	13.6	14.8	19.3	14.3	21.0	15.1	6.8	14.7	28.0	5.9	16.6	15.9	15.5	20.1	34.4	13.5	17.0	60.2	62.2	32.9	24.3	56.8	26.2	22.3	22.0	35.9	0.4	39.0	52.6	36.8	29.1	46.8	59.6	25.1	12.5	28.5	166.6	18.0	112.1	316.6	79.6	88.8	107.5	37.1	22.9	39.7	84.2	37.4	38.3	71.1	35.7	50.3	31.0	22.3	42.0	9.9	15.5	37.6	12.2	19.3	123.4	77.0	25.2	0.7	8.3	27.4	76.7	77.9	21.6	58.3	55.0	126.1	46.8	30.0	25.5	42.7	32.7	69.5	13.8	99.6	187.5	26.9	34.5	18.8	3.3	9.6	8.1	2.3	0.1	2.4	6.0	25.3	0.1	3.1	2.7	1.3	5.7	8.4	1.9	2.5	9.7	13.9	14.2	14.8	21.3	14.2	15.7	15.6	16.2	12.2	14.8	14.8	15.1	15.5	3.0	3.2	13.8	9.8	4.1	6.8	17.5	30.8	15.4	0.4	19.1	13.7	15.5	21.5	12.5	33.1	0.0	37.9	4.9	9.3	52.8	9.3	7.5	3.0	16.2	3.2	4.2	24.4	0.4	3.5	14.1	16.6	3.6	4.0	41.9	6.3	8.9	266.8	72.5	0.0	2.5	13.0	24.4	21.4	6.6	13.5	9.9	30.5	19.6	1.0	5.7	7.3	3.1	2.5	0.6	4.5	12.8	7.9	5.2	9.7	54.1	305.5	5.3	0.4	0.0	9.2	11.2	1.5	2.1	18.2	5.7	22.0	7.7	8.7	22.4	16.4
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086905-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 83.2;lung: 66.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Hepatocytes: 31.2;Skeletal myocytes: 141.2;Theca cells: 36.7;Undifferentiated cells: 38.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 42.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CACO-2: 173.9;Hep G2: 176.4;RH-30: 274.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	NA	NA		7400000			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	0.8	14.1	1.3	4.1	1.1	0.5	4.6	2.6	2.2	2.8	1.0	13.1	21.5	2.4	0.2	3.2	4.2	10.3	2.0	1.4	1.0	39.7	83.2	66.0	0.8	1.1	0.9	1.0	27.7	29.7	0.2	2.0	2.1	1.3	5.3	6.1	1.5	1.1	0.7	6.6	1.6	20.1	1.1	0.7	22.9	8.9	6.0	0.9	0.2	0.9	1.9	0.2	6.4	3.3	1.3	3.2	48.8	1.0	11.7	0.1	0.1	24.5	0.2	0.1	0.2	0.3	173.9	6.5	5.3	23.0	0.1	2.4	2.8	9.5	1.8	0.1	3.2	13.8	0.5	2.8	176.4	5.2	0.6	4.7	1.1	0.2	8.4	0.2	0.3	0.2	3.5	18.1	0.7	3.9	40.3	0.1	3.6	29.2	30.9	4.5	8.2	274.3	30.9	22.9	0.4	1.8	2.9	1.8	12.4	5.9	5.9	11.7	2.5	1.1	0.0	23.4	0.3	0.7	1.6	1.9	3.7	0.1	1.1	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.3	1.1	2.6	2.2	1.4	1.0	1.1	0.9	1.0	1.3	0.7	0.9	1.3	0.3	0.0	0.0	0.3	0.3	0.6	0.7	0.4	0.0	0.9	2.9	2.0	0.9	78.6	0.1	3.7	0.0	1.3	0.1	12.9	3.9	10.9	0.1	1.6	0.3	0.7	4.2	0.0	0.5	4.9	3.8	9.6	9.7	2.9	0.0	0.7	3.9	31.2	0.3	0.0	0.5	10.1	0.0	0.9	0.5	0.0	0.6	0.7	0.0	1.9	0.6	0.6	0.0	0.5	0.1	3.0	4.4	1.5	0.1	1.7	15.9	21.6	0.1	0.4	19.7	141.2	0.7	3.0	9.9	0.8	0.4	8.8	0.4	36.7	38.6	0.5
FGGY	FLJ10986	ENSG00000172456	"FGGY carbohydrate kinase domain containing"	Q96C11	1	59296638-59810647	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 77.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 191.7;Cholangiocytes: 343.1;Hepatocytes: 142.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.9;RH-30: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054971, HPA075137"			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		220000	Nucleoplasm	"Nuclear bodies"	"HPA054971: , HPA075137: "	"unprognostic (4.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.80e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.36e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.78e-1)"	4.2	14.7	10.1	2.0	10.7	2.3	6.6	20.9	8.7	6.3	3.7	7.2	7.2	4.8	36.9	5.5	10.0	5.5	11.5	6.0	10.2	19.3	77.7	4.7	3.4	11.8	11.2	5.1	4.9	12.1	10.6	9.8	3.1	11.4	7.9	6.7	9.7	7.5	10.4	42.2	5.2	8.1	4.2	8.4	2.8	6.2	4.3	12.4	4.2	7.7	17.3	3.6	7.0	5.2	11.7	4.8	1.4	9.2	3.9	4.7	16.6	0.8	4.1	6.8	2.3	3.4	0.0	3.8	5.4	13.0	11.0	4.1	2.0	1.6	11.9	4.9	42.9	1.1	3.8	2.9	8.6	12.3	2.3	2.4	23.2	10.2	5.0	7.9	10.0	4.6	6.0	2.7	3.4	15.3	5.2	3.0	3.2	5.8	13.0	5.3	6.5	28.3	2.1	12.9	8.8	7.2	3.2	5.6	3.3	12.0	8.0	2.8	2.3	4.7	4.0	2.6	4.7	2.8	7.5	2.9	4.6	12.9	9.2	3.8	1.5	1.3	1.4	3.0	1.3	2.7	5.1	1.4	3.8	2.2	3.6	2.7	4.3	2.2	2.9	3.4	1.1	2.8	1.8	10.1	10.7	20.9	8.7	6.0	10.2	11.8	11.2	5.1	11.4	8.4	12.4	11.7	3.7	54.5	191.7	83.2	7.9	20.9	23.8	45.2	14.2	10.1	33.1	66.9	29.9	343.1	40.4	12.9	12.5	9.3	3.7	4.2	17.6	62.6	14.0	33.2	7.5	6.9	2.4	12.2	20.4	42.5	4.5	7.6	7.1	20.4	10.1	5.3	5.3	142.3	11.4	8.4	33.7	11.3	22.4	8.8	7.6	11.4	1.8	6.7	35.6	17.8	11.2	12.2	3.1	39.2	36.0	17.7	7.7	3.0	3.4	19.1	14.9	47.9	91.2	16.4	0.0	31.4	8.9	4.6	11.5	13.5	31.5	4.5	5.1	5.9	17.1	35.5
FST	FS	ENSG00000134363	Follistatin	P19883	5	53480626-53487134	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 69.2"	"Cell type enriched"	"Detected in many"	6	"Granulosa cells: 700.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 45.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 351.1;HaCaT: 292.3;HBEC3-KT: 191.3;HMC-1: 206.5;PC-3: 558.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA016612, CAB026025"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA		1800000	Vesicles		"CAB026025: , HPA016612: "	"unprognostic (1.43e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (4.44e-5)"	"unprognostic (1.21e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-1)"	21.9	6.3	0.8	3.0	0.7	0.4	15.3	0.4	0.8	6.2	0.7	8.4	1.8	4.3	3.7	6.6	11.9	7.2	7.7	1.9	1.5	2.8	69.2	8.3	1.6	1.9	1.0	0.7	10.0	2.6	0.5	5.9	24.3	1.0	15.7	3.0	0.3	11.4	10.9	9.2	17.5	8.8	4.8	0.6	0.3	11.2	5.0	1.1	2.3	4.1	7.8	13.0	40.8	7.6	0.9	20.0	1.8	33.7	0.0	38.6	13.5	55.4	76.3	351.1	46.4	45.4	0.3	0.2	0.0	0.6	19.9	2.3	292.3	0.0	191.3	32.7	0.8	0.2	4.0	1.7	31.3	20.4	0.3	206.5	31.0	0.5	84.5	55.0	31.3	40.0	0.0	0.0	0.6	29.7	0.1	0.1	1.6	52.1	0.0	558.2	4.2	43.6	0.0	0.0	31.9	0.5	0.1	3.1	0.2	2.0	83.9	0.3	0.3	0.2	124.1	35.3	13.2	11.1	0.4	0.1	0.1	14.8	4.1	116.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.7	0.4	0.8	1.9	1.5	1.9	1.0	0.7	1.0	0.6	1.1	0.9	5.2	0.0	1.1	0.0	1.0	20.0	31.5	64.4	13.1	0.0	0.9	23.4	11.4	0.0	8.3	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.4	0.1	3.4	2.9	0.0	0.0	0.1	4.6	14.8	107.7	3.6	0.1	0.0	700.1	1.1	57.2	1.8	0.0	0.7	0.0	2.0	0.8	16.4	1.5	3.1	1.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	11.3	0.2	37.1	0.0	0.1	1.6	0.0	13.1	29.6	33.3	0.3	12.2	4.0	4.7	6.0	2.0	0.3	0.0	51.8
GALK1	GALK	ENSG00000108479	"Galactokinase 1"	P51570	17	75751594-75765236	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Kinase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 127.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 100.1;Hepatocytes: 116.7;Proximal enterocytes: 139.4;Proximal tubular cells: 122.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 42.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007094, HPA016960"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA		57000	Cytosol	"Golgi apparatus"	"HPA007094: AB_1078939, HPA016960: AB_1849430"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.62e-5)"	17.8	12.6	4.5	7.9	5.1	5.7	17.3	5.1	8.5	17.6	4.7	12.2	20.8	16.7	1.0	24.6	15.1	4.3	17.4	4.4	5.5	31.8	127.4	18.9	7.5	6.4	4.8	4.0	13.8	31.5	10.7	5.7	5.9	5.7	13.4	2.0	0.7	20.2	5.7	8.7	20.5	18.4	3.9	5.7	24.7	17.7	16.1	5.5	6.2	11.7	3.6	3.4	13.1	17.9	6.8	20.4	65.2	4.9	20.7	6.8	16.6	16.7	16.9	14.3	16.8	15.8	35.4	4.2	31.2	19.5	9.3	12.6	11.9	5.0	4.4	1.9	14.2	39.3	20.1	25.1	62.4	22.1	13.0	41.9	15.3	6.9	8.5	3.5	8.5	39.1	16.9	15.9	21.2	11.7	77.3	38.6	44.7	4.7	9.8	32.3	43.6	50.1	50.9	9.8	7.3	9.9	26.1	14.6	35.8	35.0	3.8	29.8	20.9	33.4	24.3	22.3	21.7	14.6	44.4	12.4	8.2	26.7	30.3	18.3	7.2	77.2	23.0	23.0	67.8	20.8	27.7	18.5	21.2	70.1	18.9	10.0	14.5	53.1	16.2	55.6	93.3	23.6	40.8	4.5	5.1	5.1	8.5	4.4	5.5	6.4	4.8	4.0	5.7	5.7	5.5	6.8	42.1	16.0	12.9	3.3	17.7	8.7	10.0	4.4	7.4	7.3	22.4	20.6	22.6	22.8	10.6	12.9	0.0	48.4	16.3	8.4	68.4	28.5	1.3	4.9	24.5	23.5	8.4	9.0	1.5	55.2	100.1	25.3	10.2	8.6	27.9	16.6	29.3	116.7	56.1	3.3	1.7	20.9	22.4	49.0	25.2	5.6	31.1	33.3	39.2	0.0	42.3	19.2	20.6	2.5	1.6	19.3	49.6	24.0	29.1	5.7	139.4	122.0	4.0	6.1	6.6	19.2	20.8	1.7	22.1	16.6	12.5	42.3	14.9	6.1	28.2	9.2
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625509-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 40.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 39.8;Excitatory neurons: 114.9;Inhibitory neurons: 141.9;Oligodendrocytes: 83.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Hep G2: 43.2;JURKAT: 24.0;Karpas-707: 85.2;SCLC-21H: 24.8;U-266/84: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		Yes	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: AB_2683850"	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favorable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.4	0.8	3.8	0.3	1.8	0.2	0.8	4.4	5.4	0.9	0.0	0.6	1.8	0.8	0.0	0.8	1.2	1.6	3.5	0.7	1.7	5.4	40.0	1.0	1.0	6.4	5.9	1.0	2.0	9.7	0.1	2.5	0.4	6.5	1.0	0.5	2.2	1.5	0.6	4.7	0.8	1.7	0.3	5.0	1.4	2.6	0.9	7.7	8.3	0.8	1.8	0.7	1.0	0.7	6.6	0.0	0.1	1.7	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.7	0.4	0.2	0.0	43.2	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.3	0.0	24.0	1.6	85.2	0.0	0.4	0.3	0.1	0.3	2.4	0.0	0.9	0.5	4.4	0.0	1.1	24.8	1.3	0.0	0.0	0.5	0.2	0.1	0.0	1.8	0.0	0.4	1.1	0.0	1.1	30.7	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	1.8	4.4	5.4	0.7	1.7	6.4	5.9	1.0	6.5	5.0	7.7	6.6	0.1	0.0	0.0	39.8	0.4	0.1	0.4	0.1	0.6	1.9	0.4	0.1	12.7	10.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	2.3	1.3	0.1	0.4	0.0	0.0	114.9	3.3	0.0	1.0	3.1	0.7	0.0	0.2	0.7	22.9	0.0	0.0	141.9	0.6	0.0	0.0	0.0	5.4	0.6	0.0	0.0	9.4	0.2	0.2	0.0	18.6	83.9	1.6	1.4	0.0	0.5	0.1	0.1	3.2	4.0	1.2	0.0	0.3	0.8	0.4	1.1	0.6	0.0	0.0	0.4	0.1	0.9	0.3
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"kidney: 2119.1;liver: 2827.1;pancreas: 2960.4"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 1495.2;Proximal tubular cells: 3703.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	5	"B-cells: 11.0;dendritic cells: 6.8"	"Group enriched"	"Detected in many"	4	"RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria		NA	NA		600000	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	14.6	21.6	146.8	12.5	149.1	1.8	25.7	166.1	218.4	10.0	112.0	16.7	177.1	8.5	10.6	25.3	11.7	48.2	57.8	144.0	163.3	2119.1	2827.1	7.4	18.6	160.5	148.2	131.6	166.7	2960.4	2.8	8.4	75.4	170.5	12.5	11.6	7.6	58.0	15.3	143.9	138.7	111.1	14.6	164.7	33.9	100.1	78.9	156.2	12.7	63.6	47.3	29.9	18.2	15.6	194.5	12.9	6.5	4.4	0.6	0.1	0.2	0.8	0.1	0.1	0.0	0.2	1.4	21.4	34.4	1.0	0.0	5.7	2.2	17.0	0.6	0.4	1.9	0.3	2.8	0.4	0.3	0.8	20.7	2.6	0.8	0.7	0.0	0.4	0.0	0.3	7.8	0.4	0.7	0.2	0.6	2.2	0.6	11.2	31.3	0.0	0.5	210.1	1.5	3.5	55.8	23.5	4.1	6.9	0.4	1.2	2.1	2.9	23.7	0.0	0.0	0.5	0.2	6.3	126.3	165.5	0.8	1.6	0.3	1.0	0.0	1.1	0.3	0.2	1.6	0.0	11.0	0.0	0.2	6.6	5.4	0.0	1.4	0.0	0.1	0.6	6.8	0.0	1.0	146.8	149.1	166.1	218.4	144.0	163.3	160.5	148.2	131.6	170.5	164.7	156.2	194.5	2.4	3.2	1.1	67.3	42.3	54.3	14.9	5.2	5.7	8.1	16.9	9.5	35.5	228.8	5.4	71.7	0.0	1.0	0.8	3.1	295.4	58.2	8.8	1.3	0.4	7.3	0.0	29.3	6.8	290.0	1.2	19.8	69.8	2.7	3.8	219.5	23.9	1495.2	89.6	8.4	3.3	3.1	2.0	80.3	80.3	18.3	4.4	50.6	23.2	20.6	3.1	19.1	2.1	57.3	196.3	97.3	3.9	3.4	7.2	6.4	98.4	3703.0	1.9	3.8	6.6	38.4	16.8	22.0	9.7	16.0	133.7	1.8	17.6	4.1	3.4	20.4
GCK	"HK4, MODY2"	ENSG00000106633	Glucokinase	P35557	7	44143213-44198170	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.7;liver: 21.7;pituitary gland: 24.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Cardiomyocytes: 4.9;Fibroblasts: 5.2;Horizontal cells: 5.0;Smooth muscle cells: 3.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.3;naive CD4 T-cell: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 6.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007034, HPA007093"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA007034: AB_1079050, HPA007093: AB_1079051"	"unprognostic (3.09e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.64e-7)"	"unprognostic (8.00e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.11e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.53e-1)"	0.8	0.3	8.6	0.3	7.9	0.2	0.7	7.8	9.6	2.7	7.0	0.5	0.1	1.2	0.8	0.4	1.2	0.5	5.3	7.9	9.8	0.5	21.7	0.4	0.2	8.4	9.4	7.8	1.5	1.8	0.1	24.1	1.6	8.7	1.2	0.2	1.0	0.3	0.7	0.2	0.7	0.5	0.3	7.7	0.6	0.6	0.4	10.7	0.1	0.5	0.1	0.2	1.1	2.0	8.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.5	0.0	0.7	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.2	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.3	2.3	0.7	0.1	0.1	0.3	2.0	0.4	0.8	0.1	0.0	0.1	0.0	0.3	8.6	7.9	7.8	9.6	7.9	9.8	8.4	9.4	7.8	8.7	7.7	10.7	8.7	0.3	0.0	0.0	0.7	0.3	1.1	0.7	0.0	1.2	5.0	0.1	0.8	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.5	2.4	0.0	1.8	0.0	0.2	5.2	0.0	0.0	0.0	2.4	0.0	0.4	0.7	5.0	2.4	0.0	0.0	0.0	0.7	0.3	0.9	0.1	0.0	1.0	0.0	2.8	0.0	0.5	1.0	0.1	0.1	2.2	0.2	1.7	0.0	0.1	0.0	0.8	0.0	0.6	3.7	0.5	1.1	0.0	0.1	0.8	0.3	0.5	0.0	0.7
GHRHR		ENSG00000106128	"Growth hormone releasing hormone receptor"	Q02643	7	30938669-30993254	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	351	"pituitary gland: 213.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.5;Spermatocytes: 1.2;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (8.32e-2)"		"unprognostic (1.45e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.39e-1)"		"unprognostic (7.23e-2)"	"unprognostic (4.15e-1)"		"unprognostic (2.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.87e-3)"		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	213.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.1	1.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJB1	"CMTX, CMTX1, CX32"	ENSG00000169562	"Gap junction protein beta 1"	P08034	X	71212811-71225516	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 101.7;liver: 338.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 114.4;Hepatocytes: 286.4;Proximal enterocytes: 118.8;Proximal tubular cells: 68.9;Undifferentiated cells: 66.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 163.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 143.2;SK-MEL-30: 155.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012994	Uncertain					NA	NA					"CAB012994: AB_2533228"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.85e-6)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.97e-2)"	0.1	0.0	32.6	3.7	58.9	0.0	6.5	74.0	43.0	8.8	15.4	34.2	44.4	1.7	22.7	0.3	27.7	41.9	0.0	28.2	45.8	43.3	338.4	2.5	0.0	75.6	66.8	22.2	0.1	83.7	0.0	0.1	0.0	69.8	11.7	24.0	0.0	38.0	7.6	0.0	0.9	34.7	1.8	63.2	0.1	16.5	10.3	56.8	0.0	0.1	0.1	0.0	0.4	0.1	101.7	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.5	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.3	0.0	5.1	0.2	0.0	0.2	0.0	0.0	155.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	32.6	58.9	74.0	43.0	28.2	45.8	75.6	66.8	22.2	69.8	63.2	56.8	101.7	0.0	0.0	4.8	0.3	0.8	0.6	0.7	0.5	0.0	0.0	7.7	2.4	0.1	114.4	2.7	9.2	0.0	0.0	0.1	50.2	9.8	34.1	0.3	8.2	3.4	0.6	9.6	8.0	0.2	58.9	0.0	0.1	15.8	29.0	4.5	0.0	3.3	286.4	0.0	0.0	0.2	29.4	2.0	4.8	0.4	0.4	0.3	0.8	23.2	0.0	0.6	0.0	0.0	1.0	51.3	32.3	53.4	0.4	0.0	2.6	118.8	68.9	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	1.0	0.0	66.1	2.8
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182378098-182392206	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1455.4"	"Group enriched"	"Detected in all"	4	"Late spermatids: 8544.2;Muller glia cells: 6247.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 365.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 656.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 656.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1150.8;ASC TERT1: 807.6;HSkMC: 702.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	"Plasma membrane,Mitochondria,Cytosol"		NA	NA		150000	"Mitochondria, Cytosol"	"Plasma membrane"	"CAB008636: AB_1616669, HPA007316: AB_888438, HPA007571: AB_1078980"	"prognostic favorable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	760.3	76.7	757.6	158.3	794.5	235.0	578.3	775.1	1074.3	162.8	663.1	154.0	24.6	117.7	116.7	220.7	226.2	106.3	119.9	740.8	848.8	65.3	283.0	223.6	75.9	929.5	841.8	735.1	305.6	206.4	32.6	71.1	178.0	842.4	104.3	93.4	898.9	235.4	96.9	1455.4	219.7	149.5	125.2	771.6	218.1	653.5	87.9	829.5	97.8	259.8	476.2	104.1	187.0	294.5	880.0	26.4	10.8	117.2	0.2	1150.8	807.6	86.0	44.1	141.7	25.9	23.4	64.1	26.7	22.4	46.3	85.5	23.8	59.3	51.8	309.4	21.5	61.2	143.3	296.5	47.6	124.8	61.1	132.6	227.2	702.1	363.3	32.9	384.6	39.1	52.8	71.7	254.3	13.3	92.6	15.0	208.2	126.5	87.3	36.8	55.0	74.3	31.3	38.6	45.8	114.0	79.7	52.5	12.4	157.3	17.4	93.3	153.1	165.9	39.7	0.9	1.9	0.8	10.1	4.8	3.4	0.4	22.3	73.9	5.0	396.5	153.4	409.4	42.3	145.8	17.6	11.5	29.9	35.5	80.0	17.8	15.3	25.3	656.8	27.2	130.5	43.7	13.0	172.0	757.6	794.5	775.1	1074.3	740.8	848.8	929.5	841.8	735.1	842.4	771.6	829.5	880.0	127.8	125.0	173.8	599.4	37.6	134.7	533.8	1190.7	260.0	105.6	166.6	99.1	216.2	171.6	855.3	82.8	52.1	161.7	113.4	118.3	74.3	124.2	1491.3	140.2	150.0	191.5	325.9	319.7	3.4	116.6	65.9	404.4	388.4	124.6	786.3	88.0	152.8	597.1	798.0	43.7	22.0	256.7	451.6	907.2	614.1	8544.2	487.4	687.4	136.9	74.9	112.7	6247.0	42.2	38.2	330.0	108.1	105.3	375.0	38.7	421.0	10.3	46.6	569.9	176.0	92.1	481.5	218.5	48.2	63.6	186.5	128.3	235.3	108.6	53.3	173.3	1420.5
GPD1		ENSG00000167588	"Glycerol-3-phosphate dehydrogenase 1"	P21695	12	50103982-50111313	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 615.3;skeletal muscle: 582.7"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 99.1;Proximal enterocytes: 247.0;Proximal tubular cells: 298.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC diff: 134.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044620, HPA058621"	Enhanced					NA	NA		4700000			"HPA044620: AB_10796803, HPA058621: "	"unprognostic (2.65e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	615.3	4.7	10.8	1.6	17.2	0.2	231.1	24.4	11.4	0.3	6.9	6.5	77.1	0.2	5.3	4.9	0.5	16.7	9.0	11.7	17.4	150.7	148.8	18.6	1.0	30.5	19.9	8.5	0.3	7.3	13.1	1.3	0.0	25.7	1.3	3.3	1.0	33.2	1.4	582.7	10.0	77.5	1.3	36.7	0.4	3.3	0.8	19.5	1.5	2.8	217.6	0.4	4.2	1.0	55.1	0.1	0.2	0.1	0.1	134.0	0.0	0.3	0.1	0.0	0.0	0.0	27.0	0.1	0.4	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.6	0.1	0.6	25.2	0.0	0.2	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.7	0.7	0.3	0.0	0.2	0.1	0.4	0.1	3.7	0.0	0.2	0.2	30.2	0.2	0.0	0.6	0.2	0.0	1.5	1.0	0.0	1.8	0.0	0.0	0.0	0.3	0.2	0.1	0.6	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	17.2	24.4	11.4	11.7	17.4	30.5	19.9	8.5	25.7	36.7	19.5	55.1	3.4	3.2	3.2	0.0	2.4	0.0	0.2	0.3	0.6	3.2	3.4	3.7	5.8	11.5	1.8	5.5	8.4	0.0	0.0	3.0	43.0	0.9	0.1	0.5	0.1	0.2	1.2	5.3	0.2	0.7	0.0	0.8	4.1	0.2	0.0	0.1	1.1	99.1	2.3	3.3	0.2	9.7	0.0	1.0	0.4	0.0	0.0	5.2	1.8	0.0	1.0	2.8	0.0	0.0	4.0	0.6	8.0	0.0	0.0	0.1	247.0	298.4	0.4	1.7	0.0	7.0	1.1	0.0	0.0	0.8	0.4	0.0	1.2	0.0	10.6	0.2
GRB14		ENSG00000115290	"Growth factor receptor bound protein 14"	Q14449	2	164492417-164621482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 12.7;tongue: 20.5"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 92.0;Granulosa cells: 272.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.5;HUVEC TERT2: 9.6;RPTEC TERT1: 9.1;TIME: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022294, HPA035052, HPA035053"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB022294: , HPA035052: , HPA035053: AB_2674432"	"unprognostic (2.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.74e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.47e-2)"	"unprognostic (8.33e-5)"	"unprognostic (5.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.33e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.10e-2)"	"unprognostic (5.19e-2)"	"unprognostic (9.27e-2)"	0.7	3.0	0.2	0.3	0.5	0.0	0.3	0.0	0.8	0.2	0.2	0.6	0.9	0.2	5.5	1.2	0.1	0.1	2.2	1.3	0.1	6.7	12.7	0.4	0.0	0.3	0.3	0.3	2.0	4.7	0.0	0.3	1.7	0.1	0.3	0.3	0.4	0.3	0.3	2.4	0.2	0.2	0.4	0.0	0.2	0.2	2.6	0.2	0.0	0.9	20.5	0.0	0.0	0.1	0.2	0.8	5.5	0.3	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	2.5	0.5	0.0	2.9	0.0	0.9	0.3	0.8	1.2	0.3	0.0	4.1	0.0	0.3	1.3	0.1	0.0	0.0	0.3	0.8	1.8	0.0	1.6	9.6	0.0	0.0	0.0	1.5	2.1	0.0	0.0	1.9	0.2	1.2	0.0	0.0	0.1	9.1	0.4	3.1	0.3	0.0	0.3	0.0	1.1	0.7	0.0	11.8	0.1	1.2	0.0	0.1	0.4	0.1	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.5	0.0	0.8	1.3	0.1	0.3	0.3	0.3	0.1	0.0	0.2	0.2	4.5	0.0	5.4	0.7	0.1	0.1	0.3	0.0	0.0	1.3	1.6	1.4	17.7	22.8	0.0	16.5	0.0	0.2	1.3	0.3	92.0	13.5	1.5	0.6	0.2	3.0	0.0	0.0	24.5	3.3	0.2	2.4	0.0	1.9	0.0	272.4	1.1	40.4	0.0	0.0	6.2	2.6	0.0	1.0	0.3	4.4	9.3	3.2	19.6	1.9	1.0	0.3	0.0	3.5	2.3	4.0	0.0	17.3	0.0	0.8	0.3	14.7	0.0	0.8	13.1	0.8	10.9	0.7	6.4	0.1	0.0	0.1	0.2	30.4	1.6	0.2
GUCA2B		ENSG00000044012	"Guanylate cyclase activator 2B"	Q16661	1	42153410-42155820	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 144.2"	"Cell type enriched"	"Detected in some"	7	"Paneth cells: 18841.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 1.4;CACO-2: 3.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"						"Secreted to blood"	NA	NA	77700	1200000						"unprognostic (2.59e-2)"				"unprognostic (1.44e-2)"				"unprognostic (1.34e-1)"		"unprognostic (6.22e-2)"	"unprognostic (1.86e-1)"				0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	90.2	36.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	23.5	0.0	0.0	0.6	0.0	0.1	144.2	0.6	0.0	0.0	18.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1098.8	0.0	0.9	1.0	0.0	0.0	0.0	22.8	0.0	0.0	47.9	0.3	0.0	0.0	0.0	22.3	0.0	0.4	3.1	0.1	0.0	0.0	107.2	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	18841.5	0.0	0.0	0.0	2568.9	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	1.3	0.0	55.3	0.9
HCN3	KIAA1535	ENSG00000143630	"Hyperpolarization activated cyclic nucleotide gated potassium channel 3"	Q9P1Z3	1	155277463-155289848	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 14.8"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 9.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026584	Approved					NA	NA					"HPA026584: AB_1850534"	"unprognostic (1.04e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	"prognostic favorable (6.93e-4)"	1.5	3.1	0.5	0.5	0.3	0.1	1.7	2.4	0.8	4.3	0.0	3.9	2.6	2.6	0.0	4.6	1.5	0.0	1.1	0.1	1.2	6.0	14.8	1.4	0.3	1.1	0.7	0.5	3.7	2.6	0.1	7.3	0.2	1.7	2.9	0.5	0.2	3.4	0.2	0.7	5.7	5.1	0.0	0.1	1.5	2.3	1.2	1.3	0.0	2.9	0.0	0.1	2.5	4.2	2.6	2.0	0.7	2.4	0.7	0.6	0.0	1.3	1.6	0.7	0.0	0.3	0.0	2.7	1.8	1.2	0.0	1.2	5.1	0.3	0.0	0.0	2.5	3.1	0.7	2.6	0.5	0.0	0.8	1.3	0.0	0.0	0.0	0.1	0.7	0.2	2.7	4.3	3.1	0.4	0.0	1.4	0.7	1.9	0.3	2.3	3.0	2.0	2.7	0.0	0.3	4.3	5.2	1.3	1.7	0.0	0.0	1.4	0.3	0.2	1.3	1.3	4.0	1.5	1.6	0.7	1.1	0.5	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.4	0.8	0.1	1.2	1.1	0.7	0.5	1.7	0.1	1.3	2.6	1.1	0.0	0.6	2.3	0.2	1.3	0.9	1.3	1.8	3.1	2.0	1.8	1.8	1.5	1.4	1.8	4.2	0.4	0.2	5.8	0.0	1.1	0.6	0.5	0.9	0.6	4.2	0.4	5.0	0.4	0.4	1.1	2.0	1.4	1.3	1.3	2.5	2.1	0.8	0.0	9.3	2.0	4.1	0.3	1.0	0.8	0.9	0.8	0.0	2.8	0.6	1.4	0.0	4.5	1.5	1.3	2.6	1.2	0.7	0.8	6.1	1.2	0.2	1.9	0.0	0.6	0.6	3.6	3.6	2.2	2.7	0.0	0.6	1.5	4.0	0.9
HLF	MGC33822	ENSG00000108924	"HLF transcription factor, PAR bZIP family member"	Q16534	17	55264960-55325187	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 123.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 120.7;Excitatory neurons: 77.5;Hepatocytes: 156.8;Horizontal cells: 92.5;Microglial cells: 74.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 48.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 163.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068156, HPA071210"			Enhanced	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA068156: AB_2685963, HPA071210: AB_2686361"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.88e-4)"	"unprognostic (5.30e-3)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.55e-6)"	"unprognostic (8.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.60e-2)"	15.2	21.7	4.9	2.0	26.2	0.4	15.6	0.0	48.8	14.5	0.0	13.1	1.4	14.5	11.1	26.5	12.3	7.9	24.4	16.0	8.2	12.9	123.4	13.5	2.2	3.8	2.3	13.0	50.4	3.0	4.0	9.9	1.0	10.8	13.3	3.4	43.5	24.3	12.5	7.8	16.9	4.4	12.4	0.0	8.2	6.1	4.1	2.0	3.5	34.6	10.0	7.8	12.4	7.9	14.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.9	0.5	0.0	0.0	0.0	0.4	0.2	0.0	27.3	0.7	0.0	0.1	163.0	0.1	0.9	0.2	0.1	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.6	0.0	0.6	1.1	0.0	0.1	0.0	2.4	0.0	0.4	0.4	13.0	0.1	11.1	0.6	0.0	7.2	0.2	0.0	0.2	0.0	0.1	0.8	0.2	0.6	0.5	5.1	4.9	0.0	0.3	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.9	26.2	0.0	48.8	16.0	8.2	3.8	2.3	13.0	10.8	0.0	2.0	14.1	13.8	3.2	42.8	22.2	0.4	22.3	4.4	1.4	56.9	120.7	5.9	16.4	38.6	12.8	6.3	7.3	10.4	0.1	0.5	0.0	11.7	1.9	1.3	0.1	6.2	19.7	3.0	0.8	77.5	0.9	0.0	17.6	0.0	0.6	0.0	0.5	6.1	156.8	0.1	92.5	36.6	0.6	0.0	3.5	4.0	4.7	28.3	0.7	10.6	74.0	0.1	60.7	0.0	24.6	6.9	0.4	0.0	39.1	1.5	1.3	2.8	23.3	1.0	15.0	13.1	4.5	7.4	0.4	5.0	33.7	27.6	1.2	3.8	0.5	0.4	0.4
HNF4A	"HNF4, MODY, MODY1, NR2A1, TCF14"	ENSG00000101076	"Hepatocyte nuclear factor 4 alpha"	P41235	20	44355700-44434596	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 103.3;kidney: 43.7;liver: 118.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 232.6;Hepatocytes: 186.8;Intestinal goblet cells: 69.8;Paneth cells: 120.0;Proximal enterocytes: 153.9;Proximal tubular cells: 170.1;Undifferentiated cells: 136.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 48.2;liver cancer: 38.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 154.4;Hep G2: 114.8;OE19: 42.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004712, CAB019417"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB019417: AB_2295208, HPA004712: AB_1079075"	"unprognostic (2.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.12e-1)"		"unprognostic (2.70e-2)"	0.2	0.1	0.1	6.0	0.2	0.1	0.1	0.3	0.3	0.0	6.8	59.1	103.3	0.1	0.0	0.1	1.0	5.9	0.0	0.4	0.0	43.7	118.0	0.1	0.1	0.1	0.0	0.2	0.0	25.4	0.0	0.0	0.0	0.1	0.0	44.5	0.1	0.0	0.1	0.2	0.0	83.3	1.8	0.0	0.0	22.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	154.4	6.0	0.1	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	114.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	42.2	0.0	0.0	0.1	0.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.3	0.4	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	35.8	0.0	12.9	0.0	0.0	0.0	232.6	15.6	7.8	4.0	2.5	0.1	0.4	35.9	2.7	0.5	22.1	0.0	0.1	38.2	0.1	4.5	0.0	3.6	186.8	0.0	0.0	0.3	69.8	0.0	5.3	0.0	18.7	0.3	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.1	21.0	120.0	0.4	0.1	0.3	153.9	170.1	0.0	0.0	0.0	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.7	0.8	136.1	0.2
HPN	TMPRSS1	ENSG00000105707	Hepsin	P05981	19	35040506-35066573	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 198.2;liver: 873.3;pancreas: 274.4"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 442.2;Proximal tubular cells: 201.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 127.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"EFO-21: 31.5;Hep G2: 47.8;T-47d: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006804	Approved					NA	NA		3300000			"HPA006804: AB_1079046"	"unprognostic (6.74e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.96e-2)"	1.5	0.9	4.8	0.2	7.6	0.0	11.7	6.0	7.3	1.2	3.5	1.1	1.5	4.0	3.9	0.3	7.5	4.0	5.0	4.7	5.6	198.2	873.3	11.9	0.4	6.6	7.3	3.9	1.4	274.4	24.4	14.9	0.5	7.7	20.3	0.3	0.3	15.7	4.7	22.2	0.7	1.1	0.2	5.9	2.6	58.6	1.3	6.5	0.2	20.1	5.5	0.1	0.6	0.5	10.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.5	0.0	0.1	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.3	0.1	0.0	0.0	3.2	0.2	0.1	0.0	0.2	0.5	22.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	7.6	6.0	7.3	4.7	5.6	6.6	7.3	3.9	7.7	5.9	6.5	10.9	0.5	9.6	32.4	8.8	3.0	0.1	5.1	0.0	0.0	7.2	12.0	8.9	3.4	51.5	1.3	33.1	0.0	0.1	0.0	0.1	52.8	7.5	8.9	4.9	1.0	1.1	2.4	10.7	2.3	26.5	0.3	1.9	18.3	12.5	2.5	0.1	8.6	442.2	1.1	0.0	1.7	2.4	0.0	9.7	0.3	26.0	0.0	1.8	0.0	2.8	0.6	1.6	0.0	0.0	41.6	14.4	0.0	0.4	0.0	7.5	0.0	201.0	0.0	0.6	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.8	1.8	0.1	0.1	0.5
HS3ST3B1	"30ST3B1, 3OST3B1"	ENSG00000125430	"Heparan sulfate-glucosamine 3-sulfotransferase 3B1"	Q9Y662	17	14301081-14349404	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.7;retina: 11.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 39.6;dendritic cells: 32.5;Hepatic stellate cells: 25.7;Hepatocytes: 39.7;Syncytiotrophoblasts: 36.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 35.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 35.1;T-cells: 26.2"	"Cell line enhanced"	"Detected in many"		"AF22: 20.7;BEWO: 14.9;Hep G2: 18.8;HSkMC: 20.2;U-251 MG: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA064126			Approved	Vesicles		NA	NA			Vesicles		"HPA064126: AB_2685194"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.22e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.13e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.77e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-3)"	0.9	0.9	0.5	4.7	1.1	1.4	0.9	0.6	1.4	2.4	1.5	1.3	1.3	0.6	0.2	1.8	0.9	1.4	1.1	0.5	1.2	3.0	28.7	1.6	6.3	5.4	3.0	0.6	3.5	0.6	0.3	0.7	3.5	1.9	2.0	1.7	11.6	5.3	2.0	1.0	1.2	1.8	0.5	2.7	3.4	1.2	0.4	1.6	3.2	0.7	0.9	4.9	2.6	1.9	1.7	0.0	0.4	20.7	0.0	6.2	6.9	14.9	6.1	8.7	5.3	5.6	0.0	0.1	0.0	0.0	8.2	0.0	0.1	0.5	3.3	2.7	1.8	4.5	0.5	2.9	18.8	8.1	0.8	3.2	20.2	1.1	1.9	4.8	1.2	0.0	1.1	6.6	0.1	4.3	1.1	1.0	0.8	0.7	0.1	0.6	3.9	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.4	0.6	0.0	5.2	0.0	0.1	19.9	0.0	0.0	0.0	4.0	0.0	1.2	0.2	0.4	0.0	10.2	0.7	8.1	0.9	12.0	8.0	0.8	0.7	12.1	11.8	0.9	6.6	0.8	35.1	26.2	5.1	0.5	1.1	0.6	1.4	0.5	1.2	5.4	3.0	0.6	1.9	2.7	1.6	1.7	2.9	0.0	1.1	6.2	3.5	11.5	0.3	4.9	21.1	3.2	1.2	2.2	3.0	10.0	3.9	7.3	39.6	7.2	32.5	0.0	0.0	0.7	14.3	0.3	1.5	2.9	0.0	0.4	3.3	0.2	11.9	6.6	0.0	0.8	0.0	2.4	25.7	39.7	1.6	8.4	2.2	0.1	2.0	3.8	12.9	3.3	2.8	6.7	1.8	1.9	1.3	7.3	14.4	3.5	0.1	0.2	0.0	1.2	2.2	1.1	0.4	0.1	3.9	17.9	13.1	15.0	2.6	4.0	0.3	10.0	14.8	36.3	12.4	0.1	0.2	0.3
HSPB9	CT51	ENSG00000260325	"Heat shock protein family B (small) member 9"	Q9BQS6	17	42122804-42123352	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 18.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 375.3;Late spermatids: 1017.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEK 293: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053091			Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA053091: "	"unprognostic (2.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.42e-6)"	"unprognostic (2.31e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.68e-4)"	"unprognostic (4.78e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.24e-1)"	0.4	0.2	1.2	0.4	1.2	0.6	0.2	1.4	1.7	0.2	0.8	0.3	0.3	0.2	0.0	0.1	0.8	0.6	0.2	1.1	1.1	0.6	3.6	0.3	0.4	1.2	1.0	0.9	1.3	4.8	0.2	0.5	0.2	1.1	0.5	0.0	0.0	2.9	0.5	1.5	0.4	0.4	0.1	1.1	0.5	0.4	18.0	1.2	0.0	0.2	1.0	0.0	0.2	0.2	1.5	0.2	0.2	0.3	0.9	0.0	0.0	3.3	0.0	0.0	0.0	0.3	1.0	0.1	0.3	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.3	3.0	0.5	1.2	0.4	0.0	0.3	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.4	0.2	0.0	0.4	0.3	1.1	0.1	0.3	0.0	0.1	0.2	1.0	0.0	0.7	1.4	0.3	0.0	1.5	0.2	0.1	0.2	0.1	0.4	0.7	0.0	0.6	0.2	0.6	0.3	0.6	0.1	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.0	1.2	1.2	1.4	1.7	1.1	1.1	1.2	1.0	0.9	1.1	1.1	1.2	1.5	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.1	0.6	0.6	0.6	0.5	0.6	2.8	0.0	0.0	2.1	3.2	0.2	0.4	19.6	0.0	375.3	0.5	0.3	0.6	0.0	0.0	0.1	1.1	0.8	0.7	0.0	0.3	0.0	0.5	1.8	15.3	0.2	3.3	0.1	0.7	0.0	0.8	0.4	1017.0	7.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.3	6.8	0.0	0.4	0.6	0.9	0.1	0.4	0.0	0.8	0.3	127.3	4.5	0.1	0.3	0.3	0.2	0.6	0.3	0.2
HYAL1	"HYAL-1, LUCA1"	ENSG00000114378	"Hyaluronidase 1"	Q12794	3	50299890-50312381	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 203.2;lymphoid tissue: 95.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Hepatic stellate cells: 33.2;Hepatocytes: 137.1;Proximal tubular cells: 58.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 100.9;SK-BR-3: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"	NA	NA		590000			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	9.5	21.7	4.7	2.9	4.4	0.3	9.2	6.2	6.3	8.5	15.8	5.5	3.5	8.2	0.8	5.6	7.4	13.4	43.8	4.3	3.8	49.4	203.2	31.0	1.8	5.2	4.6	3.7	3.0	9.5	20.0	3.3	2.5	5.0	4.6	2.9	3.1	7.4	2.9	15.2	20.3	6.0	6.0	3.1	95.9	19.6	1.7	5.1	0.8	8.3	19.2	1.3	4.9	12.4	4.5	2.9	1.8	0.4	0.9	0.6	0.7	0.5	0.1	0.3	0.1	0.4	11.4	3.1	0.0	0.8	0.6	0.6	6.6	0.2	0.4	0.0	0.1	0.0	0.3	8.6	100.9	4.4	0.7	0.7	3.9	13.8	0.1	0.4	0.8	2.9	0.3	0.3	0.5	0.4	0.6	0.1	0.3	0.6	7.1	0.6	0.0	0.2	0.3	5.9	0.4	0.2	2.1	0.2	28.0	0.3	2.4	2.0	0.3	1.9	0.6	0.6	0.6	0.3	0.2	0.3	0.4	0.4	0.6	0.3	1.3	0.4	1.5	0.3	0.1	0.8	0.4	0.3	0.4	0.2	0.5	0.6	0.4	3.1	0.3	0.3	0.5	0.4	0.1	4.7	4.4	6.2	6.3	4.3	3.8	5.2	4.6	3.7	5.0	3.1	5.1	4.5	18.1	19.2	18.5	1.6	0.3	2.9	0.4	3.3	0.0	1.0	0.3	0.1	20.8	30.0	2.0	11.0	4.2	0.1	0.0	2.5	23.5	16.5	8.2	0.2	0.9	25.8	1.8	2.7	3.1	14.4	0.1	3.3	19.4	0.2	0.0	0.6	33.2	137.1	0.1	0.0	3.1	1.4	0.0	4.4	0.9	7.7	2.1	0.9	0.0	7.5	0.0	0.4	0.0	1.5	1.6	12.1	0.3	1.2	0.0	0.2	0.4	58.2	0.9	0.5	6.6	1.2	4.3	0.4	1.1	0.9	3.1	0.7	0.9	7.4	0.9	1.7
IGFALS	ALS	ENSG00000099769	"Insulin like growth factor binding protein acid labile subunit"	P35858	16	1790413-1794971	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 117.6"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 85.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.9;U-266/70: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040692, HPA040948"	Supported				"Secreted to blood"	NA	NA	14700000000	26000000000			"HPA040692: AB_10794067, HPA040948: AB_10794999"	"unprognostic (2.74e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (5.54e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.51e-2)"	0.2	0.2	0.6	0.3	0.8	0.4	0.4	1.4	0.7	0.4	0.7	0.6	0.3	0.3	0.1	0.1	0.7	1.6	0.2	0.3	0.3	1.0	117.6	0.8	0.0	0.7	0.6	0.2	0.7	2.5	0.0	0.7	0.0	0.9	0.5	0.1	0.2	0.8	0.1	0.5	0.8	0.6	0.0	0.4	0.3	11.0	2.0	0.4	0.9	0.9	0.0	0.0	0.4	0.2	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.5	0.0	0.0	1.7	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.4	0.7	0.3	0.3	0.7	0.6	0.2	0.9	0.4	0.4	1.9	0.1	0.0	0.0	1.6	0.1	0.1	0.2	0.2	0.0	0.5	0.9	0.6	1.6	14.3	0.2	0.0	6.2	0.0	0.0	0.6	0.0	2.7	1.1	0.4	0.0	0.2	0.0	0.0	0.5	0.6	0.0	0.4	8.2	0.1	0.0	0.2	2.9	85.2	0.0	0.0	0.6	14.6	0.0	1.3	0.3	1.7	0.0	0.0	1.8	0.0	0.0	0.3	1.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.0	0.2	0.1	0.4	0.4	0.0	0.3	0.0	0.2	0.1	0.7	0.1
KCNJ4	"HIR, hIRK2, HRK1, IRK3, Kir2.3"	ENSG00000168135	"Potassium inwardly rectifying channel subfamily J member 4"	P48050	22	38426327-38455199	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 28.7;heart muscle: 29.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.3;Excitatory neurons: 14.3;Horizontal cells: 10.1;Inhibitory neurons: 11.1;Microglial cells: 3.7;Muller glia cells: 6.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1;liver cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 11.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	14	"amygdala: 5.9;basal ganglia: 13.7;cerebral cortex: 14.7;hippocampal formation: 12.3;olfactory bulb: 15.9"							NA	NA							"unprognostic (4.76e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.12e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.07e-1)"		"unprognostic (3.15e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.41e-2)"		0.1	0.2	10.1	0.0	21.2	0.0	0.0	0.0	28.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.8	0.6	29.8	21.3	6.5	0.2	2.1	0.0	0.0	5.5	1.3	24.8	0.0	0.0	0.1	2.0	0.0	8.6	0.0	0.0	0.8	0.1	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	1.1	0.9	1.2	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.1	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.4	0.8	0.0	0.3	0.1	0.0	1.7	0.0	0.1	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	21.2	0.0	28.7	21.3	6.5	5.5	1.3	24.8	8.6	0.0	0.9	10.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	11.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	3.7	0.0	6.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
KCNU1	"KCa5.1, Kcnma3, KCNMC1, Slo3"	ENSG00000215262	"Potassium calcium-activated channel subfamily U member 1"	A8MYU2	8	36784324-36936125	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 7.5"	"Group enriched"	"Detected in some"	15	"Early spermatids: 61.1;Late spermatids: 24.3"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 7.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA063317			Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA063317: "	"unprognostic (2.42e-3)"	"unprognostic (4.26e-2)"		"unprognostic (2.07e-1)"	"unprognostic (4.76e-3)"		"unprognostic (7.57e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.73e-2)"		"unprognostic (1.24e-2)"				0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	7.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.5	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	24.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2
KLF15	KKLF	ENSG00000163884	"Kruppel like factor 15"	Q9UIH9	3	126342635-126357408	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 93.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.9;Cardiomyocytes: 29.7;Distal tubular cells: 29.4;Hepatocytes: 66.9;Peritubular cells: 19.9;Proximal tubular cells: 22.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 57.4;HHSteC: 34.8;RPMI-8226: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003286, HPA028866"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles,Vesicles"		NA	NA			"Nucleoplasm, Nuclear speckles"	Vesicles	"HPA003286: , HPA028866: AB_10600819"	"unprognostic (3.77e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (3.27e-7)"	"unprognostic (6.75e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.58e-3)"	36.8	6.2	35.7	0.8	43.3	0.1	25.6	39.9	70.1	15.3	31.0	15.1	1.3	19.2	4.2	7.1	29.9	3.5	28.2	35.1	34.6	19.9	93.2	18.8	1.8	58.9	39.8	31.3	46.6	48.9	4.6	10.5	1.7	39.6	17.7	0.9	3.9	19.9	5.3	67.9	9.3	10.3	2.5	38.0	3.6	30.4	5.6	38.6	1.2	11.2	32.7	0.8	27.3	12.1	43.0	0.8	0.0	2.2	9.2	57.4	1.0	10.0	0.6	1.4	0.7	1.3	1.1	0.0	3.4	0.9	0.0	1.7	0.1	5.3	0.1	0.2	0.2	2.0	0.1	0.8	7.9	34.8	0.0	0.2	5.4	0.5	0.0	1.2	0.0	0.6	4.5	4.3	7.4	0.2	0.7	0.0	1.3	6.6	1.3	0.3	4.7	0.2	20.2	0.1	0.8	0.7	7.7	0.1	0.3	10.2	3.3	0.5	4.6	0.3	0.3	0.4	0.3	0.3	4.7	0.6	0.7	0.2	1.5	1.3	25.1	7.6	10.3	7.0	10.2	8.2	12.3	7.3	7.4	8.2	11.4	9.4	11.3	16.7	12.8	9.3	9.0	10.5	11.7	35.7	43.3	39.9	70.1	35.1	34.6	58.9	39.8	31.3	39.6	38.0	38.6	43.0	1.5	6.4	4.6	22.9	0.8	0.0	2.9	0.2	0.6	1.3	7.8	1.8	29.7	15.7	0.7	0.0	0.0	0.1	0.1	0.0	29.4	0.1	0.1	2.5	4.4	2.1	0.0	2.7	0.6	0.0	0.2	8.1	3.1	3.4	0.0	13.7	8.2	66.9	0.1	0.0	2.8	0.1	0.0	2.6	0.0	0.8	12.2	0.4	1.8	2.8	0.0	12.0	0.0	15.1	5.7	0.4	0.0	19.9	0.9	5.2	0.0	22.1	0.8	3.3	0.0	12.0	5.5	0.1	0.1	0.3	0.0	0.3	0.5	0.6	0.1	1.8
LDHD		ENSG00000166816	"Lactate dehydrogenase D"	Q86WU2	16	75111860-75116780	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 136.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 37.3;Distal enterocytes: 80.2;Distal tubular cells: 37.2;Hepatocytes: 88.6;Proximal tubular cells: 118.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 11.1"	"Group enriched"	"Detected in many"	45	"granulocytes: 11.1;monocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 11.4;HMC-1: 14.4;T-47d: 29.1;U-266/70: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041766, HPA048639, HPA066148"	Enhanced		Approved	Cytosol		No	NA			Cytosol		"HPA041766: AB_2677660, HPA048639: AB_2680473, HPA066148: AB_2685626"	"unprognostic (8.75e-2)"	"unprognostic (3.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (2.49e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-14)"	"unprognostic (4.10e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.20e-1)"	25.1	14.5	15.2	2.1	16.0	0.7	11.8	18.3	22.8	5.4	27.5	19.1	8.9	3.5	1.1	10.8	5.5	3.1	59.7	13.9	15.6	35.5	136.6	4.9	0.8	19.3	17.1	13.4	16.6	18.8	17.2	11.9	0.7	19.9	8.2	9.7	1.3	21.5	3.2	69.3	4.8	5.7	1.2	13.9	1.1	23.3	1.7	16.8	0.5	10.7	53.1	0.6	2.6	3.7	16.2	0.7	2.1	0.0	0.2	1.6	1.4	6.1	0.2	0.1	0.2	0.2	2.8	2.6	0.1	2.1	0.9	1.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.8	11.4	2.6	0.0	14.4	2.0	0.3	0.0	0.0	0.6	0.1	0.4	0.7	2.5	0.0	5.3	0.1	0.8	1.4	2.7	1.3	0.0	0.0	7.8	1.4	0.1	0.0	0.0	0.2	5.2	0.3	0.7	29.1	3.3	0.0	0.0	0.2	0.0	0.0	11.5	0.6	0.0	1.9	0.1	0.0	11.1	2.2	0.6	0.0	3.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.8	15.2	16.0	18.3	22.8	13.9	15.6	19.3	17.1	13.4	19.9	13.9	16.8	16.2	1.6	0.0	6.7	7.8	1.0	0.6	1.8	2.2	0.6	0.5	6.5	2.4	37.3	11.5	2.3	11.0	0.0	2.1	0.1	80.2	37.2	2.3	0.4	2.2	0.3	1.7	3.0	2.7	1.0	6.2	1.2	2.3	32.6	3.8	10.2	2.1	4.2	88.6	7.2	1.7	1.4	11.0	0.0	6.0	1.0	0.6	0.0	3.0	5.4	1.9	2.0	12.0	0.0	1.0	3.2	3.0	28.3	0.0	0.8	2.1	2.4	118.1	2.0	1.4	0.0	4.1	1.3	0.0	0.7	3.6	0.3	3.1	1.0	1.8	15.7	1.5
MBNL3	"CHCR, FLJ11316, MBLX39, MBXL"	ENSG00000076770	"Muscleblind like splicing regulator 3"	Q9NUK0	X	132369317-132489968	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 59.8;placenta: 172.2"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 328.3;Hepatocytes: 119.6;Syncytiotrophoblasts: 344.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.8"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 123.8;Hep G2: 171.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001584	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA001584: AB_1079326"	"unprognostic (3.38e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.37e-1)"	6.9	11.8	1.1	8.8	2.0	14.9	4.8	1.8	2.7	3.7	6.3	11.8	10.0	4.9	24.5	11.0	9.5	5.8	6.1	0.9	3.2	8.0	59.8	6.0	13.9	3.5	3.0	0.4	4.8	10.1	4.3	1.6	172.2	2.8	4.1	11.6	0.1	6.7	11.2	0.6	12.7	9.9	4.0	1.9	11.4	13.1	43.2	1.5	14.4	8.3	3.5	15.3	8.6	2.8	3.7	7.2	0.0	8.6	1.4	1.6	3.6	15.7	0.5	3.2	1.1	0.0	123.8	22.7	32.6	0.7	1.3	1.1	7.7	19.8	8.2	0.8	3.3	7.6	29.1	25.9	171.5	1.5	32.9	10.2	1.5	7.1	0.0	3.6	0.1	1.1	20.4	2.6	9.2	1.6	19.2	56.3	12.5	1.3	27.5	1.6	53.2	10.7	18.6	5.7	18.6	3.1	10.5	14.8	8.6	4.3	15.1	3.1	8.4	3.9	6.3	1.2	8.2	6.7	18.2	13.0	47.0	1.2	21.8	20.2	11.9	7.9	5.5	16.6	9.9	14.4	20.6	9.8	11.6	8.8	25.5	10.0	11.2	1.2	18.7	21.7	17.0	2.2	9.1	1.1	2.0	1.8	2.7	0.9	3.2	3.5	3.0	0.4	2.8	1.9	1.5	3.7	4.1	3.2	6.8	16.0	16.9	8.8	2.2	2.1	5.2	0.7	3.5	3.6	14.7	41.5	5.0	11.0	0.0	328.3	9.5	12.8	3.9	1.5	5.8	12.6	1.3	3.6	6.7	55.8	0.9	5.4	56.6	7.5	15.3	6.6	8.8	6.8	6.4	119.6	29.3	0.0	0.9	9.8	0.0	27.2	6.5	9.4	23.0	9.6	7.2	30.0	10.6	0.2	9.2	0.0	20.6	1.3	3.6	50.8	12.2	1.4	6.4	9.7	4.5	1.9	0.0	3.1	2.7	2.1	1.7	13.6	8.5	344.1	10.3	5.7	10.3	3.3
METTL7B	"ALDI, MGC17301"	ENSG00000170439	"Methyltransferase like 7B"	Q6UX53	12	55681678-55684611	"Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 134.3;liver: 286.6"	"Cell type enhanced"	"Detected in some"		"Hepatocytes: 83.9;Hofbauer cells: 72.7;Proximal enterocytes: 192.4;Proximal tubular cells: 55.6"	"Cancer enhanced"	"Detected in many"		"glioma: 97.9;liver cancer: 97.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.5;myeloid DC: 7.0;naive B-cell: 1.7;non-classical monocyte: 3.3"	"Group enriched"	"Detected in many"	45	"B-cells: 1.7;dendritic cells: 7.0;monocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 28.4;CAPAN-2: 56.6;EFO-21: 41.3;Hep G2: 28.7;LHCN-M2: 47.0;OE19: 32.5;THP-1: 42.2;U-87 MG: 41.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038644	Enhanced		Approved	Vesicles,Microtubules		NA	NA			Microtubules	Vesicles	"HPA038644: AB_2676130"	"unprognostic (7.54e-2)"	"unprognostic (7.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.10e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (2.43e-1)"	2.1	1.7	6.0	1.8	6.6	1.2	0.9	5.7	11.3	0.3	6.5	28.8	60.2	0.4	134.3	0.1	3.1	11.9	72.8	13.8	11.8	52.6	286.6	1.6	2.4	8.9	6.0	5.4	0.1	2.9	0.2	3.1	11.0	6.0	0.3	23.8	1.3	0.5	0.8	7.5	0.6	55.8	2.1	6.9	4.3	4.3	0.7	10.4	0.2	3.3	10.1	0.5	1.3	0.1	8.4	0.4	21.8	0.1	0.5	4.3	15.3	0.3	0.8	3.2	0.2	1.4	28.4	56.6	11.6	41.3	1.2	1.1	0.1	4.1	0.3	0.8	0.0	5.4	1.2	3.2	28.7	0.0	0.6	0.0	4.0	0.0	1.0	0.0	4.2	0.0	0.0	0.2	0.0	47.0	20.2	0.0	0.4	5.7	32.5	2.7	0.0	1.5	2.7	0.5	0.1	0.1	0.3	2.2	0.0	3.9	0.2	3.8	42.2	0.0	3.1	3.5	0.4	2.9	0.0	0.6	3.5	41.9	9.9	0.2	0.0	0.8	0.0	0.0	4.5	0.0	0.5	0.0	0.0	7.0	1.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.4	6.0	6.6	5.7	11.3	13.8	11.8	8.9	6.0	5.4	6.0	6.9	10.4	8.4	0.0	0.0	1.5	0.7	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.1	26.5	22.8	0.6	0.0	0.0	0.5	0.0	29.0	3.9	3.9	0.0	0.1	0.0	0.5	1.2	4.0	0.7	5.1	0.5	2.0	2.6	0.2	0.0	0.8	1.1	83.9	72.7	0.0	0.1	14.0	0.0	17.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	4.6	20.7	1.2	0.0	0.1	192.4	55.6	0.0	0.0	0.0	7.8	0.6	0.0	0.1	0.0	0.0	0.7	0.3	0.1	22.2	0.1
MOGAT2	"DGAT2L5, FLJ22644, MGAT2"	ENSG00000166391	"Monoacylglycerol O-acyltransferase 2"	Q3SYC2	11	75717838-75732958	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 48.6;liver: 25.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 73.8;Hepatocytes: 79.6;Intestinal goblet cells: 36.2;Proximal enterocytes: 159.6;Undifferentiated cells: 32.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 4.5;RPMI-8226: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028834	Uncertain					NA	NA					"HPA028834: AB_10601865"	"unprognostic (5.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.15e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.24e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-3)"	0.0	0.0	0.0	1.9	0.2	0.0	1.4	0.0	0.1	0.1	0.0	14.0	45.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	25.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	12.7	0.0	0.2	0.2	0.0	0.3	48.6	0.7	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.3	1.5	0.2	0.0	0.0	0.0	0.0	73.8	0.0	0.0	0.0	0.1	0.0	0.0	2.4	2.7	0.0	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.4	79.6	0.0	0.0	0.0	36.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.3	0.0	0.0	0.6	159.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.4	0.1
MPPED1	"239AB, C22orf1, FAM1A"	ENSG00000186732	"Metallophosphoesterase domain containing 1"	O15442	22	43411196-43507848	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 60.9;liver: 24.7"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 69.4;Inhibitory neurons: 68.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 60.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 5.3;SCLC-21H: 2.3"	"Group enriched"	"Detected in all"	5	"amygdala: 105.7;basal ganglia: 66.2;cerebral cortex: 163.5;hippocampal formation: 174.4;white matter: 106.3"	"Group enriched"	"Detected in all"	6	"cerebral cortex: 95.0;hippocampal formation: 83.0"							NA	NA						"unprognostic (1.15e-1)"	"unprognostic (4.29e-1)"		"unprognostic (8.17e-2)"	"unprognostic (4.81e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.87e-1)"		"unprognostic (6.92e-3)"	0.0	0.1	11.2	0.0	30.0	0.0	0.1	0.0	60.9	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.1	24.6	4.2	0.0	24.7	0.0	0.0	0.9	1.9	21.2	1.6	0.0	0.0	1.7	0.0	12.4	0.9	0.0	0.5	1.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.9	2.0	0.0	0.4	0.0	0.0	0.0	0.3	0.3	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.2	30.0	0.0	60.9	24.6	4.2	0.9	1.9	21.2	12.4	0.0	0.0	23.9	0.1	0.0	0.0	3.6	0.0	0.5	0.1	0.0	0.0	2.7	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	68.6	0.2	0.0	0.6	0.0	2.7	0.6	0.0	0.0	4.7	0.0	0.5	0.0	2.0	13.3	0.0	0.0	7.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MTARC2	"FLJ20605, MARC2, MOSC2"	ENSG00000117791	"Mitochondrial amidoxime reducing component 2"	Q969Z3	1	220748225-220784815	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 133.7;liver: 225.4"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 29.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 35.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 14.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 36.0;TIME: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015085, HPA017572"	Enhanced					NA	NA					"HPA015085: AB_1848780, HPA017572: AB_1848778"	"unprognostic (8.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.20e-2)"	"prognostic favorable (1.40e-10)"	"unprognostic (4.78e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.23e-2)"	30.7	18.0	10.5	6.2	12.1	0.6	16.6	8.8	15.6	11.7	47.7	18.0	59.7	6.8	15.7	9.8	10.9	21.8	25.3	11.2	10.0	133.7	225.4	31.5	7.4	9.0	10.8	11.0	22.1	30.2	125.9	9.6	12.8	8.7	20.4	20.7	3.0	36.7	12.6	34.8	4.6	58.7	9.6	8.0	11.7	28.1	11.1	10.8	3.1	42.5	21.5	8.3	12.6	10.5	10.1	9.5	7.8	4.1	5.4	10.1	4.6	3.2	6.7	11.7	8.0	8.1	5.3	11.9	0.0	4.6	6.5	4.3	1.3	0.0	9.4	7.5	0.0	15.7	0.0	16.5	11.0	9.3	4.5	0.0	8.0	14.1	3.0	0.0	12.1	22.2	0.0	6.3	0.1	5.1	2.3	0.0	15.7	6.6	3.2	7.8	0.0	13.0	0.2	28.2	10.3	2.3	6.1	10.6	0.1	15.2	4.5	36.0	5.6	33.9	0.0	4.8	10.6	12.0	2.0	0.1	0.0	1.7	0.0	0.1	14.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.5	12.1	8.8	15.6	11.2	10.0	9.0	10.8	11.0	8.7	8.0	10.8	10.1	7.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0
MYOM1		ENSG00000101605	"Myomesin 1"	P52179	18	3066807-3219968	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	23	"heart muscle: 416.6;skeletal muscle: 853.6;tongue: 439.4"	"Cell type enriched"	"Detected in many"	15	"Cardiomyocytes: 1346.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"HAP1: 13.5;HMC-1: 3.5;HSkMC: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014305, HPA049193"	Enhanced					NA	NA		33000			"HPA014305: AB_1854257, HPA049193: AB_2680670"	"unprognostic (2.51e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.19e-3)"	"unprognostic (8.01e-3)"	"unprognostic (8.94e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	15.2	2.3	7.6	1.4	8.7	0.6	4.2	8.6	6.4	2.9	4.3	10.3	1.9	6.4	3.0	14.2	6.9	14.7	416.6	6.3	10.6	1.3	24.9	1.5	1.3	11.5	11.2	4.9	2.9	11.6	0.4	1.6	1.6	11.3	12.5	2.4	2.0	5.4	4.5	853.6	1.3	4.6	12.0	9.2	1.0	3.2	5.8	8.6	0.8	2.8	439.4	0.7	7.7	2.4	9.3	0.0	0.1	0.2	0.0	0.7	0.7	0.3	0.4	0.5	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	13.5	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.0	3.5	6.2	0.3	0.2	0.0	0.3	0.0	0.2	0.0	0.4	0.2	0.0	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.0	0.6	0.0	0.2	7.6	8.7	8.6	6.4	6.3	10.6	11.5	11.2	4.9	11.3	9.2	8.6	9.3	1.2	0.0	0.5	49.0	1.7	1.7	2.3	0.7	0.0	2.1	1.0	0.8	1346.0	27.1	1.2	0.0	2.1	0.9	2.7	7.4	0.0	0.6	11.7	1.1	0.4	12.0	0.0	0.8	3.5	6.3	0.1	27.4	6.6	1.0	0.0	3.4	2.5	19.1	0.3	1.7	7.1	0.7	4.1	1.3	2.1	14.1	2.1	1.3	0.0	7.5	1.5	0.2	2.1	24.6	13.5	1.5	88.9	4.1	0.1	0.8	0.5	0.3	2.1	1.6	6.6	24.6	40.8	4.4	5.4	0.1	1.3	2.2	1.3	1.3	0.6	0.6
MYRIP	"DKFZp586F1018, exophilin-8, SLAC2-C, SLAC2C"	ENSG00000170011	"Myosin VIIA and Rab interacting protein"	Q8NFW9	3	39808914-40260321	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 295.6;Inhibitory neurons: 507.3;Microglial cells: 210.8;Oligodendrocyte precursor cells: 98.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.1;HUVEC TERT2: 15.6;REH: 3.7;SCLC-21H: 3.2;SH-SY5Y: 9.4;T-47d: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006433			Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center, Golgi apparatus"		"HPA006433: AB_10603023"	"unprognostic (1.87e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (3.96e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.16e-2)"	3.6	1.0	16.7	1.3	13.9	0.0	3.7	10.2	17.5	5.7	13.8	2.7	1.7	3.3	2.2	1.3	2.9	2.7	1.7	18.2	8.1	1.5	11.6	0.8	1.7	11.1	14.0	14.0	3.1	9.0	2.1	2.9	0.1	11.6	2.0	2.7	4.3	12.6	0.8	1.7	1.1	2.4	2.3	3.7	7.2	5.7	0.9	10.4	0.5	1.5	0.5	1.7	1.4	2.6	17.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.2	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.0	0.1	3.7	0.0	0.0	0.4	2.0	3.2	9.4	0.0	0.0	0.0	0.0	3.8	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	13.9	10.2	17.5	18.2	8.1	11.1	14.0	14.0	11.6	3.7	10.4	17.9	15.8	0.0	3.2	36.2	0.4	0.8	0.1	0.0	1.2	2.7	0.5	0.3	2.4	5.7	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.1	19.9	1.1	0.7	21.3	0.0	1.7	295.6	2.8	0.0	1.6	3.1	6.2	2.5	14.0	42.8	17.4	0.0	5.0	507.3	11.9	0.0	2.8	0.7	6.1	0.9	0.1	0.0	210.8	0.0	6.6	0.0	98.0	24.5	0.6	0.1	0.0	0.0	1.4	0.1	1.8	0.1	4.2	0.0	0.3	0.7	3.1	0.6	0.1	0.6	0.0	0.3	0.1	0.7	0.1
NADK2	"C5orf33, FLJ30596, MNADK, NADKD1"	ENSG00000152620	"NAD kinase 2, mitochondrial"	Q4G0N4	5	36192589-36242279	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"liver: 330.7"	"Group enriched"	"Detected in many"	5	"Astrocytes: 105.4;Early spermatids: 324.5;Hepatocytes: 211.9;Late spermatids: 154.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 36.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038366, HPA038367, HPA061492"	Enhanced		Supported	Mitochondria		NA	NA		30000	Mitochondria		"HPA038366: AB_2675977, HPA038367: AB_10672743, HPA061492: AB_2684538"	"unprognostic (1.15e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.06e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	13.7	20.3	25.5	9.4	22.6	10.7	15.6	23.1	23.1	13.8	13.3	14.1	16.8	13.4	8.0	10.5	12.8	12.0	20.3	21.4	27.4	23.4	330.7	8.5	9.6	24.6	24.4	19.5	19.8	27.1	10.8	5.6	17.1	23.3	19.1	13.9	11.3	13.1	16.4	29.7	6.7	13.0	14.3	29.9	8.6	17.3	18.4	22.8	10.4	17.5	30.0	11.5	28.2	8.9	29.7	21.5	14.6	22.4	23.5	32.2	27.2	27.5	19.5	13.2	17.5	13.2	41.4	27.4	74.3	14.0	23.3	23.0	14.9	20.0	14.3	24.2	21.2	16.3	22.0	43.1	23.9	22.7	46.5	8.0	28.9	22.5	21.6	29.9	22.4	18.4	30.2	52.0	27.8	18.0	9.0	42.3	18.2	10.7	18.1	19.2	40.2	51.6	15.8	24.2	18.2	8.7	20.1	102.0	32.4	10.5	16.7	22.9	39.8	15.1	34.1	18.2	27.0	23.9	23.7	30.3	23.2	14.5	57.2	14.2	8.2	1.2	1.1	1.3	1.4	1.8	1.3	1.9	1.5	2.3	5.3	1.6	1.4	0.1	6.7	3.3	1.2	2.1	1.4	25.5	22.6	23.1	23.1	21.4	27.4	24.6	24.4	19.5	23.3	29.9	22.8	29.7	9.6	3.2	6.9	105.4	7.5	6.8	6.8	5.4	6.2	5.7	18.3	11.2	29.3	25.8	7.1	5.5	8.4	9.2	9.6	7.4	25.4	5.0	324.5	6.1	9.4	6.8	7.2	13.7	23.8	9.5	8.9	12.5	5.6	7.1	1.3	10.0	12.1	211.9	8.9	3.3	18.3	11.7	4.1	10.4	9.6	154.9	19.9	6.4	14.2	11.2	3.7	16.9	5.2	21.1	23.6	6.9	8.8	23.0	14.3	14.9	6.6	23.1	7.2	5.4	0.0	11.6	13.5	35.1	11.0	7.7	5.7	7.3	6.9	26.4	11.6	12.3
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004622-44009068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Urea cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 16.0;liver: 48.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 21.7;Proximal enterocytes: 44.2;Proximal tubular cells: 20.7;Spermatocytes: 16.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 12.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.5;HHSteC: 5.2;TIME: 7.1;U-87 MG: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA027300: AB_2672207"	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.7	0.7	1.9	0.5	1.2	0.0	1.4	0.9	2.0	0.7	0.0	1.4	16.0	0.8	1.8	1.5	0.7	0.4	0.7	0.9	2.6	4.8	48.6	1.9	0.3	2.0	1.2	0.6	0.6	0.3	3.3	0.5	0.1	1.8	1.2	0.5	0.0	1.0	1.4	0.2	0.9	13.7	0.1	1.0	0.4	0.4	0.6	2.8	0.1	4.5	0.2	0.1	0.4	1.0	1.7	2.9	0.1	0.0	0.4	0.0	5.5	0.1	0.5	0.1	0.1	0.2	1.7	0.7	0.0	1.1	0.0	0.1	1.3	0.1	1.5	0.3	0.2	0.7	0.1	0.2	2.2	5.2	0.0	0.0	3.2	0.0	0.7	0.0	0.6	1.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	1.5	2.7	0.0	0.3	0.0	0.1	0.0	2.1	0.0	0.9	0.0	0.0	0.2	0.2	0.0	7.1	2.5	0.7	0.2	0.6	0.1	0.1	0.1	10.0	0.0	0.3	0.8	0.5	0.7	0.9	0.4	0.7	0.3	0.6	0.8	0.5	0.3	0.3	0.4	0.3	0.2	0.8	0.1	0.5	0.3	1.9	1.2	0.9	2.0	0.9	2.6	2.0	1.2	0.6	1.8	1.0	2.8	1.7	1.8	3.2	4.2	0.0	0.9	1.5	0.9	1.9	6.8	0.4	3.5	4.8	2.6	2.8	2.9	12.9	0.0	0.9	1.1	10.5	7.9	1.9	5.8	0.5	0.2	2.3	7.2	0.0	0.0	4.2	1.9	0.9	2.0	0.2	0.0	0.3	0.7	21.7	1.1	0.0	0.3	3.8	4.1	1.9	5.3	5.3	1.5	2.1	0.0	1.0	6.1	1.0	3.1	0.0	0.0	5.1	11.1	0.7	0.0	0.6	44.2	20.7	1.1	0.5	0.0	0.2	0.9	16.0	2.5	1.0	0.9	0.4	1.4	0.7	6.6	0.6
NAT2	AAC2	ENSG00000156006	"N-acetyltransferase 2"	P11245	8	18391282-18401218	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"intestine: 33.8;liver: 129.6"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 14.8;Hepatocytes: 59.0;Paneth cells: 15.9;Proximal enterocytes: 36.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.0;liver cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.0;RT4: 1.6;SCLC-21H: 2.2;SK-BR-3: 1.4"									HPA043704	Uncertain					NA	NA					"HPA043704: AB_2678625"	"unprognostic (2.74e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.61e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.67e-2)"		"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	0.1	0.1	0.2	1.6	0.2	0.0	1.1	0.2	0.6	0.6	0.1	15.1	33.8	0.9	0.7	0.1	0.2	0.2	0.2	0.1	0.4	1.9	129.6	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.6	0.3	0.4	13.4	0.0	0.0	0.5	0.0	0.0	25.8	1.6	0.1	1.3	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.0	1.0	1.6	2.2	0.0	0.0	1.4	0.0	0.1	0.3	0.2	0.5	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.1	0.4	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	1.0	0.0	14.8	5.9	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.4	59.0	0.2	0.0	0.0	7.4	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.9	2.6	0.0	0.0	36.0	0.8	0.3	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	4.4	0.1	0.8	6.7	0.1
NECAB2	EFCBP2	ENSG00000103154	"N-terminal EF-hand calcium binding protein 2"	Q7Z6G3	16	83968244-84002776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 107.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.6;Hepatocytes: 10.7;Inhibitory neurons: 22.2;Late spermatids: 49.2;Muller glia cells: 17.8;Proximal tubular cells: 27.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	66	"neutrophil: 55.4"	"Lineage enriched"	"Detected in single"	66	"granulocytes: 55.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.1;MCF7: 6.8;SCLC-21H: 37.6;U-87 MG: 12.2"	"Low region specificity"	"Detected in all"							"HPA013998, HPA014144, CAB068211"	Enhanced	Supported				NA	NA					"CAB068211: AB_2665678, HPA013998: AB_1848016, HPA014144: AB_1848017"	"unprognostic (5.27e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.48e-5)"	"unprognostic (3.45e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.74e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (8.89e-3)"	"unprognostic (3.48e-1)"	"unprognostic (8.61e-3)"	"unprognostic (3.75e-2)"	0.9	0.5	65.0	0.6	70.0	0.5	0.7	19.5	107.2	1.5	23.5	1.2	1.2	1.2	0.3	0.1	0.4	0.5	1.2	71.8	58.7	11.1	26.2	0.5	0.2	35.5	48.1	78.8	0.5	1.9	6.7	16.3	0.3	63.1	0.3	0.2	3.1	0.1	0.1	0.2	0.2	1.2	0.4	22.2	1.6	1.8	10.5	46.5	0.2	0.5	0.2	0.0	0.3	0.2	43.3	0.2	4.4	10.1	0.0	0.0	1.4	0.1	0.1	0.2	0.1	0.1	0.3	0.2	0.0	1.6	0.2	0.8	0.0	1.9	0.0	0.0	0.1	2.9	0.0	0.0	0.5	0.1	0.0	1.7	0.5	0.2	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.0	6.8	0.0	0.0	5.0	0.4	0.6	0.1	0.0	0.6	0.0	0.0	37.6	1.5	0.0	0.2	3.1	1.4	5.2	1.4	0.3	0.2	2.8	0.4	0.0	0.1	0.0	0.0	12.2	0.5	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.1	65.0	70.0	19.5	107.2	71.8	58.7	35.5	48.1	78.8	63.1	22.2	46.5	43.3	0.1	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	16.6	0.0	0.1	0.1	7.2	0.0	2.2	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.0	10.7	3.4	0.0	22.2	0.0	0.0	0.0	0.0	49.2	0.3	0.3	0.0	3.7	0.2	17.8	0.0	4.0	0.6	0.0	0.0	0.7	0.0	0.0	0.3	27.8	0.0	0.3	0.0	0.1	0.0	2.1	3.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0
NR5A2	"B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1, LRH1"	ENSG00000116833	"Nuclear receptor subfamily 5 group A member 2"	O00482	1	200027614-200177420	"Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 18.0;liver: 38.9;pancreas: 61.7"	"Cell type enriched"	"Detected in many"	5	"Granulosa cells: 276.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"A549: 25.0;CACO-2: 6.2;HAP1: 14.9;HMC-1: 6.4;HUVEC TERT2: 20.4"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Not detected"	"Not detected"			"HPA005455, HPA017067"	Approved		Uncertain	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA005455: AB_1078140, HPA017067: AB_1844767"	"unprognostic (7.47e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-7)"	"unprognostic (5.48e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-1)"	5.4	0.4	0.4	2.6	0.3	0.9	3.8	0.5	0.3	3.5	0.3	12.0	17.5	3.3	1.4	0.9	2.2	8.0	1.1	0.3	2.3	0.5	38.9	2.7	2.1	0.6	0.8	0.1	1.0	61.7	0.4	0.1	0.4	0.8	1.6	13.2	0.2	0.5	0.8	1.1	1.1	18.0	4.4	0.3	0.2	1.3	0.8	0.7	0.6	0.9	0.7	1.4	1.8	1.2	0.6	0.0	25.0	0.0	0.1	0.0	0.2	0.6	0.0	0.4	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.7	0.7	14.9	0.0	0.0	3.3	1.1	0.0	0.3	2.7	0.5	0.1	6.4	0.1	0.0	0.0	0.1	0.0	20.4	0.1	0.0	0.3	0.0	0.6	0.0	0.4	0.9	0.0	0.3	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	1.7	4.7	0.3	0.1	1.0	0.2	0.1	0.2	3.4	2.3	2.6	0.3	0.2	0.1	3.2	0.4	0.4	0.2	0.2	0.2	0.3	0.3	0.3	0.1	0.4	0.4	0.3	1.5	0.5	0.2	0.5	0.4	0.1	0.4	0.3	0.5	0.3	0.3	2.3	0.6	0.8	0.1	0.8	0.3	0.7	0.6	23.7	0.0	1.7	0.3	0.2	1.9	0.1	0.0	0.0	0.2	0.2	0.0	9.9	32.9	0.0	0.0	0.0	0.0	0.3	37.5	0.0	38.2	0.4	0.3	0.3	32.4	4.9	2.7	0.4	54.5	0.0	0.8	0.0	0.2	13.3	276.2	38.6	38.5	0.1	0.0	0.6	13.8	0.0	4.9	1.5	0.3	0.6	0.6	0.0	0.0	3.1	0.0	0.0	1.0	0.3	22.0	21.8	0.0	1.2	0.3	49.9	0.0	0.8	0.3	0.0	0.5	6.1	0.1	0.1	0.0	1.4	0.0	0.3	0.1	32.3	0.2
OR2I1P	"HS6M1-14, OR2I1, OR2I2, OR2I3P, OR2I4P"	ENSG00000237988	"Olfactory receptor family 2 subfamily I member 1 pseudogene"		6	29550407-29557721	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Ductal cells: 1.0;granulocytes: 1.3;monocytes: 1.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 71.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (7.45e-3)"	"unprognostic (1.69e-2)"	"unprognostic (6.00e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.34e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (4.00e-6)"	"unprognostic (8.46e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0
OXER1	"GPCR, GPR170, TG1019"	ENSG00000162881	"Oxoeicosanoid receptor 1"	Q8TDS5	2	42762481-42764261	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 56.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 8.3;Proximal enterocytes: 16.1;Skeletal myocytes: 12.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 12.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 67.0;eosinophil: 144.5"	"Lineage enriched"	"Detected in many"	79	"granulocytes: 144.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.6;Hep G2: 7.6;HMC-1: 6.1;REH: 3.2;THP-1: 2.8"									HPA051433	Approved					NA	NA					"HPA051433: AB_2681485"	"unprognostic (6.77e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.09e-3)"	"unprognostic (4.45e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.46e-2)"	1.9	1.8	1.3	1.6	1.3	2.4	1.9	0.4	1.8	6.2	1.3	2.9	5.1	3.1	2.4	2.4	3.6	1.4	2.3	1.4	0.7	8.2	56.8	1.9	1.2	1.1	0.8	0.8	9.2	7.2	0.3	3.8	1.7	1.1	6.7	1.8	0.3	1.5	1.7	0.9	3.1	8.6	0.8	0.6	4.9	2.3	1.2	0.7	1.0	2.2	0.4	1.1	6.1	4.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	6.6	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.3	2.2	0.0	7.6	0.0	0.1	6.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	1.4	0.0	0.0	3.2	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.6	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	67.0	1.8	144.5	0.1	0.6	0.0	0.2	0.0	0.0	1.4	0.1	0.0	0.0	16.9	0.0	0.1	0.2	0.0	0.8	1.3	1.3	0.4	1.8	1.4	0.7	1.1	0.8	0.8	1.1	0.6	0.7	1.4	0.1	0.0	0.5	0.7	0.1	0.5	0.6	0.2	0.6	1.6	0.4	0.6	0.4	2.8	0.2	1.8	0.0	0.1	0.0	1.9	1.9	0.6	0.0	0.1	2.0	0.1	1.2	0.0	0.0	2.0	0.1	2.0	0.0	0.1	2.5	0.4	0.4	8.3	1.0	0.0	0.0	3.4	0.0	1.3	1.2	0.3	3.4	1.5	3.6	1.0	3.0	0.9	0.0	0.0	0.0	0.6	5.3	1.9	0.0	0.5	16.1	4.9	0.2	0.0	0.0	12.9	1.1	0.3	0.2	0.3	0.1	0.3	1.1	0.3	5.1	0.3
PAGE2B	CT16.5	ENSG00000238269	"PAGE family member 2B"	Q5JRK9	X	55075030-55078909	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 57.0"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 240.8;Spermatogonia: 322.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"U-266/70: 1390.8;U-266/84: 2279.6"									HPA052619	Supported					NA	NA					"HPA052619: AB_2681887"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-2)"		"prognostic unfavorable (3.02e-4)"	"unprognostic (1.40e-1)"		"unprognostic (1.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.81e-2)"		"unprognostic (2.05e-8)"		"unprognostic (1.41e-1)"		"unprognostic (8.84e-2)"	0.1	0.0	0.3	0.0	0.3	4.1	0.3	0.3	0.7	0.2	0.3	0.1	0.1	0.0	0.0	0.1	0.4	0.3	0.1	0.4	0.4	0.2	0.4	0.2	0.2	0.4	0.4	0.3	0.3	0.1	0.0	0.2	0.3	0.4	0.3	0.0	0.1	0.1	0.2	0.0	0.7	0.4	0.1	0.4	0.7	0.1	57.0	0.4	0.2	0.1	0.7	0.4	0.2	0.2	0.4	3.8	0.0	0.0	0.8	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.9	0.0	0.2	0.0	1.3	0.4	2.9	0.5	0.2	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.0	0.0	0.3	1.7	0.1	0.0	0.0	0.3	0.1	0.5	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.9	0.0	0.0	216.2	0.2	2.6	1390.8	2279.6	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.7	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.5	36.1	0.0	0.0	0.3	0.0	26.5	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.3	13.0	4.4	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.8	4.1	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.0	19.7	0.0	0.0	240.8	322.4	0.0	0.0	0.3	0.1	0.4	0.0	0.0
PBLD	"FLJ14767, MAWBP, MAWDBP"	ENSG00000108187	"Phenazine biosynthesis like protein domain containing"	P30039	10	68282660-68333049	"Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 173.1;kidney: 272.6;liver: 337.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 97.5;Distal tubular cells: 109.5;Hepatocytes: 216.9;Proximal enterocytes: 380.2;Proximal tubular cells: 426.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 16.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038035, HPA038036"	Enhanced		Approved	Vesicles		NA	NA		1100000	Vesicles		"HPA038035: AB_10672470, HPA038036: AB_10675625"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.25e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.26e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.68e-2)"	9.0	11.3	4.0	8.5	6.1	9.3	4.5	5.7	4.9	4.0	4.6	33.5	173.1	6.0	3.8	3.4	7.3	9.5	6.3	3.4	5.6	272.6	337.9	3.9	5.5	4.9	4.6	3.2	3.6	63.5	5.7	2.3	4.2	5.1	5.7	27.9	8.8	4.6	5.1	5.7	5.7	147.6	5.1	3.8	4.6	55.3	3.8	4.6	2.1	5.6	3.1	2.2	5.5	2.2	9.7	3.8	7.5	7.1	4.9	6.4	3.6	3.3	15.1	9.5	5.6	5.8	6.9	9.5	4.2	5.6	10.6	2.3	5.8	3.3	3.9	4.8	2.0	5.4	3.3	9.3	6.4	3.0	5.0	3.3	6.4	4.0	3.4	4.2	10.1	3.5	4.0	3.1	9.2	8.9	5.9	4.7	8.7	2.1	3.0	3.2	8.0	9.4	7.1	11.3	5.4	4.1	5.5	10.1	5.8	7.0	2.0	20.0	5.9	10.9	5.5	3.9	2.7	2.5	5.5	4.3	6.3	6.6	2.7	1.4	2.6	2.8	1.5	0.4	1.4	0.8	0.8	0.6	0.4	2.8	0.6	1.1	0.7	3.3	1.8	0.9	1.2	1.1	1.2	4.0	6.1	5.7	4.9	3.4	5.6	4.9	4.6	3.2	5.1	3.8	4.6	9.7	1.6	3.2	4.2	3.6	4.5	1.9	1.7	2.2	1.2	5.0	6.2	2.8	3.5	24.3	4.3	55.2	10.4	3.9	3.7	97.5	109.5	8.8	1.2	17.9	5.7	3.4	7.2	6.6	1.8	31.8	2.0	3.2	33.1	6.5	1.3	8.2	6.4	216.9	3.1	10.1	2.8	42.6	2.0	10.4	4.4	0.4	4.1	5.5	1.8	3.7	5.0	5.5	3.1	3.0	7.5	12.5	46.4	3.0	1.5	2.0	380.2	426.5	12.9	17.2	0.0	2.0	6.6	1.6	1.4	1.8	0.6	3.1	2.8	9.6	57.3	3.0
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848417-66958386	"Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 61.4;liver: 149.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 201.9;Late spermatids: 53.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		200000	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	61.4	23.9	31.7	2.9	31.8	3.5	28.7	34.6	36.1	3.2	14.0	4.2	6.5	3.8	1.9	9.4	3.2	2.8	4.3	29.3	41.3	23.5	149.2	2.7	1.3	40.9	36.0	22.6	5.1	5.0	18.3	8.6	4.4	34.9	7.3	2.8	2.5	35.6	9.4	12.2	4.6	7.7	1.4	33.9	1.5	9.2	10.8	40.5	2.0	4.7	6.6	2.0	2.9	4.5	34.2	6.1	19.3	6.5	17.2	25.4	8.9	6.6	3.4	15.5	6.9	7.5	8.8	6.0	0.0	7.4	6.0	9.6	6.8	7.7	39.5	1.5	2.8	11.0	10.3	57.4	41.2	21.0	0.1	10.8	40.2	10.1	5.8	12.4	4.4	5.7	14.3	17.4	0.0	2.1	44.6	9.2	4.6	12.0	15.1	16.2	8.3	13.0	3.2	5.7	1.9	15.2	21.0	33.6	18.0	15.5	4.8	14.6	2.7	6.3	7.8	6.6	8.8	4.7	3.5	4.8	0.1	7.7	5.7	6.7	0.0	1.3	0.0	0.5	0.3	0.5	0.0	0.1	0.5	0.9	0.2	0.9	0.5	0.1	0.1	0.1	0.3	0.5	0.7	31.7	31.8	34.6	36.1	29.3	41.3	40.9	36.0	22.6	34.9	33.9	40.5	34.2	0.9	0.0	3.0	26.4	1.4	1.3	1.6	9.1	2.8	5.6	4.8	5.8	4.4	11.5	3.0	3.7	2.1	17.4	0.6	27.6	1.9	3.1	18.4	2.3	7.1	1.5	9.0	28.0	18.5	1.8	4.2	3.2	5.6	3.0	8.9	16.0	4.6	201.9	12.3	0.0	18.6	5.0	0.0	7.0	1.8	53.2	0.6	1.8	5.4	7.5	18.9	9.4	2.1	10.1	16.7	2.3	8.5	4.1	0.1	3.1	23.6	39.0	1.5	4.8	0.0	2.2	2.2	11.2	4.7	4.1	0.6	25.4	1.2	6.0	6.4	1.3
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 197.9;kidney: 100.0;liver: 377.2"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 309.3;Proximal enterocytes: 752.6;Proximal tubular cells: 237.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 104.7;hTCEpi: 104.7;SK-MEL-30: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		NA	NA		3500000	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	25.2	10.8	3.3	8.1	3.6	4.5	21.3	3.5	3.2	6.3	3.1	28.1	197.9	5.9	3.1	20.1	6.0	4.6	4.9	2.8	4.5	100.0	377.2	16.6	8.8	4.1	3.8	2.6	3.0	35.0	17.6	8.0	2.8	3.8	9.1	19.4	2.7	18.7	7.2	2.6	12.4	137.5	3.9	3.8	21.9	16.2	19.9	3.7	3.7	19.0	1.2	7.6	10.9	10.1	3.8	17.6	9.8	2.7	18.1	11.0	10.5	46.0	21.5	25.6	17.4	28.4	16.1	19.9	44.6	2.6	33.4	5.6	25.4	18.0	28.1	13.8	22.8	0.8	8.0	5.0	84.2	104.7	15.8	33.4	12.9	104.7	10.6	26.5	5.0	14.0	50.6	23.4	79.3	6.4	74.6	4.0	7.6	3.1	39.4	13.0	8.7	10.5	26.0	5.3	26.7	11.3	18.2	16.5	21.2	103.9	2.6	28.5	24.1	2.7	3.8	19.7	5.6	6.0	53.2	18.6	11.0	10.6	24.5	9.6	0.3	11.6	3.5	4.0	21.6	4.1	11.4	4.5	4.5	15.3	7.3	2.7	2.5	1.3	2.2	22.0	2.5	9.1	6.1	3.3	3.6	3.5	3.2	2.8	4.5	4.1	3.8	2.6	3.8	3.8	3.7	3.8	4.8	12.8	28.5	1.3	17.9	3.3	10.2	12.3	5.7	4.7	8.6	5.2	1.8	18.6	8.0	18.4	0.0	4.7	4.3	91.2	35.2	18.9	60.1	1.6	5.2	5.6	9.1	24.4	0.5	76.3	14.3	7.4	16.8	4.5	1.3	1.6	13.2	309.3	63.8	0.0	0.9	60.8	18.3	25.8	5.7	30.8	3.4	16.4	7.2	1.0	22.9	5.8	7.2	0.0	0.1	29.0	87.8	3.0	13.3	7.6	752.6	237.1	4.8	5.5	0.0	3.4	18.7	19.8	1.0	9.1	4.8	3.0	7.6	6.8	72.0	15.0
PCSK6	"PACE4, SPC4"	ENSG00000140479	"Proprotein convertase subtilisin/kexin type 6"	P29122	15	101289784-101525202	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 149.1;liver: 161.3;lymphoid tissue: 82.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 231.6;Horizontal cells: 196.9;Oligodendrocytes: 561.9;Theca cells: 106.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.2;CACO-2: 35.7;HEK 293: 60.3;Hep G2: 53.8;OE19: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004774	Uncertain				"Secreted to extracellular matrix"	NA	NA		480000			"HPA004774: AB_1079583"	"prognostic favorable (9.99e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.14e-2)"	"unprognostic (2.20e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.06e-7)"	"unprognostic (2.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-2)"	5.3	2.2	19.9	3.0	56.5	1.1	11.3	52.0	37.3	2.3	3.3	16.6	6.9	2.0	3.4	9.1	2.8	3.1	20.2	16.5	44.4	2.7	161.3	3.7	2.5	106.2	63.5	8.6	6.2	2.6	0.6	5.1	32.3	79.6	3.1	14.9	7.7	2.8	0.6	11.4	9.3	10.2	3.6	58.7	82.1	9.9	13.1	49.1	21.1	2.2	16.4	1.9	3.7	2.6	149.1	19.7	14.6	2.6	0.9	0.2	0.4	47.2	0.7	2.5	0.0	0.1	35.7	8.3	0.4	2.4	0.6	1.1	11.4	12.5	1.5	0.0	2.8	60.3	33.5	8.4	53.8	1.6	4.5	0.4	0.3	7.5	0.2	0.2	0.2	0.1	4.3	24.5	0.2	0.0	8.8	0.1	4.7	9.3	65.9	6.5	0.2	0.4	4.4	4.4	25.4	7.3	8.6	26.2	1.5	9.1	6.6	2.2	21.9	0.2	0.3	1.2	0.3	0.2	0.5	0.6	0.7	0.2	0.6	7.3	0.8	0.2	0.9	0.2	0.4	0.3	0.5	0.4	0.2	0.1	1.0	0.6	0.5	0.4	3.3	1.3	0.4	0.1	1.2	19.9	56.5	52.0	37.3	16.5	44.4	106.2	63.5	8.6	79.6	58.7	49.1	149.1	1.7	3.2	0.6	2.9	1.3	0.4	0.3	0.9	0.6	1.7	15.4	6.6	2.0	8.6	1.4	1.8	20.9	6.7	0.6	22.6	0.0	0.6	1.6	4.7	21.6	4.9	0.0	3.2	19.4	0.8	24.3	15.5	1.5	6.9	0.0	4.2	12.5	231.6	1.4	196.9	30.8	3.7	0.0	5.2	1.1	2.4	10.5	1.7	0.0	5.6	1.0	1.7	3.1	25.6	561.9	7.3	8.2	0.0	0.0	1.7	2.3	0.1	1.2	1.6	0.0	2.0	1.0	4.7	2.4	0.9	0.1	3.3	1.0	106.5	8.5	0.2
PECR	"HSA250303, SDR29C1, TERP"	ENSG00000115425	"Peroxisomal trans-2-enoyl-CoA reductase"	Q9BY49	2	215996329-216082955	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 161.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 91.0;Proximal enterocytes: 49.5;Proximal tubular cells: 79.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 30.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 38.3;RPTEC TERT1: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021593, HPA022539"	Enhanced		Supported	Peroxisomes		NA	NA			Peroxisomes		"HPA021593: AB_1855177, HPA022539: AB_1855178"	"unprognostic (7.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.90e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.01e-3)"	"unprognostic (5.61e-2)"	"prognostic favorable (1.36e-5)"	"unprognostic (6.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.75e-2)"	"unprognostic (6.64e-2)"	25.6	5.4	2.5	2.9	3.0	7.2	10.3	3.6	2.9	4.5	5.2	8.8	26.3	3.3	4.2	3.1	8.2	9.8	2.4	2.5	2.8	34.3	161.5	6.5	4.0	3.1	3.1	2.6	4.1	4.9	7.2	3.2	1.1	3.2	5.0	7.6	2.2	5.6	3.4	6.8	3.4	20.3	3.3	2.6	3.1	4.0	0.5	2.9	3.4	16.2	5.2	3.8	2.4	2.3	3.5	6.0	6.6	2.6	0.1	15.7	5.7	3.1	1.4	3.3	3.7	6.3	7.6	17.1	0.1	11.9	3.5	9.2	1.4	7.5	8.7	6.5	9.5	7.7	7.8	3.6	38.3	15.7	2.0	5.1	5.0	6.1	3.9	5.5	5.6	3.8	4.6	3.3	8.6	8.2	4.4	2.4	2.2	4.8	0.1	4.9	5.3	5.0	0.9	35.9	1.0	3.6	5.2	3.6	7.4	15.6	6.2	8.6	6.5	0.0	2.4	2.5	6.0	4.3	9.8	8.9	3.1	5.3	2.8	5.6	1.2	4.2	1.5	6.5	1.6	7.7	4.3	8.8	7.5	1.5	5.7	9.2	6.1	4.5	9.9	2.3	0.2	16.6	4.1	2.5	3.0	3.6	2.9	2.5	2.8	3.1	3.1	2.6	3.2	2.6	2.9	3.5	4.3	6.4	13.6	6.5	7.0	3.7	4.7	4.0	3.4	10.8	2.4	2.9	3.7	35.8	3.4	29.5	14.6	3.9	5.9	11.5	13.7	13.2	0.1	10.1	2.7	3.9	7.2	9.4	15.4	3.8	7.3	5.0	7.7	6.3	1.3	2.0	6.8	91.0	9.6	3.3	18.4	8.0	6.1	4.7	3.7	0.3	5.6	5.5	10.6	8.4	27.4	10.1	9.2	8.5	10.6	5.0	17.7	8.2	5.9	2.0	49.5	79.1	13.1	6.4	0.0	6.6	4.4	0.1	1.6	4.9	2.8	1.6	11.4	1.9	14.6	2.7
PHYH	"PAHX, PHYH1, RD"	ENSG00000107537	"Phytanoyl-CoA 2-hydroxylase"	O14832	10	13277796-13302412	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 673.3;skeletal muscle: 488.2;tongue: 416.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 258.6;Proximal tubular cells: 414.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007598, HPA011796"	Enhanced					NA	NA					"HPA007598: AB_1855334, HPA011796: AB_1855335"	"unprognostic (5.78e-2)"	"unprognostic (3.83e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.09e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.24e-1)"	"prognostic favorable (7.28e-12)"	"unprognostic (2.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.19e-1)"	58.5	67.1	22.7	9.6	23.1	8.3	32.5	23.4	28.6	29.1	30.1	47.0	59.3	22.3	16.8	23.1	16.8	28.4	127.7	22.3	26.6	193.2	673.3	17.4	7.6	22.3	23.7	20.2	37.1	48.6	57.1	21.0	19.5	22.3	22.7	37.5	28.5	34.0	25.6	488.2	16.6	56.3	23.4	22.2	12.9	44.6	15.3	24.9	5.7	56.5	416.4	5.4	27.2	14.9	23.3	17.2	35.2	15.6	22.5	110.7	69.9	12.4	17.2	23.9	19.4	19.1	9.1	30.3	0.9	12.9	29.0	47.0	7.8	20.5	20.2	11.8	41.4	10.7	14.9	9.3	36.6	54.8	2.5	26.8	50.3	28.9	21.0	8.4	22.7	18.7	16.8	8.4	32.2	45.5	16.3	9.2	12.1	14.4	49.4	12.6	15.7	24.1	5.8	40.6	21.9	5.3	16.8	64.8	1.4	32.9	12.5	64.8	44.2	6.4	29.5	10.6	36.4	11.8	36.6	26.3	3.3	38.3	18.9	11.6	16.3	18.7	8.2	8.0	14.2	17.6	11.0	9.9	10.4	15.8	5.6	12.5	12.7	0.8	4.4	11.2	14.4	10.5	12.3	22.7	23.1	23.4	28.6	22.3	26.6	22.3	23.7	20.2	22.3	22.2	24.9	23.3	53.6	12.8	19.2	8.5	14.5	11.9	27.6	19.1	6.2	47.0	22.6	24.5	258.6	77.2	19.7	35.0	22.9	137.8	20.5	72.9	144.8	40.6	33.1	18.5	29.0	29.7	31.8	15.2	7.1	19.6	34.3	41.3	41.8	26.8	30.4	28.3	25.0	145.5	55.4	21.9	5.6	57.4	46.8	21.0	22.0	45.4	25.4	25.3	17.8	4.7	10.3	69.3	7.2	2.5	2.4	16.7	46.0	37.6	15.1	11.9	141.9	414.6	19.6	41.8	19.7	30.2	37.5	12.5	1.6	7.3	13.4	83.9	25.2	103.3	46.9	18.1
PLIN5	"LSDA5, LSDP5, MLDP, OXPAT"	ENSG00000214456	"Perilipin 5"	Q00G26	19	4522531-4535224	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 203.7;pancreas: 113.2;skeletal muscle: 150.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 47.1;Astrocytes: 53.8;Cardiomyocytes: 39.8;Hepatic stellate cells: 42.1;Hepatocytes: 140.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.9"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 13.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;BEWO: 3.2;RT4: 3.1;SH-SY5Y: 2.8;T-47d: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA077050			Supported	"Vesicles,Lipid droplets"		NA	NA			"Vesicles, Lipid droplets"		"HPA077050: "	"prognostic favorable (7.68e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (8.56e-4)"	"unprognostic (1.24e-2)"	"unprognostic (6.06e-3)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"prognostic favorable (2.16e-4)"	37.5	6.5	10.9	3.6	10.2	5.3	29.5	7.1	9.6	5.1	11.2	4.9	1.5	2.7	3.9	3.4	12.7	2.0	46.2	8.3	7.7	29.9	203.7	9.4	0.5	9.6	7.8	7.9	91.5	113.2	1.5	19.0	0.2	8.7	17.8	0.6	0.9	61.6	3.9	150.4	5.6	5.4	0.5	6.3	8.2	59.4	3.4	9.7	0.4	9.9	25.0	1.0	11.3	2.7	6.6	0.2	0.1	0.5	2.3	1.7	0.1	3.2	0.1	0.1	0.1	0.0	0.2	0.5	0.1	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.4	0.3	0.4	0.4	0.0	0.0	0.0	0.2	0.2	0.1	0.7	0.2	0.1	0.6	0.1	0.4	0.4	0.3	0.3	0.1	0.1	2.1	0.2	3.1	0.3	2.8	0.2	0.4	0.0	0.2	6.3	0.4	0.3	0.3	0.3	0.2	0.2	0.3	0.1	0.1	0.2	0.6	0.1	1.9	0.4	0.8	0.3	0.3	0.2	0.3	0.2	0.2	0.1	0.4	0.3	0.3	13.9	0.6	0.3	0.3	0.1	0.1	10.9	10.2	7.1	9.6	8.3	7.7	9.6	7.8	7.9	8.7	6.3	9.7	6.6	6.0	9.6	47.1	53.8	1.6	0.5	18.4	2.3	4.0	1.2	9.2	1.9	39.8	35.8	11.5	1.8	0.0	0.4	0.1	11.9	9.8	8.7	1.5	20.8	1.4	7.4	0.0	2.7	1.1	12.3	0.5	1.3	16.3	5.1	3.8	18.7	42.1	140.5	0.5	0.0	1.8	6.9	4.1	6.9	0.5	0.3	0.3	2.5	0.0	5.6	0.1	8.1	0.0	11.1	2.0	4.8	1.3	2.6	0.5	6.6	0.5	11.1	10.4	1.2	13.1	25.8	1.8	6.2	6.6	0.5	1.0	1.4	1.1	20.5	8.8	11.5
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923792-43964488	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 31.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 35.9;Cone photoreceptor cells: 18.8;Hepatocytes: 42.3;Rod photoreceptor cells: 37.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 16.7;LHCN-M2: 19.3"	"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.2	0.2	0.6	0.5	0.8	0.1	1.6	0.2	1.4	0.6	4.8	0.1	0.8	0.3	0.1	0.2	0.9	0.4	0.2	1.2	0.5	4.6	31.3	0.8	0.3	1.4	1.6	0.7	0.3	0.0	0.2	0.0	0.3	2.1	0.0	0.1	6.4	0.7	0.0	1.7	5.3	0.5	0.0	0.2	0.4	0.2	0.4	1.2	0.1	0.1	0.1	0.2	0.0	0.3	2.2	5.1	1.6	16.7	6.8	4.6	5.2	0.5	3.1	1.8	4.1	8.8	5.0	9.0	0.0	2.5	5.2	2.4	4.3	10.6	5.0	3.4	0.0	0.9	0.3	4.5	9.4	7.5	0.0	0.3	6.0	3.8	13.2	0.6	7.0	0.5	0.2	0.0	0.0	19.3	0.7	0.3	0.0	11.5	0.6	0.0	0.1	8.9	0.2	1.7	0.2	1.5	0.1	3.4	1.4	4.8	2.9	5.3	5.8	0.6	1.6	4.9	0.1	0.1	0.1	0.0	0.0	14.3	0.1	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.2	1.4	1.2	0.5	1.4	1.6	0.7	2.1	0.2	1.2	2.2	0.4	0.0	0.0	4.2	0.2	0.4	0.5	2.4	0.0	35.9	0.5	0.1	1.3	10.0	1.4	0.0	18.8	0.0	0.2	0.2	0.0	0.4	0.0	1.5	0.5	0.4	1.8	0.0	1.9	0.0	0.1	0.5	0.0	3.6	0.0	1.9	0.7	42.3	0.7	0.0	1.2	0.8	0.0	2.8	0.3	0.3	0.3	0.9	1.8	0.0	0.0	1.1	0.0	0.0	0.8	2.6	0.0	0.7	0.0	0.7	0.4	5.0	0.1	37.3	0.0	1.0	0.8	0.6	0.6	0.0	0.1	0.0	0.2	1.6	0.4	0.4
PPP1R1A		ENSG00000135447	"Protein phosphatase 1 regulatory inhibitor subunit 1A"	Q13522	12	54575387-54588659	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 243.4;skeletal muscle: 839.5;tongue: 273.5"	"Cell type enriched"	"Detected in many"	4	"Distal tubular cells: 1348.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 8.8;NTERA-2: 29.4;RPTEC TERT1: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007811, HPA041542"	Approved					NA	NA					"CAB007811: AB_598171, HPA041542: AB_2677542"	"unprognostic (6.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (8.49e-3)"	"unprognostic (7.49e-2)"	243.4	2.6	36.1	1.1	60.4	0.3	171.2	25.7	45.0	1.5	19.5	21.6	3.1	2.2	0.7	10.4	3.9	1.5	108.1	38.1	41.2	93.3	139.2	1.0	0.5	37.1	31.3	35.1	7.8	14.3	21.0	1.8	0.0	41.2	8.0	1.8	14.7	9.8	3.2	839.5	6.2	13.3	3.3	23.7	0.5	28.0	2.2	28.5	0.2	2.6	273.5	0.5	5.4	1.5	33.3	0.0	0.0	3.9	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	5.4	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	29.4	0.0	0.0	0.0	0.0	0.2	32.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	1.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	60.4	25.7	45.0	38.1	41.2	37.1	31.3	35.1	41.2	23.7	28.5	33.3	7.9	0.0	0.0	3.3	3.4	0.1	0.0	0.0	0.0	2.2	23.7	40.6	300.7	5.7	0.0	18.4	0.0	0.0	0.5	0.0	1348.0	3.5	1.6	10.4	0.5	4.6	2.4	2.7	3.1	0.4	0.1	24.5	0.0	13.8	0.0	21.0	6.4	218.4	0.6	112.7	1.8	2.1	0.0	3.8	0.0	1.9	1.2	1.6	0.0	0.0	0.0	3.7	0.0	0.0	0.5	2.5	0.1	1.2	0.0	0.3	0.5	156.8	0.0	2.8	0.0	19.2	21.6	0.2	5.9	0.0	0.3	0.0	0.9	4.2	2.0	0.2
PPP1R3G		ENSG00000219607	"Protein phosphatase 1 regulatory subunit 3G"	B7ZBB8	6	5085341-5089487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 5.9;liver: 6.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 18.5;Glandular and luminal cells: 7.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.3;PC-3: 3.9;THP-1: 14.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA056393	Uncertain					NA	NA					"HPA056393: AB_2683115"	"unprognostic (1.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-3)"	"unprognostic (8.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.27e-1)"	1.6	3.1	2.3	0.3	1.9	0.1	1.4	1.5	2.7	2.0	0.9	1.5	0.2	1.2	1.1	1.8	1.0	0.3	5.9	2.0	1.5	0.5	6.2	0.3	0.5	2.2	2.0	1.7	0.8	0.1	0.3	0.2	0.7	2.1	1.2	0.5	0.2	0.6	1.5	0.5	1.1	0.5	0.5	1.4	2.8	0.6	0.2	2.1	0.2	0.3	0.2	0.4	2.8	2.2	1.9	0.0	0.2	0.1	0.0	1.6	1.0	0.0	0.3	0.4	0.2	0.3	0.0	0.3	0.0	3.3	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.3	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	3.9	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.3	0.0	14.6	0.0	0.0	0.0	0.8	0.5	2.0	1.7	0.0	0.6	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	2.3	1.9	1.5	2.7	2.0	1.5	2.2	2.0	1.7	2.1	1.4	2.1	1.9	4.2	0.0	0.0	0.0	0.4	0.5	0.5	0.4	0.0	0.5	0.2	0.1	18.5	0.0	0.1	3.7	0.0	0.8	0.0	1.3	0.0	0.3	0.0	1.2	2.0	1.9	1.2	0.0	0.0	0.0	0.4	3.7	0.0	7.2	0.0	1.4	2.9	0.0	4.5	0.0	0.0	0.9	0.0	4.0	4.7	0.2	0.9	1.8	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.6	1.8	3.0	1.8	0.4	0.0	2.1	0.2	0.2	0.0	2.0	2.5	0.1	0.9	0.2	0.3	0.8	0.2	0.5	1.4	1.2
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041510	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3;liver: 87.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 196.4;Hepatocytes: 285.9;Horizontal cells: 523.3;Paneth cells: 130.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 31.4;RH-30: 15.9;SH-SY5Y: 77.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000842, HPA001030, HPA027298"			Enhanced	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	1.5	10.1	12.2	1.5	21.0	0.0	1.8	21.9	18.2	1.0	0.0	2.6	2.1	1.1	1.2	0.6	2.3	1.9	15.8	22.7	11.6	4.8	87.5	1.2	2.9	14.9	18.5	3.0	7.5	15.7	0.1	4.0	0.4	15.1	0.5	2.7	21.4	0.3	0.4	3.6	0.6	2.6	0.9	13.6	7.2	2.1	5.4	26.6	0.2	7.6	2.1	0.7	1.0	0.8	37.3	0.0	0.0	0.6	0.0	0.3	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.0	0.3	0.2	2.3	0.0	0.1	0.0	1.0	0.6	0.0	31.4	0.0	0.0	0.2	0.3	0.1	0.0	0.2	0.1	3.5	2.3	5.7	0.0	0.4	0.0	0.4	0.0	1.7	2.0	1.3	0.0	15.9	2.5	0.2	0.5	2.3	77.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.2	0.7	0.2	0.9	0.0	0.0	0.0	0.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	21.0	21.9	18.2	22.7	11.6	14.9	18.5	3.0	15.1	13.6	26.6	37.3	14.3	0.0	2.3	1.3	1.9	5.9	1.1	0.3	5.7	196.4	4.8	4.7	105.9	102.9	1.3	9.2	2.1	0.0	0.1	3.2	15.6	34.7	52.7	0.1	1.0	36.5	66.9	5.3	2.9	2.7	0.1	8.7	8.6	0.3	0.0	9.3	11.0	285.9	0.9	523.3	66.8	16.5	12.2	4.4	6.6	10.4	1.2	2.2	10.6	8.4	0.0	36.0	0.0	27.2	114.0	3.4	130.6	1.2	0.1	3.9	3.3	0.4	0.9	11.7	0.0	113.6	3.7	2.9	0.4	0.4	4.5	0.0	1.9	29.6	10.5	0.9
PXMP2	"MPV17L3, PMP22"	ENSG00000176894	"Peroxisomal membrane protein 2"	Q9NR77	12	132687587-132704985	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 314.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 187.3;Hepatocytes: 577.4;Proximal enterocytes: 333.3;Proximal tubular cells: 303.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 43.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.12e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.84e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.04e-1)"	20.5	14.8	22.1	7.6	22.3	23.6	18.9	23.0	30.0	13.7	33.0	46.8	52.6	15.0	22.5	16.3	18.8	15.5	47.1	26.9	22.0	57.8	314.6	13.0	11.6	22.3	22.1	22.3	23.2	42.9	14.6	9.3	8.1	22.1	20.0	39.5	7.6	18.8	9.8	42.7	14.6	55.6	9.6	20.9	13.2	99.0	9.2	22.9	26.1	14.8	30.8	10.8	16.1	12.9	22.2	60.5	24.8	36.6	34.1	21.5	16.6	21.4	21.0	19.4	44.7	39.6	30.3	22.4	37.2	24.9	30.0	15.7	42.0	49.1	26.6	24.3	21.3	77.8	33.2	43.9	33.8	41.7	24.8	14.4	21.7	21.8	18.6	14.7	31.2	12.1	56.2	58.2	28.4	23.8	54.2	78.9	39.2	35.7	70.0	33.9	80.1	39.2	30.6	32.9	25.2	69.0	22.5	45.6	23.6	29.6	28.1	63.2	56.0	14.3	21.9	51.1	19.1	35.6	25.7	26.7	60.6	24.6	34.9	17.7	0.0	1.2	2.9	2.3	0.6	2.1	2.5	1.8	2.4	2.1	2.7	1.8	1.5	0.7	1.5	0.6	6.3	3.1	1.2	22.1	22.3	23.0	30.0	26.9	22.0	22.3	22.1	22.3	22.1	20.9	22.9	22.2	10.9	3.2	7.2	8.1	8.2	8.4	20.0	10.6	15.4	6.1	50.3	51.1	35.8	138.7	6.0	25.8	4.2	60.1	7.3	187.3	166.3	16.5	18.7	11.8	16.9	14.1	18.7	55.9	5.9	10.3	36.6	17.0	65.7	17.4	4.5	32.4	46.8	577.4	34.9	0.0	7.1	85.1	2.0	19.2	9.4	38.8	31.1	8.1	12.4	5.6	2.7	45.5	13.4	4.5	1.0	10.2	143.4	35.0	20.9	28.1	333.3	303.7	2.1	7.3	19.7	7.5	14.8	44.9	30.2	31.2	10.7	28.5	8.1	12.4	158.6	23.2
PZP	CPAMD6	ENSG00000126838	"PZP alpha-2-macroglobulin like"	P20742	12	9148840-9208395	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 82.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 26.2;Hepatocytes: 26.4;Late spermatids: 11.0;Oligodendrocyte precursor cells: 8.5;Respiratory ciliated cells: 24.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.0;liver cancer: 0.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.1;MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Group enriched"	"Detected in some"	9	"HeLa: 5.7;SiHa: 2.5"									"HPA041403, HPA041471"	Supported				"Secreted to blood"	NA	NA		15000000000			"HPA041403: AB_10804003, HPA041471: AB_10795636"	"unprognostic (8.48e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-4)"	"unprognostic (4.79e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.81e-3)"	0.2	0.0	5.7	0.0	0.9	0.1	0.2	1.6	0.9	0.1	0.4	0.0	0.0	1.3	0.1	0.0	1.2	0.0	0.4	0.7	1.9	0.1	82.2	0.8	0.0	2.2	3.9	0.2	0.0	0.0	0.0	0.1	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.6	0.0	2.3	3.9	0.0	0.1	0.1	0.0	0.1	0.1	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.1	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.9	1.6	0.9	0.7	1.9	2.2	3.9	0.2	4.1	1.4	3.9	1.3	1.9	3.2	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.8	0.0	0.0	1.6	0.0	2.7	0.0	2.1	0.0	1.4	0.0	0.0	0.0	26.2	4.7	0.2	2.1	0.0	0.0	3.7	0.0	0.0	0.1	0.0	1.7	0.0	0.0	1.8	26.4	0.0	0.0	2.9	0.0	0.0	0.3	0.0	11.0	0.0	0.2	0.0	2.8	0.0	0.0	2.1	8.5	4.6	0.0	0.0	0.4	0.7	0.0	0.0	0.0	24.7	0.6	0.0	0.3	0.4	0.5	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0
RARRES2	"HP10433, TIG2"	ENSG00000106538	"Retinoic acid receptor responder 2"	Q99969	7	150338317-150341662	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 2420.1;liver: 2010.9;pancreas: 1494.7"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 659.2;Hepatocytes: 2819.0;Muller glia cells: 785.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 420.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 5.4"	"Group enriched"	"Detected in many"	6	"AF22: 132.9;Hep G2: 213.8;HHSteC: 172.9;NTERA-2: 411.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	75000000	460000000				"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (2.94e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.17e-2)"	530.2	2420.1	54.8	88.2	51.3	0.4	298.1	50.7	70.8	499.0	269.0	314.1	53.7	362.2	56.4	79.3	412.0	117.6	126.1	54.0	63.1	269.1	2010.9	470.9	110.7	58.2	61.9	39.7	631.6	1494.7	632.0	104.9	59.5	53.6	264.7	79.0	34.2	56.7	115.8	18.4	58.1	187.5	103.9	59.1	150.7	181.5	27.1	57.1	9.9	85.7	34.9	63.6	267.5	383.9	58.8	0.0	0.1	132.9	0.3	0.0	0.0	2.1	11.9	25.2	4.2	17.2	1.2	8.2	1.1	15.0	2.9	1.3	0.5	0.0	0.0	0.0	2.4	0.5	0.6	23.6	213.8	172.9	2.2	0.4	36.4	0.0	0.0	0.0	2.8	0.0	0.4	0.4	0.4	4.2	0.9	2.1	2.4	411.9	1.2	0.0	0.1	17.1	0.4	2.8	1.1	0.6	1.2	2.3	0.1	0.4	1.9	0.6	0.0	0.0	0.4	1.8	0.8	0.6	1.4	0.9	1.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.4	0.0	0.0	54.8	51.3	50.7	70.8	54.0	63.1	58.2	61.9	39.7	53.6	59.1	57.1	58.8	47.1	67.3	32.0	9.4	7.0	35.1	80.7	16.8	15.9	7.0	26.2	39.0	75.0	381.8	45.0	82.8	2.1	10.1	1.9	172.6	103.7	19.8	3.7	39.9	128.7	27.1	97.4	32.0	0.4	659.2	4.3	469.6	8.2	16.4	12.0	207.5	84.6	2819.0	11.6	10.1	0.4	233.9	541.2	53.8	42.4	19.3	454.2	8.9	44.4	7.5	1.0	785.1	0.0	9.0	0.3	209.1	107.4	194.9	1.2	82.0	1.2	269.1	29.8	25.4	13.1	302.5	181.1	4.9	5.2	4.4	28.8	14.6	12.3	307.5	418.7	31.9
REEP6	"C19orf32, DP1L1, FLJ25383, Yip2f"	ENSG00000115255	"Receptor accessory protein 6"	Q96HR9	19	1491166-1497927	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 219.4;liver: 401.3;testis: 286.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 559.1;Late spermatids: 3135.0;Proximal enterocytes: 898.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 114.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 57.9;Hep G2: 56.2;K-562: 155.7;T-47d: 121.4"									"HPA003895, HPA048015"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA003895: AB_1845723, HPA048015: AB_2680233"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.38e-2)"	8.5	87.3	8.9	1.3	9.4	1.2	17.7	8.0	18.2	4.4	4.9	3.0	219.4	3.5	14.7	14.4	4.6	7.0	3.0	10.2	11.1	21.7	401.3	1.6	1.4	8.8	7.6	7.4	7.7	28.7	2.0	9.9	1.6	9.2	20.3	1.7	94.8	18.1	6.9	2.0	8.2	201.3	0.9	5.6	1.7	4.2	286.1	9.5	0.7	6.0	0.7	1.0	9.2	7.0	8.9	7.3	9.2	2.6	34.3	5.6	2.0	39.5	1.8	0.7	1.9	1.9	57.9	22.5	3.9	12.2	1.1	2.3	7.3	9.8	0.6	1.0	1.9	4.1	21.3	1.3	56.2	4.2	1.6	6.6	4.7	4.1	0.4	1.4	3.2	1.1	4.9	155.7	5.0	0.3	29.6	1.8	4.7	12.8	21.1	19.5	4.9	1.1	10.0	10.9	2.7	0.7	17.2	9.8	14.2	6.3	1.9	121.4	5.7	3.4	2.8	5.4	8.7	1.2	16.4	5.3	0.8	11.2	9.4	8.2	0.0	1.1	0.0	5.5	1.2	2.8	0.1	1.4	1.2	1.9	0.6	2.0	2.2	0.0	4.9	4.3	3.3	1.6	1.6	8.9	9.4	8.0	18.2	10.2	11.1	8.8	7.6	7.4	9.2	5.6	9.5	8.9	1.5	3.2	3.2	2.6	2.7	6.8	7.9	6.8	10.8	30.4	47.4	20.3	1.8	91.5	10.5	5.5	33.3	69.4	2.5	7.8	7.9	34.5	559.1	4.5	7.1	4.2	6.0	10.1	1.5	69.2	12.8	4.7	2.6	3.0	10.2	132.9	5.0	267.4	9.6	23.5	1.2	51.9	4.1	6.3	4.3	3135.0	34.2	4.1	30.2	0.0	1.7	44.2	2.1	0.0	1.5	25.0	53.6	16.6	1.9	13.1	898.7	52.0	8.3	292.8	19.7	0.8	3.3	29.9	36.5	17.5	6.7	36.0	4.3	50.1	70.7	14.7
RELN	"PRO1598, RL"	ENSG00000189056	Reelin	P78509	7	103471381-103989658	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein, Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 63.3"	"Group enriched"	"Detected in some"	8	"Hepatic stellate cells: 128.5;Inhibitory neurons: 372.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Group enriched"	"Detected in all"	7	"cerebellum: 63.3;pons: 16.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 16.2;PC-3: 8.6;SCLC-21H: 11.1;SH-SY5Y: 13.7;TIME: 33.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 110.0"	HPA077891			Approved	"Golgi apparatus,Vesicles"	"Secreted in brain"	NA	NA		30000000	"Golgi apparatus"	Vesicles	"HPA077891: "	"unprognostic (1.42e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.31e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.30e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.06e-2)"	1.3	1.8	1.9	0.6	1.7	0.0	2.7	63.3	3.5	1.5	0.4	0.7	0.2	0.4	0.1	0.8	2.9	0.7	1.2	3.1	5.5	0.3	13.5	0.5	0.4	2.1	4.9	1.7	0.4	0.1	0.0	0.5	0.0	16.8	0.6	0.9	2.9	0.8	0.9	0.2	0.6	0.9	0.7	1.8	0.3	0.5	0.7	3.6	0.0	1.7	1.1	0.2	0.7	0.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	2.1	0.0	0.1	0.0	0.0	4.3	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	1.9	0.0	0.0	0.0	11.1	13.7	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.7	63.3	3.5	3.1	5.5	2.1	4.9	1.7	16.8	1.8	3.6	2.5	1.0	0.0	0.0	9.1	0.5	0.6	0.0	0.0	0.6	30.2	0.5	0.4	5.1	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	13.6	0.1	0.0	8.3	0.0	7.0	2.6	1.2	0.1	7.5	0.0	0.1	0.0	0.0	128.5	3.3	0.2	0.0	372.4	0.0	0.0	5.3	2.2	6.1	0.0	0.1	0.0	2.8	0.0	0.2	0.0	3.0	10.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.8	0.7	0.1	0.8	0.0	0.6	0.3	0.4	0.0	0.0	0.0
RIPPLY1		ENSG00000147223	"Ripply transcriptional repressor 1"	Q0D2K3	X	106900063-106903341	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 2.1;liver: 5.8"	"Group enriched"	"Detected in some"	9	"Hepatocytes: 4.3;Proximal tubular cells: 1.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.2;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"RH-30: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052284	Uncertain				"Intracellular and membrane"	NA	NA					"HPA052284: AB_2681785"	"unprognostic (1.48e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.52e-3)"	"unprognostic (7.00e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.31e-1)"	0.1	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.8	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	2.1	5.8	0.0	0.0	0.1	0.4	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
RNASE4	RAB1	ENSG00000258818	"Ribonuclease A family member 4"	P34096	14	20684560-20701216	"Plasma proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 482.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 67.3;Gastric mucus-secreting cells: 47.4;Hepatocytes: 55.8;Intestinal goblet cells: 110.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 24.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 92.6;ASC TERT1: 107.2;Hep G2: 136.9;HSkMC: 63.1;OE19: 92.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		61000000				"unprognostic (1.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.18e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"prognostic favorable (9.62e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.27e-2)"	98.3	7.9	6.1	8.9	5.6	1.2	97.4	5.7	8.4	94.5	8.8	57.0	22.2	59.7	37.3	20.2	78.0	56.1	32.9	5.4	11.0	40.6	482.7	40.7	12.3	6.9	6.1	4.8	112.7	41.3	14.8	12.6	5.7	6.5	77.4	65.8	4.8	75.4	46.2	14.3	46.2	42.2	26.1	6.8	11.9	85.4	10.6	5.3	5.9	26.7	31.8	10.7	65.9	76.5	7.8	2.7	12.1	2.6	0.1	92.6	107.2	0.5	10.5	23.8	1.4	4.5	3.4	4.1	0.1	2.9	24.6	6.2	2.5	1.4	2.6	1.7	17.2	1.8	0.3	2.9	136.9	10.2	1.3	0.6	63.1	5.8	1.6	10.3	34.6	12.6	4.2	0.1	12.2	6.9	1.5	1.0	0.2	0.5	92.3	10.3	0.6	2.1	3.6	2.9	2.4	0.1	0.5	5.0	2.3	2.6	4.2	3.4	0.2	13.3	3.0	1.7	4.1	0.3	2.6	3.5	0.4	4.7	1.3	2.7	0.2	24.1	0.1	0.8	1.2	1.0	5.3	1.5	0.6	13.8	4.9	0.3	0.6	0.6	0.6	0.1	3.3	3.3	8.4	6.1	5.6	5.7	8.4	5.4	11.0	6.9	6.1	4.8	6.5	6.8	5.3	7.8	1.8	38.5	19.1	2.0	3.4	2.8	1.7	2.5	11.4	0.0	9.9	2.5	0.2	28.6	4.7	3.7	0.0	0.2	0.3	30.4	0.0	34.4	0.2	0.1	0.8	4.0	67.3	8.4	0.1	22.2	0.4	39.2	47.4	0.8	1.3	0.3	5.0	55.8	1.6	0.0	0.2	110.0	2.0	6.2	4.0	0.3	12.5	3.6	3.6	1.9	2.7	1.3	1.0	0.0	0.9	12.8	33.2	4.1	5.9	1.7	41.7	10.2	11.6	0.3	0.0	2.6	8.1	0.2	0.1	10.2	4.1	0.4	0.8	0.1	39.6	1.5
RND1	"ARHS, Rho6, RHOS"	ENSG00000172602	"Rho family GTPase 1"	Q92730	12	48857145-48865870	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 132.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 205.5;Ductal cells: 220.6;Exocrine glandular cells: 147.1;Pancreatic endocrine cells: 350.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"SK-BR-3: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077800			Supported	"Vesicles,Plasma membrane,Actin filaments"		NA	NA			"Vesicles, Plasma membrane, Actin filaments"		"HPA077800: AB_2686854"	"unprognostic (5.60e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.59e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (8.38e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.35e-3)"	6.7	0.8	23.6	2.6	28.9	1.8	5.7	21.0	36.1	1.1	17.9	4.7	2.4	3.9	1.0	3.1	2.7	14.6	5.2	27.4	25.4	4.0	132.9	38.2	1.0	23.3	23.6	25.6	1.2	2.8	2.4	8.1	1.2	26.1	6.5	1.9	1.7	4.0	0.8	1.0	1.4	2.7	2.4	21.3	0.8	23.6	1.0	22.7	2.4	15.5	0.7	2.3	14.1	2.7	26.8	1.1	7.9	3.8	2.0	0.8	0.0	0.6	0.0	0.4	1.2	1.3	4.9	1.7	6.0	1.4	0.0	0.4	0.1	3.1	0.3	0.7	1.8	1.9	0.8	0.0	3.0	0.4	1.8	1.1	0.0	0.2	0.6	0.8	0.0	2.0	3.9	0.2	6.0	0.0	10.2	0.9	0.5	8.9	13.6	0.5	1.9	0.4	2.6	1.1	1.5	0.0	1.0	0.2	67.7	0.3	9.1	6.9	0.4	0.2	0.0	0.7	0.0	0.9	2.9	5.4	10.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.6	28.9	21.0	36.1	27.4	25.4	23.3	23.6	25.6	26.1	21.3	22.7	26.8	28.9	28.9	205.5	5.9	8.5	11.5	8.4	14.1	9.1	2.5	37.5	25.4	3.8	18.6	27.5	1.8	8.4	1.1	9.0	21.7	0.0	220.6	0.4	4.5	2.0	87.3	31.5	2.7	10.6	147.1	0.7	10.5	55.5	12.6	15.2	0.8	6.1	10.9	1.2	0.0	2.7	11.4	18.3	0.8	24.1	0.0	0.0	6.6	14.2	1.0	6.4	3.0	0.0	7.1	1.0	350.9	42.2	0.4	6.5	19.5	11.1	1.7	7.7	3.6	0.0	5.8	16.7	0.8	1.6	4.3	10.5	1.5	9.9	0.6	5.4	8.6
SEC14L4	"dJ130H16.5, TAP3"	ENSG00000133488	"SEC14 like lipid binding 4"	Q9UDX3	22	30488902-30505711	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.2;liver: 19.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 22.4;Alveolar cells type 2: 6.9;Cholangiocytes: 11.5;Erythroid cells: 26.5;Hepatocytes: 22.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.0"	"Cell line enriched"	"Detected in some"	4	"BEWO: 37.7"	"Region enhanced"	"Detected in single"		"thalamus: 1.2"					HPA069748			Approved	Centrosome		NA	NA		82000	Centrosome		"HPA069748: AB_2686187"	"unprognostic (6.98e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.88e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.06e-8)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.98e-2)"	0.0	0.9	0.3	0.1	0.4	8.2	0.2	0.3	0.4	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.2	0.2	19.4	4.5	0.1	0.4	0.3	0.1	0.2	0.2	3.4	0.1	0.2	0.5	0.1	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.2	0.5	4.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.3	7.1	0.0	0.0	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.3	2.5	0.0	0.1	0.0	0.1	0.1	0.2	0.1	9.2	0.4	0.1	0.0	0.0	0.0	0.2	0.1	0.1	2.4	0.1	0.0	0.1	0.0	0.1	0.1	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.3	0.4	0.3	0.4	0.2	0.2	0.4	0.3	0.1	0.5	0.2	0.2	0.4	0.3	22.4	6.9	0.7	0.1	0.1	0.5	0.3	0.0	0.4	0.2	0.3	0.7	11.5	1.4	1.8	0.0	0.1	1.3	0.0	0.0	0.5	0.7	1.8	0.2	0.2	0.0	26.5	0.4	0.0	0.4	0.3	0.0	0.2	1.3	0.2	0.4	22.8	0.1	1.7	0.4	0.2	0.0	0.3	0.3	0.1	0.6	0.4	0.0	0.0	0.1	5.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	4.3	0.9	0.0	0.9	0.1	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6
SERPINA3	"AACT, ACT"	ENSG00000196136	"Serpin family A member 3"	P01011	14	94612384-94624055	"Cancer-related genes, Candidate cardiovascular disease genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 9252.3;pancreas: 4951.4"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 20.9;Exocrine glandular cells: 33.0;Fibroblasts: 68.6;Late spermatids: 12.2;Pancreatic endocrine cells: 18.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	7	"Hep G2: 449.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000893, HPA002560, CAB016647"	Enhanced				"Secreted to blood"	NA	NA	697000000000	94000000000			"CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717"	"prognostic favorable (8.92e-4)"	"unprognostic (3.33e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.74e-12)"	"unprognostic (6.47e-2)"	"unprognostic (1.33e-2)"		"unprognostic (2.02e-2)"	78.3	58.5	120.0	43.8	129.1	2.1	374.3	144.7	295.9	371.8	129.3	70.8	11.8	45.3	11.6	42.8	117.6	147.3	203.4	113.2	743.5	211.1	9252.3	171.4	5.0	225.8	161.5	94.4	183.0	4951.4	1.0	273.4	14.8	155.6	585.3	13.4	132.6	1518.1	55.4	179.2	45.4	92.4	83.9	163.0	32.0	292.9	67.5	324.8	2.6	73.2	39.3	6.4	209.2	71.0	174.9	0.2	0.5	0.0	0.3	0.2	0.8	0.3	0.1	0.1	0.0	0.0	1.2	4.9	0.6	4.5	0.0	3.3	0.9	0.0	4.4	0.0	2.7	0.0	1.0	0.2	449.9	56.9	1.9	0.7	52.0	63.9	0.0	2.5	5.4	0.0	0.0	0.3	0.2	0.0	17.1	0.5	0.5	0.8	1.6	0.0	0.6	2.2	0.2	3.8	0.2	0.1	0.0	1.8	2.5	65.6	0.4	2.4	0.0	0.6	0.0	8.5	0.1	19.4	1.1	2.0	2.1	0.4	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.0	129.1	144.7	295.9	113.2	743.5	225.8	161.5	94.4	155.6	163.0	324.8	174.9	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.5	1.8	0.0	5.6	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	20.9	3.7	0.2	0.1	0.3	0.0	0.0	0.0	33.0	0.0	68.6	9.7	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.3	0.0	0.0	1.0	0.2	0.0	0.0	0.0	18.7	0.0	0.4	0.3	0.5	0.0	0.1	1.5	0.0	0.0	1.7	0.8	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA5	"PAI3, PCI, PLANH3, PROCI"	ENSG00000188488	"Serpin family A member 5"	P05154	14	94561442-94593118	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Fertilization, Lipid transport, Transport"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 488.5;liver: 792.0;testis: 436.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 400.4;Endometrial ciliated cells: 175.2;Glandular and luminal cells: 345.3;Hepatocytes: 198.2;Late spermatids: 277.8;Peritubular cells: 144.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 121.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"Hep G2: 261.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078846	Enhanced				"Secreted to blood"	NA	NA		2100000000			"HPA078846: "	"unprognostic (5.94e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (3.34e-3)"	"unprognostic (6.10e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.38e-3)"	"unprognostic (9.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.23e-1)"	4.8	488.5	2.2	3.4	2.2	0.0	19.8	2.6	1.7	29.8	3.6	4.7	5.5	32.1	1.2	0.8	26.5	162.0	11.3	1.6	13.5	152.8	792.0	1.0	3.7	3.5	3.6	0.9	30.3	175.4	0.2	3.2	0.1	6.2	6.9	1.9	14.1	9.5	154.7	46.9	3.2	3.6	2.1	2.1	113.1	12.2	436.4	4.0	0.9	4.2	153.9	4.8	2.4	4.0	4.0	0.8	0.1	2.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	12.0	12.2	0.0	8.3	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	261.3	0.3	0.4	0.0	1.7	0.3	0.1	0.0	2.3	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.7	0.2	0.0	0.1	0.5	0.2	3.9	0.1	0.4	17.4	0.2	0.1	7.9	0.9	0.1	0.0	0.5	0.0	0.6	0.4	1.5	0.2	0.1	0.2	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.2	2.6	1.7	1.6	13.5	3.5	3.6	0.9	6.2	2.1	4.0	4.0	0.9	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.2	18.9	14.1	0.8	400.4	0.1	33.1	2.1	0.0	0.1	0.0	64.6	103.2	78.7	175.2	19.7	40.3	0.0	2.7	0.0	122.2	0.0	18.2	0.5	345.3	0.0	78.2	2.5	198.2	0.0	8.4	0.0	0.0	0.0	3.2	0.7	277.8	57.2	1.9	0.0	0.0	0.6	5.4	0.0	0.0	0.2	18.3	0.0	144.4	0.0	0.1	0.0	7.5	0.0	1.4	6.6	11.6	1.5	11.1	2.9	0.0	0.6	0.3	1.8	58.7	0.0	0.1
SERPINF1	"EPC-1, PEDF, PIG35"	ENSG00000132386	"Serpin family F member 1"	P36955	17	1762029-1777565	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 1550.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 697.8;Cytotrophoblasts: 795.6;Fibroblasts: 951.9;Hepatocytes: 765.0;Leydig cells: 1818.0;Peritubular cells: 1045.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 245.2"	"Region enhanced"	"Detected in all"		"hippocampal formation: 93.8"	"Immune cell enriched"	"Detected in many"	18	"plasmacytoid DC: 1454.4"	"Lineage enriched"	"Detected in all"	121	"dendritic cells: 1454.4"	"Group enriched"	"Detected in many"	4	"ASC diff: 1232.0;ASC TERT1: 956.3;Hep G2: 606.0;HHSteC: 410.6;HSkMC: 1313.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005825	Uncertain				"Secreted to blood"	NA	NA	9290000000	44000000000			"HPA005825: AB_1079921"	"unprognostic (3.85e-1)"	"prognostic favorable (5.49e-4)"	"unprognostic (9.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.18e-2)"	"prognostic unfavorable (1.40e-8)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.25e-3)"	532.5	58.0	14.6	125.3	16.6	12.0	494.4	21.8	33.6	537.0	1550.0	127.1	42.3	361.2	91.0	110.2	562.2	564.6	287.6	93.8	9.7	34.4	982.8	160.2	134.6	8.9	17.6	15.7	411.8	209.4	11.3	62.9	314.3	7.7	204.5	52.5	61.9	125.6	106.8	438.4	161.5	132.8	223.6	8.0	134.2	125.8	280.2	21.9	107.2	194.7	469.6	118.7	326.5	275.8	20.6	0.5	3.7	2.8	2.0	1232.0	956.3	20.4	56.8	49.8	0.6	0.0	9.7	0.5	2.3	1.9	71.8	0.3	3.2	86.0	4.4	0.0	0.6	46.0	1.0	1.2	606.0	410.6	1.1	1.1	1313.4	6.9	0.9	1.1	11.4	0.6	4.2	117.5	0.4	63.2	0.2	7.0	7.2	30.7	0.3	1.0	2.9	219.9	1.6	0.1	6.0	1.9	42.2	0.7	0.7	57.0	3.4	6.7	184.2	2.0	0.5	17.6	14.1	1.2	0.7	2.4	28.1	1.7	0.6	0.8	0.1	12.0	1.1	0.6	4.4	0.4	9.0	0.7	0.9	79.8	5.2	2.0	5.5	1.7	1.3	0.2	1454.4	0.8	14.2	14.6	16.6	21.8	33.6	93.8	9.7	8.9	17.6	15.7	7.7	8.0	21.9	20.6	59.0	3.2	10.4	0.3	10.8	95.0	238.0	697.8	27.9	59.3	6.7	71.2	12.1	11.5	167.7	1.8	223.1	795.6	226.1	0.0	0.0	0.3	11.2	12.5	372.4	26.2	0.0	19.2	5.3	24.5	98.7	951.9	11.2	6.7	22.9	1.7	28.2	765.0	151.6	3.3	2.6	0.0	366.2	60.4	262.6	53.0	1818.0	79.0	108.5	9.4	79.0	11.6	1.0	0.5	2.0	6.8	0.1	1045.7	7.0	155.5	0.2	27.3	105.5	39.1	19.7	193.3	202.8	12.7	8.7	4.5	78.6	534.8	14.3	10.2	0.3	47.7
SERPING1	"C1-INH, C1IN, C1INH, C1NH, HAE1, HAE2"	ENSG00000149131	"Serpin family G member 1"	P05155	11	57597387-57619171	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 2644.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 726.4;Ductal cells: 604.0;Fibroblasts: 793.6;Hepatocytes: 2530.0;Leydig cells: 735.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 609.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 65.2;plasmacytoid DC: 60.6"	"Group enriched"	"Detected in many"	243	"dendritic cells: 60.6;granulocytes: 65.2;monocytes: 25.7"	"Group enriched"	"Detected in many"	6	"ASC diff: 1372.2;ASC TERT1: 694.9;HSkMC: 1159.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 194.1"	"CAB026161, HPA048738"	Supported				"Secreted to blood"	NA	NA		28000000000			"CAB026161: , HPA048738: AB_2680505"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (8.03e-4)"	"unprognostic (5.92e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (2.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.17e-1)"	911.7	145.4	24.3	90.8	25.9	11.0	739.3	24.8	36.3	613.4	60.8	319.7	52.5	621.8	164.7	163.4	800.2	537.7	407.2	22.2	47.2	333.7	2644.0	791.8	148.8	66.4	30.6	20.6	926.0	269.7	55.6	139.3	200.5	30.5	332.1	98.0	34.8	252.6	260.6	153.1	268.9	285.9	228.8	39.2	242.7	347.7	51.0	30.2	36.5	341.0	174.9	64.9	560.6	524.2	37.8	0.0	0.0	48.2	0.0	1372.2	694.9	7.3	74.2	57.0	16.8	30.7	2.5	0.0	0.0	96.7	42.1	0.0	0.0	0.4	4.7	9.4	0.0	0.1	33.7	0.0	1.7	170.3	0.9	5.4	1159.0	15.5	5.7	0.2	6.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	1.3	46.6	0.0	0.0	4.3	4.0	0.7	7.4	0.0	0.2	14.4	0.3	0.0	0.9	41.8	0.2	3.3	0.0	0.8	21.2	0.7	0.0	0.2	0.4	0.6	0.2	0.5	0.0	0.0	18.3	0.3	0.0	25.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	65.2	0.2	11.5	60.6	0.0	5.7	24.3	25.9	24.8	36.3	22.2	47.2	66.4	30.6	20.6	30.5	39.2	30.2	37.8	162.1	118.6	110.8	5.5	8.0	75.8	61.2	7.1	24.5	0.8	24.2	57.7	28.7	726.4	57.5	158.2	0.0	37.1	15.3	0.0	43.0	604.0	4.8	76.0	297.4	150.5	0.0	69.2	3.6	44.0	93.4	793.6	8.6	69.6	7.6	8.3	260.5	2530.0	43.6	0.0	6.2	0.1	2.0	118.9	94.2	25.6	735.3	46.9	90.7	15.9	10.4	57.2	0.0	3.5	0.5	41.4	0.0	228.7	4.5	32.4	0.0	53.5	23.1	4.5	269.5	143.6	259.6	2.5	10.4	9.0	59.5	25.2	16.8	3.4	0.0	37.4
SGK2		ENSG00000101049	"Serum/glucocorticoid regulated kinase 2"	Q9HBY8	20	43558968-43588237	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.9;kidney: 41.1;liver: 63.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 76.5;Distal tubular cells: 76.3;Hepatocytes: 32.8;Paneth cells: 21.7;Proximal enterocytes: 23.8;Proximal tubular cells: 25.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 20.5;CAPAN-2: 14.2;Hep G2: 18.7;OE19: 61.7;RPTEC TERT1: 25.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008859, HPA011387"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008859: AB_2668159, HPA011387: AB_1856744"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.98e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.72e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.11e-2)"	"prognostic favorable (5.65e-4)"	23.7	1.4	5.2	1.5	13.2	0.5	6.2	12.0	10.1	3.5	1.0	38.0	31.8	1.8	34.1	1.0	3.7	10.1	0.9	5.4	7.7	41.1	63.8	1.0	0.2	16.9	13.4	3.3	6.6	16.4	0.5	3.0	0.8	16.7	2.6	40.9	5.6	1.8	2.9	0.4	6.3	20.3	1.6	13.3	1.1	23.0	1.8	10.6	0.3	1.7	0.4	0.3	4.2	3.0	24.7	0.0	20.5	0.3	0.1	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.6	14.2	0.1	8.7	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.4	0.0	18.7	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	0.4	0.2	0.1	0.0	0.1	0.1	0.5	0.1	61.7	0.0	0.1	0.1	0.0	25.4	4.2	0.2	1.0	0.0	1.2	0.1	0.4	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	13.2	12.0	10.1	5.4	7.7	16.9	13.4	3.3	16.7	13.3	10.6	24.7	0.3	0.0	0.0	4.9	0.2	0.1	0.1	0.2	0.0	0.8	0.3	0.8	4.9	8.6	0.0	11.0	0.0	5.1	0.0	76.5	76.3	6.8	0.3	0.9	0.5	0.6	1.8	0.0	0.7	6.3	1.3	0.4	11.2	2.4	0.0	0.7	0.7	32.8	0.7	6.7	1.3	4.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	3.5	20.7	2.5	21.7	0.4	0.0	0.1	23.8	25.5	0.2	0.8	0.0	0.2	0.4	0.1	0.1	0.0	0.1	17.1	0.2	0.0	7.7	0.3
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 411.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.8;Cytotrophoblasts: 106.6;Excitatory neurons: 65.0;Oligodendrocytes: 178.1;Proximal tubular cells: 245.9;Syncytiotrophoblasts: 79.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.1;EFO-21: 18.8;Hep G2: 56.1;HHSteC: 18.4;K-562: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	1.2	2.4	13.1	0.7	20.8	0.2	1.9	15.7	15.8	2.0	5.7	0.7	0.3	1.8	1.0	0.9	2.4	1.9	0.9	9.8	15.9	411.3	21.8	1.4	0.6	16.5	19.8	10.0	4.5	9.1	0.3	2.6	43.5	21.0	6.3	0.5	1.1	4.9	0.8	1.0	2.3	0.4	1.9	13.1	0.6	4.8	8.8	19.3	1.2	1.4	0.3	0.7	1.9	1.4	38.0	0.1	0.0	1.6	5.6	8.3	7.7	16.1	3.5	2.0	1.9	1.4	0.0	0.1	0.2	18.8	0.2	0.1	2.1	0.1	2.6	4.5	0.0	0.6	6.8	0.4	56.1	18.4	0.1	4.8	10.5	7.5	10.9	5.4	5.4	0.0	0.0	15.3	0.3	0.0	0.6	0.1	0.7	10.3	0.2	0.0	0.2	0.0	0.1	1.2	0.4	0.7	0.2	0.0	4.0	0.8	1.0	2.9	0.3	0.2	0.1	4.0	8.7	0.1	0.5	1.2	0.1	0.6	0.0	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.0	13.1	20.8	15.7	15.8	9.8	15.9	16.5	19.8	10.0	21.0	13.1	19.3	38.0	0.3	0.0	2.2	53.8	3.8	1.3	1.0	0.8	6.2	0.7	1.2	1.7	1.7	0.0	0.5	7.3	0.0	106.6	0.0	0.1	15.6	0.2	23.3	0.5	2.0	0.6	0.0	0.0	65.0	0.9	7.1	2.3	3.1	0.8	0.0	3.0	0.4	17.5	9.5	0.0	40.3	0.0	0.0	0.3	0.7	27.8	3.1	2.0	0.0	11.2	0.0	0.4	0.0	24.1	178.1	0.9	0.0	0.4	1.2	3.5	0.0	245.9	6.4	0.2	0.0	0.4	1.0	6.6	1.2	1.2	0.6	79.4	1.5	2.2	0.0	0.6
SLC16A11	"FLJ90193, MCT11"	ENSG00000174326	"Solute carrier family 16 member 11"	Q8NCK7	17	7041621-7044092	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid metabolism, Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 12.9;thyroid gland: 13.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Muller glia cells: 32.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 12.0"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	8	"B-cells: 1.0;T-cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.65e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.10e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.97e-5)"	"unprognostic (5.22e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.22e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.58e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.30e-2)"	"prognostic favorable (3.19e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.83e-2)"	1.4	0.7	1.2	0.3	1.3	0.0	3.7	2.1	1.9	1.8	5.8	1.2	0.4	1.3	1.4	2.3	12.9	0.4	2.1	1.2	2.9	4.1	9.7	2.8	0.4	1.4	1.4	0.8	2.6	4.0	5.5	4.9	0.0	1.8	3.1	0.0	0.2	10.5	1.9	0.5	6.1	1.8	0.0	1.9	1.8	1.3	0.8	1.1	0.2	13.6	0.1	0.2	0.9	1.8	1.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.6	0.3	1.4	0.0	1.0	0.7	1.3	0.0	0.1	0.0	0.0	0.0	0.2	1.2	1.3	2.1	1.9	1.2	2.9	1.4	1.4	0.8	1.8	1.9	1.1	1.6	9.8	12.8	8.4	2.6	5.9	1.8	5.4	4.0	4.6	0.4	7.0	8.8	2.6	8.6	8.3	7.3	0.0	0.0	3.0	0.2	1.9	3.9	0.3	0.4	0.1	4.0	9.6	0.0	0.6	1.3	0.0	1.7	0.0	0.2	0.0	0.0	1.4	5.0	0.0	0.0	0.3	1.2	6.1	0.3	0.4	0.7	6.8	0.4	3.6	0.0	0.4	32.0	9.2	2.0	0.1	0.1	0.1	4.9	1.1	3.1	0.0	1.5	6.5	1.9	0.0	1.2	1.3	1.5	1.2	5.9	3.1	0.1	3.9	0.4	1.4	7.9
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 16.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Excitatory neurons: 4.4;Hepatocytes: 10.4;Inhibitory neurons: 4.4;Oligodendrocyte precursor cells: 5.5;Proximal enterocytes: 6.4;Proximal tubular cells: 9.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.8;HMC-1: 8.7;T-47d: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA041654	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.7	7.1	2.4	1.5	2.2	1.4	2.7	4.2	3.3	2.4	0.0	1.9	5.2	2.1	0.2	1.6	2.1	1.2	1.1	2.8	1.4	5.8	16.9	2.0	1.5	3.6	1.6	2.1	2.5	3.4	0.1	3.3	0.3	3.5	3.1	0.1	0.6	3.3	0.1	1.4	2.6	4.6	0.0	0.8	2.4	3.1	1.2	1.5	0.1	3.2	0.3	0.1	1.8	1.9	2.5	1.3	2.1	0.0	1.6	0.1	0.4	4.1	1.7	0.1	0.0	0.0	4.6	2.7	0.7	2.4	0.0	1.6	1.3	0.1	0.0	0.0	2.7	0.8	3.0	3.3	13.8	0.1	2.1	8.7	0.5	0.2	0.1	0.0	1.0	0.3	2.6	3.3	0.0	0.3	2.8	1.4	3.5	0.8	1.6	7.2	6.9	0.0	0.3	0.7	4.5	0.2	1.2	0.4	0.2	1.2	0.3	9.1	1.3	2.0	4.4	0.9	4.8	1.3	6.5	3.2	1.0	1.4	4.1	2.1	5.4	0.3	0.2	0.2	0.1	0.3	0.2	0.5	0.4	0.1	0.0	0.3	0.7	0.0	0.6	0.1	0.1	0.8	0.3	2.4	2.2	4.2	3.3	2.8	1.4	3.6	1.6	2.1	3.5	0.8	1.5	2.5	0.3	0.0	1.1	6.2	0.2	0.0	0.2	0.3	0.0	0.0	0.8	0.8	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	1.9	0.1	0.0	0.7	0.3	0.3	0.0	0.0	4.4	0.4	3.6	0.3	0.5	0.8	1.3	0.8	1.4	10.4	0.7	0.0	4.4	0.8	0.0	0.3	0.0	0.0	0.9	0.4	1.8	1.0	0.3	0.3	0.0	5.5	1.7	0.4	1.3	0.4	0.1	0.2	6.4	9.7	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.2	0.1	0.8	0.5	0.6	0.7	0.1
SLC27A2	"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS"	ENSG00000140284	"Solute carrier family 27 member 2"	O14975	15	50182196-50236385	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 159.1;liver: 290.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 265.5;Hepatocytes: 205.7;Proximal enterocytes: 81.0;Proximal tubular cells: 198.9;Respiratory ciliated cells: 70.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 49.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	30	"basophil: 63.5"	"Lineage enriched"	"Detected in many"	30	"granulocytes: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 50.0;HaCaT: 89.3;HL-60: 66.3;OE19: 101.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA026089	Enhanced					NA	NA					"HPA026089: AB_1857060"	"unprognostic (3.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.38e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.48e-6)"	"unprognostic (5.01e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.40e-4)"	4.8	16.1	1.6	2.9	2.2	6.6	13.5	1.8	3.5	1.6	7.8	18.3	11.2	0.3	66.5	2.6	11.0	2.4	0.0	2.9	2.0	159.1	290.4	1.7	1.5	1.0	1.2	1.8	0.1	7.2	4.2	12.5	17.5	1.2	5.5	16.4	3.5	1.0	1.0	0.0	1.3	21.5	0.9	0.8	0.4	1.8	1.0	2.0	0.5	4.6	0.0	1.7	3.7	1.2	1.3	0.0	50.0	0.0	0.0	0.0	0.0	0.1	0.9	0.4	0.9	1.3	26.2	6.9	0.0	0.6	1.2	0.6	89.3	22.8	0.7	2.3	36.0	27.9	37.5	43.0	23.6	0.5	66.3	25.8	0.0	2.1	0.2	0.1	0.0	0.0	16.9	11.6	0.0	0.0	8.3	1.8	44.5	1.7	101.8	1.8	0.0	0.0	1.8	4.7	45.7	40.4	2.6	8.7	1.1	0.0	1.1	4.7	22.8	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	21.2	0.0	63.5	0.0	0.9	0.8	0.0	0.7	0.3	0.7	0.8	0.0	0.2	0.1	0.2	0.3	2.0	0.0	0.0	0.9	0.5	1.6	2.2	1.8	3.5	2.9	2.0	1.0	1.2	1.8	1.2	0.8	2.0	1.3	0.3	0.0	1.1	0.7	2.2	1.0	1.3	8.7	1.2	1.1	1.1	0.3	0.3	0.0	13.6	9.2	0.0	265.5	1.6	17.2	11.7	0.6	0.7	9.8	0.1	0.8	4.2	8.0	4.9	2.0	7.6	0.9	1.5	0.7	6.3	0.1	3.9	205.7	16.4	1.7	6.6	18.9	10.2	3.2	0.3	0.9	0.3	1.2	0.0	1.0	0.0	0.6	1.0	0.0	0.4	1.4	26.6	0.0	0.8	3.3	81.0	198.9	70.2	1.9	0.0	0.0	1.0	4.4	4.2	5.1	0.3	54.9	4.6	0.2	25.9	4.9
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"intestine: 239.6;kidney: 111.0;liver: 172.5;pancreas: 309.3"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 798.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 30.6;liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	53	"CACO-2: 39.9;Hep G2: 58.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected"	"Not detected"			HPA018423			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.3	0.1	0.2	5.6	0.2	0.1	0.3	0.4	0.3	0.3	0.1	74.4	239.6	0.4	0.0	0.1	0.3	6.5	0.1	0.1	0.1	111.0	172.5	0.2	0.4	0.2	0.1	0.0	0.4	309.3	0.0	0.2	0.1	0.2	0.3	46.3	6.4	0.1	0.3	0.1	0.3	220.8	2.6	0.0	0.3	1.4	0.2	0.1	0.0	0.3	0.3	0.0	0.2	0.2	0.3	0.0	0.3	0.1	0.2	0.2	0.3	0.5	0.0	0.0	0.1	0.0	39.9	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.6	0.1	0.2	0.2	58.5	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.8	0.0	0.9	0.1	0.2	0.2	0.3	0.5	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	1.4	0.6	0.1	0.0	0.0	0.9	0.1	0.3	0.2	15.7	0.0	3.7	116.7	0.0	0.0	171.9	19.6	0.3	0.6	0.0	0.1	0.2	25.3	2.7	0.2	20.6	0.0	0.1	0.0	0.0	0.0	0.0	2.2	138.9	0.1	0.0	0.2	112.7	0.0	1.6	1.2	1.4	0.0	1.3	0.0	0.0	0.6	0.6	0.0	0.0	0.1	7.4	192.8	0.0	0.0	0.1	798.4	169.9	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.8	0.0	168.7	0.0
SLC43A1	"PB39, POV1, R00504"	ENSG00000149150	"Solute carrier family 43 member 1"	O75387	11	57484534-57515780	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 129.7;pancreas: 235.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 47.1;Erythroid cells: 82.9;Exocrine glandular cells: 35.4;Hepatocytes: 138.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 45.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 62.7;NB-4: 74.3;U-937: 70.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018813, HPA018826"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles, Plasma membrane"		"HPA018813: AB_1857164, HPA018826: AB_1857165"	"unprognostic (3.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (7.30e-2)"	13.7	10.8	3.6	4.8	3.8	36.0	11.2	2.8	5.0	13.1	2.9	13.3	8.7	12.7	10.4	4.4	13.7	18.4	8.5	3.6	3.6	6.4	129.7	10.0	7.4	3.8	3.3	3.6	20.5	235.2	1.8	4.5	6.3	4.1	12.9	9.5	1.3	13.9	6.3	17.3	18.9	9.3	8.7	2.6	8.6	30.7	3.4	3.3	2.1	12.8	9.1	6.7	16.3	9.9	3.9	1.1	1.7	1.8	20.3	25.7	18.8	0.2	10.4	13.8	3.0	7.6	6.5	2.8	59.5	2.7	7.9	3.9	1.0	18.1	1.2	3.7	2.8	4.6	30.9	0.5	62.7	33.7	54.3	7.2	23.8	4.4	5.2	23.2	7.3	13.4	34.7	43.9	10.7	3.8	2.3	0.5	74.3	6.6	27.0	13.6	51.0	9.8	27.2	0.5	0.1	23.5	3.6	1.9	0.3	23.8	0.5	1.6	27.3	5.5	3.1	7.1	26.2	1.7	12.1	4.3	35.3	1.5	70.6	4.2	11.1	6.2	0.7	10.9	2.4	9.2	2.9	4.9	7.7	8.4	1.5	4.9	6.9	0.5	7.5	0.2	1.9	9.5	5.5	3.6	3.8	2.8	5.0	3.6	3.6	3.8	3.3	3.6	4.1	2.6	3.3	3.9	4.4	0.0	7.3	1.6	3.3	7.0	1.6	0.0	3.4	5.7	1.8	2.4	6.8	47.1	0.6	0.0	0.0	0.2	3.6	3.1	3.9	3.4	21.5	5.3	6.0	4.7	6.0	82.9	3.5	35.4	0.4	10.9	4.6	13.4	3.8	1.3	15.4	138.2	7.4	0.0	1.4	8.8	0.0	8.1	2.9	14.8	15.5	3.2	5.4	5.6	1.3	0.2	5.2	4.0	0.6	11.1	2.9	7.9	6.2	3.2	0.3	0.1	0.7	0.4	6.6	6.4	7.7	0.7	1.5	0.3	3.7	0.1	6.4	2.9	9.0	0.9
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 subunit beta"	Q86UW2	15	65045387-65053397	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 42.2;intestine: 108.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 354.6;Paneth cells: 145.1;Proximal enterocytes: 721.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 18.5;EFO-21: 11.9;Hep G2: 15.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria		No	NA			Mitochondria	Vesicles	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.7	1.2	5.7	3.6	5.0	0.8	0.3	4.3	2.8	42.2	0.0	42.3	87.7	3.1	0.3	2.4	3.7	2.8	2.4	3.9	5.8	19.7	2.2	6.2	0.6	11.8	9.5	1.2	1.2	0.3	0.0	0.4	0.6	8.0	2.7	29.7	0.7	1.0	0.6	1.0	0.8	108.0	1.7	6.2	0.8	0.8	9.7	8.8	0.0	0.7	0.0	0.0	1.5	0.9	4.2	0.0	1.5	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.2	0.0	18.5	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	15.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.4	0.1	0.4	0.4	0.1	0.4	0.0	0.0	0.9	0.4	0.0	0.6	0.5	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	5.0	4.3	2.8	3.9	5.8	11.8	9.5	1.2	8.0	6.2	8.8	4.2	0.0	0.0	1.1	0.3	1.3	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.1	0.0	354.6	13.7	0.0	60.8	10.4	0.2	1.2	1.8	2.7	0.0	0.0	0.0	0.5	0.0	1.9	4.5	0.0	0.4	1.8	0.1	0.0	0.0	23.0	0.0	0.3	0.0	14.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.1	0.0	0.0	0.0	721.4	73.3	15.6	0.0	6.6	1.0	0.4	27.9	0.5	0.0	0.0	0.1	0.6	0.1	45.8	0.0
SLC5A9	SGLT4	ENSG00000117834	"Solute carrier family 5 member 9"	Q2M3M2	1	48222685-48248644	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 43.7"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 22.4;Proximal enterocytes: 84.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.1;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050263			Approved	"Actin filaments,Cytosol"		NA	NA			"Actin filaments"	Cytosol	"HPA050263: "	"unprognostic (3.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.56e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.06e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.6	43.7	0.1	1.3	0.2	0.1	2.5	0.0	0.0	0.0	3.7	7.8	3.0	0.0	0.2	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.8	0.1	1.1	42.3	0.0	0.0	0.0	0.5	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.2	22.4	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	2.8	0.0	0.0	0.0	0.0	0.0	3.1	1.9	0.5	6.3	0.5	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.5	4.5	0.0	0.7	4.4	0.1	0.0	0.2	2.9	0.0	1.3	0.0	11.0	0.3	0.3	0.0	1.9	0.1	0.0	0.0	7.5	2.9	0.1	1.7	0.4	0.0	0.0	84.0	4.1	0.0	0.0	0.0	0.2	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.0	3.0	0.0
SLC6A12	BGT-1	ENSG00000111181	"Solute carrier family 6 member 12"	P48065	12	190077-214570	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.7;kidney: 28.7;liver: 82.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Hepatocytes: 22.7;monocytes: 10.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.8;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	50	"classical monocyte: 5.7;intermediate monocyte: 5.7;myeloid DC: 2.4;neutrophil: 3.0;non-classical monocyte: 7.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 2.4;granulocytes: 3.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.2;RPTEC TERT1: 13.8;SuSa: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034973	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA034973: AB_10610427"	"unprognostic (3.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (2.70e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-4)"	"unprognostic (3.35e-1)"	"unprognostic (4.31e-4)"	0.2	0.4	22.5	1.1	22.3	0.1	0.4	16.6	30.7	0.8	11.9	0.7	4.6	1.2	6.9	0.0	3.4	1.0	0.3	17.1	19.6	28.7	82.2	2.4	0.5	19.5	23.7	14.4	0.3	1.6	0.4	0.8	0.5	23.4	0.1	1.8	0.6	0.1	0.0	0.1	0.3	0.9	0.9	14.7	0.5	2.4	1.6	20.5	0.3	6.4	0.0	0.3	0.4	0.3	21.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.8	0.1	0.0	0.4	0.0	0.0	0.1	2.9	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	3.0	0.0	7.9	0.0	0.0	1.9	22.5	22.3	16.6	30.7	17.1	19.6	19.5	23.7	14.4	23.4	14.7	20.5	21.1	0.1	0.0	0.5	4.2	0.6	0.1	0.0	0.0	0.0	0.5	0.9	0.6	0.7	0.0	0.1	46.0	0.0	0.0	0.0	1.6	1.9	0.0	4.6	3.5	1.7	0.2	0.0	0.0	0.4	0.4	0.0	0.6	2.0	8.8	0.0	0.1	0.7	22.7	2.4	0.0	0.3	1.7	0.0	1.9	2.5	6.2	0.6	1.6	0.0	8.4	10.7	5.2	0.0	0.5	9.2	0.0	1.2	0.0	0.0	0.0	0.0	8.0	0.0	0.4	6.6	0.6	0.4	2.3	4.5	0.0	0.4	0.8	0.1	0.1	1.0	0.1
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 21.9;brain: 77.2"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.3;Extravillous trophoblasts: 10.6;Late spermatids: 4.4;Spermatocytes: 11.5;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Group enriched"	"Detected in many"	12	"midbrain: 40.2;pons: 77.2;white matter: 20.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"SH-SY5Y: 489.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 7.8"	"Region enriched"	"Detected in single"	19	"pons: 13.8"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	0.7	21.9	0.8	0.0	0.1	0.0	0.8	0.0	1.2	2.4	0.0	0.2	0.1	5.4	0.2	0.2	0.5	0.1	0.0	0.1	0.1	0.4	0.4	0.1	0.0	3.7	40.2	0.1	0.1	0.0	0.5	0.0	12.7	77.2	0.2	0.3	0.0	1.9	0.6	0.0	13.5	0.2	0.8	0.2	0.0	0.1	6.3	0.3	0.1	0.0	0.0	0.1	0.2	0.5	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.7	489.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.2	0.1	0.1	3.7	40.2	0.1	77.2	0.2	0.3	20.9	1.8	0.0	0.0	0.0	0.0	1.5	0.2	0.4	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	10.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.5	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	11.5	0.3	0.0	0.4	5.6	0.0	0.0	0.0	0.1
SMR3A	"PBI, PRL5, PROL5"	ENSG00000109208	"Submaxillary gland androgen regulated protein 3A"	Q99954	4	70360760-70367158	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"salivary gland: 60.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 0.7;liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044567	Enhanced				"Secreted to digestive system"	NA	NA					"HPA044567: AB_10796114"																"unprognostic (2.06e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	60.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SNORC	"ASCL830, C2orf82, UNQ830"	ENSG00000182600	"Secondary ossification center associated regulator of chondrocyte maturation"	Q6UX34	2	232857270-232878708	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 61.9;skin 1: 29.1"	"Group enriched"	"Detected in some"	22	"Breast glandular cells: 367.0;Breast myoepithelial cells: 324.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	20	"basophil: 2.8"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 2.8"	"Cell line enriched"	"Detected in some"	13	"Hep G2: 59.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052824	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"		"HPA052824: AB_2681964"	"unprognostic (4.58e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.30e-7)"	"unprognostic (1.83e-3)"	"unprognostic (8.15e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-2)"	0.9	0.9	7.3	0.2	11.2	0.5	14.3	21.4	9.1	0.7	0.6	2.3	0.9	0.7	0.5	1.0	1.3	0.0	0.8	11.3	26.1	1.3	7.5	0.9	0.6	34.0	19.0	2.7	0.7	1.7	0.3	1.6	0.2	26.1	1.5	0.3	0.6	4.7	0.1	1.0	29.1	1.7	0.1	36.6	1.1	0.8	8.2	29.5	0.1	0.6	0.0	0.0	0.9	0.8	61.9	0.9	0.0	0.3	1.4	1.0	1.6	2.4	0.3	0.0	0.3	0.7	0.0	0.2	0.0	0.7	0.1	0.5	0.5	0.0	0.0	0.0	0.6	2.1	0.5	0.4	59.6	0.8	0.1	1.7	0.0	1.3	0.4	0.8	0.7	1.6	0.6	0.1	0.2	0.2	0.2	0.2	0.5	0.0	0.0	2.2	0.4	0.6	0.4	0.1	0.9	0.2	0.8	0.4	0.0	2.2	1.0	0.1	2.6	0.9	0.2	0.8	0.8	0.8	3.8	4.7	0.2	0.1	1.4	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	11.2	21.4	9.1	11.3	26.1	34.0	19.0	2.7	26.1	36.6	29.5	61.9	3.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	367.0	324.9	0.0	0.0	0.0	1.8	0.0	0.1	10.1	0.0	5.9	0.5	0.0	3.8	0.4	6.3	0.0	0.0	0.0	0.8	0.1	2.9	0.0	2.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.0	2.3	0.9	0.0	0.0
SSX1	CT5.1	ENSG00000126752	"SSX family member 1"	Q16384	X	48255392-48267444	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"testis: 6.9"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 24.2;Spermatogonia: 30.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"Daudi: 66.1;Karpas-707: 90.5;U-2197: 22.7"									"HPA045683, HPA071685"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA045683: AB_2679418, HPA071685: "					"unprognostic (2.25e-1)"		"unprognostic (3.51e-3)"		"unprognostic (2.36e-1)"	"unprognostic (4.32e-3)"				"unprognostic (3.38e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.94e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	90.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.2	22.7	0.1	0.0	4.8	0.1	5.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	24.2	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ST6GAL1	SIAT1	ENSG00000073849	"ST6 beta-galactoside alpha-2,6-sialyltransferase 1"	P15907	3	186930325-187078553	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 500.0;lymphoid tissue: 149.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 237.3;Hepatic stellate cells: 258.5;Hepatocytes: 608.7;Microglial cells: 602.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 70.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 250.6;U-266/70: 628.0;U-266/84: 887.9;U-698: 334.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015018, CAB016122"	Supported				"Secreted to blood"	NA	NA	15000000	3300000			"CAB015018: AB_629203, CAB016122: AB_627178"	"unprognostic (5.85e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-2)"	24.8	12.6	29.7	50.7	25.2	15.4	32.8	30.4	26.8	61.9	32.5	38.5	14.0	16.2	6.0	13.6	27.2	18.0	36.4	24.4	31.8	60.6	500.0	30.3	102.5	41.0	33.2	17.1	10.2	8.1	45.8	9.9	18.7	46.7	49.2	45.8	2.7	39.7	14.7	13.0	8.3	29.4	19.1	40.2	68.1	29.0	3.6	39.9	67.2	65.4	20.3	149.3	28.2	9.0	47.6	4.3	5.0	20.6	17.1	1.1	0.0	36.3	1.6	3.0	1.4	2.0	1.9	2.0	250.6	19.5	0.1	8.8	10.1	132.7	15.4	1.6	11.3	7.4	10.1	0.8	119.0	1.3	22.8	75.0	1.7	28.3	0.0	11.5	19.9	77.5	24.2	52.2	20.3	5.2	8.7	17.0	14.7	49.9	11.3	7.6	38.2	0.4	8.1	9.9	0.5	36.4	4.1	1.5	26.6	64.6	29.1	38.9	16.8	32.6	0.2	3.3	0.6	2.1	628.0	887.9	334.0	0.5	45.4	84.7	22.6	8.9	3.6	46.9	16.2	42.9	87.9	51.3	39.7	14.2	83.3	80.4	58.4	4.2	26.9	29.3	11.9	43.8	58.7	29.7	25.2	30.4	26.8	24.4	31.8	41.0	33.2	17.1	46.7	40.2	39.9	47.6	34.6	44.8	27.4	13.4	110.0	4.0	13.8	68.0	4.6	0.3	5.1	4.1	26.2	75.8	55.9	237.3	0.0	0.3	26.3	20.7	0.0	17.1	0.5	8.9	5.0	56.0	94.1	24.8	47.2	0.9	3.5	3.7	7.7	16.1	10.8	7.3	258.5	608.7	20.3	0.0	31.5	10.9	34.6	61.3	16.4	1.1	0.3	18.2	7.2	602.4	17.2	0.1	26.8	145.3	2.8	6.0	17.8	0.7	124.3	103.6	0.6	0.5	39.8	1.1	0.0	2.2	6.8	0.0	0.5	0.8	1.6	0.7	28.4	0.3	37.3	39.0
SULT1A2	"HAST4, STP2"	ENSG00000197165	"Sulfotransferase family 1A member 2"	P50226	16	28591943-28597050	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 48.7;liver: 50.5"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 204.8;Paneth cells: 146.1;Proximal enterocytes: 505.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 9.1;intermediate monocyte: 7.7;myeloid DC: 3.3;neutrophil: 12.4;non-classical monocyte: 3.9"	"Group enriched"	"Detected in many"	24	"dendritic cells: 3.3;granulocytes: 12.4;monocytes: 9.1"	"Cell line enriched"	"Detected in many"	4	"Hep G2: 50.2"									"HPA049500, HPA051051"	Supported					NA	NA					"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (4.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.13e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.49e-4)"	"unprognostic (5.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.52e-3)"	1.5	2.9	1.2	0.7	1.0	1.2	1.1	2.2	1.4	0.2	0.5	13.7	48.7	0.4	1.3	0.3	1.0	1.0	1.8	1.2	0.5	3.2	50.5	6.9	0.9	0.8	0.7	1.1	0.7	2.2	2.9	1.9	1.7	1.4	0.5	13.1	0.7	1.5	1.0	0.9	0.8	45.7	0.7	0.6	4.3	1.1	0.7	0.7	0.4	7.3	0.2	0.7	2.1	0.2	1.4	1.9	1.1	1.0	0.7	0.3	0.4	9.7	1.0	0.0	0.1	0.1	2.0	5.1	0.3	12.2	0.3	0.1	2.9	0.5	0.6	0.2	1.0	0.5	1.5	2.4	50.2	0.7	1.0	1.9	0.3	0.7	0.8	0.2	0.6	0.3	0.8	1.0	2.3	0.4	1.8	0.3	2.6	1.4	0.3	0.3	1.6	0.3	1.0	0.2	1.5	0.6	1.4	0.3	3.9	0.1	1.6	3.2	0.7	0.6	2.5	1.4	1.9	0.8	2.2	1.6	0.4	0.6	0.7	0.8	1.0	9.1	0.1	0.1	7.7	0.0	0.1	0.1	0.1	3.3	0.1	0.1	0.2	12.4	0.2	3.9	0.8	0.3	4.6	1.2	1.0	2.2	1.4	1.2	0.5	0.8	0.7	1.1	1.4	0.6	0.7	1.4	0.6	28.9	15.1	2.0	0.5	0.3	0.4	1.9	0.0	0.3	1.9	3.7	2.4	5.7	7.1	3.7	0.0	0.1	0.1	204.8	15.6	7.8	0.2	2.5	0.5	3.8	3.0	0.0	2.8	4.5	0.2	5.4	4.1	0.8	11.4	1.2	7.5	69.5	1.6	0.0	1.8	20.9	0.0	7.6	0.4	1.4	1.5	1.1	0.0	1.0	1.2	4.4	0.0	1.5	0.6	4.2	146.1	1.5	0.1	0.3	505.6	38.2	2.9	0.5	0.0	0.4	0.8	0.7	0.3	0.1	0.1	0.3	0.5	1.6	14.3	0.9
TCP10L	PRED77	ENSG00000242220	"T-complex 10 like"	Q8TDR4	21	32497967-32587373	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"testis: 205.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 1153.7;Late spermatids: 1940.5;Spermatocytes: 455.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.2;hTERT-RPE1: 2.0;SCLC-21H: 1.4;THP-1: 1.8"									HPA044709	Approved					NA	NA					"HPA044709: AB_10961410"	"unprognostic (2.31e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.41e-5)"	"unprognostic (4.98e-2)"	"unprognostic (5.94e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.64e-3)"	0.6	0.8	2.2	0.0	1.8	1.4	0.8	3.7	4.2	1.6	0.9	0.9	0.3	0.9	1.9	0.5	1.8	0.4	2.0	1.7	1.4	1.5	18.7	0.6	0.2	1.5	1.1	1.5	1.4	0.6	0.2	1.4	0.4	1.8	1.6	0.4	1.9	0.7	0.5	0.7	0.9	0.5	0.0	0.9	0.8	0.6	205.2	1.1	0.4	1.0	0.3	0.4	0.7	1.0	2.3	0.0	0.2	0.3	0.1	0.4	0.2	0.2	0.1	0.4	0.2	0.2	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.4	2.2	0.2	0.2	0.2	0.2	0.1	0.4	0.0	2.0	0.0	0.1	0.1	0.1	0.3	0.6	0.3	0.8	0.1	0.1	0.0	0.1	0.2	0.3	0.4	0.1	1.4	0.0	0.0	0.0	0.4	0.5	0.3	1.8	0.6	0.4	0.1	0.1	0.0	0.5	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	2.2	1.8	3.7	4.2	1.7	1.4	1.5	1.1	1.5	1.8	0.9	1.1	2.3	1.1	0.0	0.5	2.0	0.3	1.1	0.5	1.2	0.0	1.1	0.8	0.9	2.5	1.5	0.9	0.0	0.0	0.2	0.0	0.2	0.0	0.6	1153.7	1.9	0.4	0.9	0.0	0.0	2.9	0.2	0.2	0.8	0.0	0.5	4.5	0.7	0.7	23.0	0.3	0.0	1.7	0.8	2.0	0.8	0.3	1940.5	16.8	1.2	0.0	0.0	0.0	3.8	0.0	0.5	1.6	0.2	0.1	10.1	0.0	0.7	0.0	1.5	1.6	1.1	26.3	0.4	0.6	455.0	9.2	0.0	1.4	0.3	0.1	0.1	0.4	0.2
TFDP3	"CT30, E2F-like, HCA661"	ENSG00000183434	"Transcription factor Dp family member 3"	Q5H9I0	X	133216662-133218354	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	35	"testis: 4.3"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 23.5;Spermatogonia: 31.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7;testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077304			Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA077304: "	"unprognostic (1.57e-1)"								"unprognostic (2.17e-1)"					"unprognostic (3.22e-1)"	"unprognostic (2.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.5	31.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFPI	"EPI, LACI, TFI, TFPI1"	ENSG00000003436	"Tissue factor pathway inhibitor"	P10646	2	187464230-187565760	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 274.5;placenta: 192.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 2284.2;Hepatic stellate cells: 872.4;Syncytiotrophoblasts: 879.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 22.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 3.3;neutrophil: 1.3;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.7;granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 386.2;HUVEC TERT2: 742.5;LHCN-M2: 459.9;TIME: 451.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA005575, CAB020842"	Supported				"Secreted to blood"	NA	NA	58100000	87000000			"CAB020842: , HPA005575: AB_1080290"	"unprognostic (8.75e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (7.95e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.81e-2)"	62.3	12.7	2.7	20.7	3.5	8.3	52.8	4.9	5.9	41.9	10.5	23.5	53.0	25.9	18.7	33.7	35.9	58.2	32.8	4.2	2.4	56.9	274.5	127.8	33.6	6.6	2.9	2.8	26.7	25.2	7.1	6.2	192.8	4.0	15.8	27.6	4.6	15.1	12.9	27.0	18.0	42.1	30.9	3.6	20.8	19.4	6.9	3.3	11.2	36.5	43.1	17.8	53.4	30.1	3.4	38.9	24.7	29.3	0.8	224.3	267.7	0.7	66.0	156.3	42.7	65.1	22.6	192.6	0.7	27.3	52.7	74.7	2.1	15.9	3.6	110.3	1.9	7.6	12.3	73.8	197.3	386.2	0.9	0.4	123.1	5.1	232.8	61.9	93.4	742.5	0.7	31.2	0.7	459.9	35.4	4.6	0.7	22.9	0.8	68.8	0.3	40.2	0.3	72.9	1.4	0.3	0.5	56.7	2.1	3.5	95.8	0.7	0.2	451.4	30.6	29.0	61.4	13.5	1.1	1.7	0.4	239.4	0.6	35.4	3.3	0.2	0.2	0.2	0.1	0.1	0.4	0.1	0.0	0.2	0.5	0.2	0.2	1.3	0.5	0.1	2.7	0.1	2.3	2.7	3.5	4.9	5.9	4.2	2.4	6.6	2.9	2.8	4.0	3.6	3.3	3.4	99.2	35.3	335.5	1.3	4.4	20.8	2.9	33.5	4.6	0.6	16.1	9.1	7.0	173.0	102.5	38.6	0.0	59.5	4.8	0.5	13.7	140.0	41.5	7.3	74.2	287.1	105.0	43.1	0.7	273.1	2284.2	283.0	12.2	5.3	13.9	1.5	872.4	382.1	50.2	1.7	0.2	11.3	158.7	63.7	41.3	15.2	171.8	21.9	26.6	13.1	33.7	33.1	1.0	0.0	0.1	157.6	34.1	70.0	9.5	8.0	36.6	109.4	45.2	1.1	216.9	141.2	127.8	2.7	0.5	10.2	18.5	879.2	8.1	30.6	18.5	16.7
THRSP	"Lpgp, LPGP1, S14, SPOT14, THRP"	ENSG00000151365	"Thyroid hormone responsive"	Q92748	11	78063861-78068351	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 211.8;liver: 412.3"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 128.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 44.1"	"Region enhanced"	"Detected in single"		"cerebellum: 2.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"ASC diff: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040642	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040642: AB_10794878"	"unprognostic (1.19e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.59e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.69e-3)"	211.8	6.0	0.2	0.4	0.2	0.0	96.1	2.8	0.4	0.1	0.0	2.6	0.0	0.1	0.4	0.3	1.0	3.5	18.7	0.3	0.0	4.5	412.3	0.1	0.7	0.1	0.3	0.2	0.1	3.7	15.7	0.1	0.0	0.8	0.1	0.2	1.5	49.3	2.3	8.3	21.2	4.7	0.5	0.0	0.1	0.7	0.1	0.0	0.2	5.8	3.3	0.0	0.8	1.1	0.2	0.0	0.0	0.0	0.0	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	2.8	0.4	0.3	0.0	0.1	0.3	0.2	0.8	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	2.3	21.1	11.2	0.1	4.3	0.0	0.0	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.6	0.1	0.4	0.0	2.7	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.1	2.9	128.4	0.0	0.0	0.4	0.3	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1
TLCD4	"FLJ31842, TMEM56"	ENSG00000152078	"TLC domain containing 4"	Q96MV1	1	95117355-95197607	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 131.0"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 77.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 22.4;RH-30: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046762			Approved	"Nuclear speckles"		No	No			"Nuclear speckles"		"HPA046762: AB_2679792"	"unprognostic (1.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.82e-3)"	"unprognostic (3.63e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.69e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	5.4	10.0	10.9	2.2	10.6	20.7	2.6	21.7	15.0	2.4	2.3	13.7	5.5	3.5	2.6	2.3	2.5	4.3	26.0	11.2	9.7	5.8	131.0	3.7	0.4	7.0	7.5	10.2	1.7	7.5	6.4	3.4	4.5	7.6	5.4	10.3	3.1	8.3	2.9	13.1	1.1	8.6	3.6	9.7	0.7	5.1	4.9	8.0	0.3	7.4	9.8	0.5	4.7	1.3	14.1	22.4	12.6	1.7	2.6	0.8	0.0	2.9	0.8	0.5	2.8	6.5	9.1	10.4	0.0	10.7	0.4	20.0	0.2	7.4	1.1	4.8	15.5	4.1	0.5	9.2	2.0	0.8	0.4	0.6	1.2	0.4	2.1	0.0	4.4	0.0	1.2	19.8	1.2	0.6	1.9	1.3	0.1	1.7	0.7	6.9	0.0	35.7	0.6	12.0	14.4	4.5	3.6	15.6	10.8	6.7	1.8	11.7	0.4	0.2	0.3	9.0	1.1	7.9	3.8	8.0	0.0	1.5	0.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.9	10.6	21.7	15.0	11.2	9.7	7.0	7.5	10.2	7.6	9.7	8.0	14.1	5.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.9	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.5	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
TM6SF2	Lpr4	ENSG00000213996	"Transmembrane 6 superfamily member 2"	Q9BZW4	19	19264364-19273391	"Predicted membrane proteins, Transporters"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"intestine: 76.2;liver: 33.9"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 231.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.4;HHSteC: 1.8;LHCN-M2: 1.5;NTERA-2: 1.0;SH-SY5Y: 1.8"	"Low region specificity"	"Detected in single"							HPA066026	Uncertain					NA	NA					"HPA066026: AB_2685598"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.55e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.15e-2)"	0.2	0.4	0.2	0.1	0.2	0.0	0.2	0.2	0.5	0.9	0.4	2.0	76.2	0.6	0.2	0.1	0.3	0.5	0.4	0.2	0.6	3.2	33.9	0.4	0.1	0.3	0.3	0.2	0.0	0.1	0.2	0.6	0.5	0.2	0.6	2.1	0.0	0.1	0.3	0.0	0.1	69.4	0.3	0.1	0.1	2.4	0.1	0.3	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.8	0.4	0.4	0.5	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.6	0.3	0.3	0.2	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.9	0.0	0.0	0.2	1.8	0.1	0.0	0.0	0.8	0.2	0.3	1.2	21.4	0.1	4.5	0.0	1.1	35.6	0.1	0.0	1.1	8.6	0.0	0.3	0.4	0.0	0.6	0.0	1.8	1.0	0.0	0.0	0.0	3.5	0.1	0.1	29.7	0.4	0.0	0.0	231.1	5.5	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.1	0.1	0.1	0.1	0.1	9.6	0.0
TMEM176A	"HCA112, MS4B1"	ENSG00000002933	"Transmembrane protein 176A"	Q96HP8	7	150800403-150805118	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 381.3;liver: 1180.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 1043.9;Paneth cells: 779.4;Proximal enterocytes: 1294.5;Proximal tubular cells: 1103.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 210.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 146.5;intermediate monocyte: 98.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 146.5"	"Cell line enriched"	"Detected in some"	31	"HSkMC: 730.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008770	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008770: AB_2256120"	"unprognostic (4.70e-2)"	"unprognostic (7.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.91e-2)"	75.6	33.4	40.8	125.9	41.2	6.8	49.8	45.4	51.2	46.0	36.5	145.3	114.2	18.8	18.0	28.7	49.4	131.0	64.6	38.6	67.9	381.3	1180.2	59.0	86.3	58.6	47.1	36.2	105.5	30.0	3.9	11.7	67.2	51.3	26.7	152.7	20.8	24.4	16.1	6.4	19.6	204.7	50.7	60.0	51.4	49.1	6.1	47.5	15.6	21.5	17.6	66.5	98.9	54.9	61.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	3.5	14.2	0.2	0.6	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.3	730.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	23.3	0.0	0.0	2.7	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	146.5	12.6	0.3	98.4	0.4	2.1	0.1	0.2	30.9	0.0	0.2	0.0	1.8	0.3	46.0	2.4	0.4	53.3	40.8	41.2	45.4	51.2	38.6	67.9	58.6	47.1	36.2	51.3	60.0	47.5	61.1	15.8	0.0	5.2	3.9	9.8	7.4	0.4	0.9	5.2	56.2	40.6	63.8	24.9	118.7	10.9	200.5	4.2	0.6	2.0	348.5	152.6	64.6	0.3	4.9	14.8	20.5	74.1	6.6	0.0	27.2	0.6	185.3	17.9	2.5	29.0	29.9	23.2	1043.9	52.2	0.0	0.2	237.7	73.2	56.9	26.2	1.5	60.3	109.4	5.4	1.9	313.0	80.8	1.0	1.0	0.0	56.0	779.4	7.5	0.9	1.8	1294.5	1103.9	10.6	5.3	0.0	5.7	32.8	0.9	1.6	2.9	8.4	1.4	6.4	0.1	262.4	2.7
TMEM176B	"LR8, MS4B2"	ENSG00000106565	"Transmembrane protein 176B"	Q3YBM2	7	150791285-150801360	"Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 1670.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 1171.9;monocytes: 502.3;Paneth cells: 762.4;Proximal enterocytes: 922.5;Proximal tubular cells: 976.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 537.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 865.5;intermediate monocyte: 586.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 865.5"	"Group enriched"	"Detected in some"	17	"HSkMC: 642.7;THP-1: 215.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047509	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA047509: AB_2680072"	"unprognostic (5.21e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.05e-2)"	122.0	49.9	42.0	192.5	44.4	13.6	78.5	46.1	66.3	75.2	41.3	254.2	169.2	26.2	26.0	50.9	82.2	199.1	144.8	39.5	67.4	359.8	1670.0	96.4	179.0	63.3	51.2	37.3	144.3	54.1	7.4	22.9	116.0	56.7	49.3	247.2	34.4	42.8	28.6	11.1	32.1	289.0	100.0	63.5	87.8	95.3	11.2	51.3	26.3	33.9	36.4	94.5	160.1	93.2	65.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	25.7	0.4	0.8	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.6	0.8	0.2	642.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.1	0.9	0.5	0.1	0.0	0.1	1.0	11.8	0.1	0.0	1.9	1.4	0.6	0.3	0.2	0.2	0.0	215.7	0.0	0.0	3.2	0.5	0.2	0.4	0.2	0.6	0.0	0.3	0.0	5.3	865.5	50.5	2.3	586.0	3.4	2.5	0.6	0.7	164.3	0.6	0.7	0.4	8.6	0.6	309.3	7.7	0.6	498.5	42.0	44.4	46.1	66.3	39.5	67.4	63.3	51.2	37.3	56.7	63.5	51.3	65.5	22.2	3.2	9.3	14.4	16.9	12.6	0.5	0.9	5.7	156.9	52.2	74.0	73.7	190.1	14.4	375.2	2.1	0.9	2.8	419.4	166.3	95.1	18.5	6.1	14.5	19.8	128.1	13.5	0.1	34.0	1.0	243.7	14.8	2.1	54.4	61.9	22.9	1171.9	92.5	6.7	0.6	252.1	46.8	98.5	44.4	12.2	43.5	190.0	16.0	8.4	502.3	87.3	1.0	7.5	0.1	65.4	762.4	3.4	1.5	2.5	922.5	976.5	11.3	17.9	0.0	6.7	34.0	4.0	3.8	1.8	15.6	2.7	9.1	0.4	263.7	2.8
TMEM82		ENSG00000162460	"Transmembrane protein 82"	A0PJX8	1	15742499-15747982	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 24.6;kidney: 11.2;liver: 53.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 42.8;Hepatocytes: 49.3;Paneth cells: 60.2;Proximal enterocytes: 173.6;Proximal tubular cells: 53.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 10.2;renal cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"CACO-2: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA060282	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA060282: AB_2684241"	"unprognostic (2.46e-2)"		"unprognostic (7.96e-2)"	"unprognostic (4.88e-2)"			"unprognostic (1.40e-2)"	"unprognostic (6.45e-2)"		"unprognostic (6.90e-2)"	"unprognostic (4.80e-2)"		"prognostic favorable (3.80e-7)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	24.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	53.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	1.6	0.0	42.8	7.9	0.0	0.0	0.0	0.0	0.0	2.4	2.7	0.0	0.2	2.9	0.0	1.5	0.1	0.0	0.0	0.4	49.3	0.1	0.0	0.0	9.2	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	60.2	0.0	0.0	0.0	173.6	53.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	12.5	0.0
TMPRSS9		ENSG00000178297	"Transmembrane serine protease 9"	Q7Z410	19	2360238-2426239	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 4.2;lymphoid tissue: 2.4;testis: 3.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 23.4;Erythroid cells: 48.6;Granulosa cells: 22.1;Late spermatids: 59.9;Theca cells: 41.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.5;melanoma: 1.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.2;SK-BR-3: 1.2;U-266/70: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA051483	Uncertain					NA	NA					"HPA051483: AB_2681501"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.44e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.30e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.73e-2)"	0.1	0.7	0.8	0.1	0.6	0.8	0.4	0.8	1.4	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.9	0.2	0.0	4.2	0.0	0.1	0.8	0.4	0.2	0.2	0.7	0.0	0.1	0.0	1.7	0.1	0.0	0.1	0.2	0.0	0.6	0.5	0.1	0.0	0.2	2.4	0.1	3.7	0.5	0.2	0.0	0.0	0.0	0.1	0.0	1.6	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.9	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.2	0.0	0.3	0.0	0.1	0.2	0.0	0.3	0.4	0.0	0.3	0.0	0.1	0.0	0.1	0.1	1.2	0.0	0.1	0.1	0.7	0.1	0.3	0.3	0.3	0.3	2.2	0.5	0.4	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.6	0.8	1.4	0.9	0.2	0.8	0.4	0.2	1.7	0.2	0.5	1.6	0.2	0.0	0.0	1.3	0.3	0.0	0.1	0.0	0.0	0.7	0.2	0.9	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	23.4	0.2	0.5	0.1	0.0	48.6	2.4	0.0	0.1	0.5	0.0	0.9	0.0	22.1	0.7	4.8	0.2	0.0	2.1	0.0	0.0	0.0	0.3	59.9	0.9	0.4	0.0	0.0	0.1	0.1	0.0	2.5	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	11.0	3.5	0.0	0.0	0.5	0.1	41.0	0.0	0.0
TNFSF14	"CD258, HVEM-L, LIGHT, LTg"	ENSG00000125735	"TNF superfamily member 14"	O43557	19	6661253-6670588	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 108.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 26.3;dendritic cells: 40.5;granulocytes: 26.1;Macrophages: 20.0;NK-cells: 26.8;T-cells: 43.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 199.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 199.7;T-cells: 61.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 16.9;NB-4: 4.9;THP-1: 3.1;U-937: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA012700	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	41000		Vesicles		"HPA012700: AB_1852870"	"unprognostic (2.78e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (3.82e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (6.07e-13)"	"unprognostic (1.09e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.62e-2)"	14.5	1.7	2.2	3.2	1.5	1.9	2.7	0.8	5.9	1.9	2.7	2.6	1.8	0.9	0.3	1.8	9.8	1.2	2.9	1.0	8.9	1.3	108.8	4.9	2.6	1.4	1.3	0.6	5.2	4.5	0.0	1.1	0.2	1.7	2.0	1.3	0.2	2.3	0.2	0.5	0.6	6.0	1.2	1.0	3.2	2.3	0.6	2.7	1.1	2.8	0.6	2.0	4.1	2.3	5.1	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.5	0.0	0.0	0.0	16.9	0.0	0.0	0.2	1.1	0.0	0.5	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	10.4	0.0	140.9	17.6	115.3	41.8	4.0	61.2	0.4	17.7	34.5	6.9	1.9	2.8	15.0	199.7	30.7	0.5	0.7	15.9	12.8	2.2	1.5	0.8	5.9	1.0	8.9	1.4	1.3	0.6	1.7	1.0	2.7	5.1	0.7	9.6	26.3	0.0	1.6	2.9	0.7	0.9	0.0	0.0	1.1	0.8	0.8	15.7	8.2	0.0	0.0	0.1	40.5	0.0	0.0	4.1	1.2	4.8	2.6	0.9	0.0	0.4	0.1	3.8	0.2	12.4	1.1	18.1	26.1	0.2	1.8	15.8	12.8	0.0	0.1	0.2	0.0	3.4	12.3	0.0	0.3	20.0	3.6	1.0	5.8	0.0	26.8	0.0	0.1	6.0	0.0	0.0	4.8	0.6	0.0	0.4	2.8	0.0	0.0	1.4	1.0	0.2	0.3	0.3	3.3	0.0	43.7	0.0	0.0	0.4
TPPP2	"C14orf8, CT152, p18, p25beta"	ENSG00000179636	"Tubulin polymerization promoting protein family member 2"	P59282	14	21024109-21036276	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 256.8"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 9161.6"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004120	Enhanced					NA	NA					"HPA004120: AB_2303582"	"unprognostic (2.91e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.54e-1)"		"unprognostic (1.66e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (4.63e-4)"		"unprognostic (3.83e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.64e-4)"	"unprognostic (2.51e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.21e-1)"	0.1	0.4	0.7	0.1	0.7	0.0	0.5	0.7	1.1	0.2	1.0	0.1	0.1	0.2	3.5	0.0	0.2	0.3	0.6	0.7	0.7	0.9	13.4	0.1	0.0	0.8	0.7	0.4	0.8	0.2	0.2	0.1	0.1	0.7	0.4	0.3	0.3	1.4	0.2	3.2	0.1	0.3	0.0	0.8	0.1	0.1	256.8	0.7	0.0	0.1	4.8	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.7	1.1	0.7	0.7	0.8	0.7	0.4	0.7	0.8	0.7	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.1	1897.4	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9161.6	47.5	2.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	52.0	30.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1
TSPO2	"BZRPL1, dJ34B21.2"	ENSG00000112212	"Translocator protein 2"	Q5TGU0	6	41042467-41044337	"Predicted membrane proteins, Transporters"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	34	"bone marrow: 50.6"	"Cell type enriched"	"Detected in some"	115	"Erythroid cells: 253.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA060691, HPA066996"			Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA060691: , HPA066996: AB_2685761"	"unprognostic (1.89e-3)"	"unprognostic (8.35e-3)"	"unprognostic (2.57e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.76e-2)"	0.0	0.0	0.2	0.1	0.5	50.6	0.0	0.0	0.5	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.5	0.6	0.2	0.1	0.5	0.2	0.0	0.1	0.1	0.0	0.0	1.2	1.3	0.0	0.0	0.4	0.0	0.0	0.1	0.5	0.7	0.0	0.1	1.3	0.6	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.4	0.0	11.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	0.0	0.1	0.5	0.2	0.0	1.3	0.1	0.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.9	0.3	0.1	0.0	0.0	0.0	253.9	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0
TST	RDS	ENSG00000128311	"Thiosulfate sulfurtransferase"	Q16762	22	37010859-37020183	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 565.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 565.8;Hepatocytes: 414.9;Paneth cells: 463.4;Proximal enterocytes: 278.5;Proximal tubular cells: 254.5;Undifferentiated cells: 217.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 177.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 25.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 25.0;granulocytes: 21.8;monocytes: 17.7"	"Cell line enhanced"	"Detected in many"		"OE19: 264.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003044, HPA003643, CAB009546"	Enhanced		Supported	Mitochondria		NA	NA		560000	Mitochondria		"CAB009546: AB_2211220, HPA003044: AB_1858417, HPA003643: AB_1080411"	"unprognostic (3.09e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.96e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (7.59e-6)"	"unprognostic (6.08e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.04e-4)"	42.9	155.3	31.5	21.1	38.3	27.3	37.6	38.7	36.3	34.4	30.8	151.9	149.1	19.1	3.0	97.4	25.9	76.6	54.1	29.5	32.8	98.8	565.8	22.9	8.2	37.1	34.9	27.9	27.2	64.1	9.5	12.5	7.9	37.0	26.6	81.1	1.3	40.2	18.4	53.3	32.4	115.2	13.4	34.3	17.0	89.2	8.2	35.9	4.4	17.3	35.2	16.3	30.2	57.2	39.7	42.6	86.1	10.8	36.8	25.9	10.6	21.4	23.0	18.6	12.6	18.3	25.4	25.7	11.1	18.8	17.0	11.9	35.1	7.9	22.3	2.7	33.6	50.0	11.5	15.5	49.7	64.9	16.4	26.4	20.1	23.9	9.1	7.6	17.5	31.1	5.9	14.2	18.2	6.0	90.8	0.5	49.9	18.7	264.4	39.3	37.0	11.7	19.7	35.9	36.7	6.4	17.1	24.2	41.4	31.7	10.2	43.4	39.3	25.1	14.0	27.2	24.2	7.4	14.0	15.4	3.4	5.3	46.4	8.5	10.9	17.7	8.0	0.8	4.7	1.7	2.8	0.8	0.6	25.0	1.7	0.4	0.2	21.8	3.7	1.5	1.7	2.1	8.1	31.5	38.3	38.7	36.3	29.5	32.8	37.1	34.9	27.9	37.0	34.3	35.9	39.7	13.9	28.9	74.8	10.1	7.8	1.3	9.5	20.4	12.0	1.3	32.7	16.6	39.2	170.1	23.7	20.2	0.0	11.6	2.5	565.8	46.9	45.3	1.9	53.3	30.2	13.4	34.3	35.3	0.3	44.0	6.4	14.6	126.9	74.3	14.0	60.9	39.3	414.9	15.1	1.7	0.5	162.8	8.2	28.9	6.8	3.5	13.1	23.2	1.8	1.0	18.6	27.3	3.1	3.5	7.4	36.8	463.4	7.9	24.5	10.5	278.5	254.5	19.2	0.8	0.0	10.7	11.5	2.4	0.5	39.8	2.4	11.4	5.0	57.5	217.4	17.3
TUBA3C	"bA408E5.3, TUBA2"	ENSG00000198033	"Tubulin alpha 3c"	P0DPH7	13	19173772-19181824	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	714	"testis: 408.0"	"Group enriched"	"Detected in some"	25	"Early spermatids: 703.3;Late spermatids: 250.4;Spermatocytes: 947.8;Spermatogonia: 255.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 2.7;testis cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"HDLM-2: 107.5;U-2 OS: 256.9;U-266/70: 84.2;U-266/84: 109.7"									"HPA039247, HPA043684, HPA063394"	Uncertain		Supported	Microtubules		NA	Yes			Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (3.76e-3)"				"unprognostic (1.33e-1)"							"unprognostic (3.00e-1)"		"unprognostic (1.04e-1)"	"unprognostic (1.26e-1)"			0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	408.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	107.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.4	256.9	0.2	0.3	84.2	109.7	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	703.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	250.4	21.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.6	947.8	255.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559732	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 152.5"	"Group enriched"	"Detected in many"	7	"Ductal cells: 534.8;Exocrine glandular cells: 273.8;monocytes: 151.9;Pancreatic endocrine cells: 510.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"Hep G2: 63.9;RT4: 52.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"	3.2	0.4	0.3	35.9	0.4	0.0	8.7	0.3	0.7	1.4	0.4	13.4	4.2	1.9	1.2	8.3	4.8	0.9	0.6	0.3	0.7	22.9	25.7	11.0	88.2	0.4	0.3	0.3	1.2	27.5	1.7	1.4	0.0	0.3	12.0	19.2	0.0	14.7	1.3	0.4	1.8	31.3	1.2	0.3	23.1	27.3	0.8	0.3	91.0	3.0	0.1	152.5	26.1	1.7	0.3	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	63.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	52.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.9	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.7	0.3	0.7	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.2	3.2	3.1	0.0	0.7	0.1	0.1	2.3	16.5	0.0	1.9	1.9	0.0	21.5	13.3	0.0	0.0	0.0	0.1	6.9	1.9	534.8	0.0	0.3	0.2	7.1	3.6	0.0	0.0	273.8	0.0	2.2	13.3	0.2	0.0	0.0	0.7	0.3	0.1	0.0	0.0	5.2	6.1	0.3	0.0	0.0	0.0	1.2	0.0	0.0	151.9	0.0	0.0	0.0	0.0	510.6	8.3	0.0	0.0	0.5	49.1	1.1	9.7	0.0	0.0	0.0	3.4	0.0	0.0	2.2	0.0	0.0	0.2	0.0	11.1	0.1
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	P0DTE4	4	69588417-69653249	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 2.9;kidney: 2.2;liver: 3.7;pituitary gland: 5.6"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 107.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7;lung cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA017261, HPA045108"	Uncertain					NA	NA					"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	3.7	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
UNC93A	"dJ366N23.1, dJ366N23.2"	ENSG00000112494	"Unc-93 homolog A"	Q86WB7	6	167271169-167316014	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"esophagus: 5.1;intestine: 9.7;liver: 14.2;skin 1: 17.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 11.0;Endometrial ciliated cells: 2.5;Erythroid cells: 2.7;Hepatocytes: 6.9;Intestinal goblet cells: 2.4;Proximal enterocytes: 3.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 7.4;Hep G2: 3.1;OE19: 7.5;SCLC-21H: 3.1"					"Not detected"	"Not detected"			HPA035729	Uncertain					NA	NA					"HPA035729: AB_10696508"		"unprognostic (2.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.32e-1)"		"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.99e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.92e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.2	9.7	0.2	0.5	5.1	1.1	0.9	0.0	0.0	0.0	1.1	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	17.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.4	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	6.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0
VEGFD	"FIGF, VEGF-D"	ENSG00000165197	"Vascular endothelial growth factor D"	O43915	X	15345596-15384413	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.0"	"Cell type enriched"	"Detected in some"	12	"Fibroblasts: 39.8"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;ASC TERT1: 2.8;EFO-21: 1.3;HSkMC: 2.8"	"Group enriched"	"Detected in many"	4	"amygdala: 2.1;cerebral cortex: 3.5;hippocampal formation: 3.3;white matter: 2.6"	"Not detected"	"Not detected"			HPA027342	Uncertain				"Secreted to blood"	NA	NA	592000	450000			"HPA027342: AB_1848597"	"unprognostic (5.90e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-5)"	"unprognostic (3.08e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.75e-2)"	11.5	10.0	1.8	0.8	1.8	0.0	20.5	1.6	2.3	14.2	1.5	4.4	1.2	3.8	5.0	2.7	4.2	2.8	9.2	1.7	2.0	1.7	1.6	43.0	0.4	1.8	1.8	1.7	4.5	0.8	2.7	7.0	0.2	2.1	1.5	2.0	0.4	2.3	1.9	17.7	1.1	4.3	3.4	1.5	2.9	5.9	0.6	2.0	0.3	1.5	23.2	1.3	6.1	8.2	2.2	0.0	0.6	0.5	0.9	3.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.3	2.8	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.0	0.3	0.6	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.2	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	1.6	2.3	1.7	2.0	1.8	1.8	1.7	2.1	1.5	2.0	2.2	3.1	3.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.3	1.6	0.0	0.0
VNN1	Tiff66	ENSG00000112299	"Vanin 1"	O95497	6	132680849-132714055	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"gallbladder: 90.0;intestine: 137.5;liver: 220.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 50.1;Ductal cells: 244.2;Hepatocytes: 70.6;Pancreatic endocrine cells: 98.0;Proximal enterocytes: 61.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 41.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 13.7;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	80	"dendritic cells: 5.0;granulocytes: 8.5;monocytes: 13.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.5;CAPAN-2: 2.5;EFO-21: 8.7;HBEC3-KT: 2.3;LHCN-M2: 2.5"	"Region enhanced"	"Detected in single"		"white matter: 2.4"	"Not detected"	"Not detected"			"HPA046103, HPA064145"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		980000000	Vesicles		"HPA046103: , HPA064145: AB_2685197"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (2.26e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-1)"	2.4	0.6	0.3	3.2	0.6	9.5	1.1	0.5	1.3	1.0	0.5	6.2	137.5	8.9	0.2	0.6	2.6	90.0	0.6	0.3	0.4	21.9	220.5	4.7	2.5	0.6	0.4	0.3	0.3	1.4	0.1	0.1	2.7	1.2	0.3	1.8	1.0	2.3	0.2	0.3	0.9	80.2	0.9	0.2	10.2	1.5	0.5	0.5	0.6	0.4	1.1	2.5	1.7	0.7	1.0	2.5	0.0	0.3	0.1	0.0	0.7	0.5	0.2	0.2	0.0	0.0	0.0	2.5	0.1	8.7	0.0	0.4	0.0	0.0	2.3	0.6	0.0	0.0	0.1	0.1	1.4	1.3	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	1.1	0.5	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.3	3.0	13.7	0.0	0.0	8.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.0	8.5	0.0	11.9	0.2	0.0	3.8	0.3	0.6	0.5	1.3	0.3	0.4	0.6	0.4	0.3	1.2	0.2	0.5	1.0	0.0	0.0	3.0	0.0	0.3	1.3	0.2	14.9	0.0	0.0	1.2	0.4	0.2	50.1	11.4	1.8	0.0	0.1	0.2	12.5	0.0	244.2	0.0	7.6	4.1	0.2	0.0	0.0	0.0	19.4	0.1	0.3	4.6	39.6	0.0	0.0	1.1	70.6	18.1	0.0	0.0	11.2	22.4	12.0	3.9	0.0	0.0	23.1	0.0	0.0	17.6	0.0	0.0	0.0	0.0	98.0	1.6	0.0	0.5	6.6	61.7	21.9	16.0	0.0	0.0	0.4	1.1	0.1	0.0	0.1	0.1	0.1	0.5	0.0	2.0	14.7
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738949-129769536	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 168.0;kidney: 157.4"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 475.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.3;intermediate monocyte: 1.4;MAIT T-cell: 1.2;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 2.0;non-classical monocyte: 2.8;T-reg: 1.4"	"Group enriched"	"Detected in many"	7	"monocytes: 2.8;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.2;ASC TERT1: 40.1;HSkMC: 21.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		13000000	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	6.9	0.9	0.2	3.7	0.1	0.2	3.0	0.1	0.1	3.7	0.1	4.9	99.9	2.5	0.1	2.2	6.3	4.4	3.3	0.1	0.1	157.4	23.2	2.1	0.5	0.2	0.1	0.1	1.8	0.3	0.3	0.1	1.2	0.1	1.8	6.4	0.0	1.5	0.4	0.5	3.9	168.0	6.0	0.1	0.3	3.4	0.1	0.1	1.0	1.4	2.4	0.4	7.8	4.0	0.1	0.0	0.0	0.5	0.0	8.2	40.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.4	1.2	0.0	1.3	2.8	0.2	0.2	0.4	2.0	0.1	0.0	2.8	0.4	1.4	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.2	0.5	11.4	5.9	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.2	0.0	0.0	10.0	1.1	0.0	0.0	0.0	0.4	18.5	0.8	0.0	0.3	12.8	0.0	1.0	3.6	0.0	0.0	1.0	1.8	1.0	0.0	0.0	3.1	0.0	0.1	0.0	21.0	0.0	0.1	0.0	475.9	75.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.0	1.2	0.9	0.0	8.4	0.0
